data_2m8h_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m8h _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.476 0.84 0 CA-C-O 121.073 0.463 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.7 tp -92.33 129.0 38.38 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.478 1.511 . . . . 0.0 110.513 -176.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -83.23 130.58 35.09 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.235 0.54 . . . . 0.0 110.001 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.1 t -122.9 129.37 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 120.783 -1.198 . . . . 0.0 108.539 172.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.3 -175.8 14.19 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.314 1.911 . . . . 0.0 111.086 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.8 t30 66.67 19.49 10.78 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.207 2.203 . . . . 0.0 113.458 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.1 145.76 54.98 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 125.411 1.484 . . . . 0.0 111.083 -168.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.458 ' CD ' ' HB2' ' A' ' 83' ' ' TYR . 10.6 mt-10 -60.87 161.65 7.88 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 177.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -73.42 -32.15 64.25 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.563 1.145 . . . . 0.0 113.168 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? -100.14 15.9 25.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.975 2.11 . . . . 0.0 113.417 172.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.0 p -62.54 156.18 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.0 p -156.03 161.57 40.43 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.508 2.323 . . . . 0.0 110.953 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -55.79 -31.76 62.91 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.535 1.534 . . . . 0.0 111.797 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.45 -35.78 79.88 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.177 1.391 . . . . 0.0 113.157 175.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.3 tp -72.31 -39.23 68.38 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 122.616 1.198 . . . . 0.0 108.598 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 89.4 mt -65.15 -54.66 26.36 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.412 1.085 . . . . 0.0 112.644 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -56.33 -37.18 69.61 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.193 1.36 . . . . 0.0 110.189 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -73.9 -37.11 64.78 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tt -67.5 -43.7 80.25 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.337 1.426 . . . . 0.0 111.156 172.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -82.96 -9.81 59.1 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -46.83 -37.42 8.69 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.35 1.86 . . . . 0.0 112.701 164.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -73.0 -30.6 63.91 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.173 1.389 . . . . 0.0 110.908 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HA ' HD11 ' A' ' 76' ' ' LEU . . . -85.08 -2.99 58.63 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -166.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.59 -167.05 12.21 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 126.754 2.121 . . . . 0.0 111.375 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -48.77 121.02 5.95 Favored 'Trans proline' 0 C--N 1.346 0.426 1 C-N-CA 126.484 4.789 . . . . 0.0 112.242 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.23 136.02 54.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 173.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.7 -46.92 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 123.558 0.743 . . . . 0.0 109.26 -172.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.84 158.91 36.06 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.059 2.544 . . . . 0.0 110.46 171.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.5 t -105.91 162.4 5.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 126.208 1.803 . . . . 0.0 110.742 171.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -136.72 121.32 18.39 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.337 1.855 . . . . 0.0 114.37 169.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.2 mm -107.29 120.41 47.81 Favored Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 126.267 1.827 . . . . 0.0 110.556 166.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -75.44 167.98 25.47 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 125.032 3.821 . . . . 0.0 113.036 165.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -160.91 105.12 1.35 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.307 1.843 . . . . 0.0 113.205 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -53.1 173.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 130.435 3.494 . . . . 0.0 114.31 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.58 -24.47 8.32 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 168.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -91.43 -0.43 57.63 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.458 1.503 . . . . 0.0 114.852 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.0 41.5 54.55 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.361 1.458 . . . . 0.0 113.459 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -116.25 136.99 23.15 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 124.753 1.221 . . . . 0.0 112.92 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -70.82 17.05 0.26 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.115 2.543 . . . . 0.0 115.644 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.19 20.61 3.49 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 120.627 -1.296 . . . . 0.0 113.899 175.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 62.28 33.83 16.31 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.356 1.862 . . . . 0.0 114.496 -172.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -153.79 165.13 36.98 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.318 -1.489 . . . . 0.0 110.447 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -159.14 178.38 10.09 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.007 2.123 . . . . 0.0 110.589 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -135.52 156.15 49.35 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.574 -1.329 . . . . 0.0 111.312 168.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.71 132.13 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.7 1.2 . . . . 0.0 109.57 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 CA--C 1.542 0.654 0 O-C-N 120.254 -1.529 . . . . 0.0 110.006 176.712 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo . . . . . 0 CA--C 1.52 -0.191 0 N-CA-C 108.441 -1.407 . . . . 0.0 108.441 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -60.63 -34.26 73.99 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -168.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.39 -34.57 64.47 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 117.148 -1.406 . . . . 0.0 114.166 173.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -59.68 -21.79 61.05 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 120.613 1.551 . . . . 0.0 112.563 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -104.38 -40.42 6.09 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 127.359 2.264 . . . . 0.0 113.093 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.4 HD11 ' HA ' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -66.93 -61.65 1.84 Allowed 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 123.527 0.731 . . . . 0.0 112.669 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.14 -85.13 0.2 Allowed 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.5 1.12 . . . . 0.0 108.565 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 26.81 76.85 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 125.66 1.584 . . . . 0.0 114.322 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 125.45 18.02 2.55 Favored Glycine 0 CA--C 1.549 2.166 0 N-CA-C 117.555 1.782 . . . . 0.0 117.555 177.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -129.13 156.44 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 127.848 2.459 . . . . 0.0 111.583 -171.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.416 ' HB2' ' OE2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -176.73 -176.8 0.74 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.095 0.958 . . . . 0.0 112.442 -170.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.3 mt -141.16 -11.69 0.95 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.425 1.89 . . . . 0.0 115.885 -177.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.458 ' HB2' ' CD ' ' A' ' 25' ' ' GLU . 19.8 m-85 -109.77 -48.38 3.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.65 2.38 . . . . 0.0 111.802 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 179.06 -39.23 0.08 OUTLIER Glycine 0 CA--C 1.542 1.74 0 C-N-CA 125.955 1.74 . . . . 0.0 114.411 171.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -98.91 113.6 64.69 Favored Pre-proline 0 N--CA 1.483 1.219 0 CA-C-N 121.379 2.59 . . . . 0.0 112.247 -168.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.25 134.17 47.42 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.801 2.334 . . . . 0.0 111.753 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.0 mm -63.04 127.27 22.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 O-C-N 121.457 -0.777 . . . . 0.0 109.523 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -109.83 110.52 21.53 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 124.989 1.315 . . . . 0.0 110.02 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -86.33 136.74 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 120.324 -1.485 . . . . 0.0 109.668 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 . . . . . 0 CA--C 1.537 0.462 0 C-N-CA 125.355 1.462 . . . . 0.0 111.632 178.099 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 122.214 1.007 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.3 tp -131.28 131.01 43.54 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.797 2.439 . . . . 0.0 109.71 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -80.25 138.77 36.85 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.842 1.656 . . . . 0.0 112.226 167.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.48 128.58 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.834 1.253 . . . . 0.0 108.558 173.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.83 -170.84 13.62 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.556 1.55 . . . . 0.0 111.92 168.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.0 t30 66.44 19.37 10.93 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.92 2.088 . . . . 0.0 113.649 -175.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.35 135.69 57.16 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 125.358 1.463 . . . . 0.0 112.02 -174.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.495 ' CD ' ' HB2' ' A' ' 83' ' ' TYR . 2.0 mt-10 -55.88 152.98 9.15 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 174.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.0 p -68.24 -14.46 63.0 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.532 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -112.0 11.01 20.53 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.998 2.119 . . . . 0.0 111.566 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 p -66.76 159.72 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 119.919 -1.738 . . . . 0.0 114.764 -172.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.4 p -155.38 170.59 21.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.255 1.422 . . . . 0.0 111.32 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -63.87 -28.29 69.74 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.501 -0.749 . . . . 0.0 110.611 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -64.81 -48.32 74.84 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.906 0.883 . . . . 0.0 109.699 174.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.8 tp -65.19 -38.03 89.18 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.209 0.459 . . . . 0.0 111.593 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.0 mt -67.72 -48.57 66.14 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.428 -1.42 . . . . 0.0 111.864 175.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -62.07 -44.9 95.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.722 -1.237 . . . . 0.0 113.0 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -68.73 -25.05 64.56 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.783 0.433 . . . . 0.0 111.162 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.0 tt -78.72 -46.57 18.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.838 1.255 . . . . 0.0 108.272 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -74.89 -5.81 45.69 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.784 -1.197 . . . . 0.0 113.274 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -58.8 -32.0 68.94 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.935 1.698 . . . . 0.0 111.277 171.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -72.35 -31.0 65.25 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.292 1.437 . . . . 0.0 111.426 176.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.03 3.29 39.33 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -171.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.77 -156.16 15.74 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.936 1.731 . . . . 0.0 114.885 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -85.05 90.75 0.76 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.148 1.899 . . . . 0.0 112.135 -167.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.68 134.65 29.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 112.709 -2.041 . . . . 0.0 106.993 168.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.1 mt -83.71 -63.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 165.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.4 ' HG2' ' HB3' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -155.18 147.13 23.49 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.878 1.271 . . . . 0.0 113.011 -164.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.5 t -108.77 145.14 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.312 2.245 . . . . 0.0 112.969 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -122.0 124.19 43.42 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 126.24 1.816 . . . . 0.0 113.01 170.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.5 mm -107.42 121.5 44.21 Favored Pre-proline 0 C--O 1.243 0.719 0 C-N-CA 125.952 1.701 . . . . 0.0 108.509 163.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.2 162.25 42.22 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.269 2.646 . . . . 0.0 109.718 165.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -147.36 116.09 6.76 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.143 1.777 . . . . 0.0 107.632 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -54.48 171.99 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.568 2.347 . . . . 0.0 109.665 165.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.16 -34.17 55.71 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.952 0.901 . . . . 0.0 112.938 172.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -75.4 -9.31 58.45 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 128.123 2.569 . . . . 0.0 113.889 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.32 38.72 12.19 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.555 1.55 . . . . 0.0 111.4 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -125.47 135.27 26.7 Favored Pre-proline 0 N--CA 1.473 0.707 0 O-C-N 121.613 -0.933 . . . . 0.0 112.052 -172.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.76 12.65 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.928 3.085 . . . . 0.0 116.782 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.485 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 61.0 25.11 15.17 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 173.323 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.25 6.0 mt-30 56.43 30.47 17.07 Favored 'General case' 0 CA--C 1.573 1.854 0 O-C-N 120.922 -1.111 . . . . 0.0 113.306 -171.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.485 ' CD2' ' HB2' ' A' ' 57' ' ' LYS . 3.6 p90 -150.08 155.42 39.83 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 128.24 2.616 . . . . 0.0 115.264 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -155.88 175.08 14.41 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 127.64 2.376 . . . . 0.0 112.552 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -140.08 141.8 36.15 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 120.568 -1.333 . . . . 0.0 114.503 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.9 t -131.33 130.02 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 120.555 -1.341 . . . . 0.0 111.116 -172.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.4 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 4.6 t-20 . . . . . 0 CA--C 1.545 0.782 0 C-N-CA 125.944 1.698 . . . . 0.0 112.776 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo . . . . . 0 CA--C 1.536 0.615 0 CA-C-O 121.11 0.379 . . . . 0.0 112.795 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -56.55 -42.41 78.47 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.118 -0.989 . . . . 0.0 111.474 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.84 -35.38 66.36 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.9 ttp -59.07 -8.63 1.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 126.89 2.076 . . . . 0.0 115.998 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -114.86 -32.54 5.75 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.491 1.517 . . . . 0.0 110.617 165.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.26 -56.85 5.2 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -98.29 -92.39 0.25 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.853 1.661 . . . . 0.0 110.115 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 32.89 69.92 0.11 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.27 1.428 . . . . 0.0 112.002 175.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.5 19.42 1.07 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 121.297 -0.877 . . . . 0.0 114.12 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -131.74 157.85 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.64 0.776 . . . . 0.0 109.36 -176.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.81 -179.25 7.42 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.5 tp -107.83 -47.44 3.59 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.849 1.26 . . . . 0.0 110.586 167.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.495 ' HB2' ' CD ' ' A' ' 25' ' ' GLU . 78.4 m-85 -95.09 -42.27 8.69 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.187 1.795 . . . . 0.0 113.9 -162.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.99 -23.46 0.32 Allowed Glycine 0 CA--C 1.55 2.276 0 C-N-CA 126.436 1.97 . . . . 0.0 116.766 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -103.7 109.35 61.93 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-N 121.991 2.895 . . . . 0.0 112.524 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.27 125.77 12.82 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.323 2.016 . . . . 0.0 114.615 -173.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.9 mm -54.07 124.61 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 124.795 1.238 . . . . 0.0 109.988 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -114.68 110.23 19.44 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.596 1.189 . . . . 0.0 111.178 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -83.73 148.03 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.792 174.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 . . . . . 0 CA--C 1.545 0.77 0 C-N-CA 125.075 1.35 . . . . 0.0 113.31 168.871 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.474 0.75 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.9 tp -83.08 128.19 34.26 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.414 2.285 . . . . 0.0 108.705 -169.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -77.45 138.77 39.44 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.123 0.963 . . . . 0.0 110.936 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.0 t -134.15 124.05 45.18 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 59' ' ' PHE . . . -124.71 -171.33 13.33 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 173.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.5 t30 60.92 41.47 14.24 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 123.089 1.423 . . . . 0.0 111.588 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.429 ' HB3' HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -86.94 148.65 25.24 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.698 1.599 . . . . 0.0 110.779 178.532 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 162.85 26.84 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 125.656 2.646 . . . . 0.0 116.89 170.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.6 p -69.45 -29.01 66.61 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 127.879 2.471 . . . . 0.0 109.445 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.591 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 8.5 mmpt? -103.42 15.93 27.8 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 128.129 2.571 . . . . 0.0 114.163 176.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.429 HG11 ' HB3' ' A' ' 24' ' ' LEU . 3.9 p -71.0 157.27 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 120.841 -1.162 . . . . 0.0 112.04 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.2 p -156.56 166.76 32.46 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.51 1.124 . . . . 0.0 110.546 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -60.75 -27.9 68.29 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.321 -0.862 . . . . 0.0 109.957 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -61.01 -35.1 75.95 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.065 2.546 . . . . 0.0 112.536 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.0 tp -79.52 -39.94 30.77 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.703 0.763 . . . . 0.0 110.732 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.413 ' HB2' HG12 ' A' ' 46' ' ' VAL . 82.3 mt -65.39 -45.9 82.19 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.187 -0.945 . . . . 0.0 112.917 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -58.65 -34.13 70.86 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.294 1.038 . . . . 0.0 112.036 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -88.6 -28.23 20.82 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.25 0.62 . . . . 0.0 112.5 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.19 -41.17 74.07 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.356 -0.84 . . . . 0.0 111.176 176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -81.54 21.42 0.8 Allowed 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 120.376 1.444 . . . . 0.0 112.773 -173.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.06 -9.07 59.44 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 117.576 2.436 . . . . 0.0 117.576 -156.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -116.55 7.2 13.62 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 125.581 1.552 . . . . 0.0 113.163 163.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.6 31.4 0.76 Allowed 'General case' 0 CA--C 1.55 0.956 0 O-C-N 119.871 -1.768 . . . . 0.0 115.041 -167.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.97 136.19 3.53 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 107.545 -2.222 . . . . 0.0 107.545 -163.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.68 101.55 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.715 1 C-N-CA 125.307 4.005 . . . . 0.0 114.187 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.53 133.17 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.535 1.134 . . . . 0.0 110.118 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.1 mt -87.33 -47.86 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.174 1.39 . . . . 0.0 108.948 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.33 161.77 16.79 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 126.929 2.092 . . . . 0.0 111.104 -173.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.413 HG12 ' HB2' ' A' ' 33' ' ' LEU . 91.3 t -116.53 149.24 18.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 127.663 2.385 . . . . 0.0 111.808 173.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -120.66 122.77 41.2 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.693 1.197 . . . . 0.0 113.741 166.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.6 mm -101.24 121.47 51.73 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 124.073 0.949 . . . . 0.0 110.208 165.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -66.77 165.98 23.92 Favored 'Trans proline' 0 CA--C 1.55 1.291 1 C-N-CA 125.341 4.028 . . . . 0.0 110.12 164.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -156.35 112.25 3.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.198 1.799 . . . . 0.0 109.893 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.437 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 35.2 t70 -57.25 172.64 0.29 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.267 2.227 . . . . 0.0 113.149 174.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.51 -37.76 5.66 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.594 -0.691 . . . . 0.0 112.752 171.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -76.72 -13.41 60.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.444 2.698 . . . . 0.0 116.28 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.32 30.79 11.54 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.981 2.229 . . . . 0.0 114.818 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.32 141.22 31.46 Favored Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 119.801 1.801 . . . . 0.0 114.28 -174.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.04 8.07 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.599 2.866 . . . . 0.0 116.401 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.437 ' HE2' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER 56.13 32.79 20.78 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 120.418 -1.426 . . . . 0.0 112.716 177.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.609 ' NE2' HH11 ' A' ' 85' ' ' ARG . 20.5 mt-30 56.93 30.32 17.83 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -176.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.412 ' HA ' ' HA2' ' A' ' 22' ' ' GLY . 2.0 p90 -151.29 165.01 35.31 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.009 -1.682 . . . . 0.0 111.097 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -155.46 -175.3 5.36 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 127.333 2.253 . . . . 0.0 111.254 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -138.08 160.7 38.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.738 1.615 . . . . 0.0 112.444 170.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.6 t -147.16 127.77 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 122.344 1.068 . . . . 0.0 113.726 -175.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 . . . . . 0 C--N 1.325 -0.471 0 C-N-CA 124.46 1.104 . . . . 0.0 109.582 171.022 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 CA--C 1.541 0.831 0 N-CA-C 109.835 -0.871 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -58.15 -42.59 86.24 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.133 -0.98 . . . . 0.0 112.921 -170.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.15 -29.79 70.59 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.939 -1.029 . . . . 0.0 113.767 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.5 ttp -58.36 -20.47 43.92 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.701 1.137 . . . . 0.0 112.289 176.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -103.34 -35.63 8.33 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 170.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.29 -34.18 72.45 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 120.003 1.274 . . . . 0.0 114.221 -175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.0 mt -120.64 -92.75 0.53 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 128.727 2.811 . . . . 0.0 110.406 -170.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.5 t30 26.24 74.75 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 128.496 2.719 . . . . 0.0 115.449 175.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 135.48 16.97 0.88 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-N 113.775 -1.557 . . . . 0.0 112.87 -176.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -132.84 152.24 35.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 118.557 1.178 . . . . 0.0 111.827 -169.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.31 -173.23 1.21 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.976 2.51 . . . . 0.0 110.507 -167.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.5 tp -143.33 -39.05 0.32 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.392 1.477 . . . . 0.0 108.767 160.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -55.13 -57.13 13.0 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.224 1.01 . . . . 0.0 112.034 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.64 -46.54 0.23 Allowed Glycine 0 N--CA 1.48 1.62 0 N-CA-C 117.58 1.792 . . . . 0.0 117.58 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.609 HH11 ' NE2' ' A' ' 58' ' ' GLN . 3.3 mpt_? -95.13 117.61 66.72 Favored Pre-proline 0 C--O 1.238 0.467 0 CA-C-N 118.272 1.036 . . . . 0.0 108.244 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -71.06 128.75 15.24 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.849 1.699 . . . . 0.0 112.47 -174.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.1 mm -53.13 126.93 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 C-N-CA 123.481 0.712 . . . . 0.0 109.667 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -117.8 115.82 25.76 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.491 1.516 . . . . 0.0 110.058 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -87.49 141.05 14.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 . . . . . 0 C--N 1.328 -0.359 0 C-N-CA 124.163 0.985 . . . . 0.0 109.946 172.051 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.1 m . . . . . 0 C--O 1.234 0.272 0 CA-C-O 121.688 0.756 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.7 mp -108.47 129.62 55.27 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.258 2.223 . . . . 0.0 108.276 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -79.46 139.93 37.49 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.625 0.77 . . . . 0.0 109.341 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.3 t -130.6 133.07 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 172.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.85 -177.55 14.92 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.742 1.163 . . . . 0.0 110.625 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.5 t30 75.17 19.34 2.29 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.646 1.579 . . . . 0.0 112.815 -176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.17 147.66 53.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.436 -168.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.61 157.36 32.63 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 125.953 2.787 . . . . 0.0 113.277 173.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 p -66.39 -18.51 65.4 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 129.424 3.09 . . . . 0.0 112.548 -174.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -128.23 19.67 6.38 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 131.454 3.902 . . . . 0.0 112.208 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.8 p -60.53 151.59 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 O-C-N 120.931 -1.106 . . . . 0.0 112.216 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.4 p -152.24 168.99 23.57 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.542 1.537 . . . . 0.0 110.635 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -66.94 -29.03 68.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.115 0.966 . . . . 0.0 109.637 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -56.93 -47.54 80.37 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.6 tp -70.72 -43.59 68.61 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.864 1.265 . . . . 0.0 113.142 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.92 -41.96 95.12 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.238 -0.914 . . . . 0.0 112.022 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -61.16 -47.34 86.65 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 118.744 0.702 . . . . 0.0 111.292 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -64.96 -33.9 77.15 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 119.683 1.129 . . . . 0.0 112.301 176.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.1 tt -72.68 -39.93 66.69 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.814 1.245 . . . . 0.0 113.223 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -94.71 -19.77 20.11 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 -175.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -49.18 -36.69 20.34 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.05 1.74 . . . . 0.0 112.922 167.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -73.5 -15.79 61.31 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 174.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.63 -4.81 47.05 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.758 0.823 . . . . 0.0 112.668 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 138.3 -157.34 24.42 Favored Glycine 0 CA--C 1.545 1.94 0 C-N-CA 126.501 2.0 . . . . 0.0 113.966 168.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.01 93.32 0.96 Allowed 'Trans proline' 0 CA--C 1.551 1.334 0 C-N-CA 123.358 2.706 . . . . 0.0 113.452 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.1 m -81.65 137.61 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 122.712 1.244 . . . . 0.0 110.857 171.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.9 mm -99.16 -51.02 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 125.645 1.578 . . . . 0.0 111.749 -171.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.01 158.11 41.54 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.446 1.099 . . . . 0.0 108.494 176.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.5 t -124.06 147.85 28.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 125.668 1.587 . . . . 0.0 110.07 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -132.02 119.82 21.56 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 125.004 1.321 . . . . 0.0 112.851 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 mm -103.57 124.01 39.44 Favored Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 126.452 1.901 . . . . 0.0 107.719 165.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.99 170.38 19.06 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.788 2.326 . . . . 0.0 111.842 162.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -158.17 114.73 2.82 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 127.065 2.146 . . . . 0.0 111.347 172.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -58.68 169.66 0.92 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.014 -1.903 . . . . 0.0 109.868 170.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -32.47 69.62 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 120.961 -1.087 . . . . 0.0 113.573 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -64.81 -25.69 68.02 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.34 2.256 . . . . 0.0 113.017 171.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.78 39.37 2.54 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.093 1.33 . . . . 0.0 112.845 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 tppt? -133.58 130.64 20.96 Favored Pre-proline 0 C--N 1.35 0.619 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 -170.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.53 15.81 0.11 Allowed 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 125.136 3.89 . . . . 0.0 115.449 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.87 28.27 10.21 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 119.633 -1.917 . . . . 0.0 114.07 169.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 56.29 33.81 22.92 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.745 1.618 . . . . 0.0 115.137 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -153.42 161.83 41.89 Favored 'General case' 0 CA--C 1.555 1.146 0 O-C-N 120.75 -1.219 . . . . 0.0 112.927 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -158.88 173.45 16.49 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 126.665 1.986 . . . . 0.0 113.19 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -127.08 155.68 42.91 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.287 2.235 . . . . 0.0 112.056 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.7 t -148.71 122.37 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.333 1.453 . . . . 0.0 109.144 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 . . . . . 0 CA--C 1.548 0.903 0 C-N-CA 124.718 1.207 . . . . 0.0 110.997 -178.763 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo . . . . . 0 CA--C 1.55 1.3 0 CA-C-O 121.596 0.582 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -51.63 -46.76 63.78 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 128.493 2.717 . . . . 0.0 114.019 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.44 -21.78 60.53 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.4 ttt -67.79 -26.46 66.1 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.95 0.795 . . . . 0.0 111.297 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -81.7 -35.27 30.01 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.521 -0.737 . . . . 0.0 111.908 167.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.2 tp -81.28 -53.43 6.35 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -163.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -97.13 -83.6 0.39 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 125.611 1.564 . . . . 0.0 110.479 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 24.19 66.41 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 128.422 2.689 . . . . 0.0 116.243 173.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.04 20.26 0.94 Allowed Glycine 0 CA--C 1.538 1.492 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.908 -173.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.59 152.02 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-N 118.721 1.26 . . . . 0.0 112.576 -171.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.6 172.89 4.85 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.337 2.255 . . . . 0.0 110.185 -176.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.27 -45.0 2.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.314 1.446 . . . . 0.0 110.236 166.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -61.39 -51.57 68.22 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.569 1.148 . . . . 0.0 113.679 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.6 -63.29 0.18 Allowed Glycine 0 N--CA 1.477 1.423 0 N-CA-C 117.222 1.649 . . . . 0.0 117.222 -168.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -88.2 123.96 67.53 Favored Pre-proline 0 N--CA 1.478 0.929 0 CA-C-N 119.75 1.775 . . . . 0.0 110.642 -175.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -76.23 134.22 15.61 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.054 2.503 . . . . 0.0 115.734 -174.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.1 mm -64.06 123.06 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.647 0.737 . . . . 0.0 109.912 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -110.06 117.2 33.12 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 113.779 -1.555 . . . . 0.0 108.923 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 mp -78.78 149.32 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 172.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 . . . . . 0 N--CA 1.471 0.607 0 C-N-CA 126.605 1.962 . . . . 0.0 110.146 176.98 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.1 m . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 122.208 1.004 . . . . 0.0 108.871 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.8 tp -113.53 130.0 56.44 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.325 1.45 . . . . 0.0 110.436 -160.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -78.09 138.58 38.83 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.1 t -138.21 123.79 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 121.026 -1.047 . . . . 0.0 110.038 174.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.84 -170.34 15.05 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.616 2.055 . . . . 0.0 111.35 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.1 t30 58.23 35.8 25.25 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.446 1.499 . . . . 0.0 112.293 -176.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 58' ' ' GLN . 0.4 OUTLIER -68.13 163.19 23.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.364 1.078 . . . . 0.0 110.236 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.34 170.27 12.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.087 171.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.5 p -83.48 -14.17 53.02 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.971 2.108 . . . . 0.0 113.646 -175.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 8.8 mmpt? -111.96 17.03 20.05 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 128.261 2.624 . . . . 0.0 112.33 177.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.7 p -72.18 153.03 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -173.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.3 p -155.71 160.83 40.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.45 1.9 . . . . 0.0 111.753 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -58.45 -20.05 41.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.956 0.902 . . . . 0.0 113.157 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -76.19 -34.54 59.3 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.597 1.159 . . . . 0.0 113.455 174.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.26 -48.44 70.48 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.854 0.862 . . . . 0.0 109.789 168.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 87.6 mt -59.89 -43.83 94.57 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.98 0.912 . . . . 0.0 111.113 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -65.45 -43.94 88.81 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 119.503 1.047 . . . . 0.0 110.723 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -61.11 -33.3 73.15 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.006 1.323 . . . . 0.0 113.344 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 tt -82.55 -42.46 18.33 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.844 2.057 . . . . 0.0 113.564 174.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.407 ' CD2' HG22 ' A' ' 62' ' ' VAL . 69.7 m-85 -84.87 -12.45 53.48 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.365 -1.459 . . . . 0.0 113.776 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -54.36 -36.65 64.07 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 121.309 1.868 . . . . 0.0 112.393 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -83.94 -0.31 50.91 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 173.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.42 14.68 14.02 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.915 1.286 . . . . 0.0 112.375 169.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.35 -157.45 23.19 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.459 1.504 . . . . 0.0 112.593 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.4 77.31 4.14 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.314 2.676 . . . . 0.0 112.643 -163.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.43 142.82 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 122.263 1.03 . . . . 0.0 108.527 167.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.0 mm -86.67 -51.83 12.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 124.951 1.3 . . . . 0.0 109.2 175.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -165.21 165.68 19.49 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.288 1.835 . . . . 0.0 111.696 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.4 t -119.65 150.9 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 125.66 1.584 . . . . 0.0 112.11 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -115.93 125.31 52.39 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 127.19 2.196 . . . . 0.0 114.131 165.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.6 mm -101.4 126.46 34.42 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 127.532 2.333 . . . . 0.0 111.64 158.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.74 172.2 16.13 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 125.294 3.996 . . . . 0.0 112.358 163.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -161.06 122.61 2.96 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.755 2.022 . . . . 0.0 111.427 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.44 166.9 2.82 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.254 2.222 . . . . 0.0 112.882 170.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.86 -44.46 29.28 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.769 0.828 . . . . 0.0 111.257 166.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.43 -29.91 70.65 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.05 -1.031 . . . . 0.0 111.143 174.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.53 45.78 1.19 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.679 1.133 . . . . 0.0 114.782 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -129.64 141.11 40.7 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-N 119.924 1.862 . . . . 0.0 111.888 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.52 10.04 0.29 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.227 3.285 . . . . 0.0 117.285 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.39 25.15 13.82 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 173.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' A' ' 24' ' ' LEU 0.283 35.6 mt-30 63.77 30.49 14.6 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.055 2.542 . . . . 0.0 114.688 -172.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -153.14 168.91 24.37 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 126.045 1.738 . . . . 0.0 111.747 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.79 -174.06 2.62 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 130.51 3.524 . . . . 0.0 108.909 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -137.93 164.02 30.06 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 124.665 1.186 . . . . 0.0 112.287 169.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.407 HG22 ' CD2' ' A' ' 37' ' ' PHE . 34.7 t -139.98 139.19 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 125.577 1.551 . . . . 0.0 114.001 174.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 126.074 1.75 . . . . 0.0 114.989 -173.238 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--O 1.233 0.24 0 N-CA-C 110.996 -0.425 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -58.9 -44.05 91.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.03 0.919 . . . . 0.0 111.245 -165.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.69 -27.53 68.76 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.152 1.381 . . . . 0.0 113.682 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -62.72 -22.52 66.58 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.79 1.236 . . . . 0.0 111.782 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -95.91 -38.91 10.06 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 163.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.87 -49.63 19.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 120.654 1.57 . . . . 0.0 114.658 -165.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -98.31 -94.58 0.23 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.733 1.213 . . . . 0.0 109.133 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 21.84 79.35 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 128.115 2.566 . . . . 0.0 115.097 -169.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.82 26.33 1.58 Allowed Glycine 0 N--CA 1.476 1.33 0 C-N-CA 125.223 1.392 . . . . 0.0 113.984 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -128.07 144.66 37.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-N 117.874 0.837 . . . . 0.0 109.405 -171.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.98 177.45 10.34 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 177.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.5 tp -136.31 -44.35 0.62 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 130.834 3.654 . . . . 0.0 108.508 171.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -65.97 -52.72 47.11 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.351 1.86 . . . . 0.0 111.942 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 160.86 -38.71 0.43 Allowed Glycine 0 N--CA 1.477 1.375 0 N-CA-C 115.64 1.016 . . . . 0.0 115.64 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -100.3 115.93 64.95 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 125.728 1.611 . . . . 0.0 108.97 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.62 137.11 29.58 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.472 2.781 . . . . 0.0 113.204 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.7 mm -67.56 125.32 24.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 123.502 0.721 . . . . 0.0 111.106 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -113.79 107.21 15.42 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.432 1.893 . . . . 0.0 112.041 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.79 140.23 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.387 1.075 . . . . 0.0 111.316 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 . . . . . 0 CA--C 1.535 0.37 0 C-N-CA 127.53 2.332 . . . . 0.0 111.139 -179.805 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.514 -0.44 0 CA-C-O 122.388 1.089 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.5 tp -109.18 133.92 52.39 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.103 1.761 . . . . 0.0 114.47 -171.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -80.46 133.66 35.88 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.568 0.699 . . . . 0.0 110.602 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -128.62 127.85 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 169.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.27 -174.1 14.79 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.83 1.205 . . . . 0.0 112.236 170.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.7 t30 64.04 26.12 13.96 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.373 1.469 . . . . 0.0 114.739 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.87 164.96 5.77 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.519 1.528 . . . . 0.0 109.64 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.81 172.97 12.72 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.059 1.504 . . . . 0.0 115.059 176.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.2 p -71.76 -21.23 61.77 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.015 2.126 . . . . 0.0 110.381 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.04 30.6 5.62 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 127.431 2.292 . . . . 0.0 116.369 173.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.68 165.47 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 118.885 -2.385 . . . . 0.0 115.472 176.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.4 p -154.63 173.53 16.24 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.682 1.193 . . . . 0.0 112.743 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -73.29 -26.92 61.28 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.135 0.974 . . . . 0.0 110.195 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.72 -45.82 92.31 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 171.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.78 -47.22 75.87 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.825 0.85 . . . . 0.0 110.579 -174.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.89 -48.69 77.58 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.854 1.262 . . . . 0.0 111.112 173.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -59.35 -37.95 79.16 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.363 0.983 . . . . 0.0 112.26 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -75.45 -33.41 60.87 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.995 0.816 . . . . 0.0 110.345 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 tt -68.18 -39.82 82.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.113 1.765 . . . . 0.0 113.35 176.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -85.5 -1.2 56.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 117.9 -1.047 . . . . 0.0 113.694 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -60.32 -41.48 93.59 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.802 1.637 . . . . 0.0 110.904 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -75.25 -14.71 60.54 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 172.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.03 -24.41 47.83 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 120.709 1.595 . . . . 0.0 110.14 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 154.12 -172.58 32.75 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 128.639 3.018 . . . . 0.0 114.412 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.73 79.66 2.69 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 124.853 3.702 . . . . 0.0 110.403 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.6 m -52.7 141.2 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.842 1.257 . . . . 0.0 113.365 172.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 80.3 mt -79.69 -59.68 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 126.8 2.04 . . . . 0.0 107.818 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.36 168.47 25.94 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.337 1.455 . . . . 0.0 113.282 174.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.5 t -116.65 157.19 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 126.662 1.985 . . . . 0.0 112.631 171.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -134.93 123.56 23.59 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.616 1.966 . . . . 0.0 113.75 169.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.4 mm -100.16 124.74 42.21 Favored Pre-proline 0 C--N 1.324 -0.512 0 C-N-CA 126.681 1.993 . . . . 0.0 108.612 167.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -72.76 167.08 28.17 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.461 2.774 . . . . 0.0 111.583 161.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -158.77 114.83 2.66 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.857 2.463 . . . . 0.0 109.054 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.526 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 30.6 t70 -54.04 174.59 0.05 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.413 2.285 . . . . 0.0 112.545 170.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.68 -35.08 60.68 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.289 -1.507 . . . . 0.0 112.881 167.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -68.65 -13.76 62.57 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.944 2.498 . . . . 0.0 113.486 175.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.84 54.21 6.67 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -173.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -135.85 132.91 19.63 Favored Pre-proline 0 CA--C 1.517 -0.309 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.61 22.25 0.4 Allowed 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 124.276 3.318 . . . . 0.0 114.594 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.526 ' HE2' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER 51.47 26.95 3.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 119.727 -1.858 . . . . 0.0 115.612 168.175 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 52.02 35.11 15.3 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 127.185 2.194 . . . . 0.0 114.418 -170.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -150.8 157.91 43.51 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 120.001 -1.687 . . . . 0.0 112.224 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -153.91 174.86 14.06 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.247 1.819 . . . . 0.0 111.541 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -126.9 153.29 45.95 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 119.848 -1.783 . . . . 0.0 111.956 175.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 84.3 t -139.44 124.51 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.122 0.969 . . . . 0.0 112.692 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 . . . . . 0 CA--C 1.55 0.966 0 C-N-CA 126.347 1.859 . . . . 0.0 109.931 -177.067 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 CA--C 1.547 1.137 0 N-CA-C 108.383 -1.43 . . . . 0.0 108.383 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -57.22 -34.91 69.04 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.608 1.563 . . . . 0.0 113.689 -169.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.35 -27.78 62.57 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.116 -0.99 . . . . 0.0 112.789 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.1 ttp -77.42 -13.24 59.97 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.831 0.852 . . . . 0.0 112.184 -170.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -106.34 -25.29 11.99 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.271 1.429 . . . . 0.0 113.627 163.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.3 tp -78.04 -49.34 14.21 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.773 1.229 . . . . 0.0 112.474 -172.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -100.8 -106.99 0.23 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 42.24 70.69 0.26 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.996 2.118 . . . . 0.0 114.805 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.98 16.9 1.07 Allowed Glycine 0 CA--C 1.53 0.998 0 CA-C-N 115.594 -0.73 . . . . 0.0 114.281 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.86 151.64 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 118.37 1.085 . . . . 0.0 111.773 -167.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.95 175.12 9.79 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.437 1.495 . . . . 0.0 110.965 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 70.0 tp -119.28 -38.74 2.98 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.173 1.389 . . . . 0.0 112.072 161.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -79.04 -41.41 28.89 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.106 0.962 . . . . 0.0 113.509 -170.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.33 -44.18 0.29 Allowed Glycine 0 N--CA 1.473 1.108 0 N-CA-C 115.692 1.037 . . . . 0.0 115.692 173.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.54 124.98 55.58 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 124.339 1.056 . . . . 0.0 108.664 177.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -77.02 134.9 14.97 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 124.443 3.429 . . . . 0.0 115.012 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.1 mm -64.16 131.62 29.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 123.786 0.834 . . . . 0.0 110.736 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 tptm -121.01 112.01 18.19 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.252 1.821 . . . . 0.0 110.016 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.4 mp -88.28 140.73 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 . . . . . 0 N--CA 1.45 -0.46 0 CA-C-O 123.087 1.422 . . . . 0.0 109.041 -179.009 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 122.457 1.122 . . . . 0.0 108.836 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.22 132.75 39.85 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 125.216 1.407 . . . . 0.0 109.707 -175.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -81.04 129.92 34.77 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.929 0.871 . . . . 0.0 110.912 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.4 t -127.14 130.62 71.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.18 -173.56 13.31 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 122.61 1.117 . . . . 0.0 113.712 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.1 t30 62.8 36.14 13.29 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.877 1.671 . . . . 0.0 113.994 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.15 154.96 40.11 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.478 1.111 . . . . 0.0 109.763 -174.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.34 162.58 12.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 123.752 1.739 . . . . 0.0 113.626 170.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.6 p -73.94 -7.54 52.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.152 2.181 . . . . 0.0 110.908 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -133.68 18.5 3.89 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.295 2.238 . . . . 0.0 114.279 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.42 161.03 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 O-C-N 120.837 -1.164 . . . . 0.0 113.594 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 p -158.18 161.43 37.85 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.262 1.825 . . . . 0.0 108.835 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -66.03 -25.52 67.09 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.806 1.643 . . . . 0.0 111.444 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -66.23 -35.86 81.52 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.592 1.157 . . . . 0.0 113.955 170.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.404 HD11 ' CE1' ' A' ' 83' ' ' TYR . 41.6 tp -77.3 -40.63 43.67 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.232 0.924 . . . . 0.0 110.388 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.77 -46.65 87.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.397 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -60.15 -46.88 88.18 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.765 1.166 . . . . 0.0 111.844 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.04 -31.48 72.73 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.16 0.891 . . . . 0.0 111.919 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 tt -75.07 -42.48 56.78 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.459 1.104 . . . . 0.0 112.976 173.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -83.9 -20.4 33.08 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -70.01 -24.9 63.36 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.21 1.368 . . . . 0.0 110.66 172.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -60.7 -28.87 68.97 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.778 -1.201 . . . . 0.0 112.442 165.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.51 17.25 10.33 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.918 1.287 . . . . 0.0 114.05 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.54 -168.01 12.86 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.441 1.02 . . . . 0.0 114.706 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.3 79.41 3.09 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 124.657 3.571 . . . . 0.0 111.107 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.0 t -55.91 148.92 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.652 0.781 . . . . 0.0 110.284 171.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.5 mm -92.54 -52.04 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 126.396 1.878 . . . . 0.0 112.283 172.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -158.85 160.79 36.58 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.895 2.478 . . . . 0.0 108.352 -171.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.3 155.63 38.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 126.789 2.036 . . . . 0.0 107.217 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -133.01 137.29 46.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.542 1.937 . . . . 0.0 110.176 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.4 mm -114.13 125.35 29.45 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 126.655 1.982 . . . . 0.0 111.866 163.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.2 167.53 26.65 Favored 'Trans proline' 0 C--N 1.347 0.485 1 C-N-CA 125.519 4.146 . . . . 0.0 112.713 167.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -152.65 116.58 4.84 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 125.848 1.659 . . . . 0.0 110.532 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -49.2 164.2 0.08 Allowed 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 126.407 1.883 . . . . 0.0 112.08 161.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.35 -38.02 62.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.456 1.102 . . . . 0.0 112.062 170.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -74.3 -14.34 60.89 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.202 1.001 . . . . 0.0 112.373 174.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.7 41.93 3.74 Favored Glycine 0 C--N 1.343 0.967 0 O-C-N 120.303 -1.498 . . . . 0.0 115.676 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -133.28 139.08 33.01 Favored Pre-proline 0 N--CA 1.469 0.491 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -67.26 14.83 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.377 1 C-N-CA 125.762 4.308 . . . . 0.0 117.14 -178.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.27 18.06 2.33 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.371 -1.456 . . . . 0.0 114.117 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 68.04 31.62 5.39 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.262 1.825 . . . . 0.0 111.955 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.4 158.91 44.68 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.755 1.222 . . . . 0.0 113.254 -174.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.42 169.66 24.21 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.06 1.744 . . . . 0.0 111.891 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -121.4 150.32 41.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.168 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.4 t -139.58 146.97 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.734 1.214 . . . . 0.0 109.899 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 . . . . . 0 CA--C 1.543 0.703 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -173.338 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo . . . . . 0 CA--C 1.542 0.881 0 N-CA-C 117.067 1.91 . . . . 0.0 117.067 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -58.54 -42.36 87.64 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.492 1.117 . . . . 0.0 112.779 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.14 -32.22 67.95 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 121.343 1.883 . . . . 0.0 111.751 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.3 tpt -65.64 -26.83 67.99 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 118.372 0.533 . . . . 0.0 112.189 -175.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -86.56 -21.35 26.94 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 121.217 -0.927 . . . . 0.0 113.033 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -105.35 -38.85 6.35 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.789 1.635 . . . . 0.0 111.798 -155.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.8 -96.77 0.42 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.114 1.766 . . . . 0.0 111.443 174.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 29.97 66.37 0.12 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.791 2.036 . . . . 0.0 111.938 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.88 17.91 0.16 Allowed Glycine 0 N--CA 1.468 0.776 0 N-CA-C 117.347 1.699 . . . . 0.0 117.347 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -139.48 148.98 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 117.769 0.784 . . . . 0.0 112.578 -160.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.62 175.3 13.37 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.1 tp -138.53 -18.87 1.08 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.302 2.641 . . . . 0.0 112.819 171.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.404 ' CE1' HD11 ' A' ' 32' ' ' LEU . 3.1 m-30 -101.92 -40.76 6.75 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.453 1.501 . . . . 0.0 112.986 -175.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.74 -45.48 0.22 Allowed Glycine 0 N--CA 1.479 1.532 0 N-CA-C 118.477 2.151 . . . . 0.0 118.477 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -113.98 122.47 34.63 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 126.231 1.812 . . . . 0.0 111.459 -173.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.25 123.33 7.66 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.371 2.047 . . . . 0.0 115.106 -171.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.1 mm -52.6 118.61 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 124.495 1.118 . . . . 0.0 113.005 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -103.57 114.72 29.2 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.242 1.817 . . . . 0.0 111.658 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mp -84.0 146.77 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 O-C-N 121.649 -0.657 . . . . 0.0 110.574 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 . . . . . 0 N--CA 1.476 0.874 0 C-N-CA 126.122 1.769 . . . . 0.0 113.986 179.666 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.866 0.841 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.7 tp -117.47 133.63 55.75 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.981 2.112 . . . . 0.0 112.927 -166.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -85.03 124.57 31.88 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 123.322 1.534 . . . . 0.0 111.84 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 t -122.06 134.06 66.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.41 -171.13 12.59 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 121.201 -0.937 . . . . 0.0 112.18 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.4 t30 62.43 38.62 12.7 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.645 1.178 . . . . 0.0 111.165 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.2 158.06 37.07 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.458 1.103 . . . . 0.0 109.065 -176.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.79 158.47 35.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.808 1.29 . . . . 0.0 110.0 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.2 p -73.26 -13.49 61.14 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.992 1.317 . . . . 0.0 113.3 -169.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 27' ' ' LYS . 25.4 mmmt -129.72 21.21 5.5 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 129.733 3.213 . . . . 0.0 112.364 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.2 p -53.64 160.69 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.524 1.13 . . . . 0.0 112.751 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 36.3 p -148.41 162.15 40.16 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.931 1.692 . . . . 0.0 110.707 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -56.12 -37.34 69.29 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.707 1.203 . . . . 0.0 108.972 171.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -66.26 -32.32 73.67 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.4 tp -75.17 -35.49 61.59 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.009 -1.057 . . . . 0.0 111.906 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.0 mt -71.4 -43.67 66.37 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.049 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -53.5 -46.89 70.21 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.85 1.205 . . . . 0.0 110.658 175.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -73.14 -28.2 62.11 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.5 tt -77.58 -49.01 15.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.467 1.107 . . . . 0.0 112.666 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -81.25 -17.94 47.72 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 120.344 1.429 . . . . 0.0 113.263 -175.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -53.23 -32.4 48.12 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 120.312 1.415 . . . . 0.0 110.94 169.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -56.55 -38.4 71.85 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.464 1.505 . . . . 0.0 114.847 168.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.07 -20.37 30.49 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.227 1.811 . . . . 0.0 111.814 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.43 -168.78 29.08 Favored Glycine 0 CA--C 1.55 2.257 0 N-CA-C 117.774 1.869 . . . . 0.0 117.774 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.66 74.83 5.01 Favored 'Trans proline' 0 CA--C 1.548 1.185 1 C-N-CA 126.468 4.779 . . . . 0.0 110.806 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 m -57.72 127.11 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.827 1.651 . . . . 0.0 110.024 173.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.544 HG22 ' HE3' ' A' ' 45' ' ' LYS . 34.5 mm -69.08 -40.23 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.665 0.786 . . . . 0.0 111.018 -175.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.544 ' HE3' HG22 ' A' ' 44' ' ' ILE . 13.3 ptpt -171.49 160.14 5.84 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.59 2.356 . . . . 0.0 111.042 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 85.2 t -122.24 137.19 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 127.148 2.179 . . . . 0.0 112.156 -175.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -113.96 123.77 50.54 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.7 mm -110.91 111.9 56.14 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 125.754 1.622 . . . . 0.0 111.436 165.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.8 165.73 24.84 Favored 'Trans proline' 0 CA--C 1.552 1.399 1 C-N-CA 125.717 4.278 . . . . 0.0 111.258 172.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -157.24 114.82 3.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.966 2.107 . . . . 0.0 111.667 171.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.455 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 31.4 t0 -63.02 176.51 0.71 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 126.759 2.024 . . . . 0.0 113.093 170.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.79 -36.92 27.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.491 1.916 . . . . 0.0 113.072 172.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -77.04 -9.15 58.52 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.937 1.695 . . . . 0.0 114.538 174.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.08 41.54 6.61 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 125.669 1.604 . . . . 0.0 112.629 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -130.29 133.84 25.38 Favored Pre-proline 0 N--CA 1.467 0.412 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -169.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.24 13.63 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 1 C-N-CA 126.411 4.741 . . . . 0.0 115.037 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.455 ' HE2' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER 54.84 21.13 3.43 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 174.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 60.26 34.79 20.91 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.587 1.955 . . . . 0.0 112.96 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -151.04 155.91 40.0 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.142 1.377 . . . . 0.0 113.343 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -151.3 169.62 21.5 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.496 1.919 . . . . 0.0 112.914 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -126.24 159.56 32.7 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.265 1.031 . . . . 0.0 113.283 172.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.7 t -144.49 133.22 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.995 0.918 . . . . 0.0 110.874 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 . . . . . 0 CA--C 1.54 0.582 0 C-N-CA 125.578 1.551 . . . . 0.0 113.069 179.361 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo . . . . . 0 CA--C 1.534 0.496 0 N-CA-C 112.695 0.229 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -52.91 -39.88 63.11 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.93 -26.69 67.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.6 ttt -70.48 -24.63 62.9 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 121.024 1.738 . . . . 0.0 112.765 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -87.04 -27.53 23.13 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.234 1.013 . . . . 0.0 112.109 169.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.33 -57.78 2.59 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -167.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -88.69 -94.92 0.1 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.547 1.139 . . . . 0.0 108.813 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 30.32 78.04 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.397 1.879 . . . . 0.0 113.38 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.9 28.01 1.78 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.022 0.82 . . . . 0.0 112.648 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -130.66 148.01 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.99 -175.17 3.91 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.239 2.216 . . . . 0.0 112.258 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.6 mt -131.37 -31.85 1.59 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.601 1.56 . . . . 0.0 112.841 154.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -65.61 -51.95 55.75 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.05 -50.03 0.16 Allowed Glycine 0 CA--C 1.534 1.264 0 O-C-N 121.134 -0.979 . . . . 0.0 115.191 170.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -93.45 111.91 54.29 Favored Pre-proline 0 N--CA 1.479 1.014 0 C-N-CA 124.472 1.109 . . . . 0.0 109.247 -172.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.56 127.22 12.24 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.776 2.317 . . . . 0.0 112.536 -170.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 mm -56.74 122.54 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 122.223 1.011 . . . . 0.0 109.121 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -103.39 121.27 42.43 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.671 1.988 . . . . 0.0 109.732 171.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.46 141.23 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 169.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 . . . . . 0 C--O 1.235 0.333 0 CA-C-O 122.705 1.24 . . . . 0.0 111.552 174.706 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 83.7 m . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.9 tp -89.41 127.43 35.82 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.29 1.436 . . . . 0.0 113.367 -160.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -72.26 135.56 46.05 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.965 0.888 . . . . 0.0 111.769 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.04 134.97 62.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 168.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.82 -175.53 13.96 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 126.187 1.851 . . . . 0.0 111.23 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 42.9 t30 65.82 24.71 11.34 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.095 1.358 . . . . 0.0 112.315 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.8 160.09 21.01 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 123.282 1.515 . . . . 0.0 110.654 -175.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.27 163.36 27.11 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.995 -1.912 . . . . 0.0 110.511 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.2 p -64.29 -27.4 69.01 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.17 1.788 . . . . 0.0 109.869 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -123.59 26.13 7.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.0 p -51.8 161.46 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.839 1.2 . . . . 0.0 111.777 169.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.6 p -158.93 159.46 34.95 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.458 1.903 . . . . 0.0 110.542 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -55.02 -38.82 68.42 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 126.478 1.911 . . . . 0.0 109.171 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -67.26 -30.87 70.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.594 1.958 . . . . 0.0 112.376 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.3 tp -75.4 -43.74 48.46 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.8 0.727 . . . . 0.0 111.422 168.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.82 -54.42 45.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.106 0.963 . . . . 0.0 110.521 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -53.9 -45.41 71.1 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.059 0.845 . . . . 0.0 112.425 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -69.33 -31.76 70.42 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.127 1.33 . . . . 0.0 112.714 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.2 tt -74.18 -36.17 64.02 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.458 1.103 . . . . 0.0 111.014 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -95.54 -12.78 25.19 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -56.2 -35.74 67.63 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.969 1.708 . . . . 0.0 109.804 163.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.6 mm100 -62.36 -36.19 81.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.773 1.229 . . . . 0.0 113.284 168.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.86 2.76 44.59 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.574 1.15 . . . . 0.0 113.401 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 134.38 -169.63 22.98 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.737 1.637 . . . . 0.0 115.369 167.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.32 99.82 0.17 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.695 2.93 . . . . 0.0 111.159 167.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.5 t -88.2 131.69 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.019 1.727 . . . . 0.0 110.19 172.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.42 -46.29 20.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.949 1.3 . . . . 0.0 111.18 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -171.07 150.46 3.05 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.689 1.596 . . . . 0.0 112.033 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.2 t -115.87 151.17 17.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 129.297 3.039 . . . . 0.0 110.383 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -129.68 121.09 26.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.93 2.092 . . . . 0.0 111.209 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.5 mm -101.0 122.33 49.11 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.583 1.553 . . . . 0.0 110.124 160.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.36 163.75 35.24 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 125.188 3.925 . . . . 0.0 111.114 164.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -154.92 113.64 3.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.525 1.53 . . . . 0.0 113.149 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -53.04 168.9 0.11 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 130.444 3.497 . . . . 0.0 113.83 173.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -28.4 59.96 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.852 0.461 . . . . 0.0 110.471 168.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -83.37 -6.17 59.38 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.67 40.91 8.57 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 126.556 2.027 . . . . 0.0 111.943 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -128.82 137.11 30.28 Favored Pre-proline 0 N--CA 1.465 0.325 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.58 14.23 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 124.275 3.316 . . . . 0.0 116.682 176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.42 27.81 6.82 Favored 'General case' 0 CA--C 1.554 1.125 0 O-C-N 120.538 -1.351 . . . . 0.0 114.307 175.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 57.42 32.47 21.83 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 127.464 2.305 . . . . 0.0 116.156 -173.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -147.0 162.57 38.51 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 127.205 2.202 . . . . 0.0 112.53 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -158.67 177.43 11.21 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.622 1.969 . . . . 0.0 110.362 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -129.06 154.35 46.74 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.106 1.362 . . . . 0.0 114.22 171.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.16 133.52 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.523 1.529 . . . . 0.0 110.609 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 . . . . . 0 CA--C 1.544 0.725 0 C-N-CA 125.914 1.686 . . . . 0.0 112.207 173.113 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo . . . . . 0 CA--C 1.551 1.338 0 N-CA-C 114.48 0.915 . . . . 0.0 114.48 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -74.55 -42.09 59.42 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 120.521 -1.362 . . . . 0.0 112.044 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.91 -42.28 79.65 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.089 1.755 . . . . 0.0 114.482 -166.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.18 -22.95 2.91 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 173.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -109.06 -34.3 6.64 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 125.257 1.423 . . . . 0.0 110.343 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.2 tp -64.1 -60.85 2.73 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 118.831 0.741 . . . . 0.0 111.298 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -87.88 -86.42 0.16 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.458 1.903 . . . . 0.0 106.662 -174.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 37.57 64.56 0.63 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 126.289 1.836 . . . . 0.0 114.621 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.97 35.1 0.56 Allowed Glycine 0 N--CA 1.481 1.658 0 O-C-N 120.814 -1.179 . . . . 0.0 115.234 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.01 143.95 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.525 1.53 . . . . 0.0 112.476 -174.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.23 170.7 12.97 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.82 2.048 . . . . 0.0 112.653 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 15.5 tp -123.21 -30.73 3.68 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.867 2.467 . . . . 0.0 112.272 163.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -83.7 -21.52 32.34 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.082 2.153 . . . . 0.0 114.001 -172.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 150.79 -59.8 0.42 Allowed Glycine 0 N--CA 1.483 1.791 0 N-CA-C 116.166 1.226 . . . . 0.0 116.166 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -102.47 129.04 26.84 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 126.267 1.827 . . . . 0.0 109.033 -173.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -76.38 134.68 15.83 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.76 2.974 . . . . 0.0 113.747 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 mm -57.57 129.33 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 O-C-N 121.834 -0.541 . . . . 0.0 110.4 176.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -119.37 110.52 17.05 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.528 1.931 . . . . 0.0 109.582 170.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -85.32 134.29 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 126.125 1.77 . . . . 0.0 109.256 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 . . . . . 0 CA--C 1.544 0.73 0 C-N-CA 126.679 1.992 . . . . 0.0 111.399 -166.901 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.3 m . . . . . 0 CA--C 1.543 0.695 0 CA-C-O 122.532 1.158 . . . . 0.0 108.102 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.5 tp -119.28 125.12 48.35 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 130.917 3.687 . . . . 0.0 111.01 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -80.65 135.95 36.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.602 1.161 . . . . 0.0 108.47 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.3 t -135.37 139.39 46.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 125.098 1.359 . . . . 0.0 108.753 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.02 -174.7 14.24 Favored Glycine 0 N--CA 1.449 -0.454 0 O-C-N 121.098 -1.001 . . . . 0.0 112.448 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.5 t30 71.19 24.44 3.84 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.943 1.697 . . . . 0.0 112.383 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.24 145.75 47.73 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 125.191 1.397 . . . . 0.0 109.766 -169.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.24 162.05 18.1 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 176.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.4 p -63.1 -22.41 66.84 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.822 1.649 . . . . 0.0 111.639 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -113.38 23.2 13.46 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.466 1.506 . . . . 0.0 113.618 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.7 p -60.25 155.47 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 O-C-N 119.784 -1.823 . . . . 0.0 112.131 171.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.6 p -153.52 159.8 42.33 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 129.132 2.973 . . . . 0.0 108.58 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -59.9 -28.06 67.25 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.08 2.152 . . . . 0.0 111.9 177.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -73.08 -32.58 65.09 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.067 1.347 . . . . 0.0 112.252 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.456 HD22 ' CZ ' ' A' ' 83' ' ' TYR . 21.7 tp -76.08 -36.49 58.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.676 0.79 . . . . 0.0 112.999 172.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.0 mt -69.71 -42.31 74.21 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -63.03 -40.74 98.63 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.786 1.63 . . . . 0.0 112.938 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -69.86 -29.72 67.02 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.141 -0.975 . . . . 0.0 111.37 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.1 tt -73.38 -39.06 65.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.58 0.752 . . . . 0.0 110.388 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -93.41 17.36 11.54 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.779 1.231 . . . . 0.0 114.274 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -67.39 -30.28 70.01 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 120.286 1.403 . . . . 0.0 114.671 -173.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -101.24 0.24 37.06 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.126 1.77 . . . . 0.0 113.123 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.77 30.95 0.54 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.14 179.28 39.97 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.104 0.859 . . . . 0.0 111.748 -173.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -62.13 109.24 0.79 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.43 2.086 . . . . 0.0 109.716 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.9 t -94.04 105.05 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.798 1.239 . . . . 0.0 109.11 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.1 mt -62.51 -49.37 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.437 1.895 . . . . 0.0 111.825 171.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.17 170.1 19.66 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.681 0.792 . . . . 0.0 110.13 175.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.3 t -119.58 160.77 19.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 125.355 1.462 . . . . 0.0 109.132 169.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -138.54 124.05 19.54 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.884 1.273 . . . . 0.0 111.939 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mm -108.37 121.69 42.73 Favored Pre-proline 0 C--N 1.32 -0.692 0 C-N-CA 125.721 1.608 . . . . 0.0 109.896 169.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.16 164.83 33.37 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 125.198 3.932 . . . . 0.0 112.304 165.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -159.51 118.32 2.85 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 126.923 2.089 . . . . 0.0 108.769 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -55.53 168.92 0.35 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 127.106 2.162 . . . . 0.0 113.06 171.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.35 -35.44 62.74 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.001 1.32 . . . . 0.0 110.116 172.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -89.16 6.79 38.44 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 128.321 2.648 . . . . 0.0 114.79 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.47 46.55 7.34 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 126.759 2.123 . . . . 0.0 115.416 168.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -136.26 137.27 24.1 Favored Pre-proline 0 N--CA 1.476 0.842 0 CA-C-N 118.761 1.281 . . . . 0.0 113.467 -173.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.79 17.88 0.92 Allowed 'Trans proline' 0 C--O 1.223 -0.261 1 C-N-CA 126.412 4.741 . . . . 0.0 115.596 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.435 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 50.5 27.86 3.07 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.815 1.646 . . . . 0.0 113.341 175.501 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.25 11.3 mt-30 53.83 32.59 15.29 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -171.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.435 ' CD2' ' HB2' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -149.21 150.98 33.5 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 126.337 1.855 . . . . 0.0 112.873 -176.04 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -155.1 176.06 13.03 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.911 1.685 . . . . 0.0 112.505 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -135.39 163.16 30.66 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.1 t -145.48 143.6 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.608 1.563 . . . . 0.0 109.813 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.885 0.85 . . . . 0.0 110.499 -176.314 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo . . . . . 0 CA--C 1.54 0.803 0 N-CA-C 109.266 -1.09 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -61.48 -40.9 96.24 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 120.084 -1.635 . . . . 0.0 112.888 -169.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.99 -27.96 63.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.145 1.378 . . . . 0.0 112.348 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.5 ttt -69.69 -17.7 63.5 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.323 1.049 . . . . 0.0 111.893 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -98.92 -38.87 8.84 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.216 0.917 . . . . 0.0 111.787 166.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.51 -40.09 94.99 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 118.8 0.727 . . . . 0.0 111.392 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 mt -124.81 -86.45 0.63 Allowed 'General case' 0 C--N 1.348 0.527 0 CA-C-O 116.36 -1.781 . . . . 0.0 111.191 -158.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 23.03 71.67 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.769 2.028 . . . . 0.0 112.439 169.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.75 25.19 0.7 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.752 1.644 . . . . 0.0 114.289 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -134.81 151.68 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.645 1.178 . . . . 0.0 113.096 -172.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.94 168.95 20.43 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.416 1.486 . . . . 0.0 112.526 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.0 tp -111.89 -33.59 6.25 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 128.553 2.741 . . . . 0.0 111.146 173.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.456 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 6.4 m-30 -93.57 -67.0 0.88 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.632 1.573 . . . . 0.0 110.687 -173.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.37 -38.55 0.07 OUTLIER Glycine 0 CA--C 1.53 1.003 0 CA-C-O 117.92 -1.489 . . . . 0.0 116.108 -175.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -101.94 108.07 54.89 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 120.205 2.003 . . . . 0.0 110.86 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -65.73 128.9 20.92 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.236 3.291 . . . . 0.0 113.585 -166.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.0 mm -58.85 124.78 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -117.13 109.8 17.38 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 128.258 2.623 . . . . 0.0 110.749 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 mp -88.93 142.74 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.255 0.622 . . . . 0.0 109.677 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 . . . . . 0 CA--C 1.542 0.645 0 CA-C-O 123.467 1.603 . . . . 0.0 113.93 -176.706 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.3 tp -122.85 123.6 41.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.873 1.669 . . . . 0.0 114.347 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -71.77 132.53 44.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.298 1.047 . . . . 0.0 112.497 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.43 119.88 51.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 174.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.43 -171.48 16.6 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 122.988 1.327 . . . . 0.0 112.067 166.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.3 t30 71.39 31.22 2.37 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.438 2.295 . . . . 0.0 114.595 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.16 155.78 38.02 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.879 1.272 . . . . 0.0 113.91 -172.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -65.79 160.32 23.31 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.1 p -62.64 -26.75 68.79 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 128.712 2.805 . . . . 0.0 111.867 168.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -113.38 10.4 18.34 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.43 1.892 . . . . 0.0 113.448 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.2 p -61.92 158.97 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -174.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.6 p -154.1 168.92 24.86 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 128.356 2.662 . . . . 0.0 110.625 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -62.44 -25.2 67.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.409 1.484 . . . . 0.0 110.22 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -80.66 -26.48 37.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 117.361 -1.304 . . . . 0.0 113.672 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.8 tp -73.65 -29.89 62.6 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.283 0.947 . . . . 0.0 111.681 169.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.4 mt -78.83 -44.69 22.47 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.298 1.039 . . . . 0.0 113.663 171.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -63.9 -43.67 95.3 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 120.137 -1.602 . . . . 0.0 110.971 -174.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -63.42 -18.38 63.66 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.292 1.037 . . . . 0.0 113.573 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 tt -99.19 -43.95 6.44 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 129.093 2.957 . . . . 0.0 110.224 -169.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -78.69 -14.13 59.46 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.152 1.381 . . . . 0.0 111.841 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -66.62 -27.4 67.66 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 120.37 -1.456 . . . . 0.0 111.877 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -68.14 -23.99 64.95 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 127.754 2.422 . . . . 0.0 114.117 165.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.71 -22.15 23.51 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.707 1.603 . . . . 0.0 110.325 -176.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 132.81 -147.15 18.82 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.447 1.022 . . . . 0.0 114.299 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -81.25 114.73 2.84 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.917 3.078 . . . . 0.0 110.306 -172.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.1 t -110.6 120.39 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.422 1.489 . . . . 0.0 110.57 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -61.41 -57.14 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 163.87 38.5 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 127.281 2.232 . . . . 0.0 113.582 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 73.2 t -118.22 146.66 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 128.651 2.78 . . . . 0.0 110.136 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -122.58 128.52 50.82 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.803 1.638 . . . . 0.0 113.607 171.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.3 mm -107.35 120.96 46.01 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 125.459 1.503 . . . . 0.0 110.647 163.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.42 168.45 24.72 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 125.029 3.819 . . . . 0.0 113.318 165.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -158.6 122.55 3.99 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.639 2.775 . . . . 0.0 111.965 166.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.62 164.95 0.3 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.218 2.607 . . . . 0.0 113.248 165.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -49.88 -29.71 8.67 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 164.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.12 -7.84 59.11 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.002 1.321 . . . . 0.0 114.555 170.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.15 38.93 7.6 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 119.88 -1.763 . . . . 0.0 111.952 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.28 132.91 24.6 Favored Pre-proline 0 C--N 1.347 0.493 0 CA-C-N 118.619 1.209 . . . . 0.0 114.26 -176.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.21 12.16 0.3 Allowed 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.308 3.339 . . . . 0.0 113.861 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.436 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 58.82 22.32 10.02 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.485 -1.384 . . . . 0.0 113.147 172.244 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 57.86 34.39 24.31 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.13 1.372 . . . . 0.0 114.106 -171.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.436 ' CD2' ' HB2' ' A' ' 57' ' ' LYS . 0.2 OUTLIER -150.8 158.74 44.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.75 1.22 . . . . 0.0 113.247 -176.488 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.64 -176.86 6.18 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.251 1.42 . . . . 0.0 112.501 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -140.43 154.57 46.7 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.159 -0.963 . . . . 0.0 113.189 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.46 139.34 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.766 0.826 . . . . 0.0 113.174 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 . . . . . 0 C--O 1.234 0.246 0 C-N-CA 125.113 1.365 . . . . 0.0 112.881 174.703 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo . . . . . 0 CA--C 1.54 0.798 0 N-CA-C 109.993 -0.811 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -64.59 -29.29 70.3 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.844 -1.16 . . . . 0.0 113.593 -161.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.06 -18.68 64.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.7 ttp -61.12 -17.84 54.88 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 120.137 1.335 . . . . 0.0 112.206 173.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -109.22 -44.2 3.99 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.54 1.136 . . . . 0.0 111.888 171.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.29 -43.15 95.68 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.566 0.347 . . . . 0.0 111.55 -170.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -107.96 -88.34 0.48 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.616 1.166 . . . . 0.0 111.258 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 27.01 71.11 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 129.73 3.212 . . . . 0.0 115.712 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.43 14.98 1.49 Allowed Glycine 0 CA--C 1.532 1.155 0 CA-C-O 117.598 -1.668 . . . . 0.0 116.085 -174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -125.08 150.98 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 119.793 1.797 . . . . 0.0 111.2 -168.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.88 171.21 16.98 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.745 1.218 . . . . 0.0 113.742 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.8 tp -120.28 -46.58 2.39 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.637 1.175 . . . . 0.0 109.75 166.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -69.32 -54.8 12.72 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.29 -46.2 0.06 OUTLIER Glycine 0 CA--C 1.537 1.414 0 N-CA-C 116.265 1.266 . . . . 0.0 116.265 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -105.15 114.71 63.28 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 127.619 2.368 . . . . 0.0 114.101 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.92 119.5 6.53 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.715 2.943 . . . . 0.0 113.033 -171.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.7 mm -50.24 124.08 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.903 1.281 . . . . 0.0 110.1 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -118.86 109.88 16.54 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 124.487 1.115 . . . . 0.0 112.037 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mp -81.88 131.23 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 . . . . . 0 CA--C 1.558 1.285 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 179.028 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 CA--C 1.548 0.899 0 CA-C-O 121.54 0.686 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.8 tp -75.28 132.53 41.1 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.732 2.413 . . . . 0.0 110.549 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -84.79 137.73 33.01 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 120.288 1.404 . . . . 0.0 110.622 175.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.57 115.79 32.77 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 59' ' ' PHE . . . -115.87 -177.28 18.37 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.357 1.456 . . . . 0.0 110.396 172.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.2 t30 65.52 37.72 5.9 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.119 1.368 . . . . 0.0 111.698 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.81 152.04 39.02 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.028 1.731 . . . . 0.0 109.468 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.47 ' CD ' ' H ' ' A' ' 26' ' ' THR . 0.7 OUTLIER -67.9 170.96 7.27 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 123.966 1.841 . . . . 0.0 112.587 169.451 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.47 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 24.9 p -82.54 -13.77 56.06 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 126.293 1.837 . . . . 0.0 113.331 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -119.11 20.33 12.69 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.25 2.62 . . . . 0.0 113.08 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.67 158.23 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.1 p -153.5 167.0 30.93 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.441 1.096 . . . . 0.0 111.697 -173.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -63.78 -32.12 73.52 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.011 0.924 . . . . 0.0 108.713 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.12 -47.85 81.03 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.559 1.944 . . . . 0.0 113.109 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.3 tp -67.11 -36.94 83.01 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.095 0.558 . . . . 0.0 110.922 -175.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 99.2 mt -65.89 -51.17 61.02 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.17 1.388 . . . . 0.0 111.042 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -52.59 -43.52 65.36 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.838 2.055 . . . . 0.0 113.523 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -75.23 -27.63 59.6 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -76.14 -38.73 56.4 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.608 -0.683 . . . . 0.0 112.067 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -82.03 11.53 5.06 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.595 -1.315 . . . . 0.0 114.06 176.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -62.95 -44.78 95.12 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.124 1.37 . . . . 0.0 113.786 -174.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.72 6.7 44.93 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.639 1.576 . . . . 0.0 111.351 168.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.66 3.66 43.72 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 120.744 1.611 . . . . 0.0 112.673 171.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.85 -167.94 12.59 Favored Glycine 0 CA--C 1.538 1.515 0 C-N-CA 127.918 2.675 . . . . 0.0 111.831 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.04 97.74 0.93 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.697 2.264 . . . . 0.0 111.328 -173.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.8 t -68.33 119.23 13.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 122.58 1.181 . . . . 0.0 110.335 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.9 mm -80.54 -46.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -175.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.99 155.19 30.87 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.885 1.674 . . . . 0.0 110.111 174.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.5 t -112.64 153.87 14.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 125.681 1.593 . . . . 0.0 107.45 170.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -126.91 126.4 43.19 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.905 1.282 . . . . 0.0 112.39 169.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.6 mm -105.54 122.78 41.59 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 123.892 0.877 . . . . 0.0 109.594 164.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.71 166.21 30.17 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.847 3.031 . . . . 0.0 110.153 164.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -160.72 120.06 2.67 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 128.087 2.555 . . . . 0.0 106.072 174.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.25 172.81 2.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.359 -1.746 . . . . 0.0 110.75 167.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -32.61 62.97 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 122.405 1.098 . . . . 0.0 111.045 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -77.45 -3.61 41.23 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.648 1.979 . . . . 0.0 113.116 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.95 41.51 8.1 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.541 2.019 . . . . 0.0 113.618 170.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -136.46 135.48 20.77 Favored Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.32 15.39 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.585 1 C-N-CA 126.106 4.537 . . . . 0.0 116.005 -174.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.76 29.22 9.24 Favored 'General case' 0 CA--C 1.557 1.22 0 O-C-N 121.548 -0.72 . . . . 0.0 111.91 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 53.99 38.41 28.83 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -174.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.414 ' HA ' ' HA2' ' A' ' 22' ' ' GLY . 1.1 p90 -152.72 173.36 15.37 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 127.787 2.435 . . . . 0.0 113.257 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -169.71 174.51 5.72 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 128.882 2.873 . . . . 0.0 112.737 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -127.01 153.92 45.3 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.706 2.003 . . . . 0.0 112.274 170.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 t -141.2 140.17 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.66 1.984 . . . . 0.0 108.008 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.927 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo . . . . . 0 CA--C 1.533 0.458 0 N-CA-C 113.731 0.627 . . . . 0.0 113.731 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -59.7 -42.6 93.36 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.847 1.259 . . . . 0.0 109.547 -175.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.86 -25.4 28.54 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 173.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 tpt -71.93 -16.05 62.1 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 121.456 1.935 . . . . 0.0 113.788 -173.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -103.16 -35.96 8.29 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.315 1.846 . . . . 0.0 111.271 169.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.67 -48.98 23.1 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.964 1.706 . . . . 0.0 112.633 -169.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.15 -97.14 0.33 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.73 1.612 . . . . 0.0 108.63 177.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 39.55 57.57 2.13 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.447 1.899 . . . . 0.0 112.69 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.52 22.54 0.13 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.89 151.6 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 118.711 1.255 . . . . 0.0 113.806 -168.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.51 176.91 6.24 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.91 1.684 . . . . 0.0 110.93 -170.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.9 tp -125.87 -35.83 2.45 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.088 1.755 . . . . 0.0 112.428 170.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 14.7 m-30 -81.79 -61.23 1.98 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.986 1.715 . . . . 0.0 111.059 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.87 -49.1 0.06 OUTLIER Glycine 0 N--CA 1.468 0.809 0 N-CA-C 117.297 1.679 . . . . 0.0 117.297 -176.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -90.87 116.67 66.91 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -171.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.08 128.82 13.43 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.177 2.585 . . . . 0.0 110.393 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.3 mm -63.87 118.65 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.155 -174.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -103.5 91.73 4.17 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.87 1.668 . . . . 0.0 110.799 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -60.14 139.13 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.203 165.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 . . . . . 0 N--CA 1.467 0.415 0 C-N-CA 125.282 1.433 . . . . 0.0 112.342 167.91 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 51.1 tp -106.83 133.37 51.59 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.195 2.598 . . . . 0.0 111.792 -172.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -88.0 133.0 34.05 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.56 0.618 . . . . 0.0 110.492 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.3 t -130.57 122.87 53.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 O-C-N 120.966 -1.084 . . . . 0.0 108.76 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 59' ' ' PHE . . . -125.32 -175.78 14.33 Favored Glycine 0 N--CA 1.464 0.548 0 C-N-CA 126.264 1.888 . . . . 0.0 112.057 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.1 t30 64.45 31.95 12.21 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.854 2.062 . . . . 0.0 111.907 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.74 166.4 13.18 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.391 1.876 . . . . 0.0 111.531 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 26' ' ' THR . 1.0 OUTLIER -82.74 165.82 19.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 123.126 1.441 . . . . 0.0 113.65 166.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.542 ' HB ' ' HZ2' ' A' ' 55' ' ' LYS . 67.4 p -65.91 -34.2 77.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.505 1.522 . . . . 0.0 111.88 175.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.09 19.52 20.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.736 2.014 . . . . 0.0 115.395 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.8 p -64.88 155.85 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 125.012 1.325 . . . . 0.0 111.264 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.7 p -159.75 162.06 34.83 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.667 1.987 . . . . 0.0 110.319 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -60.09 -30.49 69.28 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.204 0.602 . . . . 0.0 110.316 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -59.94 -41.87 92.78 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.153 1.781 . . . . 0.0 112.321 174.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -72.04 -51.99 19.05 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.7 mt -56.41 -39.87 73.75 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -66.44 -46.36 76.72 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.01 0.823 . . . . 0.0 110.757 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -57.04 -39.71 75.36 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.807 1.643 . . . . 0.0 111.721 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -81.61 -42.85 19.45 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.933 1.693 . . . . 0.0 112.884 -175.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . 0.329 48.0 m-85 -76.54 -4.93 45.37 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 172.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -54.7 -42.62 71.69 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 121.902 2.137 . . . . 0.0 111.503 164.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -72.66 -15.86 61.71 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.16 -1.23 57.89 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.495 1.043 . . . . 0.0 113.773 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.64 -148.51 18.41 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.071 0.843 . . . . 0.0 111.221 -174.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -75.62 157.5 40.17 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.798 2.332 . . . . 0.0 112.78 171.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.1 147.32 21.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 127.116 2.167 . . . . 0.0 107.502 170.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.7 mm -88.49 -51.6 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 121.006 -1.059 . . . . 0.0 109.608 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.74 168.84 25.9 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.549 2.339 . . . . 0.0 112.561 175.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.8 t -122.9 144.63 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 129.874 3.269 . . . . 0.0 110.609 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -127.41 122.58 33.96 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 130.307 3.443 . . . . 0.0 115.275 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.0 mm -107.09 125.89 31.44 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.145 1.778 . . . . 0.0 110.067 167.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.14 167.62 23.06 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.776 3.65 . . . . 0.0 111.289 163.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -160.58 118.56 2.51 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 128.111 2.564 . . . . 0.0 110.35 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -52.37 163.43 0.41 Allowed 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 126.852 2.061 . . . . 0.0 113.698 169.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -30.6 43.46 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.031 1.332 . . . . 0.0 113.093 172.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -87.04 -9.67 54.91 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 171.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.25 51.71 1.21 Allowed Glycine 0 C--N 1.338 0.653 0 C-N-CA 125.937 1.732 . . . . 0.0 113.453 165.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.542 ' HZ2' ' HB ' ' A' ' 26' ' ' THR . 10.5 tppt? -141.13 134.93 14.82 Favored Pre-proline 0 N--CA 1.467 0.392 0 CA-C-O 117.547 -1.216 . . . . 0.0 112.988 -176.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.53 12.51 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.531 1 C-N-CA 126.673 4.916 . . . . 0.0 115.422 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.11 20.81 10.05 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.703 -1.248 . . . . 0.0 111.722 173.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 59.08 38.47 23.91 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.701 2.0 . . . . 0.0 113.515 -173.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.418 ' HA ' ' HA2' ' A' ' 22' ' ' GLY . 0.2 OUTLIER -156.32 165.01 37.6 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.837 2.055 . . . . 0.0 111.529 -179.114 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.03 -179.21 6.07 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 128.671 2.788 . . . . 0.0 111.149 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -142.42 154.17 44.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.464 1.506 . . . . 0.0 114.411 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.8 t -143.32 120.92 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.958 1.303 . . . . 0.0 111.73 -176.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 . . . . . 0 CA--C 1.544 0.715 0 O-C-N 120.848 -1.157 . . . . 0.0 111.58 177.91 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo . . . . . 0 C--O 1.232 0.213 0 CA-C-O 121.491 0.538 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -50.5 -36.56 34.44 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -164.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.96 -22.92 60.63 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.439 1.496 . . . . 0.0 114.528 -176.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.7 ttt -64.45 -21.01 66.53 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.652 1.181 . . . . 0.0 110.192 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -101.36 -34.63 9.53 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.253 1.821 . . . . 0.0 112.987 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.61 -39.92 23.75 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -172.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.3 -84.25 0.59 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.293 1.037 . . . . 0.0 109.852 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.263 0.4 OUTLIER 23.7 59.85 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 129.306 3.043 . . . . 0.0 114.277 176.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.14 18.51 0.24 Allowed Glycine 0 CA--C 1.549 2.201 0 N-CA-C 118.162 2.025 . . . . 0.0 118.162 -169.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -138.41 149.71 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 121.124 2.462 . . . . 0.0 110.784 -165.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.33 156.76 24.36 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 mp -110.12 3.15 19.94 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.097 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -129.27 -85.56 0.55 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 129.033 2.933 . . . . 0.0 108.141 -173.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.43 -43.39 0.02 OUTLIER Glycine 0 N--CA 1.481 1.679 0 N-CA-C 115.91 1.124 . . . . 0.0 115.91 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -95.59 118.94 65.9 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 118.154 -0.927 . . . . 0.0 109.792 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -74.9 125.95 9.72 Favored 'Trans proline' 0 C--N 1.351 0.705 1 C-N-CA 125.801 4.334 . . . . 0.0 114.373 -172.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.2 mm -55.31 124.99 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 122.808 0.443 . . . . 0.0 110.292 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -109.38 118.14 35.87 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 126.764 2.026 . . . . 0.0 110.055 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.5 mp -93.0 141.18 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.423 -0.798 . . . . 0.0 110.074 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 . . . . . 0 CA--C 1.535 0.399 0 C-N-CA 125.445 1.498 . . . . 0.0 110.338 171.702 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.542 0.642 0 CA-C-O 122.41 1.1 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.7 tp -99.93 138.08 37.5 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.949 2.1 . . . . 0.0 111.803 -170.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -88.17 137.94 31.89 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 122.06 0.933 . . . . 0.0 111.746 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -133.74 131.07 56.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.356 -0.84 . . . . 0.0 109.166 178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.64 -176.73 14.54 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 126.225 1.869 . . . . 0.0 110.262 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.9 t30 69.09 13.2 8.7 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.807 1.643 . . . . 0.0 114.646 -178.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.99 144.26 55.35 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 126.253 1.821 . . . . 0.0 112.878 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -50.77 162.22 0.28 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 173.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.5 p -72.51 -22.37 61.05 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.948 175.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.96 21.28 9.88 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 129.895 3.278 . . . . 0.0 113.014 -177.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 p -64.15 162.04 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 120.855 -1.153 . . . . 0.0 112.066 173.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.3 p -159.64 168.91 24.91 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.31 1.844 . . . . 0.0 112.86 174.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.66 -27.17 69.04 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.174 1.39 . . . . 0.0 112.31 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -62.8 -49.94 72.98 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.76 1.164 . . . . 0.0 111.921 170.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.8 tp -64.66 -47.57 77.98 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.1 mt -62.57 -37.49 86.37 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -63.14 -47.09 84.19 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.06 0.845 . . . . 0.0 112.11 173.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -72.05 -19.57 61.82 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.451 1.5 . . . . 0.0 113.324 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.5 tt -92.61 -49.25 6.2 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.146 1.779 . . . . 0.0 112.162 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -72.77 -18.07 61.53 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.209 -0.932 . . . . 0.0 112.442 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -60.86 -26.5 67.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.775 1.625 . . . . 0.0 113.356 171.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -64.25 -31.39 72.57 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.247 -1.533 . . . . 0.0 112.78 168.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.86 1.45 34.94 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.39 1.076 . . . . 0.0 112.465 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.52 -146.53 16.91 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.295 1.426 . . . . 0.0 113.631 169.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -74.13 90.8 0.96 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 CA-C-N 119.567 1.684 . . . . 0.0 114.637 -167.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.7 t -74.91 133.42 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 125.535 1.534 . . . . 0.0 109.791 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.8 mt -85.24 -55.69 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 127.272 2.229 . . . . 0.0 111.047 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.06 152.65 28.3 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 128.019 2.528 . . . . 0.0 107.54 -175.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.3 t -106.48 151.13 8.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 127.946 2.498 . . . . 0.0 105.423 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -127.75 124.33 37.49 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 124.113 0.965 . . . . 0.0 113.358 166.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.9 mm -101.57 120.31 54.85 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.053 163.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.95 167.95 21.89 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 124.689 3.592 . . . . 0.0 110.222 165.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -157.45 115.87 3.19 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.134 1.374 . . . . 0.0 107.829 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -50.54 164.32 0.14 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.237 2.215 . . . . 0.0 111.264 161.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.5 pptp? -53.24 -29.53 33.08 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 120.808 -1.183 . . . . 0.0 113.567 167.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.29 -4.37 55.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.077 0.951 . . . . 0.0 112.604 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.55 35.62 8.46 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 125.962 1.744 . . . . 0.0 111.532 170.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -124.11 136.66 27.83 Favored Pre-proline 0 C--N 1.345 0.388 0 CA-C-N 118.958 1.379 . . . . 0.0 113.641 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.25 12.11 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 124.01 3.14 . . . . 0.0 118.316 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.62 27.78 11.0 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 121.286 1.857 . . . . 0.0 113.383 176.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 54.36 35.26 22.55 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.199 1.8 . . . . 0.0 113.413 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.93 162.66 38.85 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.783 -1.198 . . . . 0.0 110.494 -177.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -154.68 -179.23 7.81 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.213 1.405 . . . . 0.0 110.763 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -134.96 163.83 28.96 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.058 1.743 . . . . 0.0 109.808 165.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.4 t -145.96 134.7 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 127.145 2.178 . . . . 0.0 108.449 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 . . . . . 0 CA--C 1.545 0.751 0 C-N-CA 125.938 1.695 . . . . 0.0 111.059 -179.259 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 CA--C 1.534 0.506 0 CA-C-O 121.671 0.613 . . . . 0.0 113.111 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -51.06 -36.09 38.11 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.98 0.912 . . . . 0.0 111.748 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.96 -27.21 64.55 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 ttt -59.55 -28.22 66.92 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 119.754 1.161 . . . . 0.0 111.069 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -86.98 -19.32 28.89 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.753 2.021 . . . . 0.0 110.787 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.62 -45.05 4.12 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.348 1.459 . . . . 0.0 112.533 -161.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.54 -92.85 0.43 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.955 1.702 . . . . 0.0 109.322 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.261 0.9 OUTLIER 37.75 52.23 1.4 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.742 2.017 . . . . 0.0 115.191 165.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.38 17.79 0.21 Allowed Glycine 0 CA--C 1.534 1.246 0 CA-C-N 114.795 -1.093 . . . . 0.0 115.749 -167.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -141.82 150.59 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 118.285 1.043 . . . . 0.0 113.734 -170.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.09 167.32 26.54 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -173.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.0 tp -98.0 -34.93 10.61 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 113.349 -1.75 . . . . 0.0 111.593 169.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -104.26 -50.22 3.4 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -167.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 172.39 -30.9 0.11 Allowed Glycine 0 CA--C 1.543 1.785 0 CA-C-O 117.991 -1.45 . . . . 0.0 115.192 -175.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -99.69 97.47 5.8 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 127.148 2.179 . . . . 0.0 115.242 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.05 114.99 2.86 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.943 3.095 . . . . 0.0 113.249 -173.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.6 mm -47.83 124.7 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 C-N-CA 125.926 1.69 . . . . 0.0 111.906 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -108.63 113.0 25.62 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 124.479 1.112 . . . . 0.0 111.584 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mp -88.64 137.93 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 . . . . . 0 C--N 1.32 -0.679 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 172.153 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.7 m . . . . . 0 CA--C 1.519 -0.232 0 CA-C-O 121.995 0.902 . . . . 0.0 108.832 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.3 tp -100.33 133.23 45.06 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 125.083 1.353 . . . . 0.0 112.163 -167.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -82.26 130.45 35.1 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.143 1.377 . . . . 0.0 114.042 177.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 t -145.39 128.45 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 124.941 1.296 . . . . 0.0 107.581 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.5 -176.51 14.45 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 126.308 1.908 . . . . 0.0 110.581 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.5 t30 71.67 16.78 5.68 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.846 2.059 . . . . 0.0 114.085 -172.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.85 139.57 58.35 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 127.295 2.238 . . . . 0.0 110.392 -172.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.416 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 4.6 mt-10 -60.41 162.13 6.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 124.414 2.054 . . . . 0.0 116.109 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.1 p -68.94 -28.14 66.38 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.888 1.675 . . . . 0.0 111.615 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.1 tppt? -107.11 9.18 30.45 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 131.056 3.743 . . . . 0.0 115.649 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 p -59.7 161.73 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.127 1.371 . . . . 0.0 112.885 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 p -158.56 165.03 35.48 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.754 1.622 . . . . 0.0 112.321 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -59.47 -27.52 66.18 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.581 -0.7 . . . . 0.0 110.156 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -67.53 -44.17 78.99 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.834 1.254 . . . . 0.0 111.831 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.3 tp -72.44 -39.75 67.57 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.531 0.732 . . . . 0.0 111.095 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.414 ' HB2' HG12 ' A' ' 46' ' ' VAL . 71.6 mt -63.52 -40.85 98.13 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.486 1.039 . . . . 0.0 110.653 174.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -59.16 -46.41 88.47 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.27 -33.13 67.24 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.504 1.047 . . . . 0.0 112.53 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.2 tt -69.03 -41.51 77.6 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.317 0.647 . . . . 0.0 112.206 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -89.57 8.57 30.56 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.806 1.242 . . . . 0.0 113.941 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -56.91 -48.79 77.4 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.263 -1.523 . . . . 0.0 113.131 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -74.19 -9.46 58.64 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.88 36.52 1.4 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -166.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.58 -165.83 40.97 Favored Glycine 0 CA--C 1.542 1.744 0 C-N-CA 123.764 0.697 . . . . 0.0 114.322 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -81.43 85.51 1.74 Allowed 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 121.446 1.431 . . . . 0.0 114.891 -168.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.82 129.92 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 126.648 1.979 . . . . 0.0 108.882 166.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mt -91.04 -54.49 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.17 1.788 . . . . 0.0 111.4 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.57 158.49 43.6 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.058 1.743 . . . . 0.0 111.624 -178.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.414 HG12 ' HB2' ' A' ' 33' ' ' LEU . 91.7 t -116.22 143.26 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.667 1.587 . . . . 0.0 111.529 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -121.59 132.25 54.57 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.38 1.872 . . . . 0.0 114.932 172.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.9 mm -118.47 119.14 33.21 Favored Pre-proline 0 N--CA 1.471 0.584 0 C-N-CA 128.039 2.536 . . . . 0.0 109.745 172.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.23 172.84 15.22 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.151 2.567 . . . . 0.0 113.691 169.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -153.17 108.92 3.29 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.513 2.325 . . . . 0.0 111.461 172.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -43.45 164.52 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 130.741 3.617 . . . . 0.0 115.643 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.25 -29.0 3.4 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 114.744 1.386 . . . . 0.0 114.744 165.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -93.73 -11.07 32.27 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 168.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.55 47.2 1.69 Allowed Glycine 0 N--CA 1.477 1.395 0 O-C-N 119.767 -1.833 . . . . 0.0 115.206 174.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -138.14 141.42 32.03 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 125.926 1.69 . . . . 0.0 113.31 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.81 14.27 0.2 Allowed 'Trans proline' 0 CA--C 1.545 1.028 1 C-N-CA 125.96 4.44 . . . . 0.0 115.145 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.68 21.78 6.18 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 174.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 59.01 35.78 24.14 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 125.105 1.362 . . . . 0.0 113.93 -169.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -155.74 161.59 40.67 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.552 1.541 . . . . 0.0 113.849 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.55 167.06 15.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.982 1.313 . . . . 0.0 113.197 -174.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -120.76 156.12 32.53 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.858 0.863 . . . . 0.0 112.734 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.3 t -144.45 112.51 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 C-N-CA 123.509 0.724 . . . . 0.0 110.176 -178.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 . . . . . 0 N--CA 1.444 -0.774 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.206 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo . . . . . 0 CA--C 1.536 0.606 0 CA-C-O 120.846 0.269 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -56.06 -35.65 67.18 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.098 1.359 . . . . 0.0 112.208 -166.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.11 -21.16 64.78 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.35 -23.19 64.07 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.767 1.627 . . . . 0.0 114.167 175.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -112.61 -30.04 7.24 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.652 1.581 . . . . 0.0 111.459 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.49 -45.65 52.67 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.972 0.909 . . . . 0.0 112.532 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -111.14 -84.28 0.57 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.76 2.024 . . . . 0.0 107.802 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 17.27 70.01 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 128.668 2.787 . . . . 0.0 115.264 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.6 19.88 0.24 Allowed Glycine 0 N--CA 1.469 0.835 0 N-CA-C 116.706 1.442 . . . . 0.0 116.706 -175.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.99 147.5 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.233 1.013 . . . . 0.0 112.872 -163.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.48 166.77 16.15 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 123.06 1.41 . . . . 0.0 113.345 -164.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.8 mt -132.34 -19.16 2.48 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.006 -1.906 . . . . 0.0 114.67 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.409 ' HB2' ' CD ' ' A' ' 25' ' ' GLU . 55.0 m-85 -106.88 -50.82 3.03 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.357 1.863 . . . . 0.0 108.485 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 176.99 -39.44 0.1 OUTLIER Glycine 0 CA--C 1.544 1.862 0 N-CA-C 116.944 1.538 . . . . 0.0 116.944 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.416 ' HB2' ' HG3' ' A' ' 25' ' ' GLU . 1.7 mpt_? -97.47 109.23 49.35 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 126.519 1.928 . . . . 0.0 111.847 -170.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.48 121.13 8.61 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.676 2.917 . . . . 0.0 115.198 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.2 mm -51.85 132.43 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.536 1.534 . . . . 0.0 110.244 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -123.8 109.57 13.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.802 1.641 . . . . 0.0 111.739 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -92.74 136.18 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 O-C-N 121.655 -0.653 . . . . 0.0 110.049 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 117.769 2.507 . . . . 0.0 117.769 -178.507 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.557 1.241 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.4 tp -89.94 121.24 31.86 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 130.06 3.344 . . . . 0.0 112.28 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -75.83 138.33 41.07 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.451 1.023 . . . . 0.0 112.397 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.3 t -139.31 117.99 12.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 O-C-N 121.222 -0.924 . . . . 0.0 109.915 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.55 -173.65 15.92 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 122.303 0.946 . . . . 0.0 112.457 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.9 t30 65.83 35.66 6.57 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.679 1.191 . . . . 0.0 111.138 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 58' ' ' GLN . 1.7 mm? -70.53 163.93 25.86 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.961 2.105 . . . . 0.0 111.35 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.41 161.9 17.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 123.624 1.678 . . . . 0.0 114.998 174.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.8 p -75.14 -24.16 57.93 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.999 1.32 . . . . 0.0 110.162 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -103.01 16.76 25.78 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.766 1.626 . . . . 0.0 113.357 171.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.8 p -66.23 153.02 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.5 p -156.43 162.62 39.99 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.949 2.1 . . . . 0.0 112.342 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -64.7 -23.03 67.12 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.223 1.009 . . . . 0.0 112.016 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -66.85 -46.03 76.36 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 118.059 -0.972 . . . . 0.0 112.149 170.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.6 tp -64.74 -43.25 93.99 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.915 0.864 . . . . 0.0 109.562 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.1 mt -65.19 -33.81 76.89 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.04 -1.038 . . . . 0.0 113.161 178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -70.1 -45.79 66.21 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.153 -0.967 . . . . 0.0 112.168 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.69 -23.33 66.12 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 121.512 -0.742 . . . . 0.0 112.684 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 tt -81.39 -44.59 17.34 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.184 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -84.94 -20.97 29.83 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.168 1.349 . . . . 0.0 112.505 -170.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -52.42 -34.98 50.86 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 167.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -58.51 -32.71 69.08 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.503 2.321 . . . . 0.0 114.683 167.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.62 -12.86 55.48 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-O 121.357 0.599 . . . . 0.0 110.696 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.2 -163.56 26.33 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 126.909 2.195 . . . . 0.0 111.934 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -82.02 88.28 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 CA-C-N 120.559 2.18 . . . . 0.0 112.737 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -65.56 141.76 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 121.169 -0.957 . . . . 0.0 113.156 176.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.415 HG21 ' HE3' ' A' ' 45' ' ' LYS . 41.9 mm -71.05 -48.92 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.415 ' HE3' HG21 ' A' ' 44' ' ' ILE . 11.2 ptpt -171.44 161.35 6.33 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.161 1.784 . . . . 0.0 111.891 -171.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 82.9 t -125.59 153.47 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 126.37 1.868 . . . . 0.0 110.871 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -128.15 141.27 51.53 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.11 2.564 . . . . 0.0 110.509 169.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mm -121.01 125.31 27.06 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 126.906 2.082 . . . . 0.0 108.727 163.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.86 172.14 15.15 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.779 2.986 . . . . 0.0 112.878 170.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -153.72 126.48 8.23 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 127.457 2.303 . . . . 0.0 110.774 164.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -55.57 163.3 1.34 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 112.128 -2.305 . . . . 0.0 111.487 162.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.96 -25.15 1.25 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 167.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -100.25 1.64 41.99 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.41 1.084 . . . . 0.0 113.304 176.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.78 39.88 4.82 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 120.92 -1.113 . . . . 0.0 115.449 170.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.418 ' CD ' ' HD2' ' A' ' 56' ' ' PRO . 3.0 tppt? -134.42 140.84 36.95 Favored Pre-proline 0 N--CA 1.476 0.836 0 CA-C-N 119.819 1.809 . . . . 0.0 114.68 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.418 ' HD2' ' CD ' ' A' ' 55' ' ' LYS . 53.6 Cg_endo -68.17 12.44 0.23 Allowed 'Trans proline' 0 CA--C 1.551 1.353 0 C-N-CA 124.124 3.216 . . . . 0.0 117.834 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.75 27.46 7.01 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 119.538 -1.976 . . . . 0.0 115.145 176.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 33.8 mt-30 55.05 37.35 28.76 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -150.91 160.58 43.81 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.189 1.396 . . . . 0.0 112.151 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.03 178.86 9.88 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.838 2.055 . . . . 0.0 109.057 175.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -137.72 153.16 49.8 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.7 t -141.26 138.6 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 126.198 1.799 . . . . 0.0 110.284 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 . . . . . 0 CA--C 1.541 0.604 0 C-N-CA 124.248 1.019 . . . . 0.0 110.938 172.88 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 CA--C 1.532 0.41 0 N-CA-C 112.758 0.253 . . . . 0.0 112.758 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -52.91 -44.41 66.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.782 1.233 . . . . 0.0 110.813 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.14 -31.64 63.53 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 ttp -66.42 -14.47 62.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.924 1.238 . . . . 0.0 113.244 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -105.92 -35.79 7.19 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 155.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.11 -55.51 21.5 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.477 0.711 . . . . 0.0 111.483 -171.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -91.96 -92.32 0.15 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 27.23 70.7 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 127.459 2.304 . . . . 0.0 113.908 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.7 14.5 0.68 Allowed Glycine 0 CA--C 1.535 1.34 0 N-CA-C 115.461 0.945 . . . . 0.0 115.461 -174.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -130.55 145.25 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 -165.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.38 172.65 10.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.73 2.012 . . . . 0.0 110.126 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 57.9 mt -118.71 -48.71 2.47 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.999 0.92 . . . . 0.0 110.208 159.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -51.37 -59.24 4.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.748 1.219 . . . . 0.0 112.346 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.53 -64.16 0.07 OUTLIER Glycine 0 N--CA 1.47 0.931 0 N-CA-C 116.458 1.343 . . . . 0.0 116.458 -162.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -106.07 119.44 52.16 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 118.097 0.948 . . . . 0.0 111.031 -168.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -77.62 132.61 12.24 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.709 2.273 . . . . 0.0 113.926 -166.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.3 mm -59.38 119.81 4.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 123.811 0.844 . . . . 0.0 111.394 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -108.19 103.15 12.28 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.902 2.081 . . . . 0.0 110.345 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.5 mp -74.83 141.61 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 . . . . . 0 CA--C 1.536 0.442 0 C-N-CA 126.779 2.032 . . . . 0.0 108.141 -179.067 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.474 0.767 0 CA-C-O 122.54 1.162 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.1 tp -116.44 124.04 49.0 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.903 2.481 . . . . 0.0 112.722 -161.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -74.65 132.89 42.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 122.198 0.999 . . . . 0.0 109.82 175.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.6 t -129.19 125.42 62.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 169.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.84 -169.23 13.78 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 122.456 1.031 . . . . 0.0 113.035 168.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.2 t30 65.92 29.67 10.2 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 128.545 2.738 . . . . 0.0 114.258 -173.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.14 156.67 38.3 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.764 1.225 . . . . 0.0 109.413 -175.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.475 ' HG2' ' H ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.4 165.12 24.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 123.914 1.816 . . . . 0.0 114.126 172.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.3 p -68.29 -14.78 63.24 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 128.49 2.716 . . . . 0.0 110.392 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -113.59 5.24 16.48 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 129.19 2.996 . . . . 0.0 114.435 -176.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.14 154.28 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 120.131 -1.606 . . . . 0.0 114.213 -170.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.5 p -148.46 171.4 16.13 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 127.218 2.207 . . . . 0.0 111.343 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -77.41 -15.89 59.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.49 1.516 . . . . 0.0 111.393 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -76.24 -45.99 30.3 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.63 1.572 . . . . 0.0 109.407 170.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.8 tp -63.95 -39.31 93.85 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.621 0.724 . . . . 0.0 110.778 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 92.6 mt -70.83 -48.44 54.04 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.569 0.747 . . . . 0.0 111.969 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -58.31 -43.03 87.98 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -65.25 -32.18 73.72 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.743 0.817 . . . . 0.0 110.986 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 tt -76.29 -43.27 42.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.817 2.047 . . . . 0.0 113.193 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.444 ' CD2' HG22 ' A' ' 62' ' ' VAL . 23.9 m-85 -87.48 -6.16 58.5 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.012 0.925 . . . . 0.0 112.018 -173.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -53.89 -43.01 69.29 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.314 0.646 . . . . 0.0 109.745 160.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -55.96 -25.95 46.02 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 173.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.38 -8.45 32.44 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.239 1.019 . . . . 0.0 112.681 -171.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.74 -153.55 17.55 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.643 1.116 . . . . 0.0 113.593 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.05 107.52 2.48 Favored 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 123.497 2.798 . . . . 0.0 111.936 -165.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.0 t -94.96 126.37 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 128.266 2.627 . . . . 0.0 109.666 169.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mt -78.37 -48.71 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.947 1.299 . . . . 0.0 109.672 173.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.57 163.78 19.34 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.317 1.047 . . . . 0.0 113.266 -175.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 82.9 t -122.94 145.27 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.74 1.616 . . . . 0.0 112.197 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -126.11 121.29 32.45 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.133 2.173 . . . . 0.0 112.603 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.0 mm -110.38 120.76 43.31 Favored Pre-proline 0 N--CA 1.467 0.405 0 C-N-CA 126.487 1.915 . . . . 0.0 107.241 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -74.11 172.25 16.35 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.018 2.479 . . . . 0.0 111.545 168.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -156.87 115.08 3.25 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.611 1.964 . . . . 0.0 108.413 169.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -56.38 168.61 0.52 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 129.115 2.966 . . . . 0.0 111.696 164.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.4 pptp? -47.0 -32.58 4.01 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.469 1.508 . . . . 0.0 114.272 170.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.8 -18.04 61.51 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.802 1.641 . . . . 0.0 114.327 173.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.32 56.98 2.72 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -175.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -143.15 133.18 12.03 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.286 1.034 . . . . 0.0 113.328 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.99 19.67 0.13 Allowed 'Trans proline' 0 CA--C 1.55 1.325 0 C-N-CA 124.978 3.785 . . . . 0.0 116.538 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.417 ' HB2' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 52.02 22.02 1.71 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 174.233 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 57.72 36.53 26.66 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 116.817 2.154 . . . . 0.0 116.817 -166.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 57' ' ' LYS . 13.5 p90 -153.93 167.54 29.38 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.926 1.29 . . . . 0.0 113.453 175.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -163.95 170.06 17.19 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.979 2.112 . . . . 0.0 110.295 176.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -127.38 146.49 50.45 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.862 1.265 . . . . 0.0 110.932 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.444 HG22 ' CD2' ' A' ' 37' ' ' PHE . 20.8 t -125.91 132.67 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 126.581 1.953 . . . . 0.0 110.247 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 CA--C 1.545 0.762 0 C-N-CA 124.596 1.158 . . . . 0.0 108.75 176.443 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 N--CA 1.447 -1.255 0 CA-C-O 123.932 1.555 . . . . 0.0 113.912 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -68.98 -40.94 78.53 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.665 2.386 . . . . 0.0 111.007 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.94 -28.92 66.71 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.06 -1.025 . . . . 0.0 113.239 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.0 ttp -64.19 -21.36 66.54 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.733 1.213 . . . . 0.0 113.609 -176.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -97.63 -29.04 13.65 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.504 1.522 . . . . 0.0 112.115 168.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.82 -40.96 13.6 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.186 -0.946 . . . . 0.0 113.238 -169.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -107.68 -97.68 0.37 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.055 1.342 . . . . 0.0 110.83 176.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 37.83 59.13 1.35 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.37 1.868 . . . . 0.0 115.584 175.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.17 16.47 0.11 Allowed Glycine 0 CA--C 1.519 0.311 0 O-C-N 120.869 -1.145 . . . . 0.0 114.236 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -128.71 149.46 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 117.829 0.814 . . . . 0.0 109.509 -163.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.21 172.68 9.68 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.737 1.215 . . . . 0.0 110.802 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.9 tp -133.59 -19.84 2.08 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.867 0.867 . . . . 0.0 109.806 163.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -72.82 -68.59 0.47 Allowed 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.164 -0.96 . . . . 0.0 112.399 167.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.17 -51.36 0.07 OUTLIER Glycine 0 C--N 1.339 0.735 0 N-CA-C 116.985 1.554 . . . . 0.0 116.985 -168.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.475 ' H ' ' HG2' ' A' ' 25' ' ' GLU . 5.8 mpt_? -100.96 121.87 50.8 Favored Pre-proline 0 N--CA 1.462 0.151 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -177.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.2 126.91 10.15 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.256 1.97 . . . . 0.0 113.963 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.1 mm -51.01 126.95 6.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.696 1.198 . . . . 0.0 109.758 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -121.86 116.81 25.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.206 1.802 . . . . 0.0 112.753 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.4 mp -91.34 134.07 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.178 -0.951 . . . . 0.0 111.206 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 . . . . . 0 CA--C 1.544 0.735 0 CA-C-O 123.831 1.777 . . . . 0.0 115.396 175.979 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.467 0.421 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.2 tp -92.55 140.75 29.24 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 128.363 2.665 . . . . 0.0 115.013 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -89.63 130.19 35.96 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 125.869 1.667 . . . . 0.0 110.033 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.2 t -132.4 128.61 58.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 120.756 -1.215 . . . . 0.0 107.78 173.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.59 -171.35 12.93 Favored Glycine 0 CA--C 1.543 1.794 0 CA-C-O 122.485 1.047 . . . . 0.0 111.854 171.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.6 t30 62.68 33.77 15.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.1 1.76 . . . . 0.0 112.897 -175.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -70.26 154.43 41.92 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.164 1.786 . . . . 0.0 111.145 177.192 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.88 160.67 32.38 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 125.082 2.373 . . . . 0.0 114.059 173.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.6 p -67.85 -24.83 65.3 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 111.139 -2.755 . . . . 0.0 111.868 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -118.73 22.48 11.98 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 127.424 2.289 . . . . 0.0 115.938 174.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.425 ' CG2' ' H ' ' A' ' 29' ' ' THR . 8.5 p -60.71 170.77 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 116.733 2.123 . . . . 0.0 116.733 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.425 ' H ' ' CG2' ' A' ' 28' ' ' VAL . 10.6 p -165.88 156.59 13.21 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 128.113 2.565 . . . . 0.0 111.349 -177.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.71 -17.75 17.07 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.576 2.35 . . . . 0.0 110.546 174.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -78.48 -38.51 40.83 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.907 1.683 . . . . 0.0 112.097 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.9 tp -70.25 -47.81 59.69 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.004 1.322 . . . . 0.0 108.576 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.9 mt -59.04 -50.96 72.09 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.082 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -62.5 -41.5 98.87 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.318 1.417 . . . . 0.0 111.393 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.02 -23.69 64.11 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.357 1.244 . . . . 0.0 114.357 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.65 -39.85 35.79 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.793 1.637 . . . . 0.0 112.737 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -89.87 1.1 56.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.037 0.935 . . . . 0.0 111.792 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -64.8 -35.03 79.79 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.55 1.14 . . . . 0.0 113.9 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -79.21 -17.53 54.67 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.905 0.482 . . . . 0.0 110.694 167.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.69 21.59 0.65 Allowed 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.702 -1.249 . . . . 0.0 113.762 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.19 -125.62 7.47 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.23 0.919 . . . . 0.0 114.461 173.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -71.29 127.0 12.85 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 CA-C-N 118.38 1.09 . . . . 0.0 110.615 -173.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.1 t -138.35 124.82 25.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 168.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 mm -89.05 -54.68 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 125.443 1.497 . . . . 0.0 108.481 171.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -151.7 153.37 34.24 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.918 0.887 . . . . 0.0 113.316 -173.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.8 t -117.79 152.1 19.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 126.876 2.07 . . . . 0.0 108.782 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -129.22 122.91 30.69 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.372 1.869 . . . . 0.0 114.465 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.5 mm -106.14 117.37 57.61 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 126.165 1.786 . . . . 0.0 110.573 168.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.5 165.07 33.04 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.704 3.603 . . . . 0.0 111.834 165.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -155.31 117.12 4.08 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 126.963 2.105 . . . . 0.0 109.297 172.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.408 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 28.8 t0 -55.22 169.53 0.26 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 128.453 2.701 . . . . 0.0 114.269 175.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.27 -40.69 25.64 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.155 -0.341 . . . . 0.0 111.826 164.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -81.97 3.64 25.71 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 126.045 1.738 . . . . 0.0 113.506 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.94 42.37 30.38 Favored Glycine 0 N--CA 1.474 1.226 0 C-N-CA 126.377 1.941 . . . . 0.0 113.607 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -129.79 138.31 32.83 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 119.241 1.521 . . . . 0.0 113.063 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.89 9.61 0.35 Allowed 'Trans proline' 0 CA--C 1.54 0.824 1 C-N-CA 126.699 4.933 . . . . 0.0 115.372 176.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER 58.73 26.92 15.24 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 169.41 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 15.9 mt-30 59.47 24.93 13.64 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.991 1.316 . . . . 0.0 114.31 -172.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -150.9 165.91 32.2 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 119.93 -1.731 . . . . 0.0 113.408 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -169.0 177.34 4.96 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 128.214 2.606 . . . . 0.0 112.744 -172.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -131.43 158.4 40.9 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 126.154 1.781 . . . . 0.0 115.414 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.5 t -143.98 129.68 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 126.301 1.84 . . . . 0.0 111.487 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 . . . . . 0 N--CA 1.474 0.731 0 C-N-CA 125.878 1.671 . . . . 0.0 114.618 178.339 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 N--CA 1.457 -0.644 0 N-CA-C 113.958 0.714 . . . . 0.0 113.958 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -48.1 -41.92 27.63 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 125.205 1.402 . . . . 0.0 114.606 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.35 -20.56 63.85 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 123.855 0.862 . . . . 0.0 111.405 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.1 ttp -75.08 -22.39 58.33 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 119.12 0.873 . . . . 0.0 112.347 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -89.02 -30.58 18.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.049 0.94 . . . . 0.0 111.661 167.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tp -81.33 -51.73 8.05 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.71 -89.66 0.32 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.587 1.085 . . . . 0.0 113.348 -171.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 41.84 63.66 1.26 Allowed 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 125.251 1.421 . . . . 0.0 114.485 170.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.9 16.42 1.79 Allowed Glycine 0 CA--C 1.537 1.459 0 O-C-N 119.19 -2.194 . . . . 0.0 115.28 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.64 146.83 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.059 1.344 . . . . 0.0 112.163 -167.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.57 168.98 15.91 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -175.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.7 mt -130.17 -16.68 3.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 112.995 -1.911 . . . . 0.0 112.707 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -103.03 -44.11 5.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.849 0.859 . . . . 0.0 112.111 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.28 -38.8 0.28 Allowed Glycine 0 CA--C 1.532 1.155 0 N-CA-C 115.752 1.061 . . . . 0.0 115.752 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -93.12 114.43 62.72 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 125.041 1.336 . . . . 0.0 108.99 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.8 128.9 16.65 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 124.578 3.519 . . . . 0.0 113.492 -175.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.8 mm -61.32 124.96 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.329 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -108.33 117.67 34.76 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 128.506 2.722 . . . . 0.0 110.392 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -93.08 140.91 15.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 . . . . . 0 CA--C 1.54 0.577 0 C-N-CA 124.084 0.954 . . . . 0.0 108.625 174.09 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.9 tp -83.78 128.08 34.27 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.811 2.045 . . . . 0.0 110.266 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -82.44 140.92 33.14 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 t -143.46 130.34 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.743 0.817 . . . . 0.0 109.089 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.96 -172.28 13.66 Favored Glycine 0 CA--C 1.546 1.99 0 C-N-CA 125.365 1.46 . . . . 0.0 112.925 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.4 t30 66.38 24.82 10.43 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 128.447 2.699 . . . . 0.0 113.693 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.39 137.4 57.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.095 1.358 . . . . 0.0 111.009 -178.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.41 161.42 11.72 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 176.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.0 p -69.07 -12.01 61.3 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 126.565 1.946 . . . . 0.0 114.148 -168.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.23 5.28 7.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.829 2.852 . . . . 0.0 113.114 -175.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.2 p -54.06 158.26 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.97 1.308 . . . . 0.0 113.861 -175.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.4 p -155.56 169.17 24.92 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.749 2.02 . . . . 0.0 109.381 -177.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -64.83 -34.14 77.65 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.851 1.26 . . . . 0.0 108.367 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -66.02 -32.01 73.24 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.697 1.599 . . . . 0.0 114.607 175.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -72.2 -49.55 34.54 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.308 1.413 . . . . 0.0 108.552 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 79.8 mt -59.62 -48.73 80.51 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -60.77 -37.6 82.4 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.244 -0.91 . . . . 0.0 112.991 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -60.42 -50.63 72.83 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.763 0.825 . . . . 0.0 109.755 172.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 tt -72.83 -40.17 66.0 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.717 2.407 . . . . 0.0 113.529 -173.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -81.2 -1.78 46.09 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.077 1.351 . . . . 0.0 111.654 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -70.76 -25.78 63.06 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 121.33 1.877 . . . . 0.0 110.464 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -70.05 -29.07 66.0 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.179 1.392 . . . . 0.0 112.611 169.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.38 -20.04 24.46 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 138.22 -149.49 20.52 Favored Glycine 0 C--O 1.235 0.176 0 O-C-N 121.4 -0.813 . . . . 0.0 113.976 171.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.18 118.69 4.06 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 121.936 1.757 . . . . 0.0 110.414 -173.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.6 m -117.54 118.76 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.128 1.371 . . . . 0.0 109.514 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.1 mm -61.22 -53.49 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.717 1.607 . . . . 0.0 110.549 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.33 167.88 26.49 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 131.563 3.945 . . . . 0.0 109.25 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.5 t -116.81 163.54 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 128.368 2.667 . . . . 0.0 111.422 170.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -127.1 135.48 50.81 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.82 1.648 . . . . 0.0 113.569 164.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.1 mm -118.48 124.05 28.8 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 125.364 1.465 . . . . 0.0 108.145 167.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.67 167.33 27.45 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.926 2.417 . . . . 0.0 112.798 166.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -160.74 119.38 2.56 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 127.505 2.322 . . . . 0.0 108.58 172.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.81 173.28 0.21 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.626 1.17 . . . . 0.0 111.873 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -23.79 29.29 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 120.498 -1.376 . . . . 0.0 112.48 162.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -80.62 -2.77 47.85 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.492 1.117 . . . . 0.0 112.554 175.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.24 45.19 56.82 Favored Glycine 0 C--N 1.341 0.828 0 O-C-N 120.341 -1.475 . . . . 0.0 109.959 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.42 132.01 19.71 Favored Pre-proline 0 N--CA 1.465 0.293 0 C-N-CA 123.392 0.677 . . . . 0.0 111.828 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.09 15.58 0.31 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 125.241 3.961 . . . . 0.0 116.105 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.77 24.62 2.53 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 176.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 55.85 30.94 16.75 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -171.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -144.88 161.75 38.54 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 120.222 -1.549 . . . . 0.0 112.41 -176.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.05 -177.78 5.99 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.079 2.151 . . . . 0.0 112.728 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -137.44 157.2 47.08 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.233 1.813 . . . . 0.0 113.19 171.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.2 t -128.41 140.58 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.796 1.638 . . . . 0.0 111.848 169.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 . . . . . 0 CA--C 1.539 0.538 0 C-N-CA 125.161 1.384 . . . . 0.0 111.111 178.008 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo . . . . . 0 CA--C 1.541 0.828 0 N-CA-C 111.7 -0.154 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -52.91 -42.36 65.3 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.885 1.274 . . . . 0.0 110.336 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.74 -27.67 65.15 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 175.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.8 tmm? -66.3 -26.82 67.49 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.302 1.441 . . . . 0.0 108.862 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -98.35 -30.66 12.45 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -79.69 -34.29 40.35 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.736 1.214 . . . . 0.0 114.211 -174.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.3 -82.11 0.6 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.94 1.296 . . . . 0.0 111.082 -175.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 19.99 70.52 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 127.97 2.508 . . . . 0.0 114.314 -176.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.79 9.78 0.28 Allowed Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 pp -135.86 158.24 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 119.306 1.553 . . . . 0.0 113.558 -164.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.44 172.8 8.02 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -172.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.4 tp -140.19 22.95 2.4 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.958 2.103 . . . . 0.0 112.812 -175.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -149.47 -49.66 0.14 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.621 1.968 . . . . 0.0 110.174 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.0 -48.89 0.16 Allowed Glycine 0 CA--C 1.541 1.658 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -95.52 124.25 53.7 Favored Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 120.743 2.271 . . . . 0.0 110.837 -175.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.28 126.6 11.84 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 124.146 3.231 . . . . 0.0 113.129 -170.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.6 mm -57.54 122.91 7.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.776 0.798 . . . . 0.0 109.442 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -109.02 115.75 30.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.15 1.78 . . . . 0.0 108.812 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 mp -92.58 144.58 9.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.668 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 N--CA 1.468 0.453 0 C-N-CA 125.534 1.534 . . . . 0.0 111.966 179.005 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.0 m . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 123.595 1.664 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.5 tp -107.23 132.32 53.21 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 127.576 2.35 . . . . 0.0 109.956 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -86.62 137.02 32.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 123.442 1.592 . . . . 0.0 112.163 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.2 t -132.62 122.66 47.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.334 -175.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.91 -173.42 14.43 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.495 1.521 . . . . 0.0 112.293 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 t30 61.82 23.92 14.15 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.913 1.685 . . . . 0.0 113.637 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.58 140.94 57.98 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 125.5 1.52 . . . . 0.0 109.258 -177.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.24 165.61 1.93 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 123.088 1.423 . . . . 0.0 113.805 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.4 p -67.25 -26.39 66.55 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.158 -0.964 . . . . 0.0 112.844 -172.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -116.97 7.02 13.06 Favored 'General case' 0 N--CA 1.474 0.765 1 C-N-CA 132.547 4.339 . . . . 0.0 111.31 -168.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.6 156.39 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.908 1.683 . . . . 0.0 112.606 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.2 p -151.13 158.68 44.32 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.508 1.523 . . . . 0.0 110.082 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -59.15 -30.22 67.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.18 0.992 . . . . 0.0 109.59 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -66.07 -42.12 89.85 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.225 0.92 . . . . 0.0 112.823 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.8 tp -66.18 -45.28 81.43 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.579 0.627 . . . . 0.0 109.315 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 91.8 mt -58.25 -49.53 76.77 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.43 1.492 . . . . 0.0 112.833 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -60.32 -42.57 95.88 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.85 -1.156 . . . . 0.0 111.654 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -65.87 -34.52 78.34 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.969 1.259 . . . . 0.0 111.614 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.0 tt -70.86 -50.03 39.69 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.701 1.6 . . . . 0.0 111.966 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.413 ' CD2' HG22 ' A' ' 62' ' ' VAL . 55.6 m-85 -83.09 -15.46 50.75 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -170.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -51.4 -33.07 28.56 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 168.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -74.74 -18.25 60.52 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.185 0.994 . . . . 0.0 110.896 175.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.56 11.88 27.17 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.644 1.578 . . . . 0.0 113.328 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.57 -164.11 13.47 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 127.541 2.496 . . . . 0.0 115.51 167.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.74 101.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 123.484 2.789 . . . . 0.0 113.112 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.4 t -98.29 115.79 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.6 mm -69.21 -54.3 20.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 123.005 0.522 . . . . 0.0 111.077 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -163.08 157.79 21.17 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.952 2.101 . . . . 0.0 110.789 -172.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.2 t -117.35 152.63 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 128.699 2.8 . . . . 0.0 111.267 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -127.16 126.72 43.36 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 126.948 2.099 . . . . 0.0 112.384 170.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.4 mm -106.64 117.08 57.78 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.997 2.119 . . . . 0.0 108.948 165.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.0 163.16 34.97 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.866 2.377 . . . . 0.0 110.434 165.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -155.27 112.34 3.29 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.26 2.224 . . . . 0.0 110.767 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.72 175.76 0.08 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.746 2.418 . . . . 0.0 113.192 175.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -52.95 -26.33 14.77 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.742 1.217 . . . . 0.0 114.148 173.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -93.9 -9.81 35.94 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.79 61.13 1.11 Allowed Glycine 0 N--CA 1.47 0.9 0 C-N-CA 125.896 1.712 . . . . 0.0 114.331 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -144.54 132.88 10.85 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 118.65 1.225 . . . . 0.0 113.555 -172.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.38 8.48 0.68 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.397 3.398 . . . . 0.0 115.78 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.76 18.32 3.69 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 120.417 -1.427 . . . . 0.0 114.438 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 63.21 31.17 15.73 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -169.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -146.56 167.99 22.35 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.077 1.751 . . . . 0.0 111.484 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -163.68 172.15 14.64 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 128.807 2.843 . . . . 0.0 111.217 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -124.9 149.45 47.56 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.34 -1.475 . . . . 0.0 110.879 176.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.413 HG22 ' CD2' ' A' ' 37' ' ' PHE . 20.5 t -132.08 136.86 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.038 1.335 . . . . 0.0 109.601 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 . . . . . 0 CA--C 1.548 0.872 0 C-N-CA 126.088 1.755 . . . . 0.0 108.508 -175.938 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 CA--C 1.557 1.641 0 N-CA-C 114.901 1.077 . . . . 0.0 114.901 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -48.16 -46.16 34.32 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.841 1.657 . . . . 0.0 114.635 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.79 -24.37 61.7 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.461 -1.4 . . . . 0.0 113.509 -176.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.0 ttp -68.94 -28.18 66.41 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.079 1.352 . . . . 0.0 110.865 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -82.84 -41.0 19.57 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.995 0.918 . . . . 0.0 110.438 171.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.3 tp -83.62 -36.63 23.72 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -161.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.8 mt -113.79 -86.02 0.59 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.31 1.444 . . . . 0.0 109.08 -169.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.264 0.2 OUTLIER 26.82 59.48 0.08 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.907 2.883 . . . . 0.0 113.419 172.429 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.36 11.99 0.14 Allowed Glycine 0 CA--C 1.538 1.501 0 CA-C-O 118.556 -1.136 . . . . 0.0 115.42 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -134.55 154.35 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 119.745 1.772 . . . . 0.0 112.399 -168.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.23 178.35 2.45 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.496 1.918 . . . . 0.0 112.675 -172.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -140.15 -22.32 0.85 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.901 2.48 . . . . 0.0 112.461 170.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -83.26 -49.12 9.73 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.211 1.404 . . . . 0.0 110.262 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 170.81 -50.57 0.19 Allowed Glycine 0 CA--C 1.535 1.324 0 N-CA-C 115.987 1.155 . . . . 0.0 115.987 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -102.63 117.56 60.57 Favored Pre-proline 0 N--CA 1.479 1.022 0 CA-C-N 119.424 1.612 . . . . 0.0 109.587 -172.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.03 128.93 20.66 Favored 'Trans proline' 0 C--N 1.347 0.474 1 C-N-CA 125.366 4.044 . . . . 0.0 113.375 -175.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.0 mm -61.65 125.27 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.556 1.142 . . . . 0.0 108.976 -176.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -110.64 105.02 13.78 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 124.724 1.21 . . . . 0.0 107.947 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -80.41 145.06 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 . . . . . 0 N--CA 1.468 0.445 0 C-N-CA 128.356 2.662 . . . . 0.0 108.966 178.297 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.362 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.9 m -108.59 -48.6 3.29 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.446 2.298 . . . . 0.0 113.211 -174.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -141.8 144.71 34.08 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.509 1.924 . . . . 0.0 110.475 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -107.53 -30.0 8.88 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.424 1.89 . . . . 0.0 113.72 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -117.27 27.33 9.16 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.538 1.535 . . . . 0.0 114.808 -164.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -117.46 147.94 42.27 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 118.085 2.624 . . . . 0.0 118.085 -171.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.87 128.8 39.01 Favored 'General case' 0 C--N 1.345 0.407 0 C-N-CA 124.955 1.302 . . . . 0.0 114.171 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -88.8 53.73 2.79 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.327 1.851 . . . . 0.0 114.321 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -127.62 149.71 50.06 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.843 1.657 . . . . 0.0 107.435 169.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -55.34 -47.9 75.02 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -163.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.53 174.21 14.72 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 118.039 2.607 . . . . 0.0 118.039 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 34.0 mt -98.06 136.49 38.24 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.505 2.722 . . . . 0.0 113.082 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -161.11 -61.15 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.767 1.227 . . . . 0.0 113.69 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 51.33 7.82 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.31 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 -164.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.4 159.81 42.48 Favored 'General case' 0 C--N 1.343 0.286 0 O-C-N 120.027 -1.671 . . . . 0.0 114.138 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -116.52 -26.72 6.97 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 128.982 2.913 . . . . 0.0 111.055 -173.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.4 mtt-85 -114.82 -7.04 12.66 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 126.601 1.96 . . . . 0.0 112.128 176.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m -123.09 135.29 54.33 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.519 0.728 . . . . 0.0 111.214 -171.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.7 tp -92.33 129.0 38.38 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.478 1.511 . . . . 0.0 110.513 -176.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -83.23 130.58 35.09 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.235 0.54 . . . . 0.0 110.001 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.1 t -122.9 129.37 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 120.783 -1.198 . . . . 0.0 108.539 172.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.3 -175.8 14.19 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.314 1.911 . . . . 0.0 111.086 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.8 t30 66.67 19.49 10.78 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.207 2.203 . . . . 0.0 113.458 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.1 145.76 54.98 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 125.411 1.484 . . . . 0.0 111.083 -168.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.458 ' CD ' ' HB2' ' A' ' 83' ' ' TYR . 10.6 mt-10 -60.87 161.65 7.88 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 177.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -73.42 -32.15 64.25 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.563 1.145 . . . . 0.0 113.168 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? -100.14 15.9 25.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.975 2.11 . . . . 0.0 113.417 172.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.0 p -62.54 156.18 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.0 p -156.03 161.57 40.43 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.508 2.323 . . . . 0.0 110.953 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -55.79 -31.76 62.91 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.535 1.534 . . . . 0.0 111.797 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.45 -35.78 79.88 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.177 1.391 . . . . 0.0 113.157 175.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.3 tp -72.31 -39.23 68.38 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 122.616 1.198 . . . . 0.0 108.598 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 89.4 mt -65.15 -54.66 26.36 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.412 1.085 . . . . 0.0 112.644 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -56.33 -37.18 69.61 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.193 1.36 . . . . 0.0 110.189 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -73.9 -37.11 64.78 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tt -67.5 -43.7 80.25 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.337 1.426 . . . . 0.0 111.156 172.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -82.96 -9.81 59.1 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -46.83 -37.42 8.69 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.35 1.86 . . . . 0.0 112.701 164.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -73.0 -30.6 63.91 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.173 1.389 . . . . 0.0 110.908 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HA ' HD11 ' A' ' 76' ' ' LEU . . . -85.08 -2.99 58.63 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -166.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.59 -167.05 12.21 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 126.754 2.121 . . . . 0.0 111.375 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -48.77 121.02 5.95 Favored 'Trans proline' 0 C--N 1.346 0.426 1 C-N-CA 126.484 4.789 . . . . 0.0 112.242 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.23 136.02 54.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 173.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.7 -46.92 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 123.558 0.743 . . . . 0.0 109.26 -172.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.84 158.91 36.06 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.059 2.544 . . . . 0.0 110.46 171.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.5 t -105.91 162.4 5.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 126.208 1.803 . . . . 0.0 110.742 171.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -136.72 121.32 18.39 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.337 1.855 . . . . 0.0 114.37 169.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.2 mm -107.29 120.41 47.81 Favored Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 126.267 1.827 . . . . 0.0 110.556 166.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -75.44 167.98 25.47 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 125.032 3.821 . . . . 0.0 113.036 165.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -160.91 105.12 1.35 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.307 1.843 . . . . 0.0 113.205 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -53.1 173.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 130.435 3.494 . . . . 0.0 114.31 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.58 -24.47 8.32 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 168.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -91.43 -0.43 57.63 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.458 1.503 . . . . 0.0 114.852 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.0 41.5 54.55 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.361 1.458 . . . . 0.0 113.459 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -116.25 136.99 23.15 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 124.753 1.221 . . . . 0.0 112.92 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -70.82 17.05 0.26 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.115 2.543 . . . . 0.0 115.644 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.19 20.61 3.49 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 120.627 -1.296 . . . . 0.0 113.899 175.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 62.28 33.83 16.31 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.356 1.862 . . . . 0.0 114.496 -172.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -153.79 165.13 36.98 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.318 -1.489 . . . . 0.0 110.447 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -159.14 178.38 10.09 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.007 2.123 . . . . 0.0 110.589 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -135.52 156.15 49.35 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.574 -1.329 . . . . 0.0 111.312 168.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.71 132.13 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.7 1.2 . . . . 0.0 109.57 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -88.18 139.42 30.52 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.254 -1.529 . . . . 0.0 110.006 176.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -151.79 167.63 27.65 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.219 1.008 . . . . 0.0 110.843 -160.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . 0.281 77.2 tttt -94.68 58.34 2.3 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.935 -1.103 . . . . 0.0 112.234 -157.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 53.76 42.62 31.74 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 122.3 1.048 . . . . 0.0 111.428 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -85.23 59.68 5.78 Favored 'General case' 0 CA--C 1.556 1.177 0 O-C-N 121.363 -0.836 . . . . 0.0 111.199 -171.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.2 m -81.67 -25.23 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 119.848 3.277 . . . . 0.0 119.848 -165.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -81.45 70.36 8.3 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.413 1.46 . . . . 0.0 109.043 171.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.8 t 73.52 119.14 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 128.513 2.725 . . . . 0.0 113.205 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -72.68 129.23 14.28 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 123.094 2.53 . . . . 0.0 108.441 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -60.63 -34.26 73.99 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -168.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.39 -34.57 64.47 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 117.148 -1.406 . . . . 0.0 114.166 173.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -59.68 -21.79 61.05 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 120.613 1.551 . . . . 0.0 112.563 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -104.38 -40.42 6.09 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 127.359 2.264 . . . . 0.0 113.093 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.4 HD11 ' HA ' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -66.93 -61.65 1.84 Allowed 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 123.527 0.731 . . . . 0.0 112.669 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.14 -85.13 0.2 Allowed 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.5 1.12 . . . . 0.0 108.565 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 26.81 76.85 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 125.66 1.584 . . . . 0.0 114.322 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 125.45 18.02 2.55 Favored Glycine 0 CA--C 1.549 2.166 0 N-CA-C 117.555 1.782 . . . . 0.0 117.555 177.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -129.13 156.44 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 127.848 2.459 . . . . 0.0 111.583 -171.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.416 ' HB2' ' OE2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -176.73 -176.8 0.74 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.095 0.958 . . . . 0.0 112.442 -170.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.3 mt -141.16 -11.69 0.95 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.425 1.89 . . . . 0.0 115.885 -177.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.458 ' HB2' ' CD ' ' A' ' 25' ' ' GLU . 19.8 m-85 -109.77 -48.38 3.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.65 2.38 . . . . 0.0 111.802 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 179.06 -39.23 0.08 OUTLIER Glycine 0 CA--C 1.542 1.74 0 C-N-CA 125.955 1.74 . . . . 0.0 114.411 171.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -98.91 113.6 64.69 Favored Pre-proline 0 N--CA 1.483 1.219 0 CA-C-N 121.379 2.59 . . . . 0.0 112.247 -168.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.25 134.17 47.42 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.801 2.334 . . . . 0.0 111.753 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.0 mm -63.04 127.27 22.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 O-C-N 121.457 -0.777 . . . . 0.0 109.523 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -109.83 110.52 21.53 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 124.989 1.315 . . . . 0.0 110.02 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -86.33 136.74 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 120.324 -1.485 . . . . 0.0 109.668 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -134.44 146.7 50.06 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.355 1.462 . . . . 0.0 111.632 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -162.13 168.26 22.85 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 113.771 -1.559 . . . . 0.0 113.708 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.54 -47.85 1.17 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 127.597 2.359 . . . . 0.0 115.976 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.7 m 58.76 69.19 0.75 Allowed 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 -177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 170.17 115.51 0.34 Allowed Glycine 0 CA--C 1.538 1.495 0 C-N-CA 126.07 1.795 . . . . 0.0 115.891 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.5 m -137.67 49.09 1.99 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.543 1.537 . . . . 0.0 107.938 163.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 51.7 p -150.41 139.86 21.46 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.515 1.126 . . . . 0.0 110.734 -175.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -63.64 -34.84 78.73 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.32 1.048 . . . . 0.0 111.583 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -158.76 153.72 21.43 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.838 1.255 . . . . 0.0 111.34 171.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -54.53 165.26 2.48 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.646 2.231 . . . . 0.0 114.531 170.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -81.61 -60.11 2.37 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 113.894 -1.503 . . . . 0.0 112.013 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.1 t70 . . . . . 0 C--O 1.256 1.437 0 C-N-CA 126.007 1.723 . . . . 0.0 112.357 -164.269 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.426 ' HA3' ' OE2' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.539 1.574 0 CA-C-O 121.448 0.471 . . . . 0.0 112.419 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -139.41 34.34 2.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 119.493 -2.181 . . . . 0.0 111.668 165.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.426 ' OE2' ' HA3' ' A' ' 1' ' ' GLY . 9.8 mp0 -86.96 104.36 16.21 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -162.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -130.11 -40.61 1.31 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.197 1.799 . . . . 0.0 113.12 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -85.53 10.27 13.55 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.962 1.705 . . . . 0.0 114.359 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.46 133.3 35.38 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.075 -1.016 . . . . 0.0 112.736 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.81 139.56 45.21 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.956 2.503 . . . . 0.0 110.774 170.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -139.6 -173.78 3.71 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 129.449 3.1 . . . . 0.0 108.072 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -111.15 167.35 10.34 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.084 -1.01 . . . . 0.0 111.64 160.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -74.51 -12.65 60.54 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.68 178.85 2.98 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.146 1.379 . . . . 0.0 110.636 -167.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 pp -126.43 145.94 50.28 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.817 1.647 . . . . 0.0 113.189 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.42 170.97 7.64 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 125.455 1.502 . . . . 0.0 114.127 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -146.45 159.67 43.1 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.3 156.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.89 142.15 54.12 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.215 2.206 . . . . 0.0 113.364 -172.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -160.64 143.37 13.02 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.626 1.971 . . . . 0.0 108.341 170.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -94.45 -13.18 26.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 127.71 2.404 . . . . 0.0 116.463 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 m -112.76 168.67 9.49 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.953 1.301 . . . . 0.0 109.907 -176.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.3 tp -131.28 131.01 43.54 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.797 2.439 . . . . 0.0 109.71 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -80.25 138.77 36.85 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.842 1.656 . . . . 0.0 112.226 167.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.48 128.58 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.834 1.253 . . . . 0.0 108.558 173.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.83 -170.84 13.62 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.556 1.55 . . . . 0.0 111.92 168.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.0 t30 66.44 19.37 10.93 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.92 2.088 . . . . 0.0 113.649 -175.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.35 135.69 57.16 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 125.358 1.463 . . . . 0.0 112.02 -174.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.495 ' CD ' ' HB2' ' A' ' 83' ' ' TYR . 2.0 mt-10 -55.88 152.98 9.15 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 174.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.0 p -68.24 -14.46 63.0 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.532 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -112.0 11.01 20.53 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.998 2.119 . . . . 0.0 111.566 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 p -66.76 159.72 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 119.919 -1.738 . . . . 0.0 114.764 -172.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.4 p -155.38 170.59 21.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.255 1.422 . . . . 0.0 111.32 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -63.87 -28.29 69.74 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.501 -0.749 . . . . 0.0 110.611 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -64.81 -48.32 74.84 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.906 0.883 . . . . 0.0 109.699 174.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.8 tp -65.19 -38.03 89.18 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.209 0.459 . . . . 0.0 111.593 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.0 mt -67.72 -48.57 66.14 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.428 -1.42 . . . . 0.0 111.864 175.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -62.07 -44.9 95.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.722 -1.237 . . . . 0.0 113.0 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -68.73 -25.05 64.56 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.783 0.433 . . . . 0.0 111.162 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.0 tt -78.72 -46.57 18.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.838 1.255 . . . . 0.0 108.272 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -74.89 -5.81 45.69 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.784 -1.197 . . . . 0.0 113.274 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -58.8 -32.0 68.94 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.935 1.698 . . . . 0.0 111.277 171.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -72.35 -31.0 65.25 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.292 1.437 . . . . 0.0 111.426 176.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.03 3.29 39.33 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -171.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.77 -156.16 15.74 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.936 1.731 . . . . 0.0 114.885 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -85.05 90.75 0.76 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.148 1.899 . . . . 0.0 112.135 -167.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.68 134.65 29.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 112.709 -2.041 . . . . 0.0 106.993 168.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.1 mt -83.71 -63.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 165.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.4 ' HG2' ' HB3' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -155.18 147.13 23.49 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.878 1.271 . . . . 0.0 113.011 -164.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.5 t -108.77 145.14 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.312 2.245 . . . . 0.0 112.969 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -122.0 124.19 43.42 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 126.24 1.816 . . . . 0.0 113.01 170.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.5 mm -107.42 121.5 44.21 Favored Pre-proline 0 C--O 1.243 0.719 0 C-N-CA 125.952 1.701 . . . . 0.0 108.509 163.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.2 162.25 42.22 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.269 2.646 . . . . 0.0 109.718 165.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -147.36 116.09 6.76 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.143 1.777 . . . . 0.0 107.632 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -54.48 171.99 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.568 2.347 . . . . 0.0 109.665 165.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.16 -34.17 55.71 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.952 0.901 . . . . 0.0 112.938 172.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -75.4 -9.31 58.45 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 128.123 2.569 . . . . 0.0 113.889 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.32 38.72 12.19 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.555 1.55 . . . . 0.0 111.4 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -125.47 135.27 26.7 Favored Pre-proline 0 N--CA 1.473 0.707 0 O-C-N 121.613 -0.933 . . . . 0.0 112.052 -172.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.76 12.65 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.928 3.085 . . . . 0.0 116.782 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.485 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 61.0 25.11 15.17 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 173.323 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.25 6.0 mt-30 56.43 30.47 17.07 Favored 'General case' 0 CA--C 1.573 1.854 0 O-C-N 120.922 -1.111 . . . . 0.0 113.306 -171.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.485 ' CD2' ' HB2' ' A' ' 57' ' ' LYS . 3.6 p90 -150.08 155.42 39.83 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 128.24 2.616 . . . . 0.0 115.264 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -155.88 175.08 14.41 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 127.64 2.376 . . . . 0.0 112.552 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -140.08 141.8 36.15 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 120.568 -1.333 . . . . 0.0 114.503 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.9 t -131.33 130.02 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 120.555 -1.341 . . . . 0.0 111.116 -172.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.4 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 4.6 t-20 -89.09 140.75 29.13 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.944 1.698 . . . . 0.0 112.776 177.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -125.38 155.56 40.15 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.725 1.61 . . . . 0.0 110.552 -175.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -62.48 -42.76 99.71 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.83 0.852 . . . . 0.0 111.12 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -92.54 135.77 33.78 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 122.301 1.048 . . . . 0.0 111.862 -172.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -97.16 4.06 51.32 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.92 1.288 . . . . 0.0 112.543 -165.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.8 m -85.34 32.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 127.011 2.124 . . . . 0.0 115.251 -176.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.0 p 40.84 44.32 1.9 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.959 1.304 . . . . 0.0 113.282 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -85.85 119.4 71.88 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 127.322 2.249 . . . . 0.0 109.228 -174.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -106.75 57.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.648 3.565 . . . . 0.0 112.795 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -56.55 -42.41 78.47 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.118 -0.989 . . . . 0.0 111.474 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.84 -35.38 66.36 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.9 ttp -59.07 -8.63 1.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 126.89 2.076 . . . . 0.0 115.998 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -114.86 -32.54 5.75 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.491 1.517 . . . . 0.0 110.617 165.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.26 -56.85 5.2 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -98.29 -92.39 0.25 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.853 1.661 . . . . 0.0 110.115 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 32.89 69.92 0.11 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.27 1.428 . . . . 0.0 112.002 175.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.5 19.42 1.07 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 121.297 -0.877 . . . . 0.0 114.12 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -131.74 157.85 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.64 0.776 . . . . 0.0 109.36 -176.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.81 -179.25 7.42 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.5 tp -107.83 -47.44 3.59 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.849 1.26 . . . . 0.0 110.586 167.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.495 ' HB2' ' CD ' ' A' ' 25' ' ' GLU . 78.4 m-85 -95.09 -42.27 8.69 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.187 1.795 . . . . 0.0 113.9 -162.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.99 -23.46 0.32 Allowed Glycine 0 CA--C 1.55 2.276 0 C-N-CA 126.436 1.97 . . . . 0.0 116.766 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -103.7 109.35 61.93 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-N 121.991 2.895 . . . . 0.0 112.524 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.27 125.77 12.82 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.323 2.016 . . . . 0.0 114.615 -173.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.9 mm -54.07 124.61 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 124.795 1.238 . . . . 0.0 109.988 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -114.68 110.23 19.44 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.596 1.189 . . . . 0.0 111.178 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -83.73 148.03 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.792 174.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -128.09 160.81 30.85 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.075 1.35 . . . . 0.0 113.31 168.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -111.7 161.02 16.72 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.94 1.296 . . . . 0.0 112.172 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -104.95 138.89 40.47 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.371 1.868 . . . . 0.0 110.123 165.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.3 p -94.42 30.28 2.01 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 119.825 -1.797 . . . . 0.0 112.954 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.3 -177.92 53.96 Favored Glycine 0 CA--C 1.536 1.392 0 O-C-N 120.891 -1.131 . . . . 0.0 112.008 -163.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.6 t -117.4 157.95 25.3 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.3 m -140.15 102.34 4.35 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 128.298 2.639 . . . . 0.0 110.766 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -126.47 174.09 8.9 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.416 1.486 . . . . 0.0 111.546 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.84 164.54 56.78 Favored Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 124.491 1.116 . . . . 0.0 111.12 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -67.96 177.32 4.4 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.5 1.467 . . . . 0.0 112.148 157.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -135.29 -7.36 2.27 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.9 t70 . . . . . 0 C--O 1.256 1.425 0 C-N-CA 127.488 2.315 . . . . 0.0 110.112 169.648 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.659 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.7 m -137.77 34.64 2.42 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -164.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 68.16 135.2 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.722 2.409 . . . . 0.0 113.604 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -84.53 -33.72 23.44 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 119.821 -1.8 . . . . 0.0 109.706 164.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -107.33 46.39 0.94 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.663 1.585 . . . . 0.0 112.16 -173.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.77 138.2 58.38 Favored 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.756 -1.215 . . . . 0.0 111.504 -174.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -48.29 136.16 12.62 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.032 -1.668 . . . . 0.0 111.645 163.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -73.23 178.25 4.59 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.69 2.396 . . . . 0.0 112.068 -171.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -136.15 -21.11 1.42 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 165.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -70.84 11.4 0.39 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -172.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -157.91 -171.44 3.53 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 127.166 2.187 . . . . 0.0 112.018 -175.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.2 mt -45.98 145.04 1.62 Allowed 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 164.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.34 -31.83 71.52 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . 0.263 2.8 tp10 40.91 49.52 2.95 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 128.156 2.583 . . . . 0.0 116.853 -165.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.79 154.14 40.78 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 117.319 2.341 . . . . 0.0 117.319 -173.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -123.87 133.75 53.7 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.342 1.857 . . . . 0.0 108.986 170.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.8 mtm180 -65.84 -15.85 63.28 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -167.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m -67.39 130.41 42.99 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.068 1.347 . . . . 0.0 112.822 -176.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.9 tp -83.08 128.19 34.26 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.414 2.285 . . . . 0.0 108.705 -169.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -77.45 138.77 39.44 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.123 0.963 . . . . 0.0 110.936 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.0 t -134.15 124.05 45.18 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 59' ' ' PHE . . . -124.71 -171.33 13.33 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 173.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.5 t30 60.92 41.47 14.24 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 123.089 1.423 . . . . 0.0 111.588 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.429 ' HB3' HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -86.94 148.65 25.24 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.698 1.599 . . . . 0.0 110.779 178.532 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 162.85 26.84 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 125.656 2.646 . . . . 0.0 116.89 170.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.6 p -69.45 -29.01 66.61 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 127.879 2.471 . . . . 0.0 109.445 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.591 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 8.5 mmpt? -103.42 15.93 27.8 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 128.129 2.571 . . . . 0.0 114.163 176.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.429 HG11 ' HB3' ' A' ' 24' ' ' LEU . 3.9 p -71.0 157.27 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 120.841 -1.162 . . . . 0.0 112.04 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.2 p -156.56 166.76 32.46 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.51 1.124 . . . . 0.0 110.546 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -60.75 -27.9 68.29 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.321 -0.862 . . . . 0.0 109.957 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -61.01 -35.1 75.95 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.065 2.546 . . . . 0.0 112.536 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.0 tp -79.52 -39.94 30.77 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.703 0.763 . . . . 0.0 110.732 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.413 ' HB2' HG12 ' A' ' 46' ' ' VAL . 82.3 mt -65.39 -45.9 82.19 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.187 -0.945 . . . . 0.0 112.917 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -58.65 -34.13 70.86 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.294 1.038 . . . . 0.0 112.036 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -88.6 -28.23 20.82 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.25 0.62 . . . . 0.0 112.5 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.19 -41.17 74.07 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.356 -0.84 . . . . 0.0 111.176 176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -81.54 21.42 0.8 Allowed 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 120.376 1.444 . . . . 0.0 112.773 -173.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.06 -9.07 59.44 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 117.576 2.436 . . . . 0.0 117.576 -156.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -116.55 7.2 13.62 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 125.581 1.552 . . . . 0.0 113.163 163.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.6 31.4 0.76 Allowed 'General case' 0 CA--C 1.55 0.956 0 O-C-N 119.871 -1.768 . . . . 0.0 115.041 -167.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.97 136.19 3.53 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 107.545 -2.222 . . . . 0.0 107.545 -163.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.68 101.55 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.715 1 C-N-CA 125.307 4.005 . . . . 0.0 114.187 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.53 133.17 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.535 1.134 . . . . 0.0 110.118 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.1 mt -87.33 -47.86 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.174 1.39 . . . . 0.0 108.948 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.33 161.77 16.79 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 126.929 2.092 . . . . 0.0 111.104 -173.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.413 HG12 ' HB2' ' A' ' 33' ' ' LEU . 91.3 t -116.53 149.24 18.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 127.663 2.385 . . . . 0.0 111.808 173.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -120.66 122.77 41.2 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.693 1.197 . . . . 0.0 113.741 166.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.6 mm -101.24 121.47 51.73 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 124.073 0.949 . . . . 0.0 110.208 165.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -66.77 165.98 23.92 Favored 'Trans proline' 0 CA--C 1.55 1.291 1 C-N-CA 125.341 4.028 . . . . 0.0 110.12 164.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -156.35 112.25 3.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.198 1.799 . . . . 0.0 109.893 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.437 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 35.2 t70 -57.25 172.64 0.29 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.267 2.227 . . . . 0.0 113.149 174.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.51 -37.76 5.66 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.594 -0.691 . . . . 0.0 112.752 171.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -76.72 -13.41 60.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.444 2.698 . . . . 0.0 116.28 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.32 30.79 11.54 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.981 2.229 . . . . 0.0 114.818 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.32 141.22 31.46 Favored Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 119.801 1.801 . . . . 0.0 114.28 -174.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.04 8.07 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.599 2.866 . . . . 0.0 116.401 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.437 ' HE2' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER 56.13 32.79 20.78 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 120.418 -1.426 . . . . 0.0 112.716 177.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.609 ' NE2' HH11 ' A' ' 85' ' ' ARG . 20.5 mt-30 56.93 30.32 17.83 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -176.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.412 ' HA ' ' HA2' ' A' ' 22' ' ' GLY . 2.0 p90 -151.29 165.01 35.31 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.009 -1.682 . . . . 0.0 111.097 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -155.46 -175.3 5.36 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 127.333 2.253 . . . . 0.0 111.254 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -138.08 160.7 38.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.738 1.615 . . . . 0.0 112.444 170.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.6 t -147.16 127.77 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 122.344 1.068 . . . . 0.0 113.726 -175.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -95.14 130.18 41.96 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.46 1.104 . . . . 0.0 109.582 171.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -149.21 171.26 16.76 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.458 1.903 . . . . 0.0 113.907 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -127.22 154.07 45.29 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.069 1.348 . . . . 0.0 111.749 166.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.509 ' CG ' ' H ' ' A' ' 67' ' ' GLU . 54.6 t-80 -158.07 174.64 14.92 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.014 1.726 . . . . 0.0 110.541 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.509 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 10.3 mt-10 -71.23 -16.6 62.51 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.459 1.504 . . . . 0.0 112.788 -172.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.9 t -142.71 152.99 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 130.51 3.524 . . . . 0.0 106.274 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.1 m -78.16 54.03 1.3 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.101 1.361 . . . . 0.0 111.86 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.3 m -105.79 146.32 32.62 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 124.561 1.144 . . . . 0.0 111.983 -172.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -78.05 76.78 4.21 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.387 2.058 . . . . 0.0 109.835 174.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -58.15 -42.59 86.24 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.133 -0.98 . . . . 0.0 112.921 -170.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.15 -29.79 70.59 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.939 -1.029 . . . . 0.0 113.767 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.5 ttp -58.36 -20.47 43.92 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.701 1.137 . . . . 0.0 112.289 176.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -103.34 -35.63 8.33 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 170.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.29 -34.18 72.45 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 120.003 1.274 . . . . 0.0 114.221 -175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.0 mt -120.64 -92.75 0.53 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 128.727 2.811 . . . . 0.0 110.406 -170.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.5 t30 26.24 74.75 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 128.496 2.719 . . . . 0.0 115.449 175.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 135.48 16.97 0.88 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-N 113.775 -1.557 . . . . 0.0 112.87 -176.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -132.84 152.24 35.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 118.557 1.178 . . . . 0.0 111.827 -169.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.31 -173.23 1.21 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.976 2.51 . . . . 0.0 110.507 -167.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.5 tp -143.33 -39.05 0.32 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.392 1.477 . . . . 0.0 108.767 160.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -55.13 -57.13 13.0 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.224 1.01 . . . . 0.0 112.034 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.64 -46.54 0.23 Allowed Glycine 0 N--CA 1.48 1.62 0 N-CA-C 117.58 1.792 . . . . 0.0 117.58 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.609 HH11 ' NE2' ' A' ' 58' ' ' GLN . 3.3 mpt_? -95.13 117.61 66.72 Favored Pre-proline 0 C--O 1.238 0.467 0 CA-C-N 118.272 1.036 . . . . 0.0 108.244 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -71.06 128.75 15.24 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.849 1.699 . . . . 0.0 112.47 -174.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.1 mm -53.13 126.93 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 C-N-CA 123.481 0.712 . . . . 0.0 109.667 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -117.8 115.82 25.76 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.491 1.516 . . . . 0.0 110.058 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -87.49 141.05 14.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -125.67 167.11 15.57 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.163 0.985 . . . . 0.0 109.946 172.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -156.63 157.14 34.72 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -166.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -140.54 126.09 19.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.743 1.217 . . . . 0.0 112.188 169.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 86.9 p -95.97 155.78 16.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.475 1.11 . . . . 0.0 111.516 -170.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.09 174.98 34.67 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.704 1.145 . . . . 0.0 111.8 170.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.2 m -93.32 52.54 1.78 Allowed 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.625 -0.926 . . . . 0.0 111.418 -172.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 35.3 m -97.78 145.47 26.35 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -156.41 170.94 21.16 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.224 1.81 . . . . 0.0 111.013 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -149.81 159.53 35.7 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.46 1.504 . . . . 0.0 110.341 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -84.42 172.36 9.37 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 124.429 3.419 . . . . 0.0 113.803 171.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -68.16 -46.55 70.42 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.227 1.411 . . . . 0.0 109.797 167.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 C--O 1.257 1.499 0 C-N-CA 128.388 2.675 . . . . 0.0 109.08 176.889 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.3 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -91.29 151.22 20.98 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.48 151.75 24.41 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.146 -0.971 . . . . 0.0 111.524 -164.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -142.1 -37.44 0.4 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.716 1.206 . . . . 0.0 112.233 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -93.6 2.27 56.42 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 126.599 1.959 . . . . 0.0 115.965 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.33 161.2 30.85 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.523 1.529 . . . . 0.0 112.938 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.35 149.89 28.69 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.649 1.18 . . . . 0.0 113.117 156.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.6 ttt85 -140.23 51.63 1.68 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 128.097 2.559 . . . . 0.0 110.889 175.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -75.36 173.04 11.44 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.072 1.349 . . . . 0.0 114.185 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -111.87 -27.51 8.43 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 117.029 2.233 . . . . 0.0 117.029 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.86 -176.86 4.79 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 126.349 1.86 . . . . 0.0 112.733 -166.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.4 mt -50.89 147.86 4.64 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.266 -0.896 . . . . 0.0 110.45 163.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.4 112.05 23.83 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 176.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -141.8 154.18 45.04 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.025 1.73 . . . . 0.0 108.84 -170.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -113.67 156.04 24.45 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 120.496 1.498 . . . . 0.0 114.739 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -161.5 -170.1 2.5 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 129.162 2.985 . . . . 0.0 107.145 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.8 ptt-85 -55.36 -17.44 4.88 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.957 2.103 . . . . 0.0 116.411 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.1 m -92.48 151.24 20.31 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.693 1.597 . . . . 0.0 109.044 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.7 mp -108.47 129.62 55.27 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.258 2.223 . . . . 0.0 108.276 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -79.46 139.93 37.49 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.625 0.77 . . . . 0.0 109.341 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.3 t -130.6 133.07 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 172.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.85 -177.55 14.92 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.742 1.163 . . . . 0.0 110.625 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.5 t30 75.17 19.34 2.29 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.646 1.579 . . . . 0.0 112.815 -176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.17 147.66 53.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.436 -168.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.61 157.36 32.63 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 125.953 2.787 . . . . 0.0 113.277 173.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 p -66.39 -18.51 65.4 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 129.424 3.09 . . . . 0.0 112.548 -174.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -128.23 19.67 6.38 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 131.454 3.902 . . . . 0.0 112.208 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.8 p -60.53 151.59 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 O-C-N 120.931 -1.106 . . . . 0.0 112.216 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.4 p -152.24 168.99 23.57 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.542 1.537 . . . . 0.0 110.635 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -66.94 -29.03 68.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.115 0.966 . . . . 0.0 109.637 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -56.93 -47.54 80.37 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.6 tp -70.72 -43.59 68.61 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.864 1.265 . . . . 0.0 113.142 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.92 -41.96 95.12 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.238 -0.914 . . . . 0.0 112.022 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -61.16 -47.34 86.65 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 118.744 0.702 . . . . 0.0 111.292 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -64.96 -33.9 77.15 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 119.683 1.129 . . . . 0.0 112.301 176.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.1 tt -72.68 -39.93 66.69 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.814 1.245 . . . . 0.0 113.223 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -94.71 -19.77 20.11 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 -175.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -49.18 -36.69 20.34 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.05 1.74 . . . . 0.0 112.922 167.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -73.5 -15.79 61.31 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 174.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.63 -4.81 47.05 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.758 0.823 . . . . 0.0 112.668 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 138.3 -157.34 24.42 Favored Glycine 0 CA--C 1.545 1.94 0 C-N-CA 126.501 2.0 . . . . 0.0 113.966 168.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.01 93.32 0.96 Allowed 'Trans proline' 0 CA--C 1.551 1.334 0 C-N-CA 123.358 2.706 . . . . 0.0 113.452 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.1 m -81.65 137.61 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 122.712 1.244 . . . . 0.0 110.857 171.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.9 mm -99.16 -51.02 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 125.645 1.578 . . . . 0.0 111.749 -171.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.01 158.11 41.54 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.446 1.099 . . . . 0.0 108.494 176.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.5 t -124.06 147.85 28.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 125.668 1.587 . . . . 0.0 110.07 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -132.02 119.82 21.56 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 125.004 1.321 . . . . 0.0 112.851 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 mm -103.57 124.01 39.44 Favored Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 126.452 1.901 . . . . 0.0 107.719 165.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.99 170.38 19.06 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.788 2.326 . . . . 0.0 111.842 162.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -158.17 114.73 2.82 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 127.065 2.146 . . . . 0.0 111.347 172.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -58.68 169.66 0.92 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.014 -1.903 . . . . 0.0 109.868 170.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -32.47 69.62 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 120.961 -1.087 . . . . 0.0 113.573 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -64.81 -25.69 68.02 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.34 2.256 . . . . 0.0 113.017 171.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.78 39.37 2.54 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.093 1.33 . . . . 0.0 112.845 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 tppt? -133.58 130.64 20.96 Favored Pre-proline 0 C--N 1.35 0.619 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 -170.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.53 15.81 0.11 Allowed 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 125.136 3.89 . . . . 0.0 115.449 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.87 28.27 10.21 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 119.633 -1.917 . . . . 0.0 114.07 169.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 56.29 33.81 22.92 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.745 1.618 . . . . 0.0 115.137 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -153.42 161.83 41.89 Favored 'General case' 0 CA--C 1.555 1.146 0 O-C-N 120.75 -1.219 . . . . 0.0 112.927 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -158.88 173.45 16.49 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 126.665 1.986 . . . . 0.0 113.19 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -127.08 155.68 42.91 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.287 2.235 . . . . 0.0 112.056 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.7 t -148.71 122.37 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.333 1.453 . . . . 0.0 109.144 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -86.98 120.79 28.62 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.718 1.207 . . . . 0.0 110.997 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -108.7 156.37 19.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.733 1.613 . . . . 0.0 111.422 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -54.88 137.07 46.21 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.928 1.691 . . . . 0.0 112.829 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -61.01 157.85 14.69 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -160.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 55.74 43.21 28.28 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.698 1.999 . . . . 0.0 113.844 -174.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 m -54.87 129.08 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.079 1.351 . . . . 0.0 111.522 163.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 m -88.9 -33.43 17.3 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.9 m -143.29 146.56 36.79 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 126.856 2.062 . . . . 0.0 112.371 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -73.08 97.06 0.89 Allowed 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 121.756 1.637 . . . . 0.0 111.289 169.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -51.63 -46.76 63.78 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 128.493 2.717 . . . . 0.0 114.019 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.44 -21.78 60.53 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.4 ttt -67.79 -26.46 66.1 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.95 0.795 . . . . 0.0 111.297 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -81.7 -35.27 30.01 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.521 -0.737 . . . . 0.0 111.908 167.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.2 tp -81.28 -53.43 6.35 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -163.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -97.13 -83.6 0.39 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 125.611 1.564 . . . . 0.0 110.479 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 24.19 66.41 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 128.422 2.689 . . . . 0.0 116.243 173.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.04 20.26 0.94 Allowed Glycine 0 CA--C 1.538 1.492 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.908 -173.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.59 152.02 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-N 118.721 1.26 . . . . 0.0 112.576 -171.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.6 172.89 4.85 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.337 2.255 . . . . 0.0 110.185 -176.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.27 -45.0 2.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.314 1.446 . . . . 0.0 110.236 166.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -61.39 -51.57 68.22 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.569 1.148 . . . . 0.0 113.679 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.6 -63.29 0.18 Allowed Glycine 0 N--CA 1.477 1.423 0 N-CA-C 117.222 1.649 . . . . 0.0 117.222 -168.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -88.2 123.96 67.53 Favored Pre-proline 0 N--CA 1.478 0.929 0 CA-C-N 119.75 1.775 . . . . 0.0 110.642 -175.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -76.23 134.22 15.61 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.054 2.503 . . . . 0.0 115.734 -174.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.1 mm -64.06 123.06 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.647 0.737 . . . . 0.0 109.912 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -110.06 117.2 33.12 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 113.779 -1.555 . . . . 0.0 108.923 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 mp -78.78 149.32 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 172.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -140.28 147.33 39.79 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.605 1.962 . . . . 0.0 110.146 176.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -165.19 139.78 5.01 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.376 -0.828 . . . . 0.0 112.059 -173.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -89.54 133.62 34.5 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.499 1.52 . . . . 0.0 109.44 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.3 p -68.8 165.09 20.41 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 175.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.87 -169.44 38.15 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 115.123 0.809 . . . . 0.0 115.123 170.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.5 t -154.41 161.46 41.7 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.175 1.39 . . . . 0.0 111.694 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 39.4 m -106.57 179.97 4.11 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.798 1.239 . . . . 0.0 110.153 168.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -104.94 166.23 10.52 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -165.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -147.33 146.16 24.24 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 120.535 -1.353 . . . . 0.0 113.503 -169.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.21 150.44 76.76 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.127 1.885 . . . . 0.0 114.221 -169.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.3 mm-40 -81.93 -49.82 9.87 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.821 0.82 . . . . 0.0 110.432 174.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.5 p30 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 129.751 3.22 . . . . 0.0 112.561 177.882 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.453 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.7 p -152.55 164.79 36.93 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.374 1.07 . . . . 0.0 110.281 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -77.47 154.01 32.96 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -97.06 -44.7 6.87 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 113.71 -1.587 . . . . 0.0 111.369 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -120.28 119.1 32.19 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 171.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mt -141.43 151.11 43.14 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.405 1.082 . . . . 0.0 113.759 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -87.61 130.81 34.64 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.181 1.392 . . . . 0.0 113.497 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -99.98 2.85 43.91 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 128.675 2.79 . . . . 0.0 114.755 167.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -78.23 -78.05 0.15 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.798 1.636 . . . . 0.0 110.112 169.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 52.03 -30.76 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.958 1 C-N-CA 132.883 4.473 . . . . 0.0 120.091 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.35 -171.88 3.49 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.23 2.612 . . . . 0.0 110.609 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.7 mt -71.55 174.46 6.65 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.998 1.719 . . . . 0.0 115.035 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.9 159.16 43.87 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.431 1.892 . . . . 0.0 111.396 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -139.76 144.94 37.68 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 120.687 -1.258 . . . . 0.0 110.193 167.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -121.2 160.43 23.83 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -170.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 55.07 58.07 5.05 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.858 1.663 . . . . 0.0 113.02 171.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 -82.96 23.41 0.84 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -173.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.1 m -139.56 142.92 37.16 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.594 1.158 . . . . 0.0 108.871 -169.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.8 tp -113.53 130.0 56.44 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.325 1.45 . . . . 0.0 110.436 -160.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -78.09 138.58 38.83 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.1 t -138.21 123.79 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 121.026 -1.047 . . . . 0.0 110.038 174.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.84 -170.34 15.05 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.616 2.055 . . . . 0.0 111.35 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.1 t30 58.23 35.8 25.25 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.446 1.499 . . . . 0.0 112.293 -176.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 58' ' ' GLN . 0.4 OUTLIER -68.13 163.19 23.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.364 1.078 . . . . 0.0 110.236 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.34 170.27 12.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.087 171.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.5 p -83.48 -14.17 53.02 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.971 2.108 . . . . 0.0 113.646 -175.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 8.8 mmpt? -111.96 17.03 20.05 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 128.261 2.624 . . . . 0.0 112.33 177.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.7 p -72.18 153.03 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -173.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.3 p -155.71 160.83 40.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.45 1.9 . . . . 0.0 111.753 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -58.45 -20.05 41.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.956 0.902 . . . . 0.0 113.157 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -76.19 -34.54 59.3 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.597 1.159 . . . . 0.0 113.455 174.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.26 -48.44 70.48 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.854 0.862 . . . . 0.0 109.789 168.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 87.6 mt -59.89 -43.83 94.57 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.98 0.912 . . . . 0.0 111.113 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -65.45 -43.94 88.81 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 119.503 1.047 . . . . 0.0 110.723 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -61.11 -33.3 73.15 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.006 1.323 . . . . 0.0 113.344 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 tt -82.55 -42.46 18.33 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.844 2.057 . . . . 0.0 113.564 174.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.407 ' CD2' HG22 ' A' ' 62' ' ' VAL . 69.7 m-85 -84.87 -12.45 53.48 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.365 -1.459 . . . . 0.0 113.776 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -54.36 -36.65 64.07 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 121.309 1.868 . . . . 0.0 112.393 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -83.94 -0.31 50.91 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 173.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.42 14.68 14.02 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.915 1.286 . . . . 0.0 112.375 169.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.35 -157.45 23.19 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.459 1.504 . . . . 0.0 112.593 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.4 77.31 4.14 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.314 2.676 . . . . 0.0 112.643 -163.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.43 142.82 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 122.263 1.03 . . . . 0.0 108.527 167.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.0 mm -86.67 -51.83 12.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 124.951 1.3 . . . . 0.0 109.2 175.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -165.21 165.68 19.49 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.288 1.835 . . . . 0.0 111.696 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.4 t -119.65 150.9 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 125.66 1.584 . . . . 0.0 112.11 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -115.93 125.31 52.39 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 127.19 2.196 . . . . 0.0 114.131 165.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.6 mm -101.4 126.46 34.42 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 127.532 2.333 . . . . 0.0 111.64 158.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.74 172.2 16.13 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 125.294 3.996 . . . . 0.0 112.358 163.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -161.06 122.61 2.96 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.755 2.022 . . . . 0.0 111.427 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.44 166.9 2.82 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.254 2.222 . . . . 0.0 112.882 170.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.86 -44.46 29.28 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.769 0.828 . . . . 0.0 111.257 166.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.43 -29.91 70.65 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.05 -1.031 . . . . 0.0 111.143 174.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.53 45.78 1.19 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.679 1.133 . . . . 0.0 114.782 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -129.64 141.11 40.7 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-N 119.924 1.862 . . . . 0.0 111.888 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.52 10.04 0.29 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.227 3.285 . . . . 0.0 117.285 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.39 25.15 13.82 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 173.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' A' ' 24' ' ' LEU 0.283 35.6 mt-30 63.77 30.49 14.6 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.055 2.542 . . . . 0.0 114.688 -172.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -153.14 168.91 24.37 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 126.045 1.738 . . . . 0.0 111.747 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.79 -174.06 2.62 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 130.51 3.524 . . . . 0.0 108.909 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -137.93 164.02 30.06 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 124.665 1.186 . . . . 0.0 112.287 169.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.407 HG22 ' CD2' ' A' ' 37' ' ' PHE . 34.7 t -139.98 139.19 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 125.577 1.551 . . . . 0.0 114.001 174.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -95.91 144.85 25.88 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.074 1.75 . . . . 0.0 114.989 -173.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -135.58 163.78 29.34 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.215 2.206 . . . . 0.0 109.548 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -88.02 62.01 6.62 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 129.922 3.289 . . . . 0.0 109.591 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 11.5 m80 56.38 29.84 15.88 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.523 1.529 . . . . 0.0 113.585 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . 0.286 13.2 pt-20 -123.94 36.07 4.7 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.181 1.392 . . . . 0.0 114.047 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 m -59.27 -16.93 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 168.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.7 t -65.98 139.67 58.24 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.714 1.606 . . . . 0.0 112.619 173.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.6 t 36.65 66.67 1.91 Allowed Pre-proline 0 N--CA 1.488 1.431 0 C-N-CA 126.063 1.745 . . . . 0.0 109.714 -165.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.95 121.31 9.84 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.02 2.48 . . . . 0.0 110.996 -173.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -58.9 -44.05 91.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.03 0.919 . . . . 0.0 111.245 -165.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.69 -27.53 68.76 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.152 1.381 . . . . 0.0 113.682 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -62.72 -22.52 66.58 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.79 1.236 . . . . 0.0 111.782 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -95.91 -38.91 10.06 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 163.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.87 -49.63 19.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 120.654 1.57 . . . . 0.0 114.658 -165.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -98.31 -94.58 0.23 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.733 1.213 . . . . 0.0 109.133 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 21.84 79.35 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 128.115 2.566 . . . . 0.0 115.097 -169.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.82 26.33 1.58 Allowed Glycine 0 N--CA 1.476 1.33 0 C-N-CA 125.223 1.392 . . . . 0.0 113.984 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -128.07 144.66 37.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-N 117.874 0.837 . . . . 0.0 109.405 -171.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.98 177.45 10.34 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 177.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.5 tp -136.31 -44.35 0.62 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 130.834 3.654 . . . . 0.0 108.508 171.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -65.97 -52.72 47.11 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.351 1.86 . . . . 0.0 111.942 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 160.86 -38.71 0.43 Allowed Glycine 0 N--CA 1.477 1.375 0 N-CA-C 115.64 1.016 . . . . 0.0 115.64 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -100.3 115.93 64.95 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 125.728 1.611 . . . . 0.0 108.97 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.62 137.11 29.58 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.472 2.781 . . . . 0.0 113.204 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.7 mm -67.56 125.32 24.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 123.502 0.721 . . . . 0.0 111.106 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -113.79 107.21 15.42 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.432 1.893 . . . . 0.0 112.041 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.79 140.23 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.387 1.075 . . . . 0.0 111.316 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -141.68 179.98 6.51 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.53 2.332 . . . . 0.0 111.139 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -147.14 158.57 43.99 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.688 165.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -139.91 145.8 38.43 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.975 1.71 . . . . 0.0 109.046 161.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.8 m -102.24 157.66 16.74 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.118 1.367 . . . . 0.0 111.331 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.7 -175.27 49.43 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 122.646 1.137 . . . . 0.0 114.996 168.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.4 m -69.01 153.3 44.03 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.802 2.041 . . . . 0.0 112.62 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.1 t -144.58 143.22 30.69 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.957 2.503 . . . . 0.0 108.202 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.5 m170 54.63 46.28 25.08 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.568 1.947 . . . . 0.0 112.81 -165.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.72 164.27 40.5 Favored Pre-proline 0 CA--C 1.553 1.083 0 O-C-N 119.885 -1.759 . . . . 0.0 111.869 171.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -84.49 135.96 6.26 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 125.229 3.953 . . . . 0.0 115.729 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -71.68 -30.4 65.65 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 C--O 1.26 1.607 0 C-N-CA 130.354 3.462 . . . . 0.0 110.267 175.598 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.532 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -92.31 -19.69 21.88 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 118.839 2.903 . . . . 0.0 118.839 169.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -104.14 150.47 24.31 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 122.023 2.192 . . . . 0.0 110.657 175.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -138.16 -47.36 0.53 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.051 1.74 . . . . 0.0 112.129 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -103.76 -5.25 22.66 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 119.835 -1.79 . . . . 0.0 114.769 -167.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.09 130.68 39.68 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.289 1.835 . . . . 0.0 107.438 175.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.22 144.98 56.82 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.745 1.218 . . . . 0.0 108.533 170.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -62.98 -28.65 70.24 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.951 1.301 . . . . 0.0 113.995 -172.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -141.81 157.74 44.64 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.395 1.478 . . . . 0.0 112.437 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -56.48 -57.59 11.67 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -158.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.79 169.58 21.88 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 126.349 1.86 . . . . 0.0 108.457 170.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.3 mt -59.08 134.73 57.25 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 126.481 1.912 . . . . 0.0 112.766 -175.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.33 10.81 5.34 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.83 4.63 0.99 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.655 1.982 . . . . 0.0 115.84 -178.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.27 -22.4 21.62 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.564 1.146 . . . . 0.0 113.493 -168.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -115.19 151.21 34.84 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.75 1.62 . . . . 0.0 113.006 -177.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -135.99 -1.33 2.44 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.891 1.677 . . . . 0.0 111.817 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m -134.26 141.36 46.95 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.882 1.673 . . . . 0.0 111.594 -174.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.5 tp -109.18 133.92 52.39 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.103 1.761 . . . . 0.0 114.47 -171.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -80.46 133.66 35.88 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.568 0.699 . . . . 0.0 110.602 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -128.62 127.85 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 169.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.27 -174.1 14.79 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.83 1.205 . . . . 0.0 112.236 170.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.7 t30 64.04 26.12 13.96 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.373 1.469 . . . . 0.0 114.739 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.87 164.96 5.77 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.519 1.528 . . . . 0.0 109.64 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.81 172.97 12.72 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.059 1.504 . . . . 0.0 115.059 176.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.2 p -71.76 -21.23 61.77 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.015 2.126 . . . . 0.0 110.381 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.04 30.6 5.62 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 127.431 2.292 . . . . 0.0 116.369 173.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.68 165.47 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 118.885 -2.385 . . . . 0.0 115.472 176.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.4 p -154.63 173.53 16.24 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.682 1.193 . . . . 0.0 112.743 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -73.29 -26.92 61.28 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.135 0.974 . . . . 0.0 110.195 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.72 -45.82 92.31 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 171.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.78 -47.22 75.87 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.825 0.85 . . . . 0.0 110.579 -174.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.89 -48.69 77.58 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.854 1.262 . . . . 0.0 111.112 173.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -59.35 -37.95 79.16 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.363 0.983 . . . . 0.0 112.26 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -75.45 -33.41 60.87 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.995 0.816 . . . . 0.0 110.345 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 tt -68.18 -39.82 82.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.113 1.765 . . . . 0.0 113.35 176.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -85.5 -1.2 56.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 117.9 -1.047 . . . . 0.0 113.694 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -60.32 -41.48 93.59 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.802 1.637 . . . . 0.0 110.904 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -75.25 -14.71 60.54 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 172.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.03 -24.41 47.83 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 120.709 1.595 . . . . 0.0 110.14 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 154.12 -172.58 32.75 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 128.639 3.018 . . . . 0.0 114.412 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.73 79.66 2.69 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 124.853 3.702 . . . . 0.0 110.403 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.6 m -52.7 141.2 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.842 1.257 . . . . 0.0 113.365 172.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 80.3 mt -79.69 -59.68 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 126.8 2.04 . . . . 0.0 107.818 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.36 168.47 25.94 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.337 1.455 . . . . 0.0 113.282 174.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.5 t -116.65 157.19 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 126.662 1.985 . . . . 0.0 112.631 171.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -134.93 123.56 23.59 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.616 1.966 . . . . 0.0 113.75 169.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.4 mm -100.16 124.74 42.21 Favored Pre-proline 0 C--N 1.324 -0.512 0 C-N-CA 126.681 1.993 . . . . 0.0 108.612 167.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -72.76 167.08 28.17 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.461 2.774 . . . . 0.0 111.583 161.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -158.77 114.83 2.66 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.857 2.463 . . . . 0.0 109.054 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.526 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 30.6 t70 -54.04 174.59 0.05 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.413 2.285 . . . . 0.0 112.545 170.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.68 -35.08 60.68 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.289 -1.507 . . . . 0.0 112.881 167.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -68.65 -13.76 62.57 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.944 2.498 . . . . 0.0 113.486 175.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.84 54.21 6.67 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -173.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -135.85 132.91 19.63 Favored Pre-proline 0 CA--C 1.517 -0.309 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.61 22.25 0.4 Allowed 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 124.276 3.318 . . . . 0.0 114.594 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.526 ' HE2' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER 51.47 26.95 3.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 119.727 -1.858 . . . . 0.0 115.612 168.175 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 52.02 35.11 15.3 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 127.185 2.194 . . . . 0.0 114.418 -170.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -150.8 157.91 43.51 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 120.001 -1.687 . . . . 0.0 112.224 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -153.91 174.86 14.06 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.247 1.819 . . . . 0.0 111.541 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -126.9 153.29 45.95 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 119.848 -1.783 . . . . 0.0 111.956 175.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 84.3 t -139.44 124.51 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.122 0.969 . . . . 0.0 112.692 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -91.59 133.68 35.33 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.347 1.859 . . . . 0.0 109.931 -177.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.08 159.96 39.54 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.734 1.614 . . . . 0.0 111.922 -168.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -132.33 135.87 46.48 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.251 1.82 . . . . 0.0 111.107 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -159.7 176.24 12.21 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.394 2.678 . . . . 0.0 107.531 173.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -128.84 126.71 40.41 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.156 -0.965 . . . . 0.0 109.653 166.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.35 13.7 m 48.11 32.23 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 129.353 3.061 . . . . 0.0 115.415 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.9 p -121.24 166.03 14.6 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 -172.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 m -66.39 154.72 90.08 Favored Pre-proline 0 N--CA 1.48 1.037 0 O-C-N 121.412 -0.805 . . . . 0.0 112.31 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -76.04 101.82 1.54 Allowed 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.778 2.319 . . . . 0.0 108.383 165.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -57.22 -34.91 69.04 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.608 1.563 . . . . 0.0 113.689 -169.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.35 -27.78 62.57 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.116 -0.99 . . . . 0.0 112.789 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.1 ttp -77.42 -13.24 59.97 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.831 0.852 . . . . 0.0 112.184 -170.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -106.34 -25.29 11.99 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.271 1.429 . . . . 0.0 113.627 163.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.3 tp -78.04 -49.34 14.21 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.773 1.229 . . . . 0.0 112.474 -172.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -100.8 -106.99 0.23 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 42.24 70.69 0.26 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.996 2.118 . . . . 0.0 114.805 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.98 16.9 1.07 Allowed Glycine 0 CA--C 1.53 0.998 0 CA-C-N 115.594 -0.73 . . . . 0.0 114.281 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 pp -132.86 151.64 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 118.37 1.085 . . . . 0.0 111.773 -167.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.95 175.12 9.79 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.437 1.495 . . . . 0.0 110.965 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 70.0 tp -119.28 -38.74 2.98 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.173 1.389 . . . . 0.0 112.072 161.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -79.04 -41.41 28.89 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.106 0.962 . . . . 0.0 113.509 -170.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.33 -44.18 0.29 Allowed Glycine 0 N--CA 1.473 1.108 0 N-CA-C 115.692 1.037 . . . . 0.0 115.692 173.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.54 124.98 55.58 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 124.339 1.056 . . . . 0.0 108.664 177.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -77.02 134.9 14.97 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 124.443 3.429 . . . . 0.0 115.012 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.1 mm -64.16 131.62 29.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 123.786 0.834 . . . . 0.0 110.736 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 tptm -121.01 112.01 18.19 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.252 1.821 . . . . 0.0 110.016 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.4 mp -88.28 140.73 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -139.8 154.99 47.51 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 123.087 1.422 . . . . 0.0 109.041 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -82.88 147.5 28.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.21 -1.814 . . . . 0.0 110.929 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -91.54 58.76 3.64 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 128.108 2.563 . . . . 0.0 110.005 -170.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.74 -178.1 6.97 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.827 0.822 . . . . 0.0 112.465 174.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.5 -172.04 32.43 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-O 122.089 0.827 . . . . 0.0 114.216 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.8 p -60.18 139.33 57.61 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.521 -0.84 . . . . 0.0 109.425 172.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 m -57.22 136.35 56.47 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -172.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -78.16 168.02 20.5 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.488 1.915 . . . . 0.0 112.161 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.11 157.54 50.54 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 124.875 1.27 . . . . 0.0 111.296 -173.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -64.96 152.38 82.55 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 CA-C-N 120.783 1.315 . . . . 0.0 111.92 170.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -71.96 -28.39 63.41 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.908 1.283 . . . . 0.0 113.19 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 t70 . . . . . 0 C--O 1.257 1.462 0 C-N-CA 127.626 2.37 . . . . 0.0 113.022 -179.184 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.277 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -125.1 11.37 8.22 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.975 1.31 . . . . 0.0 112.882 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -56.55 131.14 47.87 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.302 1.041 . . . . 0.0 112.072 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -57.64 -40.76 80.01 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.239 -1.538 . . . . 0.0 113.46 -170.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -71.96 2.43 5.64 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 127.326 2.25 . . . . 0.0 114.826 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.8 mt -81.35 138.17 35.67 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 120.464 -1.398 . . . . 0.0 109.882 173.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -81.52 97.75 7.96 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.983 0.913 . . . . 0.0 110.017 176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -125.53 78.59 1.74 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 128.348 2.659 . . . . 0.0 105.674 -176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -136.06 156.81 48.17 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -162.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -56.96 -28.78 62.59 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.12 160.66 42.16 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.497 1.044 . . . . 0.0 113.351 -175.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.8 mt 46.01 -4.49 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 130.009 3.323 . . . . 0.0 117.4 -170.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.09 -0.55 55.88 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -101.33 157.68 16.61 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.141 2.576 . . . . 0.0 111.119 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -112.99 166.95 10.92 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 -165.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -155.82 176.17 12.98 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.261 2.225 . . . . 0.0 109.793 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.4 mtt-85 -55.94 -37.33 68.83 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.255 1.822 . . . . 0.0 111.539 160.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.3 m -63.3 146.12 54.13 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.552 1.141 . . . . 0.0 108.836 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.22 132.75 39.85 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 125.216 1.407 . . . . 0.0 109.707 -175.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -81.04 129.92 34.77 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.929 0.871 . . . . 0.0 110.912 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.4 t -127.14 130.62 71.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.18 -173.56 13.31 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 122.61 1.117 . . . . 0.0 113.712 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.1 t30 62.8 36.14 13.29 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.877 1.671 . . . . 0.0 113.994 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.15 154.96 40.11 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.478 1.111 . . . . 0.0 109.763 -174.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.34 162.58 12.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 123.752 1.739 . . . . 0.0 113.626 170.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.6 p -73.94 -7.54 52.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.152 2.181 . . . . 0.0 110.908 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -133.68 18.5 3.89 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.295 2.238 . . . . 0.0 114.279 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.42 161.03 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 O-C-N 120.837 -1.164 . . . . 0.0 113.594 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 p -158.18 161.43 37.85 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.262 1.825 . . . . 0.0 108.835 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -66.03 -25.52 67.09 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.806 1.643 . . . . 0.0 111.444 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -66.23 -35.86 81.52 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.592 1.157 . . . . 0.0 113.955 170.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.404 HD11 ' CE1' ' A' ' 83' ' ' TYR . 41.6 tp -77.3 -40.63 43.67 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.232 0.924 . . . . 0.0 110.388 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.77 -46.65 87.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.397 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -60.15 -46.88 88.18 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.765 1.166 . . . . 0.0 111.844 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.04 -31.48 72.73 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.16 0.891 . . . . 0.0 111.919 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 tt -75.07 -42.48 56.78 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.459 1.104 . . . . 0.0 112.976 173.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -83.9 -20.4 33.08 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -70.01 -24.9 63.36 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.21 1.368 . . . . 0.0 110.66 172.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -60.7 -28.87 68.97 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.778 -1.201 . . . . 0.0 112.442 165.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.51 17.25 10.33 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.918 1.287 . . . . 0.0 114.05 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.54 -168.01 12.86 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.441 1.02 . . . . 0.0 114.706 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.3 79.41 3.09 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 124.657 3.571 . . . . 0.0 111.107 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.0 t -55.91 148.92 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.652 0.781 . . . . 0.0 110.284 171.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.5 mm -92.54 -52.04 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 126.396 1.878 . . . . 0.0 112.283 172.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -158.85 160.79 36.58 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.895 2.478 . . . . 0.0 108.352 -171.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.3 155.63 38.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 126.789 2.036 . . . . 0.0 107.217 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -133.01 137.29 46.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.542 1.937 . . . . 0.0 110.176 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.4 mm -114.13 125.35 29.45 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 126.655 1.982 . . . . 0.0 111.866 163.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.2 167.53 26.65 Favored 'Trans proline' 0 C--N 1.347 0.485 1 C-N-CA 125.519 4.146 . . . . 0.0 112.713 167.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -152.65 116.58 4.84 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 125.848 1.659 . . . . 0.0 110.532 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -49.2 164.2 0.08 Allowed 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 126.407 1.883 . . . . 0.0 112.08 161.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.35 -38.02 62.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.456 1.102 . . . . 0.0 112.062 170.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -74.3 -14.34 60.89 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.202 1.001 . . . . 0.0 112.373 174.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.7 41.93 3.74 Favored Glycine 0 C--N 1.343 0.967 0 O-C-N 120.303 -1.498 . . . . 0.0 115.676 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -133.28 139.08 33.01 Favored Pre-proline 0 N--CA 1.469 0.491 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -67.26 14.83 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.377 1 C-N-CA 125.762 4.308 . . . . 0.0 117.14 -178.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.27 18.06 2.33 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.371 -1.456 . . . . 0.0 114.117 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 68.04 31.62 5.39 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.262 1.825 . . . . 0.0 111.955 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.4 158.91 44.68 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.755 1.222 . . . . 0.0 113.254 -174.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.42 169.66 24.21 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.06 1.744 . . . . 0.0 111.891 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -121.4 150.32 41.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.168 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.4 t -139.58 146.97 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.734 1.214 . . . . 0.0 109.899 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -121.57 139.57 53.35 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -173.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -134.45 150.7 50.86 Favored 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 128.695 2.798 . . . . 0.0 111.816 172.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -93.03 144.23 25.46 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 129.925 3.29 . . . . 0.0 112.439 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.3 t60 43.55 62.69 1.8 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.923 2.089 . . . . 0.0 111.833 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -65.24 151.41 46.23 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 m -128.24 153.74 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 126.689 1.996 . . . . 0.0 111.126 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.8 p -54.77 149.16 11.61 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.427 0.691 . . . . 0.0 111.5 170.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.4 t 61.98 76.7 0.38 Allowed Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 126.797 2.039 . . . . 0.0 114.134 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -38.09 125.79 0.82 Allowed 'Trans proline' 0 CA--C 1.542 0.881 1 C-N-CA 125.818 4.346 . . . . 0.0 117.067 170.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -58.54 -42.36 87.64 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.492 1.117 . . . . 0.0 112.779 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.14 -32.22 67.95 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 121.343 1.883 . . . . 0.0 111.751 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.3 tpt -65.64 -26.83 67.99 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 118.372 0.533 . . . . 0.0 112.189 -175.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -86.56 -21.35 26.94 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 121.217 -0.927 . . . . 0.0 113.033 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -105.35 -38.85 6.35 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.789 1.635 . . . . 0.0 111.798 -155.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.8 -96.77 0.42 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.114 1.766 . . . . 0.0 111.443 174.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 29.97 66.37 0.12 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.791 2.036 . . . . 0.0 111.938 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.88 17.91 0.16 Allowed Glycine 0 N--CA 1.468 0.776 0 N-CA-C 117.347 1.699 . . . . 0.0 117.347 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -139.48 148.98 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 117.769 0.784 . . . . 0.0 112.578 -160.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.62 175.3 13.37 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.1 tp -138.53 -18.87 1.08 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.302 2.641 . . . . 0.0 112.819 171.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.404 ' CE1' HD11 ' A' ' 32' ' ' LEU . 3.1 m-30 -101.92 -40.76 6.75 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.453 1.501 . . . . 0.0 112.986 -175.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.74 -45.48 0.22 Allowed Glycine 0 N--CA 1.479 1.532 0 N-CA-C 118.477 2.151 . . . . 0.0 118.477 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -113.98 122.47 34.63 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 126.231 1.812 . . . . 0.0 111.459 -173.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.25 123.33 7.66 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.371 2.047 . . . . 0.0 115.106 -171.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.1 mm -52.6 118.61 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 124.495 1.118 . . . . 0.0 113.005 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -103.57 114.72 29.2 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.242 1.817 . . . . 0.0 111.658 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mp -84.0 146.77 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 O-C-N 121.649 -0.657 . . . . 0.0 110.574 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -146.18 161.25 40.64 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.122 1.769 . . . . 0.0 113.986 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -155.13 149.87 26.52 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.42 1.088 . . . . 0.0 113.106 171.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -67.99 123.46 20.69 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 128.495 2.718 . . . . 0.0 111.332 -173.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.1 148.48 49.77 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.62 0.19 0.51 Allowed Glycine 0 CA--C 1.534 1.27 0 CA-C-O 117.387 -1.785 . . . . 0.0 116.468 176.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 51.5 m 35.1 53.48 0.69 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.923 2.089 . . . . 0.0 114.612 169.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 79.3 p -172.27 160.43 5.05 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.228 1.411 . . . . 0.0 113.482 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -106.7 169.35 8.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.074 1.75 . . . . 0.0 109.778 170.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -106.35 153.19 40.6 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 118.56 0.618 . . . . 0.0 111.224 169.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -76.39 166.1 28.09 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.553 2.835 . . . . 0.0 109.311 169.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -128.66 -8.84 5.06 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 128.438 2.695 . . . . 0.0 111.619 174.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 . . . . . 0 C--O 1.257 1.49 0 C-N-CA 127.24 2.216 . . . . 0.0 115.392 176.197 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.174 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 t -139.75 -163.52 1.52 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.282 1.833 . . . . 0.0 109.957 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -136.57 147.01 46.78 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.875 2.07 . . . . 0.0 108.368 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -49.04 -43.42 40.69 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 126.367 1.867 . . . . 0.0 113.334 -175.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -132.96 133.66 43.47 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 125.065 1.346 . . . . 0.0 108.262 172.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 mt -144.34 172.39 13.0 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.335 1.454 . . . . 0.0 111.2 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.71 131.5 34.12 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.885 1.674 . . . . 0.0 114.746 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -168.43 -17.55 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.872 2.069 . . . . 0.0 116.185 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.455 ' C ' ' H ' ' A' ' 11' ' ' ALA . 13.0 mt-30 -118.89 -23.05 7.07 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -164.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -78.31 22.72 0.31 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.587 1.555 . . . . 0.0 111.123 -174.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 9' ' ' GLN . . . -158.61 159.35 35.33 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.502 2.321 . . . . 0.0 113.828 -169.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.9 pp -103.01 158.47 16.27 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 128.355 2.662 . . . . 0.0 111.177 169.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -162.34 149.69 13.85 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 128.492 2.717 . . . . 0.0 111.568 -174.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -158.66 133.82 8.48 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 128.237 2.615 . . . . 0.0 109.647 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.73 140.72 49.67 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -118.23 59.28 0.81 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.278 1.431 . . . . 0.0 111.413 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 57.32 7.12 0.44 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 m -138.53 146.34 41.8 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.396 0.998 . . . . 0.0 111.457 -164.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.7 tp -117.47 133.63 55.75 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.981 2.112 . . . . 0.0 112.927 -166.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -85.03 124.57 31.88 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 123.322 1.534 . . . . 0.0 111.84 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 t -122.06 134.06 66.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.41 -171.13 12.59 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 121.201 -0.937 . . . . 0.0 112.18 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.4 t30 62.43 38.62 12.7 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.645 1.178 . . . . 0.0 111.165 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.2 158.06 37.07 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.458 1.103 . . . . 0.0 109.065 -176.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.79 158.47 35.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.808 1.29 . . . . 0.0 110.0 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.2 p -73.26 -13.49 61.14 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.992 1.317 . . . . 0.0 113.3 -169.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 27' ' ' LYS . 25.4 mmmt -129.72 21.21 5.5 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 129.733 3.213 . . . . 0.0 112.364 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.2 p -53.64 160.69 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.524 1.13 . . . . 0.0 112.751 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 36.3 p -148.41 162.15 40.16 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.931 1.692 . . . . 0.0 110.707 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -56.12 -37.34 69.29 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.707 1.203 . . . . 0.0 108.972 171.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -66.26 -32.32 73.67 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.4 tp -75.17 -35.49 61.59 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.009 -1.057 . . . . 0.0 111.906 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.0 mt -71.4 -43.67 66.37 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.049 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -53.5 -46.89 70.21 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.85 1.205 . . . . 0.0 110.658 175.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -73.14 -28.2 62.11 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.5 tt -77.58 -49.01 15.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.467 1.107 . . . . 0.0 112.666 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -81.25 -17.94 47.72 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 120.344 1.429 . . . . 0.0 113.263 -175.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -53.23 -32.4 48.12 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 120.312 1.415 . . . . 0.0 110.94 169.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -56.55 -38.4 71.85 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.464 1.505 . . . . 0.0 114.847 168.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.07 -20.37 30.49 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.227 1.811 . . . . 0.0 111.814 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.43 -168.78 29.08 Favored Glycine 0 CA--C 1.55 2.257 0 N-CA-C 117.774 1.869 . . . . 0.0 117.774 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.66 74.83 5.01 Favored 'Trans proline' 0 CA--C 1.548 1.185 1 C-N-CA 126.468 4.779 . . . . 0.0 110.806 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 m -57.72 127.11 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.827 1.651 . . . . 0.0 110.024 173.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.544 HG22 ' HE3' ' A' ' 45' ' ' LYS . 34.5 mm -69.08 -40.23 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.665 0.786 . . . . 0.0 111.018 -175.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.544 ' HE3' HG22 ' A' ' 44' ' ' ILE . 13.3 ptpt -171.49 160.14 5.84 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.59 2.356 . . . . 0.0 111.042 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 85.2 t -122.24 137.19 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 127.148 2.179 . . . . 0.0 112.156 -175.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -113.96 123.77 50.54 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.7 mm -110.91 111.9 56.14 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 125.754 1.622 . . . . 0.0 111.436 165.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.8 165.73 24.84 Favored 'Trans proline' 0 CA--C 1.552 1.399 1 C-N-CA 125.717 4.278 . . . . 0.0 111.258 172.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -157.24 114.82 3.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.966 2.107 . . . . 0.0 111.667 171.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.455 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 31.4 t0 -63.02 176.51 0.71 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 126.759 2.024 . . . . 0.0 113.093 170.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.79 -36.92 27.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.491 1.916 . . . . 0.0 113.072 172.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -77.04 -9.15 58.52 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.937 1.695 . . . . 0.0 114.538 174.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.08 41.54 6.61 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 125.669 1.604 . . . . 0.0 112.629 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -130.29 133.84 25.38 Favored Pre-proline 0 N--CA 1.467 0.412 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -169.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.24 13.63 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 1 C-N-CA 126.411 4.741 . . . . 0.0 115.037 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.455 ' HE2' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER 54.84 21.13 3.43 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 174.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 60.26 34.79 20.91 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.587 1.955 . . . . 0.0 112.96 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -151.04 155.91 40.0 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.142 1.377 . . . . 0.0 113.343 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -151.3 169.62 21.5 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.496 1.919 . . . . 0.0 112.914 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -126.24 159.56 32.7 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.265 1.031 . . . . 0.0 113.283 172.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.7 t -144.49 133.22 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.995 0.918 . . . . 0.0 110.874 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -99.36 147.32 25.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.578 1.551 . . . . 0.0 113.069 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -137.22 157.9 45.63 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.102 2.161 . . . . 0.0 110.33 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -59.04 149.97 26.11 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.235 -1.54 . . . . 0.0 108.454 165.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -64.87 123.3 19.04 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 126.612 1.965 . . . . 0.0 112.784 -171.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -151.7 155.09 37.62 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.7 t -88.99 85.48 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 C-N-CA 126.633 1.973 . . . . 0.0 107.029 169.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.7 p -160.54 157.84 28.12 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.13 142.39 75.64 Favored Pre-proline 0 N--CA 1.473 0.714 0 O-C-N 120.918 -1.114 . . . . 0.0 109.108 157.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -53.39 128.64 30.06 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.628 2.219 . . . . 0.0 112.695 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -52.91 -39.88 63.11 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.93 -26.69 67.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.6 ttt -70.48 -24.63 62.9 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 121.024 1.738 . . . . 0.0 112.765 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -87.04 -27.53 23.13 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.234 1.013 . . . . 0.0 112.109 169.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.33 -57.78 2.59 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -167.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -88.69 -94.92 0.1 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.547 1.139 . . . . 0.0 108.813 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 30.32 78.04 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.397 1.879 . . . . 0.0 113.38 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.9 28.01 1.78 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.022 0.82 . . . . 0.0 112.648 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -130.66 148.01 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.99 -175.17 3.91 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.239 2.216 . . . . 0.0 112.258 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.6 mt -131.37 -31.85 1.59 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.601 1.56 . . . . 0.0 112.841 154.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -65.61 -51.95 55.75 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.05 -50.03 0.16 Allowed Glycine 0 CA--C 1.534 1.264 0 O-C-N 121.134 -0.979 . . . . 0.0 115.191 170.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -93.45 111.91 54.29 Favored Pre-proline 0 N--CA 1.479 1.014 0 C-N-CA 124.472 1.109 . . . . 0.0 109.247 -172.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.56 127.22 12.24 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.776 2.317 . . . . 0.0 112.536 -170.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 mm -56.74 122.54 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 122.223 1.011 . . . . 0.0 109.121 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -103.39 121.27 42.43 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.671 1.988 . . . . 0.0 109.732 171.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.46 141.23 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 169.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -124.12 140.93 52.49 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.705 1.24 . . . . 0.0 111.552 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -147.03 147.28 30.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.057 -1.429 . . . . 0.0 112.288 173.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -140.01 134.55 31.62 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.278 1.831 . . . . 0.0 108.231 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 m -79.01 138.02 37.84 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.14 0.976 . . . . 0.0 111.729 -170.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.49 135.87 39.12 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 122.254 0.919 . . . . 0.0 111.726 168.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.3 p -71.47 -24.74 62.05 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.514 1.526 . . . . 0.0 113.781 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.5 m 48.98 33.17 4.34 Favored 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -167.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -73.94 -28.64 61.61 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 119.804 -1.81 . . . . 0.0 113.183 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.95 152.86 77.45 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.123 0.969 . . . . 0.0 111.829 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.55 140.34 21.25 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.257 2.638 . . . . 0.0 112.941 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -69.58 -34.53 74.28 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 122.104 -0.373 . . . . 0.0 111.408 167.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.071 1.348 . . . . 0.0 114.044 179.74 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.215 0 CA-C-O 121.449 0.472 . . . . 0.0 112.592 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 t -53.16 137.29 34.34 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.554 2.342 . . . . 0.0 114.726 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.262 29.7 mt-10 47.93 31.49 2.38 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 131.675 3.99 . . . . 0.0 117.186 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -68.46 -21.26 64.64 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -173.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -83.06 3.82 28.79 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 168.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.27 170.26 8.17 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 129.129 2.971 . . . . 0.0 108.721 169.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -82.4 139.09 34.23 Favored 'General case' 0 C--N 1.339 0.112 0 O-C-N 120.394 -1.441 . . . . 0.0 107.956 165.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -119.32 84.4 2.19 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.508 1.523 . . . . 0.0 113.626 -170.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.3 mp0 -140.35 173.83 11.11 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 129.293 3.037 . . . . 0.0 113.149 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -68.44 -14.18 62.82 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -173.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.13 179.73 5.0 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.4 1.48 . . . . 0.0 112.139 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.9 mt -66.93 148.8 51.48 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.088 1.355 . . . . 0.0 111.076 167.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.79 -14.68 0.73 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 166.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -83.79 -3.18 57.63 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 126.193 1.797 . . . . 0.0 111.581 167.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.57 166.38 28.43 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 129.982 3.313 . . . . 0.0 108.223 159.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -148.21 -45.47 0.16 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.014 1.326 . . . . 0.0 113.397 171.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.8 mmt-85 -91.9 17.76 8.75 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.954 1.701 . . . . 0.0 113.722 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 83.7 m -151.54 144.33 24.4 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.624 1.169 . . . . 0.0 112.595 -165.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.9 tp -89.41 127.43 35.82 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.29 1.436 . . . . 0.0 113.367 -160.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -72.26 135.56 46.05 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.965 0.888 . . . . 0.0 111.769 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.04 134.97 62.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 168.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.82 -175.53 13.96 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 126.187 1.851 . . . . 0.0 111.23 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 42.9 t30 65.82 24.71 11.34 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.095 1.358 . . . . 0.0 112.315 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.8 160.09 21.01 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 123.282 1.515 . . . . 0.0 110.654 -175.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.27 163.36 27.11 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.995 -1.912 . . . . 0.0 110.511 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.2 p -64.29 -27.4 69.01 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.17 1.788 . . . . 0.0 109.869 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -123.59 26.13 7.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.0 p -51.8 161.46 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.839 1.2 . . . . 0.0 111.777 169.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.6 p -158.93 159.46 34.95 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.458 1.903 . . . . 0.0 110.542 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -55.02 -38.82 68.42 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 126.478 1.911 . . . . 0.0 109.171 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -67.26 -30.87 70.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.594 1.958 . . . . 0.0 112.376 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.3 tp -75.4 -43.74 48.46 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.8 0.727 . . . . 0.0 111.422 168.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.82 -54.42 45.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.106 0.963 . . . . 0.0 110.521 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -53.9 -45.41 71.1 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.059 0.845 . . . . 0.0 112.425 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -69.33 -31.76 70.42 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.127 1.33 . . . . 0.0 112.714 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.2 tt -74.18 -36.17 64.02 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.458 1.103 . . . . 0.0 111.014 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -95.54 -12.78 25.19 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -56.2 -35.74 67.63 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.969 1.708 . . . . 0.0 109.804 163.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.6 mm100 -62.36 -36.19 81.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.773 1.229 . . . . 0.0 113.284 168.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.86 2.76 44.59 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.574 1.15 . . . . 0.0 113.401 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 134.38 -169.63 22.98 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.737 1.637 . . . . 0.0 115.369 167.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.32 99.82 0.17 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.695 2.93 . . . . 0.0 111.159 167.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.5 t -88.2 131.69 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.019 1.727 . . . . 0.0 110.19 172.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.42 -46.29 20.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.949 1.3 . . . . 0.0 111.18 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -171.07 150.46 3.05 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.689 1.596 . . . . 0.0 112.033 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.2 t -115.87 151.17 17.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 129.297 3.039 . . . . 0.0 110.383 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -129.68 121.09 26.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.93 2.092 . . . . 0.0 111.209 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.5 mm -101.0 122.33 49.11 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.583 1.553 . . . . 0.0 110.124 160.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.36 163.75 35.24 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 125.188 3.925 . . . . 0.0 111.114 164.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -154.92 113.64 3.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.525 1.53 . . . . 0.0 113.149 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -53.04 168.9 0.11 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 130.444 3.497 . . . . 0.0 113.83 173.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -28.4 59.96 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.852 0.461 . . . . 0.0 110.471 168.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -83.37 -6.17 59.38 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.67 40.91 8.57 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 126.556 2.027 . . . . 0.0 111.943 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -128.82 137.11 30.28 Favored Pre-proline 0 N--CA 1.465 0.325 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.58 14.23 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 124.275 3.316 . . . . 0.0 116.682 176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.42 27.81 6.82 Favored 'General case' 0 CA--C 1.554 1.125 0 O-C-N 120.538 -1.351 . . . . 0.0 114.307 175.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 57.42 32.47 21.83 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 127.464 2.305 . . . . 0.0 116.156 -173.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -147.0 162.57 38.51 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 127.205 2.202 . . . . 0.0 112.53 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -158.67 177.43 11.21 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.622 1.969 . . . . 0.0 110.362 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -129.06 154.35 46.74 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.106 1.362 . . . . 0.0 114.22 171.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.16 133.52 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.523 1.529 . . . . 0.0 110.609 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -99.06 141.25 32.06 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.914 1.686 . . . . 0.0 112.207 173.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -147.17 1.3 0.74 Allowed 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 176.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -172.01 161.11 5.56 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 127.676 2.39 . . . . 0.0 111.473 -170.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -71.34 -47.32 57.24 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 120.696 1.589 . . . . 0.0 114.71 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -112.85 146.41 38.94 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 167.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.1 t -82.23 102.0 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -176.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.2 p -76.53 -81.53 0.08 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 113.468 -1.696 . . . . 0.0 108.984 168.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.2 p -165.45 127.79 1.5 Allowed Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 125.159 1.384 . . . . 0.0 113.223 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -88.49 149.1 6.33 Favored 'Trans proline' 0 CA--C 1.551 1.338 0 C-N-CA 123.692 2.928 . . . . 0.0 114.48 -169.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -74.55 -42.09 59.42 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 120.521 -1.362 . . . . 0.0 112.044 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.91 -42.28 79.65 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.089 1.755 . . . . 0.0 114.482 -166.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.18 -22.95 2.91 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 173.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -109.06 -34.3 6.64 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 125.257 1.423 . . . . 0.0 110.343 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.2 tp -64.1 -60.85 2.73 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 118.831 0.741 . . . . 0.0 111.298 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -87.88 -86.42 0.16 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.458 1.903 . . . . 0.0 106.662 -174.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 37.57 64.56 0.63 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 126.289 1.836 . . . . 0.0 114.621 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.97 35.1 0.56 Allowed Glycine 0 N--CA 1.481 1.658 0 O-C-N 120.814 -1.179 . . . . 0.0 115.234 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.01 143.95 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.525 1.53 . . . . 0.0 112.476 -174.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.23 170.7 12.97 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.82 2.048 . . . . 0.0 112.653 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 15.5 tp -123.21 -30.73 3.68 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.867 2.467 . . . . 0.0 112.272 163.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -83.7 -21.52 32.34 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.082 2.153 . . . . 0.0 114.001 -172.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 150.79 -59.8 0.42 Allowed Glycine 0 N--CA 1.483 1.791 0 N-CA-C 116.166 1.226 . . . . 0.0 116.166 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -102.47 129.04 26.84 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 126.267 1.827 . . . . 0.0 109.033 -173.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -76.38 134.68 15.83 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.76 2.974 . . . . 0.0 113.747 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 mm -57.57 129.33 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 O-C-N 121.834 -0.541 . . . . 0.0 110.4 176.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -119.37 110.52 17.05 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.528 1.931 . . . . 0.0 109.582 170.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -85.32 134.29 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 126.125 1.77 . . . . 0.0 109.256 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -130.09 147.92 51.88 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.679 1.992 . . . . 0.0 111.399 -166.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.4 t80 64.32 130.19 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.302 1.841 . . . . 0.0 111.644 -154.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -107.07 -63.24 1.31 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.506 1.522 . . . . 0.0 109.907 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.9 t -162.14 162.66 28.59 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -78.94 108.96 2.76 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 125.058 1.314 . . . . 0.0 112.739 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.8 m -122.47 157.97 30.81 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.766 1.626 . . . . 0.0 110.008 171.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.3 m -65.53 151.88 45.35 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.305 1.842 . . . . 0.0 114.121 -172.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -172.34 134.71 0.7 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.054 2.542 . . . . 0.0 110.908 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 78.67 166.66 0.12 Allowed Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 127.325 2.25 . . . . 0.0 115.016 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -62.8 161.57 28.45 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.921 2.414 . . . . 0.0 115.888 167.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -135.71 -47.28 0.67 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.001 -1.062 . . . . 0.0 109.091 167.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.4 t70 . . . . . 0 C--O 1.259 1.567 0 C-N-CA 125.586 1.555 . . . . 0.0 113.545 179.924 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.733 0 N-CA-C 107.627 -2.189 . . . . 0.0 107.627 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 m -85.92 -46.31 10.69 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.562 2.345 . . . . 0.0 115.764 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.326 3.0 mp0 67.07 175.76 0.25 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 130.385 3.474 . . . . 0.0 116.594 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -117.31 -44.1 2.79 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.49 1.116 . . . . 0.0 112.664 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -93.18 37.48 1.04 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.672 1.989 . . . . 0.0 113.293 -171.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.9 mt -95.89 155.63 16.67 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.511 1.925 . . . . 0.0 113.857 173.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.63 159.76 0.73 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.018 1.727 . . . . 0.0 115.363 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -66.33 147.78 52.81 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.338 1.855 . . . . 0.0 111.23 172.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.427 ' C ' ' H ' ' A' ' 11' ' ' ALA . 77.1 mt-30 -108.88 -24.46 11.25 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.318 1.847 . . . . 0.0 111.758 -174.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -68.59 12.19 0.14 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.046 2.139 . . . . 0.0 112.883 163.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' A' ' 9' ' ' GLN . . . -126.05 167.56 15.17 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -162.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.2 mt -65.87 156.6 32.88 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.746 1.618 . . . . 0.0 113.928 -165.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.81 -43.1 65.7 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.568 1.147 . . . . 0.0 113.372 -172.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 41.27 38.49 0.79 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 127.997 2.519 . . . . 0.0 115.303 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.43 145.77 28.8 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 120.452 -1.405 . . . . 0.0 110.942 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.97 -175.59 4.47 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.09 0.956 . . . . 0.0 112.797 -175.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.28 7.32 6.59 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.3 m -105.37 152.95 22.31 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 122.532 1.158 . . . . 0.0 108.102 -175.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.5 tp -119.28 125.12 48.35 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 130.917 3.687 . . . . 0.0 111.01 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -80.65 135.95 36.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.602 1.161 . . . . 0.0 108.47 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.3 t -135.37 139.39 46.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 125.098 1.359 . . . . 0.0 108.753 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.02 -174.7 14.24 Favored Glycine 0 N--CA 1.449 -0.454 0 O-C-N 121.098 -1.001 . . . . 0.0 112.448 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.5 t30 71.19 24.44 3.84 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.943 1.697 . . . . 0.0 112.383 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.24 145.75 47.73 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 125.191 1.397 . . . . 0.0 109.766 -169.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.24 162.05 18.1 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 176.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.4 p -63.1 -22.41 66.84 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.822 1.649 . . . . 0.0 111.639 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -113.38 23.2 13.46 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.466 1.506 . . . . 0.0 113.618 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.7 p -60.25 155.47 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 O-C-N 119.784 -1.823 . . . . 0.0 112.131 171.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.6 p -153.52 159.8 42.33 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 129.132 2.973 . . . . 0.0 108.58 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -59.9 -28.06 67.25 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.08 2.152 . . . . 0.0 111.9 177.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -73.08 -32.58 65.09 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.067 1.347 . . . . 0.0 112.252 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.456 HD22 ' CZ ' ' A' ' 83' ' ' TYR . 21.7 tp -76.08 -36.49 58.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.676 0.79 . . . . 0.0 112.999 172.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.0 mt -69.71 -42.31 74.21 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -63.03 -40.74 98.63 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.786 1.63 . . . . 0.0 112.938 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -69.86 -29.72 67.02 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.141 -0.975 . . . . 0.0 111.37 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.1 tt -73.38 -39.06 65.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.58 0.752 . . . . 0.0 110.388 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -93.41 17.36 11.54 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.779 1.231 . . . . 0.0 114.274 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -67.39 -30.28 70.01 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 120.286 1.403 . . . . 0.0 114.671 -173.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -101.24 0.24 37.06 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.126 1.77 . . . . 0.0 113.123 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.77 30.95 0.54 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.14 179.28 39.97 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.104 0.859 . . . . 0.0 111.748 -173.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -62.13 109.24 0.79 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.43 2.086 . . . . 0.0 109.716 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.9 t -94.04 105.05 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.798 1.239 . . . . 0.0 109.11 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.1 mt -62.51 -49.37 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.437 1.895 . . . . 0.0 111.825 171.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.17 170.1 19.66 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.681 0.792 . . . . 0.0 110.13 175.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.3 t -119.58 160.77 19.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 125.355 1.462 . . . . 0.0 109.132 169.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -138.54 124.05 19.54 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.884 1.273 . . . . 0.0 111.939 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mm -108.37 121.69 42.73 Favored Pre-proline 0 C--N 1.32 -0.692 0 C-N-CA 125.721 1.608 . . . . 0.0 109.896 169.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.16 164.83 33.37 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 125.198 3.932 . . . . 0.0 112.304 165.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -159.51 118.32 2.85 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 126.923 2.089 . . . . 0.0 108.769 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -55.53 168.92 0.35 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 127.106 2.162 . . . . 0.0 113.06 171.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.35 -35.44 62.74 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.001 1.32 . . . . 0.0 110.116 172.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -89.16 6.79 38.44 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 128.321 2.648 . . . . 0.0 114.79 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.47 46.55 7.34 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 126.759 2.123 . . . . 0.0 115.416 168.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -136.26 137.27 24.1 Favored Pre-proline 0 N--CA 1.476 0.842 0 CA-C-N 118.761 1.281 . . . . 0.0 113.467 -173.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.79 17.88 0.92 Allowed 'Trans proline' 0 C--O 1.223 -0.261 1 C-N-CA 126.412 4.741 . . . . 0.0 115.596 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.435 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 50.5 27.86 3.07 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.815 1.646 . . . . 0.0 113.341 175.501 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.25 11.3 mt-30 53.83 32.59 15.29 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -171.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.435 ' CD2' ' HB2' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -149.21 150.98 33.5 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 126.337 1.855 . . . . 0.0 112.873 -176.04 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -155.1 176.06 13.03 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.911 1.685 . . . . 0.0 112.505 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -135.39 163.16 30.66 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.1 t -145.48 143.6 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.608 1.563 . . . . 0.0 109.813 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -112.26 130.76 55.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.885 0.85 . . . . 0.0 110.499 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -145.96 141.89 28.16 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.074 1.349 . . . . 0.0 111.953 -161.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -149.04 127.88 12.58 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.089 0.955 . . . . 0.0 109.846 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.496 ' CD2' ' H ' ' A' ' 68' ' ' VAL . 76.0 t60 -150.15 167.01 28.1 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 126.309 1.844 . . . . 0.0 109.79 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -55.98 -30.86 62.42 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 177.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.496 ' H ' ' CD2' ' A' ' 66' ' ' HIS . 13.7 m -118.39 147.26 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 120.231 -1.543 . . . . 0.0 111.222 160.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.5 m -89.16 76.83 7.65 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 119.962 -1.712 . . . . 0.0 113.582 174.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 m -121.98 156.23 59.87 Favored Pre-proline 0 N--CA 1.483 1.185 0 C-N-CA 124.857 1.263 . . . . 0.0 110.794 174.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -94.74 84.54 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.467 2.111 . . . . 0.0 109.266 -164.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -61.48 -40.9 96.24 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 120.084 -1.635 . . . . 0.0 112.888 -169.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.99 -27.96 63.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.145 1.378 . . . . 0.0 112.348 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.5 ttt -69.69 -17.7 63.5 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.323 1.049 . . . . 0.0 111.893 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -98.92 -38.87 8.84 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.216 0.917 . . . . 0.0 111.787 166.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.51 -40.09 94.99 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 118.8 0.727 . . . . 0.0 111.392 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 mt -124.81 -86.45 0.63 Allowed 'General case' 0 C--N 1.348 0.527 0 CA-C-O 116.36 -1.781 . . . . 0.0 111.191 -158.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 23.03 71.67 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.769 2.028 . . . . 0.0 112.439 169.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.75 25.19 0.7 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.752 1.644 . . . . 0.0 114.289 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -134.81 151.68 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.645 1.178 . . . . 0.0 113.096 -172.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.94 168.95 20.43 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.416 1.486 . . . . 0.0 112.526 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.0 tp -111.89 -33.59 6.25 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 128.553 2.741 . . . . 0.0 111.146 173.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.456 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 6.4 m-30 -93.57 -67.0 0.88 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.632 1.573 . . . . 0.0 110.687 -173.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.37 -38.55 0.07 OUTLIER Glycine 0 CA--C 1.53 1.003 0 CA-C-O 117.92 -1.489 . . . . 0.0 116.108 -175.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -101.94 108.07 54.89 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 120.205 2.003 . . . . 0.0 110.86 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -65.73 128.9 20.92 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.236 3.291 . . . . 0.0 113.585 -166.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.0 mm -58.85 124.78 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -117.13 109.8 17.38 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 128.258 2.623 . . . . 0.0 110.749 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 mp -88.93 142.74 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.255 0.622 . . . . 0.0 109.677 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -132.84 154.48 50.29 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 123.467 1.603 . . . . 0.0 113.93 -176.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -164.96 152.26 11.09 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.09 -163.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -158.47 138.98 12.63 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.143 0.977 . . . . 0.0 112.722 175.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.5 p -150.29 164.36 35.95 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 120.978 -1.076 . . . . 0.0 113.641 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 155.22 -28.92 0.63 Allowed Glycine 0 CA--C 1.541 1.704 0 C-N-CA 125.474 1.511 . . . . 0.0 114.714 175.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.0 m -108.75 -1.59 19.23 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.3 m -104.11 17.0 25.0 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.862 1.665 . . . . 0.0 113.992 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -64.62 142.45 58.42 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.083 2.153 . . . . 0.0 112.523 174.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -143.98 165.66 23.13 Favored Pre-proline 0 C--O 1.236 0.361 0 C-N-CA 126.999 2.12 . . . . 0.0 111.16 -168.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.96 157.67 57.43 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 CA-C-O 123.373 1.322 . . . . 0.0 115.217 170.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -80.5 -73.93 0.34 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.921 1.688 . . . . 0.0 107.777 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.5 t70 . . . . . 0 C--O 1.26 1.654 0 C-N-CA 125.012 1.325 . . . . 0.0 113.254 174.784 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 CA-C-O 119.291 -0.727 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 p -143.92 155.92 44.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.204 2.602 . . . . 0.0 111.951 -170.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -151.11 139.9 20.82 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 123.093 1.425 . . . . 0.0 114.024 174.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -121.45 -42.67 2.43 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 128.028 2.531 . . . . 0.0 111.581 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -88.55 56.65 3.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.273 1.429 . . . . 0.0 109.267 171.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.0 tp -91.25 163.7 14.15 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 122.61 1.195 . . . . 0.0 111.0 -175.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.94 124.77 21.94 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.071 -1.422 . . . . 0.0 108.42 175.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -157.03 148.47 22.23 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -133.61 175.09 9.74 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 128.41 2.684 . . . . 0.0 112.495 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -90.09 -30.25 17.81 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 119.545 -1.972 . . . . 0.0 113.429 -166.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.82 -176.53 2.05 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 129.36 3.064 . . . . 0.0 109.612 -175.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.7 mt -55.16 125.9 22.53 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.378 1.871 . . . . 0.0 112.232 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.11 136.32 36.61 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.816 0.846 . . . . 0.0 112.763 -163.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -125.56 143.54 50.97 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.648 1.579 . . . . 0.0 110.18 176.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.93 141.48 54.98 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 153.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -156.57 104.26 2.17 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.882 1.273 . . . . 0.0 109.292 177.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 61.03 -14.66 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.72 2.408 . . . . 0.0 117.033 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.54 167.24 21.46 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.703 1.601 . . . . 0.0 109.252 -163.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.3 tp -122.85 123.6 41.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.873 1.669 . . . . 0.0 114.347 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -71.77 132.53 44.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.298 1.047 . . . . 0.0 112.497 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.43 119.88 51.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 174.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.43 -171.48 16.6 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 122.988 1.327 . . . . 0.0 112.067 166.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.3 t30 71.39 31.22 2.37 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.438 2.295 . . . . 0.0 114.595 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.16 155.78 38.02 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.879 1.272 . . . . 0.0 113.91 -172.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -65.79 160.32 23.31 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.1 p -62.64 -26.75 68.79 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 128.712 2.805 . . . . 0.0 111.867 168.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -113.38 10.4 18.34 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.43 1.892 . . . . 0.0 113.448 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.2 p -61.92 158.97 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -174.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.6 p -154.1 168.92 24.86 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 128.356 2.662 . . . . 0.0 110.625 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -62.44 -25.2 67.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.409 1.484 . . . . 0.0 110.22 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -80.66 -26.48 37.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 117.361 -1.304 . . . . 0.0 113.672 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.8 tp -73.65 -29.89 62.6 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.283 0.947 . . . . 0.0 111.681 169.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.4 mt -78.83 -44.69 22.47 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.298 1.039 . . . . 0.0 113.663 171.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -63.9 -43.67 95.3 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 120.137 -1.602 . . . . 0.0 110.971 -174.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -63.42 -18.38 63.66 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.292 1.037 . . . . 0.0 113.573 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 tt -99.19 -43.95 6.44 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 129.093 2.957 . . . . 0.0 110.224 -169.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -78.69 -14.13 59.46 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.152 1.381 . . . . 0.0 111.841 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -66.62 -27.4 67.66 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 120.37 -1.456 . . . . 0.0 111.877 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -68.14 -23.99 64.95 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 127.754 2.422 . . . . 0.0 114.117 165.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.71 -22.15 23.51 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.707 1.603 . . . . 0.0 110.325 -176.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 132.81 -147.15 18.82 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.447 1.022 . . . . 0.0 114.299 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -81.25 114.73 2.84 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.917 3.078 . . . . 0.0 110.306 -172.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.1 t -110.6 120.39 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.422 1.489 . . . . 0.0 110.57 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -61.41 -57.14 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 163.87 38.5 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 127.281 2.232 . . . . 0.0 113.582 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 73.2 t -118.22 146.66 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 128.651 2.78 . . . . 0.0 110.136 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -122.58 128.52 50.82 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.803 1.638 . . . . 0.0 113.607 171.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.3 mm -107.35 120.96 46.01 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 125.459 1.503 . . . . 0.0 110.647 163.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.42 168.45 24.72 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 125.029 3.819 . . . . 0.0 113.318 165.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -158.6 122.55 3.99 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.639 2.775 . . . . 0.0 111.965 166.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.62 164.95 0.3 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.218 2.607 . . . . 0.0 113.248 165.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -49.88 -29.71 8.67 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 164.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.12 -7.84 59.11 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.002 1.321 . . . . 0.0 114.555 170.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.15 38.93 7.6 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 119.88 -1.763 . . . . 0.0 111.952 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.28 132.91 24.6 Favored Pre-proline 0 C--N 1.347 0.493 0 CA-C-N 118.619 1.209 . . . . 0.0 114.26 -176.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.21 12.16 0.3 Allowed 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.308 3.339 . . . . 0.0 113.861 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.436 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 58.82 22.32 10.02 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.485 -1.384 . . . . 0.0 113.147 172.244 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 57.86 34.39 24.31 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.13 1.372 . . . . 0.0 114.106 -171.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.436 ' CD2' ' HB2' ' A' ' 57' ' ' LYS . 0.2 OUTLIER -150.8 158.74 44.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.75 1.22 . . . . 0.0 113.247 -176.488 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.64 -176.86 6.18 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.251 1.42 . . . . 0.0 112.501 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -140.43 154.57 46.7 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.159 -0.963 . . . . 0.0 113.189 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.46 139.34 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.766 0.826 . . . . 0.0 113.174 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -95.3 123.91 39.06 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.113 1.365 . . . . 0.0 112.881 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -100.14 152.26 20.45 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 122.612 1.196 . . . . 0.0 114.119 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -91.13 -27.07 18.79 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 128.223 2.609 . . . . 0.0 112.809 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -150.97 -7.57 0.26 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 116.778 2.14 . . . . 0.0 116.778 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -79.98 38.12 0.39 Allowed 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -159.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.5 t -67.56 123.63 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 120.364 -1.46 . . . . 0.0 108.986 -175.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.268 3.0 m 69.74 -8.42 0.78 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.68 82.93 15.17 Favored Pre-proline 0 N--CA 1.493 1.687 0 CA-C-N 121.816 2.098 . . . . 0.0 112.909 169.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.83 115.01 3.74 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 125.284 3.989 . . . . 0.0 109.993 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -64.59 -29.29 70.3 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.844 -1.16 . . . . 0.0 113.593 -161.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.06 -18.68 64.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.7 ttp -61.12 -17.84 54.88 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 120.137 1.335 . . . . 0.0 112.206 173.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -109.22 -44.2 3.99 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.54 1.136 . . . . 0.0 111.888 171.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.29 -43.15 95.68 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.566 0.347 . . . . 0.0 111.55 -170.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -107.96 -88.34 0.48 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.616 1.166 . . . . 0.0 111.258 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 27.01 71.11 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 129.73 3.212 . . . . 0.0 115.712 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.43 14.98 1.49 Allowed Glycine 0 CA--C 1.532 1.155 0 CA-C-O 117.598 -1.668 . . . . 0.0 116.085 -174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -125.08 150.98 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 119.793 1.797 . . . . 0.0 111.2 -168.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.88 171.21 16.98 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.745 1.218 . . . . 0.0 113.742 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.8 tp -120.28 -46.58 2.39 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.637 1.175 . . . . 0.0 109.75 166.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -69.32 -54.8 12.72 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.29 -46.2 0.06 OUTLIER Glycine 0 CA--C 1.537 1.414 0 N-CA-C 116.265 1.266 . . . . 0.0 116.265 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -105.15 114.71 63.28 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 127.619 2.368 . . . . 0.0 114.101 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.92 119.5 6.53 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.715 2.943 . . . . 0.0 113.033 -171.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.7 mm -50.24 124.08 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.903 1.281 . . . . 0.0 110.1 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -118.86 109.88 16.54 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 124.487 1.115 . . . . 0.0 112.037 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mp -81.88 131.23 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -118.35 145.01 45.45 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -158.63 145.19 17.22 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 118.366 2.728 . . . . 0.0 118.366 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -105.27 131.88 52.17 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 129.465 3.106 . . . . 0.0 111.333 174.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 86.0 p -69.64 162.44 27.65 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.455 1.102 . . . . 0.0 112.148 170.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.11 -9.2 0.03 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.472 1.51 . . . . 0.0 114.123 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 56.8 m -95.01 151.17 19.4 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.88 2.072 . . . . 0.0 110.234 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 40.2 m -116.16 161.28 19.18 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 127.182 2.193 . . . . 0.0 111.935 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -74.56 -24.8 58.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.433 1.493 . . . . 0.0 111.881 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . 0.257 . . 68.89 153.73 0.14 Allowed Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 127.856 2.462 . . . . 0.0 114.195 177.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -94.49 -173.13 0.3 Allowed 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 124.985 3.79 . . . . 0.0 113.23 174.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -151.49 -29.68 0.18 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 176.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 C--O 1.256 1.412 0 C-N-CA 128.086 2.554 . . . . 0.0 115.946 174.88 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.748 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.9 m -94.43 64.79 3.16 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.248 1.419 . . . . 0.0 110.765 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -66.76 145.53 55.42 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -172.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -64.09 -37.94 89.26 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.241 -1.537 . . . . 0.0 112.269 -178.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -80.76 31.37 0.3 Allowed 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -175.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.1 mt -120.55 148.34 43.98 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 127.214 2.206 . . . . 0.0 112.616 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -68.45 95.88 0.65 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 122.889 1.328 . . . . 0.0 110.404 164.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.3 mtm105 -134.46 9.68 3.71 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 129.17 2.988 . . . . 0.0 115.269 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -78.73 158.43 28.29 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 127.157 2.183 . . . . 0.0 111.756 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -34.89 -28.06 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 131.259 3.824 . . . . 0.0 120.845 -175.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.71 162.89 40.67 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.556 1.071 . . . . 0.0 111.41 -173.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 29.2 mt 59.3 4.19 0.45 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 127.593 2.357 . . . . 0.0 117.206 171.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.39 -5.02 55.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.956 2.102 . . . . 0.0 115.372 -167.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -118.76 167.89 11.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -153.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.97 151.61 46.4 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.676 2.39 . . . . 0.0 111.791 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -162.42 165.39 26.41 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.343 1.457 . . . . 0.0 113.122 -174.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -70.95 -15.32 62.58 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.867 -1.145 . . . . 0.0 113.687 161.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.5 m -104.41 138.28 41.05 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.723 2.009 . . . . 0.0 111.218 -175.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.8 tp -75.28 132.53 41.1 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.732 2.413 . . . . 0.0 110.549 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -84.79 137.73 33.01 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 120.288 1.404 . . . . 0.0 110.622 175.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.57 115.79 32.77 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 59' ' ' PHE . . . -115.87 -177.28 18.37 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.357 1.456 . . . . 0.0 110.396 172.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.2 t30 65.52 37.72 5.9 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.119 1.368 . . . . 0.0 111.698 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.81 152.04 39.02 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.028 1.731 . . . . 0.0 109.468 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.47 ' CD ' ' H ' ' A' ' 26' ' ' THR . 0.7 OUTLIER -67.9 170.96 7.27 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 123.966 1.841 . . . . 0.0 112.587 169.451 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.47 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 24.9 p -82.54 -13.77 56.06 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 126.293 1.837 . . . . 0.0 113.331 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -119.11 20.33 12.69 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.25 2.62 . . . . 0.0 113.08 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.67 158.23 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.1 p -153.5 167.0 30.93 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.441 1.096 . . . . 0.0 111.697 -173.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -63.78 -32.12 73.52 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.011 0.924 . . . . 0.0 108.713 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.12 -47.85 81.03 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.559 1.944 . . . . 0.0 113.109 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.3 tp -67.11 -36.94 83.01 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.095 0.558 . . . . 0.0 110.922 -175.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 99.2 mt -65.89 -51.17 61.02 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.17 1.388 . . . . 0.0 111.042 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -52.59 -43.52 65.36 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.838 2.055 . . . . 0.0 113.523 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -75.23 -27.63 59.6 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -76.14 -38.73 56.4 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.608 -0.683 . . . . 0.0 112.067 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -82.03 11.53 5.06 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.595 -1.315 . . . . 0.0 114.06 176.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -62.95 -44.78 95.12 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.124 1.37 . . . . 0.0 113.786 -174.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.72 6.7 44.93 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.639 1.576 . . . . 0.0 111.351 168.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.66 3.66 43.72 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 120.744 1.611 . . . . 0.0 112.673 171.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.85 -167.94 12.59 Favored Glycine 0 CA--C 1.538 1.515 0 C-N-CA 127.918 2.675 . . . . 0.0 111.831 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.04 97.74 0.93 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.697 2.264 . . . . 0.0 111.328 -173.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.8 t -68.33 119.23 13.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 122.58 1.181 . . . . 0.0 110.335 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.9 mm -80.54 -46.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -175.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.99 155.19 30.87 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.885 1.674 . . . . 0.0 110.111 174.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.5 t -112.64 153.87 14.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 125.681 1.593 . . . . 0.0 107.45 170.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -126.91 126.4 43.19 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.905 1.282 . . . . 0.0 112.39 169.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.6 mm -105.54 122.78 41.59 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 123.892 0.877 . . . . 0.0 109.594 164.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.71 166.21 30.17 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.847 3.031 . . . . 0.0 110.153 164.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -160.72 120.06 2.67 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 128.087 2.555 . . . . 0.0 106.072 174.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.25 172.81 2.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.359 -1.746 . . . . 0.0 110.75 167.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -32.61 62.97 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 122.405 1.098 . . . . 0.0 111.045 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -77.45 -3.61 41.23 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.648 1.979 . . . . 0.0 113.116 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.95 41.51 8.1 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.541 2.019 . . . . 0.0 113.618 170.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -136.46 135.48 20.77 Favored Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.32 15.39 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.585 1 C-N-CA 126.106 4.537 . . . . 0.0 116.005 -174.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.76 29.22 9.24 Favored 'General case' 0 CA--C 1.557 1.22 0 O-C-N 121.548 -0.72 . . . . 0.0 111.91 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 53.99 38.41 28.83 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -174.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.414 ' HA ' ' HA2' ' A' ' 22' ' ' GLY . 1.1 p90 -152.72 173.36 15.37 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 127.787 2.435 . . . . 0.0 113.257 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -169.71 174.51 5.72 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 128.882 2.873 . . . . 0.0 112.737 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -127.01 153.92 45.3 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.706 2.003 . . . . 0.0 112.274 170.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 t -141.2 140.17 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.66 1.984 . . . . 0.0 108.008 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -105.86 131.07 53.64 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -127.57 152.92 47.01 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.878 1.671 . . . . 0.0 109.293 162.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -98.61 158.02 15.87 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.499 -1.376 . . . . 0.0 111.99 -176.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 37.9 56.45 1.58 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.619 2.368 . . . . 0.0 113.29 176.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -88.75 146.83 24.79 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.49 1.916 . . . . 0.0 110.322 -173.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.3 m -118.8 -171.36 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 127.295 2.238 . . . . 0.0 108.984 175.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.4 143.81 56.91 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.475 1.11 . . . . 0.0 111.076 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 t 70.04 107.35 0.03 OUTLIER Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 127.869 2.468 . . . . 0.0 116.745 -175.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.23 137.34 36.75 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 124.629 3.553 . . . . 0.0 113.731 173.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -59.7 -42.6 93.36 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.847 1.259 . . . . 0.0 109.547 -175.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.86 -25.4 28.54 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 173.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 tpt -71.93 -16.05 62.1 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 121.456 1.935 . . . . 0.0 113.788 -173.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -103.16 -35.96 8.29 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.315 1.846 . . . . 0.0 111.271 169.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.67 -48.98 23.1 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.964 1.706 . . . . 0.0 112.633 -169.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.15 -97.14 0.33 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.73 1.612 . . . . 0.0 108.63 177.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 39.55 57.57 2.13 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.447 1.899 . . . . 0.0 112.69 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.52 22.54 0.13 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.89 151.6 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 118.711 1.255 . . . . 0.0 113.806 -168.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.51 176.91 6.24 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.91 1.684 . . . . 0.0 110.93 -170.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.9 tp -125.87 -35.83 2.45 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.088 1.755 . . . . 0.0 112.428 170.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 14.7 m-30 -81.79 -61.23 1.98 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.986 1.715 . . . . 0.0 111.059 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.87 -49.1 0.06 OUTLIER Glycine 0 N--CA 1.468 0.809 0 N-CA-C 117.297 1.679 . . . . 0.0 117.297 -176.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -90.87 116.67 66.91 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -171.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.08 128.82 13.43 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.177 2.585 . . . . 0.0 110.393 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.3 mm -63.87 118.65 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.155 -174.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -103.5 91.73 4.17 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.87 1.668 . . . . 0.0 110.799 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mp -60.14 139.13 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.203 165.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -138.71 157.31 46.35 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.282 1.433 . . . . 0.0 112.342 167.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -150.95 155.27 38.75 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 174.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.7 mmm-85 -89.44 149.13 23.08 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.9 m -124.06 173.02 8.54 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 128.64 2.776 . . . . 0.0 112.938 165.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 158.5 23.9 0.03 OUTLIER Glycine 0 CA--C 1.551 2.327 0 N-CA-C 118.338 2.095 . . . . 0.0 118.338 -172.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.8 m 45.86 44.69 11.24 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.785 2.292 . . . . 0.0 116.862 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.1 p -163.07 163.13 26.0 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.682 -1.261 . . . . 0.0 113.628 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -133.6 141.93 47.89 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 127.508 2.323 . . . . 0.0 112.191 -168.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -51.45 142.0 22.31 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.018 0.927 . . . . 0.0 110.506 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -81.98 129.39 6.15 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 124.183 3.255 . . . . 0.0 111.774 172.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -103.14 -22.64 13.72 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 127.552 2.341 . . . . 0.0 114.984 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 N--CA 1.489 1.511 0 C-N-CA 128.405 2.682 . . . . 0.0 113.57 -171.509 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.515 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.8 m -61.5 145.4 51.98 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.545 1.138 . . . . 0.0 113.185 -167.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -62.83 146.69 52.08 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.028 0.531 . . . . 0.0 110.874 -173.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -148.85 -25.74 0.31 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.658 1.983 . . . . 0.0 115.238 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -110.3 2.77 19.36 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.599 1.56 . . . . 0.0 113.162 -177.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.43 156.9 30.89 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 120.784 1.629 . . . . 0.0 108.936 163.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -64.75 138.94 58.68 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 169.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.4 -23.41 37.63 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.463 1.105 . . . . 0.0 112.848 171.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -86.58 160.18 19.01 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.745 1.218 . . . . 0.0 110.235 164.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -61.55 -31.63 71.67 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 -168.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.1 167.4 24.19 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 120.803 1.638 . . . . 0.0 113.265 -172.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 pp -54.92 153.1 6.59 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.361 1.865 . . . . 0.0 108.331 160.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -132.27 1.46 3.82 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 120.45 -1.406 . . . . 0.0 114.589 -150.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -145.93 136.06 23.73 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 118.814 0.733 . . . . 0.0 112.854 -172.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.44 166.53 32.97 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 126.585 1.954 . . . . 0.0 112.383 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -146.38 153.87 40.99 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 127.006 2.122 . . . . 0.0 111.529 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.24 13.04 4.52 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 -174.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.52 149.81 39.61 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -155.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 51.1 tp -106.83 133.37 51.59 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.195 2.598 . . . . 0.0 111.792 -172.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -88.0 133.0 34.05 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.56 0.618 . . . . 0.0 110.492 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.3 t -130.57 122.87 53.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 O-C-N 120.966 -1.084 . . . . 0.0 108.76 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 59' ' ' PHE . . . -125.32 -175.78 14.33 Favored Glycine 0 N--CA 1.464 0.548 0 C-N-CA 126.264 1.888 . . . . 0.0 112.057 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.1 t30 64.45 31.95 12.21 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.854 2.062 . . . . 0.0 111.907 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.74 166.4 13.18 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.391 1.876 . . . . 0.0 111.531 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 26' ' ' THR . 1.0 OUTLIER -82.74 165.82 19.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 123.126 1.441 . . . . 0.0 113.65 166.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.542 ' HB ' ' HZ2' ' A' ' 55' ' ' LYS . 67.4 p -65.91 -34.2 77.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.505 1.522 . . . . 0.0 111.88 175.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.09 19.52 20.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.736 2.014 . . . . 0.0 115.395 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.8 p -64.88 155.85 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 125.012 1.325 . . . . 0.0 111.264 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.7 p -159.75 162.06 34.83 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.667 1.987 . . . . 0.0 110.319 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -60.09 -30.49 69.28 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.204 0.602 . . . . 0.0 110.316 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -59.94 -41.87 92.78 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.153 1.781 . . . . 0.0 112.321 174.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -72.04 -51.99 19.05 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.7 mt -56.41 -39.87 73.75 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -66.44 -46.36 76.72 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.01 0.823 . . . . 0.0 110.757 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -57.04 -39.71 75.36 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.807 1.643 . . . . 0.0 111.721 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -81.61 -42.85 19.45 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.933 1.693 . . . . 0.0 112.884 -175.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . 0.329 48.0 m-85 -76.54 -4.93 45.37 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 172.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -54.7 -42.62 71.69 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 121.902 2.137 . . . . 0.0 111.503 164.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -72.66 -15.86 61.71 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.16 -1.23 57.89 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.495 1.043 . . . . 0.0 113.773 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.64 -148.51 18.41 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.071 0.843 . . . . 0.0 111.221 -174.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -75.62 157.5 40.17 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.798 2.332 . . . . 0.0 112.78 171.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.1 147.32 21.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 127.116 2.167 . . . . 0.0 107.502 170.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.7 mm -88.49 -51.6 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 121.006 -1.059 . . . . 0.0 109.608 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.74 168.84 25.9 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.549 2.339 . . . . 0.0 112.561 175.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.8 t -122.9 144.63 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 129.874 3.269 . . . . 0.0 110.609 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -127.41 122.58 33.96 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 130.307 3.443 . . . . 0.0 115.275 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.0 mm -107.09 125.89 31.44 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.145 1.778 . . . . 0.0 110.067 167.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.14 167.62 23.06 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.776 3.65 . . . . 0.0 111.289 163.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -160.58 118.56 2.51 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 128.111 2.564 . . . . 0.0 110.35 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -52.37 163.43 0.41 Allowed 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 126.852 2.061 . . . . 0.0 113.698 169.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -30.6 43.46 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.031 1.332 . . . . 0.0 113.093 172.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -87.04 -9.67 54.91 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 171.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.25 51.71 1.21 Allowed Glycine 0 C--N 1.338 0.653 0 C-N-CA 125.937 1.732 . . . . 0.0 113.453 165.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.542 ' HZ2' ' HB ' ' A' ' 26' ' ' THR . 10.5 tppt? -141.13 134.93 14.82 Favored Pre-proline 0 N--CA 1.467 0.392 0 CA-C-O 117.547 -1.216 . . . . 0.0 112.988 -176.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.53 12.51 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.531 1 C-N-CA 126.673 4.916 . . . . 0.0 115.422 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.11 20.81 10.05 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.703 -1.248 . . . . 0.0 111.722 173.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 59.08 38.47 23.91 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.701 2.0 . . . . 0.0 113.515 -173.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.418 ' HA ' ' HA2' ' A' ' 22' ' ' GLY . 0.2 OUTLIER -156.32 165.01 37.6 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.837 2.055 . . . . 0.0 111.529 -179.114 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.03 -179.21 6.07 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 128.671 2.788 . . . . 0.0 111.149 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -142.42 154.17 44.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.464 1.506 . . . . 0.0 114.411 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.8 t -143.32 120.92 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.958 1.303 . . . . 0.0 111.73 -176.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -73.21 129.9 39.06 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.848 -1.157 . . . . 0.0 111.58 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -148.64 140.92 24.11 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.706 1.202 . . . . 0.0 113.784 -164.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.0 3.67 44.98 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 128.19 2.596 . . . . 0.0 116.33 -167.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -80.11 139.93 36.65 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.921 0.782 . . . . 0.0 112.337 175.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -105.8 2.45 27.82 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.412 1.485 . . . . 0.0 112.322 -173.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.02 165.34 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.457 1.903 . . . . 0.0 111.114 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.6 m -83.06 31.37 0.44 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.49 1.916 . . . . 0.0 115.391 -160.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.256 18.0 m -118.65 55.18 2.39 Favored Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -174.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -65.99 119.03 6.0 Favored 'Trans proline' 0 C--N 1.355 0.878 1 C-N-CA 125.412 4.075 . . . . 0.0 112.128 -166.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -50.5 -36.56 34.44 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -164.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.96 -22.92 60.63 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.439 1.496 . . . . 0.0 114.528 -176.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.7 ttt -64.45 -21.01 66.53 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.652 1.181 . . . . 0.0 110.192 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -101.36 -34.63 9.53 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.253 1.821 . . . . 0.0 112.987 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.61 -39.92 23.75 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -172.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.3 -84.25 0.59 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.293 1.037 . . . . 0.0 109.852 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.263 0.4 OUTLIER 23.7 59.85 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 129.306 3.043 . . . . 0.0 114.277 176.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.14 18.51 0.24 Allowed Glycine 0 CA--C 1.549 2.201 0 N-CA-C 118.162 2.025 . . . . 0.0 118.162 -169.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -138.41 149.71 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 121.124 2.462 . . . . 0.0 110.784 -165.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.33 156.76 24.36 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 mp -110.12 3.15 19.94 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.097 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -129.27 -85.56 0.55 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 129.033 2.933 . . . . 0.0 108.141 -173.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.43 -43.39 0.02 OUTLIER Glycine 0 N--CA 1.481 1.679 0 N-CA-C 115.91 1.124 . . . . 0.0 115.91 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -95.59 118.94 65.9 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 118.154 -0.927 . . . . 0.0 109.792 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -74.9 125.95 9.72 Favored 'Trans proline' 0 C--N 1.351 0.705 1 C-N-CA 125.801 4.334 . . . . 0.0 114.373 -172.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.2 mm -55.31 124.99 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 122.808 0.443 . . . . 0.0 110.292 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -109.38 118.14 35.87 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 126.764 2.026 . . . . 0.0 110.055 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.5 mp -93.0 141.18 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.423 -0.798 . . . . 0.0 110.074 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -135.18 167.25 21.33 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.445 1.498 . . . . 0.0 110.338 171.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -129.01 156.94 43.02 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.671 1.988 . . . . 0.0 113.572 175.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -123.68 20.66 9.37 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.622 2.369 . . . . 0.0 114.024 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.52 130.85 40.95 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.348 -1.47 . . . . 0.0 108.951 176.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.02 -137.4 26.61 Favored Glycine 0 CA--C 1.538 1.483 0 O-C-N 121.116 -0.99 . . . . 0.0 113.604 -170.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 57.4 m -130.09 133.04 46.41 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.639 1.576 . . . . 0.0 110.859 -168.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.3 m -69.59 -31.0 68.89 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.39 0.995 . . . . 0.0 113.622 170.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -123.62 156.28 36.11 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.177 2.191 . . . . 0.0 110.585 -173.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.34 153.83 41.75 Favored Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 120.566 -1.334 . . . . 0.0 111.093 -173.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -63.82 158.46 46.69 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 122.08 1.853 . . . . 0.0 111.505 168.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -93.88 -29.41 15.32 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 127.532 2.333 . . . . 0.0 112.737 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.7 t0 . . . . . 0 C--O 1.258 1.539 0 C-N-CA 130.364 3.466 . . . . 0.0 106.744 167.323 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.678 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -131.08 -9.62 3.81 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.79 1.636 . . . . 0.0 113.533 169.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.1 mp0 -85.93 120.45 27.35 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.095 1.358 . . . . 0.0 112.134 -161.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -110.37 -30.55 7.63 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.294 1.038 . . . . 0.0 113.333 -169.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -104.9 -6.54 20.08 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.243 1.817 . . . . 0.0 114.709 -162.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.0 mt -69.92 157.48 37.37 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.932 -0.48 . . . . 0.0 110.761 173.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.06 149.23 39.25 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 127.387 2.275 . . . . 0.0 110.951 -171.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -155.75 161.56 40.67 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.389 2.275 . . . . 0.0 111.571 170.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -59.44 164.22 3.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.443 0.697 . . . . 0.0 112.723 173.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -53.76 -36.85 62.8 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.296 1.438 . . . . 0.0 112.02 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.69 166.66 15.81 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 125.746 1.618 . . . . 0.0 109.625 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.92 160.15 18.28 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 121.948 0.88 . . . . 0.0 111.76 173.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -152.2 167.15 29.51 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.388 1.475 . . . . 0.0 113.001 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -139.71 -171.83 3.24 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.251 1.021 . . . . 0.0 110.61 -158.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.48 149.22 28.83 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -152.92 122.57 6.83 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.346 2.658 . . . . 0.0 111.185 166.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -85.95 -12.28 50.89 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.776 1.23 . . . . 0.0 113.971 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.7 m -127.58 128.38 45.47 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 122.41 1.1 . . . . 0.0 110.563 -163.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.7 tp -99.93 138.08 37.5 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.949 2.1 . . . . 0.0 111.803 -170.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -88.17 137.94 31.89 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 122.06 0.933 . . . . 0.0 111.746 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -133.74 131.07 56.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.356 -0.84 . . . . 0.0 109.166 178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.64 -176.73 14.54 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 126.225 1.869 . . . . 0.0 110.262 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.9 t30 69.09 13.2 8.7 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.807 1.643 . . . . 0.0 114.646 -178.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.99 144.26 55.35 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 126.253 1.821 . . . . 0.0 112.878 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -50.77 162.22 0.28 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 173.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.5 p -72.51 -22.37 61.05 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.948 175.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.96 21.28 9.88 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 129.895 3.278 . . . . 0.0 113.014 -177.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 p -64.15 162.04 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 120.855 -1.153 . . . . 0.0 112.066 173.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.3 p -159.64 168.91 24.91 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.31 1.844 . . . . 0.0 112.86 174.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.66 -27.17 69.04 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.174 1.39 . . . . 0.0 112.31 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -62.8 -49.94 72.98 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.76 1.164 . . . . 0.0 111.921 170.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.8 tp -64.66 -47.57 77.98 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.1 mt -62.57 -37.49 86.37 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -63.14 -47.09 84.19 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.06 0.845 . . . . 0.0 112.11 173.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -72.05 -19.57 61.82 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.451 1.5 . . . . 0.0 113.324 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.5 tt -92.61 -49.25 6.2 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.146 1.779 . . . . 0.0 112.162 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -72.77 -18.07 61.53 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.209 -0.932 . . . . 0.0 112.442 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -60.86 -26.5 67.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.775 1.625 . . . . 0.0 113.356 171.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -64.25 -31.39 72.57 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.247 -1.533 . . . . 0.0 112.78 168.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.86 1.45 34.94 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.39 1.076 . . . . 0.0 112.465 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.52 -146.53 16.91 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.295 1.426 . . . . 0.0 113.631 169.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -74.13 90.8 0.96 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 CA-C-N 119.567 1.684 . . . . 0.0 114.637 -167.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.7 t -74.91 133.42 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 125.535 1.534 . . . . 0.0 109.791 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.8 mt -85.24 -55.69 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 127.272 2.229 . . . . 0.0 111.047 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.06 152.65 28.3 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 128.019 2.528 . . . . 0.0 107.54 -175.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.3 t -106.48 151.13 8.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 127.946 2.498 . . . . 0.0 105.423 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -127.75 124.33 37.49 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 124.113 0.965 . . . . 0.0 113.358 166.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.9 mm -101.57 120.31 54.85 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.053 163.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.95 167.95 21.89 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 124.689 3.592 . . . . 0.0 110.222 165.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -157.45 115.87 3.19 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.134 1.374 . . . . 0.0 107.829 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -50.54 164.32 0.14 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.237 2.215 . . . . 0.0 111.264 161.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.5 pptp? -53.24 -29.53 33.08 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 120.808 -1.183 . . . . 0.0 113.567 167.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.29 -4.37 55.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.077 0.951 . . . . 0.0 112.604 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.55 35.62 8.46 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 125.962 1.744 . . . . 0.0 111.532 170.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -124.11 136.66 27.83 Favored Pre-proline 0 C--N 1.345 0.388 0 CA-C-N 118.958 1.379 . . . . 0.0 113.641 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.25 12.11 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 124.01 3.14 . . . . 0.0 118.316 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.62 27.78 11.0 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 121.286 1.857 . . . . 0.0 113.383 176.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 54.36 35.26 22.55 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.199 1.8 . . . . 0.0 113.413 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.93 162.66 38.85 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.783 -1.198 . . . . 0.0 110.494 -177.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -154.68 -179.23 7.81 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.213 1.405 . . . . 0.0 110.763 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -134.96 163.83 28.96 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.058 1.743 . . . . 0.0 109.808 165.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.4 t -145.96 134.7 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 127.145 2.178 . . . . 0.0 108.449 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -104.2 144.31 31.76 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.938 1.695 . . . . 0.0 111.059 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -133.07 157.35 45.48 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 121.949 2.158 . . . . 0.0 114.033 -167.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.1 mmtp -68.88 -22.03 64.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.156 -1.59 . . . . 0.0 113.538 166.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -69.93 146.52 51.12 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.768 0.827 . . . . 0.0 110.418 172.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -123.97 -23.64 4.58 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 m -68.3 27.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 128.775 2.83 . . . . 0.0 115.953 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 99.8 p 50.13 46.79 24.36 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.938 2.095 . . . . 0.0 111.032 177.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 p -97.44 103.17 14.97 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 126.139 1.775 . . . . 0.0 111.381 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -80.75 70.71 7.41 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.93 2.42 . . . . 0.0 113.111 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -51.06 -36.09 38.11 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.98 0.912 . . . . 0.0 111.748 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.96 -27.21 64.55 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 ttt -59.55 -28.22 66.92 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 119.754 1.161 . . . . 0.0 111.069 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -86.98 -19.32 28.89 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.753 2.021 . . . . 0.0 110.787 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.62 -45.05 4.12 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.348 1.459 . . . . 0.0 112.533 -161.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.54 -92.85 0.43 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.955 1.702 . . . . 0.0 109.322 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.261 0.9 OUTLIER 37.75 52.23 1.4 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.742 2.017 . . . . 0.0 115.191 165.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.38 17.79 0.21 Allowed Glycine 0 CA--C 1.534 1.246 0 CA-C-N 114.795 -1.093 . . . . 0.0 115.749 -167.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -141.82 150.59 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 118.285 1.043 . . . . 0.0 113.734 -170.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.09 167.32 26.54 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -173.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.0 tp -98.0 -34.93 10.61 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 113.349 -1.75 . . . . 0.0 111.593 169.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -104.26 -50.22 3.4 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -167.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 172.39 -30.9 0.11 Allowed Glycine 0 CA--C 1.543 1.785 0 CA-C-O 117.991 -1.45 . . . . 0.0 115.192 -175.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -99.69 97.47 5.8 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 127.148 2.179 . . . . 0.0 115.242 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.05 114.99 2.86 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.943 3.095 . . . . 0.0 113.249 -173.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.6 mm -47.83 124.7 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 C-N-CA 125.926 1.69 . . . . 0.0 111.906 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -108.63 113.0 25.62 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 124.479 1.112 . . . . 0.0 111.584 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mp -88.64 137.93 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -130.49 172.6 11.71 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 172.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -151.81 146.5 25.75 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 120.013 -1.679 . . . . 0.0 113.132 -160.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -113.61 148.14 36.79 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.016 1.326 . . . . 0.0 108.382 165.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.8 p -102.24 3.92 38.74 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 125.25 1.42 . . . . 0.0 112.882 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.61 172.8 18.82 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.39 1.472 . . . . 0.0 113.308 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.6 m -102.92 114.19 28.27 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.493 1.117 . . . . 0.0 112.305 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 68.5 m -53.99 142.06 26.05 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 161.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.43 148.87 35.15 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.766 1.226 . . . . 0.0 110.372 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.87 160.06 27.46 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.022 0.929 . . . . 0.0 113.361 -171.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.68 166.06 29.09 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 122.829 2.353 . . . . 0.0 112.195 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -114.77 -19.73 10.92 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 128.668 2.787 . . . . 0.0 113.696 172.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 N--CA 1.493 1.7 0 C-N-CA 126.676 1.991 . . . . 0.0 111.667 -179.085 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.164 0 N-CA-C 114.959 0.743 . . . . 0.0 114.959 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 m -64.76 -21.6 66.8 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 117.271 2.323 . . . . 0.0 117.271 -162.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -113.3 133.76 54.95 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.343 0.974 . . . . 0.0 111.62 -170.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -159.79 -15.06 0.06 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 127.754 2.422 . . . . 0.0 112.806 168.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -92.64 0.92 57.49 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 119.65 -1.906 . . . . 0.0 113.246 176.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -96.36 167.31 11.25 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.361 1.464 . . . . 0.0 111.041 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.572 ' HD3' ' H ' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -47.12 135.9 9.36 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 129.195 2.998 . . . . 0.0 111.592 169.366 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -129.93 18.07 5.61 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 118.628 2.825 . . . . 0.0 118.628 -165.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -73.38 164.22 26.98 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 119.875 -1.766 . . . . 0.0 110.367 169.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . 0.309 8.3 pt20 -73.91 -77.11 0.12 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -174.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -164.17 173.5 12.33 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.257 1.023 . . . . 0.0 113.114 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.9 mt -109.87 153.66 24.14 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 130.029 3.331 . . . . 0.0 113.648 -175.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.88 -50.53 0.16 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 170.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 57.13 -14.34 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 119.149 3.018 . . . . 0.0 119.149 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -157.36 169.65 24.24 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 129.075 2.95 . . . . 0.0 111.013 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -128.77 -25.96 2.76 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 173.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -88.63 -13.03 40.86 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 127.402 2.281 . . . . 0.0 110.891 168.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.7 m -126.74 132.23 51.15 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.07 1.348 . . . . 0.0 108.832 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.3 tp -100.33 133.23 45.06 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 125.083 1.353 . . . . 0.0 112.163 -167.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -82.26 130.45 35.1 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.143 1.377 . . . . 0.0 114.042 177.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 t -145.39 128.45 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 124.941 1.296 . . . . 0.0 107.581 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.5 -176.51 14.45 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 126.308 1.908 . . . . 0.0 110.581 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.5 t30 71.67 16.78 5.68 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.846 2.059 . . . . 0.0 114.085 -172.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.85 139.57 58.35 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 127.295 2.238 . . . . 0.0 110.392 -172.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.416 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 4.6 mt-10 -60.41 162.13 6.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 124.414 2.054 . . . . 0.0 116.109 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.1 p -68.94 -28.14 66.38 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.888 1.675 . . . . 0.0 111.615 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.1 tppt? -107.11 9.18 30.45 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 131.056 3.743 . . . . 0.0 115.649 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 p -59.7 161.73 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.127 1.371 . . . . 0.0 112.885 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 p -158.56 165.03 35.48 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.754 1.622 . . . . 0.0 112.321 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -59.47 -27.52 66.18 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.581 -0.7 . . . . 0.0 110.156 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -67.53 -44.17 78.99 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.834 1.254 . . . . 0.0 111.831 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.3 tp -72.44 -39.75 67.57 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.531 0.732 . . . . 0.0 111.095 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.414 ' HB2' HG12 ' A' ' 46' ' ' VAL . 71.6 mt -63.52 -40.85 98.13 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.486 1.039 . . . . 0.0 110.653 174.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -59.16 -46.41 88.47 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.27 -33.13 67.24 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.504 1.047 . . . . 0.0 112.53 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.2 tt -69.03 -41.51 77.6 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.317 0.647 . . . . 0.0 112.206 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -89.57 8.57 30.56 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.806 1.242 . . . . 0.0 113.941 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -56.91 -48.79 77.4 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.263 -1.523 . . . . 0.0 113.131 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -74.19 -9.46 58.64 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.88 36.52 1.4 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -166.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.58 -165.83 40.97 Favored Glycine 0 CA--C 1.542 1.744 0 C-N-CA 123.764 0.697 . . . . 0.0 114.322 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -81.43 85.51 1.74 Allowed 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 121.446 1.431 . . . . 0.0 114.891 -168.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.82 129.92 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 126.648 1.979 . . . . 0.0 108.882 166.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mt -91.04 -54.49 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.17 1.788 . . . . 0.0 111.4 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.57 158.49 43.6 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.058 1.743 . . . . 0.0 111.624 -178.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.414 HG12 ' HB2' ' A' ' 33' ' ' LEU . 91.7 t -116.22 143.26 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.667 1.587 . . . . 0.0 111.529 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -121.59 132.25 54.57 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.38 1.872 . . . . 0.0 114.932 172.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.9 mm -118.47 119.14 33.21 Favored Pre-proline 0 N--CA 1.471 0.584 0 C-N-CA 128.039 2.536 . . . . 0.0 109.745 172.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.23 172.84 15.22 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.151 2.567 . . . . 0.0 113.691 169.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -153.17 108.92 3.29 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.513 2.325 . . . . 0.0 111.461 172.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -43.45 164.52 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 130.741 3.617 . . . . 0.0 115.643 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.25 -29.0 3.4 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 114.744 1.386 . . . . 0.0 114.744 165.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -93.73 -11.07 32.27 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 168.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.55 47.2 1.69 Allowed Glycine 0 N--CA 1.477 1.395 0 O-C-N 119.767 -1.833 . . . . 0.0 115.206 174.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -138.14 141.42 32.03 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 125.926 1.69 . . . . 0.0 113.31 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.81 14.27 0.2 Allowed 'Trans proline' 0 CA--C 1.545 1.028 1 C-N-CA 125.96 4.44 . . . . 0.0 115.145 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.68 21.78 6.18 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 174.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 59.01 35.78 24.14 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 125.105 1.362 . . . . 0.0 113.93 -169.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -155.74 161.59 40.67 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.552 1.541 . . . . 0.0 113.849 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.55 167.06 15.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.982 1.313 . . . . 0.0 113.197 -174.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -120.76 156.12 32.53 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.858 0.863 . . . . 0.0 112.734 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.3 t -144.45 112.51 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 C-N-CA 123.509 0.724 . . . . 0.0 110.176 -178.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -76.4 125.04 28.48 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.8 146.53 51.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.774 1.273 . . . . 0.0 110.683 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -75.87 105.85 7.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.793 -171.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 56.84 18.07 3.62 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 166.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -80.83 69.81 7.47 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 171.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.42 6.54 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 119.923 -1.736 . . . . 0.0 114.981 -169.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.5 t -170.68 164.04 8.11 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.585 1.554 . . . . 0.0 112.335 -160.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t 31.68 59.68 1.21 Allowed Pre-proline 0 N--CA 1.485 1.283 0 C-N-CA 127.592 2.357 . . . . 0.0 111.735 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.41 120.88 8.77 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.449 3.433 . . . . 0.0 112.499 -171.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -56.06 -35.65 67.18 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.098 1.359 . . . . 0.0 112.208 -166.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.11 -21.16 64.78 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.35 -23.19 64.07 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.767 1.627 . . . . 0.0 114.167 175.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -112.61 -30.04 7.24 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.652 1.581 . . . . 0.0 111.459 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.49 -45.65 52.67 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.972 0.909 . . . . 0.0 112.532 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -111.14 -84.28 0.57 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.76 2.024 . . . . 0.0 107.802 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 17.27 70.01 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 128.668 2.787 . . . . 0.0 115.264 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.6 19.88 0.24 Allowed Glycine 0 N--CA 1.469 0.835 0 N-CA-C 116.706 1.442 . . . . 0.0 116.706 -175.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.99 147.5 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.233 1.013 . . . . 0.0 112.872 -163.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.48 166.77 16.15 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 123.06 1.41 . . . . 0.0 113.345 -164.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.8 mt -132.34 -19.16 2.48 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.006 -1.906 . . . . 0.0 114.67 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.409 ' HB2' ' CD ' ' A' ' 25' ' ' GLU . 55.0 m-85 -106.88 -50.82 3.03 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.357 1.863 . . . . 0.0 108.485 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 176.99 -39.44 0.1 OUTLIER Glycine 0 CA--C 1.544 1.862 0 N-CA-C 116.944 1.538 . . . . 0.0 116.944 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.416 ' HB2' ' HG3' ' A' ' 25' ' ' GLU . 1.7 mpt_? -97.47 109.23 49.35 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 126.519 1.928 . . . . 0.0 111.847 -170.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.48 121.13 8.61 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.676 2.917 . . . . 0.0 115.198 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.2 mm -51.85 132.43 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.536 1.534 . . . . 0.0 110.244 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -123.8 109.57 13.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.802 1.641 . . . . 0.0 111.739 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -92.74 136.18 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 O-C-N 121.655 -0.653 . . . . 0.0 110.049 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -121.44 142.6 49.87 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 117.769 2.507 . . . . 0.0 117.769 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -124.84 136.37 53.75 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 111.757 -2.474 . . . . 0.0 109.148 167.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.74 -28.68 11.05 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.925 1.69 . . . . 0.0 111.3 165.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.8 m 51.39 38.15 21.0 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.674 2.39 . . . . 0.0 113.695 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.18 73.25 0.23 Allowed Glycine 0 CA--C 1.526 0.753 0 O-C-N 121.515 -0.741 . . . . 0.0 114.341 -169.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -145.04 -22.27 0.49 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.355 1.462 . . . . 0.0 114.566 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 55.3 p -100.61 -179.9 4.23 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.338 1.855 . . . . 0.0 113.453 174.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -132.38 -24.11 2.07 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -165.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -139.7 155.06 71.59 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.805 0.842 . . . . 0.0 111.222 -169.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.64 140.07 35.23 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.757 2.305 . . . . 0.0 111.022 170.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -88.89 -17.04 30.43 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.504 2.722 . . . . 0.0 116.237 -159.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.1 t0 . . . . . 0 C--O 1.259 1.593 0 CA-C-N 120.424 1.465 . . . . 0.0 112.857 -171.168 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.214 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -142.47 120.31 11.96 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.877 0.838 . . . . 0.0 112.045 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -59.64 145.36 44.95 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.118 0.967 . . . . 0.0 111.086 177.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -71.44 -44.72 64.32 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -164.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -133.38 55.47 1.9 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.83 2.052 . . . . 0.0 111.66 -173.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.5 mt -81.65 147.28 29.62 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.327 -0.858 . . . . 0.0 109.086 168.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.32 141.19 58.86 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.934 0.894 . . . . 0.0 108.996 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -158.15 -28.47 0.08 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -152.79 -36.51 0.11 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -171.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -63.7 -2.4 1.72 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.849 1.659 . . . . 0.0 115.213 -176.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.96 151.63 28.73 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.116 1.366 . . . . 0.0 110.737 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 pp -75.52 133.96 40.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.291 1.044 . . . . 0.0 112.002 -169.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -157.96 155.03 28.74 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.834 1.654 . . . . 0.0 110.47 165.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -129.37 169.86 14.37 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.612 1.165 . . . . 0.0 111.955 161.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.46 166.24 19.19 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 171.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -128.32 60.69 1.48 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 123.273 1.511 . . . . 0.0 111.189 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.6 mtp85 52.62 11.98 0.22 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 128.53 2.732 . . . . 0.0 113.972 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m -136.04 152.07 50.52 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 129.513 3.125 . . . . 0.0 110.797 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.4 tp -89.94 121.24 31.86 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 130.06 3.344 . . . . 0.0 112.28 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -75.83 138.33 41.07 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.451 1.023 . . . . 0.0 112.397 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.3 t -139.31 117.99 12.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 O-C-N 121.222 -0.924 . . . . 0.0 109.915 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.55 -173.65 15.92 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 122.303 0.946 . . . . 0.0 112.457 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.9 t30 65.83 35.66 6.57 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.679 1.191 . . . . 0.0 111.138 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 58' ' ' GLN . 1.7 mm? -70.53 163.93 25.86 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.961 2.105 . . . . 0.0 111.35 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.41 161.9 17.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 123.624 1.678 . . . . 0.0 114.998 174.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.8 p -75.14 -24.16 57.93 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.999 1.32 . . . . 0.0 110.162 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -103.01 16.76 25.78 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.766 1.626 . . . . 0.0 113.357 171.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.8 p -66.23 153.02 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.5 p -156.43 162.62 39.99 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.949 2.1 . . . . 0.0 112.342 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -64.7 -23.03 67.12 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.223 1.009 . . . . 0.0 112.016 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -66.85 -46.03 76.36 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 118.059 -0.972 . . . . 0.0 112.149 170.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.6 tp -64.74 -43.25 93.99 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.915 0.864 . . . . 0.0 109.562 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.1 mt -65.19 -33.81 76.89 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.04 -1.038 . . . . 0.0 113.161 178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -70.1 -45.79 66.21 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.153 -0.967 . . . . 0.0 112.168 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.69 -23.33 66.12 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 121.512 -0.742 . . . . 0.0 112.684 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 tt -81.39 -44.59 17.34 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.184 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -84.94 -20.97 29.83 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.168 1.349 . . . . 0.0 112.505 -170.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -52.42 -34.98 50.86 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 167.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -58.51 -32.71 69.08 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.503 2.321 . . . . 0.0 114.683 167.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.62 -12.86 55.48 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-O 121.357 0.599 . . . . 0.0 110.696 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.2 -163.56 26.33 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 126.909 2.195 . . . . 0.0 111.934 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -82.02 88.28 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 CA-C-N 120.559 2.18 . . . . 0.0 112.737 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -65.56 141.76 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 121.169 -0.957 . . . . 0.0 113.156 176.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.415 HG21 ' HE3' ' A' ' 45' ' ' LYS . 41.9 mm -71.05 -48.92 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.415 ' HE3' HG21 ' A' ' 44' ' ' ILE . 11.2 ptpt -171.44 161.35 6.33 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.161 1.784 . . . . 0.0 111.891 -171.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 82.9 t -125.59 153.47 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 126.37 1.868 . . . . 0.0 110.871 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -128.15 141.27 51.53 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.11 2.564 . . . . 0.0 110.509 169.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mm -121.01 125.31 27.06 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 126.906 2.082 . . . . 0.0 108.727 163.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.86 172.14 15.15 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.779 2.986 . . . . 0.0 112.878 170.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -153.72 126.48 8.23 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 127.457 2.303 . . . . 0.0 110.774 164.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -55.57 163.3 1.34 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 112.128 -2.305 . . . . 0.0 111.487 162.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.96 -25.15 1.25 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 167.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -100.25 1.64 41.99 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.41 1.084 . . . . 0.0 113.304 176.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.78 39.88 4.82 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 120.92 -1.113 . . . . 0.0 115.449 170.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.418 ' CD ' ' HD2' ' A' ' 56' ' ' PRO . 3.0 tppt? -134.42 140.84 36.95 Favored Pre-proline 0 N--CA 1.476 0.836 0 CA-C-N 119.819 1.809 . . . . 0.0 114.68 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.418 ' HD2' ' CD ' ' A' ' 55' ' ' LYS . 53.6 Cg_endo -68.17 12.44 0.23 Allowed 'Trans proline' 0 CA--C 1.551 1.353 0 C-N-CA 124.124 3.216 . . . . 0.0 117.834 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.75 27.46 7.01 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 119.538 -1.976 . . . . 0.0 115.145 176.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 33.8 mt-30 55.05 37.35 28.76 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -150.91 160.58 43.81 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.189 1.396 . . . . 0.0 112.151 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.03 178.86 9.88 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.838 2.055 . . . . 0.0 109.057 175.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -137.72 153.16 49.8 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.7 t -141.26 138.6 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 126.198 1.799 . . . . 0.0 110.284 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -99.19 140.75 32.88 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.248 1.019 . . . . 0.0 110.938 172.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -139.69 150.15 44.54 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 128.468 2.707 . . . . 0.0 108.358 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -58.63 119.56 7.3 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 173.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -55.39 154.27 6.39 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.356 1.062 . . . . 0.0 113.406 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -162.21 165.71 26.49 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.648 -1.283 . . . . 0.0 112.76 -170.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.3 t -88.45 5.47 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 O-C-N 120.481 -1.387 . . . . 0.0 112.102 173.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.2 p -95.11 168.15 10.93 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 118.869 -2.394 . . . . 0.0 111.914 174.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.2 m -79.25 153.71 76.9 Favored Pre-proline 0 N--CA 1.483 1.206 0 O-C-N 120.99 -1.069 . . . . 0.0 111.227 162.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.47 124.11 15.35 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.753 2.969 . . . . 0.0 112.758 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -52.91 -44.41 66.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.782 1.233 . . . . 0.0 110.813 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.14 -31.64 63.53 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 ttp -66.42 -14.47 62.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.924 1.238 . . . . 0.0 113.244 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -105.92 -35.79 7.19 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 155.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.11 -55.51 21.5 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.477 0.711 . . . . 0.0 111.483 -171.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -91.96 -92.32 0.15 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 27.23 70.7 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 127.459 2.304 . . . . 0.0 113.908 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.7 14.5 0.68 Allowed Glycine 0 CA--C 1.535 1.34 0 N-CA-C 115.461 0.945 . . . . 0.0 115.461 -174.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -130.55 145.25 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 -165.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.38 172.65 10.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.73 2.012 . . . . 0.0 110.126 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 57.9 mt -118.71 -48.71 2.47 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.999 0.92 . . . . 0.0 110.208 159.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -51.37 -59.24 4.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.748 1.219 . . . . 0.0 112.346 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.53 -64.16 0.07 OUTLIER Glycine 0 N--CA 1.47 0.931 0 N-CA-C 116.458 1.343 . . . . 0.0 116.458 -162.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -106.07 119.44 52.16 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 118.097 0.948 . . . . 0.0 111.031 -168.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -77.62 132.61 12.24 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.709 2.273 . . . . 0.0 113.926 -166.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.3 mm -59.38 119.81 4.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 123.811 0.844 . . . . 0.0 111.394 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -108.19 103.15 12.28 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.902 2.081 . . . . 0.0 110.345 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.5 mp -74.83 141.61 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -132.28 136.3 46.84 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.779 2.032 . . . . 0.0 108.141 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -140.72 144.28 35.49 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.0 1.32 . . . . 0.0 110.897 -174.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -127.85 129.88 47.66 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 125.017 1.327 . . . . 0.0 108.883 162.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.7 p -70.44 154.81 41.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 122.585 1.183 . . . . 0.0 112.473 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.88 139.21 25.86 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.421 1.01 . . . . 0.0 114.503 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.6 p -76.96 -31.06 56.31 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.245 1.818 . . . . 0.0 113.203 172.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.7 m 53.93 13.43 0.55 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 129.846 3.258 . . . . 0.0 117.513 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -66.56 -25.59 66.72 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 128.213 2.605 . . . . 0.0 115.123 -167.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.09 157.07 85.65 Favored Pre-proline 0 CA--C 1.561 1.372 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.38 138.69 30.08 Favored 'Trans proline' 0 CA--C 1.551 1.351 0 C-N-CA 124.963 3.775 . . . . 0.0 111.149 172.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -67.77 -40.92 83.99 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 120.306 -1.496 . . . . 0.0 113.598 -162.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.4 t70 . . . . . 0 C--O 1.26 1.647 0 C-N-CA 128.238 2.615 . . . . 0.0 110.181 178.481 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.895 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.7 m -109.41 154.57 22.4 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 128.086 2.554 . . . . 0.0 111.368 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -105.98 120.29 41.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 126.964 2.106 . . . . 0.0 113.802 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -130.02 -42.98 1.22 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.257 1.423 . . . . 0.0 113.476 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -77.57 17.91 0.49 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 -173.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 mp -109.72 147.93 32.31 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 120.729 -1.232 . . . . 0.0 111.117 -170.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.04 145.74 55.5 Favored 'General case' 0 CA--C 1.556 1.207 0 O-C-N 121.228 -0.92 . . . . 0.0 112.848 176.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 28.7 ptt-85 -146.66 169.69 18.49 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 129.783 3.233 . . . . 0.0 108.433 175.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -120.43 175.01 6.19 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.657 1.983 . . . . 0.0 108.056 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -80.68 -42.94 21.16 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 121.171 -0.956 . . . . 0.0 111.381 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.33 -154.08 0.33 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 128.52 2.728 . . . . 0.0 109.027 168.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.9 mt -85.34 157.82 20.44 Favored 'General case' 0 CA--C 1.552 1.043 0 O-C-N 120.04 -1.663 . . . . 0.0 111.052 -173.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.63 166.73 30.34 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.684 1.594 . . . . 0.0 111.67 -175.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -149.04 163.19 38.25 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.803 1.641 . . . . 0.0 112.447 170.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.67 149.74 35.02 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -171.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -139.15 107.61 5.84 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 129.905 3.282 . . . . 0.0 105.785 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 48.51 20.92 0.34 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 130.123 3.369 . . . . 0.0 116.945 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.28 138.01 39.61 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.675 -1.266 . . . . 0.0 111.575 -171.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.1 tp -116.44 124.04 49.0 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.903 2.481 . . . . 0.0 112.722 -161.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -74.65 132.89 42.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 122.198 0.999 . . . . 0.0 109.82 175.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.6 t -129.19 125.42 62.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 169.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.84 -169.23 13.78 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 122.456 1.031 . . . . 0.0 113.035 168.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.2 t30 65.92 29.67 10.2 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 128.545 2.738 . . . . 0.0 114.258 -173.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.14 156.67 38.3 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.764 1.225 . . . . 0.0 109.413 -175.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.475 ' HG2' ' H ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.4 165.12 24.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 123.914 1.816 . . . . 0.0 114.126 172.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.3 p -68.29 -14.78 63.24 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 128.49 2.716 . . . . 0.0 110.392 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -113.59 5.24 16.48 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 129.19 2.996 . . . . 0.0 114.435 -176.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.14 154.28 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 120.131 -1.606 . . . . 0.0 114.213 -170.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.5 p -148.46 171.4 16.13 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 127.218 2.207 . . . . 0.0 111.343 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -77.41 -15.89 59.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.49 1.516 . . . . 0.0 111.393 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -76.24 -45.99 30.3 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.63 1.572 . . . . 0.0 109.407 170.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.8 tp -63.95 -39.31 93.85 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.621 0.724 . . . . 0.0 110.778 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 92.6 mt -70.83 -48.44 54.04 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.569 0.747 . . . . 0.0 111.969 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -58.31 -43.03 87.98 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -65.25 -32.18 73.72 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.743 0.817 . . . . 0.0 110.986 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 tt -76.29 -43.27 42.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.817 2.047 . . . . 0.0 113.193 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.444 ' CD2' HG22 ' A' ' 62' ' ' VAL . 23.9 m-85 -87.48 -6.16 58.5 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.012 0.925 . . . . 0.0 112.018 -173.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -53.89 -43.01 69.29 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.314 0.646 . . . . 0.0 109.745 160.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -55.96 -25.95 46.02 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 173.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.38 -8.45 32.44 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.239 1.019 . . . . 0.0 112.681 -171.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.74 -153.55 17.55 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.643 1.116 . . . . 0.0 113.593 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.05 107.52 2.48 Favored 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 123.497 2.798 . . . . 0.0 111.936 -165.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.0 t -94.96 126.37 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 128.266 2.627 . . . . 0.0 109.666 169.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mt -78.37 -48.71 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.947 1.299 . . . . 0.0 109.672 173.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.57 163.78 19.34 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.317 1.047 . . . . 0.0 113.266 -175.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 82.9 t -122.94 145.27 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.74 1.616 . . . . 0.0 112.197 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -126.11 121.29 32.45 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.133 2.173 . . . . 0.0 112.603 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.0 mm -110.38 120.76 43.31 Favored Pre-proline 0 N--CA 1.467 0.405 0 C-N-CA 126.487 1.915 . . . . 0.0 107.241 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -74.11 172.25 16.35 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.018 2.479 . . . . 0.0 111.545 168.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -156.87 115.08 3.25 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.611 1.964 . . . . 0.0 108.413 169.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -56.38 168.61 0.52 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 129.115 2.966 . . . . 0.0 111.696 164.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.4 pptp? -47.0 -32.58 4.01 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.469 1.508 . . . . 0.0 114.272 170.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.8 -18.04 61.51 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.802 1.641 . . . . 0.0 114.327 173.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.32 56.98 2.72 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -175.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -143.15 133.18 12.03 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.286 1.034 . . . . 0.0 113.328 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.99 19.67 0.13 Allowed 'Trans proline' 0 CA--C 1.55 1.325 0 C-N-CA 124.978 3.785 . . . . 0.0 116.538 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.417 ' HB2' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 52.02 22.02 1.71 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 174.233 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 57.72 36.53 26.66 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 116.817 2.154 . . . . 0.0 116.817 -166.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 57' ' ' LYS . 13.5 p90 -153.93 167.54 29.38 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.926 1.29 . . . . 0.0 113.453 175.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -163.95 170.06 17.19 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.979 2.112 . . . . 0.0 110.295 176.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -127.38 146.49 50.45 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.862 1.265 . . . . 0.0 110.932 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.444 HG22 ' CD2' ' A' ' 37' ' ' PHE . 20.8 t -125.91 132.67 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 126.581 1.953 . . . . 0.0 110.247 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -93.4 132.74 37.36 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.596 1.158 . . . . 0.0 108.75 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -124.44 162.52 23.73 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.6 1.96 . . . . 0.0 113.172 -166.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -101.7 -49.61 3.94 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.684 1.594 . . . . 0.0 113.846 -171.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -144.37 -6.93 0.71 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 -171.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -79.12 40.21 0.4 Allowed 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 121.282 1.856 . . . . 0.0 111.822 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.6 t -53.58 141.22 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 C-N-CA 127.09 2.156 . . . . 0.0 109.225 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.2 m 68.77 -28.45 0.16 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 129.245 3.018 . . . . 0.0 118.472 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 p -149.39 93.2 4.12 Favored Pre-proline 0 N--CA 1.471 0.593 0 CA-C-N 119.721 1.146 . . . . 0.0 110.919 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.84 136.47 76.65 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 123.526 2.817 . . . . 0.0 113.912 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -68.98 -40.94 78.53 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.665 2.386 . . . . 0.0 111.007 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.94 -28.92 66.71 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.06 -1.025 . . . . 0.0 113.239 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.0 ttp -64.19 -21.36 66.54 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.733 1.213 . . . . 0.0 113.609 -176.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -97.63 -29.04 13.65 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.504 1.522 . . . . 0.0 112.115 168.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.82 -40.96 13.6 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.186 -0.946 . . . . 0.0 113.238 -169.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -107.68 -97.68 0.37 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.055 1.342 . . . . 0.0 110.83 176.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 37.83 59.13 1.35 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.37 1.868 . . . . 0.0 115.584 175.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.17 16.47 0.11 Allowed Glycine 0 CA--C 1.519 0.311 0 O-C-N 120.869 -1.145 . . . . 0.0 114.236 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -128.71 149.46 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 117.829 0.814 . . . . 0.0 109.509 -163.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.21 172.68 9.68 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.737 1.215 . . . . 0.0 110.802 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.9 tp -133.59 -19.84 2.08 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.867 0.867 . . . . 0.0 109.806 163.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -72.82 -68.59 0.47 Allowed 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.164 -0.96 . . . . 0.0 112.399 167.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.17 -51.36 0.07 OUTLIER Glycine 0 C--N 1.339 0.735 0 N-CA-C 116.985 1.554 . . . . 0.0 116.985 -168.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.475 ' H ' ' HG2' ' A' ' 25' ' ' GLU . 5.8 mpt_? -100.96 121.87 50.8 Favored Pre-proline 0 N--CA 1.462 0.151 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -177.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.2 126.91 10.15 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.256 1.97 . . . . 0.0 113.963 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.1 mm -51.01 126.95 6.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.696 1.198 . . . . 0.0 109.758 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -121.86 116.81 25.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.206 1.802 . . . . 0.0 112.753 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.4 mp -91.34 134.07 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.178 -0.951 . . . . 0.0 111.206 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -134.42 148.76 50.69 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 123.831 1.777 . . . . 0.0 115.396 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -166.44 133.37 2.56 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.667 2.387 . . . . 0.0 111.691 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -79.67 135.29 36.51 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 126.394 1.878 . . . . 0.0 110.999 169.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.7 p -57.48 99.59 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.313 1.845 . . . . 0.0 115.494 -167.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -68.86 -14.88 68.44 Favored Glycine 0 N--CA 1.477 1.373 0 C-N-CA 126.991 2.234 . . . . 0.0 117.269 -166.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.3 m -151.08 138.99 19.91 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 175.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.1 m -109.77 144.45 38.16 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.62 1.568 . . . . 0.0 112.288 172.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -100.5 -14.89 18.07 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 129.553 3.141 . . . . 0.0 112.159 -166.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 70.3 152.62 0.14 Allowed Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 127.522 2.329 . . . . 0.0 115.904 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -66.41 165.62 24.28 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.414 2.076 . . . . 0.0 111.442 170.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -97.94 -24.42 15.39 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -168.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 C--O 1.261 1.683 0 C-N-CA 126.55 1.94 . . . . 0.0 112.985 -171.296 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.942 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.5 m -68.97 125.83 27.88 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 117.42 0.61 . . . . 0.0 110.925 -173.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 58.37 16.91 4.38 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 119.12 3.007 . . . . 0.0 119.12 171.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -51.56 -43.43 62.39 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.461 1.105 . . . . 0.0 113.881 172.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -89.25 -4.01 58.33 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.59 172.28 12.84 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.115 0.966 . . . . 0.0 112.234 173.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -68.65 118.03 11.13 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -94.54 -9.52 35.02 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.846 1.658 . . . . 0.0 113.446 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -59.51 157.12 11.95 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.06 2.144 . . . . 0.0 111.77 -169.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -63.06 -26.67 68.95 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.75 174.41 10.65 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.818 1.647 . . . . 0.0 110.707 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.0 mt -82.67 166.98 18.68 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.391 1.076 . . . . 0.0 111.666 -175.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.01 -4.96 0.47 Allowed 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 125.885 1.674 . . . . 0.0 114.817 172.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -130.82 -5.74 4.03 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 127.422 2.289 . . . . 0.0 114.7 -169.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.57 146.72 22.57 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 119.709 -1.869 . . . . 0.0 113.276 -173.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -157.39 -23.34 0.09 Allowed 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 125.082 1.353 . . . . 0.0 114.517 174.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.87 -9.39 3.92 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 128.221 2.608 . . . . 0.0 117.121 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.7 m -107.41 150.1 27.14 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.373 2.269 . . . . 0.0 105.649 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.2 tp -92.55 140.75 29.24 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 128.363 2.665 . . . . 0.0 115.013 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -89.63 130.19 35.96 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 125.869 1.667 . . . . 0.0 110.033 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.2 t -132.4 128.61 58.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 120.756 -1.215 . . . . 0.0 107.78 173.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.59 -171.35 12.93 Favored Glycine 0 CA--C 1.543 1.794 0 CA-C-O 122.485 1.047 . . . . 0.0 111.854 171.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.6 t30 62.68 33.77 15.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.1 1.76 . . . . 0.0 112.897 -175.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -70.26 154.43 41.92 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.164 1.786 . . . . 0.0 111.145 177.192 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.88 160.67 32.38 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 125.082 2.373 . . . . 0.0 114.059 173.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.6 p -67.85 -24.83 65.3 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 111.139 -2.755 . . . . 0.0 111.868 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -118.73 22.48 11.98 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 127.424 2.289 . . . . 0.0 115.938 174.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.425 ' CG2' ' H ' ' A' ' 29' ' ' THR . 8.5 p -60.71 170.77 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 116.733 2.123 . . . . 0.0 116.733 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.425 ' H ' ' CG2' ' A' ' 28' ' ' VAL . 10.6 p -165.88 156.59 13.21 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 128.113 2.565 . . . . 0.0 111.349 -177.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.71 -17.75 17.07 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.576 2.35 . . . . 0.0 110.546 174.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -78.48 -38.51 40.83 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.907 1.683 . . . . 0.0 112.097 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.9 tp -70.25 -47.81 59.69 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.004 1.322 . . . . 0.0 108.576 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.9 mt -59.04 -50.96 72.09 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.082 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -62.5 -41.5 98.87 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.318 1.417 . . . . 0.0 111.393 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.02 -23.69 64.11 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.357 1.244 . . . . 0.0 114.357 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.65 -39.85 35.79 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.793 1.637 . . . . 0.0 112.737 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -89.87 1.1 56.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.037 0.935 . . . . 0.0 111.792 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -64.8 -35.03 79.79 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.55 1.14 . . . . 0.0 113.9 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -79.21 -17.53 54.67 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.905 0.482 . . . . 0.0 110.694 167.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.69 21.59 0.65 Allowed 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.702 -1.249 . . . . 0.0 113.762 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.19 -125.62 7.47 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.23 0.919 . . . . 0.0 114.461 173.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -71.29 127.0 12.85 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 CA-C-N 118.38 1.09 . . . . 0.0 110.615 -173.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.1 t -138.35 124.82 25.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 168.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 mm -89.05 -54.68 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 125.443 1.497 . . . . 0.0 108.481 171.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -151.7 153.37 34.24 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.918 0.887 . . . . 0.0 113.316 -173.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.8 t -117.79 152.1 19.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 126.876 2.07 . . . . 0.0 108.782 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -129.22 122.91 30.69 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.372 1.869 . . . . 0.0 114.465 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.5 mm -106.14 117.37 57.61 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 126.165 1.786 . . . . 0.0 110.573 168.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.5 165.07 33.04 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.704 3.603 . . . . 0.0 111.834 165.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -155.31 117.12 4.08 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 126.963 2.105 . . . . 0.0 109.297 172.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.408 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 28.8 t0 -55.22 169.53 0.26 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 128.453 2.701 . . . . 0.0 114.269 175.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.27 -40.69 25.64 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.155 -0.341 . . . . 0.0 111.826 164.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -81.97 3.64 25.71 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 126.045 1.738 . . . . 0.0 113.506 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.94 42.37 30.38 Favored Glycine 0 N--CA 1.474 1.226 0 C-N-CA 126.377 1.941 . . . . 0.0 113.607 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -129.79 138.31 32.83 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 119.241 1.521 . . . . 0.0 113.063 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.89 9.61 0.35 Allowed 'Trans proline' 0 CA--C 1.54 0.824 1 C-N-CA 126.699 4.933 . . . . 0.0 115.372 176.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER 58.73 26.92 15.24 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 169.41 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 15.9 mt-30 59.47 24.93 13.64 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.991 1.316 . . . . 0.0 114.31 -172.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -150.9 165.91 32.2 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 119.93 -1.731 . . . . 0.0 113.408 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -169.0 177.34 4.96 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 128.214 2.606 . . . . 0.0 112.744 -172.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -131.43 158.4 40.9 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 126.154 1.781 . . . . 0.0 115.414 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.5 t -143.98 129.68 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 126.301 1.84 . . . . 0.0 111.487 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -107.33 139.26 42.09 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.878 1.671 . . . . 0.0 114.618 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.469 ' CZ ' HG23 ' A' ' 68' ' ' VAL . 6.2 p90 -154.98 -18.32 0.12 Allowed 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 117.74 2.496 . . . . 0.0 117.74 -172.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.2 tttp -156.0 144.84 20.38 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 121.616 2.007 . . . . 0.0 115.859 -166.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -68.17 -34.46 76.35 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 118.068 -0.968 . . . . 0.0 113.576 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -139.21 138.65 37.05 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 121.573 1.988 . . . . 0.0 107.547 164.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.469 HG23 ' CZ ' ' A' ' 64' ' ' PHE . 36.0 t -107.25 142.11 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 125.14 1.376 . . . . 0.0 112.27 -170.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.7 p -133.65 -28.36 1.43 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 127.405 2.282 . . . . 0.0 114.989 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 1.8 p -159.03 145.58 12.6 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 123.957 0.903 . . . . 0.0 110.388 -176.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 70' ' ' VAL . 36.5 Cg_endo -105.08 114.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 124.047 3.165 . . . . 0.0 113.958 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -48.1 -41.92 27.63 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 125.205 1.402 . . . . 0.0 114.606 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.35 -20.56 63.85 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 123.855 0.862 . . . . 0.0 111.405 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.1 ttp -75.08 -22.39 58.33 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 119.12 0.873 . . . . 0.0 112.347 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -89.02 -30.58 18.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.049 0.94 . . . . 0.0 111.661 167.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tp -81.33 -51.73 8.05 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.71 -89.66 0.32 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.587 1.085 . . . . 0.0 113.348 -171.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 41.84 63.66 1.26 Allowed 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 125.251 1.421 . . . . 0.0 114.485 170.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.9 16.42 1.79 Allowed Glycine 0 CA--C 1.537 1.459 0 O-C-N 119.19 -2.194 . . . . 0.0 115.28 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.64 146.83 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.059 1.344 . . . . 0.0 112.163 -167.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.57 168.98 15.91 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -175.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.7 mt -130.17 -16.68 3.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 112.995 -1.911 . . . . 0.0 112.707 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -103.03 -44.11 5.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.849 0.859 . . . . 0.0 112.111 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.28 -38.8 0.28 Allowed Glycine 0 CA--C 1.532 1.155 0 N-CA-C 115.752 1.061 . . . . 0.0 115.752 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -93.12 114.43 62.72 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 125.041 1.336 . . . . 0.0 108.99 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.8 128.9 16.65 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 124.578 3.519 . . . . 0.0 113.492 -175.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.8 mm -61.32 124.96 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.329 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -108.33 117.67 34.76 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 128.506 2.722 . . . . 0.0 110.392 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -93.08 140.91 15.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -129.71 174.2 9.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.084 0.954 . . . . 0.0 108.625 174.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . 0.277 51.0 t80 77.53 157.01 0.17 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 129.099 2.959 . . . . 0.0 112.347 -170.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -147.58 -68.2 0.25 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.171 2.189 . . . . 0.0 110.423 173.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.8 t -157.62 158.71 36.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.569 1.548 . . . . 0.0 110.841 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -72.8 162.67 54.78 Favored Glycine 0 CA--C 1.545 1.946 0 CA-C-N 119.736 1.153 . . . . 0.0 111.094 168.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.3 m -141.61 167.88 21.1 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 -173.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 96.7 p -64.65 163.68 13.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 128.075 2.55 . . . . 0.0 114.33 162.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -148.35 135.23 20.03 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.608 1.163 . . . . 0.0 110.099 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 58.72 154.1 0.09 OUTLIER Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 129.599 3.16 . . . . 0.0 116.302 170.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.31 172.18 15.0 Favored 'Trans proline' 0 N--CA 1.452 -0.971 0 C-N-CA 122.428 2.085 . . . . 0.0 112.172 -171.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -66.08 -36.93 84.5 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.674 1.19 . . . . 0.0 114.085 -172.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 41.9 t0 . . . . . 0 C--O 1.257 1.487 0 C-N-CA 126.238 1.815 . . . . 0.0 111.464 -175.762 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.906 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 95.1 p -85.01 177.44 7.93 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -69.29 120.24 14.8 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 129.514 3.126 . . . . 0.0 112.16 173.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -96.08 -27.35 15.13 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 127.069 2.148 . . . . 0.0 114.065 -175.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -109.67 -8.67 14.92 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -160.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.6 mt -62.48 138.07 58.39 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 121.521 0.677 . . . . 0.0 112.612 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.01 158.41 3.9 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.156 1.783 . . . . 0.0 112.297 173.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -79.68 -41.11 27.53 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.849 2.06 . . . . 0.0 110.0 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -62.71 140.4 58.72 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.59 -1.319 . . . . 0.0 107.685 159.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -77.97 -13.91 59.71 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -176.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.71 166.13 24.77 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.594 1.157 . . . . 0.0 111.903 -168.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 pp -96.08 134.4 39.18 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.18 1.392 . . . . 0.0 109.524 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.11 9.42 36.33 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -60.34 125.56 24.14 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.2 1.4 . . . . 0.0 110.96 -177.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -122.37 156.07 34.73 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.174 1.39 . . . . 0.0 109.063 -176.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -152.1 162.89 40.42 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.2 1.0 . . . . 0.0 110.945 162.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -119.62 0.71 11.03 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.475 1.91 . . . . 0.0 112.796 171.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.42 137.72 51.06 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -154.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.9 tp -83.78 128.08 34.27 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.811 2.045 . . . . 0.0 110.266 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -82.44 140.92 33.14 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 t -143.46 130.34 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.743 0.817 . . . . 0.0 109.089 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.96 -172.28 13.66 Favored Glycine 0 CA--C 1.546 1.99 0 C-N-CA 125.365 1.46 . . . . 0.0 112.925 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.4 t30 66.38 24.82 10.43 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 128.447 2.699 . . . . 0.0 113.693 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.39 137.4 57.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.095 1.358 . . . . 0.0 111.009 -178.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.41 161.42 11.72 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 176.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.0 p -69.07 -12.01 61.3 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 126.565 1.946 . . . . 0.0 114.148 -168.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.23 5.28 7.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.829 2.852 . . . . 0.0 113.114 -175.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.2 p -54.06 158.26 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.97 1.308 . . . . 0.0 113.861 -175.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.4 p -155.56 169.17 24.92 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.749 2.02 . . . . 0.0 109.381 -177.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -64.83 -34.14 77.65 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.851 1.26 . . . . 0.0 108.367 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -66.02 -32.01 73.24 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.697 1.599 . . . . 0.0 114.607 175.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -72.2 -49.55 34.54 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.308 1.413 . . . . 0.0 108.552 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 79.8 mt -59.62 -48.73 80.51 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -60.77 -37.6 82.4 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.244 -0.91 . . . . 0.0 112.991 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -60.42 -50.63 72.83 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.763 0.825 . . . . 0.0 109.755 172.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 tt -72.83 -40.17 66.0 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.717 2.407 . . . . 0.0 113.529 -173.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -81.2 -1.78 46.09 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.077 1.351 . . . . 0.0 111.654 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -70.76 -25.78 63.06 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 121.33 1.877 . . . . 0.0 110.464 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -70.05 -29.07 66.0 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.179 1.392 . . . . 0.0 112.611 169.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.38 -20.04 24.46 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 138.22 -149.49 20.52 Favored Glycine 0 C--O 1.235 0.176 0 O-C-N 121.4 -0.813 . . . . 0.0 113.976 171.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.18 118.69 4.06 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 121.936 1.757 . . . . 0.0 110.414 -173.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.6 m -117.54 118.76 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.128 1.371 . . . . 0.0 109.514 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.1 mm -61.22 -53.49 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.717 1.607 . . . . 0.0 110.549 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.33 167.88 26.49 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 131.563 3.945 . . . . 0.0 109.25 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.5 t -116.81 163.54 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 128.368 2.667 . . . . 0.0 111.422 170.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -127.1 135.48 50.81 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.82 1.648 . . . . 0.0 113.569 164.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.1 mm -118.48 124.05 28.8 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 125.364 1.465 . . . . 0.0 108.145 167.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.67 167.33 27.45 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.926 2.417 . . . . 0.0 112.798 166.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -160.74 119.38 2.56 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 127.505 2.322 . . . . 0.0 108.58 172.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.81 173.28 0.21 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.626 1.17 . . . . 0.0 111.873 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -23.79 29.29 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 120.498 -1.376 . . . . 0.0 112.48 162.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -80.62 -2.77 47.85 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.492 1.117 . . . . 0.0 112.554 175.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.24 45.19 56.82 Favored Glycine 0 C--N 1.341 0.828 0 O-C-N 120.341 -1.475 . . . . 0.0 109.959 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.42 132.01 19.71 Favored Pre-proline 0 N--CA 1.465 0.293 0 C-N-CA 123.392 0.677 . . . . 0.0 111.828 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.09 15.58 0.31 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 125.241 3.961 . . . . 0.0 116.105 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.77 24.62 2.53 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 176.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 55.85 30.94 16.75 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -171.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -144.88 161.75 38.54 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 120.222 -1.549 . . . . 0.0 112.41 -176.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.05 -177.78 5.99 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.079 2.151 . . . . 0.0 112.728 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -137.44 157.2 47.08 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.233 1.813 . . . . 0.0 113.19 171.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.2 t -128.41 140.58 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.796 1.638 . . . . 0.0 111.848 169.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -95.46 127.66 41.68 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.161 1.384 . . . . 0.0 111.111 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.544 ' CZ ' ' HA ' ' A' ' 69' ' ' SER . 5.1 p90 -105.85 165.43 11.19 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.04 2.136 . . . . 0.0 109.62 173.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -88.0 -29.44 20.74 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -173.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -75.14 171.78 13.55 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.311 1.044 . . . . 0.0 111.134 -175.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -89.76 -20.04 24.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.0 p -119.47 144.72 27.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 123.972 0.909 . . . . 0.0 109.089 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.544 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 9.7 t -52.67 137.02 31.98 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.825 1.65 . . . . 0.0 114.128 -173.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.78 76.15 37.66 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.432 1.893 . . . . 0.0 108.735 177.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -82.87 48.63 2.81 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.762 2.975 . . . . 0.0 111.7 -167.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -52.91 -42.36 65.3 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.885 1.274 . . . . 0.0 110.336 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.74 -27.67 65.15 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 175.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.8 tmm? -66.3 -26.82 67.49 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.302 1.441 . . . . 0.0 108.862 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -98.35 -30.66 12.45 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -79.69 -34.29 40.35 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.736 1.214 . . . . 0.0 114.211 -174.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.3 -82.11 0.6 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.94 1.296 . . . . 0.0 111.082 -175.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 19.99 70.52 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 127.97 2.508 . . . . 0.0 114.314 -176.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.79 9.78 0.28 Allowed Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 pp -135.86 158.24 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 119.306 1.553 . . . . 0.0 113.558 -164.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.44 172.8 8.02 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -172.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.4 tp -140.19 22.95 2.4 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.958 2.103 . . . . 0.0 112.812 -175.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -149.47 -49.66 0.14 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.621 1.968 . . . . 0.0 110.174 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.0 -48.89 0.16 Allowed Glycine 0 CA--C 1.541 1.658 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -95.52 124.25 53.7 Favored Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 120.743 2.271 . . . . 0.0 110.837 -175.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.28 126.6 11.84 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 124.146 3.231 . . . . 0.0 113.129 -170.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.6 mm -57.54 122.91 7.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.776 0.798 . . . . 0.0 109.442 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -109.02 115.75 30.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.15 1.78 . . . . 0.0 108.812 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 mp -92.58 144.58 9.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.668 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -138.17 151.9 48.17 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.534 1.534 . . . . 0.0 111.966 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -104.17 153.29 21.13 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 126.75 2.02 . . . . 0.0 114.61 -171.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -99.35 -2.75 35.55 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.559 2.344 . . . . 0.0 115.085 -166.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.3 p -91.22 139.27 30.9 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -168.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 90.97 168.15 41.79 Favored Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.997 1.159 . . . . 0.0 115.997 176.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 87.5 p -86.32 154.31 21.32 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.22 1.808 . . . . 0.0 115.834 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.6 m -127.32 -41.61 1.73 Allowed 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 173.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -133.22 148.56 52.02 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 121.772 2.078 . . . . 0.0 108.999 -171.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -150.22 153.04 34.58 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.61 145.51 14.66 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.13 3.22 . . . . 0.0 110.715 167.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -61.85 -36.1 80.22 Favored 'General case' 0 CA--C 1.554 1.117 0 O-C-N 121.047 -1.033 . . . . 0.0 111.678 173.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.9 t70 . . . . . 0 N--CA 1.49 1.556 0 C-N-CA 128.545 2.738 . . . . 0.0 112.86 173.036 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.684 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.7 p -167.37 48.77 0.06 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.252 1.421 . . . . 0.0 111.151 170.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -104.91 136.77 43.79 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.318 -1.489 . . . . 0.0 113.236 -175.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -142.26 -39.53 0.36 Allowed 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -168.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -112.44 60.86 0.63 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 129.155 2.982 . . . . 0.0 111.321 -174.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.2 -8.66 12.94 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.745 2.418 . . . . 0.0 114.793 -175.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? 46.09 37.49 3.91 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 128.515 2.726 . . . . 0.0 116.77 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -56.34 -46.69 79.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.743 1.617 . . . . 0.0 112.245 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -150.0 169.62 20.78 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.387 1.875 . . . . 0.0 109.436 168.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -66.19 -42.95 88.15 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.873 -1.142 . . . . 0.0 113.348 174.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.56 -162.72 1.57 Allowed 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 127.671 2.388 . . . . 0.0 110.822 -170.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 73.2 mt -102.15 4.5 39.58 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 119.661 -1.899 . . . . 0.0 114.899 -174.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 46.16 2.32 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 121.088 3.736 . . . . 0.0 121.088 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -148.34 172.05 15.02 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 130.179 3.392 . . . . 0.0 108.822 -172.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.42 136.32 3.22 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.106 0.962 . . . . 0.0 111.214 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -150.28 139.83 21.55 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 172.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.3 mtm105 -68.59 -12.67 61.62 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 120.453 1.479 . . . . 0.0 114.728 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.0 m -98.47 130.33 45.07 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 123.595 1.664 . . . . 0.0 111.56 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.5 tp -107.23 132.32 53.21 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 127.576 2.35 . . . . 0.0 109.956 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -86.62 137.02 32.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 123.442 1.592 . . . . 0.0 112.163 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.2 t -132.62 122.66 47.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.334 -175.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.91 -173.42 14.43 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.495 1.521 . . . . 0.0 112.293 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 t30 61.82 23.92 14.15 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.913 1.685 . . . . 0.0 113.637 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.58 140.94 57.98 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 125.5 1.52 . . . . 0.0 109.258 -177.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.24 165.61 1.93 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 123.088 1.423 . . . . 0.0 113.805 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.4 p -67.25 -26.39 66.55 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.158 -0.964 . . . . 0.0 112.844 -172.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -116.97 7.02 13.06 Favored 'General case' 0 N--CA 1.474 0.765 1 C-N-CA 132.547 4.339 . . . . 0.0 111.31 -168.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.6 156.39 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.908 1.683 . . . . 0.0 112.606 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.2 p -151.13 158.68 44.32 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.508 1.523 . . . . 0.0 110.082 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -59.15 -30.22 67.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.18 0.992 . . . . 0.0 109.59 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -66.07 -42.12 89.85 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.225 0.92 . . . . 0.0 112.823 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.8 tp -66.18 -45.28 81.43 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.579 0.627 . . . . 0.0 109.315 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 91.8 mt -58.25 -49.53 76.77 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.43 1.492 . . . . 0.0 112.833 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -60.32 -42.57 95.88 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.85 -1.156 . . . . 0.0 111.654 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -65.87 -34.52 78.34 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.969 1.259 . . . . 0.0 111.614 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.0 tt -70.86 -50.03 39.69 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.701 1.6 . . . . 0.0 111.966 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.413 ' CD2' HG22 ' A' ' 62' ' ' VAL . 55.6 m-85 -83.09 -15.46 50.75 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -170.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -51.4 -33.07 28.56 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 168.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -74.74 -18.25 60.52 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.185 0.994 . . . . 0.0 110.896 175.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.56 11.88 27.17 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.644 1.578 . . . . 0.0 113.328 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.57 -164.11 13.47 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 127.541 2.496 . . . . 0.0 115.51 167.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.74 101.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 123.484 2.789 . . . . 0.0 113.112 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.4 t -98.29 115.79 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.6 mm -69.21 -54.3 20.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 123.005 0.522 . . . . 0.0 111.077 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -163.08 157.79 21.17 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.952 2.101 . . . . 0.0 110.789 -172.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.2 t -117.35 152.63 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 128.699 2.8 . . . . 0.0 111.267 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -127.16 126.72 43.36 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 126.948 2.099 . . . . 0.0 112.384 170.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.4 mm -106.64 117.08 57.78 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.997 2.119 . . . . 0.0 108.948 165.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.0 163.16 34.97 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.866 2.377 . . . . 0.0 110.434 165.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -155.27 112.34 3.29 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.26 2.224 . . . . 0.0 110.767 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.72 175.76 0.08 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.746 2.418 . . . . 0.0 113.192 175.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -52.95 -26.33 14.77 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.742 1.217 . . . . 0.0 114.148 173.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -93.9 -9.81 35.94 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.79 61.13 1.11 Allowed Glycine 0 N--CA 1.47 0.9 0 C-N-CA 125.896 1.712 . . . . 0.0 114.331 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -144.54 132.88 10.85 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 118.65 1.225 . . . . 0.0 113.555 -172.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.38 8.48 0.68 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.397 3.398 . . . . 0.0 115.78 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.76 18.32 3.69 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 120.417 -1.427 . . . . 0.0 114.438 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 63.21 31.17 15.73 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -169.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -146.56 167.99 22.35 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.077 1.751 . . . . 0.0 111.484 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -163.68 172.15 14.64 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 128.807 2.843 . . . . 0.0 111.217 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -124.9 149.45 47.56 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.34 -1.475 . . . . 0.0 110.879 176.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.413 HG22 ' CD2' ' A' ' 37' ' ' PHE . 20.5 t -132.08 136.86 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.038 1.335 . . . . 0.0 109.601 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -108.78 138.36 45.23 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.088 1.755 . . . . 0.0 108.508 -175.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -122.47 140.55 52.6 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.901 1.68 . . . . 0.0 112.707 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -55.33 144.25 25.72 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.848 -1.158 . . . . 0.0 111.892 171.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -56.94 -31.29 64.82 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.902 2.081 . . . . 0.0 113.437 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -75.09 -19.23 60.05 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.294 -1.504 . . . . 0.0 113.948 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.4 m -116.78 27.45 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 127.905 2.482 . . . . 0.0 113.03 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 t -75.68 78.66 2.65 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.45 149.15 53.39 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 112.514 -2.13 . . . . 0.0 110.223 165.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -73.91 52.49 2.61 Favored 'Trans proline' 0 CA--C 1.557 1.641 0 C-N-CA 123.134 2.556 . . . . 0.0 114.901 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -48.16 -46.16 34.32 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.841 1.657 . . . . 0.0 114.635 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.79 -24.37 61.7 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.461 -1.4 . . . . 0.0 113.509 -176.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.0 ttp -68.94 -28.18 66.41 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.079 1.352 . . . . 0.0 110.865 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -82.84 -41.0 19.57 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.995 0.918 . . . . 0.0 110.438 171.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.3 tp -83.62 -36.63 23.72 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -161.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.8 mt -113.79 -86.02 0.59 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.31 1.444 . . . . 0.0 109.08 -169.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.264 0.2 OUTLIER 26.82 59.48 0.08 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.907 2.883 . . . . 0.0 113.419 172.429 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.36 11.99 0.14 Allowed Glycine 0 CA--C 1.538 1.501 0 CA-C-O 118.556 -1.136 . . . . 0.0 115.42 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -134.55 154.35 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 119.745 1.772 . . . . 0.0 112.399 -168.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.23 178.35 2.45 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.496 1.918 . . . . 0.0 112.675 -172.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -140.15 -22.32 0.85 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.901 2.48 . . . . 0.0 112.461 170.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -83.26 -49.12 9.73 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.211 1.404 . . . . 0.0 110.262 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 170.81 -50.57 0.19 Allowed Glycine 0 CA--C 1.535 1.324 0 N-CA-C 115.987 1.155 . . . . 0.0 115.987 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -102.63 117.56 60.57 Favored Pre-proline 0 N--CA 1.479 1.022 0 CA-C-N 119.424 1.612 . . . . 0.0 109.587 -172.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.03 128.93 20.66 Favored 'Trans proline' 0 C--N 1.347 0.474 1 C-N-CA 125.366 4.044 . . . . 0.0 113.375 -175.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.0 mm -61.65 125.27 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.556 1.142 . . . . 0.0 108.976 -176.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -110.64 105.02 13.78 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 124.724 1.21 . . . . 0.0 107.947 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -80.41 145.06 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -137.46 163.06 32.01 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 128.356 2.662 . . . . 0.0 108.966 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -120.85 129.99 53.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.884 0.85 . . . . 0.0 109.642 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -146.08 161.06 40.99 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.691 1.596 . . . . 0.0 108.667 175.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.5 t -125.52 163.25 23.11 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.566 1.946 . . . . 0.0 114.784 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 162.87 126.07 0.8 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.998 1.285 . . . . 0.0 111.375 168.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.1 m -150.17 143.0 24.74 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.796 2.038 . . . . 0.0 108.505 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.0 m -168.08 140.2 2.98 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.389 1.475 . . . . 0.0 113.164 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -158.86 117.69 2.99 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 128.081 2.552 . . . . 0.0 110.887 167.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -97.56 154.92 37.77 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.952 2.101 . . . . 0.0 108.407 168.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -68.62 152.6 74.52 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 CA-C-N 120.569 1.239 . . . . 0.0 109.309 167.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -101.88 -38.11 7.96 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--O 1.259 1.592 0 C-N-CA 125.799 1.64 . . . . 0.0 114.215 177.324 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.476 0.84 0 CA-C-O 121.073 0.463 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.7 tp -92.33 129.0 38.38 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.478 1.511 . . . . 0.0 110.513 -176.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -83.23 130.58 35.09 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.235 0.54 . . . . 0.0 110.001 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.1 t -122.9 129.37 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 120.783 -1.198 . . . . 0.0 108.539 172.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.3 -175.8 14.19 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.314 1.911 . . . . 0.0 111.086 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.8 t30 66.67 19.49 10.78 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.207 2.203 . . . . 0.0 113.458 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.507 ' HB3' HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -67.1 145.76 54.98 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 125.411 1.484 . . . . 0.0 111.083 -168.269 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.479 ' CD ' ' HB2' ' A' ' 83' ' ' TYR . 10.6 mt-10 -60.87 161.65 7.88 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 177.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -73.42 -32.15 64.25 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.563 1.145 . . . . 0.0 113.168 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? -100.14 15.9 25.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.975 2.11 . . . . 0.0 113.417 172.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.507 HG11 ' HB3' ' A' ' 24' ' ' LEU . 2.0 p -62.54 156.18 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.0 p -156.03 161.57 40.43 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.508 2.323 . . . . 0.0 110.953 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -55.79 -31.76 62.91 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.535 1.534 . . . . 0.0 111.797 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.45 -35.78 79.88 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.177 1.391 . . . . 0.0 113.157 175.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.3 tp -72.31 -39.23 68.38 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 122.616 1.198 . . . . 0.0 108.598 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.505 HD21 ' CD1' ' A' ' 24' ' ' LEU . 89.4 mt -65.15 -54.66 26.36 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.412 1.085 . . . . 0.0 112.644 173.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -56.33 -37.18 69.61 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.193 1.36 . . . . 0.0 110.189 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -73.9 -37.11 64.78 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tt -67.5 -43.7 80.25 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.337 1.426 . . . . 0.0 111.156 172.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -82.96 -9.81 59.1 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -46.83 -37.42 8.69 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.35 1.86 . . . . 0.0 112.701 164.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -73.0 -30.6 63.91 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.173 1.389 . . . . 0.0 110.908 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.409 ' HA ' HD12 ' A' ' 76' ' ' LEU . . . -85.08 -2.99 58.63 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -166.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.59 -167.05 12.21 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 126.754 2.121 . . . . 0.0 111.375 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -48.77 121.02 5.95 Favored 'Trans proline' 0 C--N 1.346 0.426 1 C-N-CA 126.484 4.789 . . . . 0.0 112.242 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.23 136.02 54.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 173.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.7 -46.92 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 123.558 0.743 . . . . 0.0 109.26 -172.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.84 158.91 36.06 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.059 2.544 . . . . 0.0 110.46 171.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.5 t -105.91 162.4 5.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 126.208 1.803 . . . . 0.0 110.742 171.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -136.72 121.32 18.39 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.337 1.855 . . . . 0.0 114.37 169.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.2 mm -107.29 120.41 47.81 Favored Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 126.267 1.827 . . . . 0.0 110.556 166.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -75.44 167.98 25.47 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 125.032 3.821 . . . . 0.0 113.036 165.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -160.91 105.12 1.35 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.307 1.843 . . . . 0.0 113.205 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -53.1 173.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 130.435 3.494 . . . . 0.0 114.31 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.58 -24.47 8.32 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 168.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -91.43 -0.43 57.63 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.458 1.503 . . . . 0.0 114.852 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.0 41.5 54.55 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.361 1.458 . . . . 0.0 113.459 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -116.25 136.99 23.15 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 124.753 1.221 . . . . 0.0 112.92 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -70.82 17.05 0.26 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.115 2.543 . . . . 0.0 115.644 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.19 20.61 3.49 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 120.627 -1.296 . . . . 0.0 113.899 175.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 62.28 33.83 16.31 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.356 1.862 . . . . 0.0 114.496 -172.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -153.79 165.13 36.98 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.318 -1.489 . . . . 0.0 110.447 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -159.14 178.38 10.09 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.007 2.123 . . . . 0.0 110.589 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -135.52 156.15 49.35 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.574 -1.329 . . . . 0.0 111.312 168.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.71 132.13 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.7 1.2 . . . . 0.0 109.57 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 CA--C 1.542 0.654 0 O-C-N 120.254 -1.529 . . . . 0.0 110.006 176.712 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo . . . . . 0 CA--C 1.52 -0.191 0 N-CA-C 108.441 -1.407 . . . . 0.0 108.441 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -60.63 -34.26 73.99 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -168.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.39 -34.57 64.47 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 117.148 -1.406 . . . . 0.0 114.166 173.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -59.68 -21.79 61.05 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 120.613 1.551 . . . . 0.0 112.563 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -104.38 -40.42 6.09 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 127.359 2.264 . . . . 0.0 113.093 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -66.93 -61.65 1.84 Allowed 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 123.527 0.731 . . . . 0.0 112.669 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.14 -85.13 0.2 Allowed 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.5 1.12 . . . . 0.0 108.565 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 26.81 76.85 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 125.66 1.584 . . . . 0.0 114.322 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 125.45 18.02 2.55 Favored Glycine 0 CA--C 1.549 2.166 0 N-CA-C 117.555 1.782 . . . . 0.0 117.555 177.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -129.13 156.44 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 127.848 2.459 . . . . 0.0 111.583 -171.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.409 ' HB2' ' OE2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -176.73 -176.8 0.74 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.095 0.958 . . . . 0.0 112.442 -170.325 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.3 mt -141.16 -11.69 0.95 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.425 1.89 . . . . 0.0 115.885 -177.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.479 ' HB2' ' CD ' ' A' ' 25' ' ' GLU . 19.8 m-85 -109.77 -48.38 3.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.65 2.38 . . . . 0.0 111.802 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 179.06 -39.23 0.08 OUTLIER Glycine 0 CA--C 1.542 1.74 0 C-N-CA 125.955 1.74 . . . . 0.0 114.411 171.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.421 ' HB2' ' HG3' ' A' ' 25' ' ' GLU . 2.2 mpt_? -98.91 113.6 64.69 Favored Pre-proline 0 N--CA 1.483 1.219 0 CA-C-N 121.379 2.59 . . . . 0.0 112.247 -168.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.25 134.17 47.42 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.801 2.334 . . . . 0.0 111.753 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.0 mm -63.04 127.27 22.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 O-C-N 121.457 -0.777 . . . . 0.0 109.523 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -109.83 110.52 21.53 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 124.989 1.315 . . . . 0.0 110.02 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -86.33 136.74 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 120.324 -1.485 . . . . 0.0 109.668 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 . . . . . 0 CA--C 1.537 0.462 0 C-N-CA 125.355 1.462 . . . . 0.0 111.632 178.099 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 122.214 1.007 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.3 tp -131.28 131.01 43.54 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.797 2.439 . . . . 0.0 109.71 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -80.25 138.77 36.85 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.842 1.656 . . . . 0.0 112.226 167.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.48 128.58 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.834 1.253 . . . . 0.0 108.558 173.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.83 -170.84 13.62 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.556 1.55 . . . . 0.0 111.92 168.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.0 t30 66.44 19.37 10.93 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.92 2.088 . . . . 0.0 113.649 -175.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.512 ' CD1' HD21 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -63.35 135.69 57.16 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 125.358 1.463 . . . . 0.0 112.02 -174.488 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 2.0 mt-10 -55.88 152.98 9.15 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 174.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.0 p -68.24 -14.46 63.0 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.532 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -112.0 11.01 20.53 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.998 2.119 . . . . 0.0 111.566 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 24' ' ' LEU . 4.9 p -66.76 159.72 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 119.919 -1.738 . . . . 0.0 114.764 -172.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.4 p -155.38 170.59 21.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.255 1.422 . . . . 0.0 111.32 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -63.87 -28.29 69.74 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.501 -0.749 . . . . 0.0 110.611 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -64.81 -48.32 74.84 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.906 0.883 . . . . 0.0 109.699 174.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.8 tp -65.19 -38.03 89.18 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.209 0.459 . . . . 0.0 111.593 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.512 HD21 ' CD1' ' A' ' 24' ' ' LEU . 94.0 mt -67.72 -48.57 66.14 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.428 -1.42 . . . . 0.0 111.864 175.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -62.07 -44.9 95.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.722 -1.237 . . . . 0.0 113.0 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -68.73 -25.05 64.56 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.783 0.433 . . . . 0.0 111.162 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.0 tt -78.72 -46.57 18.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.838 1.255 . . . . 0.0 108.272 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -74.89 -5.81 45.69 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.784 -1.197 . . . . 0.0 113.274 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -58.8 -32.0 68.94 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.935 1.698 . . . . 0.0 111.277 171.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -72.35 -31.0 65.25 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.292 1.437 . . . . 0.0 111.426 176.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.03 3.29 39.33 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -171.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.77 -156.16 15.74 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.936 1.731 . . . . 0.0 114.885 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -85.05 90.75 0.76 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.148 1.899 . . . . 0.0 112.135 -167.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.68 134.65 29.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 112.709 -2.041 . . . . 0.0 106.993 168.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.426 HD12 ' OD1' ' A' ' 63' ' ' ASN . 44.1 mt -83.71 -63.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 165.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.495 ' HG2' ' HB3' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -155.18 147.13 23.49 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.878 1.271 . . . . 0.0 113.011 -164.512 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.5 t -108.77 145.14 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.312 2.245 . . . . 0.0 112.969 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -122.0 124.19 43.42 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 126.24 1.816 . . . . 0.0 113.01 170.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.434 HG23 ' HB3' ' A' ' 56' ' ' PRO . 2.5 mm -107.42 121.5 44.21 Favored Pre-proline 0 C--O 1.243 0.719 0 C-N-CA 125.952 1.701 . . . . 0.0 108.509 163.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 71.7 Cg_endo -72.2 162.25 42.22 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.269 2.646 . . . . 0.0 109.718 165.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -147.36 116.09 6.76 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.143 1.777 . . . . 0.0 107.632 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -54.48 171.99 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.568 2.347 . . . . 0.0 109.665 165.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.16 -34.17 55.71 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.952 0.901 . . . . 0.0 112.938 172.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -75.4 -9.31 58.45 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 128.123 2.569 . . . . 0.0 113.889 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.32 38.72 12.19 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.555 1.55 . . . . 0.0 111.4 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -125.47 135.27 26.7 Favored Pre-proline 0 N--CA 1.473 0.707 0 O-C-N 121.613 -0.933 . . . . 0.0 112.052 -172.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.434 ' HB3' HG23 ' A' ' 48' ' ' ILE . 58.6 Cg_endo -71.76 12.65 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.928 3.085 . . . . 0.0 116.782 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.486 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 61.0 25.11 15.17 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 173.323 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 24' ' ' LEU 0.25 6.0 mt-30 56.43 30.47 17.07 Favored 'General case' 0 CA--C 1.573 1.854 0 O-C-N 120.922 -1.111 . . . . 0.0 113.306 -171.411 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.486 ' CD2' ' HB2' ' A' ' 57' ' ' LYS . 3.6 p90 -150.08 155.42 39.83 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 128.24 2.616 . . . . 0.0 115.264 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -155.88 175.08 14.41 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 127.64 2.376 . . . . 0.0 112.552 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -140.08 141.8 36.15 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 120.568 -1.333 . . . . 0.0 114.503 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.9 t -131.33 130.02 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 120.555 -1.341 . . . . 0.0 111.116 -172.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.495 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 4.6 t-20 . . . . . 0 CA--C 1.545 0.782 0 C-N-CA 125.944 1.698 . . . . 0.0 112.776 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo . . . . . 0 CA--C 1.536 0.615 0 CA-C-O 121.11 0.379 . . . . 0.0 112.795 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -56.55 -42.41 78.47 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.118 -0.989 . . . . 0.0 111.474 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.84 -35.38 66.36 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.9 ttp -59.07 -8.63 1.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 126.89 2.076 . . . . 0.0 115.998 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -114.86 -32.54 5.75 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.491 1.517 . . . . 0.0 110.617 165.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.26 -56.85 5.2 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -98.29 -92.39 0.25 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.853 1.661 . . . . 0.0 110.115 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 32.89 69.92 0.11 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.27 1.428 . . . . 0.0 112.002 175.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.5 19.42 1.07 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 121.297 -0.877 . . . . 0.0 114.12 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -131.74 157.85 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.64 0.776 . . . . 0.0 109.36 -176.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.81 -179.25 7.42 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.5 tp -107.83 -47.44 3.59 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.849 1.26 . . . . 0.0 110.586 167.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.495 ' HB2' ' CD ' ' A' ' 25' ' ' GLU . 78.4 m-85 -95.09 -42.27 8.69 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.187 1.795 . . . . 0.0 113.9 -162.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.99 -23.46 0.32 Allowed Glycine 0 CA--C 1.55 2.276 0 C-N-CA 126.436 1.97 . . . . 0.0 116.766 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.498 ' HB2' ' HG3' ' A' ' 25' ' ' GLU . 2.5 mpt_? -103.7 109.35 61.93 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-N 121.991 2.895 . . . . 0.0 112.524 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.27 125.77 12.82 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.323 2.016 . . . . 0.0 114.615 -173.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.9 mm -54.07 124.61 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 124.795 1.238 . . . . 0.0 109.988 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -114.68 110.23 19.44 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.596 1.189 . . . . 0.0 111.178 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -83.73 148.03 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.792 174.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 . . . . . 0 CA--C 1.545 0.77 0 C-N-CA 125.075 1.35 . . . . 0.0 113.31 168.871 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.474 0.75 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.9 tp -83.08 128.19 34.26 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.414 2.285 . . . . 0.0 108.705 -169.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -77.45 138.77 39.44 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.123 0.963 . . . . 0.0 110.936 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.0 t -134.15 124.05 45.18 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.71 -171.33 13.33 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 173.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.5 t30 60.92 41.47 14.24 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 123.089 1.423 . . . . 0.0 111.588 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.546 HD12 HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -86.94 148.65 25.24 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.698 1.599 . . . . 0.0 110.779 178.532 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 162.85 26.84 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 125.656 2.646 . . . . 0.0 116.89 170.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.6 p -69.45 -29.01 66.61 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 127.879 2.471 . . . . 0.0 109.445 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.612 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 8.5 mmpt? -103.42 15.93 27.8 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 128.129 2.571 . . . . 0.0 114.163 176.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.546 HG11 HD12 ' A' ' 24' ' ' LEU . 3.9 p -71.0 157.27 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 120.841 -1.162 . . . . 0.0 112.04 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.2 p -156.56 166.76 32.46 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.51 1.124 . . . . 0.0 110.546 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -60.75 -27.9 68.29 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.321 -0.862 . . . . 0.0 109.957 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -61.01 -35.1 75.95 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.065 2.546 . . . . 0.0 112.536 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.421 HD23 HG23 ' A' ' 28' ' ' VAL . 16.0 tp -79.52 -39.94 30.77 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.703 0.763 . . . . 0.0 110.732 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.3 mt -65.39 -45.9 82.19 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.187 -0.945 . . . . 0.0 112.917 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -58.65 -34.13 70.86 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.294 1.038 . . . . 0.0 112.036 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -88.6 -28.23 20.82 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.25 0.62 . . . . 0.0 112.5 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.423 HD13 HG13 ' A' ' 87' ' ' ILE . 2.5 tt -70.19 -41.17 74.07 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.356 -0.84 . . . . 0.0 111.176 176.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -81.54 21.42 0.8 Allowed 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 120.376 1.444 . . . . 0.0 112.773 -173.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.06 -9.07 59.44 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 117.576 2.436 . . . . 0.0 117.576 -156.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -116.55 7.2 13.62 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 125.581 1.552 . . . . 0.0 113.163 163.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.6 31.4 0.76 Allowed 'General case' 0 CA--C 1.55 0.956 0 O-C-N 119.871 -1.768 . . . . 0.0 115.041 -167.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.97 136.19 3.53 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 107.545 -2.222 . . . . 0.0 107.545 -163.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.68 101.55 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.715 1 C-N-CA 125.307 4.005 . . . . 0.0 114.187 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.53 133.17 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.535 1.134 . . . . 0.0 110.118 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.1 mt -87.33 -47.86 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.174 1.39 . . . . 0.0 108.948 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.33 161.77 16.79 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 126.929 2.092 . . . . 0.0 111.104 -173.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.3 t -116.53 149.24 18.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 127.663 2.385 . . . . 0.0 111.808 173.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -120.66 122.77 41.2 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.693 1.197 . . . . 0.0 113.741 166.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.431 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 3.6 mm -101.24 121.47 51.73 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 124.073 0.949 . . . . 0.0 110.208 165.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 52.1 Cg_endo -66.77 165.98 23.92 Favored 'Trans proline' 0 CA--C 1.55 1.291 1 C-N-CA 125.341 4.028 . . . . 0.0 110.12 164.745 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -156.35 112.25 3.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.198 1.799 . . . . 0.0 109.893 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -57.25 172.64 0.29 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.267 2.227 . . . . 0.0 113.149 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.51 -37.76 5.66 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.594 -0.691 . . . . 0.0 112.752 171.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -76.72 -13.41 60.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.444 2.698 . . . . 0.0 116.28 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.32 30.79 11.54 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.981 2.229 . . . . 0.0 114.818 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.32 141.22 31.46 Favored Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 119.801 1.801 . . . . 0.0 114.28 -174.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.04 8.07 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.599 2.866 . . . . 0.0 116.401 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.13 32.79 20.78 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 120.418 -1.426 . . . . 0.0 112.716 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 56.93 30.32 17.83 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.409 ' HA ' HD23 ' A' ' 24' ' ' LEU . 2.0 p90 -151.29 165.01 35.31 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.009 -1.682 . . . . 0.0 111.097 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -155.46 -175.3 5.36 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 127.333 2.253 . . . . 0.0 111.254 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -138.08 160.7 38.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.738 1.615 . . . . 0.0 112.444 170.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.6 t -147.16 127.77 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 122.344 1.068 . . . . 0.0 113.726 -175.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 . . . . . 0 C--N 1.325 -0.471 0 C-N-CA 124.46 1.104 . . . . 0.0 109.582 171.022 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 CA--C 1.541 0.831 0 N-CA-C 109.835 -0.871 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -58.15 -42.59 86.24 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.133 -0.98 . . . . 0.0 112.921 -170.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.15 -29.79 70.59 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.939 -1.029 . . . . 0.0 113.767 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.5 ttp -58.36 -20.47 43.92 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.701 1.137 . . . . 0.0 112.289 176.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -103.34 -35.63 8.33 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 170.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.29 -34.18 72.45 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 120.003 1.274 . . . . 0.0 114.221 -175.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.0 mt -120.64 -92.75 0.53 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 128.727 2.811 . . . . 0.0 110.406 -170.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.436 ' OD1' ' HD2' ' A' ' 88' ' ' LYS . 1.5 t30 26.24 74.75 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 128.496 2.719 . . . . 0.0 115.449 175.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 135.48 16.97 0.88 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-N 113.775 -1.557 . . . . 0.0 112.87 -176.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -132.84 152.24 35.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 118.557 1.178 . . . . 0.0 111.827 -169.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.31 -173.23 1.21 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.976 2.51 . . . . 0.0 110.507 -167.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.5 tp -143.33 -39.05 0.32 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.392 1.477 . . . . 0.0 108.767 160.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -55.13 -57.13 13.0 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.224 1.01 . . . . 0.0 112.034 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.64 -46.54 0.23 Allowed Glycine 0 N--CA 1.48 1.62 0 N-CA-C 117.58 1.792 . . . . 0.0 117.58 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -95.13 117.61 66.72 Favored Pre-proline 0 C--O 1.238 0.467 0 CA-C-N 118.272 1.036 . . . . 0.0 108.244 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -71.06 128.75 15.24 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.849 1.699 . . . . 0.0 112.47 -174.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.423 HG13 HD13 ' A' ' 36' ' ' LEU . 12.1 mm -53.13 126.93 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 C-N-CA 123.481 0.712 . . . . 0.0 109.667 174.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.436 ' HD2' ' OD1' ' A' ' 78' ' ' ASN . 10.1 tptm -117.8 115.82 25.76 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.491 1.516 . . . . 0.0 110.058 177.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -87.49 141.05 14.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 . . . . . 0 C--N 1.328 -0.359 0 C-N-CA 124.163 0.985 . . . . 0.0 109.946 172.051 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.1 m . . . . . 0 C--O 1.234 0.272 0 CA-C-O 121.688 0.756 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.7 mp -108.47 129.62 55.27 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.258 2.223 . . . . 0.0 108.276 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -79.46 139.93 37.49 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.625 0.77 . . . . 0.0 109.341 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.3 t -130.6 133.07 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 172.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.85 -177.55 14.92 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.742 1.163 . . . . 0.0 110.625 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.5 t30 75.17 19.34 2.29 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.646 1.579 . . . . 0.0 112.815 -176.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.648 HD12 HG21 ' A' ' 28' ' ' VAL . 0.6 OUTLIER -65.17 147.66 53.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.436 -168.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 0.5 OUTLIER -66.61 157.36 32.63 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 125.953 2.787 . . . . 0.0 113.277 173.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 p -66.39 -18.51 65.4 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 129.424 3.09 . . . . 0.0 112.548 -174.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -128.23 19.67 6.38 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 131.454 3.902 . . . . 0.0 112.208 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.648 HG21 HD12 ' A' ' 24' ' ' LEU . 5.8 p -60.53 151.59 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 O-C-N 120.931 -1.106 . . . . 0.0 112.216 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.4 p -152.24 168.99 23.57 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.542 1.537 . . . . 0.0 110.635 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -66.94 -29.03 68.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.115 0.966 . . . . 0.0 109.637 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -56.93 -47.54 80.37 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.6 tp -70.72 -43.59 68.61 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.864 1.265 . . . . 0.0 113.142 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.92 -41.96 95.12 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.238 -0.914 . . . . 0.0 112.022 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -61.16 -47.34 86.65 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 118.744 0.702 . . . . 0.0 111.292 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -64.96 -33.9 77.15 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 119.683 1.129 . . . . 0.0 112.301 176.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.1 tt -72.68 -39.93 66.69 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.814 1.245 . . . . 0.0 113.223 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.447 ' CD2' HG21 ' A' ' 62' ' ' VAL . 50.0 m-85 -94.71 -19.77 20.11 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 -175.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -49.18 -36.69 20.34 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.05 1.74 . . . . 0.0 112.922 167.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -73.5 -15.79 61.31 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 174.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.63 -4.81 47.05 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.758 0.823 . . . . 0.0 112.668 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 138.3 -157.34 24.42 Favored Glycine 0 CA--C 1.545 1.94 0 C-N-CA 126.501 2.0 . . . . 0.0 113.966 168.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.01 93.32 0.96 Allowed 'Trans proline' 0 CA--C 1.551 1.334 0 C-N-CA 123.358 2.706 . . . . 0.0 113.452 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.1 m -81.65 137.61 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 122.712 1.244 . . . . 0.0 110.857 171.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.9 mm -99.16 -51.02 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 125.645 1.578 . . . . 0.0 111.749 -171.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.01 158.11 41.54 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.446 1.099 . . . . 0.0 108.494 176.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.5 t -124.06 147.85 28.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 125.668 1.587 . . . . 0.0 110.07 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -132.02 119.82 21.56 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 125.004 1.321 . . . . 0.0 112.851 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 mm -103.57 124.01 39.44 Favored Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 126.452 1.901 . . . . 0.0 107.719 165.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.99 170.38 19.06 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.788 2.326 . . . . 0.0 111.842 162.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -158.17 114.73 2.82 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 127.065 2.146 . . . . 0.0 111.347 172.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -58.68 169.66 0.92 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.014 -1.903 . . . . 0.0 109.868 170.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -32.47 69.62 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 120.961 -1.087 . . . . 0.0 113.573 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -64.81 -25.69 68.02 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.34 2.256 . . . . 0.0 113.017 171.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.78 39.37 2.54 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.093 1.33 . . . . 0.0 112.845 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 tppt? -133.58 130.64 20.96 Favored Pre-proline 0 C--N 1.35 0.619 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 -170.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.53 15.81 0.11 Allowed 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 125.136 3.89 . . . . 0.0 115.449 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.87 28.27 10.21 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 119.633 -1.917 . . . . 0.0 114.07 169.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 56.29 33.81 22.92 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.745 1.618 . . . . 0.0 115.137 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -153.42 161.83 41.89 Favored 'General case' 0 CA--C 1.555 1.146 0 O-C-N 120.75 -1.219 . . . . 0.0 112.927 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -158.88 173.45 16.49 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 126.665 1.986 . . . . 0.0 113.19 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -127.08 155.68 42.91 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.287 2.235 . . . . 0.0 112.056 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 37' ' ' PHE . 43.7 t -148.71 122.37 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.333 1.453 . . . . 0.0 109.144 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 . . . . . 0 CA--C 1.548 0.903 0 C-N-CA 124.718 1.207 . . . . 0.0 110.997 -178.763 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo . . . . . 0 CA--C 1.55 1.3 0 CA-C-O 121.596 0.582 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -51.63 -46.76 63.78 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 128.493 2.717 . . . . 0.0 114.019 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . . . -59.44 -21.78 60.53 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.4 ttt -67.79 -26.46 66.1 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.95 0.795 . . . . 0.0 111.297 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -81.7 -35.27 30.01 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.521 -0.737 . . . . 0.0 111.908 167.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.453 ' HG ' HD13 ' A' ' 77' ' ' LEU . 43.2 tp -81.28 -53.43 6.35 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -163.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.453 HD13 ' HG ' ' A' ' 76' ' ' LEU . 1.2 mm? -97.13 -83.6 0.39 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 125.611 1.564 . . . . 0.0 110.479 -174.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 24.19 66.41 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 128.422 2.689 . . . . 0.0 116.243 173.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.04 20.26 0.94 Allowed Glycine 0 CA--C 1.538 1.492 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.908 -173.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.59 152.02 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-N 118.721 1.26 . . . . 0.0 112.576 -171.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.6 172.89 4.85 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.337 2.255 . . . . 0.0 110.185 -176.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.27 -45.0 2.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.314 1.446 . . . . 0.0 110.236 166.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -61.39 -51.57 68.22 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.569 1.148 . . . . 0.0 113.679 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.6 -63.29 0.18 Allowed Glycine 0 N--CA 1.477 1.423 0 N-CA-C 117.222 1.649 . . . . 0.0 117.222 -168.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.422 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 7.3 mpt_? -88.2 123.96 67.53 Favored Pre-proline 0 N--CA 1.478 0.929 0 CA-C-N 119.75 1.775 . . . . 0.0 110.642 -175.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -76.23 134.22 15.61 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.054 2.503 . . . . 0.0 115.734 -174.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 87' ' ' ILE . 4.1 mm -64.06 123.06 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.647 0.737 . . . . 0.0 109.912 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -110.06 117.2 33.12 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 113.779 -1.555 . . . . 0.0 108.923 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 mp -78.78 149.32 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 172.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 . . . . . 0 N--CA 1.471 0.607 0 C-N-CA 126.605 1.962 . . . . 0.0 110.146 176.98 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.1 m . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 122.208 1.004 . . . . 0.0 108.871 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.8 tp -113.53 130.0 56.44 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.325 1.45 . . . . 0.0 110.436 -160.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -78.09 138.58 38.83 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.1 t -138.21 123.79 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 121.026 -1.047 . . . . 0.0 110.038 174.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.84 -170.34 15.05 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.616 2.055 . . . . 0.0 111.35 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.1 t30 58.23 35.8 25.25 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.446 1.499 . . . . 0.0 112.293 -176.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.587 HD12 HG21 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -68.13 163.19 23.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.364 1.078 . . . . 0.0 110.236 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 26' ' ' THR . 0.5 OUTLIER -86.34 170.27 12.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.087 171.687 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.415 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 43.5 p -83.48 -14.17 53.02 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.971 2.108 . . . . 0.0 113.646 -175.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 8.8 mmpt? -111.96 17.03 20.05 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 128.261 2.624 . . . . 0.0 112.33 177.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.587 HG21 HD12 ' A' ' 24' ' ' LEU . 3.7 p -72.18 153.03 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -173.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.3 p -155.71 160.83 40.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.45 1.9 . . . . 0.0 111.753 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -58.45 -20.05 41.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.956 0.902 . . . . 0.0 113.157 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -76.19 -34.54 59.3 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.597 1.159 . . . . 0.0 113.455 174.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.26 -48.44 70.48 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.854 0.862 . . . . 0.0 109.789 168.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.499 ' HB2' HG11 ' A' ' 46' ' ' VAL . 87.6 mt -59.89 -43.83 94.57 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.98 0.912 . . . . 0.0 111.113 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -65.45 -43.94 88.81 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 119.503 1.047 . . . . 0.0 110.723 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -61.11 -33.3 73.15 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.006 1.323 . . . . 0.0 113.344 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.493 HD13 HG13 ' A' ' 87' ' ' ILE . 3.7 tt -82.55 -42.46 18.33 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.844 2.057 . . . . 0.0 113.564 174.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.4 ' CD2' HG21 ' A' ' 62' ' ' VAL . 69.7 m-85 -84.87 -12.45 53.48 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.365 -1.459 . . . . 0.0 113.776 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -54.36 -36.65 64.07 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 121.309 1.868 . . . . 0.0 112.393 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -83.94 -0.31 50.91 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 173.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.42 14.68 14.02 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.915 1.286 . . . . 0.0 112.375 169.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.35 -157.45 23.19 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.459 1.504 . . . . 0.0 112.593 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.4 77.31 4.14 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.314 2.676 . . . . 0.0 112.643 -163.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.43 142.82 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 122.263 1.03 . . . . 0.0 108.527 167.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.0 mm -86.67 -51.83 12.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 124.951 1.3 . . . . 0.0 109.2 175.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -165.21 165.68 19.49 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.288 1.835 . . . . 0.0 111.696 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.499 HG11 ' HB2' ' A' ' 33' ' ' LEU . 74.4 t -119.65 150.9 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 125.66 1.584 . . . . 0.0 112.11 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.481 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 49.0 tptt -115.93 125.31 52.39 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 127.19 2.196 . . . . 0.0 114.131 165.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.6 mm -101.4 126.46 34.42 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 127.532 2.333 . . . . 0.0 111.64 158.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 60' ' ' ALA . 61.2 Cg_endo -77.74 172.2 16.13 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 125.294 3.996 . . . . 0.0 112.358 163.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.428 ' C ' ' HE3' ' A' ' 57' ' ' LYS . 25.9 mttt -161.06 122.61 2.96 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.755 2.022 . . . . 0.0 111.427 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.44 166.9 2.82 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.254 2.222 . . . . 0.0 112.882 170.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.86 -44.46 29.28 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.769 0.828 . . . . 0.0 111.257 166.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.43 -29.91 70.65 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.05 -1.031 . . . . 0.0 111.143 174.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.53 45.78 1.19 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.679 1.133 . . . . 0.0 114.782 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -129.64 141.11 40.7 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-N 119.924 1.862 . . . . 0.0 111.888 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.52 10.04 0.29 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.227 3.285 . . . . 0.0 117.285 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.428 ' HE3' ' C ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER 59.39 25.15 13.82 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 173.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.486 ' HA ' ' HB2' ' A' ' 24' ' ' LEU 0.283 35.6 mt-30 63.77 30.49 14.6 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.055 2.542 . . . . 0.0 114.688 -172.774 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -153.14 168.91 24.37 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 126.045 1.738 . . . . 0.0 111.747 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 47' ' ' LYS . . . -166.79 -174.06 2.62 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 130.51 3.524 . . . . 0.0 108.909 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -137.93 164.02 30.06 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 124.665 1.186 . . . . 0.0 112.287 169.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.4 HG21 ' CD2' ' A' ' 37' ' ' PHE . 34.7 t -139.98 139.19 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 125.577 1.551 . . . . 0.0 114.001 174.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 126.074 1.75 . . . . 0.0 114.989 -173.238 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--O 1.233 0.24 0 N-CA-C 110.996 -0.425 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -58.9 -44.05 91.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.03 0.919 . . . . 0.0 111.245 -165.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.69 -27.53 68.76 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.152 1.381 . . . . 0.0 113.682 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -62.72 -22.52 66.58 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.79 1.236 . . . . 0.0 111.782 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -95.91 -38.91 10.06 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 163.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.87 -49.63 19.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 120.654 1.57 . . . . 0.0 114.658 -165.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -98.31 -94.58 0.23 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.733 1.213 . . . . 0.0 109.133 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 21.84 79.35 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 128.115 2.566 . . . . 0.0 115.097 -169.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.82 26.33 1.58 Allowed Glycine 0 N--CA 1.476 1.33 0 C-N-CA 125.223 1.392 . . . . 0.0 113.984 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -128.07 144.66 37.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-N 117.874 0.837 . . . . 0.0 109.405 -171.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.98 177.45 10.34 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 177.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.5 tp -136.31 -44.35 0.62 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 130.834 3.654 . . . . 0.0 108.508 171.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -65.97 -52.72 47.11 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.351 1.86 . . . . 0.0 111.942 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 160.86 -38.71 0.43 Allowed Glycine 0 N--CA 1.477 1.375 0 N-CA-C 115.64 1.016 . . . . 0.0 115.64 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -100.3 115.93 64.95 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 125.728 1.611 . . . . 0.0 108.97 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.62 137.11 29.58 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.472 2.781 . . . . 0.0 113.204 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.493 HG13 HD13 ' A' ' 36' ' ' LEU . 4.7 mm -67.56 125.32 24.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 123.502 0.721 . . . . 0.0 111.106 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -113.79 107.21 15.42 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.432 1.893 . . . . 0.0 112.041 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.79 140.23 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.387 1.075 . . . . 0.0 111.316 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 . . . . . 0 CA--C 1.535 0.37 0 C-N-CA 127.53 2.332 . . . . 0.0 111.139 -179.805 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.514 -0.44 0 CA-C-O 122.388 1.089 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.5 tp -109.18 133.92 52.39 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.103 1.761 . . . . 0.0 114.47 -171.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -80.46 133.66 35.88 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.568 0.699 . . . . 0.0 110.602 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -128.62 127.85 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 169.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.27 -174.1 14.79 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.83 1.205 . . . . 0.0 112.236 170.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.7 t30 64.04 26.12 13.96 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.373 1.469 . . . . 0.0 114.739 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.421 ' HB3' HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -61.87 164.96 5.77 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.519 1.528 . . . . 0.0 109.64 177.765 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.81 172.97 12.72 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.059 1.504 . . . . 0.0 115.059 176.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.2 p -71.76 -21.23 61.77 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.015 2.126 . . . . 0.0 110.381 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.04 30.6 5.62 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 127.431 2.292 . . . . 0.0 116.369 173.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.45 HG22 ' N ' ' A' ' 29' ' ' THR . 8.6 p -69.68 165.47 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 118.885 -2.385 . . . . 0.0 115.472 176.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.45 ' N ' HG22 ' A' ' 28' ' ' VAL . 11.4 p -154.63 173.53 16.24 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.682 1.193 . . . . 0.0 112.743 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -73.29 -26.92 61.28 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.135 0.974 . . . . 0.0 110.195 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.72 -45.82 92.31 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 171.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.44 HD12 HG23 ' A' ' 28' ' ' VAL . 2.8 tm? -65.78 -47.22 75.87 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.825 0.85 . . . . 0.0 110.579 -174.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.406 HD21 ' CD1' ' A' ' 24' ' ' LEU . 96.5 mt -56.89 -48.69 77.58 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.854 1.262 . . . . 0.0 111.112 173.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -59.35 -37.95 79.16 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.363 0.983 . . . . 0.0 112.26 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -75.45 -33.41 60.87 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.995 0.816 . . . . 0.0 110.345 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.443 HD11 HD11 ' A' ' 80' ' ' ILE . 4.2 tt -68.18 -39.82 82.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.113 1.765 . . . . 0.0 113.35 176.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.479 ' CE2' HG21 ' A' ' 62' ' ' VAL . 60.3 m-85 -85.5 -1.2 56.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 117.9 -1.047 . . . . 0.0 113.694 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -60.32 -41.48 93.59 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.802 1.637 . . . . 0.0 110.904 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -75.25 -14.71 60.54 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 172.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.03 -24.41 47.83 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 120.709 1.595 . . . . 0.0 110.14 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 154.12 -172.58 32.75 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 128.639 3.018 . . . . 0.0 114.412 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.73 79.66 2.69 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 124.853 3.702 . . . . 0.0 110.403 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.6 m -52.7 141.2 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.842 1.257 . . . . 0.0 113.365 172.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 80.3 mt -79.69 -59.68 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 126.8 2.04 . . . . 0.0 107.818 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.36 168.47 25.94 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.337 1.455 . . . . 0.0 113.282 174.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.5 t -116.65 157.19 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 126.662 1.985 . . . . 0.0 112.631 171.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -134.93 123.56 23.59 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.616 1.966 . . . . 0.0 113.75 169.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.413 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 3.4 mm -100.16 124.74 42.21 Favored Pre-proline 0 C--N 1.324 -0.512 0 C-N-CA 126.681 1.993 . . . . 0.0 108.612 167.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 50.3 Cg_endo -72.76 167.08 28.17 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.461 2.774 . . . . 0.0 111.583 161.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -158.77 114.83 2.66 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.857 2.463 . . . . 0.0 109.054 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.541 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 30.6 t70 -54.04 174.59 0.05 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.413 2.285 . . . . 0.0 112.545 170.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.68 -35.08 60.68 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.289 -1.507 . . . . 0.0 112.881 167.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -68.65 -13.76 62.57 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.944 2.498 . . . . 0.0 113.486 175.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.84 54.21 6.67 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -173.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -135.85 132.91 19.63 Favored Pre-proline 0 CA--C 1.517 -0.309 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.61 22.25 0.4 Allowed 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 124.276 3.318 . . . . 0.0 114.594 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.541 ' HE2' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER 51.47 26.95 3.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 119.727 -1.858 . . . . 0.0 115.612 168.175 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 52.02 35.11 15.3 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 127.185 2.194 . . . . 0.0 114.418 -170.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -150.8 157.91 43.51 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 120.001 -1.687 . . . . 0.0 112.224 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -153.91 174.86 14.06 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.247 1.819 . . . . 0.0 111.541 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -126.9 153.29 45.95 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 119.848 -1.783 . . . . 0.0 111.956 175.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.479 HG21 ' CE2' ' A' ' 37' ' ' PHE . 84.3 t -139.44 124.51 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.122 0.969 . . . . 0.0 112.692 -177.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 . . . . . 0 CA--C 1.55 0.966 0 C-N-CA 126.347 1.859 . . . . 0.0 109.931 -177.067 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 CA--C 1.547 1.137 0 N-CA-C 108.383 -1.43 . . . . 0.0 108.383 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -57.22 -34.91 69.04 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.608 1.563 . . . . 0.0 113.689 -169.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.35 -27.78 62.57 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.116 -0.99 . . . . 0.0 112.789 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.1 ttp -77.42 -13.24 59.97 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.831 0.852 . . . . 0.0 112.184 -170.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -106.34 -25.29 11.99 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.271 1.429 . . . . 0.0 113.627 163.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.3 tp -78.04 -49.34 14.21 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.773 1.229 . . . . 0.0 112.474 -172.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -100.8 -106.99 0.23 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 42.24 70.69 0.26 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.996 2.118 . . . . 0.0 114.805 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.98 16.9 1.07 Allowed Glycine 0 CA--C 1.53 0.998 0 CA-C-N 115.594 -0.73 . . . . 0.0 114.281 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.443 HD11 HD11 ' A' ' 36' ' ' LEU . 1.9 pp -132.86 151.64 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 118.37 1.085 . . . . 0.0 111.773 -167.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.95 175.12 9.79 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.437 1.495 . . . . 0.0 110.965 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 70.0 tp -119.28 -38.74 2.98 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.173 1.389 . . . . 0.0 112.072 161.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -79.04 -41.41 28.89 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.106 0.962 . . . . 0.0 113.509 -170.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.33 -44.18 0.29 Allowed Glycine 0 N--CA 1.473 1.108 0 N-CA-C 115.692 1.037 . . . . 0.0 115.692 173.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.54 124.98 55.58 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 124.339 1.056 . . . . 0.0 108.664 177.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -77.02 134.9 14.97 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 124.443 3.429 . . . . 0.0 115.012 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.422 HG13 HD13 ' A' ' 36' ' ' LEU . 10.1 mm -64.16 131.62 29.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 123.786 0.834 . . . . 0.0 110.736 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 tptm -121.01 112.01 18.19 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.252 1.821 . . . . 0.0 110.016 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.4 mp -88.28 140.73 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 . . . . . 0 N--CA 1.45 -0.46 0 CA-C-O 123.087 1.422 . . . . 0.0 109.041 -179.009 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 122.457 1.122 . . . . 0.0 108.836 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.22 132.75 39.85 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 125.216 1.407 . . . . 0.0 109.707 -175.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -81.04 129.92 34.77 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.929 0.871 . . . . 0.0 110.912 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.4 t -127.14 130.62 71.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.18 -173.56 13.31 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 122.61 1.117 . . . . 0.0 113.712 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.1 t30 62.8 36.14 13.29 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.877 1.671 . . . . 0.0 113.994 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.523 ' CD1' HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -73.15 154.96 40.11 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.478 1.111 . . . . 0.0 109.763 -174.301 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.34 162.58 12.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 123.752 1.739 . . . . 0.0 113.626 170.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.6 p -73.94 -7.54 52.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.152 2.181 . . . . 0.0 110.908 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -133.68 18.5 3.89 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.295 2.238 . . . . 0.0 114.279 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' A' ' 24' ' ' LEU . 9.1 p -57.42 161.03 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 O-C-N 120.837 -1.164 . . . . 0.0 113.594 176.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 p -158.18 161.43 37.85 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.262 1.825 . . . . 0.0 108.835 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -66.03 -25.52 67.09 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.806 1.643 . . . . 0.0 111.444 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -66.23 -35.86 81.52 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.592 1.157 . . . . 0.0 113.955 170.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.456 HD23 HG23 ' A' ' 28' ' ' VAL . 41.6 tp -77.3 -40.63 43.67 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.232 0.924 . . . . 0.0 110.388 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' A' ' 24' ' ' LEU . 82.8 mt -62.77 -46.65 87.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.397 175.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -60.15 -46.88 88.18 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.765 1.166 . . . . 0.0 111.844 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.04 -31.48 72.73 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.16 0.891 . . . . 0.0 111.919 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 tt -75.07 -42.48 56.78 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.459 1.104 . . . . 0.0 112.976 173.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -83.9 -20.4 33.08 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -70.01 -24.9 63.36 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.21 1.368 . . . . 0.0 110.66 172.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -60.7 -28.87 68.97 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.778 -1.201 . . . . 0.0 112.442 165.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.51 17.25 10.33 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.918 1.287 . . . . 0.0 114.05 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.54 -168.01 12.86 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.441 1.02 . . . . 0.0 114.706 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.3 79.41 3.09 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 124.657 3.571 . . . . 0.0 111.107 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.0 t -55.91 148.92 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.652 0.781 . . . . 0.0 110.284 171.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.5 mm -92.54 -52.04 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 126.396 1.878 . . . . 0.0 112.283 172.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -158.85 160.79 36.58 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.895 2.478 . . . . 0.0 108.352 -171.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 33' ' ' LEU . 57.7 t -127.3 155.63 38.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 126.789 2.036 . . . . 0.0 107.217 173.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -133.01 137.29 46.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.542 1.937 . . . . 0.0 110.176 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.414 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 3.4 mm -114.13 125.35 29.45 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 126.655 1.982 . . . . 0.0 111.866 163.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 55.5 Cg_endo -75.2 167.53 26.65 Favored 'Trans proline' 0 C--N 1.347 0.485 1 C-N-CA 125.519 4.146 . . . . 0.0 112.713 167.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -152.65 116.58 4.84 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 125.848 1.659 . . . . 0.0 110.532 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -49.2 164.2 0.08 Allowed 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 126.407 1.883 . . . . 0.0 112.08 161.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.35 -38.02 62.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.456 1.102 . . . . 0.0 112.062 170.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -74.3 -14.34 60.89 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.202 1.001 . . . . 0.0 112.373 174.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.7 41.93 3.74 Favored Glycine 0 C--N 1.343 0.967 0 O-C-N 120.303 -1.498 . . . . 0.0 115.676 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -133.28 139.08 33.01 Favored Pre-proline 0 N--CA 1.469 0.491 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -67.26 14.83 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.377 1 C-N-CA 125.762 4.308 . . . . 0.0 117.14 -178.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.27 18.06 2.33 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.371 -1.456 . . . . 0.0 114.117 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 68.04 31.62 5.39 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.262 1.825 . . . . 0.0 111.955 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.4 158.91 44.68 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.755 1.222 . . . . 0.0 113.254 -174.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.42 169.66 24.21 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.06 1.744 . . . . 0.0 111.891 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -121.4 150.32 41.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.168 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.4 t -139.58 146.97 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.734 1.214 . . . . 0.0 109.899 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 . . . . . 0 CA--C 1.543 0.703 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -173.338 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo . . . . . 0 CA--C 1.542 0.881 0 N-CA-C 117.067 1.91 . . . . 0.0 117.067 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -58.54 -42.36 87.64 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.492 1.117 . . . . 0.0 112.779 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.14 -32.22 67.95 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 121.343 1.883 . . . . 0.0 111.751 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.3 tpt -65.64 -26.83 67.99 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 118.372 0.533 . . . . 0.0 112.189 -175.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -86.56 -21.35 26.94 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 121.217 -0.927 . . . . 0.0 113.033 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -105.35 -38.85 6.35 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.789 1.635 . . . . 0.0 111.798 -155.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.8 -96.77 0.42 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.114 1.766 . . . . 0.0 111.443 174.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.2 t30 29.97 66.37 0.12 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.791 2.036 . . . . 0.0 111.938 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.88 17.91 0.16 Allowed Glycine 0 N--CA 1.468 0.776 0 N-CA-C 117.347 1.699 . . . . 0.0 117.347 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -139.48 148.98 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 117.769 0.784 . . . . 0.0 112.578 -160.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.62 175.3 13.37 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.1 tp -138.53 -18.87 1.08 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.302 2.641 . . . . 0.0 112.819 171.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -101.92 -40.76 6.75 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.453 1.501 . . . . 0.0 112.986 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.74 -45.48 0.22 Allowed Glycine 0 N--CA 1.479 1.532 0 N-CA-C 118.477 2.151 . . . . 0.0 118.477 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -113.98 122.47 34.63 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 126.231 1.812 . . . . 0.0 111.459 -173.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.25 123.33 7.66 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.371 2.047 . . . . 0.0 115.106 -171.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.1 mm -52.6 118.61 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 124.495 1.118 . . . . 0.0 113.005 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -103.57 114.72 29.2 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.242 1.817 . . . . 0.0 111.658 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mp -84.0 146.77 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 O-C-N 121.649 -0.657 . . . . 0.0 110.574 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 . . . . . 0 N--CA 1.476 0.874 0 C-N-CA 126.122 1.769 . . . . 0.0 113.986 179.666 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.866 0.841 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.428 HD13 ' HG3' ' A' ' 71' ' ' PRO . 42.7 tp -117.47 133.63 55.75 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.981 2.112 . . . . 0.0 112.927 -166.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -85.03 124.57 31.88 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 123.322 1.534 . . . . 0.0 111.84 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 t -122.06 134.06 66.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.436 ' HA2' HD23 ' A' ' 24' ' ' LEU . . . -141.41 -171.13 12.59 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 121.201 -0.937 . . . . 0.0 112.18 174.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.4 t30 62.43 38.62 12.7 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.645 1.178 . . . . 0.0 111.165 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.69 HD12 HG21 ' A' ' 28' ' ' VAL . 0.9 OUTLIER -71.2 158.06 37.07 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.458 1.103 . . . . 0.0 109.065 -176.067 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.79 158.47 35.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.808 1.29 . . . . 0.0 110.0 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.2 p -73.26 -13.49 61.14 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.992 1.317 . . . . 0.0 113.3 -169.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HB3' ' HE3' ' A' ' 27' ' ' LYS . 25.4 mmmt -129.72 21.21 5.5 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 129.733 3.213 . . . . 0.0 112.364 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.69 HG21 HD12 ' A' ' 24' ' ' LEU . 9.2 p -53.64 160.69 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.524 1.13 . . . . 0.0 112.751 173.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.419 ' N ' HG22 ' A' ' 28' ' ' VAL . 36.3 p -148.41 162.15 40.16 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.931 1.692 . . . . 0.0 110.707 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -56.12 -37.34 69.29 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.707 1.203 . . . . 0.0 108.972 171.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -66.26 -32.32 73.67 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.577 HD23 HG23 ' A' ' 28' ' ' VAL . 13.4 tp -75.17 -35.49 61.59 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.009 -1.057 . . . . 0.0 111.906 175.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB2' HG11 ' A' ' 46' ' ' VAL . 26.0 mt -71.4 -43.67 66.37 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.049 171.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -53.5 -46.89 70.21 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.85 1.205 . . . . 0.0 110.658 175.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -73.14 -28.2 62.11 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.5 tt -77.58 -49.01 15.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.467 1.107 . . . . 0.0 112.666 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -81.25 -17.94 47.72 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 120.344 1.429 . . . . 0.0 113.263 -175.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -53.23 -32.4 48.12 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 120.312 1.415 . . . . 0.0 110.94 169.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -56.55 -38.4 71.85 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.464 1.505 . . . . 0.0 114.847 168.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.07 -20.37 30.49 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.227 1.811 . . . . 0.0 111.814 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.43 -168.78 29.08 Favored Glycine 0 CA--C 1.55 2.257 0 N-CA-C 117.774 1.869 . . . . 0.0 117.774 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.66 74.83 5.01 Favored 'Trans proline' 0 CA--C 1.548 1.185 1 C-N-CA 126.468 4.779 . . . . 0.0 110.806 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 m -57.72 127.11 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.827 1.651 . . . . 0.0 110.024 173.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.557 HG22 ' HE3' ' A' ' 45' ' ' LYS . 34.5 mm -69.08 -40.23 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.665 0.786 . . . . 0.0 111.018 -175.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.557 ' HE3' HG22 ' A' ' 44' ' ' ILE . 13.3 ptpt -171.49 160.14 5.84 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.59 2.356 . . . . 0.0 111.042 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.472 HG11 ' HB2' ' A' ' 33' ' ' LEU . 85.2 t -122.24 137.19 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 127.148 2.179 . . . . 0.0 112.156 -175.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -113.96 123.77 50.54 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.7 mm -110.91 111.9 56.14 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 125.754 1.622 . . . . 0.0 111.436 165.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.8 165.73 24.84 Favored 'Trans proline' 0 CA--C 1.552 1.399 1 C-N-CA 125.717 4.278 . . . . 0.0 111.258 172.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -157.24 114.82 3.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.966 2.107 . . . . 0.0 111.667 171.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.452 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 31.4 t0 -63.02 176.51 0.71 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 126.759 2.024 . . . . 0.0 113.093 170.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.79 -36.92 27.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.491 1.916 . . . . 0.0 113.072 172.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -77.04 -9.15 58.52 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.937 1.695 . . . . 0.0 114.538 174.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.08 41.54 6.61 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 125.669 1.604 . . . . 0.0 112.629 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -130.29 133.84 25.38 Favored Pre-proline 0 N--CA 1.467 0.412 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -169.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.24 13.63 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 1 C-N-CA 126.411 4.741 . . . . 0.0 115.037 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER 54.84 21.13 3.43 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 174.227 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 60.26 34.79 20.91 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.587 1.955 . . . . 0.0 112.96 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.482 ' HA ' HD23 ' A' ' 24' ' ' LEU . 2.0 p90 -151.04 155.91 40.0 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.142 1.377 . . . . 0.0 113.343 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -151.3 169.62 21.5 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.496 1.919 . . . . 0.0 112.914 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -126.24 159.56 32.7 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.265 1.031 . . . . 0.0 113.283 172.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.7 t -144.49 133.22 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.995 0.918 . . . . 0.0 110.874 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 . . . . . 0 CA--C 1.54 0.582 0 C-N-CA 125.578 1.551 . . . . 0.0 113.069 179.361 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.428 ' HG3' HD13 ' A' ' 19' ' ' LEU . 12.8 Cg_endo . . . . . 0 CA--C 1.534 0.496 0 N-CA-C 112.695 0.229 . . . . 0.0 112.695 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -52.91 -39.88 63.11 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.93 -26.69 67.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.6 ttt -70.48 -24.63 62.9 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 121.024 1.738 . . . . 0.0 112.765 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -87.04 -27.53 23.13 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.234 1.013 . . . . 0.0 112.109 169.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.33 -57.78 2.59 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -167.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -88.69 -94.92 0.1 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.547 1.139 . . . . 0.0 108.813 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 30.32 78.04 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.397 1.879 . . . . 0.0 113.38 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.9 28.01 1.78 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.022 0.82 . . . . 0.0 112.648 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -130.66 148.01 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.99 -175.17 3.91 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.239 2.216 . . . . 0.0 112.258 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.6 mt -131.37 -31.85 1.59 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.601 1.56 . . . . 0.0 112.841 154.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.446 ' CE2' HD22 ' A' ' 32' ' ' LEU . 21.0 m-30 -65.61 -51.95 55.75 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.05 -50.03 0.16 Allowed Glycine 0 CA--C 1.534 1.264 0 O-C-N 121.134 -0.979 . . . . 0.0 115.191 170.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -93.45 111.91 54.29 Favored Pre-proline 0 N--CA 1.479 1.014 0 C-N-CA 124.472 1.109 . . . . 0.0 109.247 -172.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.56 127.22 12.24 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.776 2.317 . . . . 0.0 112.536 -170.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.528 HD11 HD13 ' A' ' 24' ' ' LEU . 4.8 mm -56.74 122.54 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 122.223 1.011 . . . . 0.0 109.121 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -103.39 121.27 42.43 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.671 1.988 . . . . 0.0 109.732 171.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.46 141.23 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 169.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 . . . . . 0 C--O 1.235 0.333 0 CA-C-O 122.705 1.24 . . . . 0.0 111.552 174.706 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 83.7 m . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.9 tp -89.41 127.43 35.82 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.29 1.436 . . . . 0.0 113.367 -160.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -72.26 135.56 46.05 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.965 0.888 . . . . 0.0 111.769 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.04 134.97 62.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 168.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.82 -175.53 13.96 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 126.187 1.851 . . . . 0.0 111.23 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 42.9 t30 65.82 24.71 11.34 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.095 1.358 . . . . 0.0 112.315 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.613 HD12 HG21 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -64.8 160.09 21.01 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 123.282 1.515 . . . . 0.0 110.654 -175.043 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.27 163.36 27.11 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.995 -1.912 . . . . 0.0 110.511 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.2 p -64.29 -27.4 69.01 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.17 1.788 . . . . 0.0 109.869 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -123.59 26.13 7.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.613 HG21 HD12 ' A' ' 24' ' ' LEU . 8.0 p -51.8 161.46 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.839 1.2 . . . . 0.0 111.777 169.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.41 ' N ' HG22 ' A' ' 28' ' ' VAL . 1.6 p -158.93 159.46 34.95 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.458 1.903 . . . . 0.0 110.542 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -55.02 -38.82 68.42 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 126.478 1.911 . . . . 0.0 109.171 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -67.26 -30.87 70.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.594 1.958 . . . . 0.0 112.376 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.3 tp -75.4 -43.74 48.46 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.8 0.727 . . . . 0.0 111.422 168.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.447 ' HB2' HG11 ' A' ' 46' ' ' VAL . 95.1 mt -60.82 -54.42 45.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.106 0.963 . . . . 0.0 110.521 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -53.9 -45.41 71.1 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.059 0.845 . . . . 0.0 112.425 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -69.33 -31.76 70.42 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.127 1.33 . . . . 0.0 112.714 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.2 tt -74.18 -36.17 64.02 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.458 1.103 . . . . 0.0 111.014 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -95.54 -12.78 25.19 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -56.2 -35.74 67.63 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.969 1.708 . . . . 0.0 109.804 163.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.6 mm100 -62.36 -36.19 81.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.773 1.229 . . . . 0.0 113.284 168.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.86 2.76 44.59 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.574 1.15 . . . . 0.0 113.401 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 134.38 -169.63 22.98 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.737 1.637 . . . . 0.0 115.369 167.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.32 99.82 0.17 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.695 2.93 . . . . 0.0 111.159 167.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.5 t -88.2 131.69 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.019 1.727 . . . . 0.0 110.19 172.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.42 -46.29 20.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.949 1.3 . . . . 0.0 111.18 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -171.07 150.46 3.05 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.689 1.596 . . . . 0.0 112.033 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' ' 33' ' ' LEU . 96.2 t -115.87 151.17 17.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 129.297 3.039 . . . . 0.0 110.383 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -129.68 121.09 26.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.93 2.092 . . . . 0.0 111.209 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.5 mm -101.0 122.33 49.11 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.583 1.553 . . . . 0.0 110.124 160.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.36 163.75 35.24 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 125.188 3.925 . . . . 0.0 111.114 164.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -154.92 113.64 3.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.525 1.53 . . . . 0.0 113.149 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -53.04 168.9 0.11 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 130.444 3.497 . . . . 0.0 113.83 173.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -28.4 59.96 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.852 0.461 . . . . 0.0 110.471 168.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -83.37 -6.17 59.38 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.67 40.91 8.57 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 126.556 2.027 . . . . 0.0 111.943 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -128.82 137.11 30.28 Favored Pre-proline 0 N--CA 1.465 0.325 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.58 14.23 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 124.275 3.316 . . . . 0.0 116.682 176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.42 27.81 6.82 Favored 'General case' 0 CA--C 1.554 1.125 0 O-C-N 120.538 -1.351 . . . . 0.0 114.307 175.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 57.42 32.47 21.83 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 127.464 2.305 . . . . 0.0 116.156 -173.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -147.0 162.57 38.51 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 127.205 2.202 . . . . 0.0 112.53 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -158.67 177.43 11.21 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.622 1.969 . . . . 0.0 110.362 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -129.06 154.35 46.74 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.106 1.362 . . . . 0.0 114.22 171.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.16 133.52 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.523 1.529 . . . . 0.0 110.609 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 . . . . . 0 CA--C 1.544 0.725 0 C-N-CA 125.914 1.686 . . . . 0.0 112.207 173.113 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.412 ' HG2' ' HG2' ' A' ' 74' ' ' MET . 33.0 Cg_endo . . . . . 0 CA--C 1.551 1.338 0 N-CA-C 114.48 0.915 . . . . 0.0 114.48 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -74.55 -42.09 59.42 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 120.521 -1.362 . . . . 0.0 112.044 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . . . -56.91 -42.28 79.65 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.089 1.755 . . . . 0.0 114.482 -166.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.412 ' HG2' ' HG2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -51.18 -22.95 2.91 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 173.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -109.06 -34.3 6.64 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 125.257 1.423 . . . . 0.0 110.343 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.44 ' HB3' HD22 ' A' ' 77' ' ' LEU . 28.2 tp -64.1 -60.85 2.73 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 118.831 0.741 . . . . 0.0 111.298 -176.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.44 HD22 ' HB3' ' A' ' 76' ' ' LEU . 2.1 mm? -87.88 -86.42 0.16 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.458 1.903 . . . . 0.0 106.662 -174.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 37.57 64.56 0.63 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 126.289 1.836 . . . . 0.0 114.621 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.97 35.1 0.56 Allowed Glycine 0 N--CA 1.481 1.658 0 O-C-N 120.814 -1.179 . . . . 0.0 115.234 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.01 143.95 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.525 1.53 . . . . 0.0 112.476 -174.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.23 170.7 12.97 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.82 2.048 . . . . 0.0 112.653 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 15.5 tp -123.21 -30.73 3.68 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.867 2.467 . . . . 0.0 112.272 163.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -83.7 -21.52 32.34 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.082 2.153 . . . . 0.0 114.001 -172.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 150.79 -59.8 0.42 Allowed Glycine 0 N--CA 1.483 1.791 0 N-CA-C 116.166 1.226 . . . . 0.0 116.166 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -102.47 129.04 26.84 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 126.267 1.827 . . . . 0.0 109.033 -173.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -76.38 134.68 15.83 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.76 2.974 . . . . 0.0 113.747 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 mm -57.57 129.33 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 O-C-N 121.834 -0.541 . . . . 0.0 110.4 176.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -119.37 110.52 17.05 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.528 1.931 . . . . 0.0 109.582 170.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -85.32 134.29 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 126.125 1.77 . . . . 0.0 109.256 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 . . . . . 0 CA--C 1.544 0.73 0 C-N-CA 126.679 1.992 . . . . 0.0 111.399 -166.901 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.3 m . . . . . 0 CA--C 1.543 0.695 0 CA-C-O 122.532 1.158 . . . . 0.0 108.102 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.5 tp -119.28 125.12 48.35 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 130.917 3.687 . . . . 0.0 111.01 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -80.65 135.95 36.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.602 1.161 . . . . 0.0 108.47 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.3 t -135.37 139.39 46.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 125.098 1.359 . . . . 0.0 108.753 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.02 -174.7 14.24 Favored Glycine 0 N--CA 1.449 -0.454 0 O-C-N 121.098 -1.001 . . . . 0.0 112.448 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.5 t30 71.19 24.44 3.84 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.943 1.697 . . . . 0.0 112.383 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.752 HD12 HG21 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -72.24 145.75 47.73 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 125.191 1.397 . . . . 0.0 109.766 -169.624 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.24 162.05 18.1 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 176.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.4 p -63.1 -22.41 66.84 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.822 1.649 . . . . 0.0 111.639 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -113.38 23.2 13.46 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.466 1.506 . . . . 0.0 113.618 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.752 HG21 HD12 ' A' ' 24' ' ' LEU . 6.7 p -60.25 155.47 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 O-C-N 119.784 -1.823 . . . . 0.0 112.131 171.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.6 p -153.52 159.8 42.33 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 129.132 2.973 . . . . 0.0 108.58 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -59.9 -28.06 67.25 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.08 2.152 . . . . 0.0 111.9 177.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -73.08 -32.58 65.09 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.067 1.347 . . . . 0.0 112.252 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.436 HD22 ' CZ ' ' A' ' 83' ' ' TYR . 21.7 tp -76.08 -36.49 58.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.676 0.79 . . . . 0.0 112.999 172.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.491 HD21 ' CD1' ' A' ' 24' ' ' LEU . 95.0 mt -69.71 -42.31 74.21 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 176.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -63.03 -40.74 98.63 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.786 1.63 . . . . 0.0 112.938 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -69.86 -29.72 67.02 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.141 -0.975 . . . . 0.0 111.37 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.471 HD13 HG13 ' A' ' 87' ' ' ILE . 6.1 tt -73.38 -39.06 65.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.58 0.752 . . . . 0.0 110.388 175.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -93.41 17.36 11.54 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.779 1.231 . . . . 0.0 114.274 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -67.39 -30.28 70.01 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 120.286 1.403 . . . . 0.0 114.671 -173.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -101.24 0.24 37.06 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.126 1.77 . . . . 0.0 113.123 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.77 30.95 0.54 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.14 179.28 39.97 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.104 0.859 . . . . 0.0 111.748 -173.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -62.13 109.24 0.79 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.43 2.086 . . . . 0.0 109.716 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.9 t -94.04 105.05 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.798 1.239 . . . . 0.0 109.11 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.1 mt -62.51 -49.37 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.437 1.895 . . . . 0.0 111.825 171.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.17 170.1 19.66 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.681 0.792 . . . . 0.0 110.13 175.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' A' ' 33' ' ' LEU . 87.3 t -119.58 160.77 19.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 125.355 1.462 . . . . 0.0 109.132 169.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -138.54 124.05 19.54 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.884 1.273 . . . . 0.0 111.939 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.432 HD12 HG13 ' A' ' 28' ' ' VAL . 4.5 mm -108.37 121.69 42.73 Favored Pre-proline 0 C--N 1.32 -0.692 0 C-N-CA 125.721 1.608 . . . . 0.0 109.896 169.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.16 164.83 33.37 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 125.198 3.932 . . . . 0.0 112.304 165.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -159.51 118.32 2.85 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 126.923 2.089 . . . . 0.0 108.769 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -55.53 168.92 0.35 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 127.106 2.162 . . . . 0.0 113.06 171.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.35 -35.44 62.74 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.001 1.32 . . . . 0.0 110.116 172.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -89.16 6.79 38.44 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 128.321 2.648 . . . . 0.0 114.79 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.47 46.55 7.34 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 126.759 2.123 . . . . 0.0 115.416 168.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 9.0 tppt? -136.26 137.27 24.1 Favored Pre-proline 0 N--CA 1.476 0.842 0 CA-C-N 118.761 1.281 . . . . 0.0 113.467 -173.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.474 ' HD2' ' HG3' ' A' ' 55' ' ' LYS . 72.9 Cg_endo -77.79 17.88 0.92 Allowed 'Trans proline' 0 C--O 1.223 -0.261 1 C-N-CA 126.412 4.741 . . . . 0.0 115.596 -176.578 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.45 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 50.5 27.86 3.07 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.815 1.646 . . . . 0.0 113.341 175.501 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.25 11.3 mt-30 53.83 32.59 15.29 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -171.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.45 ' CD2' ' HB2' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -149.21 150.98 33.5 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 126.337 1.855 . . . . 0.0 112.873 -176.04 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -155.1 176.06 13.03 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.911 1.685 . . . . 0.0 112.505 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -135.39 163.16 30.66 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.1 t -145.48 143.6 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.608 1.563 . . . . 0.0 109.813 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.885 0.85 . . . . 0.0 110.499 -176.314 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo . . . . . 0 CA--C 1.54 0.803 0 N-CA-C 109.266 -1.09 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -61.48 -40.9 96.24 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 120.084 -1.635 . . . . 0.0 112.888 -169.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.455 ' HB1' HD12 ' A' ' 77' ' ' LEU . . . -57.99 -27.96 63.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.145 1.378 . . . . 0.0 112.348 174.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.5 ttt -69.69 -17.7 63.5 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.323 1.049 . . . . 0.0 111.893 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -98.92 -38.87 8.84 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.216 0.917 . . . . 0.0 111.787 166.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.51 -40.09 94.99 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 118.8 0.727 . . . . 0.0 111.392 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.46 HD22 HD11 ' A' ' 80' ' ' ILE . 2.8 mt -124.81 -86.45 0.63 Allowed 'General case' 0 C--N 1.348 0.527 0 CA-C-O 116.36 -1.781 . . . . 0.0 111.191 -158.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 23.03 71.67 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.769 2.028 . . . . 0.0 112.439 169.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.75 25.19 0.7 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.752 1.644 . . . . 0.0 114.289 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.46 HD11 HD22 ' A' ' 77' ' ' LEU . 1.1 pp -134.81 151.68 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.645 1.178 . . . . 0.0 113.096 -172.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.94 168.95 20.43 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.416 1.486 . . . . 0.0 112.526 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.0 tp -111.89 -33.59 6.25 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 128.553 2.741 . . . . 0.0 111.146 173.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.436 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 6.4 m-30 -93.57 -67.0 0.88 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.632 1.573 . . . . 0.0 110.687 -173.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.37 -38.55 0.07 OUTLIER Glycine 0 CA--C 1.53 1.003 0 CA-C-O 117.92 -1.489 . . . . 0.0 116.108 -175.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.417 ' HA ' ' HD2' ' A' ' 86' ' ' PRO . 3.4 mpt_? -101.94 108.07 54.89 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 120.205 2.003 . . . . 0.0 110.86 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 21.1 Cg_endo -65.73 128.9 20.92 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.236 3.291 . . . . 0.0 113.585 -166.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.471 HG13 HD13 ' A' ' 36' ' ' LEU . 7.0 mm -58.85 124.78 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -117.13 109.8 17.38 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 128.258 2.623 . . . . 0.0 110.749 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 mp -88.93 142.74 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.255 0.622 . . . . 0.0 109.677 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 . . . . . 0 CA--C 1.542 0.645 0 CA-C-O 123.467 1.603 . . . . 0.0 113.93 -176.706 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.3 tp -122.85 123.6 41.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.873 1.669 . . . . 0.0 114.347 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -71.77 132.53 44.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.298 1.047 . . . . 0.0 112.497 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.43 119.88 51.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 174.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.43 -171.48 16.6 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 122.988 1.327 . . . . 0.0 112.067 166.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.3 t30 71.39 31.22 2.37 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.438 2.295 . . . . 0.0 114.595 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.725 HD12 HG21 ' A' ' 28' ' ' VAL . 0.9 OUTLIER -74.16 155.78 38.02 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.879 1.272 . . . . 0.0 113.91 -172.814 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -65.79 160.32 23.31 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.1 p -62.64 -26.75 68.79 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 128.712 2.805 . . . . 0.0 111.867 168.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -113.38 10.4 18.34 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.43 1.892 . . . . 0.0 113.448 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.725 HG21 HD12 ' A' ' 24' ' ' LEU . 9.2 p -61.92 158.97 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -174.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.6 p -154.1 168.92 24.86 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 128.356 2.662 . . . . 0.0 110.625 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -62.44 -25.2 67.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.409 1.484 . . . . 0.0 110.22 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -80.66 -26.48 37.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 117.361 -1.304 . . . . 0.0 113.672 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.526 HD23 HG23 ' A' ' 28' ' ' VAL . 20.8 tp -73.65 -29.89 62.6 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.283 0.947 . . . . 0.0 111.681 169.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.461 ' HB2' HG11 ' A' ' 46' ' ' VAL . 77.4 mt -78.83 -44.69 22.47 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.298 1.039 . . . . 0.0 113.663 171.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -63.9 -43.67 95.3 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 120.137 -1.602 . . . . 0.0 110.971 -174.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -63.42 -18.38 63.66 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.292 1.037 . . . . 0.0 113.573 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 tt -99.19 -43.95 6.44 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 129.093 2.957 . . . . 0.0 110.224 -169.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -78.69 -14.13 59.46 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.152 1.381 . . . . 0.0 111.841 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -66.62 -27.4 67.66 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 120.37 -1.456 . . . . 0.0 111.877 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -68.14 -23.99 64.95 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 127.754 2.422 . . . . 0.0 114.117 165.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.71 -22.15 23.51 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.707 1.603 . . . . 0.0 110.325 -176.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 132.81 -147.15 18.82 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.447 1.022 . . . . 0.0 114.299 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -81.25 114.73 2.84 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.917 3.078 . . . . 0.0 110.306 -172.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.1 t -110.6 120.39 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.422 1.489 . . . . 0.0 110.57 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.578 HG22 ' HD2' ' A' ' 45' ' ' LYS . 4.2 mt -61.41 -57.14 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.578 ' HD2' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -157.1 163.87 38.5 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 127.281 2.232 . . . . 0.0 113.582 -178.148 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 33' ' ' LEU . 73.2 t -118.22 146.66 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 128.651 2.78 . . . . 0.0 110.136 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -122.58 128.52 50.82 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.803 1.638 . . . . 0.0 113.607 171.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 4.3 mm -107.35 120.96 46.01 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 125.459 1.503 . . . . 0.0 110.647 163.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 72.9 Cg_endo -73.42 168.45 24.72 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 125.029 3.819 . . . . 0.0 113.318 165.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -158.6 122.55 3.99 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.639 2.775 . . . . 0.0 111.965 166.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.62 164.95 0.3 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.218 2.607 . . . . 0.0 113.248 165.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -49.88 -29.71 8.67 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 164.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.12 -7.84 59.11 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.002 1.321 . . . . 0.0 114.555 170.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.15 38.93 7.6 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 119.88 -1.763 . . . . 0.0 111.952 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.28 132.91 24.6 Favored Pre-proline 0 C--N 1.347 0.493 0 CA-C-N 118.619 1.209 . . . . 0.0 114.26 -176.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.21 12.16 0.3 Allowed 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.308 3.339 . . . . 0.0 113.861 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.439 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 58.82 22.32 10.02 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.485 -1.384 . . . . 0.0 113.147 172.244 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.444 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 19.8 mt-30 57.86 34.39 24.31 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.13 1.372 . . . . 0.0 114.106 -171.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.556 ' HA ' HD23 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -150.8 158.74 44.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.75 1.22 . . . . 0.0 113.247 -176.488 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.64 -176.86 6.18 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.251 1.42 . . . . 0.0 112.501 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -140.43 154.57 46.7 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.159 -0.963 . . . . 0.0 113.189 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.46 139.34 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.766 0.826 . . . . 0.0 113.174 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 . . . . . 0 C--O 1.234 0.246 0 C-N-CA 125.113 1.365 . . . . 0.0 112.881 174.703 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo . . . . . 0 CA--C 1.54 0.798 0 N-CA-C 109.993 -0.811 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -64.59 -29.29 70.3 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.844 -1.16 . . . . 0.0 113.593 -161.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.06 -18.68 64.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.7 ttp -61.12 -17.84 54.88 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 120.137 1.335 . . . . 0.0 112.206 173.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -109.22 -44.2 3.99 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.54 1.136 . . . . 0.0 111.888 171.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.29 -43.15 95.68 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.566 0.347 . . . . 0.0 111.55 -170.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -107.96 -88.34 0.48 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.616 1.166 . . . . 0.0 111.258 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 27.01 71.11 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 129.73 3.212 . . . . 0.0 115.712 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.43 14.98 1.49 Allowed Glycine 0 CA--C 1.532 1.155 0 CA-C-O 117.598 -1.668 . . . . 0.0 116.085 -174.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -125.08 150.98 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 119.793 1.797 . . . . 0.0 111.2 -168.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.88 171.21 16.98 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.745 1.218 . . . . 0.0 113.742 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.8 tp -120.28 -46.58 2.39 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.637 1.175 . . . . 0.0 109.75 166.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -69.32 -54.8 12.72 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.29 -46.2 0.06 OUTLIER Glycine 0 CA--C 1.537 1.414 0 N-CA-C 116.265 1.266 . . . . 0.0 116.265 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -105.15 114.71 63.28 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 127.619 2.368 . . . . 0.0 114.101 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.92 119.5 6.53 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.715 2.943 . . . . 0.0 113.033 -171.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.416 HD11 ' CD2' ' A' ' 33' ' ' LEU . 1.7 mm -50.24 124.08 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.903 1.281 . . . . 0.0 110.1 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -118.86 109.88 16.54 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 124.487 1.115 . . . . 0.0 112.037 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mp -81.88 131.23 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 . . . . . 0 CA--C 1.558 1.285 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 179.028 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 CA--C 1.548 0.899 0 CA-C-O 121.54 0.686 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.8 tp -75.28 132.53 41.1 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.732 2.413 . . . . 0.0 110.549 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -84.79 137.73 33.01 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 120.288 1.404 . . . . 0.0 110.622 175.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.57 115.79 32.77 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.87 -177.28 18.37 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.357 1.456 . . . . 0.0 110.396 172.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.2 t30 65.52 37.72 5.9 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.119 1.368 . . . . 0.0 111.698 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.576 ' CD1' HG21 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -74.81 152.04 39.02 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.028 1.731 . . . . 0.0 109.468 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 26' ' ' THR . 0.7 OUTLIER -67.9 170.96 7.27 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 123.966 1.841 . . . . 0.0 112.587 169.451 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.487 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 24.9 p -82.54 -13.77 56.06 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 126.293 1.837 . . . . 0.0 113.331 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -119.11 20.33 12.69 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.25 2.62 . . . . 0.0 113.08 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.576 HG21 ' CD1' ' A' ' 24' ' ' LEU . 8.0 p -71.67 158.23 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -177.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.1 p -153.5 167.0 30.93 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.441 1.096 . . . . 0.0 111.697 -173.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.442 ' HA ' HG11 ' A' ' 46' ' ' VAL . 43.0 mt-10 -63.78 -32.12 73.52 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.011 0.924 . . . . 0.0 108.713 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.12 -47.85 81.03 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.559 1.944 . . . . 0.0 113.109 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.3 tp -67.11 -36.94 83.01 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.095 0.558 . . . . 0.0 110.922 -175.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.533 HD21 ' CD1' ' A' ' 24' ' ' LEU . 99.2 mt -65.89 -51.17 61.02 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.17 1.388 . . . . 0.0 111.042 172.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -52.59 -43.52 65.36 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.838 2.055 . . . . 0.0 113.523 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -75.23 -27.63 59.6 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -76.14 -38.73 56.4 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.608 -0.683 . . . . 0.0 112.067 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.466 ' CE2' HG21 ' A' ' 62' ' ' VAL . 56.8 m-85 -82.03 11.53 5.06 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.595 -1.315 . . . . 0.0 114.06 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -62.95 -44.78 95.12 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.124 1.37 . . . . 0.0 113.786 -174.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.72 6.7 44.93 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.639 1.576 . . . . 0.0 111.351 168.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.66 3.66 43.72 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 120.744 1.611 . . . . 0.0 112.673 171.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.85 -167.94 12.59 Favored Glycine 0 CA--C 1.538 1.515 0 C-N-CA 127.918 2.675 . . . . 0.0 111.831 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.04 97.74 0.93 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.697 2.264 . . . . 0.0 111.328 -173.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.8 t -68.33 119.23 13.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 122.58 1.181 . . . . 0.0 110.335 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.9 mm -80.54 -46.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -175.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.99 155.19 30.87 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.885 1.674 . . . . 0.0 110.111 174.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.442 HG11 ' HA ' ' A' ' 30' ' ' GLU . 42.5 t -112.64 153.87 14.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 125.681 1.593 . . . . 0.0 107.45 170.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -126.91 126.4 43.19 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.905 1.282 . . . . 0.0 112.39 169.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.429 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 1.6 mm -105.54 122.78 41.59 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 123.892 0.877 . . . . 0.0 109.594 164.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 65.4 Cg_endo -71.71 166.21 30.17 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.847 3.031 . . . . 0.0 110.153 164.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -160.72 120.06 2.67 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 128.087 2.555 . . . . 0.0 106.072 174.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.25 172.81 2.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.359 -1.746 . . . . 0.0 110.75 167.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -32.61 62.97 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 122.405 1.098 . . . . 0.0 111.045 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -77.45 -3.61 41.23 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.648 1.979 . . . . 0.0 113.116 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.95 41.51 8.1 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.541 2.019 . . . . 0.0 113.618 170.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -136.46 135.48 20.77 Favored Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.32 15.39 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.585 1 C-N-CA 126.106 4.537 . . . . 0.0 116.005 -174.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.76 29.22 9.24 Favored 'General case' 0 CA--C 1.557 1.22 0 O-C-N 121.548 -0.72 . . . . 0.0 111.91 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 53.99 38.41 28.83 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -174.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.408 ' HA ' HD23 ' A' ' 24' ' ' LEU . 1.1 p90 -152.72 173.36 15.37 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 127.787 2.435 . . . . 0.0 113.257 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -169.71 174.51 5.72 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 128.882 2.873 . . . . 0.0 112.737 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -127.01 153.92 45.3 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.706 2.003 . . . . 0.0 112.274 170.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.466 HG21 ' CE2' ' A' ' 37' ' ' PHE . 4.7 t -141.2 140.17 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.66 1.984 . . . . 0.0 108.008 -178.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.927 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo . . . . . 0 CA--C 1.533 0.458 0 N-CA-C 113.731 0.627 . . . . 0.0 113.731 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -59.7 -42.6 93.36 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.847 1.259 . . . . 0.0 109.547 -175.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.86 -25.4 28.54 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 173.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 tpt -71.93 -16.05 62.1 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 121.456 1.935 . . . . 0.0 113.788 -173.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -103.16 -35.96 8.29 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.315 1.846 . . . . 0.0 111.271 169.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.67 -48.98 23.1 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.964 1.706 . . . . 0.0 112.633 -169.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.15 -97.14 0.33 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.73 1.612 . . . . 0.0 108.63 177.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 39.55 57.57 2.13 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.447 1.899 . . . . 0.0 112.69 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.52 22.54 0.13 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.89 151.6 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 118.711 1.255 . . . . 0.0 113.806 -168.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.51 176.91 6.24 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.91 1.684 . . . . 0.0 110.93 -170.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.9 tp -125.87 -35.83 2.45 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.088 1.755 . . . . 0.0 112.428 170.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 14.7 m-30 -81.79 -61.23 1.98 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.986 1.715 . . . . 0.0 111.059 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.87 -49.1 0.06 OUTLIER Glycine 0 N--CA 1.468 0.809 0 N-CA-C 117.297 1.679 . . . . 0.0 117.297 -176.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -90.87 116.67 66.91 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -171.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.08 128.82 13.43 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.177 2.585 . . . . 0.0 110.393 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.3 mm -63.87 118.65 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.155 -174.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -103.5 91.73 4.17 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.87 1.668 . . . . 0.0 110.799 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.45 ' H ' HD12 ' A' ' 89' ' ' ILE . 4.2 mp -60.14 139.13 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.203 165.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 . . . . . 0 N--CA 1.467 0.415 0 C-N-CA 125.282 1.433 . . . . 0.0 112.342 167.91 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 51.1 tp -106.83 133.37 51.59 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.195 2.598 . . . . 0.0 111.792 -172.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -88.0 133.0 34.05 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.56 0.618 . . . . 0.0 110.492 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.3 t -130.57 122.87 53.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 O-C-N 120.966 -1.084 . . . . 0.0 108.76 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 59' ' ' PHE . . . -125.32 -175.78 14.33 Favored Glycine 0 N--CA 1.464 0.548 0 C-N-CA 126.264 1.888 . . . . 0.0 112.057 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.1 t30 64.45 31.95 12.21 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.854 2.062 . . . . 0.0 111.907 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.465 ' HB3' HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -66.74 166.4 13.18 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.391 1.876 . . . . 0.0 111.531 -178.867 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 26' ' ' THR . 1.0 OUTLIER -82.74 165.82 19.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 123.126 1.441 . . . . 0.0 113.65 166.446 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.486 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 67.4 p -65.91 -34.2 77.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.505 1.522 . . . . 0.0 111.88 175.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.09 19.52 20.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.736 2.014 . . . . 0.0 115.395 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.465 HG11 ' HB3' ' A' ' 24' ' ' LEU . 3.8 p -64.88 155.85 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 125.012 1.325 . . . . 0.0 111.264 174.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.7 p -159.75 162.06 34.83 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.667 1.987 . . . . 0.0 110.319 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -60.09 -30.49 69.28 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.204 0.602 . . . . 0.0 110.316 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -59.94 -41.87 92.78 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.153 1.781 . . . . 0.0 112.321 174.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.585 HD21 HD13 ' A' ' 82' ' ' LEU . 1.6 tm? -72.04 -51.99 19.05 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.7 mt -56.41 -39.87 73.75 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -66.44 -46.36 76.72 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.01 0.823 . . . . 0.0 110.757 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -57.04 -39.71 75.36 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.807 1.643 . . . . 0.0 111.721 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -81.61 -42.85 19.45 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.933 1.693 . . . . 0.0 112.884 -175.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . 0.329 48.0 m-85 -76.54 -4.93 45.37 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 172.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -54.7 -42.62 71.69 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 121.902 2.137 . . . . 0.0 111.503 164.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -72.66 -15.86 61.71 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.16 -1.23 57.89 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.495 1.043 . . . . 0.0 113.773 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.64 -148.51 18.41 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.071 0.843 . . . . 0.0 111.221 -174.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -75.62 157.5 40.17 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.798 2.332 . . . . 0.0 112.78 171.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.1 147.32 21.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 127.116 2.167 . . . . 0.0 107.502 170.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.7 mm -88.49 -51.6 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 121.006 -1.059 . . . . 0.0 109.608 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.74 168.84 25.9 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.549 2.339 . . . . 0.0 112.561 175.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.8 t -122.9 144.63 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 129.874 3.269 . . . . 0.0 110.609 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -127.41 122.58 33.96 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 130.307 3.443 . . . . 0.0 115.275 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.0 mm -107.09 125.89 31.44 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.145 1.778 . . . . 0.0 110.067 167.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.14 167.62 23.06 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.776 3.65 . . . . 0.0 111.289 163.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -160.58 118.56 2.51 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 128.111 2.564 . . . . 0.0 110.35 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -52.37 163.43 0.41 Allowed 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 126.852 2.061 . . . . 0.0 113.698 169.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -30.6 43.46 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.031 1.332 . . . . 0.0 113.093 172.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -87.04 -9.67 54.91 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 171.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.25 51.71 1.21 Allowed Glycine 0 C--N 1.338 0.653 0 C-N-CA 125.937 1.732 . . . . 0.0 113.453 165.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -141.13 134.93 14.82 Favored Pre-proline 0 N--CA 1.467 0.392 0 CA-C-O 117.547 -1.216 . . . . 0.0 112.988 -176.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.53 12.51 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.531 1 C-N-CA 126.673 4.916 . . . . 0.0 115.422 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.11 20.81 10.05 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.703 -1.248 . . . . 0.0 111.722 173.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.441 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 44.0 mt-30 59.08 38.47 23.91 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.701 2.0 . . . . 0.0 113.515 -173.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.412 ' HA ' ' HA2' ' A' ' 22' ' ' GLY . 0.2 OUTLIER -156.32 165.01 37.6 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.837 2.055 . . . . 0.0 111.529 -179.114 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.03 -179.21 6.07 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 128.671 2.788 . . . . 0.0 111.149 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -142.42 154.17 44.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.464 1.506 . . . . 0.0 114.411 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.8 t -143.32 120.92 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.958 1.303 . . . . 0.0 111.73 -176.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 . . . . . 0 CA--C 1.544 0.715 0 O-C-N 120.848 -1.157 . . . . 0.0 111.58 177.91 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo . . . . . 0 C--O 1.232 0.213 0 CA-C-O 121.491 0.538 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -50.5 -36.56 34.44 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -164.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.446 ' HB1' HD23 ' A' ' 77' ' ' LEU . . . -72.96 -22.92 60.63 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.439 1.496 . . . . 0.0 114.528 -176.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.7 ttt -64.45 -21.01 66.53 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.652 1.181 . . . . 0.0 110.192 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -101.36 -34.63 9.53 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.253 1.821 . . . . 0.0 112.987 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.61 -39.92 23.75 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -172.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.446 HD23 ' HB1' ' A' ' 73' ' ' ALA . 1.6 mm? -113.3 -84.25 0.59 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.293 1.037 . . . . 0.0 109.852 -176.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.263 0.4 OUTLIER 23.7 59.85 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 129.306 3.043 . . . . 0.0 114.277 176.778 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.14 18.51 0.24 Allowed Glycine 0 CA--C 1.549 2.201 0 N-CA-C 118.162 2.025 . . . . 0.0 118.162 -169.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -138.41 149.71 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 121.124 2.462 . . . . 0.0 110.784 -165.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.33 156.76 24.36 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.585 HD13 HD21 ' A' ' 32' ' ' LEU . 1.3 mp -110.12 3.15 19.94 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.097 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -129.27 -85.56 0.55 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 129.033 2.933 . . . . 0.0 108.141 -173.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.43 -43.39 0.02 OUTLIER Glycine 0 N--CA 1.481 1.679 0 N-CA-C 115.91 1.124 . . . . 0.0 115.91 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' A' ' 86' ' ' PRO . 3.6 mpt_? -95.59 118.94 65.9 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 118.154 -0.927 . . . . 0.0 109.792 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 36.9 Cg_endo -74.9 125.95 9.72 Favored 'Trans proline' 0 C--N 1.351 0.705 1 C-N-CA 125.801 4.334 . . . . 0.0 114.373 -172.806 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.2 mm -55.31 124.99 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 122.808 0.443 . . . . 0.0 110.292 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -109.38 118.14 35.87 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 126.764 2.026 . . . . 0.0 110.055 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.5 mp -93.0 141.18 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.423 -0.798 . . . . 0.0 110.074 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 . . . . . 0 CA--C 1.535 0.399 0 C-N-CA 125.445 1.498 . . . . 0.0 110.338 171.702 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.542 0.642 0 CA-C-O 122.41 1.1 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.7 tp -99.93 138.08 37.5 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.949 2.1 . . . . 0.0 111.803 -170.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -88.17 137.94 31.89 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 122.06 0.933 . . . . 0.0 111.746 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -133.74 131.07 56.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.356 -0.84 . . . . 0.0 109.166 178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.64 -176.73 14.54 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 126.225 1.869 . . . . 0.0 110.262 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.9 t30 69.09 13.2 8.7 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.807 1.643 . . . . 0.0 114.646 -178.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.797 HD12 HG21 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -61.99 144.26 55.35 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 126.253 1.821 . . . . 0.0 112.878 179.35 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 13.3 mp0 -50.77 162.22 0.28 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 173.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.5 p -72.51 -22.37 61.05 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.948 175.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.96 21.28 9.88 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 129.895 3.278 . . . . 0.0 113.014 -177.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.797 HG21 HD12 ' A' ' 24' ' ' LEU . 4.9 p -64.15 162.04 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 120.855 -1.153 . . . . 0.0 112.066 173.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.3 p -159.64 168.91 24.91 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.31 1.844 . . . . 0.0 112.86 174.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HA ' HG11 ' A' ' 46' ' ' VAL . 45.2 mt-10 -62.66 -27.17 69.04 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.174 1.39 . . . . 0.0 112.31 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -62.8 -49.94 72.98 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.76 1.164 . . . . 0.0 111.921 170.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.8 tp -64.66 -47.57 77.98 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.408 HD22 ' HE2' ' A' ' 37' ' ' PHE . 31.1 mt -62.57 -37.49 86.37 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -63.14 -47.09 84.19 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.06 0.845 . . . . 0.0 112.11 173.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -72.05 -19.57 61.82 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.451 1.5 . . . . 0.0 113.324 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.5 tt -92.61 -49.25 6.2 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.146 1.779 . . . . 0.0 112.162 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.408 ' HE2' HD22 ' A' ' 33' ' ' LEU . 61.6 m-85 -72.77 -18.07 61.53 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.209 -0.932 . . . . 0.0 112.442 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -60.86 -26.5 67.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.775 1.625 . . . . 0.0 113.356 171.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -64.25 -31.39 72.57 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.247 -1.533 . . . . 0.0 112.78 168.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.86 1.45 34.94 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.39 1.076 . . . . 0.0 112.465 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.52 -146.53 16.91 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.295 1.426 . . . . 0.0 113.631 169.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -74.13 90.8 0.96 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 CA-C-N 119.567 1.684 . . . . 0.0 114.637 -167.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.7 t -74.91 133.42 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 125.535 1.534 . . . . 0.0 109.791 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.8 mt -85.24 -55.69 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 127.272 2.229 . . . . 0.0 111.047 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.06 152.65 28.3 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 128.019 2.528 . . . . 0.0 107.54 -175.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' A' ' 30' ' ' GLU . 38.3 t -106.48 151.13 8.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 127.946 2.498 . . . . 0.0 105.423 172.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -127.75 124.33 37.49 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 124.113 0.965 . . . . 0.0 113.358 166.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.428 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 6.9 mm -101.57 120.31 54.85 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.053 163.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 43.0 Cg_endo -68.95 167.95 21.89 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 124.689 3.592 . . . . 0.0 110.222 165.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -157.45 115.87 3.19 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.134 1.374 . . . . 0.0 107.829 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -50.54 164.32 0.14 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.237 2.215 . . . . 0.0 111.264 161.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.5 pptp? -53.24 -29.53 33.08 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 120.808 -1.183 . . . . 0.0 113.567 167.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.29 -4.37 55.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.077 0.951 . . . . 0.0 112.604 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.55 35.62 8.46 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 125.962 1.744 . . . . 0.0 111.532 170.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -124.11 136.66 27.83 Favored Pre-proline 0 C--N 1.345 0.388 0 CA-C-N 118.958 1.379 . . . . 0.0 113.641 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.25 12.11 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 124.01 3.14 . . . . 0.0 118.316 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.62 27.78 11.0 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 121.286 1.857 . . . . 0.0 113.383 176.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 54.36 35.26 22.55 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.199 1.8 . . . . 0.0 113.413 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.549 ' HA ' HD23 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -147.93 162.66 38.85 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.783 -1.198 . . . . 0.0 110.494 -177.125 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -154.68 -179.23 7.81 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.213 1.405 . . . . 0.0 110.763 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -134.96 163.83 28.96 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.058 1.743 . . . . 0.0 109.808 165.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.4 t -145.96 134.7 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 127.145 2.178 . . . . 0.0 108.449 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 . . . . . 0 CA--C 1.545 0.751 0 C-N-CA 125.938 1.695 . . . . 0.0 111.059 -179.259 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 CA--C 1.534 0.506 0 CA-C-O 121.671 0.613 . . . . 0.0 113.111 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -51.06 -36.09 38.11 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.98 0.912 . . . . 0.0 111.748 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.96 -27.21 64.55 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 ttt -59.55 -28.22 66.92 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 119.754 1.161 . . . . 0.0 111.069 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -86.98 -19.32 28.89 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.753 2.021 . . . . 0.0 110.787 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.62 -45.05 4.12 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.348 1.459 . . . . 0.0 112.533 -161.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.54 -92.85 0.43 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.955 1.702 . . . . 0.0 109.322 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.261 0.9 OUTLIER 37.75 52.23 1.4 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.742 2.017 . . . . 0.0 115.191 165.84 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.38 17.79 0.21 Allowed Glycine 0 CA--C 1.534 1.246 0 CA-C-N 114.795 -1.093 . . . . 0.0 115.749 -167.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -141.82 150.59 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 118.285 1.043 . . . . 0.0 113.734 -170.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.09 167.32 26.54 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -173.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.0 tp -98.0 -34.93 10.61 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 113.349 -1.75 . . . . 0.0 111.593 169.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.409 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 43.9 m-85 -104.26 -50.22 3.4 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -167.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 172.39 -30.9 0.11 Allowed Glycine 0 CA--C 1.543 1.785 0 CA-C-O 117.991 -1.45 . . . . 0.0 115.192 -175.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -99.69 97.47 5.8 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 127.148 2.179 . . . . 0.0 115.242 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.05 114.99 2.86 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.943 3.095 . . . . 0.0 113.249 -173.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.6 mm -47.83 124.7 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 C-N-CA 125.926 1.69 . . . . 0.0 111.906 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -108.63 113.0 25.62 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 124.479 1.112 . . . . 0.0 111.584 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mp -88.64 137.93 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 . . . . . 0 C--N 1.32 -0.679 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 172.153 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.7 m . . . . . 0 CA--C 1.519 -0.232 0 CA-C-O 121.995 0.902 . . . . 0.0 108.832 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.3 tp -100.33 133.23 45.06 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 125.083 1.353 . . . . 0.0 112.163 -167.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -82.26 130.45 35.1 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.143 1.377 . . . . 0.0 114.042 177.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 t -145.39 128.45 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 124.941 1.296 . . . . 0.0 107.581 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.5 -176.51 14.45 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 126.308 1.908 . . . . 0.0 110.581 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.5 t30 71.67 16.78 5.68 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.846 2.059 . . . . 0.0 114.085 -172.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.419 ' HB2' ' C ' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -61.85 139.57 58.35 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 127.295 2.238 . . . . 0.0 110.392 -172.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.492 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 4.6 mt-10 -60.41 162.13 6.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 124.414 2.054 . . . . 0.0 116.109 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.1 p -68.94 -28.14 66.38 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.888 1.675 . . . . 0.0 111.615 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.1 tppt? -107.11 9.18 30.45 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 131.056 3.743 . . . . 0.0 115.649 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 p -59.7 161.73 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.127 1.371 . . . . 0.0 112.885 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 p -158.56 165.03 35.48 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.754 1.622 . . . . 0.0 112.321 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -59.47 -27.52 66.18 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.581 -0.7 . . . . 0.0 110.156 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -67.53 -44.17 78.99 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.834 1.254 . . . . 0.0 111.831 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.3 tp -72.44 -39.75 67.57 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.531 0.732 . . . . 0.0 111.095 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.565 ' HB2' HG11 ' A' ' 46' ' ' VAL . 71.6 mt -63.52 -40.85 98.13 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.486 1.039 . . . . 0.0 110.653 174.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -59.16 -46.41 88.47 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.27 -33.13 67.24 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.504 1.047 . . . . 0.0 112.53 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.2 tt -69.03 -41.51 77.6 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.317 0.647 . . . . 0.0 112.206 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -89.57 8.57 30.56 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.806 1.242 . . . . 0.0 113.941 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -56.91 -48.79 77.4 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.263 -1.523 . . . . 0.0 113.131 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -74.19 -9.46 58.64 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.88 36.52 1.4 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -166.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.58 -165.83 40.97 Favored Glycine 0 CA--C 1.542 1.744 0 C-N-CA 123.764 0.697 . . . . 0.0 114.322 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -81.43 85.51 1.74 Allowed 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 121.446 1.431 . . . . 0.0 114.891 -168.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.82 129.92 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 126.648 1.979 . . . . 0.0 108.882 166.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mt -91.04 -54.49 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.17 1.788 . . . . 0.0 111.4 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.57 158.49 43.6 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.058 1.743 . . . . 0.0 111.624 -178.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.565 HG11 ' HB2' ' A' ' 33' ' ' LEU . 91.7 t -116.22 143.26 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.667 1.587 . . . . 0.0 111.529 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -121.59 132.25 54.57 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.38 1.872 . . . . 0.0 114.932 172.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.9 mm -118.47 119.14 33.21 Favored Pre-proline 0 N--CA 1.471 0.584 0 C-N-CA 128.039 2.536 . . . . 0.0 109.745 172.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.23 172.84 15.22 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.151 2.567 . . . . 0.0 113.691 169.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -153.17 108.92 3.29 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.513 2.325 . . . . 0.0 111.461 172.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -43.45 164.52 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 130.741 3.617 . . . . 0.0 115.643 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.25 -29.0 3.4 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 114.744 1.386 . . . . 0.0 114.744 165.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -93.73 -11.07 32.27 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 168.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.55 47.2 1.69 Allowed Glycine 0 N--CA 1.477 1.395 0 O-C-N 119.767 -1.833 . . . . 0.0 115.206 174.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -138.14 141.42 32.03 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 125.926 1.69 . . . . 0.0 113.31 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.81 14.27 0.2 Allowed 'Trans proline' 0 CA--C 1.545 1.028 1 C-N-CA 125.96 4.44 . . . . 0.0 115.145 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.68 21.78 6.18 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 174.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.419 ' C ' ' HB2' ' A' ' 24' ' ' LEU . 17.5 mt-30 59.01 35.78 24.14 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 125.105 1.362 . . . . 0.0 113.93 -169.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -155.74 161.59 40.67 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.552 1.541 . . . . 0.0 113.849 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.55 167.06 15.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.982 1.313 . . . . 0.0 113.197 -174.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -120.76 156.12 32.53 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.858 0.863 . . . . 0.0 112.734 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.3 t -144.45 112.51 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 C-N-CA 123.509 0.724 . . . . 0.0 110.176 -178.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 . . . . . 0 N--CA 1.444 -0.774 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.206 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo . . . . . 0 CA--C 1.536 0.606 0 CA-C-O 120.846 0.269 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.497 ' CD2' HD12 ' A' ' 76' ' ' LEU . 32.7 t80 -56.06 -35.65 67.18 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.098 1.359 . . . . 0.0 112.208 -166.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.11 -21.16 64.78 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.35 -23.19 64.07 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.767 1.627 . . . . 0.0 114.167 175.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -112.61 -30.04 7.24 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.652 1.581 . . . . 0.0 111.459 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.497 HD12 ' CD2' ' A' ' 72' ' ' TYR . 0.8 OUTLIER -73.49 -45.65 52.67 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.972 0.909 . . . . 0.0 112.532 -178.369 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.472 HD22 ' HB3' ' A' ' 76' ' ' LEU . 1.3 mm? -111.14 -84.28 0.57 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.76 2.024 . . . . 0.0 107.802 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 17.27 70.01 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 128.668 2.787 . . . . 0.0 115.264 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.6 19.88 0.24 Allowed Glycine 0 N--CA 1.469 0.835 0 N-CA-C 116.706 1.442 . . . . 0.0 116.706 -175.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.99 147.5 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.233 1.013 . . . . 0.0 112.872 -163.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.48 166.77 16.15 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 123.06 1.41 . . . . 0.0 113.345 -164.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.8 mt -132.34 -19.16 2.48 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.006 -1.906 . . . . 0.0 114.67 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.409 ' HB2' ' CD ' ' A' ' 25' ' ' GLU . 55.0 m-85 -106.88 -50.82 3.03 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.357 1.863 . . . . 0.0 108.485 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 176.99 -39.44 0.1 OUTLIER Glycine 0 CA--C 1.544 1.862 0 N-CA-C 116.944 1.538 . . . . 0.0 116.944 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.492 ' HB2' ' HG3' ' A' ' 25' ' ' GLU . 1.7 mpt_? -97.47 109.23 49.35 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 126.519 1.928 . . . . 0.0 111.847 -170.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.48 121.13 8.61 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.676 2.917 . . . . 0.0 115.198 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.2 mm -51.85 132.43 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.536 1.534 . . . . 0.0 110.244 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -123.8 109.57 13.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.802 1.641 . . . . 0.0 111.739 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -92.74 136.18 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 O-C-N 121.655 -0.653 . . . . 0.0 110.049 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 117.769 2.507 . . . . 0.0 117.769 -178.507 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.557 1.241 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.4 tp -89.94 121.24 31.86 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 130.06 3.344 . . . . 0.0 112.28 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -75.83 138.33 41.07 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.451 1.023 . . . . 0.0 112.397 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.3 t -139.31 117.99 12.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 O-C-N 121.222 -0.924 . . . . 0.0 109.915 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.55 -173.65 15.92 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 122.303 0.946 . . . . 0.0 112.457 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.9 t30 65.83 35.66 6.57 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.679 1.191 . . . . 0.0 111.138 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.641 HD12 HG21 ' A' ' 28' ' ' VAL . 1.7 mm? -70.53 163.93 25.86 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.961 2.105 . . . . 0.0 111.35 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.41 161.9 17.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 123.624 1.678 . . . . 0.0 114.998 174.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.8 p -75.14 -24.16 57.93 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.999 1.32 . . . . 0.0 110.162 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -103.01 16.76 25.78 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.766 1.626 . . . . 0.0 113.357 171.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.641 HG21 HD12 ' A' ' 24' ' ' LEU . 5.8 p -66.23 153.02 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.427 ' N ' HG22 ' A' ' 28' ' ' VAL . 23.5 p -156.43 162.62 39.99 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.949 2.1 . . . . 0.0 112.342 177.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -64.7 -23.03 67.12 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.223 1.009 . . . . 0.0 112.016 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -66.85 -46.03 76.36 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 118.059 -0.972 . . . . 0.0 112.149 170.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.6 tp -64.74 -43.25 93.99 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.915 0.864 . . . . 0.0 109.562 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.505 ' HB2' HG11 ' A' ' 46' ' ' VAL . 69.1 mt -65.19 -33.81 76.89 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.04 -1.038 . . . . 0.0 113.161 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -70.1 -45.79 66.21 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.153 -0.967 . . . . 0.0 112.168 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.69 -23.33 66.12 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 121.512 -0.742 . . . . 0.0 112.684 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.443 ' CD1' HD11 ' A' ' 80' ' ' ILE . 3.8 tt -81.39 -44.59 17.34 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.184 176.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.473 ' HB3' HG11 ' A' ' 43' ' ' VAL . 45.1 m-85 -84.94 -20.97 29.83 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.168 1.349 . . . . 0.0 112.505 -170.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -52.42 -34.98 50.86 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 167.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -58.51 -32.71 69.08 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.503 2.321 . . . . 0.0 114.683 167.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.62 -12.86 55.48 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-O 121.357 0.599 . . . . 0.0 110.696 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.2 -163.56 26.33 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 126.909 2.195 . . . . 0.0 111.934 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -82.02 88.28 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 CA-C-N 120.559 2.18 . . . . 0.0 112.737 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.473 HG11 ' HB3' ' A' ' 37' ' ' PHE . 2.3 m -65.56 141.76 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 121.169 -0.957 . . . . 0.0 113.156 176.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.9 mm -71.05 -48.92 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 174.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HG2' ' HB3' ' A' ' 63' ' ' ASN . 11.2 ptpt -171.44 161.35 6.33 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.161 1.784 . . . . 0.0 111.891 -171.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' A' ' 33' ' ' LEU . 82.9 t -125.59 153.47 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 126.37 1.868 . . . . 0.0 110.871 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -128.15 141.27 51.53 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.11 2.564 . . . . 0.0 110.509 169.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mm -121.01 125.31 27.06 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 126.906 2.082 . . . . 0.0 108.727 163.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.86 172.14 15.15 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.779 2.986 . . . . 0.0 112.878 170.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -153.72 126.48 8.23 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 127.457 2.303 . . . . 0.0 110.774 164.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -55.57 163.3 1.34 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 112.128 -2.305 . . . . 0.0 111.487 162.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.96 -25.15 1.25 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 167.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -100.25 1.64 41.99 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.41 1.084 . . . . 0.0 113.304 176.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.78 39.88 4.82 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 120.92 -1.113 . . . . 0.0 115.449 170.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.448 ' CD ' ' HD2' ' A' ' 56' ' ' PRO . 3.0 tppt? -134.42 140.84 36.95 Favored Pre-proline 0 N--CA 1.476 0.836 0 CA-C-N 119.819 1.809 . . . . 0.0 114.68 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.448 ' HD2' ' CD ' ' A' ' 55' ' ' LYS . 53.6 Cg_endo -68.17 12.44 0.23 Allowed 'Trans proline' 0 CA--C 1.551 1.353 0 C-N-CA 124.124 3.216 . . . . 0.0 117.834 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.75 27.46 7.01 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 119.538 -1.976 . . . . 0.0 115.145 176.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.445 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 33.8 mt-30 55.05 37.35 28.76 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -150.91 160.58 43.81 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.189 1.396 . . . . 0.0 112.151 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.03 178.86 9.88 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.838 2.055 . . . . 0.0 109.057 175.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -137.72 153.16 49.8 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.7 t -141.26 138.6 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 126.198 1.799 . . . . 0.0 110.284 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.431 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 9.1 t-20 . . . . . 0 CA--C 1.541 0.604 0 C-N-CA 124.248 1.019 . . . . 0.0 110.938 172.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 CA--C 1.532 0.41 0 N-CA-C 112.758 0.253 . . . . 0.0 112.758 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -52.91 -44.41 66.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.782 1.233 . . . . 0.0 110.813 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.14 -31.64 63.53 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 ttp -66.42 -14.47 62.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.924 1.238 . . . . 0.0 113.244 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -105.92 -35.79 7.19 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 155.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.11 -55.51 21.5 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.477 0.711 . . . . 0.0 111.483 -171.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -91.96 -92.32 0.15 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 27.23 70.7 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 127.459 2.304 . . . . 0.0 113.908 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.7 14.5 0.68 Allowed Glycine 0 CA--C 1.535 1.34 0 N-CA-C 115.461 0.945 . . . . 0.0 115.461 -174.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.443 HD11 ' CD1' ' A' ' 36' ' ' LEU . 1.1 pp -130.55 145.25 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 -165.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.38 172.65 10.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.73 2.012 . . . . 0.0 110.126 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 57.9 mt -118.71 -48.71 2.47 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.999 0.92 . . . . 0.0 110.208 159.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -51.37 -59.24 4.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.748 1.219 . . . . 0.0 112.346 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.53 -64.16 0.07 OUTLIER Glycine 0 N--CA 1.47 0.931 0 N-CA-C 116.458 1.343 . . . . 0.0 116.458 -162.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -106.07 119.44 52.16 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 118.097 0.948 . . . . 0.0 111.031 -168.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -77.62 132.61 12.24 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.709 2.273 . . . . 0.0 113.926 -166.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.429 HG13 HD13 ' A' ' 36' ' ' LEU . 13.3 mm -59.38 119.81 4.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 123.811 0.844 . . . . 0.0 111.394 -177.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -108.19 103.15 12.28 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.902 2.081 . . . . 0.0 110.345 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.5 mp -74.83 141.61 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 . . . . . 0 CA--C 1.536 0.442 0 C-N-CA 126.779 2.032 . . . . 0.0 108.141 -179.067 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.474 0.767 0 CA-C-O 122.54 1.162 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.541 HD13 ' HG2' ' A' ' 71' ' ' PRO . 11.1 tp -116.44 124.04 49.0 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.903 2.481 . . . . 0.0 112.722 -161.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -74.65 132.89 42.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 122.198 0.999 . . . . 0.0 109.82 175.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.6 t -129.19 125.42 62.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 169.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.84 -169.23 13.78 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 122.456 1.031 . . . . 0.0 113.035 168.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.2 t30 65.92 29.67 10.2 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 128.545 2.738 . . . . 0.0 114.258 -173.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.646 HD12 HG21 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -69.14 156.67 38.3 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.764 1.225 . . . . 0.0 109.413 -175.521 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.519 ' HG2' ' H ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.4 165.12 24.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 123.914 1.816 . . . . 0.0 114.126 172.22 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.3 p -68.29 -14.78 63.24 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 128.49 2.716 . . . . 0.0 110.392 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -113.59 5.24 16.48 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 129.19 2.996 . . . . 0.0 114.435 -176.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.811 HG23 HD23 ' A' ' 32' ' ' LEU . 9.8 p -66.14 154.28 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 120.131 -1.606 . . . . 0.0 114.213 -170.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.5 p -148.46 171.4 16.13 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 127.218 2.207 . . . . 0.0 111.343 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -77.41 -15.89 59.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.49 1.516 . . . . 0.0 111.393 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -76.24 -45.99 30.3 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.63 1.572 . . . . 0.0 109.407 170.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.811 HD23 HG23 ' A' ' 28' ' ' VAL . 60.8 tp -63.95 -39.31 93.85 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.621 0.724 . . . . 0.0 110.778 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.421 HD21 ' CD1' ' A' ' 24' ' ' LEU . 92.6 mt -70.83 -48.44 54.04 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.569 0.747 . . . . 0.0 111.969 176.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -58.31 -43.03 87.98 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -65.25 -32.18 73.72 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.743 0.817 . . . . 0.0 110.986 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 tt -76.29 -43.27 42.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.817 2.047 . . . . 0.0 113.193 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.446 ' CE2' HG21 ' A' ' 62' ' ' VAL . 23.9 m-85 -87.48 -6.16 58.5 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.012 0.925 . . . . 0.0 112.018 -173.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -53.89 -43.01 69.29 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.314 0.646 . . . . 0.0 109.745 160.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -55.96 -25.95 46.02 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 173.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.38 -8.45 32.44 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.239 1.019 . . . . 0.0 112.681 -171.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.74 -153.55 17.55 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.643 1.116 . . . . 0.0 113.593 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.05 107.52 2.48 Favored 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 123.497 2.798 . . . . 0.0 111.936 -165.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.0 t -94.96 126.37 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 128.266 2.627 . . . . 0.0 109.666 169.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mt -78.37 -48.71 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.947 1.299 . . . . 0.0 109.672 173.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.57 163.78 19.34 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.317 1.047 . . . . 0.0 113.266 -175.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 82.9 t -122.94 145.27 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.74 1.616 . . . . 0.0 112.197 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -126.11 121.29 32.45 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.133 2.173 . . . . 0.0 112.603 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.0 mm -110.38 120.76 43.31 Favored Pre-proline 0 N--CA 1.467 0.405 0 C-N-CA 126.487 1.915 . . . . 0.0 107.241 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -74.11 172.25 16.35 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.018 2.479 . . . . 0.0 111.545 168.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -156.87 115.08 3.25 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.611 1.964 . . . . 0.0 108.413 169.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -56.38 168.61 0.52 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 129.115 2.966 . . . . 0.0 111.696 164.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.4 pptp? -47.0 -32.58 4.01 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.469 1.508 . . . . 0.0 114.272 170.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.8 -18.04 61.51 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.802 1.641 . . . . 0.0 114.327 173.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.32 56.98 2.72 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -175.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -143.15 133.18 12.03 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.286 1.034 . . . . 0.0 113.328 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.99 19.67 0.13 Allowed 'Trans proline' 0 CA--C 1.55 1.325 0 C-N-CA 124.978 3.785 . . . . 0.0 116.538 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 52.02 22.02 1.71 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 174.233 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 57.72 36.53 26.66 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 116.817 2.154 . . . . 0.0 116.817 -166.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 57' ' ' LYS . 13.5 p90 -153.93 167.54 29.38 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.926 1.29 . . . . 0.0 113.453 175.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -163.95 170.06 17.19 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.979 2.112 . . . . 0.0 110.295 176.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -127.38 146.49 50.45 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.862 1.265 . . . . 0.0 110.932 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.446 HG21 ' CE2' ' A' ' 37' ' ' PHE . 20.8 t -125.91 132.67 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 126.581 1.953 . . . . 0.0 110.247 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 CA--C 1.545 0.762 0 C-N-CA 124.596 1.158 . . . . 0.0 108.75 176.443 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.541 ' HG2' HD13 ' A' ' 19' ' ' LEU . 51.5 Cg_exo . . . . . 0 N--CA 1.447 -1.255 0 CA-C-O 123.932 1.555 . . . . 0.0 113.912 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -68.98 -40.94 78.53 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.665 2.386 . . . . 0.0 111.007 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.94 -28.92 66.71 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.06 -1.025 . . . . 0.0 113.239 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.0 ttp -64.19 -21.36 66.54 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.733 1.213 . . . . 0.0 113.609 -176.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -97.63 -29.04 13.65 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.504 1.522 . . . . 0.0 112.115 168.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.82 -40.96 13.6 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.186 -0.946 . . . . 0.0 113.238 -169.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -107.68 -97.68 0.37 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.055 1.342 . . . . 0.0 110.83 176.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 37.83 59.13 1.35 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.37 1.868 . . . . 0.0 115.584 175.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.17 16.47 0.11 Allowed Glycine 0 CA--C 1.519 0.311 0 O-C-N 120.869 -1.145 . . . . 0.0 114.236 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -128.71 149.46 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 117.829 0.814 . . . . 0.0 109.509 -163.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.21 172.68 9.68 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.737 1.215 . . . . 0.0 110.802 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.9 tp -133.59 -19.84 2.08 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.867 0.867 . . . . 0.0 109.806 163.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -72.82 -68.59 0.47 Allowed 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.164 -0.96 . . . . 0.0 112.399 167.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.17 -51.36 0.07 OUTLIER Glycine 0 C--N 1.339 0.735 0 N-CA-C 116.985 1.554 . . . . 0.0 116.985 -168.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.519 ' H ' ' HG2' ' A' ' 25' ' ' GLU . 5.8 mpt_? -100.96 121.87 50.8 Favored Pre-proline 0 N--CA 1.462 0.151 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -177.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.2 126.91 10.15 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.256 1.97 . . . . 0.0 113.963 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.1 mm -51.01 126.95 6.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.696 1.198 . . . . 0.0 109.758 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -121.86 116.81 25.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.206 1.802 . . . . 0.0 112.753 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.424 ' CG2' HD11 ' A' ' 19' ' ' LEU . 4.4 mp -91.34 134.07 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.178 -0.951 . . . . 0.0 111.206 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 . . . . . 0 CA--C 1.544 0.735 0 CA-C-O 123.831 1.777 . . . . 0.0 115.396 175.979 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.467 0.421 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.2 tp -92.55 140.75 29.24 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 128.363 2.665 . . . . 0.0 115.013 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -89.63 130.19 35.96 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 125.869 1.667 . . . . 0.0 110.033 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.2 t -132.4 128.61 58.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 120.756 -1.215 . . . . 0.0 107.78 173.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.59 -171.35 12.93 Favored Glycine 0 CA--C 1.543 1.794 0 CA-C-O 122.485 1.047 . . . . 0.0 111.854 171.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.6 t30 62.68 33.77 15.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.1 1.76 . . . . 0.0 112.897 -175.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -70.26 154.43 41.92 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.164 1.786 . . . . 0.0 111.145 177.192 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.409 ' HG3' ' HB2' ' A' ' 83' ' ' TYR . 0.3 OUTLIER -70.88 160.67 32.38 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 125.082 2.373 . . . . 0.0 114.059 173.728 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.6 p -67.85 -24.83 65.3 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 111.139 -2.755 . . . . 0.0 111.868 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -118.73 22.48 11.98 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 127.424 2.289 . . . . 0.0 115.938 174.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.741 HG23 HD23 ' A' ' 32' ' ' LEU . 8.5 p -60.71 170.77 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 116.733 2.123 . . . . 0.0 116.733 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.615 ' H ' HG22 ' A' ' 28' ' ' VAL . 10.6 p -165.88 156.59 13.21 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 128.113 2.565 . . . . 0.0 111.349 -177.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.71 -17.75 17.07 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.576 2.35 . . . . 0.0 110.546 174.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -78.48 -38.51 40.83 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.907 1.683 . . . . 0.0 112.097 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.741 HD23 HG23 ' A' ' 28' ' ' VAL . 40.9 tp -70.25 -47.81 59.69 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.004 1.322 . . . . 0.0 108.576 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.402 HD21 ' CD1' ' A' ' 24' ' ' LEU . 52.9 mt -59.04 -50.96 72.09 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.082 176.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -62.5 -41.5 98.87 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.318 1.417 . . . . 0.0 111.393 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.02 -23.69 64.11 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.357 1.244 . . . . 0.0 114.357 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.65 -39.85 35.79 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.793 1.637 . . . . 0.0 112.737 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -89.87 1.1 56.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.037 0.935 . . . . 0.0 111.792 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -64.8 -35.03 79.79 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.55 1.14 . . . . 0.0 113.9 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -79.21 -17.53 54.67 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.905 0.482 . . . . 0.0 110.694 167.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.69 21.59 0.65 Allowed 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.702 -1.249 . . . . 0.0 113.762 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.19 -125.62 7.47 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.23 0.919 . . . . 0.0 114.461 173.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -71.29 127.0 12.85 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 CA-C-N 118.38 1.09 . . . . 0.0 110.615 -173.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.1 t -138.35 124.82 25.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 168.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 mm -89.05 -54.68 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 125.443 1.497 . . . . 0.0 108.481 171.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.423 ' HG2' ' HB3' ' A' ' 63' ' ' ASN . 17.8 ptpt -151.7 153.37 34.24 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.918 0.887 . . . . 0.0 113.316 -173.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.8 t -117.79 152.1 19.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 126.876 2.07 . . . . 0.0 108.782 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -129.22 122.91 30.69 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.372 1.869 . . . . 0.0 114.465 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.5 mm -106.14 117.37 57.61 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 126.165 1.786 . . . . 0.0 110.573 168.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.5 165.07 33.04 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.704 3.603 . . . . 0.0 111.834 165.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -155.31 117.12 4.08 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 126.963 2.105 . . . . 0.0 109.297 172.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.431 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 28.8 t0 -55.22 169.53 0.26 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 128.453 2.701 . . . . 0.0 114.269 175.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.27 -40.69 25.64 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.155 -0.341 . . . . 0.0 111.826 164.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -81.97 3.64 25.71 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 126.045 1.738 . . . . 0.0 113.506 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.94 42.37 30.38 Favored Glycine 0 N--CA 1.474 1.226 0 C-N-CA 126.377 1.941 . . . . 0.0 113.607 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -129.79 138.31 32.83 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 119.241 1.521 . . . . 0.0 113.063 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.89 9.61 0.35 Allowed 'Trans proline' 0 CA--C 1.54 0.824 1 C-N-CA 126.699 4.933 . . . . 0.0 115.372 176.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HE2' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER 58.73 26.92 15.24 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 169.41 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.494 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 15.9 mt-30 59.47 24.93 13.64 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.991 1.316 . . . . 0.0 114.31 -172.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -150.9 165.91 32.2 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 119.93 -1.731 . . . . 0.0 113.408 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -169.0 177.34 4.96 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 128.214 2.606 . . . . 0.0 112.744 -172.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -131.43 158.4 40.9 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 126.154 1.781 . . . . 0.0 115.414 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.5 t -143.98 129.68 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 126.301 1.84 . . . . 0.0 111.487 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.423 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 4.4 t-20 . . . . . 0 N--CA 1.474 0.731 0 C-N-CA 125.878 1.671 . . . . 0.0 114.618 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 N--CA 1.457 -0.644 0 N-CA-C 113.958 0.714 . . . . 0.0 113.958 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -48.1 -41.92 27.63 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 125.205 1.402 . . . . 0.0 114.606 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.35 -20.56 63.85 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 123.855 0.862 . . . . 0.0 111.405 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.1 ttp -75.08 -22.39 58.33 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 119.12 0.873 . . . . 0.0 112.347 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -89.02 -30.58 18.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.049 0.94 . . . . 0.0 111.661 167.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tp -81.33 -51.73 8.05 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.71 -89.66 0.32 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.587 1.085 . . . . 0.0 113.348 -171.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 41.84 63.66 1.26 Allowed 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 125.251 1.421 . . . . 0.0 114.485 170.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.9 16.42 1.79 Allowed Glycine 0 CA--C 1.537 1.459 0 O-C-N 119.19 -2.194 . . . . 0.0 115.28 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.64 146.83 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.059 1.344 . . . . 0.0 112.163 -167.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.57 168.98 15.91 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -175.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.7 mt -130.17 -16.68 3.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 112.995 -1.911 . . . . 0.0 112.707 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.409 ' HB2' ' HG3' ' A' ' 25' ' ' GLU . 3.5 m-30 -103.03 -44.11 5.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.849 0.859 . . . . 0.0 112.111 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.28 -38.8 0.28 Allowed Glycine 0 CA--C 1.532 1.155 0 N-CA-C 115.752 1.061 . . . . 0.0 115.752 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -93.12 114.43 62.72 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 125.041 1.336 . . . . 0.0 108.99 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.8 128.9 16.65 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 124.578 3.519 . . . . 0.0 113.492 -175.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.8 mm -61.32 124.96 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.329 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -108.33 117.67 34.76 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 128.506 2.722 . . . . 0.0 110.392 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -93.08 140.91 15.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 . . . . . 0 CA--C 1.54 0.577 0 C-N-CA 124.084 0.954 . . . . 0.0 108.625 174.09 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.9 tp -83.78 128.08 34.27 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.811 2.045 . . . . 0.0 110.266 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -82.44 140.92 33.14 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 t -143.46 130.34 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.743 0.817 . . . . 0.0 109.089 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.96 -172.28 13.66 Favored Glycine 0 CA--C 1.546 1.99 0 C-N-CA 125.365 1.46 . . . . 0.0 112.925 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.4 t30 66.38 24.82 10.43 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 128.447 2.699 . . . . 0.0 113.693 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.619 ' HB3' HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -65.39 137.4 57.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.095 1.358 . . . . 0.0 111.009 -178.255 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.41 161.42 11.72 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 176.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.0 p -69.07 -12.01 61.3 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 126.565 1.946 . . . . 0.0 114.148 -168.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.23 5.28 7.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.829 2.852 . . . . 0.0 113.114 -175.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' ' 24' ' ' LEU . 8.2 p -54.06 158.26 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.97 1.308 . . . . 0.0 113.861 -175.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.4 p -155.56 169.17 24.92 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.749 2.02 . . . . 0.0 109.381 -177.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -64.83 -34.14 77.65 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.851 1.26 . . . . 0.0 108.367 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -66.02 -32.01 73.24 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.697 1.599 . . . . 0.0 114.607 175.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -72.2 -49.55 34.54 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.308 1.413 . . . . 0.0 108.552 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.483 HD21 ' CD1' ' A' ' 24' ' ' LEU . 79.8 mt -59.62 -48.73 80.51 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -60.77 -37.6 82.4 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.244 -0.91 . . . . 0.0 112.991 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -60.42 -50.63 72.83 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.763 0.825 . . . . 0.0 109.755 172.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 tt -72.83 -40.17 66.0 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.717 2.407 . . . . 0.0 113.529 -173.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -81.2 -1.78 46.09 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.077 1.351 . . . . 0.0 111.654 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -70.76 -25.78 63.06 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 121.33 1.877 . . . . 0.0 110.464 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -70.05 -29.07 66.0 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.179 1.392 . . . . 0.0 112.611 169.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.38 -20.04 24.46 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 138.22 -149.49 20.52 Favored Glycine 0 C--O 1.235 0.176 0 O-C-N 121.4 -0.813 . . . . 0.0 113.976 171.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.18 118.69 4.06 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 121.936 1.757 . . . . 0.0 110.414 -173.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.6 m -117.54 118.76 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.128 1.371 . . . . 0.0 109.514 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.1 mm -61.22 -53.49 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.717 1.607 . . . . 0.0 110.549 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.33 167.88 26.49 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 131.563 3.945 . . . . 0.0 109.25 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.5 t -116.81 163.54 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 128.368 2.667 . . . . 0.0 111.422 170.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -127.1 135.48 50.81 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.82 1.648 . . . . 0.0 113.569 164.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.1 mm -118.48 124.05 28.8 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 125.364 1.465 . . . . 0.0 108.145 167.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.67 167.33 27.45 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.926 2.417 . . . . 0.0 112.798 166.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -160.74 119.38 2.56 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 127.505 2.322 . . . . 0.0 108.58 172.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.81 173.28 0.21 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.626 1.17 . . . . 0.0 111.873 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -23.79 29.29 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 120.498 -1.376 . . . . 0.0 112.48 162.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -80.62 -2.77 47.85 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.492 1.117 . . . . 0.0 112.554 175.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.24 45.19 56.82 Favored Glycine 0 C--N 1.341 0.828 0 O-C-N 120.341 -1.475 . . . . 0.0 109.959 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.42 132.01 19.71 Favored Pre-proline 0 N--CA 1.465 0.293 0 C-N-CA 123.392 0.677 . . . . 0.0 111.828 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.45 ' HG3' HG12 ' A' ' 28' ' ' VAL . 71.8 Cg_endo -71.09 15.58 0.31 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 125.241 3.961 . . . . 0.0 116.105 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.77 24.62 2.53 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 176.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 55.85 30.94 16.75 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -171.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -144.88 161.75 38.54 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 120.222 -1.549 . . . . 0.0 112.41 -176.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.05 -177.78 5.99 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.079 2.151 . . . . 0.0 112.728 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -137.44 157.2 47.08 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.233 1.813 . . . . 0.0 113.19 171.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.2 t -128.41 140.58 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.796 1.638 . . . . 0.0 111.848 169.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 . . . . . 0 CA--C 1.539 0.538 0 C-N-CA 125.161 1.384 . . . . 0.0 111.111 178.008 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo . . . . . 0 CA--C 1.541 0.828 0 N-CA-C 111.7 -0.154 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -52.91 -42.36 65.3 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.885 1.274 . . . . 0.0 110.336 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.74 -27.67 65.15 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 175.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.8 tmm? -66.3 -26.82 67.49 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.302 1.441 . . . . 0.0 108.862 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -98.35 -30.66 12.45 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -79.69 -34.29 40.35 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.736 1.214 . . . . 0.0 114.211 -174.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.3 -82.11 0.6 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.94 1.296 . . . . 0.0 111.082 -175.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 19.99 70.52 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 127.97 2.508 . . . . 0.0 114.314 -176.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.79 9.78 0.28 Allowed Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 pp -135.86 158.24 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 119.306 1.553 . . . . 0.0 113.558 -164.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.44 172.8 8.02 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -172.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.4 tp -140.19 22.95 2.4 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.958 2.103 . . . . 0.0 112.812 -175.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -149.47 -49.66 0.14 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.621 1.968 . . . . 0.0 110.174 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.0 -48.89 0.16 Allowed Glycine 0 CA--C 1.541 1.658 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -95.52 124.25 53.7 Favored Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 120.743 2.271 . . . . 0.0 110.837 -175.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.28 126.6 11.84 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 124.146 3.231 . . . . 0.0 113.129 -170.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.6 mm -57.54 122.91 7.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.776 0.798 . . . . 0.0 109.442 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.404 ' HE3' ' NE2' ' A' ' 90' ' ' GLN . 54.0 tptt -109.02 115.75 30.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.15 1.78 . . . . 0.0 108.812 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 mp -92.58 144.58 9.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.668 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.404 ' NE2' ' HE3' ' A' ' 88' ' ' LYS . 7.3 mm-40 . . . . . 0 N--CA 1.468 0.453 0 C-N-CA 125.534 1.534 . . . . 0.0 111.966 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.0 m . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 123.595 1.664 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.5 tp -107.23 132.32 53.21 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 127.576 2.35 . . . . 0.0 109.956 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -86.62 137.02 32.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 123.442 1.592 . . . . 0.0 112.163 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.2 t -132.62 122.66 47.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.334 -175.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.91 -173.42 14.43 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.495 1.521 . . . . 0.0 112.293 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 t30 61.82 23.92 14.15 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.913 1.685 . . . . 0.0 113.637 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.656 HD12 HG21 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -66.58 140.94 57.98 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 125.5 1.52 . . . . 0.0 109.258 -177.212 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.24 165.61 1.93 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 123.088 1.423 . . . . 0.0 113.805 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.4 p -67.25 -26.39 66.55 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.158 -0.964 . . . . 0.0 112.844 -172.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -116.97 7.02 13.06 Favored 'General case' 0 N--CA 1.474 0.765 1 C-N-CA 132.547 4.339 . . . . 0.0 111.31 -168.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.656 HG21 HD12 ' A' ' 24' ' ' LEU . 7.5 p -53.6 156.39 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.908 1.683 . . . . 0.0 112.606 -177.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.2 p -151.13 158.68 44.32 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.508 1.523 . . . . 0.0 110.082 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -59.15 -30.22 67.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.18 0.992 . . . . 0.0 109.59 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -66.07 -42.12 89.85 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.225 0.92 . . . . 0.0 112.823 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.435 HD23 HG23 ' A' ' 28' ' ' VAL . 49.8 tp -66.18 -45.28 81.43 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.579 0.627 . . . . 0.0 109.315 178.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.64 HD21 ' CD1' ' A' ' 24' ' ' LEU . 91.8 mt -58.25 -49.53 76.77 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.43 1.492 . . . . 0.0 112.833 174.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -60.32 -42.57 95.88 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.85 -1.156 . . . . 0.0 111.654 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -65.87 -34.52 78.34 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.969 1.259 . . . . 0.0 111.614 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.448 ' CD2' HD13 ' A' ' 77' ' ' LEU . 8.0 tt -70.86 -50.03 39.69 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.701 1.6 . . . . 0.0 111.966 177.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -83.09 -15.46 50.75 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -170.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -51.4 -33.07 28.56 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 168.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -74.74 -18.25 60.52 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.185 0.994 . . . . 0.0 110.896 175.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.56 11.88 27.17 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.644 1.578 . . . . 0.0 113.328 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.57 -164.11 13.47 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 127.541 2.496 . . . . 0.0 115.51 167.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.74 101.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 123.484 2.789 . . . . 0.0 113.112 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.4 t -98.29 115.79 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.6 mm -69.21 -54.3 20.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 123.005 0.522 . . . . 0.0 111.077 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -163.08 157.79 21.17 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.952 2.101 . . . . 0.0 110.789 -172.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.2 t -117.35 152.63 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 128.699 2.8 . . . . 0.0 111.267 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -127.16 126.72 43.36 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 126.948 2.099 . . . . 0.0 112.384 170.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.4 mm -106.64 117.08 57.78 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.997 2.119 . . . . 0.0 108.948 165.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.0 163.16 34.97 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.866 2.377 . . . . 0.0 110.434 165.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -155.27 112.34 3.29 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.26 2.224 . . . . 0.0 110.767 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.72 175.76 0.08 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.746 2.418 . . . . 0.0 113.192 175.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -52.95 -26.33 14.77 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.742 1.217 . . . . 0.0 114.148 173.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -93.9 -9.81 35.94 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.79 61.13 1.11 Allowed Glycine 0 N--CA 1.47 0.9 0 C-N-CA 125.896 1.712 . . . . 0.0 114.331 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -144.54 132.88 10.85 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 118.65 1.225 . . . . 0.0 113.555 -172.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.471 ' HG3' HG12 ' A' ' 28' ' ' VAL . 72.9 Cg_endo -69.38 8.48 0.68 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.397 3.398 . . . . 0.0 115.78 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.76 18.32 3.69 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 120.417 -1.427 . . . . 0.0 114.438 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 63.21 31.17 15.73 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -169.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.518 ' HA ' HD23 ' A' ' 24' ' ' LEU . 1.5 p90 -146.56 167.99 22.35 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.077 1.751 . . . . 0.0 111.484 176.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -163.68 172.15 14.64 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 128.807 2.843 . . . . 0.0 111.217 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -124.9 149.45 47.56 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.34 -1.475 . . . . 0.0 110.879 176.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.5 t -132.08 136.86 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.038 1.335 . . . . 0.0 109.601 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 . . . . . 0 CA--C 1.548 0.872 0 C-N-CA 126.088 1.755 . . . . 0.0 108.508 -175.938 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 CA--C 1.557 1.641 0 N-CA-C 114.901 1.077 . . . . 0.0 114.901 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -48.16 -46.16 34.32 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.841 1.657 . . . . 0.0 114.635 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.79 -24.37 61.7 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.461 -1.4 . . . . 0.0 113.509 -176.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.0 ttp -68.94 -28.18 66.41 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.079 1.352 . . . . 0.0 110.865 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -82.84 -41.0 19.57 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.995 0.918 . . . . 0.0 110.438 171.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.3 tp -83.62 -36.63 23.72 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -161.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.448 HD13 ' CD2' ' A' ' 36' ' ' LEU . 22.8 mt -113.79 -86.02 0.59 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.31 1.444 . . . . 0.0 109.08 -169.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.264 0.2 OUTLIER 26.82 59.48 0.08 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.907 2.883 . . . . 0.0 113.419 172.429 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.36 11.99 0.14 Allowed Glycine 0 CA--C 1.538 1.501 0 CA-C-O 118.556 -1.136 . . . . 0.0 115.42 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -134.55 154.35 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 119.745 1.772 . . . . 0.0 112.399 -168.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.23 178.35 2.45 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.496 1.918 . . . . 0.0 112.675 -172.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -140.15 -22.32 0.85 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.901 2.48 . . . . 0.0 112.461 170.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -83.26 -49.12 9.73 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.211 1.404 . . . . 0.0 110.262 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 170.81 -50.57 0.19 Allowed Glycine 0 CA--C 1.535 1.324 0 N-CA-C 115.987 1.155 . . . . 0.0 115.987 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -102.63 117.56 60.57 Favored Pre-proline 0 N--CA 1.479 1.022 0 CA-C-N 119.424 1.612 . . . . 0.0 109.587 -172.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.03 128.93 20.66 Favored 'Trans proline' 0 C--N 1.347 0.474 1 C-N-CA 125.366 4.044 . . . . 0.0 113.375 -175.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.0 mm -61.65 125.27 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.556 1.142 . . . . 0.0 108.976 -176.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -110.64 105.02 13.78 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 124.724 1.21 . . . . 0.0 107.947 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -80.41 145.06 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 . . . . . 0 N--CA 1.468 0.445 0 C-N-CA 128.356 2.662 . . . . 0.0 108.966 178.297 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.362 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.9 m -108.59 -48.6 3.29 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.446 2.298 . . . . 0.0 113.211 -174.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -141.8 144.71 34.08 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.509 1.924 . . . . 0.0 110.475 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -107.53 -30.0 8.88 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.424 1.89 . . . . 0.0 113.72 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -117.27 27.33 9.16 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.538 1.535 . . . . 0.0 114.808 -164.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 6' ' ' LEU . 2.3 mm? -117.46 147.94 42.27 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 118.085 2.624 . . . . 0.0 118.085 -171.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.87 128.8 39.01 Favored 'General case' 0 C--N 1.345 0.407 0 C-N-CA 124.955 1.302 . . . . 0.0 114.171 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -88.8 53.73 2.79 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.327 1.851 . . . . 0.0 114.321 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -127.62 149.71 50.06 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.843 1.657 . . . . 0.0 107.435 169.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -55.34 -47.9 75.02 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -163.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.53 174.21 14.72 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 118.039 2.607 . . . . 0.0 118.039 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 34.0 mt -98.06 136.49 38.24 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.505 2.722 . . . . 0.0 113.082 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -161.11 -61.15 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.767 1.227 . . . . 0.0 113.69 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 51.33 7.82 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.31 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 -164.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.4 159.81 42.48 Favored 'General case' 0 C--N 1.343 0.286 0 O-C-N 120.027 -1.671 . . . . 0.0 114.138 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -116.52 -26.72 6.97 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 128.982 2.913 . . . . 0.0 111.055 -173.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.4 mtt-85 -114.82 -7.04 12.66 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 126.601 1.96 . . . . 0.0 112.128 176.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m -123.09 135.29 54.33 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.519 0.728 . . . . 0.0 111.214 -171.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.7 tp -92.33 129.0 38.38 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.478 1.511 . . . . 0.0 110.513 -176.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -83.23 130.58 35.09 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.235 0.54 . . . . 0.0 110.001 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.1 t -122.9 129.37 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 120.783 -1.198 . . . . 0.0 108.539 172.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.3 -175.8 14.19 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.314 1.911 . . . . 0.0 111.086 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.8 t30 66.67 19.49 10.78 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.207 2.203 . . . . 0.0 113.458 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.507 ' HB3' HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -67.1 145.76 54.98 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 125.411 1.484 . . . . 0.0 111.083 -168.269 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.479 ' CD ' ' HB2' ' A' ' 83' ' ' TYR . 10.6 mt-10 -60.87 161.65 7.88 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 177.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -73.42 -32.15 64.25 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.563 1.145 . . . . 0.0 113.168 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? -100.14 15.9 25.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.975 2.11 . . . . 0.0 113.417 172.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.507 HG11 ' HB3' ' A' ' 24' ' ' LEU . 2.0 p -62.54 156.18 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.0 p -156.03 161.57 40.43 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.508 2.323 . . . . 0.0 110.953 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -55.79 -31.76 62.91 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.535 1.534 . . . . 0.0 111.797 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.45 -35.78 79.88 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.177 1.391 . . . . 0.0 113.157 175.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.3 tp -72.31 -39.23 68.38 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 122.616 1.198 . . . . 0.0 108.598 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.505 HD21 ' CD1' ' A' ' 24' ' ' LEU . 89.4 mt -65.15 -54.66 26.36 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.412 1.085 . . . . 0.0 112.644 173.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -56.33 -37.18 69.61 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.193 1.36 . . . . 0.0 110.189 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -73.9 -37.11 64.78 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tt -67.5 -43.7 80.25 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.337 1.426 . . . . 0.0 111.156 172.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -82.96 -9.81 59.1 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -46.83 -37.42 8.69 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.35 1.86 . . . . 0.0 112.701 164.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -73.0 -30.6 63.91 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.173 1.389 . . . . 0.0 110.908 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.409 ' HA ' HD12 ' A' ' 76' ' ' LEU . . . -85.08 -2.99 58.63 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -166.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.59 -167.05 12.21 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 126.754 2.121 . . . . 0.0 111.375 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -48.77 121.02 5.95 Favored 'Trans proline' 0 C--N 1.346 0.426 1 C-N-CA 126.484 4.789 . . . . 0.0 112.242 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.23 136.02 54.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 173.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.7 -46.92 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 123.558 0.743 . . . . 0.0 109.26 -172.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.84 158.91 36.06 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.059 2.544 . . . . 0.0 110.46 171.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.5 t -105.91 162.4 5.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 126.208 1.803 . . . . 0.0 110.742 171.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -136.72 121.32 18.39 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.337 1.855 . . . . 0.0 114.37 169.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.2 mm -107.29 120.41 47.81 Favored Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 126.267 1.827 . . . . 0.0 110.556 166.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -75.44 167.98 25.47 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 125.032 3.821 . . . . 0.0 113.036 165.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -160.91 105.12 1.35 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.307 1.843 . . . . 0.0 113.205 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -53.1 173.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 130.435 3.494 . . . . 0.0 114.31 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.58 -24.47 8.32 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 168.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -91.43 -0.43 57.63 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.458 1.503 . . . . 0.0 114.852 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.0 41.5 54.55 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.361 1.458 . . . . 0.0 113.459 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -116.25 136.99 23.15 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 124.753 1.221 . . . . 0.0 112.92 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -70.82 17.05 0.26 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.115 2.543 . . . . 0.0 115.644 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.19 20.61 3.49 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 120.627 -1.296 . . . . 0.0 113.899 175.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 62.28 33.83 16.31 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.356 1.862 . . . . 0.0 114.496 -172.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -153.79 165.13 36.98 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.318 -1.489 . . . . 0.0 110.447 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -159.14 178.38 10.09 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.007 2.123 . . . . 0.0 110.589 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -135.52 156.15 49.35 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.574 -1.329 . . . . 0.0 111.312 168.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.71 132.13 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.7 1.2 . . . . 0.0 109.57 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -88.18 139.42 30.52 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.254 -1.529 . . . . 0.0 110.006 176.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -151.79 167.63 27.65 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.219 1.008 . . . . 0.0 110.843 -160.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . 0.281 77.2 tttt -94.68 58.34 2.3 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.935 -1.103 . . . . 0.0 112.234 -157.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 53.76 42.62 31.74 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 122.3 1.048 . . . . 0.0 111.428 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -85.23 59.68 5.78 Favored 'General case' 0 CA--C 1.556 1.177 0 O-C-N 121.363 -0.836 . . . . 0.0 111.199 -171.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.2 m -81.67 -25.23 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 119.848 3.277 . . . . 0.0 119.848 -165.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -81.45 70.36 8.3 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.413 1.46 . . . . 0.0 109.043 171.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.8 t 73.52 119.14 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 128.513 2.725 . . . . 0.0 113.205 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -72.68 129.23 14.28 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 123.094 2.53 . . . . 0.0 108.441 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -60.63 -34.26 73.99 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -168.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.39 -34.57 64.47 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 117.148 -1.406 . . . . 0.0 114.166 173.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -59.68 -21.79 61.05 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 120.613 1.551 . . . . 0.0 112.563 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -104.38 -40.42 6.09 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 127.359 2.264 . . . . 0.0 113.093 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -66.93 -61.65 1.84 Allowed 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 123.527 0.731 . . . . 0.0 112.669 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.14 -85.13 0.2 Allowed 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.5 1.12 . . . . 0.0 108.565 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 26.81 76.85 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 125.66 1.584 . . . . 0.0 114.322 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 125.45 18.02 2.55 Favored Glycine 0 CA--C 1.549 2.166 0 N-CA-C 117.555 1.782 . . . . 0.0 117.555 177.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -129.13 156.44 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 127.848 2.459 . . . . 0.0 111.583 -171.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.409 ' HB2' ' OE2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -176.73 -176.8 0.74 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.095 0.958 . . . . 0.0 112.442 -170.325 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.3 mt -141.16 -11.69 0.95 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.425 1.89 . . . . 0.0 115.885 -177.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.479 ' HB2' ' CD ' ' A' ' 25' ' ' GLU . 19.8 m-85 -109.77 -48.38 3.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.65 2.38 . . . . 0.0 111.802 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 179.06 -39.23 0.08 OUTLIER Glycine 0 CA--C 1.542 1.74 0 C-N-CA 125.955 1.74 . . . . 0.0 114.411 171.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.421 ' HB2' ' HG3' ' A' ' 25' ' ' GLU . 2.2 mpt_? -98.91 113.6 64.69 Favored Pre-proline 0 N--CA 1.483 1.219 0 CA-C-N 121.379 2.59 . . . . 0.0 112.247 -168.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.25 134.17 47.42 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.801 2.334 . . . . 0.0 111.753 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.0 mm -63.04 127.27 22.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 O-C-N 121.457 -0.777 . . . . 0.0 109.523 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -109.83 110.52 21.53 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 124.989 1.315 . . . . 0.0 110.02 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -86.33 136.74 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 120.324 -1.485 . . . . 0.0 109.668 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -134.44 146.7 50.06 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.355 1.462 . . . . 0.0 111.632 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -162.13 168.26 22.85 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 113.771 -1.559 . . . . 0.0 113.708 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.54 -47.85 1.17 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 127.597 2.359 . . . . 0.0 115.976 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.7 m 58.76 69.19 0.75 Allowed 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 -177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 170.17 115.51 0.34 Allowed Glycine 0 CA--C 1.538 1.495 0 C-N-CA 126.07 1.795 . . . . 0.0 115.891 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.5 m -137.67 49.09 1.99 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.543 1.537 . . . . 0.0 107.938 163.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 51.7 p -150.41 139.86 21.46 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.515 1.126 . . . . 0.0 110.734 -175.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -63.64 -34.84 78.73 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.32 1.048 . . . . 0.0 111.583 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -158.76 153.72 21.43 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.838 1.255 . . . . 0.0 111.34 171.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -54.53 165.26 2.48 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.646 2.231 . . . . 0.0 114.531 170.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -81.61 -60.11 2.37 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 113.894 -1.503 . . . . 0.0 112.013 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.1 t70 . . . . . 0 C--O 1.256 1.437 0 C-N-CA 126.007 1.723 . . . . 0.0 112.357 -164.269 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.407 ' HA3' ' OE2' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.539 1.574 0 CA-C-O 121.448 0.471 . . . . 0.0 112.419 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -139.41 34.34 2.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 119.493 -2.181 . . . . 0.0 111.668 165.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.407 ' OE2' ' HA3' ' A' ' 1' ' ' GLY . 9.8 mp0 -86.96 104.36 16.21 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -162.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -130.11 -40.61 1.31 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.197 1.799 . . . . 0.0 113.12 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -85.53 10.27 13.55 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.962 1.705 . . . . 0.0 114.359 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.46 133.3 35.38 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.075 -1.016 . . . . 0.0 112.736 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.81 139.56 45.21 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.956 2.503 . . . . 0.0 110.774 170.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -139.6 -173.78 3.71 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 129.449 3.1 . . . . 0.0 108.072 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -111.15 167.35 10.34 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.084 -1.01 . . . . 0.0 111.64 160.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -74.51 -12.65 60.54 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.68 178.85 2.98 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.146 1.379 . . . . 0.0 110.636 -167.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 pp -126.43 145.94 50.28 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.817 1.647 . . . . 0.0 113.189 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.42 170.97 7.64 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 125.455 1.502 . . . . 0.0 114.127 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -146.45 159.67 43.1 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.3 156.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.89 142.15 54.12 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.215 2.206 . . . . 0.0 113.364 -172.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -160.64 143.37 13.02 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.626 1.971 . . . . 0.0 108.341 170.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -94.45 -13.18 26.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 127.71 2.404 . . . . 0.0 116.463 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 m -112.76 168.67 9.49 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.953 1.301 . . . . 0.0 109.907 -176.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.3 tp -131.28 131.01 43.54 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.797 2.439 . . . . 0.0 109.71 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -80.25 138.77 36.85 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.842 1.656 . . . . 0.0 112.226 167.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.48 128.58 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.834 1.253 . . . . 0.0 108.558 173.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.83 -170.84 13.62 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.556 1.55 . . . . 0.0 111.92 168.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.0 t30 66.44 19.37 10.93 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.92 2.088 . . . . 0.0 113.649 -175.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.512 ' CD1' HD21 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -63.35 135.69 57.16 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 125.358 1.463 . . . . 0.0 112.02 -174.488 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 2.0 mt-10 -55.88 152.98 9.15 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 174.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.0 p -68.24 -14.46 63.0 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.532 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -112.0 11.01 20.53 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.998 2.119 . . . . 0.0 111.566 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 24' ' ' LEU . 4.9 p -66.76 159.72 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 119.919 -1.738 . . . . 0.0 114.764 -172.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.4 p -155.38 170.59 21.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.255 1.422 . . . . 0.0 111.32 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -63.87 -28.29 69.74 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.501 -0.749 . . . . 0.0 110.611 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -64.81 -48.32 74.84 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.906 0.883 . . . . 0.0 109.699 174.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.8 tp -65.19 -38.03 89.18 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.209 0.459 . . . . 0.0 111.593 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.512 HD21 ' CD1' ' A' ' 24' ' ' LEU . 94.0 mt -67.72 -48.57 66.14 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.428 -1.42 . . . . 0.0 111.864 175.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -62.07 -44.9 95.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.722 -1.237 . . . . 0.0 113.0 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -68.73 -25.05 64.56 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.783 0.433 . . . . 0.0 111.162 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.0 tt -78.72 -46.57 18.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.838 1.255 . . . . 0.0 108.272 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -74.89 -5.81 45.69 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.784 -1.197 . . . . 0.0 113.274 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -58.8 -32.0 68.94 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.935 1.698 . . . . 0.0 111.277 171.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -72.35 -31.0 65.25 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.292 1.437 . . . . 0.0 111.426 176.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.03 3.29 39.33 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -171.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.77 -156.16 15.74 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.936 1.731 . . . . 0.0 114.885 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -85.05 90.75 0.76 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.148 1.899 . . . . 0.0 112.135 -167.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.68 134.65 29.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 112.709 -2.041 . . . . 0.0 106.993 168.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.426 HD12 ' OD1' ' A' ' 63' ' ' ASN . 44.1 mt -83.71 -63.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 165.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.495 ' HG2' ' HB3' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -155.18 147.13 23.49 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.878 1.271 . . . . 0.0 113.011 -164.512 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.5 t -108.77 145.14 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.312 2.245 . . . . 0.0 112.969 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -122.0 124.19 43.42 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 126.24 1.816 . . . . 0.0 113.01 170.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.434 HG23 ' HB3' ' A' ' 56' ' ' PRO . 2.5 mm -107.42 121.5 44.21 Favored Pre-proline 0 C--O 1.243 0.719 0 C-N-CA 125.952 1.701 . . . . 0.0 108.509 163.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 71.7 Cg_endo -72.2 162.25 42.22 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.269 2.646 . . . . 0.0 109.718 165.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -147.36 116.09 6.76 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.143 1.777 . . . . 0.0 107.632 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -54.48 171.99 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.568 2.347 . . . . 0.0 109.665 165.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.16 -34.17 55.71 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.952 0.901 . . . . 0.0 112.938 172.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -75.4 -9.31 58.45 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 128.123 2.569 . . . . 0.0 113.889 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.32 38.72 12.19 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.555 1.55 . . . . 0.0 111.4 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -125.47 135.27 26.7 Favored Pre-proline 0 N--CA 1.473 0.707 0 O-C-N 121.613 -0.933 . . . . 0.0 112.052 -172.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.434 ' HB3' HG23 ' A' ' 48' ' ' ILE . 58.6 Cg_endo -71.76 12.65 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.928 3.085 . . . . 0.0 116.782 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.486 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 61.0 25.11 15.17 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 173.323 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 24' ' ' LEU 0.25 6.0 mt-30 56.43 30.47 17.07 Favored 'General case' 0 CA--C 1.573 1.854 0 O-C-N 120.922 -1.111 . . . . 0.0 113.306 -171.411 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.486 ' CD2' ' HB2' ' A' ' 57' ' ' LYS . 3.6 p90 -150.08 155.42 39.83 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 128.24 2.616 . . . . 0.0 115.264 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -155.88 175.08 14.41 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 127.64 2.376 . . . . 0.0 112.552 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -140.08 141.8 36.15 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 120.568 -1.333 . . . . 0.0 114.503 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.9 t -131.33 130.02 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 120.555 -1.341 . . . . 0.0 111.116 -172.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.495 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 4.6 t-20 -89.09 140.75 29.13 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.944 1.698 . . . . 0.0 112.776 177.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -125.38 155.56 40.15 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.725 1.61 . . . . 0.0 110.552 -175.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -62.48 -42.76 99.71 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.83 0.852 . . . . 0.0 111.12 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -92.54 135.77 33.78 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 122.301 1.048 . . . . 0.0 111.862 -172.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -97.16 4.06 51.32 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.92 1.288 . . . . 0.0 112.543 -165.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.8 m -85.34 32.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 127.011 2.124 . . . . 0.0 115.251 -176.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.0 p 40.84 44.32 1.9 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.959 1.304 . . . . 0.0 113.282 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -85.85 119.4 71.88 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 127.322 2.249 . . . . 0.0 109.228 -174.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -106.75 57.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.648 3.565 . . . . 0.0 112.795 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -56.55 -42.41 78.47 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.118 -0.989 . . . . 0.0 111.474 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.84 -35.38 66.36 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.9 ttp -59.07 -8.63 1.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 126.89 2.076 . . . . 0.0 115.998 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -114.86 -32.54 5.75 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.491 1.517 . . . . 0.0 110.617 165.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.26 -56.85 5.2 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -98.29 -92.39 0.25 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.853 1.661 . . . . 0.0 110.115 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 32.89 69.92 0.11 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.27 1.428 . . . . 0.0 112.002 175.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.5 19.42 1.07 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 121.297 -0.877 . . . . 0.0 114.12 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -131.74 157.85 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.64 0.776 . . . . 0.0 109.36 -176.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.81 -179.25 7.42 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.5 tp -107.83 -47.44 3.59 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.849 1.26 . . . . 0.0 110.586 167.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.495 ' HB2' ' CD ' ' A' ' 25' ' ' GLU . 78.4 m-85 -95.09 -42.27 8.69 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.187 1.795 . . . . 0.0 113.9 -162.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.99 -23.46 0.32 Allowed Glycine 0 CA--C 1.55 2.276 0 C-N-CA 126.436 1.97 . . . . 0.0 116.766 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.498 ' HB2' ' HG3' ' A' ' 25' ' ' GLU . 2.5 mpt_? -103.7 109.35 61.93 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-N 121.991 2.895 . . . . 0.0 112.524 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.27 125.77 12.82 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.323 2.016 . . . . 0.0 114.615 -173.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.9 mm -54.07 124.61 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 124.795 1.238 . . . . 0.0 109.988 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -114.68 110.23 19.44 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.596 1.189 . . . . 0.0 111.178 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -83.73 148.03 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.792 174.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -128.09 160.81 30.85 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.075 1.35 . . . . 0.0 113.31 168.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -111.7 161.02 16.72 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.94 1.296 . . . . 0.0 112.172 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -104.95 138.89 40.47 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.371 1.868 . . . . 0.0 110.123 165.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.3 p -94.42 30.28 2.01 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 119.825 -1.797 . . . . 0.0 112.954 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.3 -177.92 53.96 Favored Glycine 0 CA--C 1.536 1.392 0 O-C-N 120.891 -1.131 . . . . 0.0 112.008 -163.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.6 t -117.4 157.95 25.3 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.3 m -140.15 102.34 4.35 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 128.298 2.639 . . . . 0.0 110.766 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -126.47 174.09 8.9 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.416 1.486 . . . . 0.0 111.546 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.84 164.54 56.78 Favored Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 124.491 1.116 . . . . 0.0 111.12 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -67.96 177.32 4.4 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.5 1.467 . . . . 0.0 112.148 157.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -135.29 -7.36 2.27 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.9 t70 . . . . . 0 C--O 1.256 1.425 0 C-N-CA 127.488 2.315 . . . . 0.0 110.112 169.648 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.659 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.7 m -137.77 34.64 2.42 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -164.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 68.16 135.2 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.722 2.409 . . . . 0.0 113.604 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -84.53 -33.72 23.44 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 119.821 -1.8 . . . . 0.0 109.706 164.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -107.33 46.39 0.94 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.663 1.585 . . . . 0.0 112.16 -173.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.77 138.2 58.38 Favored 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.756 -1.215 . . . . 0.0 111.504 -174.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -48.29 136.16 12.62 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.032 -1.668 . . . . 0.0 111.645 163.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -73.23 178.25 4.59 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.69 2.396 . . . . 0.0 112.068 -171.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -136.15 -21.11 1.42 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 165.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -70.84 11.4 0.39 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -172.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -157.91 -171.44 3.53 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 127.166 2.187 . . . . 0.0 112.018 -175.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.2 mt -45.98 145.04 1.62 Allowed 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 164.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.34 -31.83 71.52 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . 0.263 2.8 tp10 40.91 49.52 2.95 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 128.156 2.583 . . . . 0.0 116.853 -165.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.79 154.14 40.78 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 117.319 2.341 . . . . 0.0 117.319 -173.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -123.87 133.75 53.7 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.342 1.857 . . . . 0.0 108.986 170.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.8 mtm180 -65.84 -15.85 63.28 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -167.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m -67.39 130.41 42.99 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.068 1.347 . . . . 0.0 112.822 -176.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.9 tp -83.08 128.19 34.26 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.414 2.285 . . . . 0.0 108.705 -169.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -77.45 138.77 39.44 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.123 0.963 . . . . 0.0 110.936 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.0 t -134.15 124.05 45.18 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.71 -171.33 13.33 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 173.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.5 t30 60.92 41.47 14.24 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 123.089 1.423 . . . . 0.0 111.588 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.546 HD12 HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -86.94 148.65 25.24 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.698 1.599 . . . . 0.0 110.779 178.532 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 162.85 26.84 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 125.656 2.646 . . . . 0.0 116.89 170.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.6 p -69.45 -29.01 66.61 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 127.879 2.471 . . . . 0.0 109.445 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.612 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 8.5 mmpt? -103.42 15.93 27.8 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 128.129 2.571 . . . . 0.0 114.163 176.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.546 HG11 HD12 ' A' ' 24' ' ' LEU . 3.9 p -71.0 157.27 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 120.841 -1.162 . . . . 0.0 112.04 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.2 p -156.56 166.76 32.46 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.51 1.124 . . . . 0.0 110.546 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -60.75 -27.9 68.29 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.321 -0.862 . . . . 0.0 109.957 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -61.01 -35.1 75.95 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.065 2.546 . . . . 0.0 112.536 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.421 HD23 HG23 ' A' ' 28' ' ' VAL . 16.0 tp -79.52 -39.94 30.77 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.703 0.763 . . . . 0.0 110.732 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.3 mt -65.39 -45.9 82.19 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.187 -0.945 . . . . 0.0 112.917 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -58.65 -34.13 70.86 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.294 1.038 . . . . 0.0 112.036 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -88.6 -28.23 20.82 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.25 0.62 . . . . 0.0 112.5 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.423 HD13 HG13 ' A' ' 87' ' ' ILE . 2.5 tt -70.19 -41.17 74.07 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.356 -0.84 . . . . 0.0 111.176 176.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -81.54 21.42 0.8 Allowed 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 120.376 1.444 . . . . 0.0 112.773 -173.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.06 -9.07 59.44 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 117.576 2.436 . . . . 0.0 117.576 -156.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -116.55 7.2 13.62 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 125.581 1.552 . . . . 0.0 113.163 163.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.6 31.4 0.76 Allowed 'General case' 0 CA--C 1.55 0.956 0 O-C-N 119.871 -1.768 . . . . 0.0 115.041 -167.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.97 136.19 3.53 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 107.545 -2.222 . . . . 0.0 107.545 -163.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.68 101.55 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.715 1 C-N-CA 125.307 4.005 . . . . 0.0 114.187 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.53 133.17 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.535 1.134 . . . . 0.0 110.118 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.1 mt -87.33 -47.86 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.174 1.39 . . . . 0.0 108.948 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.33 161.77 16.79 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 126.929 2.092 . . . . 0.0 111.104 -173.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.3 t -116.53 149.24 18.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 127.663 2.385 . . . . 0.0 111.808 173.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -120.66 122.77 41.2 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.693 1.197 . . . . 0.0 113.741 166.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.431 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 3.6 mm -101.24 121.47 51.73 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 124.073 0.949 . . . . 0.0 110.208 165.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 52.1 Cg_endo -66.77 165.98 23.92 Favored 'Trans proline' 0 CA--C 1.55 1.291 1 C-N-CA 125.341 4.028 . . . . 0.0 110.12 164.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -156.35 112.25 3.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.198 1.799 . . . . 0.0 109.893 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -57.25 172.64 0.29 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.267 2.227 . . . . 0.0 113.149 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.51 -37.76 5.66 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.594 -0.691 . . . . 0.0 112.752 171.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -76.72 -13.41 60.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.444 2.698 . . . . 0.0 116.28 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.32 30.79 11.54 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.981 2.229 . . . . 0.0 114.818 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.32 141.22 31.46 Favored Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 119.801 1.801 . . . . 0.0 114.28 -174.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.04 8.07 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.599 2.866 . . . . 0.0 116.401 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.13 32.79 20.78 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 120.418 -1.426 . . . . 0.0 112.716 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 56.93 30.32 17.83 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.409 ' HA ' HD23 ' A' ' 24' ' ' LEU . 2.0 p90 -151.29 165.01 35.31 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.009 -1.682 . . . . 0.0 111.097 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -155.46 -175.3 5.36 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 127.333 2.253 . . . . 0.0 111.254 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -138.08 160.7 38.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.738 1.615 . . . . 0.0 112.444 170.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.6 t -147.16 127.77 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 122.344 1.068 . . . . 0.0 113.726 -175.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -95.14 130.18 41.96 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.46 1.104 . . . . 0.0 109.582 171.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -149.21 171.26 16.76 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.458 1.903 . . . . 0.0 113.907 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -127.22 154.07 45.29 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.069 1.348 . . . . 0.0 111.749 166.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.445 ' CG ' ' H ' ' A' ' 67' ' ' GLU . 54.6 t-80 -158.07 174.64 14.92 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.014 1.726 . . . . 0.0 110.541 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.445 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 10.3 mt-10 -71.23 -16.6 62.51 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.459 1.504 . . . . 0.0 112.788 -172.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.406 HG12 HG13 ' A' ' 70' ' ' VAL . 60.9 t -142.71 152.99 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 130.51 3.524 . . . . 0.0 106.274 178.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.1 m -78.16 54.03 1.3 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.101 1.361 . . . . 0.0 111.86 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.406 HG13 HG12 ' A' ' 68' ' ' VAL . 1.3 m -105.79 146.32 32.62 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 124.561 1.144 . . . . 0.0 111.983 -172.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -78.05 76.78 4.21 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.387 2.058 . . . . 0.0 109.835 174.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -58.15 -42.59 86.24 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.133 -0.98 . . . . 0.0 112.921 -170.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.15 -29.79 70.59 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.939 -1.029 . . . . 0.0 113.767 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.5 ttp -58.36 -20.47 43.92 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.701 1.137 . . . . 0.0 112.289 176.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -103.34 -35.63 8.33 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 170.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.29 -34.18 72.45 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 120.003 1.274 . . . . 0.0 114.221 -175.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.0 mt -120.64 -92.75 0.53 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 128.727 2.811 . . . . 0.0 110.406 -170.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.436 ' OD1' ' HD2' ' A' ' 88' ' ' LYS . 1.5 t30 26.24 74.75 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 128.496 2.719 . . . . 0.0 115.449 175.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 135.48 16.97 0.88 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-N 113.775 -1.557 . . . . 0.0 112.87 -176.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -132.84 152.24 35.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 118.557 1.178 . . . . 0.0 111.827 -169.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.31 -173.23 1.21 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.976 2.51 . . . . 0.0 110.507 -167.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.5 tp -143.33 -39.05 0.32 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.392 1.477 . . . . 0.0 108.767 160.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -55.13 -57.13 13.0 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.224 1.01 . . . . 0.0 112.034 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.64 -46.54 0.23 Allowed Glycine 0 N--CA 1.48 1.62 0 N-CA-C 117.58 1.792 . . . . 0.0 117.58 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -95.13 117.61 66.72 Favored Pre-proline 0 C--O 1.238 0.467 0 CA-C-N 118.272 1.036 . . . . 0.0 108.244 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -71.06 128.75 15.24 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.849 1.699 . . . . 0.0 112.47 -174.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.423 HG13 HD13 ' A' ' 36' ' ' LEU . 12.1 mm -53.13 126.93 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 C-N-CA 123.481 0.712 . . . . 0.0 109.667 174.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.436 ' HD2' ' OD1' ' A' ' 78' ' ' ASN . 10.1 tptm -117.8 115.82 25.76 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.491 1.516 . . . . 0.0 110.058 177.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -87.49 141.05 14.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -125.67 167.11 15.57 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.163 0.985 . . . . 0.0 109.946 172.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -156.63 157.14 34.72 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -166.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -140.54 126.09 19.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.743 1.217 . . . . 0.0 112.188 169.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 86.9 p -95.97 155.78 16.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.475 1.11 . . . . 0.0 111.516 -170.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.09 174.98 34.67 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.704 1.145 . . . . 0.0 111.8 170.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.2 m -93.32 52.54 1.78 Allowed 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.625 -0.926 . . . . 0.0 111.418 -172.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 35.3 m -97.78 145.47 26.35 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -156.41 170.94 21.16 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.224 1.81 . . . . 0.0 111.013 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -149.81 159.53 35.7 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.46 1.504 . . . . 0.0 110.341 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -84.42 172.36 9.37 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 124.429 3.419 . . . . 0.0 113.803 171.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -68.16 -46.55 70.42 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.227 1.411 . . . . 0.0 109.797 167.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 C--O 1.257 1.499 0 C-N-CA 128.388 2.675 . . . . 0.0 109.08 176.889 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.3 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -91.29 151.22 20.98 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.48 151.75 24.41 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.146 -0.971 . . . . 0.0 111.524 -164.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -142.1 -37.44 0.4 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.716 1.206 . . . . 0.0 112.233 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -93.6 2.27 56.42 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 126.599 1.959 . . . . 0.0 115.965 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.33 161.2 30.85 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.523 1.529 . . . . 0.0 112.938 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.35 149.89 28.69 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.649 1.18 . . . . 0.0 113.117 156.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.6 ttt85 -140.23 51.63 1.68 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 128.097 2.559 . . . . 0.0 110.889 175.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -75.36 173.04 11.44 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.072 1.349 . . . . 0.0 114.185 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -111.87 -27.51 8.43 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 117.029 2.233 . . . . 0.0 117.029 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.86 -176.86 4.79 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 126.349 1.86 . . . . 0.0 112.733 -166.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.4 mt -50.89 147.86 4.64 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.266 -0.896 . . . . 0.0 110.45 163.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.4 112.05 23.83 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 176.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -141.8 154.18 45.04 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.025 1.73 . . . . 0.0 108.84 -170.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -113.67 156.04 24.45 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 120.496 1.498 . . . . 0.0 114.739 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -161.5 -170.1 2.5 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 129.162 2.985 . . . . 0.0 107.145 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.8 ptt-85 -55.36 -17.44 4.88 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.957 2.103 . . . . 0.0 116.411 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.1 m -92.48 151.24 20.31 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.693 1.597 . . . . 0.0 109.044 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.7 mp -108.47 129.62 55.27 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.258 2.223 . . . . 0.0 108.276 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -79.46 139.93 37.49 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.625 0.77 . . . . 0.0 109.341 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.3 t -130.6 133.07 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 172.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.85 -177.55 14.92 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.742 1.163 . . . . 0.0 110.625 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.5 t30 75.17 19.34 2.29 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.646 1.579 . . . . 0.0 112.815 -176.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.648 HD12 HG21 ' A' ' 28' ' ' VAL . 0.6 OUTLIER -65.17 147.66 53.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.436 -168.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 0.5 OUTLIER -66.61 157.36 32.63 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 125.953 2.787 . . . . 0.0 113.277 173.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 p -66.39 -18.51 65.4 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 129.424 3.09 . . . . 0.0 112.548 -174.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -128.23 19.67 6.38 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 131.454 3.902 . . . . 0.0 112.208 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.648 HG21 HD12 ' A' ' 24' ' ' LEU . 5.8 p -60.53 151.59 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 O-C-N 120.931 -1.106 . . . . 0.0 112.216 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.4 p -152.24 168.99 23.57 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.542 1.537 . . . . 0.0 110.635 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -66.94 -29.03 68.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.115 0.966 . . . . 0.0 109.637 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -56.93 -47.54 80.37 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.6 tp -70.72 -43.59 68.61 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.864 1.265 . . . . 0.0 113.142 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.92 -41.96 95.12 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.238 -0.914 . . . . 0.0 112.022 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -61.16 -47.34 86.65 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 118.744 0.702 . . . . 0.0 111.292 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -64.96 -33.9 77.15 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 119.683 1.129 . . . . 0.0 112.301 176.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.1 tt -72.68 -39.93 66.69 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.814 1.245 . . . . 0.0 113.223 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.447 ' CD2' HG21 ' A' ' 62' ' ' VAL . 50.0 m-85 -94.71 -19.77 20.11 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 -175.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -49.18 -36.69 20.34 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.05 1.74 . . . . 0.0 112.922 167.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -73.5 -15.79 61.31 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 174.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.63 -4.81 47.05 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.758 0.823 . . . . 0.0 112.668 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 138.3 -157.34 24.42 Favored Glycine 0 CA--C 1.545 1.94 0 C-N-CA 126.501 2.0 . . . . 0.0 113.966 168.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.01 93.32 0.96 Allowed 'Trans proline' 0 CA--C 1.551 1.334 0 C-N-CA 123.358 2.706 . . . . 0.0 113.452 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.1 m -81.65 137.61 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 122.712 1.244 . . . . 0.0 110.857 171.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.9 mm -99.16 -51.02 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 125.645 1.578 . . . . 0.0 111.749 -171.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.01 158.11 41.54 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.446 1.099 . . . . 0.0 108.494 176.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.5 t -124.06 147.85 28.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 125.668 1.587 . . . . 0.0 110.07 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -132.02 119.82 21.56 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 125.004 1.321 . . . . 0.0 112.851 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 mm -103.57 124.01 39.44 Favored Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 126.452 1.901 . . . . 0.0 107.719 165.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.99 170.38 19.06 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.788 2.326 . . . . 0.0 111.842 162.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -158.17 114.73 2.82 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 127.065 2.146 . . . . 0.0 111.347 172.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -58.68 169.66 0.92 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.014 -1.903 . . . . 0.0 109.868 170.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -32.47 69.62 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 120.961 -1.087 . . . . 0.0 113.573 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -64.81 -25.69 68.02 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.34 2.256 . . . . 0.0 113.017 171.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.78 39.37 2.54 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.093 1.33 . . . . 0.0 112.845 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 tppt? -133.58 130.64 20.96 Favored Pre-proline 0 C--N 1.35 0.619 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 -170.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.53 15.81 0.11 Allowed 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 125.136 3.89 . . . . 0.0 115.449 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.87 28.27 10.21 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 119.633 -1.917 . . . . 0.0 114.07 169.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 56.29 33.81 22.92 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.745 1.618 . . . . 0.0 115.137 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -153.42 161.83 41.89 Favored 'General case' 0 CA--C 1.555 1.146 0 O-C-N 120.75 -1.219 . . . . 0.0 112.927 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -158.88 173.45 16.49 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 126.665 1.986 . . . . 0.0 113.19 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -127.08 155.68 42.91 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.287 2.235 . . . . 0.0 112.056 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 37' ' ' PHE . 43.7 t -148.71 122.37 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.333 1.453 . . . . 0.0 109.144 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -86.98 120.79 28.62 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.718 1.207 . . . . 0.0 110.997 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -108.7 156.37 19.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.733 1.613 . . . . 0.0 111.422 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -54.88 137.07 46.21 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.928 1.691 . . . . 0.0 112.829 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -61.01 157.85 14.69 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -160.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 55.74 43.21 28.28 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.698 1.999 . . . . 0.0 113.844 -174.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 m -54.87 129.08 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.079 1.351 . . . . 0.0 111.522 163.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 m -88.9 -33.43 17.3 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.9 m -143.29 146.56 36.79 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 126.856 2.062 . . . . 0.0 112.371 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -73.08 97.06 0.89 Allowed 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 121.756 1.637 . . . . 0.0 111.289 169.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -51.63 -46.76 63.78 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 128.493 2.717 . . . . 0.0 114.019 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . . . -59.44 -21.78 60.53 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.4 ttt -67.79 -26.46 66.1 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.95 0.795 . . . . 0.0 111.297 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -81.7 -35.27 30.01 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.521 -0.737 . . . . 0.0 111.908 167.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.453 ' HG ' HD13 ' A' ' 77' ' ' LEU . 43.2 tp -81.28 -53.43 6.35 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -163.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.453 HD13 ' HG ' ' A' ' 76' ' ' LEU . 1.2 mm? -97.13 -83.6 0.39 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 125.611 1.564 . . . . 0.0 110.479 -174.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 24.19 66.41 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 128.422 2.689 . . . . 0.0 116.243 173.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.04 20.26 0.94 Allowed Glycine 0 CA--C 1.538 1.492 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.908 -173.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.59 152.02 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-N 118.721 1.26 . . . . 0.0 112.576 -171.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.6 172.89 4.85 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.337 2.255 . . . . 0.0 110.185 -176.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.27 -45.0 2.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.314 1.446 . . . . 0.0 110.236 166.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -61.39 -51.57 68.22 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.569 1.148 . . . . 0.0 113.679 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.6 -63.29 0.18 Allowed Glycine 0 N--CA 1.477 1.423 0 N-CA-C 117.222 1.649 . . . . 0.0 117.222 -168.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.422 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 7.3 mpt_? -88.2 123.96 67.53 Favored Pre-proline 0 N--CA 1.478 0.929 0 CA-C-N 119.75 1.775 . . . . 0.0 110.642 -175.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -76.23 134.22 15.61 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.054 2.503 . . . . 0.0 115.734 -174.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 87' ' ' ILE . 4.1 mm -64.06 123.06 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.647 0.737 . . . . 0.0 109.912 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -110.06 117.2 33.12 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 113.779 -1.555 . . . . 0.0 108.923 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 mp -78.78 149.32 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 172.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -140.28 147.33 39.79 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.605 1.962 . . . . 0.0 110.146 176.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -165.19 139.78 5.01 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.376 -0.828 . . . . 0.0 112.059 -173.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -89.54 133.62 34.5 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.499 1.52 . . . . 0.0 109.44 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.3 p -68.8 165.09 20.41 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 175.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.87 -169.44 38.15 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 115.123 0.809 . . . . 0.0 115.123 170.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.5 t -154.41 161.46 41.7 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.175 1.39 . . . . 0.0 111.694 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 39.4 m -106.57 179.97 4.11 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.798 1.239 . . . . 0.0 110.153 168.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -104.94 166.23 10.52 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -165.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -147.33 146.16 24.24 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 120.535 -1.353 . . . . 0.0 113.503 -169.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.21 150.44 76.76 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.127 1.885 . . . . 0.0 114.221 -169.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.3 mm-40 -81.93 -49.82 9.87 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.821 0.82 . . . . 0.0 110.432 174.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.5 p30 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 129.751 3.22 . . . . 0.0 112.561 177.882 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.453 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.7 p -152.55 164.79 36.93 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.374 1.07 . . . . 0.0 110.281 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -77.47 154.01 32.96 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -97.06 -44.7 6.87 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 113.71 -1.587 . . . . 0.0 111.369 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -120.28 119.1 32.19 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 171.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mt -141.43 151.11 43.14 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.405 1.082 . . . . 0.0 113.759 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -87.61 130.81 34.64 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.181 1.392 . . . . 0.0 113.497 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -99.98 2.85 43.91 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 128.675 2.79 . . . . 0.0 114.755 167.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -78.23 -78.05 0.15 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.798 1.636 . . . . 0.0 110.112 169.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 52.03 -30.76 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.958 1 C-N-CA 132.883 4.473 . . . . 0.0 120.091 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.35 -171.88 3.49 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.23 2.612 . . . . 0.0 110.609 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.7 mt -71.55 174.46 6.65 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.998 1.719 . . . . 0.0 115.035 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.9 159.16 43.87 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.431 1.892 . . . . 0.0 111.396 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -139.76 144.94 37.68 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 120.687 -1.258 . . . . 0.0 110.193 167.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -121.2 160.43 23.83 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -170.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 55.07 58.07 5.05 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.858 1.663 . . . . 0.0 113.02 171.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 -82.96 23.41 0.84 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -173.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.1 m -139.56 142.92 37.16 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.594 1.158 . . . . 0.0 108.871 -169.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.8 tp -113.53 130.0 56.44 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.325 1.45 . . . . 0.0 110.436 -160.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -78.09 138.58 38.83 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.1 t -138.21 123.79 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 121.026 -1.047 . . . . 0.0 110.038 174.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.84 -170.34 15.05 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.616 2.055 . . . . 0.0 111.35 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.1 t30 58.23 35.8 25.25 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.446 1.499 . . . . 0.0 112.293 -176.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.587 HD12 HG21 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -68.13 163.19 23.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.364 1.078 . . . . 0.0 110.236 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 26' ' ' THR . 0.5 OUTLIER -86.34 170.27 12.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.087 171.687 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.415 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 43.5 p -83.48 -14.17 53.02 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.971 2.108 . . . . 0.0 113.646 -175.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 8.8 mmpt? -111.96 17.03 20.05 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 128.261 2.624 . . . . 0.0 112.33 177.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.587 HG21 HD12 ' A' ' 24' ' ' LEU . 3.7 p -72.18 153.03 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -173.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.3 p -155.71 160.83 40.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.45 1.9 . . . . 0.0 111.753 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -58.45 -20.05 41.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.956 0.902 . . . . 0.0 113.157 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -76.19 -34.54 59.3 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.597 1.159 . . . . 0.0 113.455 174.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.26 -48.44 70.48 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.854 0.862 . . . . 0.0 109.789 168.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.499 ' HB2' HG11 ' A' ' 46' ' ' VAL . 87.6 mt -59.89 -43.83 94.57 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.98 0.912 . . . . 0.0 111.113 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -65.45 -43.94 88.81 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 119.503 1.047 . . . . 0.0 110.723 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -61.11 -33.3 73.15 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.006 1.323 . . . . 0.0 113.344 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.493 HD13 HG13 ' A' ' 87' ' ' ILE . 3.7 tt -82.55 -42.46 18.33 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.844 2.057 . . . . 0.0 113.564 174.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.4 ' CD2' HG21 ' A' ' 62' ' ' VAL . 69.7 m-85 -84.87 -12.45 53.48 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.365 -1.459 . . . . 0.0 113.776 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -54.36 -36.65 64.07 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 121.309 1.868 . . . . 0.0 112.393 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -83.94 -0.31 50.91 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 173.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.42 14.68 14.02 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.915 1.286 . . . . 0.0 112.375 169.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.35 -157.45 23.19 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.459 1.504 . . . . 0.0 112.593 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.4 77.31 4.14 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.314 2.676 . . . . 0.0 112.643 -163.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.43 142.82 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 122.263 1.03 . . . . 0.0 108.527 167.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.0 mm -86.67 -51.83 12.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 124.951 1.3 . . . . 0.0 109.2 175.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -165.21 165.68 19.49 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.288 1.835 . . . . 0.0 111.696 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.499 HG11 ' HB2' ' A' ' 33' ' ' LEU . 74.4 t -119.65 150.9 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 125.66 1.584 . . . . 0.0 112.11 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.481 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 49.0 tptt -115.93 125.31 52.39 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 127.19 2.196 . . . . 0.0 114.131 165.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.6 mm -101.4 126.46 34.42 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 127.532 2.333 . . . . 0.0 111.64 158.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 60' ' ' ALA . 61.2 Cg_endo -77.74 172.2 16.13 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 125.294 3.996 . . . . 0.0 112.358 163.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.428 ' C ' ' HE3' ' A' ' 57' ' ' LYS . 25.9 mttt -161.06 122.61 2.96 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.755 2.022 . . . . 0.0 111.427 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.44 166.9 2.82 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.254 2.222 . . . . 0.0 112.882 170.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.86 -44.46 29.28 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.769 0.828 . . . . 0.0 111.257 166.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.43 -29.91 70.65 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.05 -1.031 . . . . 0.0 111.143 174.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.53 45.78 1.19 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.679 1.133 . . . . 0.0 114.782 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -129.64 141.11 40.7 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-N 119.924 1.862 . . . . 0.0 111.888 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.52 10.04 0.29 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.227 3.285 . . . . 0.0 117.285 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.428 ' HE3' ' C ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER 59.39 25.15 13.82 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 173.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.486 ' HA ' ' HB2' ' A' ' 24' ' ' LEU 0.283 35.6 mt-30 63.77 30.49 14.6 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.055 2.542 . . . . 0.0 114.688 -172.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -153.14 168.91 24.37 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 126.045 1.738 . . . . 0.0 111.747 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 47' ' ' LYS . . . -166.79 -174.06 2.62 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 130.51 3.524 . . . . 0.0 108.909 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -137.93 164.02 30.06 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 124.665 1.186 . . . . 0.0 112.287 169.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.4 HG21 ' CD2' ' A' ' 37' ' ' PHE . 34.7 t -139.98 139.19 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 125.577 1.551 . . . . 0.0 114.001 174.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -95.91 144.85 25.88 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.074 1.75 . . . . 0.0 114.989 -173.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -135.58 163.78 29.34 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.215 2.206 . . . . 0.0 109.548 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -88.02 62.01 6.62 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 129.922 3.289 . . . . 0.0 109.591 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 11.5 m80 56.38 29.84 15.88 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.523 1.529 . . . . 0.0 113.585 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . 0.286 13.2 pt-20 -123.94 36.07 4.7 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.181 1.392 . . . . 0.0 114.047 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 m -59.27 -16.93 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 168.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.7 t -65.98 139.67 58.24 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.714 1.606 . . . . 0.0 112.619 173.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.6 t 36.65 66.67 1.91 Allowed Pre-proline 0 N--CA 1.488 1.431 0 C-N-CA 126.063 1.745 . . . . 0.0 109.714 -165.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.95 121.31 9.84 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.02 2.48 . . . . 0.0 110.996 -173.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -58.9 -44.05 91.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.03 0.919 . . . . 0.0 111.245 -165.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.69 -27.53 68.76 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.152 1.381 . . . . 0.0 113.682 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -62.72 -22.52 66.58 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.79 1.236 . . . . 0.0 111.782 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -95.91 -38.91 10.06 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 163.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.87 -49.63 19.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 120.654 1.57 . . . . 0.0 114.658 -165.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -98.31 -94.58 0.23 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.733 1.213 . . . . 0.0 109.133 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 21.84 79.35 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 128.115 2.566 . . . . 0.0 115.097 -169.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.82 26.33 1.58 Allowed Glycine 0 N--CA 1.476 1.33 0 C-N-CA 125.223 1.392 . . . . 0.0 113.984 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -128.07 144.66 37.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-N 117.874 0.837 . . . . 0.0 109.405 -171.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.98 177.45 10.34 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 177.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.5 tp -136.31 -44.35 0.62 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 130.834 3.654 . . . . 0.0 108.508 171.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -65.97 -52.72 47.11 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.351 1.86 . . . . 0.0 111.942 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 160.86 -38.71 0.43 Allowed Glycine 0 N--CA 1.477 1.375 0 N-CA-C 115.64 1.016 . . . . 0.0 115.64 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -100.3 115.93 64.95 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 125.728 1.611 . . . . 0.0 108.97 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.62 137.11 29.58 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.472 2.781 . . . . 0.0 113.204 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.493 HG13 HD13 ' A' ' 36' ' ' LEU . 4.7 mm -67.56 125.32 24.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 123.502 0.721 . . . . 0.0 111.106 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -113.79 107.21 15.42 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.432 1.893 . . . . 0.0 112.041 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.79 140.23 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.387 1.075 . . . . 0.0 111.316 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -141.68 179.98 6.51 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.53 2.332 . . . . 0.0 111.139 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -147.14 158.57 43.99 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.688 165.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -139.91 145.8 38.43 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.975 1.71 . . . . 0.0 109.046 161.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.8 m -102.24 157.66 16.74 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.118 1.367 . . . . 0.0 111.331 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.7 -175.27 49.43 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 122.646 1.137 . . . . 0.0 114.996 168.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.4 m -69.01 153.3 44.03 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.802 2.041 . . . . 0.0 112.62 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.1 t -144.58 143.22 30.69 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.957 2.503 . . . . 0.0 108.202 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.5 m170 54.63 46.28 25.08 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.568 1.947 . . . . 0.0 112.81 -165.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.72 164.27 40.5 Favored Pre-proline 0 CA--C 1.553 1.083 0 O-C-N 119.885 -1.759 . . . . 0.0 111.869 171.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -84.49 135.96 6.26 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 125.229 3.953 . . . . 0.0 115.729 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -71.68 -30.4 65.65 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 C--O 1.26 1.607 0 C-N-CA 130.354 3.462 . . . . 0.0 110.267 175.598 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.532 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -92.31 -19.69 21.88 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 118.839 2.903 . . . . 0.0 118.839 169.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -104.14 150.47 24.31 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 122.023 2.192 . . . . 0.0 110.657 175.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -138.16 -47.36 0.53 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.051 1.74 . . . . 0.0 112.129 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -103.76 -5.25 22.66 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 119.835 -1.79 . . . . 0.0 114.769 -167.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.09 130.68 39.68 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.289 1.835 . . . . 0.0 107.438 175.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.22 144.98 56.82 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.745 1.218 . . . . 0.0 108.533 170.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -62.98 -28.65 70.24 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.951 1.301 . . . . 0.0 113.995 -172.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -141.81 157.74 44.64 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.395 1.478 . . . . 0.0 112.437 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -56.48 -57.59 11.67 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -158.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.79 169.58 21.88 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 126.349 1.86 . . . . 0.0 108.457 170.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.3 mt -59.08 134.73 57.25 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 126.481 1.912 . . . . 0.0 112.766 -175.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.33 10.81 5.34 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.83 4.63 0.99 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.655 1.982 . . . . 0.0 115.84 -178.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.27 -22.4 21.62 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.564 1.146 . . . . 0.0 113.493 -168.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -115.19 151.21 34.84 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.75 1.62 . . . . 0.0 113.006 -177.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -135.99 -1.33 2.44 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.891 1.677 . . . . 0.0 111.817 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m -134.26 141.36 46.95 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.882 1.673 . . . . 0.0 111.594 -174.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.5 tp -109.18 133.92 52.39 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.103 1.761 . . . . 0.0 114.47 -171.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -80.46 133.66 35.88 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.568 0.699 . . . . 0.0 110.602 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -128.62 127.85 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 169.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.27 -174.1 14.79 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.83 1.205 . . . . 0.0 112.236 170.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.7 t30 64.04 26.12 13.96 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.373 1.469 . . . . 0.0 114.739 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.421 ' HB3' HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -61.87 164.96 5.77 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.519 1.528 . . . . 0.0 109.64 177.765 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.81 172.97 12.72 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.059 1.504 . . . . 0.0 115.059 176.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.2 p -71.76 -21.23 61.77 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.015 2.126 . . . . 0.0 110.381 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.04 30.6 5.62 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 127.431 2.292 . . . . 0.0 116.369 173.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.45 HG22 ' N ' ' A' ' 29' ' ' THR . 8.6 p -69.68 165.47 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 118.885 -2.385 . . . . 0.0 115.472 176.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.45 ' N ' HG22 ' A' ' 28' ' ' VAL . 11.4 p -154.63 173.53 16.24 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.682 1.193 . . . . 0.0 112.743 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -73.29 -26.92 61.28 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.135 0.974 . . . . 0.0 110.195 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.72 -45.82 92.31 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 171.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.44 HD12 HG23 ' A' ' 28' ' ' VAL . 2.8 tm? -65.78 -47.22 75.87 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.825 0.85 . . . . 0.0 110.579 -174.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.406 HD21 ' CD1' ' A' ' 24' ' ' LEU . 96.5 mt -56.89 -48.69 77.58 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.854 1.262 . . . . 0.0 111.112 173.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -59.35 -37.95 79.16 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.363 0.983 . . . . 0.0 112.26 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -75.45 -33.41 60.87 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.995 0.816 . . . . 0.0 110.345 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.443 HD11 HD11 ' A' ' 80' ' ' ILE . 4.2 tt -68.18 -39.82 82.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.113 1.765 . . . . 0.0 113.35 176.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.479 ' CE2' HG21 ' A' ' 62' ' ' VAL . 60.3 m-85 -85.5 -1.2 56.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 117.9 -1.047 . . . . 0.0 113.694 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -60.32 -41.48 93.59 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.802 1.637 . . . . 0.0 110.904 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -75.25 -14.71 60.54 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 172.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.03 -24.41 47.83 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 120.709 1.595 . . . . 0.0 110.14 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 154.12 -172.58 32.75 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 128.639 3.018 . . . . 0.0 114.412 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.73 79.66 2.69 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 124.853 3.702 . . . . 0.0 110.403 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.6 m -52.7 141.2 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.842 1.257 . . . . 0.0 113.365 172.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 80.3 mt -79.69 -59.68 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 126.8 2.04 . . . . 0.0 107.818 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.36 168.47 25.94 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.337 1.455 . . . . 0.0 113.282 174.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.5 t -116.65 157.19 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 126.662 1.985 . . . . 0.0 112.631 171.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -134.93 123.56 23.59 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.616 1.966 . . . . 0.0 113.75 169.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.413 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 3.4 mm -100.16 124.74 42.21 Favored Pre-proline 0 C--N 1.324 -0.512 0 C-N-CA 126.681 1.993 . . . . 0.0 108.612 167.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 50.3 Cg_endo -72.76 167.08 28.17 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.461 2.774 . . . . 0.0 111.583 161.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -158.77 114.83 2.66 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.857 2.463 . . . . 0.0 109.054 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.541 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 30.6 t70 -54.04 174.59 0.05 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.413 2.285 . . . . 0.0 112.545 170.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.68 -35.08 60.68 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.289 -1.507 . . . . 0.0 112.881 167.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -68.65 -13.76 62.57 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.944 2.498 . . . . 0.0 113.486 175.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.84 54.21 6.67 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -173.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -135.85 132.91 19.63 Favored Pre-proline 0 CA--C 1.517 -0.309 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.61 22.25 0.4 Allowed 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 124.276 3.318 . . . . 0.0 114.594 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.541 ' HE2' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER 51.47 26.95 3.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 119.727 -1.858 . . . . 0.0 115.612 168.175 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 52.02 35.11 15.3 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 127.185 2.194 . . . . 0.0 114.418 -170.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -150.8 157.91 43.51 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 120.001 -1.687 . . . . 0.0 112.224 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -153.91 174.86 14.06 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.247 1.819 . . . . 0.0 111.541 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -126.9 153.29 45.95 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 119.848 -1.783 . . . . 0.0 111.956 175.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.479 HG21 ' CE2' ' A' ' 37' ' ' PHE . 84.3 t -139.44 124.51 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.122 0.969 . . . . 0.0 112.692 -177.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -91.59 133.68 35.33 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.347 1.859 . . . . 0.0 109.931 -177.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.08 159.96 39.54 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.734 1.614 . . . . 0.0 111.922 -168.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -132.33 135.87 46.48 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.251 1.82 . . . . 0.0 111.107 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -159.7 176.24 12.21 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.394 2.678 . . . . 0.0 107.531 173.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -128.84 126.71 40.41 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.156 -0.965 . . . . 0.0 109.653 166.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.35 13.7 m 48.11 32.23 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 129.353 3.061 . . . . 0.0 115.415 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.9 p -121.24 166.03 14.6 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 -172.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 m -66.39 154.72 90.08 Favored Pre-proline 0 N--CA 1.48 1.037 0 O-C-N 121.412 -0.805 . . . . 0.0 112.31 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -76.04 101.82 1.54 Allowed 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.778 2.319 . . . . 0.0 108.383 165.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -57.22 -34.91 69.04 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.608 1.563 . . . . 0.0 113.689 -169.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.35 -27.78 62.57 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.116 -0.99 . . . . 0.0 112.789 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.1 ttp -77.42 -13.24 59.97 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.831 0.852 . . . . 0.0 112.184 -170.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -106.34 -25.29 11.99 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.271 1.429 . . . . 0.0 113.627 163.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.3 tp -78.04 -49.34 14.21 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.773 1.229 . . . . 0.0 112.474 -172.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -100.8 -106.99 0.23 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 42.24 70.69 0.26 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.996 2.118 . . . . 0.0 114.805 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.98 16.9 1.07 Allowed Glycine 0 CA--C 1.53 0.998 0 CA-C-N 115.594 -0.73 . . . . 0.0 114.281 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.443 HD11 HD11 ' A' ' 36' ' ' LEU . 1.9 pp -132.86 151.64 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 118.37 1.085 . . . . 0.0 111.773 -167.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.95 175.12 9.79 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.437 1.495 . . . . 0.0 110.965 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 70.0 tp -119.28 -38.74 2.98 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.173 1.389 . . . . 0.0 112.072 161.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -79.04 -41.41 28.89 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.106 0.962 . . . . 0.0 113.509 -170.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.33 -44.18 0.29 Allowed Glycine 0 N--CA 1.473 1.108 0 N-CA-C 115.692 1.037 . . . . 0.0 115.692 173.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.54 124.98 55.58 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 124.339 1.056 . . . . 0.0 108.664 177.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -77.02 134.9 14.97 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 124.443 3.429 . . . . 0.0 115.012 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.422 HG13 HD13 ' A' ' 36' ' ' LEU . 10.1 mm -64.16 131.62 29.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 123.786 0.834 . . . . 0.0 110.736 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 tptm -121.01 112.01 18.19 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.252 1.821 . . . . 0.0 110.016 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.4 mp -88.28 140.73 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -139.8 154.99 47.51 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 123.087 1.422 . . . . 0.0 109.041 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -82.88 147.5 28.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.21 -1.814 . . . . 0.0 110.929 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -91.54 58.76 3.64 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 128.108 2.563 . . . . 0.0 110.005 -170.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.74 -178.1 6.97 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.827 0.822 . . . . 0.0 112.465 174.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.5 -172.04 32.43 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-O 122.089 0.827 . . . . 0.0 114.216 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.8 p -60.18 139.33 57.61 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.521 -0.84 . . . . 0.0 109.425 172.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 m -57.22 136.35 56.47 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -172.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -78.16 168.02 20.5 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.488 1.915 . . . . 0.0 112.161 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.11 157.54 50.54 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 124.875 1.27 . . . . 0.0 111.296 -173.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -64.96 152.38 82.55 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 CA-C-N 120.783 1.315 . . . . 0.0 111.92 170.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -71.96 -28.39 63.41 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.908 1.283 . . . . 0.0 113.19 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 t70 . . . . . 0 C--O 1.257 1.462 0 C-N-CA 127.626 2.37 . . . . 0.0 113.022 -179.184 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.277 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -125.1 11.37 8.22 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.975 1.31 . . . . 0.0 112.882 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -56.55 131.14 47.87 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.302 1.041 . . . . 0.0 112.072 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -57.64 -40.76 80.01 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.239 -1.538 . . . . 0.0 113.46 -170.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -71.96 2.43 5.64 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 127.326 2.25 . . . . 0.0 114.826 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.8 mt -81.35 138.17 35.67 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 120.464 -1.398 . . . . 0.0 109.882 173.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -81.52 97.75 7.96 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.983 0.913 . . . . 0.0 110.017 176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -125.53 78.59 1.74 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 128.348 2.659 . . . . 0.0 105.674 -176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -136.06 156.81 48.17 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -162.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -56.96 -28.78 62.59 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.12 160.66 42.16 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.497 1.044 . . . . 0.0 113.351 -175.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.8 mt 46.01 -4.49 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 130.009 3.323 . . . . 0.0 117.4 -170.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.09 -0.55 55.88 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -101.33 157.68 16.61 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.141 2.576 . . . . 0.0 111.119 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -112.99 166.95 10.92 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 -165.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -155.82 176.17 12.98 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.261 2.225 . . . . 0.0 109.793 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.4 mtt-85 -55.94 -37.33 68.83 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.255 1.822 . . . . 0.0 111.539 160.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.3 m -63.3 146.12 54.13 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.552 1.141 . . . . 0.0 108.836 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.22 132.75 39.85 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 125.216 1.407 . . . . 0.0 109.707 -175.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -81.04 129.92 34.77 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.929 0.871 . . . . 0.0 110.912 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.4 t -127.14 130.62 71.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.18 -173.56 13.31 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 122.61 1.117 . . . . 0.0 113.712 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.1 t30 62.8 36.14 13.29 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.877 1.671 . . . . 0.0 113.994 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.523 ' CD1' HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -73.15 154.96 40.11 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.478 1.111 . . . . 0.0 109.763 -174.301 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.34 162.58 12.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 123.752 1.739 . . . . 0.0 113.626 170.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.6 p -73.94 -7.54 52.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.152 2.181 . . . . 0.0 110.908 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -133.68 18.5 3.89 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.295 2.238 . . . . 0.0 114.279 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' A' ' 24' ' ' LEU . 9.1 p -57.42 161.03 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 O-C-N 120.837 -1.164 . . . . 0.0 113.594 176.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 p -158.18 161.43 37.85 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.262 1.825 . . . . 0.0 108.835 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -66.03 -25.52 67.09 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.806 1.643 . . . . 0.0 111.444 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -66.23 -35.86 81.52 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.592 1.157 . . . . 0.0 113.955 170.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.456 HD23 HG23 ' A' ' 28' ' ' VAL . 41.6 tp -77.3 -40.63 43.67 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.232 0.924 . . . . 0.0 110.388 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' A' ' 24' ' ' LEU . 82.8 mt -62.77 -46.65 87.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.397 175.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -60.15 -46.88 88.18 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.765 1.166 . . . . 0.0 111.844 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.04 -31.48 72.73 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.16 0.891 . . . . 0.0 111.919 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 tt -75.07 -42.48 56.78 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.459 1.104 . . . . 0.0 112.976 173.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -83.9 -20.4 33.08 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -70.01 -24.9 63.36 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.21 1.368 . . . . 0.0 110.66 172.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -60.7 -28.87 68.97 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.778 -1.201 . . . . 0.0 112.442 165.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.51 17.25 10.33 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.918 1.287 . . . . 0.0 114.05 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.54 -168.01 12.86 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.441 1.02 . . . . 0.0 114.706 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.3 79.41 3.09 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 124.657 3.571 . . . . 0.0 111.107 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.0 t -55.91 148.92 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.652 0.781 . . . . 0.0 110.284 171.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.5 mm -92.54 -52.04 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 126.396 1.878 . . . . 0.0 112.283 172.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -158.85 160.79 36.58 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.895 2.478 . . . . 0.0 108.352 -171.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 33' ' ' LEU . 57.7 t -127.3 155.63 38.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 126.789 2.036 . . . . 0.0 107.217 173.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -133.01 137.29 46.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.542 1.937 . . . . 0.0 110.176 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.414 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 3.4 mm -114.13 125.35 29.45 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 126.655 1.982 . . . . 0.0 111.866 163.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 55.5 Cg_endo -75.2 167.53 26.65 Favored 'Trans proline' 0 C--N 1.347 0.485 1 C-N-CA 125.519 4.146 . . . . 0.0 112.713 167.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -152.65 116.58 4.84 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 125.848 1.659 . . . . 0.0 110.532 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -49.2 164.2 0.08 Allowed 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 126.407 1.883 . . . . 0.0 112.08 161.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.35 -38.02 62.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.456 1.102 . . . . 0.0 112.062 170.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -74.3 -14.34 60.89 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.202 1.001 . . . . 0.0 112.373 174.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.7 41.93 3.74 Favored Glycine 0 C--N 1.343 0.967 0 O-C-N 120.303 -1.498 . . . . 0.0 115.676 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -133.28 139.08 33.01 Favored Pre-proline 0 N--CA 1.469 0.491 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -67.26 14.83 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.377 1 C-N-CA 125.762 4.308 . . . . 0.0 117.14 -178.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.27 18.06 2.33 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.371 -1.456 . . . . 0.0 114.117 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 68.04 31.62 5.39 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.262 1.825 . . . . 0.0 111.955 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.4 158.91 44.68 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.755 1.222 . . . . 0.0 113.254 -174.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.42 169.66 24.21 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.06 1.744 . . . . 0.0 111.891 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -121.4 150.32 41.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.168 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.4 t -139.58 146.97 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.734 1.214 . . . . 0.0 109.899 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -121.57 139.57 53.35 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -173.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -134.45 150.7 50.86 Favored 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 128.695 2.798 . . . . 0.0 111.816 172.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -93.03 144.23 25.46 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 129.925 3.29 . . . . 0.0 112.439 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.3 t60 43.55 62.69 1.8 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.923 2.089 . . . . 0.0 111.833 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -65.24 151.41 46.23 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 m -128.24 153.74 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 126.689 1.996 . . . . 0.0 111.126 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.8 p -54.77 149.16 11.61 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.427 0.691 . . . . 0.0 111.5 170.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.4 t 61.98 76.7 0.38 Allowed Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 126.797 2.039 . . . . 0.0 114.134 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -38.09 125.79 0.82 Allowed 'Trans proline' 0 CA--C 1.542 0.881 1 C-N-CA 125.818 4.346 . . . . 0.0 117.067 170.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -58.54 -42.36 87.64 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.492 1.117 . . . . 0.0 112.779 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.14 -32.22 67.95 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 121.343 1.883 . . . . 0.0 111.751 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.3 tpt -65.64 -26.83 67.99 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 118.372 0.533 . . . . 0.0 112.189 -175.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -86.56 -21.35 26.94 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 121.217 -0.927 . . . . 0.0 113.033 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -105.35 -38.85 6.35 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.789 1.635 . . . . 0.0 111.798 -155.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.8 -96.77 0.42 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.114 1.766 . . . . 0.0 111.443 174.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.2 t30 29.97 66.37 0.12 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.791 2.036 . . . . 0.0 111.938 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.88 17.91 0.16 Allowed Glycine 0 N--CA 1.468 0.776 0 N-CA-C 117.347 1.699 . . . . 0.0 117.347 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -139.48 148.98 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 117.769 0.784 . . . . 0.0 112.578 -160.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.62 175.3 13.37 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.1 tp -138.53 -18.87 1.08 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.302 2.641 . . . . 0.0 112.819 171.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -101.92 -40.76 6.75 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.453 1.501 . . . . 0.0 112.986 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.74 -45.48 0.22 Allowed Glycine 0 N--CA 1.479 1.532 0 N-CA-C 118.477 2.151 . . . . 0.0 118.477 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -113.98 122.47 34.63 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 126.231 1.812 . . . . 0.0 111.459 -173.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.25 123.33 7.66 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.371 2.047 . . . . 0.0 115.106 -171.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.1 mm -52.6 118.61 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 124.495 1.118 . . . . 0.0 113.005 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -103.57 114.72 29.2 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.242 1.817 . . . . 0.0 111.658 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mp -84.0 146.77 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 O-C-N 121.649 -0.657 . . . . 0.0 110.574 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -146.18 161.25 40.64 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.122 1.769 . . . . 0.0 113.986 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -155.13 149.87 26.52 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.42 1.088 . . . . 0.0 113.106 171.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -67.99 123.46 20.69 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 128.495 2.718 . . . . 0.0 111.332 -173.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.1 148.48 49.77 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.62 0.19 0.51 Allowed Glycine 0 CA--C 1.534 1.27 0 CA-C-O 117.387 -1.785 . . . . 0.0 116.468 176.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 51.5 m 35.1 53.48 0.69 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.923 2.089 . . . . 0.0 114.612 169.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 79.3 p -172.27 160.43 5.05 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.228 1.411 . . . . 0.0 113.482 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -106.7 169.35 8.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.074 1.75 . . . . 0.0 109.778 170.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -106.35 153.19 40.6 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 118.56 0.618 . . . . 0.0 111.224 169.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -76.39 166.1 28.09 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.553 2.835 . . . . 0.0 109.311 169.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -128.66 -8.84 5.06 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 128.438 2.695 . . . . 0.0 111.619 174.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 . . . . . 0 C--O 1.257 1.49 0 C-N-CA 127.24 2.216 . . . . 0.0 115.392 176.197 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.174 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 t -139.75 -163.52 1.52 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.282 1.833 . . . . 0.0 109.957 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -136.57 147.01 46.78 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.875 2.07 . . . . 0.0 108.368 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -49.04 -43.42 40.69 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 126.367 1.867 . . . . 0.0 113.334 -175.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -132.96 133.66 43.47 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 125.065 1.346 . . . . 0.0 108.262 172.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 mt -144.34 172.39 13.0 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.335 1.454 . . . . 0.0 111.2 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.71 131.5 34.12 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.885 1.674 . . . . 0.0 114.746 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -168.43 -17.55 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.872 2.069 . . . . 0.0 116.185 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -118.89 -23.05 7.07 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -164.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -78.31 22.72 0.31 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.587 1.555 . . . . 0.0 111.123 -174.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.61 159.35 35.33 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.502 2.321 . . . . 0.0 113.828 -169.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 12' ' ' LEU . 1.9 pp -103.01 158.47 16.27 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 128.355 2.662 . . . . 0.0 111.177 169.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -162.34 149.69 13.85 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 128.492 2.717 . . . . 0.0 111.568 -174.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -158.66 133.82 8.48 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 128.237 2.615 . . . . 0.0 109.647 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.73 140.72 49.67 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -118.23 59.28 0.81 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.278 1.431 . . . . 0.0 111.413 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 57.32 7.12 0.44 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 m -138.53 146.34 41.8 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.396 0.998 . . . . 0.0 111.457 -164.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.428 HD13 ' HG3' ' A' ' 71' ' ' PRO . 42.7 tp -117.47 133.63 55.75 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.981 2.112 . . . . 0.0 112.927 -166.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -85.03 124.57 31.88 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 123.322 1.534 . . . . 0.0 111.84 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 t -122.06 134.06 66.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.436 ' HA2' HD23 ' A' ' 24' ' ' LEU . . . -141.41 -171.13 12.59 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 121.201 -0.937 . . . . 0.0 112.18 174.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.4 t30 62.43 38.62 12.7 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.645 1.178 . . . . 0.0 111.165 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.69 HD12 HG21 ' A' ' 28' ' ' VAL . 0.9 OUTLIER -71.2 158.06 37.07 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.458 1.103 . . . . 0.0 109.065 -176.067 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.79 158.47 35.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.808 1.29 . . . . 0.0 110.0 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.2 p -73.26 -13.49 61.14 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.992 1.317 . . . . 0.0 113.3 -169.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HB3' ' HE3' ' A' ' 27' ' ' LYS . 25.4 mmmt -129.72 21.21 5.5 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 129.733 3.213 . . . . 0.0 112.364 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.69 HG21 HD12 ' A' ' 24' ' ' LEU . 9.2 p -53.64 160.69 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.524 1.13 . . . . 0.0 112.751 173.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.419 ' N ' HG22 ' A' ' 28' ' ' VAL . 36.3 p -148.41 162.15 40.16 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.931 1.692 . . . . 0.0 110.707 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -56.12 -37.34 69.29 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.707 1.203 . . . . 0.0 108.972 171.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -66.26 -32.32 73.67 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.577 HD23 HG23 ' A' ' 28' ' ' VAL . 13.4 tp -75.17 -35.49 61.59 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.009 -1.057 . . . . 0.0 111.906 175.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB2' HG11 ' A' ' 46' ' ' VAL . 26.0 mt -71.4 -43.67 66.37 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.049 171.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -53.5 -46.89 70.21 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.85 1.205 . . . . 0.0 110.658 175.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -73.14 -28.2 62.11 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.5 tt -77.58 -49.01 15.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.467 1.107 . . . . 0.0 112.666 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -81.25 -17.94 47.72 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 120.344 1.429 . . . . 0.0 113.263 -175.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -53.23 -32.4 48.12 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 120.312 1.415 . . . . 0.0 110.94 169.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -56.55 -38.4 71.85 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.464 1.505 . . . . 0.0 114.847 168.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.07 -20.37 30.49 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.227 1.811 . . . . 0.0 111.814 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.43 -168.78 29.08 Favored Glycine 0 CA--C 1.55 2.257 0 N-CA-C 117.774 1.869 . . . . 0.0 117.774 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.66 74.83 5.01 Favored 'Trans proline' 0 CA--C 1.548 1.185 1 C-N-CA 126.468 4.779 . . . . 0.0 110.806 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 m -57.72 127.11 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.827 1.651 . . . . 0.0 110.024 173.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.557 HG22 ' HE3' ' A' ' 45' ' ' LYS . 34.5 mm -69.08 -40.23 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.665 0.786 . . . . 0.0 111.018 -175.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.557 ' HE3' HG22 ' A' ' 44' ' ' ILE . 13.3 ptpt -171.49 160.14 5.84 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.59 2.356 . . . . 0.0 111.042 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.472 HG11 ' HB2' ' A' ' 33' ' ' LEU . 85.2 t -122.24 137.19 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 127.148 2.179 . . . . 0.0 112.156 -175.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -113.96 123.77 50.54 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.7 mm -110.91 111.9 56.14 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 125.754 1.622 . . . . 0.0 111.436 165.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.8 165.73 24.84 Favored 'Trans proline' 0 CA--C 1.552 1.399 1 C-N-CA 125.717 4.278 . . . . 0.0 111.258 172.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -157.24 114.82 3.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.966 2.107 . . . . 0.0 111.667 171.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.452 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 31.4 t0 -63.02 176.51 0.71 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 126.759 2.024 . . . . 0.0 113.093 170.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.79 -36.92 27.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.491 1.916 . . . . 0.0 113.072 172.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -77.04 -9.15 58.52 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.937 1.695 . . . . 0.0 114.538 174.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.08 41.54 6.61 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 125.669 1.604 . . . . 0.0 112.629 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -130.29 133.84 25.38 Favored Pre-proline 0 N--CA 1.467 0.412 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -169.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.24 13.63 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 1 C-N-CA 126.411 4.741 . . . . 0.0 115.037 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER 54.84 21.13 3.43 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 174.227 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 60.26 34.79 20.91 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.587 1.955 . . . . 0.0 112.96 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.482 ' HA ' HD23 ' A' ' 24' ' ' LEU . 2.0 p90 -151.04 155.91 40.0 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.142 1.377 . . . . 0.0 113.343 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -151.3 169.62 21.5 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.496 1.919 . . . . 0.0 112.914 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -126.24 159.56 32.7 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.265 1.031 . . . . 0.0 113.283 172.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.7 t -144.49 133.22 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.995 0.918 . . . . 0.0 110.874 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -99.36 147.32 25.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.578 1.551 . . . . 0.0 113.069 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -137.22 157.9 45.63 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.102 2.161 . . . . 0.0 110.33 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -59.04 149.97 26.11 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.235 -1.54 . . . . 0.0 108.454 165.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -64.87 123.3 19.04 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 126.612 1.965 . . . . 0.0 112.784 -171.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -151.7 155.09 37.62 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.7 t -88.99 85.48 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 C-N-CA 126.633 1.973 . . . . 0.0 107.029 169.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.7 p -160.54 157.84 28.12 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.467 HG12 ' CD2' ' A' ' 91' ' ' PHE . 0.4 OUTLIER -75.13 142.39 75.64 Favored Pre-proline 0 N--CA 1.473 0.714 0 O-C-N 120.918 -1.114 . . . . 0.0 109.108 157.349 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.428 ' HG3' HD13 ' A' ' 19' ' ' LEU . 12.8 Cg_endo -53.39 128.64 30.06 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.628 2.219 . . . . 0.0 112.695 176.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -52.91 -39.88 63.11 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.93 -26.69 67.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.6 ttt -70.48 -24.63 62.9 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 121.024 1.738 . . . . 0.0 112.765 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -87.04 -27.53 23.13 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.234 1.013 . . . . 0.0 112.109 169.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.33 -57.78 2.59 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -167.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -88.69 -94.92 0.1 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.547 1.139 . . . . 0.0 108.813 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 30.32 78.04 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.397 1.879 . . . . 0.0 113.38 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.9 28.01 1.78 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.022 0.82 . . . . 0.0 112.648 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -130.66 148.01 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.99 -175.17 3.91 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.239 2.216 . . . . 0.0 112.258 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.6 mt -131.37 -31.85 1.59 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.601 1.56 . . . . 0.0 112.841 154.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.446 ' CE2' HD22 ' A' ' 32' ' ' LEU . 21.0 m-30 -65.61 -51.95 55.75 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.05 -50.03 0.16 Allowed Glycine 0 CA--C 1.534 1.264 0 O-C-N 121.134 -0.979 . . . . 0.0 115.191 170.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -93.45 111.91 54.29 Favored Pre-proline 0 N--CA 1.479 1.014 0 C-N-CA 124.472 1.109 . . . . 0.0 109.247 -172.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.56 127.22 12.24 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.776 2.317 . . . . 0.0 112.536 -170.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.528 HD11 HD13 ' A' ' 24' ' ' LEU . 4.8 mm -56.74 122.54 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 122.223 1.011 . . . . 0.0 109.121 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -103.39 121.27 42.43 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.671 1.988 . . . . 0.0 109.732 171.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.46 141.23 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 169.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -124.12 140.93 52.49 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.705 1.24 . . . . 0.0 111.552 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.467 ' CD2' HG12 ' A' ' 70' ' ' VAL . 84.1 t80 -147.03 147.28 30.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.057 -1.429 . . . . 0.0 112.288 173.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -140.01 134.55 31.62 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.278 1.831 . . . . 0.0 108.231 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 m -79.01 138.02 37.84 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.14 0.976 . . . . 0.0 111.729 -170.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.49 135.87 39.12 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 122.254 0.919 . . . . 0.0 111.726 168.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.3 p -71.47 -24.74 62.05 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.514 1.526 . . . . 0.0 113.781 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.5 m 48.98 33.17 4.34 Favored 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -167.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -73.94 -28.64 61.61 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 119.804 -1.81 . . . . 0.0 113.183 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.95 152.86 77.45 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.123 0.969 . . . . 0.0 111.829 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.55 140.34 21.25 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.257 2.638 . . . . 0.0 112.941 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -69.58 -34.53 74.28 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 122.104 -0.373 . . . . 0.0 111.408 167.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.071 1.348 . . . . 0.0 114.044 179.74 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.215 0 CA-C-O 121.449 0.472 . . . . 0.0 112.592 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 t -53.16 137.29 34.34 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.554 2.342 . . . . 0.0 114.726 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.262 29.7 mt-10 47.93 31.49 2.38 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 131.675 3.99 . . . . 0.0 117.186 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -68.46 -21.26 64.64 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -173.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -83.06 3.82 28.79 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 168.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.27 170.26 8.17 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 129.129 2.971 . . . . 0.0 108.721 169.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -82.4 139.09 34.23 Favored 'General case' 0 C--N 1.339 0.112 0 O-C-N 120.394 -1.441 . . . . 0.0 107.956 165.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -119.32 84.4 2.19 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.508 1.523 . . . . 0.0 113.626 -170.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.3 mp0 -140.35 173.83 11.11 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 129.293 3.037 . . . . 0.0 113.149 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -68.44 -14.18 62.82 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -173.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.13 179.73 5.0 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.4 1.48 . . . . 0.0 112.139 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.9 mt -66.93 148.8 51.48 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.088 1.355 . . . . 0.0 111.076 167.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.79 -14.68 0.73 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 166.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -83.79 -3.18 57.63 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 126.193 1.797 . . . . 0.0 111.581 167.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.57 166.38 28.43 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 129.982 3.313 . . . . 0.0 108.223 159.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -148.21 -45.47 0.16 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.014 1.326 . . . . 0.0 113.397 171.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.8 mmt-85 -91.9 17.76 8.75 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.954 1.701 . . . . 0.0 113.722 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 83.7 m -151.54 144.33 24.4 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.624 1.169 . . . . 0.0 112.595 -165.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.9 tp -89.41 127.43 35.82 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.29 1.436 . . . . 0.0 113.367 -160.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -72.26 135.56 46.05 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.965 0.888 . . . . 0.0 111.769 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.04 134.97 62.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 168.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.82 -175.53 13.96 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 126.187 1.851 . . . . 0.0 111.23 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 42.9 t30 65.82 24.71 11.34 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.095 1.358 . . . . 0.0 112.315 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.613 HD12 HG21 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -64.8 160.09 21.01 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 123.282 1.515 . . . . 0.0 110.654 -175.043 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.27 163.36 27.11 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.995 -1.912 . . . . 0.0 110.511 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.2 p -64.29 -27.4 69.01 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.17 1.788 . . . . 0.0 109.869 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -123.59 26.13 7.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.613 HG21 HD12 ' A' ' 24' ' ' LEU . 8.0 p -51.8 161.46 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.839 1.2 . . . . 0.0 111.777 169.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.41 ' N ' HG22 ' A' ' 28' ' ' VAL . 1.6 p -158.93 159.46 34.95 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.458 1.903 . . . . 0.0 110.542 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -55.02 -38.82 68.42 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 126.478 1.911 . . . . 0.0 109.171 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -67.26 -30.87 70.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.594 1.958 . . . . 0.0 112.376 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.3 tp -75.4 -43.74 48.46 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.8 0.727 . . . . 0.0 111.422 168.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.447 ' HB2' HG11 ' A' ' 46' ' ' VAL . 95.1 mt -60.82 -54.42 45.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.106 0.963 . . . . 0.0 110.521 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -53.9 -45.41 71.1 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.059 0.845 . . . . 0.0 112.425 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -69.33 -31.76 70.42 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.127 1.33 . . . . 0.0 112.714 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.2 tt -74.18 -36.17 64.02 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.458 1.103 . . . . 0.0 111.014 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -95.54 -12.78 25.19 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -56.2 -35.74 67.63 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.969 1.708 . . . . 0.0 109.804 163.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.6 mm100 -62.36 -36.19 81.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.773 1.229 . . . . 0.0 113.284 168.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.86 2.76 44.59 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.574 1.15 . . . . 0.0 113.401 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 134.38 -169.63 22.98 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.737 1.637 . . . . 0.0 115.369 167.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.32 99.82 0.17 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.695 2.93 . . . . 0.0 111.159 167.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.5 t -88.2 131.69 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.019 1.727 . . . . 0.0 110.19 172.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.42 -46.29 20.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.949 1.3 . . . . 0.0 111.18 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -171.07 150.46 3.05 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.689 1.596 . . . . 0.0 112.033 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' ' 33' ' ' LEU . 96.2 t -115.87 151.17 17.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 129.297 3.039 . . . . 0.0 110.383 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -129.68 121.09 26.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.93 2.092 . . . . 0.0 111.209 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.5 mm -101.0 122.33 49.11 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.583 1.553 . . . . 0.0 110.124 160.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.36 163.75 35.24 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 125.188 3.925 . . . . 0.0 111.114 164.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -154.92 113.64 3.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.525 1.53 . . . . 0.0 113.149 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -53.04 168.9 0.11 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 130.444 3.497 . . . . 0.0 113.83 173.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -28.4 59.96 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.852 0.461 . . . . 0.0 110.471 168.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -83.37 -6.17 59.38 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.67 40.91 8.57 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 126.556 2.027 . . . . 0.0 111.943 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -128.82 137.11 30.28 Favored Pre-proline 0 N--CA 1.465 0.325 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.58 14.23 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 124.275 3.316 . . . . 0.0 116.682 176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.42 27.81 6.82 Favored 'General case' 0 CA--C 1.554 1.125 0 O-C-N 120.538 -1.351 . . . . 0.0 114.307 175.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 57.42 32.47 21.83 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 127.464 2.305 . . . . 0.0 116.156 -173.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -147.0 162.57 38.51 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 127.205 2.202 . . . . 0.0 112.53 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -158.67 177.43 11.21 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.622 1.969 . . . . 0.0 110.362 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -129.06 154.35 46.74 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.106 1.362 . . . . 0.0 114.22 171.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.16 133.52 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.523 1.529 . . . . 0.0 110.609 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -99.06 141.25 32.06 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.914 1.686 . . . . 0.0 112.207 173.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -147.17 1.3 0.74 Allowed 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 176.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -172.01 161.11 5.56 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 127.676 2.39 . . . . 0.0 111.473 -170.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -71.34 -47.32 57.24 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 120.696 1.589 . . . . 0.0 114.71 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -112.85 146.41 38.94 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 167.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.1 t -82.23 102.0 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -176.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.2 p -76.53 -81.53 0.08 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 113.468 -1.696 . . . . 0.0 108.984 168.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.2 p -165.45 127.79 1.5 Allowed Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 125.159 1.384 . . . . 0.0 113.223 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.412 ' HG2' ' HG2' ' A' ' 74' ' ' MET . 33.0 Cg_endo -88.49 149.1 6.33 Favored 'Trans proline' 0 CA--C 1.551 1.338 0 C-N-CA 123.692 2.928 . . . . 0.0 114.48 -169.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -74.55 -42.09 59.42 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 120.521 -1.362 . . . . 0.0 112.044 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . . . -56.91 -42.28 79.65 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.089 1.755 . . . . 0.0 114.482 -166.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.412 ' HG2' ' HG2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -51.18 -22.95 2.91 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 173.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -109.06 -34.3 6.64 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 125.257 1.423 . . . . 0.0 110.343 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.44 ' HB3' HD22 ' A' ' 77' ' ' LEU . 28.2 tp -64.1 -60.85 2.73 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 118.831 0.741 . . . . 0.0 111.298 -176.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.44 HD22 ' HB3' ' A' ' 76' ' ' LEU . 2.1 mm? -87.88 -86.42 0.16 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.458 1.903 . . . . 0.0 106.662 -174.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 37.57 64.56 0.63 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 126.289 1.836 . . . . 0.0 114.621 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.97 35.1 0.56 Allowed Glycine 0 N--CA 1.481 1.658 0 O-C-N 120.814 -1.179 . . . . 0.0 115.234 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.01 143.95 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.525 1.53 . . . . 0.0 112.476 -174.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.23 170.7 12.97 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.82 2.048 . . . . 0.0 112.653 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 15.5 tp -123.21 -30.73 3.68 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.867 2.467 . . . . 0.0 112.272 163.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -83.7 -21.52 32.34 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.082 2.153 . . . . 0.0 114.001 -172.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 150.79 -59.8 0.42 Allowed Glycine 0 N--CA 1.483 1.791 0 N-CA-C 116.166 1.226 . . . . 0.0 116.166 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -102.47 129.04 26.84 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 126.267 1.827 . . . . 0.0 109.033 -173.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -76.38 134.68 15.83 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.76 2.974 . . . . 0.0 113.747 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 mm -57.57 129.33 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 O-C-N 121.834 -0.541 . . . . 0.0 110.4 176.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -119.37 110.52 17.05 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.528 1.931 . . . . 0.0 109.582 170.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -85.32 134.29 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 126.125 1.77 . . . . 0.0 109.256 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -130.09 147.92 51.88 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.679 1.992 . . . . 0.0 111.399 -166.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.4 t80 64.32 130.19 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.302 1.841 . . . . 0.0 111.644 -154.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -107.07 -63.24 1.31 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.506 1.522 . . . . 0.0 109.907 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.9 t -162.14 162.66 28.59 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -78.94 108.96 2.76 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 125.058 1.314 . . . . 0.0 112.739 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.8 m -122.47 157.97 30.81 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.766 1.626 . . . . 0.0 110.008 171.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.3 m -65.53 151.88 45.35 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.305 1.842 . . . . 0.0 114.121 -172.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -172.34 134.71 0.7 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.054 2.542 . . . . 0.0 110.908 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 78.67 166.66 0.12 Allowed Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 127.325 2.25 . . . . 0.0 115.016 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -62.8 161.57 28.45 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.921 2.414 . . . . 0.0 115.888 167.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -135.71 -47.28 0.67 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.001 -1.062 . . . . 0.0 109.091 167.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.4 t70 . . . . . 0 C--O 1.259 1.567 0 C-N-CA 125.586 1.555 . . . . 0.0 113.545 179.924 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.733 0 N-CA-C 107.627 -2.189 . . . . 0.0 107.627 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 m -85.92 -46.31 10.69 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.562 2.345 . . . . 0.0 115.764 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.326 3.0 mp0 67.07 175.76 0.25 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 130.385 3.474 . . . . 0.0 116.594 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -117.31 -44.1 2.79 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.49 1.116 . . . . 0.0 112.664 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -93.18 37.48 1.04 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.672 1.989 . . . . 0.0 113.293 -171.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.9 mt -95.89 155.63 16.67 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.511 1.925 . . . . 0.0 113.857 173.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.63 159.76 0.73 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.018 1.727 . . . . 0.0 115.363 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -66.33 147.78 52.81 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.338 1.855 . . . . 0.0 111.23 172.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -108.88 -24.46 11.25 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.318 1.847 . . . . 0.0 111.758 -174.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -68.59 12.19 0.14 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.046 2.139 . . . . 0.0 112.883 163.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.05 167.56 15.17 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -162.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.2 mt -65.87 156.6 32.88 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.746 1.618 . . . . 0.0 113.928 -165.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.81 -43.1 65.7 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.568 1.147 . . . . 0.0 113.372 -172.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 41.27 38.49 0.79 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 127.997 2.519 . . . . 0.0 115.303 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.43 145.77 28.8 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 120.452 -1.405 . . . . 0.0 110.942 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.97 -175.59 4.47 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.09 0.956 . . . . 0.0 112.797 -175.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.28 7.32 6.59 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.3 m -105.37 152.95 22.31 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 122.532 1.158 . . . . 0.0 108.102 -175.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.5 tp -119.28 125.12 48.35 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 130.917 3.687 . . . . 0.0 111.01 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -80.65 135.95 36.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.602 1.161 . . . . 0.0 108.47 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.3 t -135.37 139.39 46.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 125.098 1.359 . . . . 0.0 108.753 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.02 -174.7 14.24 Favored Glycine 0 N--CA 1.449 -0.454 0 O-C-N 121.098 -1.001 . . . . 0.0 112.448 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.5 t30 71.19 24.44 3.84 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.943 1.697 . . . . 0.0 112.383 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.752 HD12 HG21 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -72.24 145.75 47.73 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 125.191 1.397 . . . . 0.0 109.766 -169.624 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.24 162.05 18.1 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 176.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.4 p -63.1 -22.41 66.84 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.822 1.649 . . . . 0.0 111.639 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -113.38 23.2 13.46 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.466 1.506 . . . . 0.0 113.618 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.752 HG21 HD12 ' A' ' 24' ' ' LEU . 6.7 p -60.25 155.47 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 O-C-N 119.784 -1.823 . . . . 0.0 112.131 171.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.6 p -153.52 159.8 42.33 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 129.132 2.973 . . . . 0.0 108.58 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -59.9 -28.06 67.25 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.08 2.152 . . . . 0.0 111.9 177.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -73.08 -32.58 65.09 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.067 1.347 . . . . 0.0 112.252 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.436 HD22 ' CZ ' ' A' ' 83' ' ' TYR . 21.7 tp -76.08 -36.49 58.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.676 0.79 . . . . 0.0 112.999 172.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.491 HD21 ' CD1' ' A' ' 24' ' ' LEU . 95.0 mt -69.71 -42.31 74.21 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 176.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -63.03 -40.74 98.63 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.786 1.63 . . . . 0.0 112.938 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -69.86 -29.72 67.02 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.141 -0.975 . . . . 0.0 111.37 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.471 HD13 HG13 ' A' ' 87' ' ' ILE . 6.1 tt -73.38 -39.06 65.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.58 0.752 . . . . 0.0 110.388 175.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -93.41 17.36 11.54 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.779 1.231 . . . . 0.0 114.274 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -67.39 -30.28 70.01 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 120.286 1.403 . . . . 0.0 114.671 -173.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -101.24 0.24 37.06 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.126 1.77 . . . . 0.0 113.123 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.77 30.95 0.54 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.14 179.28 39.97 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.104 0.859 . . . . 0.0 111.748 -173.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -62.13 109.24 0.79 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.43 2.086 . . . . 0.0 109.716 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.9 t -94.04 105.05 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.798 1.239 . . . . 0.0 109.11 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.1 mt -62.51 -49.37 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.437 1.895 . . . . 0.0 111.825 171.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.17 170.1 19.66 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.681 0.792 . . . . 0.0 110.13 175.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' A' ' 33' ' ' LEU . 87.3 t -119.58 160.77 19.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 125.355 1.462 . . . . 0.0 109.132 169.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -138.54 124.05 19.54 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.884 1.273 . . . . 0.0 111.939 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.432 HD12 HG13 ' A' ' 28' ' ' VAL . 4.5 mm -108.37 121.69 42.73 Favored Pre-proline 0 C--N 1.32 -0.692 0 C-N-CA 125.721 1.608 . . . . 0.0 109.896 169.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.16 164.83 33.37 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 125.198 3.932 . . . . 0.0 112.304 165.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -159.51 118.32 2.85 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 126.923 2.089 . . . . 0.0 108.769 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -55.53 168.92 0.35 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 127.106 2.162 . . . . 0.0 113.06 171.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.35 -35.44 62.74 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.001 1.32 . . . . 0.0 110.116 172.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -89.16 6.79 38.44 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 128.321 2.648 . . . . 0.0 114.79 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.47 46.55 7.34 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 126.759 2.123 . . . . 0.0 115.416 168.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 9.0 tppt? -136.26 137.27 24.1 Favored Pre-proline 0 N--CA 1.476 0.842 0 CA-C-N 118.761 1.281 . . . . 0.0 113.467 -173.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.474 ' HD2' ' HG3' ' A' ' 55' ' ' LYS . 72.9 Cg_endo -77.79 17.88 0.92 Allowed 'Trans proline' 0 C--O 1.223 -0.261 1 C-N-CA 126.412 4.741 . . . . 0.0 115.596 -176.578 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.45 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 50.5 27.86 3.07 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.815 1.646 . . . . 0.0 113.341 175.501 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.25 11.3 mt-30 53.83 32.59 15.29 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -171.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.45 ' CD2' ' HB2' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -149.21 150.98 33.5 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 126.337 1.855 . . . . 0.0 112.873 -176.04 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -155.1 176.06 13.03 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.911 1.685 . . . . 0.0 112.505 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -135.39 163.16 30.66 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.1 t -145.48 143.6 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.608 1.563 . . . . 0.0 109.813 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -112.26 130.76 55.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.885 0.85 . . . . 0.0 110.499 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -145.96 141.89 28.16 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.074 1.349 . . . . 0.0 111.953 -161.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -149.04 127.88 12.58 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.089 0.955 . . . . 0.0 109.846 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -150.15 167.01 28.1 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 126.309 1.844 . . . . 0.0 109.79 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -55.98 -30.86 62.42 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 177.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 m -118.39 147.26 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 120.231 -1.543 . . . . 0.0 111.222 160.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.5 m -89.16 76.83 7.65 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 119.962 -1.712 . . . . 0.0 113.582 174.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 m -121.98 156.23 59.87 Favored Pre-proline 0 N--CA 1.483 1.185 0 C-N-CA 124.857 1.263 . . . . 0.0 110.794 174.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -94.74 84.54 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.467 2.111 . . . . 0.0 109.266 -164.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -61.48 -40.9 96.24 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 120.084 -1.635 . . . . 0.0 112.888 -169.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.455 ' HB1' HD12 ' A' ' 77' ' ' LEU . . . -57.99 -27.96 63.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.145 1.378 . . . . 0.0 112.348 174.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.5 ttt -69.69 -17.7 63.5 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.323 1.049 . . . . 0.0 111.893 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -98.92 -38.87 8.84 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.216 0.917 . . . . 0.0 111.787 166.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.51 -40.09 94.99 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 118.8 0.727 . . . . 0.0 111.392 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.46 HD22 HD11 ' A' ' 80' ' ' ILE . 2.8 mt -124.81 -86.45 0.63 Allowed 'General case' 0 C--N 1.348 0.527 0 CA-C-O 116.36 -1.781 . . . . 0.0 111.191 -158.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 23.03 71.67 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.769 2.028 . . . . 0.0 112.439 169.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.75 25.19 0.7 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.752 1.644 . . . . 0.0 114.289 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.46 HD11 HD22 ' A' ' 77' ' ' LEU . 1.1 pp -134.81 151.68 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.645 1.178 . . . . 0.0 113.096 -172.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.94 168.95 20.43 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.416 1.486 . . . . 0.0 112.526 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.0 tp -111.89 -33.59 6.25 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 128.553 2.741 . . . . 0.0 111.146 173.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.436 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 6.4 m-30 -93.57 -67.0 0.88 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.632 1.573 . . . . 0.0 110.687 -173.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.37 -38.55 0.07 OUTLIER Glycine 0 CA--C 1.53 1.003 0 CA-C-O 117.92 -1.489 . . . . 0.0 116.108 -175.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.417 ' HA ' ' HD2' ' A' ' 86' ' ' PRO . 3.4 mpt_? -101.94 108.07 54.89 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 120.205 2.003 . . . . 0.0 110.86 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 21.1 Cg_endo -65.73 128.9 20.92 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.236 3.291 . . . . 0.0 113.585 -166.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.471 HG13 HD13 ' A' ' 36' ' ' LEU . 7.0 mm -58.85 124.78 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -117.13 109.8 17.38 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 128.258 2.623 . . . . 0.0 110.749 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 mp -88.93 142.74 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.255 0.622 . . . . 0.0 109.677 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -132.84 154.48 50.29 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 123.467 1.603 . . . . 0.0 113.93 -176.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -164.96 152.26 11.09 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.09 -163.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -158.47 138.98 12.63 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.143 0.977 . . . . 0.0 112.722 175.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.5 p -150.29 164.36 35.95 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 120.978 -1.076 . . . . 0.0 113.641 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 155.22 -28.92 0.63 Allowed Glycine 0 CA--C 1.541 1.704 0 C-N-CA 125.474 1.511 . . . . 0.0 114.714 175.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.0 m -108.75 -1.59 19.23 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.3 m -104.11 17.0 25.0 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.862 1.665 . . . . 0.0 113.992 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -64.62 142.45 58.42 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.083 2.153 . . . . 0.0 112.523 174.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -143.98 165.66 23.13 Favored Pre-proline 0 C--O 1.236 0.361 0 C-N-CA 126.999 2.12 . . . . 0.0 111.16 -168.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.96 157.67 57.43 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 CA-C-O 123.373 1.322 . . . . 0.0 115.217 170.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -80.5 -73.93 0.34 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.921 1.688 . . . . 0.0 107.777 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.5 t70 . . . . . 0 C--O 1.26 1.654 0 C-N-CA 125.012 1.325 . . . . 0.0 113.254 174.784 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 CA-C-O 119.291 -0.727 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 p -143.92 155.92 44.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.204 2.602 . . . . 0.0 111.951 -170.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -151.11 139.9 20.82 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 123.093 1.425 . . . . 0.0 114.024 174.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -121.45 -42.67 2.43 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 128.028 2.531 . . . . 0.0 111.581 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -88.55 56.65 3.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.273 1.429 . . . . 0.0 109.267 171.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.0 tp -91.25 163.7 14.15 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 122.61 1.195 . . . . 0.0 111.0 -175.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.94 124.77 21.94 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.071 -1.422 . . . . 0.0 108.42 175.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -157.03 148.47 22.23 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -133.61 175.09 9.74 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 128.41 2.684 . . . . 0.0 112.495 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -90.09 -30.25 17.81 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 119.545 -1.972 . . . . 0.0 113.429 -166.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.82 -176.53 2.05 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 129.36 3.064 . . . . 0.0 109.612 -175.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.7 mt -55.16 125.9 22.53 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.378 1.871 . . . . 0.0 112.232 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.11 136.32 36.61 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.816 0.846 . . . . 0.0 112.763 -163.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -125.56 143.54 50.97 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.648 1.579 . . . . 0.0 110.18 176.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.93 141.48 54.98 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 153.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -156.57 104.26 2.17 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.882 1.273 . . . . 0.0 109.292 177.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 61.03 -14.66 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.72 2.408 . . . . 0.0 117.033 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.54 167.24 21.46 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.703 1.601 . . . . 0.0 109.252 -163.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.3 tp -122.85 123.6 41.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.873 1.669 . . . . 0.0 114.347 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -71.77 132.53 44.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.298 1.047 . . . . 0.0 112.497 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.43 119.88 51.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 174.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.43 -171.48 16.6 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 122.988 1.327 . . . . 0.0 112.067 166.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.3 t30 71.39 31.22 2.37 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.438 2.295 . . . . 0.0 114.595 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.725 HD12 HG21 ' A' ' 28' ' ' VAL . 0.9 OUTLIER -74.16 155.78 38.02 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.879 1.272 . . . . 0.0 113.91 -172.814 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -65.79 160.32 23.31 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.1 p -62.64 -26.75 68.79 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 128.712 2.805 . . . . 0.0 111.867 168.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -113.38 10.4 18.34 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.43 1.892 . . . . 0.0 113.448 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.725 HG21 HD12 ' A' ' 24' ' ' LEU . 9.2 p -61.92 158.97 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -174.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.6 p -154.1 168.92 24.86 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 128.356 2.662 . . . . 0.0 110.625 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -62.44 -25.2 67.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.409 1.484 . . . . 0.0 110.22 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -80.66 -26.48 37.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 117.361 -1.304 . . . . 0.0 113.672 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.526 HD23 HG23 ' A' ' 28' ' ' VAL . 20.8 tp -73.65 -29.89 62.6 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.283 0.947 . . . . 0.0 111.681 169.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.461 ' HB2' HG11 ' A' ' 46' ' ' VAL . 77.4 mt -78.83 -44.69 22.47 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.298 1.039 . . . . 0.0 113.663 171.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -63.9 -43.67 95.3 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 120.137 -1.602 . . . . 0.0 110.971 -174.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -63.42 -18.38 63.66 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.292 1.037 . . . . 0.0 113.573 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 tt -99.19 -43.95 6.44 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 129.093 2.957 . . . . 0.0 110.224 -169.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -78.69 -14.13 59.46 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.152 1.381 . . . . 0.0 111.841 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -66.62 -27.4 67.66 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 120.37 -1.456 . . . . 0.0 111.877 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -68.14 -23.99 64.95 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 127.754 2.422 . . . . 0.0 114.117 165.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.71 -22.15 23.51 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.707 1.603 . . . . 0.0 110.325 -176.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 132.81 -147.15 18.82 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.447 1.022 . . . . 0.0 114.299 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -81.25 114.73 2.84 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.917 3.078 . . . . 0.0 110.306 -172.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.1 t -110.6 120.39 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.422 1.489 . . . . 0.0 110.57 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.578 HG22 ' HD2' ' A' ' 45' ' ' LYS . 4.2 mt -61.41 -57.14 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.578 ' HD2' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -157.1 163.87 38.5 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 127.281 2.232 . . . . 0.0 113.582 -178.148 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 33' ' ' LEU . 73.2 t -118.22 146.66 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 128.651 2.78 . . . . 0.0 110.136 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -122.58 128.52 50.82 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.803 1.638 . . . . 0.0 113.607 171.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 4.3 mm -107.35 120.96 46.01 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 125.459 1.503 . . . . 0.0 110.647 163.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 72.9 Cg_endo -73.42 168.45 24.72 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 125.029 3.819 . . . . 0.0 113.318 165.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -158.6 122.55 3.99 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.639 2.775 . . . . 0.0 111.965 166.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.62 164.95 0.3 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.218 2.607 . . . . 0.0 113.248 165.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -49.88 -29.71 8.67 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 164.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.12 -7.84 59.11 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.002 1.321 . . . . 0.0 114.555 170.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.15 38.93 7.6 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 119.88 -1.763 . . . . 0.0 111.952 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.28 132.91 24.6 Favored Pre-proline 0 C--N 1.347 0.493 0 CA-C-N 118.619 1.209 . . . . 0.0 114.26 -176.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.21 12.16 0.3 Allowed 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.308 3.339 . . . . 0.0 113.861 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.439 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 58.82 22.32 10.02 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.485 -1.384 . . . . 0.0 113.147 172.244 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.444 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 19.8 mt-30 57.86 34.39 24.31 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.13 1.372 . . . . 0.0 114.106 -171.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.556 ' HA ' HD23 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -150.8 158.74 44.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.75 1.22 . . . . 0.0 113.247 -176.488 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.64 -176.86 6.18 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.251 1.42 . . . . 0.0 112.501 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -140.43 154.57 46.7 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.159 -0.963 . . . . 0.0 113.189 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.46 139.34 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.766 0.826 . . . . 0.0 113.174 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -95.3 123.91 39.06 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.113 1.365 . . . . 0.0 112.881 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -100.14 152.26 20.45 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 122.612 1.196 . . . . 0.0 114.119 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -91.13 -27.07 18.79 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 128.223 2.609 . . . . 0.0 112.809 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -150.97 -7.57 0.26 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 116.778 2.14 . . . . 0.0 116.778 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -79.98 38.12 0.39 Allowed 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -159.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.5 t -67.56 123.63 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 120.364 -1.46 . . . . 0.0 108.986 -175.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.268 3.0 m 69.74 -8.42 0.78 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.68 82.93 15.17 Favored Pre-proline 0 N--CA 1.493 1.687 0 CA-C-N 121.816 2.098 . . . . 0.0 112.909 169.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.83 115.01 3.74 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 125.284 3.989 . . . . 0.0 109.993 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -64.59 -29.29 70.3 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.844 -1.16 . . . . 0.0 113.593 -161.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.06 -18.68 64.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.7 ttp -61.12 -17.84 54.88 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 120.137 1.335 . . . . 0.0 112.206 173.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -109.22 -44.2 3.99 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.54 1.136 . . . . 0.0 111.888 171.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.29 -43.15 95.68 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.566 0.347 . . . . 0.0 111.55 -170.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -107.96 -88.34 0.48 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.616 1.166 . . . . 0.0 111.258 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 27.01 71.11 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 129.73 3.212 . . . . 0.0 115.712 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.43 14.98 1.49 Allowed Glycine 0 CA--C 1.532 1.155 0 CA-C-O 117.598 -1.668 . . . . 0.0 116.085 -174.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -125.08 150.98 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 119.793 1.797 . . . . 0.0 111.2 -168.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.88 171.21 16.98 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.745 1.218 . . . . 0.0 113.742 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.8 tp -120.28 -46.58 2.39 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.637 1.175 . . . . 0.0 109.75 166.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -69.32 -54.8 12.72 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.29 -46.2 0.06 OUTLIER Glycine 0 CA--C 1.537 1.414 0 N-CA-C 116.265 1.266 . . . . 0.0 116.265 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -105.15 114.71 63.28 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 127.619 2.368 . . . . 0.0 114.101 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.92 119.5 6.53 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.715 2.943 . . . . 0.0 113.033 -171.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.416 HD11 ' CD2' ' A' ' 33' ' ' LEU . 1.7 mm -50.24 124.08 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.903 1.281 . . . . 0.0 110.1 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -118.86 109.88 16.54 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 124.487 1.115 . . . . 0.0 112.037 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mp -81.88 131.23 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -118.35 145.01 45.45 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -158.63 145.19 17.22 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 118.366 2.728 . . . . 0.0 118.366 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -105.27 131.88 52.17 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 129.465 3.106 . . . . 0.0 111.333 174.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 86.0 p -69.64 162.44 27.65 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.455 1.102 . . . . 0.0 112.148 170.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.11 -9.2 0.03 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.472 1.51 . . . . 0.0 114.123 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 56.8 m -95.01 151.17 19.4 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.88 2.072 . . . . 0.0 110.234 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 40.2 m -116.16 161.28 19.18 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 127.182 2.193 . . . . 0.0 111.935 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -74.56 -24.8 58.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.433 1.493 . . . . 0.0 111.881 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . 0.257 . . 68.89 153.73 0.14 Allowed Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 127.856 2.462 . . . . 0.0 114.195 177.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -94.49 -173.13 0.3 Allowed 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 124.985 3.79 . . . . 0.0 113.23 174.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -151.49 -29.68 0.18 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 176.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 C--O 1.256 1.412 0 C-N-CA 128.086 2.554 . . . . 0.0 115.946 174.88 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.748 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.9 m -94.43 64.79 3.16 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.248 1.419 . . . . 0.0 110.765 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -66.76 145.53 55.42 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -172.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -64.09 -37.94 89.26 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.241 -1.537 . . . . 0.0 112.269 -178.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -80.76 31.37 0.3 Allowed 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -175.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.1 mt -120.55 148.34 43.98 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 127.214 2.206 . . . . 0.0 112.616 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -68.45 95.88 0.65 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 122.889 1.328 . . . . 0.0 110.404 164.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.3 mtm105 -134.46 9.68 3.71 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 129.17 2.988 . . . . 0.0 115.269 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -78.73 158.43 28.29 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 127.157 2.183 . . . . 0.0 111.756 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -34.89 -28.06 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 131.259 3.824 . . . . 0.0 120.845 -175.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.71 162.89 40.67 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.556 1.071 . . . . 0.0 111.41 -173.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 29.2 mt 59.3 4.19 0.45 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 127.593 2.357 . . . . 0.0 117.206 171.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.39 -5.02 55.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.956 2.102 . . . . 0.0 115.372 -167.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -118.76 167.89 11.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -153.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.97 151.61 46.4 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.676 2.39 . . . . 0.0 111.791 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -162.42 165.39 26.41 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.343 1.457 . . . . 0.0 113.122 -174.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -70.95 -15.32 62.58 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.867 -1.145 . . . . 0.0 113.687 161.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.5 m -104.41 138.28 41.05 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.723 2.009 . . . . 0.0 111.218 -175.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.8 tp -75.28 132.53 41.1 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.732 2.413 . . . . 0.0 110.549 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -84.79 137.73 33.01 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 120.288 1.404 . . . . 0.0 110.622 175.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.57 115.79 32.77 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.87 -177.28 18.37 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.357 1.456 . . . . 0.0 110.396 172.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.2 t30 65.52 37.72 5.9 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.119 1.368 . . . . 0.0 111.698 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.576 ' CD1' HG21 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -74.81 152.04 39.02 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.028 1.731 . . . . 0.0 109.468 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 26' ' ' THR . 0.7 OUTLIER -67.9 170.96 7.27 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 123.966 1.841 . . . . 0.0 112.587 169.451 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.487 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 24.9 p -82.54 -13.77 56.06 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 126.293 1.837 . . . . 0.0 113.331 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -119.11 20.33 12.69 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.25 2.62 . . . . 0.0 113.08 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.576 HG21 ' CD1' ' A' ' 24' ' ' LEU . 8.0 p -71.67 158.23 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -177.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.1 p -153.5 167.0 30.93 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.441 1.096 . . . . 0.0 111.697 -173.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.442 ' HA ' HG11 ' A' ' 46' ' ' VAL . 43.0 mt-10 -63.78 -32.12 73.52 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.011 0.924 . . . . 0.0 108.713 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.12 -47.85 81.03 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.559 1.944 . . . . 0.0 113.109 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.3 tp -67.11 -36.94 83.01 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.095 0.558 . . . . 0.0 110.922 -175.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.533 HD21 ' CD1' ' A' ' 24' ' ' LEU . 99.2 mt -65.89 -51.17 61.02 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.17 1.388 . . . . 0.0 111.042 172.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -52.59 -43.52 65.36 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.838 2.055 . . . . 0.0 113.523 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -75.23 -27.63 59.6 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -76.14 -38.73 56.4 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.608 -0.683 . . . . 0.0 112.067 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.466 ' CE2' HG21 ' A' ' 62' ' ' VAL . 56.8 m-85 -82.03 11.53 5.06 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.595 -1.315 . . . . 0.0 114.06 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -62.95 -44.78 95.12 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.124 1.37 . . . . 0.0 113.786 -174.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.72 6.7 44.93 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.639 1.576 . . . . 0.0 111.351 168.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.66 3.66 43.72 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 120.744 1.611 . . . . 0.0 112.673 171.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.85 -167.94 12.59 Favored Glycine 0 CA--C 1.538 1.515 0 C-N-CA 127.918 2.675 . . . . 0.0 111.831 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.04 97.74 0.93 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.697 2.264 . . . . 0.0 111.328 -173.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.8 t -68.33 119.23 13.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 122.58 1.181 . . . . 0.0 110.335 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.9 mm -80.54 -46.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -175.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.99 155.19 30.87 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.885 1.674 . . . . 0.0 110.111 174.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.442 HG11 ' HA ' ' A' ' 30' ' ' GLU . 42.5 t -112.64 153.87 14.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 125.681 1.593 . . . . 0.0 107.45 170.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -126.91 126.4 43.19 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.905 1.282 . . . . 0.0 112.39 169.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.429 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 1.6 mm -105.54 122.78 41.59 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 123.892 0.877 . . . . 0.0 109.594 164.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 65.4 Cg_endo -71.71 166.21 30.17 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.847 3.031 . . . . 0.0 110.153 164.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -160.72 120.06 2.67 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 128.087 2.555 . . . . 0.0 106.072 174.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.25 172.81 2.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.359 -1.746 . . . . 0.0 110.75 167.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -32.61 62.97 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 122.405 1.098 . . . . 0.0 111.045 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -77.45 -3.61 41.23 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.648 1.979 . . . . 0.0 113.116 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.95 41.51 8.1 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.541 2.019 . . . . 0.0 113.618 170.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -136.46 135.48 20.77 Favored Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.32 15.39 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.585 1 C-N-CA 126.106 4.537 . . . . 0.0 116.005 -174.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.76 29.22 9.24 Favored 'General case' 0 CA--C 1.557 1.22 0 O-C-N 121.548 -0.72 . . . . 0.0 111.91 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 53.99 38.41 28.83 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -174.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.408 ' HA ' HD23 ' A' ' 24' ' ' LEU . 1.1 p90 -152.72 173.36 15.37 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 127.787 2.435 . . . . 0.0 113.257 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -169.71 174.51 5.72 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 128.882 2.873 . . . . 0.0 112.737 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -127.01 153.92 45.3 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.706 2.003 . . . . 0.0 112.274 170.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.466 HG21 ' CE2' ' A' ' 37' ' ' PHE . 4.7 t -141.2 140.17 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.66 1.984 . . . . 0.0 108.008 -178.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -105.86 131.07 53.64 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -127.57 152.92 47.01 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.878 1.671 . . . . 0.0 109.293 162.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -98.61 158.02 15.87 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.499 -1.376 . . . . 0.0 111.99 -176.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 37.9 56.45 1.58 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.619 2.368 . . . . 0.0 113.29 176.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -88.75 146.83 24.79 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.49 1.916 . . . . 0.0 110.322 -173.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.3 m -118.8 -171.36 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 127.295 2.238 . . . . 0.0 108.984 175.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.4 143.81 56.91 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.475 1.11 . . . . 0.0 111.076 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 t 70.04 107.35 0.03 OUTLIER Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 127.869 2.468 . . . . 0.0 116.745 -175.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.23 137.34 36.75 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 124.629 3.553 . . . . 0.0 113.731 173.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -59.7 -42.6 93.36 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.847 1.259 . . . . 0.0 109.547 -175.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.86 -25.4 28.54 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 173.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 tpt -71.93 -16.05 62.1 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 121.456 1.935 . . . . 0.0 113.788 -173.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -103.16 -35.96 8.29 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.315 1.846 . . . . 0.0 111.271 169.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.67 -48.98 23.1 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.964 1.706 . . . . 0.0 112.633 -169.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.15 -97.14 0.33 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.73 1.612 . . . . 0.0 108.63 177.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 39.55 57.57 2.13 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.447 1.899 . . . . 0.0 112.69 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.52 22.54 0.13 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.89 151.6 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 118.711 1.255 . . . . 0.0 113.806 -168.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.51 176.91 6.24 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.91 1.684 . . . . 0.0 110.93 -170.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.9 tp -125.87 -35.83 2.45 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.088 1.755 . . . . 0.0 112.428 170.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 14.7 m-30 -81.79 -61.23 1.98 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.986 1.715 . . . . 0.0 111.059 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.87 -49.1 0.06 OUTLIER Glycine 0 N--CA 1.468 0.809 0 N-CA-C 117.297 1.679 . . . . 0.0 117.297 -176.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -90.87 116.67 66.91 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -171.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.08 128.82 13.43 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.177 2.585 . . . . 0.0 110.393 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.3 mm -63.87 118.65 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.155 -174.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -103.5 91.73 4.17 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.87 1.668 . . . . 0.0 110.799 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.45 ' H ' HD12 ' A' ' 89' ' ' ILE . 4.2 mp -60.14 139.13 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.203 165.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -138.71 157.31 46.35 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.282 1.433 . . . . 0.0 112.342 167.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -150.95 155.27 38.75 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 174.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.7 mmm-85 -89.44 149.13 23.08 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.9 m -124.06 173.02 8.54 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 128.64 2.776 . . . . 0.0 112.938 165.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 158.5 23.9 0.03 OUTLIER Glycine 0 CA--C 1.551 2.327 0 N-CA-C 118.338 2.095 . . . . 0.0 118.338 -172.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.8 m 45.86 44.69 11.24 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.785 2.292 . . . . 0.0 116.862 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.1 p -163.07 163.13 26.0 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.682 -1.261 . . . . 0.0 113.628 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -133.6 141.93 47.89 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 127.508 2.323 . . . . 0.0 112.191 -168.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -51.45 142.0 22.31 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.018 0.927 . . . . 0.0 110.506 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -81.98 129.39 6.15 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 124.183 3.255 . . . . 0.0 111.774 172.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -103.14 -22.64 13.72 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 127.552 2.341 . . . . 0.0 114.984 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 N--CA 1.489 1.511 0 C-N-CA 128.405 2.682 . . . . 0.0 113.57 -171.509 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.515 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.8 m -61.5 145.4 51.98 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.545 1.138 . . . . 0.0 113.185 -167.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -62.83 146.69 52.08 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.028 0.531 . . . . 0.0 110.874 -173.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -148.85 -25.74 0.31 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.658 1.983 . . . . 0.0 115.238 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -110.3 2.77 19.36 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.599 1.56 . . . . 0.0 113.162 -177.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.43 156.9 30.89 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 120.784 1.629 . . . . 0.0 108.936 163.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -64.75 138.94 58.68 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 169.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.4 -23.41 37.63 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.463 1.105 . . . . 0.0 112.848 171.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -86.58 160.18 19.01 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.745 1.218 . . . . 0.0 110.235 164.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -61.55 -31.63 71.67 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 -168.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.1 167.4 24.19 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 120.803 1.638 . . . . 0.0 113.265 -172.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 pp -54.92 153.1 6.59 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.361 1.865 . . . . 0.0 108.331 160.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -132.27 1.46 3.82 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 120.45 -1.406 . . . . 0.0 114.589 -150.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -145.93 136.06 23.73 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 118.814 0.733 . . . . 0.0 112.854 -172.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.44 166.53 32.97 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 126.585 1.954 . . . . 0.0 112.383 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -146.38 153.87 40.99 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 127.006 2.122 . . . . 0.0 111.529 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.24 13.04 4.52 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 -174.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.52 149.81 39.61 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -155.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 51.1 tp -106.83 133.37 51.59 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.195 2.598 . . . . 0.0 111.792 -172.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -88.0 133.0 34.05 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.56 0.618 . . . . 0.0 110.492 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.3 t -130.57 122.87 53.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 O-C-N 120.966 -1.084 . . . . 0.0 108.76 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 59' ' ' PHE . . . -125.32 -175.78 14.33 Favored Glycine 0 N--CA 1.464 0.548 0 C-N-CA 126.264 1.888 . . . . 0.0 112.057 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.1 t30 64.45 31.95 12.21 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.854 2.062 . . . . 0.0 111.907 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.465 ' HB3' HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -66.74 166.4 13.18 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.391 1.876 . . . . 0.0 111.531 -178.867 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 26' ' ' THR . 1.0 OUTLIER -82.74 165.82 19.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 123.126 1.441 . . . . 0.0 113.65 166.446 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.486 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 67.4 p -65.91 -34.2 77.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.505 1.522 . . . . 0.0 111.88 175.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.09 19.52 20.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.736 2.014 . . . . 0.0 115.395 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.465 HG11 ' HB3' ' A' ' 24' ' ' LEU . 3.8 p -64.88 155.85 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 125.012 1.325 . . . . 0.0 111.264 174.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.7 p -159.75 162.06 34.83 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.667 1.987 . . . . 0.0 110.319 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -60.09 -30.49 69.28 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.204 0.602 . . . . 0.0 110.316 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -59.94 -41.87 92.78 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.153 1.781 . . . . 0.0 112.321 174.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.585 HD21 HD13 ' A' ' 82' ' ' LEU . 1.6 tm? -72.04 -51.99 19.05 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.7 mt -56.41 -39.87 73.75 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -66.44 -46.36 76.72 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.01 0.823 . . . . 0.0 110.757 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -57.04 -39.71 75.36 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.807 1.643 . . . . 0.0 111.721 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -81.61 -42.85 19.45 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.933 1.693 . . . . 0.0 112.884 -175.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . 0.329 48.0 m-85 -76.54 -4.93 45.37 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 172.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -54.7 -42.62 71.69 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 121.902 2.137 . . . . 0.0 111.503 164.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -72.66 -15.86 61.71 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.16 -1.23 57.89 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.495 1.043 . . . . 0.0 113.773 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.64 -148.51 18.41 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.071 0.843 . . . . 0.0 111.221 -174.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -75.62 157.5 40.17 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.798 2.332 . . . . 0.0 112.78 171.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.1 147.32 21.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 127.116 2.167 . . . . 0.0 107.502 170.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.7 mm -88.49 -51.6 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 121.006 -1.059 . . . . 0.0 109.608 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.74 168.84 25.9 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.549 2.339 . . . . 0.0 112.561 175.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.8 t -122.9 144.63 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 129.874 3.269 . . . . 0.0 110.609 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -127.41 122.58 33.96 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 130.307 3.443 . . . . 0.0 115.275 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.0 mm -107.09 125.89 31.44 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.145 1.778 . . . . 0.0 110.067 167.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.14 167.62 23.06 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.776 3.65 . . . . 0.0 111.289 163.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -160.58 118.56 2.51 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 128.111 2.564 . . . . 0.0 110.35 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -52.37 163.43 0.41 Allowed 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 126.852 2.061 . . . . 0.0 113.698 169.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -30.6 43.46 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.031 1.332 . . . . 0.0 113.093 172.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -87.04 -9.67 54.91 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 171.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.25 51.71 1.21 Allowed Glycine 0 C--N 1.338 0.653 0 C-N-CA 125.937 1.732 . . . . 0.0 113.453 165.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -141.13 134.93 14.82 Favored Pre-proline 0 N--CA 1.467 0.392 0 CA-C-O 117.547 -1.216 . . . . 0.0 112.988 -176.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.53 12.51 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.531 1 C-N-CA 126.673 4.916 . . . . 0.0 115.422 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.11 20.81 10.05 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.703 -1.248 . . . . 0.0 111.722 173.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.441 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 44.0 mt-30 59.08 38.47 23.91 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.701 2.0 . . . . 0.0 113.515 -173.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.412 ' HA ' ' HA2' ' A' ' 22' ' ' GLY . 0.2 OUTLIER -156.32 165.01 37.6 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.837 2.055 . . . . 0.0 111.529 -179.114 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.03 -179.21 6.07 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 128.671 2.788 . . . . 0.0 111.149 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -142.42 154.17 44.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.464 1.506 . . . . 0.0 114.411 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.8 t -143.32 120.92 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.958 1.303 . . . . 0.0 111.73 -176.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -73.21 129.9 39.06 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.848 -1.157 . . . . 0.0 111.58 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -148.64 140.92 24.11 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.706 1.202 . . . . 0.0 113.784 -164.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.0 3.67 44.98 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 128.19 2.596 . . . . 0.0 116.33 -167.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -80.11 139.93 36.65 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.921 0.782 . . . . 0.0 112.337 175.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -105.8 2.45 27.82 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.412 1.485 . . . . 0.0 112.322 -173.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.02 165.34 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.457 1.903 . . . . 0.0 111.114 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.6 m -83.06 31.37 0.44 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.49 1.916 . . . . 0.0 115.391 -160.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.256 18.0 m -118.65 55.18 2.39 Favored Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -174.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -65.99 119.03 6.0 Favored 'Trans proline' 0 C--N 1.355 0.878 1 C-N-CA 125.412 4.075 . . . . 0.0 112.128 -166.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -50.5 -36.56 34.44 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -164.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.446 ' HB1' HD23 ' A' ' 77' ' ' LEU . . . -72.96 -22.92 60.63 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.439 1.496 . . . . 0.0 114.528 -176.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.7 ttt -64.45 -21.01 66.53 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.652 1.181 . . . . 0.0 110.192 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -101.36 -34.63 9.53 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.253 1.821 . . . . 0.0 112.987 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.61 -39.92 23.75 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -172.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.446 HD23 ' HB1' ' A' ' 73' ' ' ALA . 1.6 mm? -113.3 -84.25 0.59 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.293 1.037 . . . . 0.0 109.852 -176.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.263 0.4 OUTLIER 23.7 59.85 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 129.306 3.043 . . . . 0.0 114.277 176.778 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.14 18.51 0.24 Allowed Glycine 0 CA--C 1.549 2.201 0 N-CA-C 118.162 2.025 . . . . 0.0 118.162 -169.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -138.41 149.71 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 121.124 2.462 . . . . 0.0 110.784 -165.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.33 156.76 24.36 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.585 HD13 HD21 ' A' ' 32' ' ' LEU . 1.3 mp -110.12 3.15 19.94 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.097 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -129.27 -85.56 0.55 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 129.033 2.933 . . . . 0.0 108.141 -173.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.43 -43.39 0.02 OUTLIER Glycine 0 N--CA 1.481 1.679 0 N-CA-C 115.91 1.124 . . . . 0.0 115.91 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' A' ' 86' ' ' PRO . 3.6 mpt_? -95.59 118.94 65.9 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 118.154 -0.927 . . . . 0.0 109.792 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 36.9 Cg_endo -74.9 125.95 9.72 Favored 'Trans proline' 0 C--N 1.351 0.705 1 C-N-CA 125.801 4.334 . . . . 0.0 114.373 -172.806 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.2 mm -55.31 124.99 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 122.808 0.443 . . . . 0.0 110.292 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -109.38 118.14 35.87 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 126.764 2.026 . . . . 0.0 110.055 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.5 mp -93.0 141.18 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.423 -0.798 . . . . 0.0 110.074 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -135.18 167.25 21.33 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.445 1.498 . . . . 0.0 110.338 171.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -129.01 156.94 43.02 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.671 1.988 . . . . 0.0 113.572 175.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -123.68 20.66 9.37 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.622 2.369 . . . . 0.0 114.024 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.52 130.85 40.95 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.348 -1.47 . . . . 0.0 108.951 176.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.02 -137.4 26.61 Favored Glycine 0 CA--C 1.538 1.483 0 O-C-N 121.116 -0.99 . . . . 0.0 113.604 -170.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 57.4 m -130.09 133.04 46.41 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.639 1.576 . . . . 0.0 110.859 -168.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.3 m -69.59 -31.0 68.89 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.39 0.995 . . . . 0.0 113.622 170.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -123.62 156.28 36.11 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.177 2.191 . . . . 0.0 110.585 -173.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.34 153.83 41.75 Favored Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 120.566 -1.334 . . . . 0.0 111.093 -173.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -63.82 158.46 46.69 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 122.08 1.853 . . . . 0.0 111.505 168.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -93.88 -29.41 15.32 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 127.532 2.333 . . . . 0.0 112.737 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.7 t0 . . . . . 0 C--O 1.258 1.539 0 C-N-CA 130.364 3.466 . . . . 0.0 106.744 167.323 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.678 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -131.08 -9.62 3.81 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.79 1.636 . . . . 0.0 113.533 169.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.1 mp0 -85.93 120.45 27.35 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.095 1.358 . . . . 0.0 112.134 -161.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -110.37 -30.55 7.63 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.294 1.038 . . . . 0.0 113.333 -169.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -104.9 -6.54 20.08 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.243 1.817 . . . . 0.0 114.709 -162.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.0 mt -69.92 157.48 37.37 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.932 -0.48 . . . . 0.0 110.761 173.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.06 149.23 39.25 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 127.387 2.275 . . . . 0.0 110.951 -171.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -155.75 161.56 40.67 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.389 2.275 . . . . 0.0 111.571 170.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -59.44 164.22 3.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.443 0.697 . . . . 0.0 112.723 173.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -53.76 -36.85 62.8 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.296 1.438 . . . . 0.0 112.02 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.69 166.66 15.81 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 125.746 1.618 . . . . 0.0 109.625 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.92 160.15 18.28 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 121.948 0.88 . . . . 0.0 111.76 173.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -152.2 167.15 29.51 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.388 1.475 . . . . 0.0 113.001 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -139.71 -171.83 3.24 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.251 1.021 . . . . 0.0 110.61 -158.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.48 149.22 28.83 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -152.92 122.57 6.83 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.346 2.658 . . . . 0.0 111.185 166.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -85.95 -12.28 50.89 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.776 1.23 . . . . 0.0 113.971 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.7 m -127.58 128.38 45.47 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 122.41 1.1 . . . . 0.0 110.563 -163.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.7 tp -99.93 138.08 37.5 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.949 2.1 . . . . 0.0 111.803 -170.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -88.17 137.94 31.89 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 122.06 0.933 . . . . 0.0 111.746 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -133.74 131.07 56.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.356 -0.84 . . . . 0.0 109.166 178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.64 -176.73 14.54 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 126.225 1.869 . . . . 0.0 110.262 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.9 t30 69.09 13.2 8.7 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.807 1.643 . . . . 0.0 114.646 -178.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.797 HD12 HG21 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -61.99 144.26 55.35 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 126.253 1.821 . . . . 0.0 112.878 179.35 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 13.3 mp0 -50.77 162.22 0.28 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 173.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.5 p -72.51 -22.37 61.05 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.948 175.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.96 21.28 9.88 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 129.895 3.278 . . . . 0.0 113.014 -177.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.797 HG21 HD12 ' A' ' 24' ' ' LEU . 4.9 p -64.15 162.04 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 120.855 -1.153 . . . . 0.0 112.066 173.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.3 p -159.64 168.91 24.91 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.31 1.844 . . . . 0.0 112.86 174.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HA ' HG11 ' A' ' 46' ' ' VAL . 45.2 mt-10 -62.66 -27.17 69.04 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.174 1.39 . . . . 0.0 112.31 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -62.8 -49.94 72.98 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.76 1.164 . . . . 0.0 111.921 170.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.8 tp -64.66 -47.57 77.98 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.408 HD22 ' HE2' ' A' ' 37' ' ' PHE . 31.1 mt -62.57 -37.49 86.37 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -63.14 -47.09 84.19 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.06 0.845 . . . . 0.0 112.11 173.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -72.05 -19.57 61.82 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.451 1.5 . . . . 0.0 113.324 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.5 tt -92.61 -49.25 6.2 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.146 1.779 . . . . 0.0 112.162 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.408 ' HE2' HD22 ' A' ' 33' ' ' LEU . 61.6 m-85 -72.77 -18.07 61.53 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.209 -0.932 . . . . 0.0 112.442 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -60.86 -26.5 67.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.775 1.625 . . . . 0.0 113.356 171.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -64.25 -31.39 72.57 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.247 -1.533 . . . . 0.0 112.78 168.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.86 1.45 34.94 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.39 1.076 . . . . 0.0 112.465 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.52 -146.53 16.91 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.295 1.426 . . . . 0.0 113.631 169.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -74.13 90.8 0.96 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 CA-C-N 119.567 1.684 . . . . 0.0 114.637 -167.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.7 t -74.91 133.42 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 125.535 1.534 . . . . 0.0 109.791 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.8 mt -85.24 -55.69 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 127.272 2.229 . . . . 0.0 111.047 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.06 152.65 28.3 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 128.019 2.528 . . . . 0.0 107.54 -175.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' A' ' 30' ' ' GLU . 38.3 t -106.48 151.13 8.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 127.946 2.498 . . . . 0.0 105.423 172.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -127.75 124.33 37.49 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 124.113 0.965 . . . . 0.0 113.358 166.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.428 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 6.9 mm -101.57 120.31 54.85 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.053 163.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 43.0 Cg_endo -68.95 167.95 21.89 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 124.689 3.592 . . . . 0.0 110.222 165.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -157.45 115.87 3.19 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.134 1.374 . . . . 0.0 107.829 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -50.54 164.32 0.14 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.237 2.215 . . . . 0.0 111.264 161.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.5 pptp? -53.24 -29.53 33.08 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 120.808 -1.183 . . . . 0.0 113.567 167.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.29 -4.37 55.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.077 0.951 . . . . 0.0 112.604 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.55 35.62 8.46 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 125.962 1.744 . . . . 0.0 111.532 170.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -124.11 136.66 27.83 Favored Pre-proline 0 C--N 1.345 0.388 0 CA-C-N 118.958 1.379 . . . . 0.0 113.641 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.25 12.11 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 124.01 3.14 . . . . 0.0 118.316 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.62 27.78 11.0 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 121.286 1.857 . . . . 0.0 113.383 176.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 54.36 35.26 22.55 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.199 1.8 . . . . 0.0 113.413 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.549 ' HA ' HD23 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -147.93 162.66 38.85 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.783 -1.198 . . . . 0.0 110.494 -177.125 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -154.68 -179.23 7.81 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.213 1.405 . . . . 0.0 110.763 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -134.96 163.83 28.96 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.058 1.743 . . . . 0.0 109.808 165.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.4 t -145.96 134.7 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 127.145 2.178 . . . . 0.0 108.449 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -104.2 144.31 31.76 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.938 1.695 . . . . 0.0 111.059 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -133.07 157.35 45.48 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 121.949 2.158 . . . . 0.0 114.033 -167.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.1 mmtp -68.88 -22.03 64.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.156 -1.59 . . . . 0.0 113.538 166.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -69.93 146.52 51.12 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.768 0.827 . . . . 0.0 110.418 172.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -123.97 -23.64 4.58 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 m -68.3 27.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 128.775 2.83 . . . . 0.0 115.953 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 99.8 p 50.13 46.79 24.36 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.938 2.095 . . . . 0.0 111.032 177.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 p -97.44 103.17 14.97 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 126.139 1.775 . . . . 0.0 111.381 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -80.75 70.71 7.41 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.93 2.42 . . . . 0.0 113.111 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -51.06 -36.09 38.11 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.98 0.912 . . . . 0.0 111.748 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.96 -27.21 64.55 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 ttt -59.55 -28.22 66.92 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 119.754 1.161 . . . . 0.0 111.069 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -86.98 -19.32 28.89 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.753 2.021 . . . . 0.0 110.787 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.62 -45.05 4.12 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.348 1.459 . . . . 0.0 112.533 -161.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.54 -92.85 0.43 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.955 1.702 . . . . 0.0 109.322 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.261 0.9 OUTLIER 37.75 52.23 1.4 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.742 2.017 . . . . 0.0 115.191 165.84 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.38 17.79 0.21 Allowed Glycine 0 CA--C 1.534 1.246 0 CA-C-N 114.795 -1.093 . . . . 0.0 115.749 -167.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -141.82 150.59 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 118.285 1.043 . . . . 0.0 113.734 -170.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.09 167.32 26.54 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -173.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.0 tp -98.0 -34.93 10.61 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 113.349 -1.75 . . . . 0.0 111.593 169.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.409 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 43.9 m-85 -104.26 -50.22 3.4 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -167.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 172.39 -30.9 0.11 Allowed Glycine 0 CA--C 1.543 1.785 0 CA-C-O 117.991 -1.45 . . . . 0.0 115.192 -175.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -99.69 97.47 5.8 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 127.148 2.179 . . . . 0.0 115.242 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.05 114.99 2.86 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.943 3.095 . . . . 0.0 113.249 -173.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.6 mm -47.83 124.7 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 C-N-CA 125.926 1.69 . . . . 0.0 111.906 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -108.63 113.0 25.62 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 124.479 1.112 . . . . 0.0 111.584 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mp -88.64 137.93 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -130.49 172.6 11.71 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 172.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -151.81 146.5 25.75 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 120.013 -1.679 . . . . 0.0 113.132 -160.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -113.61 148.14 36.79 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.016 1.326 . . . . 0.0 108.382 165.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.8 p -102.24 3.92 38.74 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 125.25 1.42 . . . . 0.0 112.882 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.61 172.8 18.82 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.39 1.472 . . . . 0.0 113.308 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.6 m -102.92 114.19 28.27 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.493 1.117 . . . . 0.0 112.305 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 68.5 m -53.99 142.06 26.05 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 161.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.43 148.87 35.15 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.766 1.226 . . . . 0.0 110.372 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.87 160.06 27.46 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.022 0.929 . . . . 0.0 113.361 -171.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.68 166.06 29.09 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 122.829 2.353 . . . . 0.0 112.195 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -114.77 -19.73 10.92 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 128.668 2.787 . . . . 0.0 113.696 172.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 N--CA 1.493 1.7 0 C-N-CA 126.676 1.991 . . . . 0.0 111.667 -179.085 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.164 0 N-CA-C 114.959 0.743 . . . . 0.0 114.959 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 m -64.76 -21.6 66.8 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 117.271 2.323 . . . . 0.0 117.271 -162.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -113.3 133.76 54.95 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.343 0.974 . . . . 0.0 111.62 -170.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -159.79 -15.06 0.06 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 127.754 2.422 . . . . 0.0 112.806 168.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -92.64 0.92 57.49 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 119.65 -1.906 . . . . 0.0 113.246 176.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -96.36 167.31 11.25 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.361 1.464 . . . . 0.0 111.041 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.601 ' H ' ' HD3' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -47.12 135.9 9.36 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 129.195 2.998 . . . . 0.0 111.592 169.366 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -129.93 18.07 5.61 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 118.628 2.825 . . . . 0.0 118.628 -165.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -73.38 164.22 26.98 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 119.875 -1.766 . . . . 0.0 110.367 169.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . 0.309 8.3 pt20 -73.91 -77.11 0.12 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -174.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -164.17 173.5 12.33 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.257 1.023 . . . . 0.0 113.114 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.9 mt -109.87 153.66 24.14 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 130.029 3.331 . . . . 0.0 113.648 -175.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.88 -50.53 0.16 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 170.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 57.13 -14.34 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 119.149 3.018 . . . . 0.0 119.149 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -157.36 169.65 24.24 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 129.075 2.95 . . . . 0.0 111.013 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -128.77 -25.96 2.76 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 173.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -88.63 -13.03 40.86 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 127.402 2.281 . . . . 0.0 110.891 168.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.7 m -126.74 132.23 51.15 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.07 1.348 . . . . 0.0 108.832 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.3 tp -100.33 133.23 45.06 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 125.083 1.353 . . . . 0.0 112.163 -167.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -82.26 130.45 35.1 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.143 1.377 . . . . 0.0 114.042 177.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 t -145.39 128.45 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 124.941 1.296 . . . . 0.0 107.581 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.5 -176.51 14.45 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 126.308 1.908 . . . . 0.0 110.581 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.5 t30 71.67 16.78 5.68 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.846 2.059 . . . . 0.0 114.085 -172.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.419 ' HB2' ' C ' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -61.85 139.57 58.35 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 127.295 2.238 . . . . 0.0 110.392 -172.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.492 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 4.6 mt-10 -60.41 162.13 6.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 124.414 2.054 . . . . 0.0 116.109 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.1 p -68.94 -28.14 66.38 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.888 1.675 . . . . 0.0 111.615 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.1 tppt? -107.11 9.18 30.45 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 131.056 3.743 . . . . 0.0 115.649 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 p -59.7 161.73 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.127 1.371 . . . . 0.0 112.885 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 p -158.56 165.03 35.48 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.754 1.622 . . . . 0.0 112.321 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -59.47 -27.52 66.18 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.581 -0.7 . . . . 0.0 110.156 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -67.53 -44.17 78.99 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.834 1.254 . . . . 0.0 111.831 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.3 tp -72.44 -39.75 67.57 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.531 0.732 . . . . 0.0 111.095 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.565 ' HB2' HG11 ' A' ' 46' ' ' VAL . 71.6 mt -63.52 -40.85 98.13 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.486 1.039 . . . . 0.0 110.653 174.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -59.16 -46.41 88.47 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.27 -33.13 67.24 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.504 1.047 . . . . 0.0 112.53 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.2 tt -69.03 -41.51 77.6 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.317 0.647 . . . . 0.0 112.206 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -89.57 8.57 30.56 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.806 1.242 . . . . 0.0 113.941 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -56.91 -48.79 77.4 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.263 -1.523 . . . . 0.0 113.131 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -74.19 -9.46 58.64 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.88 36.52 1.4 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -166.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.58 -165.83 40.97 Favored Glycine 0 CA--C 1.542 1.744 0 C-N-CA 123.764 0.697 . . . . 0.0 114.322 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -81.43 85.51 1.74 Allowed 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 121.446 1.431 . . . . 0.0 114.891 -168.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.82 129.92 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 126.648 1.979 . . . . 0.0 108.882 166.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mt -91.04 -54.49 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.17 1.788 . . . . 0.0 111.4 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.57 158.49 43.6 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.058 1.743 . . . . 0.0 111.624 -178.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.565 HG11 ' HB2' ' A' ' 33' ' ' LEU . 91.7 t -116.22 143.26 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.667 1.587 . . . . 0.0 111.529 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -121.59 132.25 54.57 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.38 1.872 . . . . 0.0 114.932 172.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.9 mm -118.47 119.14 33.21 Favored Pre-proline 0 N--CA 1.471 0.584 0 C-N-CA 128.039 2.536 . . . . 0.0 109.745 172.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.23 172.84 15.22 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.151 2.567 . . . . 0.0 113.691 169.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -153.17 108.92 3.29 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.513 2.325 . . . . 0.0 111.461 172.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -43.45 164.52 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 130.741 3.617 . . . . 0.0 115.643 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.25 -29.0 3.4 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 114.744 1.386 . . . . 0.0 114.744 165.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -93.73 -11.07 32.27 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 168.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.55 47.2 1.69 Allowed Glycine 0 N--CA 1.477 1.395 0 O-C-N 119.767 -1.833 . . . . 0.0 115.206 174.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -138.14 141.42 32.03 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 125.926 1.69 . . . . 0.0 113.31 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.81 14.27 0.2 Allowed 'Trans proline' 0 CA--C 1.545 1.028 1 C-N-CA 125.96 4.44 . . . . 0.0 115.145 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.68 21.78 6.18 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 174.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.419 ' C ' ' HB2' ' A' ' 24' ' ' LEU . 17.5 mt-30 59.01 35.78 24.14 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 125.105 1.362 . . . . 0.0 113.93 -169.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -155.74 161.59 40.67 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.552 1.541 . . . . 0.0 113.849 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.55 167.06 15.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.982 1.313 . . . . 0.0 113.197 -174.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -120.76 156.12 32.53 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.858 0.863 . . . . 0.0 112.734 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.3 t -144.45 112.51 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 C-N-CA 123.509 0.724 . . . . 0.0 110.176 -178.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -76.4 125.04 28.48 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.8 146.53 51.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.774 1.273 . . . . 0.0 110.683 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -75.87 105.85 7.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.793 -171.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 56.84 18.07 3.62 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 166.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -80.83 69.81 7.47 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 171.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.42 6.54 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 119.923 -1.736 . . . . 0.0 114.981 -169.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.5 t -170.68 164.04 8.11 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.585 1.554 . . . . 0.0 112.335 -160.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t 31.68 59.68 1.21 Allowed Pre-proline 0 N--CA 1.485 1.283 0 C-N-CA 127.592 2.357 . . . . 0.0 111.735 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.41 120.88 8.77 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.449 3.433 . . . . 0.0 112.499 -171.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.497 ' CD2' HD12 ' A' ' 76' ' ' LEU . 32.7 t80 -56.06 -35.65 67.18 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.098 1.359 . . . . 0.0 112.208 -166.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.11 -21.16 64.78 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.35 -23.19 64.07 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.767 1.627 . . . . 0.0 114.167 175.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -112.61 -30.04 7.24 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.652 1.581 . . . . 0.0 111.459 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.497 HD12 ' CD2' ' A' ' 72' ' ' TYR . 0.8 OUTLIER -73.49 -45.65 52.67 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.972 0.909 . . . . 0.0 112.532 -178.369 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.472 HD22 ' HB3' ' A' ' 76' ' ' LEU . 1.3 mm? -111.14 -84.28 0.57 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.76 2.024 . . . . 0.0 107.802 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 17.27 70.01 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 128.668 2.787 . . . . 0.0 115.264 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.6 19.88 0.24 Allowed Glycine 0 N--CA 1.469 0.835 0 N-CA-C 116.706 1.442 . . . . 0.0 116.706 -175.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.99 147.5 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.233 1.013 . . . . 0.0 112.872 -163.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.48 166.77 16.15 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 123.06 1.41 . . . . 0.0 113.345 -164.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.8 mt -132.34 -19.16 2.48 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.006 -1.906 . . . . 0.0 114.67 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.409 ' HB2' ' CD ' ' A' ' 25' ' ' GLU . 55.0 m-85 -106.88 -50.82 3.03 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.357 1.863 . . . . 0.0 108.485 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 176.99 -39.44 0.1 OUTLIER Glycine 0 CA--C 1.544 1.862 0 N-CA-C 116.944 1.538 . . . . 0.0 116.944 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.492 ' HB2' ' HG3' ' A' ' 25' ' ' GLU . 1.7 mpt_? -97.47 109.23 49.35 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 126.519 1.928 . . . . 0.0 111.847 -170.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.48 121.13 8.61 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.676 2.917 . . . . 0.0 115.198 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.2 mm -51.85 132.43 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.536 1.534 . . . . 0.0 110.244 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -123.8 109.57 13.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.802 1.641 . . . . 0.0 111.739 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -92.74 136.18 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 O-C-N 121.655 -0.653 . . . . 0.0 110.049 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -121.44 142.6 49.87 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 117.769 2.507 . . . . 0.0 117.769 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -124.84 136.37 53.75 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 111.757 -2.474 . . . . 0.0 109.148 167.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.74 -28.68 11.05 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.925 1.69 . . . . 0.0 111.3 165.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.8 m 51.39 38.15 21.0 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.674 2.39 . . . . 0.0 113.695 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.18 73.25 0.23 Allowed Glycine 0 CA--C 1.526 0.753 0 O-C-N 121.515 -0.741 . . . . 0.0 114.341 -169.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -145.04 -22.27 0.49 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.355 1.462 . . . . 0.0 114.566 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 55.3 p -100.61 -179.9 4.23 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.338 1.855 . . . . 0.0 113.453 174.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -132.38 -24.11 2.07 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -165.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -139.7 155.06 71.59 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.805 0.842 . . . . 0.0 111.222 -169.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.64 140.07 35.23 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.757 2.305 . . . . 0.0 111.022 170.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -88.89 -17.04 30.43 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.504 2.722 . . . . 0.0 116.237 -159.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.1 t0 . . . . . 0 C--O 1.259 1.593 0 CA-C-N 120.424 1.465 . . . . 0.0 112.857 -171.168 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.214 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -142.47 120.31 11.96 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.877 0.838 . . . . 0.0 112.045 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -59.64 145.36 44.95 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.118 0.967 . . . . 0.0 111.086 177.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -71.44 -44.72 64.32 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -164.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -133.38 55.47 1.9 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.83 2.052 . . . . 0.0 111.66 -173.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.5 mt -81.65 147.28 29.62 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.327 -0.858 . . . . 0.0 109.086 168.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.32 141.19 58.86 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.934 0.894 . . . . 0.0 108.996 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -158.15 -28.47 0.08 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -152.79 -36.51 0.11 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -171.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -63.7 -2.4 1.72 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.849 1.659 . . . . 0.0 115.213 -176.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.96 151.63 28.73 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.116 1.366 . . . . 0.0 110.737 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 pp -75.52 133.96 40.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.291 1.044 . . . . 0.0 112.002 -169.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -157.96 155.03 28.74 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.834 1.654 . . . . 0.0 110.47 165.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -129.37 169.86 14.37 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.612 1.165 . . . . 0.0 111.955 161.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.46 166.24 19.19 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 171.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -128.32 60.69 1.48 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 123.273 1.511 . . . . 0.0 111.189 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.6 mtp85 52.62 11.98 0.22 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 128.53 2.732 . . . . 0.0 113.972 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m -136.04 152.07 50.52 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 129.513 3.125 . . . . 0.0 110.797 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.4 tp -89.94 121.24 31.86 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 130.06 3.344 . . . . 0.0 112.28 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -75.83 138.33 41.07 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.451 1.023 . . . . 0.0 112.397 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.3 t -139.31 117.99 12.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 O-C-N 121.222 -0.924 . . . . 0.0 109.915 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.55 -173.65 15.92 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 122.303 0.946 . . . . 0.0 112.457 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.9 t30 65.83 35.66 6.57 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.679 1.191 . . . . 0.0 111.138 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.641 HD12 HG21 ' A' ' 28' ' ' VAL . 1.7 mm? -70.53 163.93 25.86 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.961 2.105 . . . . 0.0 111.35 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.41 161.9 17.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 123.624 1.678 . . . . 0.0 114.998 174.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.8 p -75.14 -24.16 57.93 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.999 1.32 . . . . 0.0 110.162 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -103.01 16.76 25.78 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.766 1.626 . . . . 0.0 113.357 171.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.641 HG21 HD12 ' A' ' 24' ' ' LEU . 5.8 p -66.23 153.02 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.427 ' N ' HG22 ' A' ' 28' ' ' VAL . 23.5 p -156.43 162.62 39.99 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.949 2.1 . . . . 0.0 112.342 177.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -64.7 -23.03 67.12 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.223 1.009 . . . . 0.0 112.016 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -66.85 -46.03 76.36 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 118.059 -0.972 . . . . 0.0 112.149 170.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.6 tp -64.74 -43.25 93.99 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.915 0.864 . . . . 0.0 109.562 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.505 ' HB2' HG11 ' A' ' 46' ' ' VAL . 69.1 mt -65.19 -33.81 76.89 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.04 -1.038 . . . . 0.0 113.161 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -70.1 -45.79 66.21 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.153 -0.967 . . . . 0.0 112.168 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.69 -23.33 66.12 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 121.512 -0.742 . . . . 0.0 112.684 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.443 ' CD1' HD11 ' A' ' 80' ' ' ILE . 3.8 tt -81.39 -44.59 17.34 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.184 176.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.473 ' HB3' HG11 ' A' ' 43' ' ' VAL . 45.1 m-85 -84.94 -20.97 29.83 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.168 1.349 . . . . 0.0 112.505 -170.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -52.42 -34.98 50.86 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 167.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -58.51 -32.71 69.08 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.503 2.321 . . . . 0.0 114.683 167.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.62 -12.86 55.48 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-O 121.357 0.599 . . . . 0.0 110.696 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.2 -163.56 26.33 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 126.909 2.195 . . . . 0.0 111.934 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -82.02 88.28 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 CA-C-N 120.559 2.18 . . . . 0.0 112.737 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.488 HG12 ' CZ ' ' A' ' 64' ' ' PHE . 2.3 m -65.56 141.76 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 121.169 -0.957 . . . . 0.0 113.156 176.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.9 mm -71.05 -48.92 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 174.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HG2' ' HB3' ' A' ' 63' ' ' ASN . 11.2 ptpt -171.44 161.35 6.33 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.161 1.784 . . . . 0.0 111.891 -171.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' A' ' 33' ' ' LEU . 82.9 t -125.59 153.47 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 126.37 1.868 . . . . 0.0 110.871 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -128.15 141.27 51.53 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.11 2.564 . . . . 0.0 110.509 169.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mm -121.01 125.31 27.06 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 126.906 2.082 . . . . 0.0 108.727 163.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.86 172.14 15.15 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.779 2.986 . . . . 0.0 112.878 170.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -153.72 126.48 8.23 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 127.457 2.303 . . . . 0.0 110.774 164.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -55.57 163.3 1.34 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 112.128 -2.305 . . . . 0.0 111.487 162.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.96 -25.15 1.25 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 167.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -100.25 1.64 41.99 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.41 1.084 . . . . 0.0 113.304 176.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.78 39.88 4.82 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 120.92 -1.113 . . . . 0.0 115.449 170.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.448 ' CD ' ' HD2' ' A' ' 56' ' ' PRO . 3.0 tppt? -134.42 140.84 36.95 Favored Pre-proline 0 N--CA 1.476 0.836 0 CA-C-N 119.819 1.809 . . . . 0.0 114.68 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.448 ' HD2' ' CD ' ' A' ' 55' ' ' LYS . 53.6 Cg_endo -68.17 12.44 0.23 Allowed 'Trans proline' 0 CA--C 1.551 1.353 0 C-N-CA 124.124 3.216 . . . . 0.0 117.834 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.75 27.46 7.01 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 119.538 -1.976 . . . . 0.0 115.145 176.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.445 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 33.8 mt-30 55.05 37.35 28.76 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -150.91 160.58 43.81 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.189 1.396 . . . . 0.0 112.151 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.03 178.86 9.88 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.838 2.055 . . . . 0.0 109.057 175.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -137.72 153.16 49.8 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.7 t -141.26 138.6 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 126.198 1.799 . . . . 0.0 110.284 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.431 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 9.1 t-20 -99.19 140.75 32.88 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.248 1.019 . . . . 0.0 110.938 172.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.488 ' CZ ' HG12 ' A' ' 43' ' ' VAL . 43.8 m-85 -139.69 150.15 44.54 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 128.468 2.707 . . . . 0.0 108.358 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -58.63 119.56 7.3 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 173.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -55.39 154.27 6.39 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.356 1.062 . . . . 0.0 113.406 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 69' ' ' SER . 5.0 tp10 -162.21 165.71 26.49 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.648 -1.283 . . . . 0.0 112.76 -170.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.3 t -88.45 5.47 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 O-C-N 120.481 -1.387 . . . . 0.0 112.102 173.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.405 ' H ' ' HG3' ' A' ' 67' ' ' GLU . 16.2 p -95.11 168.15 10.93 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 118.869 -2.394 . . . . 0.0 111.914 174.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.2 m -79.25 153.71 76.9 Favored Pre-proline 0 N--CA 1.483 1.206 0 O-C-N 120.99 -1.069 . . . . 0.0 111.227 162.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.47 124.11 15.35 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.753 2.969 . . . . 0.0 112.758 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -52.91 -44.41 66.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.782 1.233 . . . . 0.0 110.813 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.14 -31.64 63.53 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 ttp -66.42 -14.47 62.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.924 1.238 . . . . 0.0 113.244 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -105.92 -35.79 7.19 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 155.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.11 -55.51 21.5 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.477 0.711 . . . . 0.0 111.483 -171.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -91.96 -92.32 0.15 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 27.23 70.7 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 127.459 2.304 . . . . 0.0 113.908 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.7 14.5 0.68 Allowed Glycine 0 CA--C 1.535 1.34 0 N-CA-C 115.461 0.945 . . . . 0.0 115.461 -174.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.443 HD11 ' CD1' ' A' ' 36' ' ' LEU . 1.1 pp -130.55 145.25 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 -165.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.38 172.65 10.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.73 2.012 . . . . 0.0 110.126 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 57.9 mt -118.71 -48.71 2.47 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.999 0.92 . . . . 0.0 110.208 159.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -51.37 -59.24 4.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.748 1.219 . . . . 0.0 112.346 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.53 -64.16 0.07 OUTLIER Glycine 0 N--CA 1.47 0.931 0 N-CA-C 116.458 1.343 . . . . 0.0 116.458 -162.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -106.07 119.44 52.16 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 118.097 0.948 . . . . 0.0 111.031 -168.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -77.62 132.61 12.24 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.709 2.273 . . . . 0.0 113.926 -166.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.429 HG13 HD13 ' A' ' 36' ' ' LEU . 13.3 mm -59.38 119.81 4.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 123.811 0.844 . . . . 0.0 111.394 -177.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -108.19 103.15 12.28 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.902 2.081 . . . . 0.0 110.345 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.5 mp -74.83 141.61 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -132.28 136.3 46.84 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.779 2.032 . . . . 0.0 108.141 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -140.72 144.28 35.49 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.0 1.32 . . . . 0.0 110.897 -174.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -127.85 129.88 47.66 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 125.017 1.327 . . . . 0.0 108.883 162.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.7 p -70.44 154.81 41.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 122.585 1.183 . . . . 0.0 112.473 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.88 139.21 25.86 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.421 1.01 . . . . 0.0 114.503 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.6 p -76.96 -31.06 56.31 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.245 1.818 . . . . 0.0 113.203 172.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.7 m 53.93 13.43 0.55 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 129.846 3.258 . . . . 0.0 117.513 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -66.56 -25.59 66.72 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 128.213 2.605 . . . . 0.0 115.123 -167.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.09 157.07 85.65 Favored Pre-proline 0 CA--C 1.561 1.372 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.38 138.69 30.08 Favored 'Trans proline' 0 CA--C 1.551 1.351 0 C-N-CA 124.963 3.775 . . . . 0.0 111.149 172.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -67.77 -40.92 83.99 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 120.306 -1.496 . . . . 0.0 113.598 -162.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.4 t70 . . . . . 0 C--O 1.26 1.647 0 C-N-CA 128.238 2.615 . . . . 0.0 110.181 178.481 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.895 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.7 m -109.41 154.57 22.4 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 128.086 2.554 . . . . 0.0 111.368 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -105.98 120.29 41.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 126.964 2.106 . . . . 0.0 113.802 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -130.02 -42.98 1.22 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.257 1.423 . . . . 0.0 113.476 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -77.57 17.91 0.49 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 -173.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 mp -109.72 147.93 32.31 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 120.729 -1.232 . . . . 0.0 111.117 -170.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.04 145.74 55.5 Favored 'General case' 0 CA--C 1.556 1.207 0 O-C-N 121.228 -0.92 . . . . 0.0 112.848 176.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 28.7 ptt-85 -146.66 169.69 18.49 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 129.783 3.233 . . . . 0.0 108.433 175.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -120.43 175.01 6.19 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.657 1.983 . . . . 0.0 108.056 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -80.68 -42.94 21.16 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 121.171 -0.956 . . . . 0.0 111.381 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.33 -154.08 0.33 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 128.52 2.728 . . . . 0.0 109.027 168.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.9 mt -85.34 157.82 20.44 Favored 'General case' 0 CA--C 1.552 1.043 0 O-C-N 120.04 -1.663 . . . . 0.0 111.052 -173.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.63 166.73 30.34 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.684 1.594 . . . . 0.0 111.67 -175.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -149.04 163.19 38.25 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.803 1.641 . . . . 0.0 112.447 170.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.67 149.74 35.02 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -171.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -139.15 107.61 5.84 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 129.905 3.282 . . . . 0.0 105.785 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 48.51 20.92 0.34 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 130.123 3.369 . . . . 0.0 116.945 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.28 138.01 39.61 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.675 -1.266 . . . . 0.0 111.575 -171.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.541 HD13 ' HG2' ' A' ' 71' ' ' PRO . 11.1 tp -116.44 124.04 49.0 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.903 2.481 . . . . 0.0 112.722 -161.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -74.65 132.89 42.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 122.198 0.999 . . . . 0.0 109.82 175.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.6 t -129.19 125.42 62.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 169.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.84 -169.23 13.78 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 122.456 1.031 . . . . 0.0 113.035 168.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.2 t30 65.92 29.67 10.2 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 128.545 2.738 . . . . 0.0 114.258 -173.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.646 HD12 HG21 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -69.14 156.67 38.3 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.764 1.225 . . . . 0.0 109.413 -175.521 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.519 ' HG2' ' H ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.4 165.12 24.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 123.914 1.816 . . . . 0.0 114.126 172.22 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.3 p -68.29 -14.78 63.24 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 128.49 2.716 . . . . 0.0 110.392 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -113.59 5.24 16.48 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 129.19 2.996 . . . . 0.0 114.435 -176.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.811 HG23 HD23 ' A' ' 32' ' ' LEU . 9.8 p -66.14 154.28 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 120.131 -1.606 . . . . 0.0 114.213 -170.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.5 p -148.46 171.4 16.13 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 127.218 2.207 . . . . 0.0 111.343 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -77.41 -15.89 59.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.49 1.516 . . . . 0.0 111.393 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -76.24 -45.99 30.3 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.63 1.572 . . . . 0.0 109.407 170.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.811 HD23 HG23 ' A' ' 28' ' ' VAL . 60.8 tp -63.95 -39.31 93.85 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.621 0.724 . . . . 0.0 110.778 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.421 HD21 ' CD1' ' A' ' 24' ' ' LEU . 92.6 mt -70.83 -48.44 54.04 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.569 0.747 . . . . 0.0 111.969 176.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -58.31 -43.03 87.98 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -65.25 -32.18 73.72 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.743 0.817 . . . . 0.0 110.986 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 tt -76.29 -43.27 42.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.817 2.047 . . . . 0.0 113.193 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.446 ' CE2' HG21 ' A' ' 62' ' ' VAL . 23.9 m-85 -87.48 -6.16 58.5 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.012 0.925 . . . . 0.0 112.018 -173.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -53.89 -43.01 69.29 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.314 0.646 . . . . 0.0 109.745 160.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -55.96 -25.95 46.02 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 173.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.38 -8.45 32.44 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.239 1.019 . . . . 0.0 112.681 -171.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.74 -153.55 17.55 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.643 1.116 . . . . 0.0 113.593 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.05 107.52 2.48 Favored 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 123.497 2.798 . . . . 0.0 111.936 -165.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.0 t -94.96 126.37 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 128.266 2.627 . . . . 0.0 109.666 169.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mt -78.37 -48.71 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.947 1.299 . . . . 0.0 109.672 173.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.57 163.78 19.34 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.317 1.047 . . . . 0.0 113.266 -175.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 82.9 t -122.94 145.27 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.74 1.616 . . . . 0.0 112.197 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -126.11 121.29 32.45 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.133 2.173 . . . . 0.0 112.603 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.0 mm -110.38 120.76 43.31 Favored Pre-proline 0 N--CA 1.467 0.405 0 C-N-CA 126.487 1.915 . . . . 0.0 107.241 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -74.11 172.25 16.35 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.018 2.479 . . . . 0.0 111.545 168.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -156.87 115.08 3.25 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.611 1.964 . . . . 0.0 108.413 169.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -56.38 168.61 0.52 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 129.115 2.966 . . . . 0.0 111.696 164.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.4 pptp? -47.0 -32.58 4.01 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.469 1.508 . . . . 0.0 114.272 170.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.8 -18.04 61.51 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.802 1.641 . . . . 0.0 114.327 173.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.32 56.98 2.72 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -175.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -143.15 133.18 12.03 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.286 1.034 . . . . 0.0 113.328 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.99 19.67 0.13 Allowed 'Trans proline' 0 CA--C 1.55 1.325 0 C-N-CA 124.978 3.785 . . . . 0.0 116.538 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 52.02 22.02 1.71 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 174.233 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 57.72 36.53 26.66 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 116.817 2.154 . . . . 0.0 116.817 -166.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 57' ' ' LYS . 13.5 p90 -153.93 167.54 29.38 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.926 1.29 . . . . 0.0 113.453 175.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -163.95 170.06 17.19 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.979 2.112 . . . . 0.0 110.295 176.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -127.38 146.49 50.45 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.862 1.265 . . . . 0.0 110.932 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.446 HG21 ' CE2' ' A' ' 37' ' ' PHE . 20.8 t -125.91 132.67 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 126.581 1.953 . . . . 0.0 110.247 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -93.4 132.74 37.36 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.596 1.158 . . . . 0.0 108.75 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -124.44 162.52 23.73 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.6 1.96 . . . . 0.0 113.172 -166.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -101.7 -49.61 3.94 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.684 1.594 . . . . 0.0 113.846 -171.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -144.37 -6.93 0.71 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 -171.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -79.12 40.21 0.4 Allowed 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 121.282 1.856 . . . . 0.0 111.822 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.6 t -53.58 141.22 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 C-N-CA 127.09 2.156 . . . . 0.0 109.225 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.2 m 68.77 -28.45 0.16 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 129.245 3.018 . . . . 0.0 118.472 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 p -149.39 93.2 4.12 Favored Pre-proline 0 N--CA 1.471 0.593 0 CA-C-N 119.721 1.146 . . . . 0.0 110.919 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.541 ' HG2' HD13 ' A' ' 19' ' ' LEU . 51.5 Cg_exo -56.84 136.47 76.65 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 123.526 2.817 . . . . 0.0 113.912 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -68.98 -40.94 78.53 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.665 2.386 . . . . 0.0 111.007 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.94 -28.92 66.71 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.06 -1.025 . . . . 0.0 113.239 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.0 ttp -64.19 -21.36 66.54 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.733 1.213 . . . . 0.0 113.609 -176.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -97.63 -29.04 13.65 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.504 1.522 . . . . 0.0 112.115 168.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.82 -40.96 13.6 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.186 -0.946 . . . . 0.0 113.238 -169.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -107.68 -97.68 0.37 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.055 1.342 . . . . 0.0 110.83 176.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 37.83 59.13 1.35 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.37 1.868 . . . . 0.0 115.584 175.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.17 16.47 0.11 Allowed Glycine 0 CA--C 1.519 0.311 0 O-C-N 120.869 -1.145 . . . . 0.0 114.236 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -128.71 149.46 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 117.829 0.814 . . . . 0.0 109.509 -163.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.21 172.68 9.68 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.737 1.215 . . . . 0.0 110.802 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.9 tp -133.59 -19.84 2.08 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.867 0.867 . . . . 0.0 109.806 163.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -72.82 -68.59 0.47 Allowed 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.164 -0.96 . . . . 0.0 112.399 167.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.17 -51.36 0.07 OUTLIER Glycine 0 C--N 1.339 0.735 0 N-CA-C 116.985 1.554 . . . . 0.0 116.985 -168.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.519 ' H ' ' HG2' ' A' ' 25' ' ' GLU . 5.8 mpt_? -100.96 121.87 50.8 Favored Pre-proline 0 N--CA 1.462 0.151 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -177.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.2 126.91 10.15 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.256 1.97 . . . . 0.0 113.963 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.1 mm -51.01 126.95 6.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.696 1.198 . . . . 0.0 109.758 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -121.86 116.81 25.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.206 1.802 . . . . 0.0 112.753 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.424 ' CG2' HD11 ' A' ' 19' ' ' LEU . 4.4 mp -91.34 134.07 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.178 -0.951 . . . . 0.0 111.206 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -134.42 148.76 50.69 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 123.831 1.777 . . . . 0.0 115.396 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -166.44 133.37 2.56 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.667 2.387 . . . . 0.0 111.691 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -79.67 135.29 36.51 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 126.394 1.878 . . . . 0.0 110.999 169.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.7 p -57.48 99.59 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.313 1.845 . . . . 0.0 115.494 -167.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -68.86 -14.88 68.44 Favored Glycine 0 N--CA 1.477 1.373 0 C-N-CA 126.991 2.234 . . . . 0.0 117.269 -166.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.3 m -151.08 138.99 19.91 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 175.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.1 m -109.77 144.45 38.16 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.62 1.568 . . . . 0.0 112.288 172.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -100.5 -14.89 18.07 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 129.553 3.141 . . . . 0.0 112.159 -166.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 70.3 152.62 0.14 Allowed Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 127.522 2.329 . . . . 0.0 115.904 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -66.41 165.62 24.28 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.414 2.076 . . . . 0.0 111.442 170.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -97.94 -24.42 15.39 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -168.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 C--O 1.261 1.683 0 C-N-CA 126.55 1.94 . . . . 0.0 112.985 -171.296 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.942 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.5 m -68.97 125.83 27.88 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 117.42 0.61 . . . . 0.0 110.925 -173.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 58.37 16.91 4.38 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 119.12 3.007 . . . . 0.0 119.12 171.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -51.56 -43.43 62.39 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.461 1.105 . . . . 0.0 113.881 172.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -89.25 -4.01 58.33 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.59 172.28 12.84 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.115 0.966 . . . . 0.0 112.234 173.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -68.65 118.03 11.13 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -94.54 -9.52 35.02 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.846 1.658 . . . . 0.0 113.446 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -59.51 157.12 11.95 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.06 2.144 . . . . 0.0 111.77 -169.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -63.06 -26.67 68.95 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.75 174.41 10.65 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.818 1.647 . . . . 0.0 110.707 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.0 mt -82.67 166.98 18.68 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.391 1.076 . . . . 0.0 111.666 -175.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.01 -4.96 0.47 Allowed 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 125.885 1.674 . . . . 0.0 114.817 172.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -130.82 -5.74 4.03 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 127.422 2.289 . . . . 0.0 114.7 -169.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.57 146.72 22.57 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 119.709 -1.869 . . . . 0.0 113.276 -173.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -157.39 -23.34 0.09 Allowed 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 125.082 1.353 . . . . 0.0 114.517 174.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.87 -9.39 3.92 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 128.221 2.608 . . . . 0.0 117.121 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.7 m -107.41 150.1 27.14 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.373 2.269 . . . . 0.0 105.649 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.2 tp -92.55 140.75 29.24 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 128.363 2.665 . . . . 0.0 115.013 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -89.63 130.19 35.96 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 125.869 1.667 . . . . 0.0 110.033 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.2 t -132.4 128.61 58.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 120.756 -1.215 . . . . 0.0 107.78 173.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.59 -171.35 12.93 Favored Glycine 0 CA--C 1.543 1.794 0 CA-C-O 122.485 1.047 . . . . 0.0 111.854 171.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.6 t30 62.68 33.77 15.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.1 1.76 . . . . 0.0 112.897 -175.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -70.26 154.43 41.92 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.164 1.786 . . . . 0.0 111.145 177.192 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.409 ' HG3' ' HB2' ' A' ' 83' ' ' TYR . 0.3 OUTLIER -70.88 160.67 32.38 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 125.082 2.373 . . . . 0.0 114.059 173.728 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.6 p -67.85 -24.83 65.3 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 111.139 -2.755 . . . . 0.0 111.868 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -118.73 22.48 11.98 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 127.424 2.289 . . . . 0.0 115.938 174.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.741 HG23 HD23 ' A' ' 32' ' ' LEU . 8.5 p -60.71 170.77 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 116.733 2.123 . . . . 0.0 116.733 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.615 ' H ' HG22 ' A' ' 28' ' ' VAL . 10.6 p -165.88 156.59 13.21 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 128.113 2.565 . . . . 0.0 111.349 -177.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.71 -17.75 17.07 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.576 2.35 . . . . 0.0 110.546 174.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -78.48 -38.51 40.83 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.907 1.683 . . . . 0.0 112.097 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.741 HD23 HG23 ' A' ' 28' ' ' VAL . 40.9 tp -70.25 -47.81 59.69 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.004 1.322 . . . . 0.0 108.576 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.402 HD21 ' CD1' ' A' ' 24' ' ' LEU . 52.9 mt -59.04 -50.96 72.09 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.082 176.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -62.5 -41.5 98.87 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.318 1.417 . . . . 0.0 111.393 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.02 -23.69 64.11 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.357 1.244 . . . . 0.0 114.357 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.65 -39.85 35.79 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.793 1.637 . . . . 0.0 112.737 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -89.87 1.1 56.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.037 0.935 . . . . 0.0 111.792 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -64.8 -35.03 79.79 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.55 1.14 . . . . 0.0 113.9 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -79.21 -17.53 54.67 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.905 0.482 . . . . 0.0 110.694 167.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.69 21.59 0.65 Allowed 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.702 -1.249 . . . . 0.0 113.762 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.19 -125.62 7.47 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.23 0.919 . . . . 0.0 114.461 173.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -71.29 127.0 12.85 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 CA-C-N 118.38 1.09 . . . . 0.0 110.615 -173.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.1 t -138.35 124.82 25.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 168.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 mm -89.05 -54.68 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 125.443 1.497 . . . . 0.0 108.481 171.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.423 ' HG2' ' HB3' ' A' ' 63' ' ' ASN . 17.8 ptpt -151.7 153.37 34.24 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.918 0.887 . . . . 0.0 113.316 -173.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.8 t -117.79 152.1 19.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 126.876 2.07 . . . . 0.0 108.782 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -129.22 122.91 30.69 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.372 1.869 . . . . 0.0 114.465 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.5 mm -106.14 117.37 57.61 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 126.165 1.786 . . . . 0.0 110.573 168.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.5 165.07 33.04 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.704 3.603 . . . . 0.0 111.834 165.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -155.31 117.12 4.08 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 126.963 2.105 . . . . 0.0 109.297 172.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.431 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 28.8 t0 -55.22 169.53 0.26 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 128.453 2.701 . . . . 0.0 114.269 175.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.27 -40.69 25.64 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.155 -0.341 . . . . 0.0 111.826 164.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -81.97 3.64 25.71 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 126.045 1.738 . . . . 0.0 113.506 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.94 42.37 30.38 Favored Glycine 0 N--CA 1.474 1.226 0 C-N-CA 126.377 1.941 . . . . 0.0 113.607 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -129.79 138.31 32.83 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 119.241 1.521 . . . . 0.0 113.063 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.89 9.61 0.35 Allowed 'Trans proline' 0 CA--C 1.54 0.824 1 C-N-CA 126.699 4.933 . . . . 0.0 115.372 176.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HE2' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER 58.73 26.92 15.24 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 169.41 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.494 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 15.9 mt-30 59.47 24.93 13.64 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.991 1.316 . . . . 0.0 114.31 -172.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -150.9 165.91 32.2 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 119.93 -1.731 . . . . 0.0 113.408 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -169.0 177.34 4.96 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 128.214 2.606 . . . . 0.0 112.744 -172.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -131.43 158.4 40.9 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 126.154 1.781 . . . . 0.0 115.414 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.5 t -143.98 129.68 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 126.301 1.84 . . . . 0.0 111.487 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.423 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 4.4 t-20 -107.33 139.26 42.09 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.878 1.671 . . . . 0.0 114.618 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -154.98 -18.32 0.12 Allowed 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 117.74 2.496 . . . . 0.0 117.74 -172.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.2 tttp -156.0 144.84 20.38 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 121.616 2.007 . . . . 0.0 115.859 -166.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -68.17 -34.46 76.35 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 118.068 -0.968 . . . . 0.0 113.576 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -139.21 138.65 37.05 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 121.573 1.988 . . . . 0.0 107.547 164.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 36.0 t -107.25 142.11 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 125.14 1.376 . . . . 0.0 112.27 -170.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.7 p -133.65 -28.36 1.43 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 127.405 2.282 . . . . 0.0 114.989 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.442 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 1.8 p -159.03 145.58 12.6 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 123.957 0.903 . . . . 0.0 110.388 -176.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 70' ' ' VAL . 36.5 Cg_endo -105.08 114.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 124.047 3.165 . . . . 0.0 113.958 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -48.1 -41.92 27.63 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 125.205 1.402 . . . . 0.0 114.606 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.35 -20.56 63.85 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 123.855 0.862 . . . . 0.0 111.405 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.1 ttp -75.08 -22.39 58.33 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 119.12 0.873 . . . . 0.0 112.347 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -89.02 -30.58 18.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.049 0.94 . . . . 0.0 111.661 167.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tp -81.33 -51.73 8.05 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.71 -89.66 0.32 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.587 1.085 . . . . 0.0 113.348 -171.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 41.84 63.66 1.26 Allowed 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 125.251 1.421 . . . . 0.0 114.485 170.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.9 16.42 1.79 Allowed Glycine 0 CA--C 1.537 1.459 0 O-C-N 119.19 -2.194 . . . . 0.0 115.28 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.64 146.83 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.059 1.344 . . . . 0.0 112.163 -167.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.57 168.98 15.91 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -175.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.7 mt -130.17 -16.68 3.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 112.995 -1.911 . . . . 0.0 112.707 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.409 ' HB2' ' HG3' ' A' ' 25' ' ' GLU . 3.5 m-30 -103.03 -44.11 5.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.849 0.859 . . . . 0.0 112.111 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.28 -38.8 0.28 Allowed Glycine 0 CA--C 1.532 1.155 0 N-CA-C 115.752 1.061 . . . . 0.0 115.752 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -93.12 114.43 62.72 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 125.041 1.336 . . . . 0.0 108.99 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.8 128.9 16.65 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 124.578 3.519 . . . . 0.0 113.492 -175.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.8 mm -61.32 124.96 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.329 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -108.33 117.67 34.76 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 128.506 2.722 . . . . 0.0 110.392 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -93.08 140.91 15.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -129.71 174.2 9.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.084 0.954 . . . . 0.0 108.625 174.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . 0.277 51.0 t80 77.53 157.01 0.17 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 129.099 2.959 . . . . 0.0 112.347 -170.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -147.58 -68.2 0.25 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.171 2.189 . . . . 0.0 110.423 173.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.8 t -157.62 158.71 36.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.569 1.548 . . . . 0.0 110.841 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -72.8 162.67 54.78 Favored Glycine 0 CA--C 1.545 1.946 0 CA-C-N 119.736 1.153 . . . . 0.0 111.094 168.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.3 m -141.61 167.88 21.1 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 -173.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 96.7 p -64.65 163.68 13.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 128.075 2.55 . . . . 0.0 114.33 162.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -148.35 135.23 20.03 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.608 1.163 . . . . 0.0 110.099 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 58.72 154.1 0.09 OUTLIER Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 129.599 3.16 . . . . 0.0 116.302 170.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.31 172.18 15.0 Favored 'Trans proline' 0 N--CA 1.452 -0.971 0 C-N-CA 122.428 2.085 . . . . 0.0 112.172 -171.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -66.08 -36.93 84.5 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.674 1.19 . . . . 0.0 114.085 -172.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 41.9 t0 . . . . . 0 C--O 1.257 1.487 0 C-N-CA 126.238 1.815 . . . . 0.0 111.464 -175.762 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.906 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 95.1 p -85.01 177.44 7.93 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -69.29 120.24 14.8 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 129.514 3.126 . . . . 0.0 112.16 173.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -96.08 -27.35 15.13 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 127.069 2.148 . . . . 0.0 114.065 -175.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -109.67 -8.67 14.92 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -160.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.6 mt -62.48 138.07 58.39 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 121.521 0.677 . . . . 0.0 112.612 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.01 158.41 3.9 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.156 1.783 . . . . 0.0 112.297 173.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -79.68 -41.11 27.53 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.849 2.06 . . . . 0.0 110.0 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -62.71 140.4 58.72 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.59 -1.319 . . . . 0.0 107.685 159.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -77.97 -13.91 59.71 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -176.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.71 166.13 24.77 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.594 1.157 . . . . 0.0 111.903 -168.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 pp -96.08 134.4 39.18 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.18 1.392 . . . . 0.0 109.524 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.11 9.42 36.33 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -60.34 125.56 24.14 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.2 1.4 . . . . 0.0 110.96 -177.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -122.37 156.07 34.73 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.174 1.39 . . . . 0.0 109.063 -176.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -152.1 162.89 40.42 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.2 1.0 . . . . 0.0 110.945 162.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -119.62 0.71 11.03 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.475 1.91 . . . . 0.0 112.796 171.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.42 137.72 51.06 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -154.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.9 tp -83.78 128.08 34.27 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.811 2.045 . . . . 0.0 110.266 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -82.44 140.92 33.14 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 t -143.46 130.34 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.743 0.817 . . . . 0.0 109.089 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.96 -172.28 13.66 Favored Glycine 0 CA--C 1.546 1.99 0 C-N-CA 125.365 1.46 . . . . 0.0 112.925 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.4 t30 66.38 24.82 10.43 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 128.447 2.699 . . . . 0.0 113.693 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.619 ' HB3' HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -65.39 137.4 57.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.095 1.358 . . . . 0.0 111.009 -178.255 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.41 161.42 11.72 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 176.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.0 p -69.07 -12.01 61.3 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 126.565 1.946 . . . . 0.0 114.148 -168.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.23 5.28 7.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.829 2.852 . . . . 0.0 113.114 -175.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' ' 24' ' ' LEU . 8.2 p -54.06 158.26 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.97 1.308 . . . . 0.0 113.861 -175.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.4 p -155.56 169.17 24.92 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.749 2.02 . . . . 0.0 109.381 -177.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -64.83 -34.14 77.65 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.851 1.26 . . . . 0.0 108.367 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -66.02 -32.01 73.24 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.697 1.599 . . . . 0.0 114.607 175.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -72.2 -49.55 34.54 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.308 1.413 . . . . 0.0 108.552 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.483 HD21 ' CD1' ' A' ' 24' ' ' LEU . 79.8 mt -59.62 -48.73 80.51 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -60.77 -37.6 82.4 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.244 -0.91 . . . . 0.0 112.991 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -60.42 -50.63 72.83 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.763 0.825 . . . . 0.0 109.755 172.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 tt -72.83 -40.17 66.0 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.717 2.407 . . . . 0.0 113.529 -173.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -81.2 -1.78 46.09 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.077 1.351 . . . . 0.0 111.654 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -70.76 -25.78 63.06 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 121.33 1.877 . . . . 0.0 110.464 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -70.05 -29.07 66.0 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.179 1.392 . . . . 0.0 112.611 169.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.38 -20.04 24.46 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 138.22 -149.49 20.52 Favored Glycine 0 C--O 1.235 0.176 0 O-C-N 121.4 -0.813 . . . . 0.0 113.976 171.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.18 118.69 4.06 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 121.936 1.757 . . . . 0.0 110.414 -173.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.6 m -117.54 118.76 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.128 1.371 . . . . 0.0 109.514 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.1 mm -61.22 -53.49 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.717 1.607 . . . . 0.0 110.549 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.33 167.88 26.49 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 131.563 3.945 . . . . 0.0 109.25 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.5 t -116.81 163.54 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 128.368 2.667 . . . . 0.0 111.422 170.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -127.1 135.48 50.81 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.82 1.648 . . . . 0.0 113.569 164.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.1 mm -118.48 124.05 28.8 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 125.364 1.465 . . . . 0.0 108.145 167.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.67 167.33 27.45 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.926 2.417 . . . . 0.0 112.798 166.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -160.74 119.38 2.56 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 127.505 2.322 . . . . 0.0 108.58 172.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.81 173.28 0.21 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.626 1.17 . . . . 0.0 111.873 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -23.79 29.29 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 120.498 -1.376 . . . . 0.0 112.48 162.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -80.62 -2.77 47.85 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.492 1.117 . . . . 0.0 112.554 175.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.24 45.19 56.82 Favored Glycine 0 C--N 1.341 0.828 0 O-C-N 120.341 -1.475 . . . . 0.0 109.959 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.42 132.01 19.71 Favored Pre-proline 0 N--CA 1.465 0.293 0 C-N-CA 123.392 0.677 . . . . 0.0 111.828 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.45 ' HG3' HG12 ' A' ' 28' ' ' VAL . 71.8 Cg_endo -71.09 15.58 0.31 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 125.241 3.961 . . . . 0.0 116.105 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.77 24.62 2.53 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 176.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 55.85 30.94 16.75 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -171.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -144.88 161.75 38.54 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 120.222 -1.549 . . . . 0.0 112.41 -176.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.05 -177.78 5.99 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.079 2.151 . . . . 0.0 112.728 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -137.44 157.2 47.08 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.233 1.813 . . . . 0.0 113.19 171.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.2 t -128.41 140.58 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.796 1.638 . . . . 0.0 111.848 169.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -95.46 127.66 41.68 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.161 1.384 . . . . 0.0 111.111 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.527 ' CZ ' ' HA ' ' A' ' 69' ' ' SER . 5.1 p90 -105.85 165.43 11.19 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.04 2.136 . . . . 0.0 109.62 173.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -88.0 -29.44 20.74 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -173.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -75.14 171.78 13.55 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.311 1.044 . . . . 0.0 111.134 -175.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -89.76 -20.04 24.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.0 p -119.47 144.72 27.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 123.972 0.909 . . . . 0.0 109.089 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.527 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 9.7 t -52.67 137.02 31.98 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.825 1.65 . . . . 0.0 114.128 -173.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.78 76.15 37.66 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.432 1.893 . . . . 0.0 108.735 177.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -82.87 48.63 2.81 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.762 2.975 . . . . 0.0 111.7 -167.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -52.91 -42.36 65.3 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.885 1.274 . . . . 0.0 110.336 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.74 -27.67 65.15 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 175.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.8 tmm? -66.3 -26.82 67.49 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.302 1.441 . . . . 0.0 108.862 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -98.35 -30.66 12.45 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -79.69 -34.29 40.35 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.736 1.214 . . . . 0.0 114.211 -174.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.3 -82.11 0.6 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.94 1.296 . . . . 0.0 111.082 -175.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 19.99 70.52 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 127.97 2.508 . . . . 0.0 114.314 -176.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.79 9.78 0.28 Allowed Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 pp -135.86 158.24 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 119.306 1.553 . . . . 0.0 113.558 -164.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.44 172.8 8.02 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -172.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.4 tp -140.19 22.95 2.4 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.958 2.103 . . . . 0.0 112.812 -175.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -149.47 -49.66 0.14 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.621 1.968 . . . . 0.0 110.174 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.0 -48.89 0.16 Allowed Glycine 0 CA--C 1.541 1.658 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -95.52 124.25 53.7 Favored Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 120.743 2.271 . . . . 0.0 110.837 -175.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.28 126.6 11.84 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 124.146 3.231 . . . . 0.0 113.129 -170.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.6 mm -57.54 122.91 7.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.776 0.798 . . . . 0.0 109.442 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.404 ' HE3' ' NE2' ' A' ' 90' ' ' GLN . 54.0 tptt -109.02 115.75 30.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.15 1.78 . . . . 0.0 108.812 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 mp -92.58 144.58 9.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.668 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.404 ' NE2' ' HE3' ' A' ' 88' ' ' LYS . 7.3 mm-40 -138.17 151.9 48.17 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.534 1.534 . . . . 0.0 111.966 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -104.17 153.29 21.13 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 126.75 2.02 . . . . 0.0 114.61 -171.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -99.35 -2.75 35.55 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.559 2.344 . . . . 0.0 115.085 -166.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.3 p -91.22 139.27 30.9 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -168.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 90.97 168.15 41.79 Favored Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.997 1.159 . . . . 0.0 115.997 176.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 87.5 p -86.32 154.31 21.32 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.22 1.808 . . . . 0.0 115.834 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.6 m -127.32 -41.61 1.73 Allowed 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 173.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -133.22 148.56 52.02 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 121.772 2.078 . . . . 0.0 108.999 -171.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -150.22 153.04 34.58 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.61 145.51 14.66 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.13 3.22 . . . . 0.0 110.715 167.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -61.85 -36.1 80.22 Favored 'General case' 0 CA--C 1.554 1.117 0 O-C-N 121.047 -1.033 . . . . 0.0 111.678 173.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.9 t70 . . . . . 0 N--CA 1.49 1.556 0 C-N-CA 128.545 2.738 . . . . 0.0 112.86 173.036 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.684 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.7 p -167.37 48.77 0.06 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.252 1.421 . . . . 0.0 111.151 170.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -104.91 136.77 43.79 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.318 -1.489 . . . . 0.0 113.236 -175.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -142.26 -39.53 0.36 Allowed 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -168.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -112.44 60.86 0.63 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 129.155 2.982 . . . . 0.0 111.321 -174.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.2 -8.66 12.94 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.745 2.418 . . . . 0.0 114.793 -175.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? 46.09 37.49 3.91 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 128.515 2.726 . . . . 0.0 116.77 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -56.34 -46.69 79.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.743 1.617 . . . . 0.0 112.245 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -150.0 169.62 20.78 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.387 1.875 . . . . 0.0 109.436 168.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -66.19 -42.95 88.15 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.873 -1.142 . . . . 0.0 113.348 174.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.56 -162.72 1.57 Allowed 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 127.671 2.388 . . . . 0.0 110.822 -170.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 73.2 mt -102.15 4.5 39.58 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 119.661 -1.899 . . . . 0.0 114.899 -174.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 46.16 2.32 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 121.088 3.736 . . . . 0.0 121.088 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -148.34 172.05 15.02 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 130.179 3.392 . . . . 0.0 108.822 -172.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.42 136.32 3.22 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.106 0.962 . . . . 0.0 111.214 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -150.28 139.83 21.55 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 172.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.3 mtm105 -68.59 -12.67 61.62 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 120.453 1.479 . . . . 0.0 114.728 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.0 m -98.47 130.33 45.07 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 123.595 1.664 . . . . 0.0 111.56 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.5 tp -107.23 132.32 53.21 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 127.576 2.35 . . . . 0.0 109.956 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -86.62 137.02 32.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 123.442 1.592 . . . . 0.0 112.163 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.2 t -132.62 122.66 47.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.334 -175.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.91 -173.42 14.43 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.495 1.521 . . . . 0.0 112.293 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 t30 61.82 23.92 14.15 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.913 1.685 . . . . 0.0 113.637 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.656 HD12 HG21 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -66.58 140.94 57.98 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 125.5 1.52 . . . . 0.0 109.258 -177.212 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.24 165.61 1.93 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 123.088 1.423 . . . . 0.0 113.805 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.4 p -67.25 -26.39 66.55 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.158 -0.964 . . . . 0.0 112.844 -172.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -116.97 7.02 13.06 Favored 'General case' 0 N--CA 1.474 0.765 1 C-N-CA 132.547 4.339 . . . . 0.0 111.31 -168.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.656 HG21 HD12 ' A' ' 24' ' ' LEU . 7.5 p -53.6 156.39 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.908 1.683 . . . . 0.0 112.606 -177.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.2 p -151.13 158.68 44.32 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.508 1.523 . . . . 0.0 110.082 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -59.15 -30.22 67.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.18 0.992 . . . . 0.0 109.59 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -66.07 -42.12 89.85 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.225 0.92 . . . . 0.0 112.823 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.435 HD23 HG23 ' A' ' 28' ' ' VAL . 49.8 tp -66.18 -45.28 81.43 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.579 0.627 . . . . 0.0 109.315 178.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.64 HD21 ' CD1' ' A' ' 24' ' ' LEU . 91.8 mt -58.25 -49.53 76.77 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.43 1.492 . . . . 0.0 112.833 174.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -60.32 -42.57 95.88 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.85 -1.156 . . . . 0.0 111.654 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -65.87 -34.52 78.34 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.969 1.259 . . . . 0.0 111.614 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.448 ' CD2' HD13 ' A' ' 77' ' ' LEU . 8.0 tt -70.86 -50.03 39.69 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.701 1.6 . . . . 0.0 111.966 177.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -83.09 -15.46 50.75 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -170.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -51.4 -33.07 28.56 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 168.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -74.74 -18.25 60.52 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.185 0.994 . . . . 0.0 110.896 175.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.56 11.88 27.17 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.644 1.578 . . . . 0.0 113.328 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.57 -164.11 13.47 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 127.541 2.496 . . . . 0.0 115.51 167.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.74 101.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 123.484 2.789 . . . . 0.0 113.112 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.4 t -98.29 115.79 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.6 mm -69.21 -54.3 20.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 123.005 0.522 . . . . 0.0 111.077 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -163.08 157.79 21.17 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.952 2.101 . . . . 0.0 110.789 -172.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.2 t -117.35 152.63 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 128.699 2.8 . . . . 0.0 111.267 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -127.16 126.72 43.36 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 126.948 2.099 . . . . 0.0 112.384 170.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.4 mm -106.64 117.08 57.78 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.997 2.119 . . . . 0.0 108.948 165.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.0 163.16 34.97 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.866 2.377 . . . . 0.0 110.434 165.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -155.27 112.34 3.29 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.26 2.224 . . . . 0.0 110.767 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.72 175.76 0.08 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.746 2.418 . . . . 0.0 113.192 175.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -52.95 -26.33 14.77 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.742 1.217 . . . . 0.0 114.148 173.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -93.9 -9.81 35.94 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.79 61.13 1.11 Allowed Glycine 0 N--CA 1.47 0.9 0 C-N-CA 125.896 1.712 . . . . 0.0 114.331 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -144.54 132.88 10.85 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 118.65 1.225 . . . . 0.0 113.555 -172.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.471 ' HG3' HG12 ' A' ' 28' ' ' VAL . 72.9 Cg_endo -69.38 8.48 0.68 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.397 3.398 . . . . 0.0 115.78 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.76 18.32 3.69 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 120.417 -1.427 . . . . 0.0 114.438 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 63.21 31.17 15.73 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -169.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.518 ' HA ' HD23 ' A' ' 24' ' ' LEU . 1.5 p90 -146.56 167.99 22.35 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.077 1.751 . . . . 0.0 111.484 176.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -163.68 172.15 14.64 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 128.807 2.843 . . . . 0.0 111.217 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -124.9 149.45 47.56 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.34 -1.475 . . . . 0.0 110.879 176.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.5 t -132.08 136.86 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.038 1.335 . . . . 0.0 109.601 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -108.78 138.36 45.23 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.088 1.755 . . . . 0.0 108.508 -175.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -122.47 140.55 52.6 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.901 1.68 . . . . 0.0 112.707 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -55.33 144.25 25.72 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.848 -1.158 . . . . 0.0 111.892 171.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -56.94 -31.29 64.82 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.902 2.081 . . . . 0.0 113.437 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -75.09 -19.23 60.05 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.294 -1.504 . . . . 0.0 113.948 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.4 m -116.78 27.45 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 127.905 2.482 . . . . 0.0 113.03 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 t -75.68 78.66 2.65 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.45 149.15 53.39 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 112.514 -2.13 . . . . 0.0 110.223 165.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -73.91 52.49 2.61 Favored 'Trans proline' 0 CA--C 1.557 1.641 0 C-N-CA 123.134 2.556 . . . . 0.0 114.901 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -48.16 -46.16 34.32 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.841 1.657 . . . . 0.0 114.635 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.79 -24.37 61.7 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.461 -1.4 . . . . 0.0 113.509 -176.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.0 ttp -68.94 -28.18 66.41 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.079 1.352 . . . . 0.0 110.865 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -82.84 -41.0 19.57 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.995 0.918 . . . . 0.0 110.438 171.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.3 tp -83.62 -36.63 23.72 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -161.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.448 HD13 ' CD2' ' A' ' 36' ' ' LEU . 22.8 mt -113.79 -86.02 0.59 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.31 1.444 . . . . 0.0 109.08 -169.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.264 0.2 OUTLIER 26.82 59.48 0.08 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.907 2.883 . . . . 0.0 113.419 172.429 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.36 11.99 0.14 Allowed Glycine 0 CA--C 1.538 1.501 0 CA-C-O 118.556 -1.136 . . . . 0.0 115.42 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -134.55 154.35 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 119.745 1.772 . . . . 0.0 112.399 -168.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.23 178.35 2.45 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.496 1.918 . . . . 0.0 112.675 -172.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -140.15 -22.32 0.85 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.901 2.48 . . . . 0.0 112.461 170.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -83.26 -49.12 9.73 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.211 1.404 . . . . 0.0 110.262 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 170.81 -50.57 0.19 Allowed Glycine 0 CA--C 1.535 1.324 0 N-CA-C 115.987 1.155 . . . . 0.0 115.987 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -102.63 117.56 60.57 Favored Pre-proline 0 N--CA 1.479 1.022 0 CA-C-N 119.424 1.612 . . . . 0.0 109.587 -172.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.03 128.93 20.66 Favored 'Trans proline' 0 C--N 1.347 0.474 1 C-N-CA 125.366 4.044 . . . . 0.0 113.375 -175.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.0 mm -61.65 125.27 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.556 1.142 . . . . 0.0 108.976 -176.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -110.64 105.02 13.78 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 124.724 1.21 . . . . 0.0 107.947 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -80.41 145.06 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -137.46 163.06 32.01 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 128.356 2.662 . . . . 0.0 108.966 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -120.85 129.99 53.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.884 0.85 . . . . 0.0 109.642 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -146.08 161.06 40.99 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.691 1.596 . . . . 0.0 108.667 175.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.5 t -125.52 163.25 23.11 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.566 1.946 . . . . 0.0 114.784 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 162.87 126.07 0.8 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.998 1.285 . . . . 0.0 111.375 168.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.1 m -150.17 143.0 24.74 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.796 2.038 . . . . 0.0 108.505 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.0 m -168.08 140.2 2.98 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.389 1.475 . . . . 0.0 113.164 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -158.86 117.69 2.99 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 128.081 2.552 . . . . 0.0 110.887 167.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -97.56 154.92 37.77 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.952 2.101 . . . . 0.0 108.407 168.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -68.62 152.6 74.52 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 CA-C-N 120.569 1.239 . . . . 0.0 109.309 167.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -101.88 -38.11 7.96 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--O 1.259 1.592 0 C-N-CA 125.799 1.64 . . . . 0.0 114.215 177.324 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.476 0.84 0 CA-C-O 121.073 0.463 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.7 tp -92.33 129.0 38.38 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.478 1.511 . . . . 0.0 110.513 -176.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -83.23 130.58 35.09 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.235 0.54 . . . . 0.0 110.001 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.1 t -122.9 129.37 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 120.783 -1.198 . . . . 0.0 108.539 172.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.3 -175.8 14.19 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.314 1.911 . . . . 0.0 111.086 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.8 t30 66.67 19.49 10.78 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.207 2.203 . . . . 0.0 113.458 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.507 ' HB3' HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -67.1 145.76 54.98 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 125.411 1.484 . . . . 0.0 111.083 -168.269 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.479 ' CD ' ' HB2' ' A' ' 83' ' ' TYR . 10.6 mt-10 -60.87 161.65 7.88 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 177.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -73.42 -32.15 64.25 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.563 1.145 . . . . 0.0 113.168 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? -100.14 15.9 25.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.975 2.11 . . . . 0.0 113.417 172.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.507 HG11 ' HB3' ' A' ' 24' ' ' LEU . 2.0 p -62.54 156.18 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.0 p -156.03 161.57 40.43 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.508 2.323 . . . . 0.0 110.953 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -55.79 -31.76 62.91 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.535 1.534 . . . . 0.0 111.797 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.45 -35.78 79.88 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.177 1.391 . . . . 0.0 113.157 175.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.3 tp -72.31 -39.23 68.38 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 122.616 1.198 . . . . 0.0 108.598 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.505 HD21 ' CD1' ' A' ' 24' ' ' LEU . 89.4 mt -65.15 -54.66 26.36 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.412 1.085 . . . . 0.0 112.644 173.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -56.33 -37.18 69.61 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.193 1.36 . . . . 0.0 110.189 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -73.9 -37.11 64.78 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tt -67.5 -43.7 80.25 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.337 1.426 . . . . 0.0 111.156 172.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -82.96 -9.81 59.1 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -46.83 -37.42 8.69 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.35 1.86 . . . . 0.0 112.701 164.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -73.0 -30.6 63.91 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.173 1.389 . . . . 0.0 110.908 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.409 ' HA ' HD12 ' A' ' 76' ' ' LEU . . . -85.08 -2.99 58.63 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -166.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.59 -167.05 12.21 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 126.754 2.121 . . . . 0.0 111.375 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -48.77 121.02 5.95 Favored 'Trans proline' 0 C--N 1.346 0.426 1 C-N-CA 126.484 4.789 . . . . 0.0 112.242 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.23 136.02 54.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 173.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.7 -46.92 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 123.558 0.743 . . . . 0.0 109.26 -172.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.84 158.91 36.06 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.059 2.544 . . . . 0.0 110.46 171.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.5 t -105.91 162.4 5.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 126.208 1.803 . . . . 0.0 110.742 171.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -136.72 121.32 18.39 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.337 1.855 . . . . 0.0 114.37 169.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.2 mm -107.29 120.41 47.81 Favored Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 126.267 1.827 . . . . 0.0 110.556 166.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -75.44 167.98 25.47 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 125.032 3.821 . . . . 0.0 113.036 165.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -160.91 105.12 1.35 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.307 1.843 . . . . 0.0 113.205 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -53.1 173.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 130.435 3.494 . . . . 0.0 114.31 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.58 -24.47 8.32 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 168.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -91.43 -0.43 57.63 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.458 1.503 . . . . 0.0 114.852 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.0 41.5 54.55 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.361 1.458 . . . . 0.0 113.459 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -116.25 136.99 23.15 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 124.753 1.221 . . . . 0.0 112.92 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -70.82 17.05 0.26 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.115 2.543 . . . . 0.0 115.644 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.19 20.61 3.49 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 120.627 -1.296 . . . . 0.0 113.899 175.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 62.28 33.83 16.31 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.356 1.862 . . . . 0.0 114.496 -172.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -153.79 165.13 36.98 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.318 -1.489 . . . . 0.0 110.447 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -159.14 178.38 10.09 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.007 2.123 . . . . 0.0 110.589 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -135.52 156.15 49.35 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.574 -1.329 . . . . 0.0 111.312 168.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.71 132.13 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.7 1.2 . . . . 0.0 109.57 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 CA--C 1.542 0.654 0 O-C-N 120.254 -1.529 . . . . 0.0 110.006 176.712 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo . . . . . 0 CA--C 1.52 -0.191 0 N-CA-C 108.441 -1.407 . . . . 0.0 108.441 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -60.63 -34.26 73.99 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -168.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.39 -34.57 64.47 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 117.148 -1.406 . . . . 0.0 114.166 173.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -59.68 -21.79 61.05 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 120.613 1.551 . . . . 0.0 112.563 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -104.38 -40.42 6.09 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 127.359 2.264 . . . . 0.0 113.093 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -66.93 -61.65 1.84 Allowed 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 123.527 0.731 . . . . 0.0 112.669 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.14 -85.13 0.2 Allowed 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.5 1.12 . . . . 0.0 108.565 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 26.81 76.85 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 125.66 1.584 . . . . 0.0 114.322 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 125.45 18.02 2.55 Favored Glycine 0 CA--C 1.549 2.166 0 N-CA-C 117.555 1.782 . . . . 0.0 117.555 177.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -129.13 156.44 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 127.848 2.459 . . . . 0.0 111.583 -171.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.409 ' HB2' ' OE2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -176.73 -176.8 0.74 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.095 0.958 . . . . 0.0 112.442 -170.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.3 mt -141.16 -11.69 0.95 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.425 1.89 . . . . 0.0 115.885 -177.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.479 ' HB2' ' CD ' ' A' ' 25' ' ' GLU . 19.8 m-85 -109.77 -48.38 3.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.65 2.38 . . . . 0.0 111.802 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 179.06 -39.23 0.08 OUTLIER Glycine 0 CA--C 1.542 1.74 0 C-N-CA 125.955 1.74 . . . . 0.0 114.411 171.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.421 ' HB2' ' HG3' ' A' ' 25' ' ' GLU . 2.2 mpt_? -98.91 113.6 64.69 Favored Pre-proline 0 N--CA 1.483 1.219 0 CA-C-N 121.379 2.59 . . . . 0.0 112.247 -168.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.25 134.17 47.42 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.801 2.334 . . . . 0.0 111.753 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.0 mm -63.04 127.27 22.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 O-C-N 121.457 -0.777 . . . . 0.0 109.523 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -109.83 110.52 21.53 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 124.989 1.315 . . . . 0.0 110.02 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -86.33 136.74 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 120.324 -1.485 . . . . 0.0 109.668 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 . . . . . 0 CA--C 1.537 0.462 0 C-N-CA 125.355 1.462 . . . . 0.0 111.632 178.099 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 122.214 1.007 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.3 tp -131.28 131.01 43.54 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.797 2.439 . . . . 0.0 109.71 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -80.25 138.77 36.85 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.842 1.656 . . . . 0.0 112.226 167.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.48 128.58 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.834 1.253 . . . . 0.0 108.558 173.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.83 -170.84 13.62 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.556 1.55 . . . . 0.0 111.92 168.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.0 t30 66.44 19.37 10.93 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.92 2.088 . . . . 0.0 113.649 -175.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.512 ' CD1' HD21 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -63.35 135.69 57.16 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 125.358 1.463 . . . . 0.0 112.02 -174.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 2.0 mt-10 -55.88 152.98 9.15 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 174.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.0 p -68.24 -14.46 63.0 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.532 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -112.0 11.01 20.53 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.998 2.119 . . . . 0.0 111.566 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 24' ' ' LEU . 4.9 p -66.76 159.72 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 119.919 -1.738 . . . . 0.0 114.764 -172.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.4 p -155.38 170.59 21.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.255 1.422 . . . . 0.0 111.32 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -63.87 -28.29 69.74 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.501 -0.749 . . . . 0.0 110.611 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -64.81 -48.32 74.84 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.906 0.883 . . . . 0.0 109.699 174.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.8 tp -65.19 -38.03 89.18 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.209 0.459 . . . . 0.0 111.593 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.512 HD21 ' CD1' ' A' ' 24' ' ' LEU . 94.0 mt -67.72 -48.57 66.14 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.428 -1.42 . . . . 0.0 111.864 175.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -62.07 -44.9 95.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.722 -1.237 . . . . 0.0 113.0 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -68.73 -25.05 64.56 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.783 0.433 . . . . 0.0 111.162 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.0 tt -78.72 -46.57 18.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.838 1.255 . . . . 0.0 108.272 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -74.89 -5.81 45.69 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.784 -1.197 . . . . 0.0 113.274 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -58.8 -32.0 68.94 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.935 1.698 . . . . 0.0 111.277 171.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -72.35 -31.0 65.25 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.292 1.437 . . . . 0.0 111.426 176.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.03 3.29 39.33 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -171.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.77 -156.16 15.74 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.936 1.731 . . . . 0.0 114.885 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -85.05 90.75 0.76 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.148 1.899 . . . . 0.0 112.135 -167.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.68 134.65 29.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 112.709 -2.041 . . . . 0.0 106.993 168.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.426 HD12 ' OD1' ' A' ' 63' ' ' ASN . 44.1 mt -83.71 -63.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 165.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.495 ' HG2' ' HB3' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -155.18 147.13 23.49 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.878 1.271 . . . . 0.0 113.011 -164.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.5 t -108.77 145.14 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.312 2.245 . . . . 0.0 112.969 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -122.0 124.19 43.42 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 126.24 1.816 . . . . 0.0 113.01 170.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.434 HG23 ' HB3' ' A' ' 56' ' ' PRO . 2.5 mm -107.42 121.5 44.21 Favored Pre-proline 0 C--O 1.243 0.719 0 C-N-CA 125.952 1.701 . . . . 0.0 108.509 163.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 71.7 Cg_endo -72.2 162.25 42.22 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.269 2.646 . . . . 0.0 109.718 165.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -147.36 116.09 6.76 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.143 1.777 . . . . 0.0 107.632 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -54.48 171.99 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.568 2.347 . . . . 0.0 109.665 165.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.16 -34.17 55.71 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.952 0.901 . . . . 0.0 112.938 172.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -75.4 -9.31 58.45 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 128.123 2.569 . . . . 0.0 113.889 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.32 38.72 12.19 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.555 1.55 . . . . 0.0 111.4 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -125.47 135.27 26.7 Favored Pre-proline 0 N--CA 1.473 0.707 0 O-C-N 121.613 -0.933 . . . . 0.0 112.052 -172.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.434 ' HB3' HG23 ' A' ' 48' ' ' ILE . 58.6 Cg_endo -71.76 12.65 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.928 3.085 . . . . 0.0 116.782 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.486 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 61.0 25.11 15.17 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 173.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 24' ' ' LEU 0.25 6.0 mt-30 56.43 30.47 17.07 Favored 'General case' 0 CA--C 1.573 1.854 0 O-C-N 120.922 -1.111 . . . . 0.0 113.306 -171.411 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.486 ' CD2' ' HB2' ' A' ' 57' ' ' LYS . 3.6 p90 -150.08 155.42 39.83 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 128.24 2.616 . . . . 0.0 115.264 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -155.88 175.08 14.41 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 127.64 2.376 . . . . 0.0 112.552 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -140.08 141.8 36.15 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 120.568 -1.333 . . . . 0.0 114.503 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.9 t -131.33 130.02 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 120.555 -1.341 . . . . 0.0 111.116 -172.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.495 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 4.6 t-20 . . . . . 0 CA--C 1.545 0.782 0 C-N-CA 125.944 1.698 . . . . 0.0 112.776 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo . . . . . 0 CA--C 1.536 0.615 0 CA-C-O 121.11 0.379 . . . . 0.0 112.795 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -56.55 -42.41 78.47 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.118 -0.989 . . . . 0.0 111.474 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.84 -35.38 66.36 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.9 ttp -59.07 -8.63 1.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 126.89 2.076 . . . . 0.0 115.998 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -114.86 -32.54 5.75 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.491 1.517 . . . . 0.0 110.617 165.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.26 -56.85 5.2 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -98.29 -92.39 0.25 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.853 1.661 . . . . 0.0 110.115 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 32.89 69.92 0.11 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.27 1.428 . . . . 0.0 112.002 175.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.5 19.42 1.07 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 121.297 -0.877 . . . . 0.0 114.12 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -131.74 157.85 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.64 0.776 . . . . 0.0 109.36 -176.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.81 -179.25 7.42 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.5 tp -107.83 -47.44 3.59 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.849 1.26 . . . . 0.0 110.586 167.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.495 ' HB2' ' CD ' ' A' ' 25' ' ' GLU . 78.4 m-85 -95.09 -42.27 8.69 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.187 1.795 . . . . 0.0 113.9 -162.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.99 -23.46 0.32 Allowed Glycine 0 CA--C 1.55 2.276 0 C-N-CA 126.436 1.97 . . . . 0.0 116.766 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.498 ' HB2' ' HG3' ' A' ' 25' ' ' GLU . 2.5 mpt_? -103.7 109.35 61.93 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-N 121.991 2.895 . . . . 0.0 112.524 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.27 125.77 12.82 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.323 2.016 . . . . 0.0 114.615 -173.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.9 mm -54.07 124.61 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 124.795 1.238 . . . . 0.0 109.988 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -114.68 110.23 19.44 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.596 1.189 . . . . 0.0 111.178 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -83.73 148.03 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.792 174.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 . . . . . 0 CA--C 1.545 0.77 0 C-N-CA 125.075 1.35 . . . . 0.0 113.31 168.871 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.474 0.75 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.9 tp -83.08 128.19 34.26 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.414 2.285 . . . . 0.0 108.705 -169.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -77.45 138.77 39.44 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.123 0.963 . . . . 0.0 110.936 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.0 t -134.15 124.05 45.18 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.71 -171.33 13.33 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 173.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.5 t30 60.92 41.47 14.24 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 123.089 1.423 . . . . 0.0 111.588 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.546 HD12 HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -86.94 148.65 25.24 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.698 1.599 . . . . 0.0 110.779 178.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 162.85 26.84 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 125.656 2.646 . . . . 0.0 116.89 170.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.6 p -69.45 -29.01 66.61 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 127.879 2.471 . . . . 0.0 109.445 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.612 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 8.5 mmpt? -103.42 15.93 27.8 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 128.129 2.571 . . . . 0.0 114.163 176.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.546 HG11 HD12 ' A' ' 24' ' ' LEU . 3.9 p -71.0 157.27 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 120.841 -1.162 . . . . 0.0 112.04 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.2 p -156.56 166.76 32.46 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.51 1.124 . . . . 0.0 110.546 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -60.75 -27.9 68.29 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.321 -0.862 . . . . 0.0 109.957 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -61.01 -35.1 75.95 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.065 2.546 . . . . 0.0 112.536 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.421 HD23 HG23 ' A' ' 28' ' ' VAL . 16.0 tp -79.52 -39.94 30.77 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.703 0.763 . . . . 0.0 110.732 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.3 mt -65.39 -45.9 82.19 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.187 -0.945 . . . . 0.0 112.917 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -58.65 -34.13 70.86 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.294 1.038 . . . . 0.0 112.036 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -88.6 -28.23 20.82 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.25 0.62 . . . . 0.0 112.5 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.423 HD13 HG13 ' A' ' 87' ' ' ILE . 2.5 tt -70.19 -41.17 74.07 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.356 -0.84 . . . . 0.0 111.176 176.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -81.54 21.42 0.8 Allowed 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 120.376 1.444 . . . . 0.0 112.773 -173.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.06 -9.07 59.44 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 117.576 2.436 . . . . 0.0 117.576 -156.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -116.55 7.2 13.62 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 125.581 1.552 . . . . 0.0 113.163 163.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.6 31.4 0.76 Allowed 'General case' 0 CA--C 1.55 0.956 0 O-C-N 119.871 -1.768 . . . . 0.0 115.041 -167.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.97 136.19 3.53 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 107.545 -2.222 . . . . 0.0 107.545 -163.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.68 101.55 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.715 1 C-N-CA 125.307 4.005 . . . . 0.0 114.187 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.53 133.17 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.535 1.134 . . . . 0.0 110.118 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.1 mt -87.33 -47.86 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.174 1.39 . . . . 0.0 108.948 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.33 161.77 16.79 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 126.929 2.092 . . . . 0.0 111.104 -173.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.3 t -116.53 149.24 18.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 127.663 2.385 . . . . 0.0 111.808 173.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -120.66 122.77 41.2 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.693 1.197 . . . . 0.0 113.741 166.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.431 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 3.6 mm -101.24 121.47 51.73 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 124.073 0.949 . . . . 0.0 110.208 165.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 52.1 Cg_endo -66.77 165.98 23.92 Favored 'Trans proline' 0 CA--C 1.55 1.291 1 C-N-CA 125.341 4.028 . . . . 0.0 110.12 164.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -156.35 112.25 3.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.198 1.799 . . . . 0.0 109.893 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -57.25 172.64 0.29 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.267 2.227 . . . . 0.0 113.149 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.51 -37.76 5.66 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.594 -0.691 . . . . 0.0 112.752 171.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -76.72 -13.41 60.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.444 2.698 . . . . 0.0 116.28 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.32 30.79 11.54 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.981 2.229 . . . . 0.0 114.818 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.32 141.22 31.46 Favored Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 119.801 1.801 . . . . 0.0 114.28 -174.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.04 8.07 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.599 2.866 . . . . 0.0 116.401 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.13 32.79 20.78 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 120.418 -1.426 . . . . 0.0 112.716 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.549 ' NE2' HH11 ' A' ' 85' ' ' ARG . 20.5 mt-30 56.93 30.32 17.83 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -176.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.409 ' HA ' HD23 ' A' ' 24' ' ' LEU . 2.0 p90 -151.29 165.01 35.31 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.009 -1.682 . . . . 0.0 111.097 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -155.46 -175.3 5.36 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 127.333 2.253 . . . . 0.0 111.254 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -138.08 160.7 38.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.738 1.615 . . . . 0.0 112.444 170.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.6 t -147.16 127.77 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 122.344 1.068 . . . . 0.0 113.726 -175.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 . . . . . 0 C--N 1.325 -0.471 0 C-N-CA 124.46 1.104 . . . . 0.0 109.582 171.022 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 CA--C 1.541 0.831 0 N-CA-C 109.835 -0.871 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -58.15 -42.59 86.24 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.133 -0.98 . . . . 0.0 112.921 -170.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.15 -29.79 70.59 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.939 -1.029 . . . . 0.0 113.767 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.5 ttp -58.36 -20.47 43.92 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.701 1.137 . . . . 0.0 112.289 176.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -103.34 -35.63 8.33 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 170.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.29 -34.18 72.45 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 120.003 1.274 . . . . 0.0 114.221 -175.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.0 mt -120.64 -92.75 0.53 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 128.727 2.811 . . . . 0.0 110.406 -170.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.436 ' OD1' ' HD2' ' A' ' 88' ' ' LYS . 1.5 t30 26.24 74.75 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 128.496 2.719 . . . . 0.0 115.449 175.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 135.48 16.97 0.88 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-N 113.775 -1.557 . . . . 0.0 112.87 -176.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -132.84 152.24 35.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 118.557 1.178 . . . . 0.0 111.827 -169.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.31 -173.23 1.21 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.976 2.51 . . . . 0.0 110.507 -167.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.5 tp -143.33 -39.05 0.32 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.392 1.477 . . . . 0.0 108.767 160.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -55.13 -57.13 13.0 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.224 1.01 . . . . 0.0 112.034 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.64 -46.54 0.23 Allowed Glycine 0 N--CA 1.48 1.62 0 N-CA-C 117.58 1.792 . . . . 0.0 117.58 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.549 HH11 ' NE2' ' A' ' 58' ' ' GLN . 3.3 mpt_? -95.13 117.61 66.72 Favored Pre-proline 0 C--O 1.238 0.467 0 CA-C-N 118.272 1.036 . . . . 0.0 108.244 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -71.06 128.75 15.24 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.849 1.699 . . . . 0.0 112.47 -174.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.423 HG13 HD13 ' A' ' 36' ' ' LEU . 12.1 mm -53.13 126.93 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 C-N-CA 123.481 0.712 . . . . 0.0 109.667 174.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.436 ' HD2' ' OD1' ' A' ' 78' ' ' ASN . 10.1 tptm -117.8 115.82 25.76 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.491 1.516 . . . . 0.0 110.058 177.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -87.49 141.05 14.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 . . . . . 0 C--N 1.328 -0.359 0 C-N-CA 124.163 0.985 . . . . 0.0 109.946 172.051 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.1 m . . . . . 0 C--O 1.234 0.272 0 CA-C-O 121.688 0.756 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.7 mp -108.47 129.62 55.27 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.258 2.223 . . . . 0.0 108.276 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -79.46 139.93 37.49 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.625 0.77 . . . . 0.0 109.341 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.3 t -130.6 133.07 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 172.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.85 -177.55 14.92 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.742 1.163 . . . . 0.0 110.625 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.5 t30 75.17 19.34 2.29 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.646 1.579 . . . . 0.0 112.815 -176.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.648 HD12 HG21 ' A' ' 28' ' ' VAL . 0.6 OUTLIER -65.17 147.66 53.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.436 -168.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 0.5 OUTLIER -66.61 157.36 32.63 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 125.953 2.787 . . . . 0.0 113.277 173.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 p -66.39 -18.51 65.4 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 129.424 3.09 . . . . 0.0 112.548 -174.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -128.23 19.67 6.38 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 131.454 3.902 . . . . 0.0 112.208 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.648 HG21 HD12 ' A' ' 24' ' ' LEU . 5.8 p -60.53 151.59 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 O-C-N 120.931 -1.106 . . . . 0.0 112.216 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.4 p -152.24 168.99 23.57 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.542 1.537 . . . . 0.0 110.635 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -66.94 -29.03 68.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.115 0.966 . . . . 0.0 109.637 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -56.93 -47.54 80.37 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.6 tp -70.72 -43.59 68.61 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.864 1.265 . . . . 0.0 113.142 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.92 -41.96 95.12 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.238 -0.914 . . . . 0.0 112.022 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -61.16 -47.34 86.65 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 118.744 0.702 . . . . 0.0 111.292 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -64.96 -33.9 77.15 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 119.683 1.129 . . . . 0.0 112.301 176.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.1 tt -72.68 -39.93 66.69 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.814 1.245 . . . . 0.0 113.223 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.447 ' CD2' HG21 ' A' ' 62' ' ' VAL . 50.0 m-85 -94.71 -19.77 20.11 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 -175.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -49.18 -36.69 20.34 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.05 1.74 . . . . 0.0 112.922 167.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -73.5 -15.79 61.31 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 174.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.63 -4.81 47.05 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.758 0.823 . . . . 0.0 112.668 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 138.3 -157.34 24.42 Favored Glycine 0 CA--C 1.545 1.94 0 C-N-CA 126.501 2.0 . . . . 0.0 113.966 168.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.01 93.32 0.96 Allowed 'Trans proline' 0 CA--C 1.551 1.334 0 C-N-CA 123.358 2.706 . . . . 0.0 113.452 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.1 m -81.65 137.61 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 122.712 1.244 . . . . 0.0 110.857 171.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.9 mm -99.16 -51.02 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 125.645 1.578 . . . . 0.0 111.749 -171.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.01 158.11 41.54 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.446 1.099 . . . . 0.0 108.494 176.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.5 t -124.06 147.85 28.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 125.668 1.587 . . . . 0.0 110.07 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -132.02 119.82 21.56 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 125.004 1.321 . . . . 0.0 112.851 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 mm -103.57 124.01 39.44 Favored Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 126.452 1.901 . . . . 0.0 107.719 165.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.99 170.38 19.06 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.788 2.326 . . . . 0.0 111.842 162.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -158.17 114.73 2.82 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 127.065 2.146 . . . . 0.0 111.347 172.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -58.68 169.66 0.92 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.014 -1.903 . . . . 0.0 109.868 170.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -32.47 69.62 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 120.961 -1.087 . . . . 0.0 113.573 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -64.81 -25.69 68.02 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.34 2.256 . . . . 0.0 113.017 171.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.78 39.37 2.54 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.093 1.33 . . . . 0.0 112.845 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 tppt? -133.58 130.64 20.96 Favored Pre-proline 0 C--N 1.35 0.619 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 -170.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.53 15.81 0.11 Allowed 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 125.136 3.89 . . . . 0.0 115.449 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.87 28.27 10.21 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 119.633 -1.917 . . . . 0.0 114.07 169.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 56.29 33.81 22.92 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.745 1.618 . . . . 0.0 115.137 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -153.42 161.83 41.89 Favored 'General case' 0 CA--C 1.555 1.146 0 O-C-N 120.75 -1.219 . . . . 0.0 112.927 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -158.88 173.45 16.49 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 126.665 1.986 . . . . 0.0 113.19 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -127.08 155.68 42.91 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.287 2.235 . . . . 0.0 112.056 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 37' ' ' PHE . 43.7 t -148.71 122.37 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.333 1.453 . . . . 0.0 109.144 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 . . . . . 0 CA--C 1.548 0.903 0 C-N-CA 124.718 1.207 . . . . 0.0 110.997 -178.763 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo . . . . . 0 CA--C 1.55 1.3 0 CA-C-O 121.596 0.582 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -51.63 -46.76 63.78 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 128.493 2.717 . . . . 0.0 114.019 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . . . -59.44 -21.78 60.53 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.4 ttt -67.79 -26.46 66.1 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.95 0.795 . . . . 0.0 111.297 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -81.7 -35.27 30.01 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.521 -0.737 . . . . 0.0 111.908 167.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.453 ' HG ' HD13 ' A' ' 77' ' ' LEU . 43.2 tp -81.28 -53.43 6.35 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -163.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.453 HD13 ' HG ' ' A' ' 76' ' ' LEU . 1.2 mm? -97.13 -83.6 0.39 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 125.611 1.564 . . . . 0.0 110.479 -174.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 24.19 66.41 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 128.422 2.689 . . . . 0.0 116.243 173.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.04 20.26 0.94 Allowed Glycine 0 CA--C 1.538 1.492 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.908 -173.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.59 152.02 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-N 118.721 1.26 . . . . 0.0 112.576 -171.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.6 172.89 4.85 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.337 2.255 . . . . 0.0 110.185 -176.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.27 -45.0 2.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.314 1.446 . . . . 0.0 110.236 166.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -61.39 -51.57 68.22 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.569 1.148 . . . . 0.0 113.679 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.6 -63.29 0.18 Allowed Glycine 0 N--CA 1.477 1.423 0 N-CA-C 117.222 1.649 . . . . 0.0 117.222 -168.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.422 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 7.3 mpt_? -88.2 123.96 67.53 Favored Pre-proline 0 N--CA 1.478 0.929 0 CA-C-N 119.75 1.775 . . . . 0.0 110.642 -175.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -76.23 134.22 15.61 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.054 2.503 . . . . 0.0 115.734 -174.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 87' ' ' ILE . 4.1 mm -64.06 123.06 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.647 0.737 . . . . 0.0 109.912 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -110.06 117.2 33.12 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 113.779 -1.555 . . . . 0.0 108.923 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 mp -78.78 149.32 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 172.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 . . . . . 0 N--CA 1.471 0.607 0 C-N-CA 126.605 1.962 . . . . 0.0 110.146 176.98 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.1 m . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 122.208 1.004 . . . . 0.0 108.871 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.8 tp -113.53 130.0 56.44 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.325 1.45 . . . . 0.0 110.436 -160.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -78.09 138.58 38.83 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.1 t -138.21 123.79 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 121.026 -1.047 . . . . 0.0 110.038 174.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.84 -170.34 15.05 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.616 2.055 . . . . 0.0 111.35 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.1 t30 58.23 35.8 25.25 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.446 1.499 . . . . 0.0 112.293 -176.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.587 HD12 HG21 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -68.13 163.19 23.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.364 1.078 . . . . 0.0 110.236 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 26' ' ' THR . 0.5 OUTLIER -86.34 170.27 12.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.087 171.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.415 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 43.5 p -83.48 -14.17 53.02 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.971 2.108 . . . . 0.0 113.646 -175.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 8.8 mmpt? -111.96 17.03 20.05 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 128.261 2.624 . . . . 0.0 112.33 177.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.587 HG21 HD12 ' A' ' 24' ' ' LEU . 3.7 p -72.18 153.03 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -173.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.3 p -155.71 160.83 40.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.45 1.9 . . . . 0.0 111.753 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -58.45 -20.05 41.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.956 0.902 . . . . 0.0 113.157 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -76.19 -34.54 59.3 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.597 1.159 . . . . 0.0 113.455 174.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.26 -48.44 70.48 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.854 0.862 . . . . 0.0 109.789 168.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.499 ' HB2' HG11 ' A' ' 46' ' ' VAL . 87.6 mt -59.89 -43.83 94.57 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.98 0.912 . . . . 0.0 111.113 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -65.45 -43.94 88.81 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 119.503 1.047 . . . . 0.0 110.723 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -61.11 -33.3 73.15 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.006 1.323 . . . . 0.0 113.344 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.493 HD13 HG13 ' A' ' 87' ' ' ILE . 3.7 tt -82.55 -42.46 18.33 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.844 2.057 . . . . 0.0 113.564 174.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.4 ' CD2' HG21 ' A' ' 62' ' ' VAL . 69.7 m-85 -84.87 -12.45 53.48 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.365 -1.459 . . . . 0.0 113.776 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -54.36 -36.65 64.07 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 121.309 1.868 . . . . 0.0 112.393 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -83.94 -0.31 50.91 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 173.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.42 14.68 14.02 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.915 1.286 . . . . 0.0 112.375 169.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.35 -157.45 23.19 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.459 1.504 . . . . 0.0 112.593 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.4 77.31 4.14 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.314 2.676 . . . . 0.0 112.643 -163.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.43 142.82 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 122.263 1.03 . . . . 0.0 108.527 167.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.0 mm -86.67 -51.83 12.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 124.951 1.3 . . . . 0.0 109.2 175.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -165.21 165.68 19.49 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.288 1.835 . . . . 0.0 111.696 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.499 HG11 ' HB2' ' A' ' 33' ' ' LEU . 74.4 t -119.65 150.9 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 125.66 1.584 . . . . 0.0 112.11 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.481 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 49.0 tptt -115.93 125.31 52.39 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 127.19 2.196 . . . . 0.0 114.131 165.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.6 mm -101.4 126.46 34.42 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 127.532 2.333 . . . . 0.0 111.64 158.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 60' ' ' ALA . 61.2 Cg_endo -77.74 172.2 16.13 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 125.294 3.996 . . . . 0.0 112.358 163.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.428 ' C ' ' HE3' ' A' ' 57' ' ' LYS . 25.9 mttt -161.06 122.61 2.96 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.755 2.022 . . . . 0.0 111.427 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.44 166.9 2.82 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.254 2.222 . . . . 0.0 112.882 170.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.86 -44.46 29.28 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.769 0.828 . . . . 0.0 111.257 166.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.43 -29.91 70.65 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.05 -1.031 . . . . 0.0 111.143 174.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.53 45.78 1.19 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.679 1.133 . . . . 0.0 114.782 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -129.64 141.11 40.7 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-N 119.924 1.862 . . . . 0.0 111.888 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.52 10.04 0.29 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.227 3.285 . . . . 0.0 117.285 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.428 ' HE3' ' C ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER 59.39 25.15 13.82 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 173.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.486 ' HA ' ' HB2' ' A' ' 24' ' ' LEU 0.283 35.6 mt-30 63.77 30.49 14.6 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.055 2.542 . . . . 0.0 114.688 -172.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -153.14 168.91 24.37 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 126.045 1.738 . . . . 0.0 111.747 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 47' ' ' LYS . . . -166.79 -174.06 2.62 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 130.51 3.524 . . . . 0.0 108.909 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -137.93 164.02 30.06 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 124.665 1.186 . . . . 0.0 112.287 169.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.4 HG21 ' CD2' ' A' ' 37' ' ' PHE . 34.7 t -139.98 139.19 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 125.577 1.551 . . . . 0.0 114.001 174.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 126.074 1.75 . . . . 0.0 114.989 -173.238 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--O 1.233 0.24 0 N-CA-C 110.996 -0.425 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -58.9 -44.05 91.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.03 0.919 . . . . 0.0 111.245 -165.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.69 -27.53 68.76 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.152 1.381 . . . . 0.0 113.682 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -62.72 -22.52 66.58 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.79 1.236 . . . . 0.0 111.782 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -95.91 -38.91 10.06 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 163.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.87 -49.63 19.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 120.654 1.57 . . . . 0.0 114.658 -165.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -98.31 -94.58 0.23 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.733 1.213 . . . . 0.0 109.133 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 21.84 79.35 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 128.115 2.566 . . . . 0.0 115.097 -169.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.82 26.33 1.58 Allowed Glycine 0 N--CA 1.476 1.33 0 C-N-CA 125.223 1.392 . . . . 0.0 113.984 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -128.07 144.66 37.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-N 117.874 0.837 . . . . 0.0 109.405 -171.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.98 177.45 10.34 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 177.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.5 tp -136.31 -44.35 0.62 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 130.834 3.654 . . . . 0.0 108.508 171.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -65.97 -52.72 47.11 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.351 1.86 . . . . 0.0 111.942 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 160.86 -38.71 0.43 Allowed Glycine 0 N--CA 1.477 1.375 0 N-CA-C 115.64 1.016 . . . . 0.0 115.64 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -100.3 115.93 64.95 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 125.728 1.611 . . . . 0.0 108.97 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.62 137.11 29.58 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.472 2.781 . . . . 0.0 113.204 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.493 HG13 HD13 ' A' ' 36' ' ' LEU . 4.7 mm -67.56 125.32 24.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 123.502 0.721 . . . . 0.0 111.106 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -113.79 107.21 15.42 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.432 1.893 . . . . 0.0 112.041 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.79 140.23 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.387 1.075 . . . . 0.0 111.316 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 . . . . . 0 CA--C 1.535 0.37 0 C-N-CA 127.53 2.332 . . . . 0.0 111.139 -179.805 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.514 -0.44 0 CA-C-O 122.388 1.089 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.5 tp -109.18 133.92 52.39 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.103 1.761 . . . . 0.0 114.47 -171.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -80.46 133.66 35.88 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.568 0.699 . . . . 0.0 110.602 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -128.62 127.85 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 169.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.27 -174.1 14.79 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.83 1.205 . . . . 0.0 112.236 170.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.7 t30 64.04 26.12 13.96 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.373 1.469 . . . . 0.0 114.739 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.421 ' HB3' HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -61.87 164.96 5.77 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.519 1.528 . . . . 0.0 109.64 177.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.81 172.97 12.72 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.059 1.504 . . . . 0.0 115.059 176.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.2 p -71.76 -21.23 61.77 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.015 2.126 . . . . 0.0 110.381 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.04 30.6 5.62 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 127.431 2.292 . . . . 0.0 116.369 173.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.45 HG22 ' N ' ' A' ' 29' ' ' THR . 8.6 p -69.68 165.47 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 118.885 -2.385 . . . . 0.0 115.472 176.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.45 ' N ' HG22 ' A' ' 28' ' ' VAL . 11.4 p -154.63 173.53 16.24 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.682 1.193 . . . . 0.0 112.743 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -73.29 -26.92 61.28 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.135 0.974 . . . . 0.0 110.195 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.72 -45.82 92.31 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 171.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.44 HD12 HG23 ' A' ' 28' ' ' VAL . 2.8 tm? -65.78 -47.22 75.87 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.825 0.85 . . . . 0.0 110.579 -174.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.406 HD21 ' CD1' ' A' ' 24' ' ' LEU . 96.5 mt -56.89 -48.69 77.58 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.854 1.262 . . . . 0.0 111.112 173.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -59.35 -37.95 79.16 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.363 0.983 . . . . 0.0 112.26 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -75.45 -33.41 60.87 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.995 0.816 . . . . 0.0 110.345 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.443 HD11 HD11 ' A' ' 80' ' ' ILE . 4.2 tt -68.18 -39.82 82.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.113 1.765 . . . . 0.0 113.35 176.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.479 ' CE2' HG21 ' A' ' 62' ' ' VAL . 60.3 m-85 -85.5 -1.2 56.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 117.9 -1.047 . . . . 0.0 113.694 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -60.32 -41.48 93.59 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.802 1.637 . . . . 0.0 110.904 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -75.25 -14.71 60.54 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 172.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.03 -24.41 47.83 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 120.709 1.595 . . . . 0.0 110.14 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 154.12 -172.58 32.75 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 128.639 3.018 . . . . 0.0 114.412 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.73 79.66 2.69 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 124.853 3.702 . . . . 0.0 110.403 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.6 m -52.7 141.2 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.842 1.257 . . . . 0.0 113.365 172.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 80.3 mt -79.69 -59.68 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 126.8 2.04 . . . . 0.0 107.818 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.36 168.47 25.94 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.337 1.455 . . . . 0.0 113.282 174.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.5 t -116.65 157.19 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 126.662 1.985 . . . . 0.0 112.631 171.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -134.93 123.56 23.59 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.616 1.966 . . . . 0.0 113.75 169.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.413 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 3.4 mm -100.16 124.74 42.21 Favored Pre-proline 0 C--N 1.324 -0.512 0 C-N-CA 126.681 1.993 . . . . 0.0 108.612 167.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 50.3 Cg_endo -72.76 167.08 28.17 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.461 2.774 . . . . 0.0 111.583 161.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -158.77 114.83 2.66 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.857 2.463 . . . . 0.0 109.054 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.541 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 30.6 t70 -54.04 174.59 0.05 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.413 2.285 . . . . 0.0 112.545 170.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.68 -35.08 60.68 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.289 -1.507 . . . . 0.0 112.881 167.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -68.65 -13.76 62.57 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.944 2.498 . . . . 0.0 113.486 175.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.84 54.21 6.67 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -173.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -135.85 132.91 19.63 Favored Pre-proline 0 CA--C 1.517 -0.309 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.61 22.25 0.4 Allowed 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 124.276 3.318 . . . . 0.0 114.594 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.541 ' HE2' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER 51.47 26.95 3.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 119.727 -1.858 . . . . 0.0 115.612 168.175 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 52.02 35.11 15.3 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 127.185 2.194 . . . . 0.0 114.418 -170.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -150.8 157.91 43.51 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 120.001 -1.687 . . . . 0.0 112.224 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -153.91 174.86 14.06 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.247 1.819 . . . . 0.0 111.541 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -126.9 153.29 45.95 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 119.848 -1.783 . . . . 0.0 111.956 175.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.479 HG21 ' CE2' ' A' ' 37' ' ' PHE . 84.3 t -139.44 124.51 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.122 0.969 . . . . 0.0 112.692 -177.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 . . . . . 0 CA--C 1.55 0.966 0 C-N-CA 126.347 1.859 . . . . 0.0 109.931 -177.067 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 CA--C 1.547 1.137 0 N-CA-C 108.383 -1.43 . . . . 0.0 108.383 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -57.22 -34.91 69.04 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.608 1.563 . . . . 0.0 113.689 -169.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.35 -27.78 62.57 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.116 -0.99 . . . . 0.0 112.789 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.1 ttp -77.42 -13.24 59.97 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.831 0.852 . . . . 0.0 112.184 -170.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -106.34 -25.29 11.99 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.271 1.429 . . . . 0.0 113.627 163.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.3 tp -78.04 -49.34 14.21 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.773 1.229 . . . . 0.0 112.474 -172.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -100.8 -106.99 0.23 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 42.24 70.69 0.26 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.996 2.118 . . . . 0.0 114.805 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.98 16.9 1.07 Allowed Glycine 0 CA--C 1.53 0.998 0 CA-C-N 115.594 -0.73 . . . . 0.0 114.281 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.443 HD11 HD11 ' A' ' 36' ' ' LEU . 1.9 pp -132.86 151.64 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 118.37 1.085 . . . . 0.0 111.773 -167.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.95 175.12 9.79 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.437 1.495 . . . . 0.0 110.965 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 70.0 tp -119.28 -38.74 2.98 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.173 1.389 . . . . 0.0 112.072 161.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -79.04 -41.41 28.89 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.106 0.962 . . . . 0.0 113.509 -170.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.33 -44.18 0.29 Allowed Glycine 0 N--CA 1.473 1.108 0 N-CA-C 115.692 1.037 . . . . 0.0 115.692 173.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.54 124.98 55.58 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 124.339 1.056 . . . . 0.0 108.664 177.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -77.02 134.9 14.97 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 124.443 3.429 . . . . 0.0 115.012 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.422 HG13 HD13 ' A' ' 36' ' ' LEU . 10.1 mm -64.16 131.62 29.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 123.786 0.834 . . . . 0.0 110.736 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 tptm -121.01 112.01 18.19 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.252 1.821 . . . . 0.0 110.016 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.4 mp -88.28 140.73 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 . . . . . 0 N--CA 1.45 -0.46 0 CA-C-O 123.087 1.422 . . . . 0.0 109.041 -179.009 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 122.457 1.122 . . . . 0.0 108.836 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.22 132.75 39.85 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 125.216 1.407 . . . . 0.0 109.707 -175.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -81.04 129.92 34.77 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.929 0.871 . . . . 0.0 110.912 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.4 t -127.14 130.62 71.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.18 -173.56 13.31 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 122.61 1.117 . . . . 0.0 113.712 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.1 t30 62.8 36.14 13.29 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.877 1.671 . . . . 0.0 113.994 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.523 ' CD1' HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -73.15 154.96 40.11 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.478 1.111 . . . . 0.0 109.763 -174.301 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.34 162.58 12.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 123.752 1.739 . . . . 0.0 113.626 170.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.6 p -73.94 -7.54 52.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.152 2.181 . . . . 0.0 110.908 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -133.68 18.5 3.89 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.295 2.238 . . . . 0.0 114.279 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' A' ' 24' ' ' LEU . 9.1 p -57.42 161.03 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 O-C-N 120.837 -1.164 . . . . 0.0 113.594 176.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 p -158.18 161.43 37.85 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.262 1.825 . . . . 0.0 108.835 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -66.03 -25.52 67.09 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.806 1.643 . . . . 0.0 111.444 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -66.23 -35.86 81.52 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.592 1.157 . . . . 0.0 113.955 170.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.456 HD23 HG23 ' A' ' 28' ' ' VAL . 41.6 tp -77.3 -40.63 43.67 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.232 0.924 . . . . 0.0 110.388 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' A' ' 24' ' ' LEU . 82.8 mt -62.77 -46.65 87.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.397 175.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -60.15 -46.88 88.18 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.765 1.166 . . . . 0.0 111.844 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.04 -31.48 72.73 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.16 0.891 . . . . 0.0 111.919 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 tt -75.07 -42.48 56.78 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.459 1.104 . . . . 0.0 112.976 173.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -83.9 -20.4 33.08 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -70.01 -24.9 63.36 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.21 1.368 . . . . 0.0 110.66 172.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -60.7 -28.87 68.97 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.778 -1.201 . . . . 0.0 112.442 165.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.51 17.25 10.33 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.918 1.287 . . . . 0.0 114.05 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.54 -168.01 12.86 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.441 1.02 . . . . 0.0 114.706 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.3 79.41 3.09 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 124.657 3.571 . . . . 0.0 111.107 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.0 t -55.91 148.92 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.652 0.781 . . . . 0.0 110.284 171.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.5 mm -92.54 -52.04 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 126.396 1.878 . . . . 0.0 112.283 172.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -158.85 160.79 36.58 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.895 2.478 . . . . 0.0 108.352 -171.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 33' ' ' LEU . 57.7 t -127.3 155.63 38.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 126.789 2.036 . . . . 0.0 107.217 173.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -133.01 137.29 46.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.542 1.937 . . . . 0.0 110.176 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.414 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 3.4 mm -114.13 125.35 29.45 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 126.655 1.982 . . . . 0.0 111.866 163.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 55.5 Cg_endo -75.2 167.53 26.65 Favored 'Trans proline' 0 C--N 1.347 0.485 1 C-N-CA 125.519 4.146 . . . . 0.0 112.713 167.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -152.65 116.58 4.84 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 125.848 1.659 . . . . 0.0 110.532 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -49.2 164.2 0.08 Allowed 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 126.407 1.883 . . . . 0.0 112.08 161.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.35 -38.02 62.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.456 1.102 . . . . 0.0 112.062 170.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -74.3 -14.34 60.89 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.202 1.001 . . . . 0.0 112.373 174.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.7 41.93 3.74 Favored Glycine 0 C--N 1.343 0.967 0 O-C-N 120.303 -1.498 . . . . 0.0 115.676 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -133.28 139.08 33.01 Favored Pre-proline 0 N--CA 1.469 0.491 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -67.26 14.83 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.377 1 C-N-CA 125.762 4.308 . . . . 0.0 117.14 -178.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.27 18.06 2.33 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.371 -1.456 . . . . 0.0 114.117 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 68.04 31.62 5.39 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.262 1.825 . . . . 0.0 111.955 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.4 158.91 44.68 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.755 1.222 . . . . 0.0 113.254 -174.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.42 169.66 24.21 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.06 1.744 . . . . 0.0 111.891 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -121.4 150.32 41.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.168 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.4 t -139.58 146.97 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.734 1.214 . . . . 0.0 109.899 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 . . . . . 0 CA--C 1.543 0.703 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -173.338 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo . . . . . 0 CA--C 1.542 0.881 0 N-CA-C 117.067 1.91 . . . . 0.0 117.067 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -58.54 -42.36 87.64 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.492 1.117 . . . . 0.0 112.779 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.14 -32.22 67.95 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 121.343 1.883 . . . . 0.0 111.751 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.3 tpt -65.64 -26.83 67.99 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 118.372 0.533 . . . . 0.0 112.189 -175.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -86.56 -21.35 26.94 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 121.217 -0.927 . . . . 0.0 113.033 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -105.35 -38.85 6.35 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.789 1.635 . . . . 0.0 111.798 -155.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.8 -96.77 0.42 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.114 1.766 . . . . 0.0 111.443 174.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 29.97 66.37 0.12 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.791 2.036 . . . . 0.0 111.938 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.88 17.91 0.16 Allowed Glycine 0 N--CA 1.468 0.776 0 N-CA-C 117.347 1.699 . . . . 0.0 117.347 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -139.48 148.98 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 117.769 0.784 . . . . 0.0 112.578 -160.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.62 175.3 13.37 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.1 tp -138.53 -18.87 1.08 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.302 2.641 . . . . 0.0 112.819 171.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -101.92 -40.76 6.75 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.453 1.501 . . . . 0.0 112.986 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.74 -45.48 0.22 Allowed Glycine 0 N--CA 1.479 1.532 0 N-CA-C 118.477 2.151 . . . . 0.0 118.477 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -113.98 122.47 34.63 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 126.231 1.812 . . . . 0.0 111.459 -173.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.25 123.33 7.66 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.371 2.047 . . . . 0.0 115.106 -171.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.1 mm -52.6 118.61 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 124.495 1.118 . . . . 0.0 113.005 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -103.57 114.72 29.2 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.242 1.817 . . . . 0.0 111.658 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mp -84.0 146.77 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 O-C-N 121.649 -0.657 . . . . 0.0 110.574 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 . . . . . 0 N--CA 1.476 0.874 0 C-N-CA 126.122 1.769 . . . . 0.0 113.986 179.666 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.866 0.841 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.428 HD13 ' HG3' ' A' ' 71' ' ' PRO . 42.7 tp -117.47 133.63 55.75 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.981 2.112 . . . . 0.0 112.927 -166.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -85.03 124.57 31.88 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 123.322 1.534 . . . . 0.0 111.84 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 t -122.06 134.06 66.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.436 ' HA2' HD23 ' A' ' 24' ' ' LEU . . . -141.41 -171.13 12.59 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 121.201 -0.937 . . . . 0.0 112.18 174.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.4 t30 62.43 38.62 12.7 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.645 1.178 . . . . 0.0 111.165 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.69 HD12 HG21 ' A' ' 28' ' ' VAL . 0.9 OUTLIER -71.2 158.06 37.07 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.458 1.103 . . . . 0.0 109.065 -176.067 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.79 158.47 35.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.808 1.29 . . . . 0.0 110.0 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.2 p -73.26 -13.49 61.14 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.992 1.317 . . . . 0.0 113.3 -169.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HB3' ' HE3' ' A' ' 27' ' ' LYS . 25.4 mmmt -129.72 21.21 5.5 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 129.733 3.213 . . . . 0.0 112.364 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.69 HG21 HD12 ' A' ' 24' ' ' LEU . 9.2 p -53.64 160.69 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.524 1.13 . . . . 0.0 112.751 173.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.419 ' N ' HG22 ' A' ' 28' ' ' VAL . 36.3 p -148.41 162.15 40.16 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.931 1.692 . . . . 0.0 110.707 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -56.12 -37.34 69.29 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.707 1.203 . . . . 0.0 108.972 171.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -66.26 -32.32 73.67 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.577 HD23 HG23 ' A' ' 28' ' ' VAL . 13.4 tp -75.17 -35.49 61.59 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.009 -1.057 . . . . 0.0 111.906 175.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB2' HG11 ' A' ' 46' ' ' VAL . 26.0 mt -71.4 -43.67 66.37 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.049 171.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -53.5 -46.89 70.21 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.85 1.205 . . . . 0.0 110.658 175.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -73.14 -28.2 62.11 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.5 tt -77.58 -49.01 15.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.467 1.107 . . . . 0.0 112.666 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -81.25 -17.94 47.72 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 120.344 1.429 . . . . 0.0 113.263 -175.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -53.23 -32.4 48.12 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 120.312 1.415 . . . . 0.0 110.94 169.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -56.55 -38.4 71.85 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.464 1.505 . . . . 0.0 114.847 168.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.07 -20.37 30.49 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.227 1.811 . . . . 0.0 111.814 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.43 -168.78 29.08 Favored Glycine 0 CA--C 1.55 2.257 0 N-CA-C 117.774 1.869 . . . . 0.0 117.774 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.66 74.83 5.01 Favored 'Trans proline' 0 CA--C 1.548 1.185 1 C-N-CA 126.468 4.779 . . . . 0.0 110.806 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 m -57.72 127.11 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.827 1.651 . . . . 0.0 110.024 173.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.557 HG22 ' HE3' ' A' ' 45' ' ' LYS . 34.5 mm -69.08 -40.23 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.665 0.786 . . . . 0.0 111.018 -175.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.557 ' HE3' HG22 ' A' ' 44' ' ' ILE . 13.3 ptpt -171.49 160.14 5.84 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.59 2.356 . . . . 0.0 111.042 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.472 HG11 ' HB2' ' A' ' 33' ' ' LEU . 85.2 t -122.24 137.19 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 127.148 2.179 . . . . 0.0 112.156 -175.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -113.96 123.77 50.54 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.7 mm -110.91 111.9 56.14 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 125.754 1.622 . . . . 0.0 111.436 165.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.8 165.73 24.84 Favored 'Trans proline' 0 CA--C 1.552 1.399 1 C-N-CA 125.717 4.278 . . . . 0.0 111.258 172.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -157.24 114.82 3.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.966 2.107 . . . . 0.0 111.667 171.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.452 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 31.4 t0 -63.02 176.51 0.71 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 126.759 2.024 . . . . 0.0 113.093 170.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.79 -36.92 27.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.491 1.916 . . . . 0.0 113.072 172.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -77.04 -9.15 58.52 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.937 1.695 . . . . 0.0 114.538 174.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.08 41.54 6.61 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 125.669 1.604 . . . . 0.0 112.629 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -130.29 133.84 25.38 Favored Pre-proline 0 N--CA 1.467 0.412 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -169.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.24 13.63 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 1 C-N-CA 126.411 4.741 . . . . 0.0 115.037 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER 54.84 21.13 3.43 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 174.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 60.26 34.79 20.91 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.587 1.955 . . . . 0.0 112.96 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.482 ' HA ' HD23 ' A' ' 24' ' ' LEU . 2.0 p90 -151.04 155.91 40.0 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.142 1.377 . . . . 0.0 113.343 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -151.3 169.62 21.5 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.496 1.919 . . . . 0.0 112.914 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -126.24 159.56 32.7 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.265 1.031 . . . . 0.0 113.283 172.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.7 t -144.49 133.22 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.995 0.918 . . . . 0.0 110.874 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 . . . . . 0 CA--C 1.54 0.582 0 C-N-CA 125.578 1.551 . . . . 0.0 113.069 179.361 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.428 ' HG3' HD13 ' A' ' 19' ' ' LEU . 12.8 Cg_endo . . . . . 0 CA--C 1.534 0.496 0 N-CA-C 112.695 0.229 . . . . 0.0 112.695 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -52.91 -39.88 63.11 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.93 -26.69 67.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.6 ttt -70.48 -24.63 62.9 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 121.024 1.738 . . . . 0.0 112.765 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -87.04 -27.53 23.13 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.234 1.013 . . . . 0.0 112.109 169.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.33 -57.78 2.59 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -167.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -88.69 -94.92 0.1 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.547 1.139 . . . . 0.0 108.813 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 30.32 78.04 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.397 1.879 . . . . 0.0 113.38 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.9 28.01 1.78 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.022 0.82 . . . . 0.0 112.648 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -130.66 148.01 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.99 -175.17 3.91 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.239 2.216 . . . . 0.0 112.258 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.6 mt -131.37 -31.85 1.59 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.601 1.56 . . . . 0.0 112.841 154.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.446 ' CE2' HD22 ' A' ' 32' ' ' LEU . 21.0 m-30 -65.61 -51.95 55.75 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.05 -50.03 0.16 Allowed Glycine 0 CA--C 1.534 1.264 0 O-C-N 121.134 -0.979 . . . . 0.0 115.191 170.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -93.45 111.91 54.29 Favored Pre-proline 0 N--CA 1.479 1.014 0 C-N-CA 124.472 1.109 . . . . 0.0 109.247 -172.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.56 127.22 12.24 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.776 2.317 . . . . 0.0 112.536 -170.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.528 HD11 HD13 ' A' ' 24' ' ' LEU . 4.8 mm -56.74 122.54 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 122.223 1.011 . . . . 0.0 109.121 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -103.39 121.27 42.43 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.671 1.988 . . . . 0.0 109.732 171.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.46 141.23 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 169.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 . . . . . 0 C--O 1.235 0.333 0 CA-C-O 122.705 1.24 . . . . 0.0 111.552 174.706 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 83.7 m . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.9 tp -89.41 127.43 35.82 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.29 1.436 . . . . 0.0 113.367 -160.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -72.26 135.56 46.05 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.965 0.888 . . . . 0.0 111.769 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.04 134.97 62.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 168.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.82 -175.53 13.96 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 126.187 1.851 . . . . 0.0 111.23 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 42.9 t30 65.82 24.71 11.34 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.095 1.358 . . . . 0.0 112.315 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.613 HD12 HG21 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -64.8 160.09 21.01 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 123.282 1.515 . . . . 0.0 110.654 -175.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.27 163.36 27.11 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.995 -1.912 . . . . 0.0 110.511 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.2 p -64.29 -27.4 69.01 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.17 1.788 . . . . 0.0 109.869 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -123.59 26.13 7.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.613 HG21 HD12 ' A' ' 24' ' ' LEU . 8.0 p -51.8 161.46 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.839 1.2 . . . . 0.0 111.777 169.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.41 ' N ' HG22 ' A' ' 28' ' ' VAL . 1.6 p -158.93 159.46 34.95 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.458 1.903 . . . . 0.0 110.542 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -55.02 -38.82 68.42 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 126.478 1.911 . . . . 0.0 109.171 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -67.26 -30.87 70.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.594 1.958 . . . . 0.0 112.376 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.3 tp -75.4 -43.74 48.46 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.8 0.727 . . . . 0.0 111.422 168.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.447 ' HB2' HG11 ' A' ' 46' ' ' VAL . 95.1 mt -60.82 -54.42 45.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.106 0.963 . . . . 0.0 110.521 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -53.9 -45.41 71.1 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.059 0.845 . . . . 0.0 112.425 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -69.33 -31.76 70.42 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.127 1.33 . . . . 0.0 112.714 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.2 tt -74.18 -36.17 64.02 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.458 1.103 . . . . 0.0 111.014 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -95.54 -12.78 25.19 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -56.2 -35.74 67.63 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.969 1.708 . . . . 0.0 109.804 163.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.6 mm100 -62.36 -36.19 81.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.773 1.229 . . . . 0.0 113.284 168.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.86 2.76 44.59 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.574 1.15 . . . . 0.0 113.401 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 134.38 -169.63 22.98 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.737 1.637 . . . . 0.0 115.369 167.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.32 99.82 0.17 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.695 2.93 . . . . 0.0 111.159 167.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.5 t -88.2 131.69 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.019 1.727 . . . . 0.0 110.19 172.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.42 -46.29 20.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.949 1.3 . . . . 0.0 111.18 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -171.07 150.46 3.05 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.689 1.596 . . . . 0.0 112.033 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' ' 33' ' ' LEU . 96.2 t -115.87 151.17 17.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 129.297 3.039 . . . . 0.0 110.383 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -129.68 121.09 26.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.93 2.092 . . . . 0.0 111.209 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.5 mm -101.0 122.33 49.11 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.583 1.553 . . . . 0.0 110.124 160.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.36 163.75 35.24 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 125.188 3.925 . . . . 0.0 111.114 164.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -154.92 113.64 3.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.525 1.53 . . . . 0.0 113.149 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -53.04 168.9 0.11 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 130.444 3.497 . . . . 0.0 113.83 173.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -28.4 59.96 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.852 0.461 . . . . 0.0 110.471 168.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -83.37 -6.17 59.38 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.67 40.91 8.57 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 126.556 2.027 . . . . 0.0 111.943 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -128.82 137.11 30.28 Favored Pre-proline 0 N--CA 1.465 0.325 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.58 14.23 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 124.275 3.316 . . . . 0.0 116.682 176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.42 27.81 6.82 Favored 'General case' 0 CA--C 1.554 1.125 0 O-C-N 120.538 -1.351 . . . . 0.0 114.307 175.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 57.42 32.47 21.83 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 127.464 2.305 . . . . 0.0 116.156 -173.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -147.0 162.57 38.51 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 127.205 2.202 . . . . 0.0 112.53 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -158.67 177.43 11.21 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.622 1.969 . . . . 0.0 110.362 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -129.06 154.35 46.74 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.106 1.362 . . . . 0.0 114.22 171.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.16 133.52 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.523 1.529 . . . . 0.0 110.609 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 . . . . . 0 CA--C 1.544 0.725 0 C-N-CA 125.914 1.686 . . . . 0.0 112.207 173.113 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.412 ' HG2' ' HG2' ' A' ' 74' ' ' MET . 33.0 Cg_endo . . . . . 0 CA--C 1.551 1.338 0 N-CA-C 114.48 0.915 . . . . 0.0 114.48 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -74.55 -42.09 59.42 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 120.521 -1.362 . . . . 0.0 112.044 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . . . -56.91 -42.28 79.65 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.089 1.755 . . . . 0.0 114.482 -166.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.412 ' HG2' ' HG2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -51.18 -22.95 2.91 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 173.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -109.06 -34.3 6.64 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 125.257 1.423 . . . . 0.0 110.343 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.44 ' HB3' HD22 ' A' ' 77' ' ' LEU . 28.2 tp -64.1 -60.85 2.73 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 118.831 0.741 . . . . 0.0 111.298 -176.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.44 HD22 ' HB3' ' A' ' 76' ' ' LEU . 2.1 mm? -87.88 -86.42 0.16 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.458 1.903 . . . . 0.0 106.662 -174.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 37.57 64.56 0.63 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 126.289 1.836 . . . . 0.0 114.621 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.97 35.1 0.56 Allowed Glycine 0 N--CA 1.481 1.658 0 O-C-N 120.814 -1.179 . . . . 0.0 115.234 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.01 143.95 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.525 1.53 . . . . 0.0 112.476 -174.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.23 170.7 12.97 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.82 2.048 . . . . 0.0 112.653 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 15.5 tp -123.21 -30.73 3.68 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.867 2.467 . . . . 0.0 112.272 163.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -83.7 -21.52 32.34 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.082 2.153 . . . . 0.0 114.001 -172.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 150.79 -59.8 0.42 Allowed Glycine 0 N--CA 1.483 1.791 0 N-CA-C 116.166 1.226 . . . . 0.0 116.166 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -102.47 129.04 26.84 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 126.267 1.827 . . . . 0.0 109.033 -173.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -76.38 134.68 15.83 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.76 2.974 . . . . 0.0 113.747 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 mm -57.57 129.33 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 O-C-N 121.834 -0.541 . . . . 0.0 110.4 176.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -119.37 110.52 17.05 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.528 1.931 . . . . 0.0 109.582 170.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -85.32 134.29 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 126.125 1.77 . . . . 0.0 109.256 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 . . . . . 0 CA--C 1.544 0.73 0 C-N-CA 126.679 1.992 . . . . 0.0 111.399 -166.901 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.3 m . . . . . 0 CA--C 1.543 0.695 0 CA-C-O 122.532 1.158 . . . . 0.0 108.102 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.5 tp -119.28 125.12 48.35 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 130.917 3.687 . . . . 0.0 111.01 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -80.65 135.95 36.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.602 1.161 . . . . 0.0 108.47 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.3 t -135.37 139.39 46.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 125.098 1.359 . . . . 0.0 108.753 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.02 -174.7 14.24 Favored Glycine 0 N--CA 1.449 -0.454 0 O-C-N 121.098 -1.001 . . . . 0.0 112.448 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.5 t30 71.19 24.44 3.84 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.943 1.697 . . . . 0.0 112.383 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.752 HD12 HG21 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -72.24 145.75 47.73 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 125.191 1.397 . . . . 0.0 109.766 -169.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.24 162.05 18.1 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 176.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.4 p -63.1 -22.41 66.84 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.822 1.649 . . . . 0.0 111.639 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -113.38 23.2 13.46 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.466 1.506 . . . . 0.0 113.618 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.752 HG21 HD12 ' A' ' 24' ' ' LEU . 6.7 p -60.25 155.47 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 O-C-N 119.784 -1.823 . . . . 0.0 112.131 171.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.6 p -153.52 159.8 42.33 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 129.132 2.973 . . . . 0.0 108.58 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -59.9 -28.06 67.25 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.08 2.152 . . . . 0.0 111.9 177.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -73.08 -32.58 65.09 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.067 1.347 . . . . 0.0 112.252 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.436 HD22 ' CZ ' ' A' ' 83' ' ' TYR . 21.7 tp -76.08 -36.49 58.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.676 0.79 . . . . 0.0 112.999 172.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.491 HD21 ' CD1' ' A' ' 24' ' ' LEU . 95.0 mt -69.71 -42.31 74.21 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 176.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -63.03 -40.74 98.63 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.786 1.63 . . . . 0.0 112.938 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -69.86 -29.72 67.02 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.141 -0.975 . . . . 0.0 111.37 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.471 HD13 HG13 ' A' ' 87' ' ' ILE . 6.1 tt -73.38 -39.06 65.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.58 0.752 . . . . 0.0 110.388 175.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -93.41 17.36 11.54 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.779 1.231 . . . . 0.0 114.274 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -67.39 -30.28 70.01 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 120.286 1.403 . . . . 0.0 114.671 -173.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -101.24 0.24 37.06 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.126 1.77 . . . . 0.0 113.123 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.77 30.95 0.54 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.14 179.28 39.97 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.104 0.859 . . . . 0.0 111.748 -173.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -62.13 109.24 0.79 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.43 2.086 . . . . 0.0 109.716 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.9 t -94.04 105.05 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.798 1.239 . . . . 0.0 109.11 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.1 mt -62.51 -49.37 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.437 1.895 . . . . 0.0 111.825 171.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.17 170.1 19.66 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.681 0.792 . . . . 0.0 110.13 175.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' A' ' 33' ' ' LEU . 87.3 t -119.58 160.77 19.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 125.355 1.462 . . . . 0.0 109.132 169.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -138.54 124.05 19.54 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.884 1.273 . . . . 0.0 111.939 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.432 HD12 HG13 ' A' ' 28' ' ' VAL . 4.5 mm -108.37 121.69 42.73 Favored Pre-proline 0 C--N 1.32 -0.692 0 C-N-CA 125.721 1.608 . . . . 0.0 109.896 169.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.16 164.83 33.37 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 125.198 3.932 . . . . 0.0 112.304 165.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -159.51 118.32 2.85 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 126.923 2.089 . . . . 0.0 108.769 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -55.53 168.92 0.35 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 127.106 2.162 . . . . 0.0 113.06 171.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.35 -35.44 62.74 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.001 1.32 . . . . 0.0 110.116 172.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -89.16 6.79 38.44 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 128.321 2.648 . . . . 0.0 114.79 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.47 46.55 7.34 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 126.759 2.123 . . . . 0.0 115.416 168.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 9.0 tppt? -136.26 137.27 24.1 Favored Pre-proline 0 N--CA 1.476 0.842 0 CA-C-N 118.761 1.281 . . . . 0.0 113.467 -173.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.474 ' HD2' ' HG3' ' A' ' 55' ' ' LYS . 72.9 Cg_endo -77.79 17.88 0.92 Allowed 'Trans proline' 0 C--O 1.223 -0.261 1 C-N-CA 126.412 4.741 . . . . 0.0 115.596 -176.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.45 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 50.5 27.86 3.07 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.815 1.646 . . . . 0.0 113.341 175.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.25 11.3 mt-30 53.83 32.59 15.29 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -171.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.45 ' CD2' ' HB2' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -149.21 150.98 33.5 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 126.337 1.855 . . . . 0.0 112.873 -176.04 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -155.1 176.06 13.03 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.911 1.685 . . . . 0.0 112.505 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -135.39 163.16 30.66 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.1 t -145.48 143.6 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.608 1.563 . . . . 0.0 109.813 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.885 0.85 . . . . 0.0 110.499 -176.314 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo . . . . . 0 CA--C 1.54 0.803 0 N-CA-C 109.266 -1.09 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -61.48 -40.9 96.24 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 120.084 -1.635 . . . . 0.0 112.888 -169.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.455 ' HB1' HD12 ' A' ' 77' ' ' LEU . . . -57.99 -27.96 63.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.145 1.378 . . . . 0.0 112.348 174.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.5 ttt -69.69 -17.7 63.5 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.323 1.049 . . . . 0.0 111.893 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -98.92 -38.87 8.84 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.216 0.917 . . . . 0.0 111.787 166.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.51 -40.09 94.99 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 118.8 0.727 . . . . 0.0 111.392 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.46 HD22 HD11 ' A' ' 80' ' ' ILE . 2.8 mt -124.81 -86.45 0.63 Allowed 'General case' 0 C--N 1.348 0.527 0 CA-C-O 116.36 -1.781 . . . . 0.0 111.191 -158.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 23.03 71.67 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.769 2.028 . . . . 0.0 112.439 169.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.75 25.19 0.7 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.752 1.644 . . . . 0.0 114.289 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.46 HD11 HD22 ' A' ' 77' ' ' LEU . 1.1 pp -134.81 151.68 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.645 1.178 . . . . 0.0 113.096 -172.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.94 168.95 20.43 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.416 1.486 . . . . 0.0 112.526 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.0 tp -111.89 -33.59 6.25 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 128.553 2.741 . . . . 0.0 111.146 173.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.436 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 6.4 m-30 -93.57 -67.0 0.88 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.632 1.573 . . . . 0.0 110.687 -173.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.37 -38.55 0.07 OUTLIER Glycine 0 CA--C 1.53 1.003 0 CA-C-O 117.92 -1.489 . . . . 0.0 116.108 -175.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.417 ' HA ' ' HD2' ' A' ' 86' ' ' PRO . 3.4 mpt_? -101.94 108.07 54.89 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 120.205 2.003 . . . . 0.0 110.86 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 21.1 Cg_endo -65.73 128.9 20.92 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.236 3.291 . . . . 0.0 113.585 -166.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.471 HG13 HD13 ' A' ' 36' ' ' LEU . 7.0 mm -58.85 124.78 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -117.13 109.8 17.38 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 128.258 2.623 . . . . 0.0 110.749 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 mp -88.93 142.74 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.255 0.622 . . . . 0.0 109.677 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 . . . . . 0 CA--C 1.542 0.645 0 CA-C-O 123.467 1.603 . . . . 0.0 113.93 -176.706 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.3 tp -122.85 123.6 41.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.873 1.669 . . . . 0.0 114.347 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -71.77 132.53 44.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.298 1.047 . . . . 0.0 112.497 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.43 119.88 51.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 174.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.43 -171.48 16.6 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 122.988 1.327 . . . . 0.0 112.067 166.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.3 t30 71.39 31.22 2.37 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.438 2.295 . . . . 0.0 114.595 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.725 HD12 HG21 ' A' ' 28' ' ' VAL . 0.9 OUTLIER -74.16 155.78 38.02 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.879 1.272 . . . . 0.0 113.91 -172.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -65.79 160.32 23.31 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.1 p -62.64 -26.75 68.79 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 128.712 2.805 . . . . 0.0 111.867 168.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -113.38 10.4 18.34 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.43 1.892 . . . . 0.0 113.448 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.725 HG21 HD12 ' A' ' 24' ' ' LEU . 9.2 p -61.92 158.97 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -174.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.6 p -154.1 168.92 24.86 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 128.356 2.662 . . . . 0.0 110.625 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -62.44 -25.2 67.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.409 1.484 . . . . 0.0 110.22 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -80.66 -26.48 37.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 117.361 -1.304 . . . . 0.0 113.672 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.526 HD23 HG23 ' A' ' 28' ' ' VAL . 20.8 tp -73.65 -29.89 62.6 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.283 0.947 . . . . 0.0 111.681 169.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.461 ' HB2' HG11 ' A' ' 46' ' ' VAL . 77.4 mt -78.83 -44.69 22.47 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.298 1.039 . . . . 0.0 113.663 171.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -63.9 -43.67 95.3 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 120.137 -1.602 . . . . 0.0 110.971 -174.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -63.42 -18.38 63.66 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.292 1.037 . . . . 0.0 113.573 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 tt -99.19 -43.95 6.44 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 129.093 2.957 . . . . 0.0 110.224 -169.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -78.69 -14.13 59.46 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.152 1.381 . . . . 0.0 111.841 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -66.62 -27.4 67.66 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 120.37 -1.456 . . . . 0.0 111.877 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -68.14 -23.99 64.95 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 127.754 2.422 . . . . 0.0 114.117 165.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.71 -22.15 23.51 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.707 1.603 . . . . 0.0 110.325 -176.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 132.81 -147.15 18.82 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.447 1.022 . . . . 0.0 114.299 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -81.25 114.73 2.84 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.917 3.078 . . . . 0.0 110.306 -172.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.1 t -110.6 120.39 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.422 1.489 . . . . 0.0 110.57 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.578 HG22 ' HD2' ' A' ' 45' ' ' LYS . 4.2 mt -61.41 -57.14 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.578 ' HD2' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -157.1 163.87 38.5 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 127.281 2.232 . . . . 0.0 113.582 -178.148 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 33' ' ' LEU . 73.2 t -118.22 146.66 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 128.651 2.78 . . . . 0.0 110.136 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -122.58 128.52 50.82 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.803 1.638 . . . . 0.0 113.607 171.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 4.3 mm -107.35 120.96 46.01 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 125.459 1.503 . . . . 0.0 110.647 163.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 72.9 Cg_endo -73.42 168.45 24.72 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 125.029 3.819 . . . . 0.0 113.318 165.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -158.6 122.55 3.99 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.639 2.775 . . . . 0.0 111.965 166.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.62 164.95 0.3 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.218 2.607 . . . . 0.0 113.248 165.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -49.88 -29.71 8.67 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 164.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.12 -7.84 59.11 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.002 1.321 . . . . 0.0 114.555 170.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.15 38.93 7.6 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 119.88 -1.763 . . . . 0.0 111.952 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.28 132.91 24.6 Favored Pre-proline 0 C--N 1.347 0.493 0 CA-C-N 118.619 1.209 . . . . 0.0 114.26 -176.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.21 12.16 0.3 Allowed 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.308 3.339 . . . . 0.0 113.861 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.439 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 58.82 22.32 10.02 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.485 -1.384 . . . . 0.0 113.147 172.244 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.444 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 19.8 mt-30 57.86 34.39 24.31 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.13 1.372 . . . . 0.0 114.106 -171.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.556 ' HA ' HD23 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -150.8 158.74 44.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.75 1.22 . . . . 0.0 113.247 -176.488 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.64 -176.86 6.18 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.251 1.42 . . . . 0.0 112.501 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -140.43 154.57 46.7 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.159 -0.963 . . . . 0.0 113.189 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.46 139.34 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.766 0.826 . . . . 0.0 113.174 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 . . . . . 0 C--O 1.234 0.246 0 C-N-CA 125.113 1.365 . . . . 0.0 112.881 174.703 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo . . . . . 0 CA--C 1.54 0.798 0 N-CA-C 109.993 -0.811 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -64.59 -29.29 70.3 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.844 -1.16 . . . . 0.0 113.593 -161.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.06 -18.68 64.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.7 ttp -61.12 -17.84 54.88 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 120.137 1.335 . . . . 0.0 112.206 173.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -109.22 -44.2 3.99 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.54 1.136 . . . . 0.0 111.888 171.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.29 -43.15 95.68 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.566 0.347 . . . . 0.0 111.55 -170.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -107.96 -88.34 0.48 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.616 1.166 . . . . 0.0 111.258 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 27.01 71.11 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 129.73 3.212 . . . . 0.0 115.712 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.43 14.98 1.49 Allowed Glycine 0 CA--C 1.532 1.155 0 CA-C-O 117.598 -1.668 . . . . 0.0 116.085 -174.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -125.08 150.98 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 119.793 1.797 . . . . 0.0 111.2 -168.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.88 171.21 16.98 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.745 1.218 . . . . 0.0 113.742 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.8 tp -120.28 -46.58 2.39 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.637 1.175 . . . . 0.0 109.75 166.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -69.32 -54.8 12.72 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.29 -46.2 0.06 OUTLIER Glycine 0 CA--C 1.537 1.414 0 N-CA-C 116.265 1.266 . . . . 0.0 116.265 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -105.15 114.71 63.28 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 127.619 2.368 . . . . 0.0 114.101 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.92 119.5 6.53 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.715 2.943 . . . . 0.0 113.033 -171.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.416 HD11 ' CD2' ' A' ' 33' ' ' LEU . 1.7 mm -50.24 124.08 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.903 1.281 . . . . 0.0 110.1 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -118.86 109.88 16.54 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 124.487 1.115 . . . . 0.0 112.037 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mp -81.88 131.23 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 . . . . . 0 CA--C 1.558 1.285 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 179.028 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 CA--C 1.548 0.899 0 CA-C-O 121.54 0.686 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.8 tp -75.28 132.53 41.1 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.732 2.413 . . . . 0.0 110.549 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -84.79 137.73 33.01 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 120.288 1.404 . . . . 0.0 110.622 175.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.57 115.79 32.77 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.87 -177.28 18.37 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.357 1.456 . . . . 0.0 110.396 172.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.2 t30 65.52 37.72 5.9 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.119 1.368 . . . . 0.0 111.698 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.576 ' CD1' HG21 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -74.81 152.04 39.02 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.028 1.731 . . . . 0.0 109.468 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 26' ' ' THR . 0.7 OUTLIER -67.9 170.96 7.27 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 123.966 1.841 . . . . 0.0 112.587 169.451 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.487 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 24.9 p -82.54 -13.77 56.06 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 126.293 1.837 . . . . 0.0 113.331 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -119.11 20.33 12.69 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.25 2.62 . . . . 0.0 113.08 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.576 HG21 ' CD1' ' A' ' 24' ' ' LEU . 8.0 p -71.67 158.23 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -177.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.1 p -153.5 167.0 30.93 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.441 1.096 . . . . 0.0 111.697 -173.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.442 ' HA ' HG11 ' A' ' 46' ' ' VAL . 43.0 mt-10 -63.78 -32.12 73.52 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.011 0.924 . . . . 0.0 108.713 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.12 -47.85 81.03 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.559 1.944 . . . . 0.0 113.109 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.3 tp -67.11 -36.94 83.01 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.095 0.558 . . . . 0.0 110.922 -175.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.533 HD21 ' CD1' ' A' ' 24' ' ' LEU . 99.2 mt -65.89 -51.17 61.02 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.17 1.388 . . . . 0.0 111.042 172.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -52.59 -43.52 65.36 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.838 2.055 . . . . 0.0 113.523 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -75.23 -27.63 59.6 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -76.14 -38.73 56.4 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.608 -0.683 . . . . 0.0 112.067 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.466 ' CE2' HG21 ' A' ' 62' ' ' VAL . 56.8 m-85 -82.03 11.53 5.06 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.595 -1.315 . . . . 0.0 114.06 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -62.95 -44.78 95.12 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.124 1.37 . . . . 0.0 113.786 -174.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.72 6.7 44.93 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.639 1.576 . . . . 0.0 111.351 168.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.66 3.66 43.72 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 120.744 1.611 . . . . 0.0 112.673 171.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.85 -167.94 12.59 Favored Glycine 0 CA--C 1.538 1.515 0 C-N-CA 127.918 2.675 . . . . 0.0 111.831 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.04 97.74 0.93 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.697 2.264 . . . . 0.0 111.328 -173.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.8 t -68.33 119.23 13.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 122.58 1.181 . . . . 0.0 110.335 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.9 mm -80.54 -46.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -175.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.99 155.19 30.87 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.885 1.674 . . . . 0.0 110.111 174.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.442 HG11 ' HA ' ' A' ' 30' ' ' GLU . 42.5 t -112.64 153.87 14.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 125.681 1.593 . . . . 0.0 107.45 170.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -126.91 126.4 43.19 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.905 1.282 . . . . 0.0 112.39 169.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.429 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 1.6 mm -105.54 122.78 41.59 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 123.892 0.877 . . . . 0.0 109.594 164.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 65.4 Cg_endo -71.71 166.21 30.17 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.847 3.031 . . . . 0.0 110.153 164.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -160.72 120.06 2.67 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 128.087 2.555 . . . . 0.0 106.072 174.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.25 172.81 2.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.359 -1.746 . . . . 0.0 110.75 167.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -32.61 62.97 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 122.405 1.098 . . . . 0.0 111.045 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -77.45 -3.61 41.23 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.648 1.979 . . . . 0.0 113.116 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.95 41.51 8.1 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.541 2.019 . . . . 0.0 113.618 170.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -136.46 135.48 20.77 Favored Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.32 15.39 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.585 1 C-N-CA 126.106 4.537 . . . . 0.0 116.005 -174.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.76 29.22 9.24 Favored 'General case' 0 CA--C 1.557 1.22 0 O-C-N 121.548 -0.72 . . . . 0.0 111.91 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 53.99 38.41 28.83 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -174.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.408 ' HA ' HD23 ' A' ' 24' ' ' LEU . 1.1 p90 -152.72 173.36 15.37 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 127.787 2.435 . . . . 0.0 113.257 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -169.71 174.51 5.72 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 128.882 2.873 . . . . 0.0 112.737 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -127.01 153.92 45.3 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.706 2.003 . . . . 0.0 112.274 170.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.466 HG21 ' CE2' ' A' ' 37' ' ' PHE . 4.7 t -141.2 140.17 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.66 1.984 . . . . 0.0 108.008 -178.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.927 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo . . . . . 0 CA--C 1.533 0.458 0 N-CA-C 113.731 0.627 . . . . 0.0 113.731 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -59.7 -42.6 93.36 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.847 1.259 . . . . 0.0 109.547 -175.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.86 -25.4 28.54 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 173.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 tpt -71.93 -16.05 62.1 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 121.456 1.935 . . . . 0.0 113.788 -173.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -103.16 -35.96 8.29 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.315 1.846 . . . . 0.0 111.271 169.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.67 -48.98 23.1 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.964 1.706 . . . . 0.0 112.633 -169.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.15 -97.14 0.33 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.73 1.612 . . . . 0.0 108.63 177.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 39.55 57.57 2.13 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.447 1.899 . . . . 0.0 112.69 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.52 22.54 0.13 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.89 151.6 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 118.711 1.255 . . . . 0.0 113.806 -168.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.51 176.91 6.24 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.91 1.684 . . . . 0.0 110.93 -170.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.9 tp -125.87 -35.83 2.45 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.088 1.755 . . . . 0.0 112.428 170.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 14.7 m-30 -81.79 -61.23 1.98 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.986 1.715 . . . . 0.0 111.059 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.87 -49.1 0.06 OUTLIER Glycine 0 N--CA 1.468 0.809 0 N-CA-C 117.297 1.679 . . . . 0.0 117.297 -176.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -90.87 116.67 66.91 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -171.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.08 128.82 13.43 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.177 2.585 . . . . 0.0 110.393 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.3 mm -63.87 118.65 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.155 -174.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -103.5 91.73 4.17 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.87 1.668 . . . . 0.0 110.799 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.45 ' H ' HD12 ' A' ' 89' ' ' ILE . 4.2 mp -60.14 139.13 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.203 165.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 . . . . . 0 N--CA 1.467 0.415 0 C-N-CA 125.282 1.433 . . . . 0.0 112.342 167.91 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 51.1 tp -106.83 133.37 51.59 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.195 2.598 . . . . 0.0 111.792 -172.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -88.0 133.0 34.05 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.56 0.618 . . . . 0.0 110.492 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.3 t -130.57 122.87 53.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 O-C-N 120.966 -1.084 . . . . 0.0 108.76 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 59' ' ' PHE . . . -125.32 -175.78 14.33 Favored Glycine 0 N--CA 1.464 0.548 0 C-N-CA 126.264 1.888 . . . . 0.0 112.057 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.1 t30 64.45 31.95 12.21 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.854 2.062 . . . . 0.0 111.907 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.465 ' HB3' HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -66.74 166.4 13.18 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.391 1.876 . . . . 0.0 111.531 -178.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 26' ' ' THR . 1.0 OUTLIER -82.74 165.82 19.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 123.126 1.441 . . . . 0.0 113.65 166.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.486 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 67.4 p -65.91 -34.2 77.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.505 1.522 . . . . 0.0 111.88 175.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.09 19.52 20.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.736 2.014 . . . . 0.0 115.395 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.465 HG11 ' HB3' ' A' ' 24' ' ' LEU . 3.8 p -64.88 155.85 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 125.012 1.325 . . . . 0.0 111.264 174.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.7 p -159.75 162.06 34.83 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.667 1.987 . . . . 0.0 110.319 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -60.09 -30.49 69.28 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.204 0.602 . . . . 0.0 110.316 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -59.94 -41.87 92.78 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.153 1.781 . . . . 0.0 112.321 174.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.585 HD21 HD13 ' A' ' 82' ' ' LEU . 1.6 tm? -72.04 -51.99 19.05 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.7 mt -56.41 -39.87 73.75 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -66.44 -46.36 76.72 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.01 0.823 . . . . 0.0 110.757 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -57.04 -39.71 75.36 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.807 1.643 . . . . 0.0 111.721 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -81.61 -42.85 19.45 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.933 1.693 . . . . 0.0 112.884 -175.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . 0.329 48.0 m-85 -76.54 -4.93 45.37 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 172.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -54.7 -42.62 71.69 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 121.902 2.137 . . . . 0.0 111.503 164.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -72.66 -15.86 61.71 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.16 -1.23 57.89 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.495 1.043 . . . . 0.0 113.773 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.64 -148.51 18.41 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.071 0.843 . . . . 0.0 111.221 -174.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -75.62 157.5 40.17 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.798 2.332 . . . . 0.0 112.78 171.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.1 147.32 21.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 127.116 2.167 . . . . 0.0 107.502 170.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.7 mm -88.49 -51.6 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 121.006 -1.059 . . . . 0.0 109.608 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.74 168.84 25.9 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.549 2.339 . . . . 0.0 112.561 175.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.8 t -122.9 144.63 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 129.874 3.269 . . . . 0.0 110.609 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -127.41 122.58 33.96 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 130.307 3.443 . . . . 0.0 115.275 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.0 mm -107.09 125.89 31.44 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.145 1.778 . . . . 0.0 110.067 167.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.14 167.62 23.06 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.776 3.65 . . . . 0.0 111.289 163.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -160.58 118.56 2.51 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 128.111 2.564 . . . . 0.0 110.35 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -52.37 163.43 0.41 Allowed 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 126.852 2.061 . . . . 0.0 113.698 169.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -30.6 43.46 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.031 1.332 . . . . 0.0 113.093 172.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -87.04 -9.67 54.91 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 171.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.25 51.71 1.21 Allowed Glycine 0 C--N 1.338 0.653 0 C-N-CA 125.937 1.732 . . . . 0.0 113.453 165.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -141.13 134.93 14.82 Favored Pre-proline 0 N--CA 1.467 0.392 0 CA-C-O 117.547 -1.216 . . . . 0.0 112.988 -176.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.53 12.51 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.531 1 C-N-CA 126.673 4.916 . . . . 0.0 115.422 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.11 20.81 10.05 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.703 -1.248 . . . . 0.0 111.722 173.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.441 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 44.0 mt-30 59.08 38.47 23.91 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.701 2.0 . . . . 0.0 113.515 -173.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.412 ' HA ' ' HA2' ' A' ' 22' ' ' GLY . 0.2 OUTLIER -156.32 165.01 37.6 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.837 2.055 . . . . 0.0 111.529 -179.114 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.03 -179.21 6.07 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 128.671 2.788 . . . . 0.0 111.149 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -142.42 154.17 44.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.464 1.506 . . . . 0.0 114.411 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.8 t -143.32 120.92 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.958 1.303 . . . . 0.0 111.73 -176.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 . . . . . 0 CA--C 1.544 0.715 0 O-C-N 120.848 -1.157 . . . . 0.0 111.58 177.91 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo . . . . . 0 C--O 1.232 0.213 0 CA-C-O 121.491 0.538 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -50.5 -36.56 34.44 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -164.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.446 ' HB1' HD23 ' A' ' 77' ' ' LEU . . . -72.96 -22.92 60.63 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.439 1.496 . . . . 0.0 114.528 -176.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.7 ttt -64.45 -21.01 66.53 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.652 1.181 . . . . 0.0 110.192 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -101.36 -34.63 9.53 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.253 1.821 . . . . 0.0 112.987 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.61 -39.92 23.75 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -172.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.446 HD23 ' HB1' ' A' ' 73' ' ' ALA . 1.6 mm? -113.3 -84.25 0.59 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.293 1.037 . . . . 0.0 109.852 -176.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.263 0.4 OUTLIER 23.7 59.85 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 129.306 3.043 . . . . 0.0 114.277 176.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.14 18.51 0.24 Allowed Glycine 0 CA--C 1.549 2.201 0 N-CA-C 118.162 2.025 . . . . 0.0 118.162 -169.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -138.41 149.71 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 121.124 2.462 . . . . 0.0 110.784 -165.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.33 156.76 24.36 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.585 HD13 HD21 ' A' ' 32' ' ' LEU . 1.3 mp -110.12 3.15 19.94 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.097 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -129.27 -85.56 0.55 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 129.033 2.933 . . . . 0.0 108.141 -173.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.43 -43.39 0.02 OUTLIER Glycine 0 N--CA 1.481 1.679 0 N-CA-C 115.91 1.124 . . . . 0.0 115.91 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' A' ' 86' ' ' PRO . 3.6 mpt_? -95.59 118.94 65.9 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 118.154 -0.927 . . . . 0.0 109.792 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 36.9 Cg_endo -74.9 125.95 9.72 Favored 'Trans proline' 0 C--N 1.351 0.705 1 C-N-CA 125.801 4.334 . . . . 0.0 114.373 -172.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.2 mm -55.31 124.99 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 122.808 0.443 . . . . 0.0 110.292 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -109.38 118.14 35.87 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 126.764 2.026 . . . . 0.0 110.055 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.5 mp -93.0 141.18 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.423 -0.798 . . . . 0.0 110.074 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 . . . . . 0 CA--C 1.535 0.399 0 C-N-CA 125.445 1.498 . . . . 0.0 110.338 171.702 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.542 0.642 0 CA-C-O 122.41 1.1 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.7 tp -99.93 138.08 37.5 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.949 2.1 . . . . 0.0 111.803 -170.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -88.17 137.94 31.89 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 122.06 0.933 . . . . 0.0 111.746 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -133.74 131.07 56.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.356 -0.84 . . . . 0.0 109.166 178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.64 -176.73 14.54 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 126.225 1.869 . . . . 0.0 110.262 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.9 t30 69.09 13.2 8.7 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.807 1.643 . . . . 0.0 114.646 -178.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.797 HD12 HG21 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -61.99 144.26 55.35 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 126.253 1.821 . . . . 0.0 112.878 179.35 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 13.3 mp0 -50.77 162.22 0.28 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 173.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.5 p -72.51 -22.37 61.05 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.948 175.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.96 21.28 9.88 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 129.895 3.278 . . . . 0.0 113.014 -177.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.797 HG21 HD12 ' A' ' 24' ' ' LEU . 4.9 p -64.15 162.04 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 120.855 -1.153 . . . . 0.0 112.066 173.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.3 p -159.64 168.91 24.91 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.31 1.844 . . . . 0.0 112.86 174.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HA ' HG11 ' A' ' 46' ' ' VAL . 45.2 mt-10 -62.66 -27.17 69.04 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.174 1.39 . . . . 0.0 112.31 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -62.8 -49.94 72.98 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.76 1.164 . . . . 0.0 111.921 170.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.8 tp -64.66 -47.57 77.98 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.408 HD22 ' HE2' ' A' ' 37' ' ' PHE . 31.1 mt -62.57 -37.49 86.37 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -63.14 -47.09 84.19 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.06 0.845 . . . . 0.0 112.11 173.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -72.05 -19.57 61.82 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.451 1.5 . . . . 0.0 113.324 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.5 tt -92.61 -49.25 6.2 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.146 1.779 . . . . 0.0 112.162 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.408 ' HE2' HD22 ' A' ' 33' ' ' LEU . 61.6 m-85 -72.77 -18.07 61.53 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.209 -0.932 . . . . 0.0 112.442 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -60.86 -26.5 67.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.775 1.625 . . . . 0.0 113.356 171.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -64.25 -31.39 72.57 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.247 -1.533 . . . . 0.0 112.78 168.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.86 1.45 34.94 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.39 1.076 . . . . 0.0 112.465 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.52 -146.53 16.91 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.295 1.426 . . . . 0.0 113.631 169.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -74.13 90.8 0.96 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 CA-C-N 119.567 1.684 . . . . 0.0 114.637 -167.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.7 t -74.91 133.42 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 125.535 1.534 . . . . 0.0 109.791 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.8 mt -85.24 -55.69 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 127.272 2.229 . . . . 0.0 111.047 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.06 152.65 28.3 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 128.019 2.528 . . . . 0.0 107.54 -175.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' A' ' 30' ' ' GLU . 38.3 t -106.48 151.13 8.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 127.946 2.498 . . . . 0.0 105.423 172.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -127.75 124.33 37.49 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 124.113 0.965 . . . . 0.0 113.358 166.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.428 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 6.9 mm -101.57 120.31 54.85 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.053 163.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 43.0 Cg_endo -68.95 167.95 21.89 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 124.689 3.592 . . . . 0.0 110.222 165.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -157.45 115.87 3.19 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.134 1.374 . . . . 0.0 107.829 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -50.54 164.32 0.14 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.237 2.215 . . . . 0.0 111.264 161.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.5 pptp? -53.24 -29.53 33.08 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 120.808 -1.183 . . . . 0.0 113.567 167.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.29 -4.37 55.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.077 0.951 . . . . 0.0 112.604 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.55 35.62 8.46 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 125.962 1.744 . . . . 0.0 111.532 170.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -124.11 136.66 27.83 Favored Pre-proline 0 C--N 1.345 0.388 0 CA-C-N 118.958 1.379 . . . . 0.0 113.641 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.25 12.11 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 124.01 3.14 . . . . 0.0 118.316 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.62 27.78 11.0 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 121.286 1.857 . . . . 0.0 113.383 176.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 54.36 35.26 22.55 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.199 1.8 . . . . 0.0 113.413 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.549 ' HA ' HD23 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -147.93 162.66 38.85 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.783 -1.198 . . . . 0.0 110.494 -177.125 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -154.68 -179.23 7.81 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.213 1.405 . . . . 0.0 110.763 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -134.96 163.83 28.96 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.058 1.743 . . . . 0.0 109.808 165.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.4 t -145.96 134.7 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 127.145 2.178 . . . . 0.0 108.449 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 . . . . . 0 CA--C 1.545 0.751 0 C-N-CA 125.938 1.695 . . . . 0.0 111.059 -179.259 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 CA--C 1.534 0.506 0 CA-C-O 121.671 0.613 . . . . 0.0 113.111 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -51.06 -36.09 38.11 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.98 0.912 . . . . 0.0 111.748 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.96 -27.21 64.55 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 ttt -59.55 -28.22 66.92 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 119.754 1.161 . . . . 0.0 111.069 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -86.98 -19.32 28.89 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.753 2.021 . . . . 0.0 110.787 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.62 -45.05 4.12 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.348 1.459 . . . . 0.0 112.533 -161.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.54 -92.85 0.43 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.955 1.702 . . . . 0.0 109.322 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.261 0.9 OUTLIER 37.75 52.23 1.4 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.742 2.017 . . . . 0.0 115.191 165.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.38 17.79 0.21 Allowed Glycine 0 CA--C 1.534 1.246 0 CA-C-N 114.795 -1.093 . . . . 0.0 115.749 -167.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -141.82 150.59 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 118.285 1.043 . . . . 0.0 113.734 -170.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.09 167.32 26.54 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -173.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.0 tp -98.0 -34.93 10.61 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 113.349 -1.75 . . . . 0.0 111.593 169.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.409 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 43.9 m-85 -104.26 -50.22 3.4 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -167.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 172.39 -30.9 0.11 Allowed Glycine 0 CA--C 1.543 1.785 0 CA-C-O 117.991 -1.45 . . . . 0.0 115.192 -175.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -99.69 97.47 5.8 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 127.148 2.179 . . . . 0.0 115.242 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.05 114.99 2.86 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.943 3.095 . . . . 0.0 113.249 -173.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.6 mm -47.83 124.7 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 C-N-CA 125.926 1.69 . . . . 0.0 111.906 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -108.63 113.0 25.62 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 124.479 1.112 . . . . 0.0 111.584 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mp -88.64 137.93 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 . . . . . 0 C--N 1.32 -0.679 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 172.153 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.7 m . . . . . 0 CA--C 1.519 -0.232 0 CA-C-O 121.995 0.902 . . . . 0.0 108.832 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.3 tp -100.33 133.23 45.06 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 125.083 1.353 . . . . 0.0 112.163 -167.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -82.26 130.45 35.1 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.143 1.377 . . . . 0.0 114.042 177.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 t -145.39 128.45 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 124.941 1.296 . . . . 0.0 107.581 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.5 -176.51 14.45 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 126.308 1.908 . . . . 0.0 110.581 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.5 t30 71.67 16.78 5.68 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.846 2.059 . . . . 0.0 114.085 -172.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.419 ' HB2' ' C ' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -61.85 139.57 58.35 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 127.295 2.238 . . . . 0.0 110.392 -172.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.492 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 4.6 mt-10 -60.41 162.13 6.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 124.414 2.054 . . . . 0.0 116.109 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.1 p -68.94 -28.14 66.38 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.888 1.675 . . . . 0.0 111.615 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.1 tppt? -107.11 9.18 30.45 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 131.056 3.743 . . . . 0.0 115.649 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 p -59.7 161.73 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.127 1.371 . . . . 0.0 112.885 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 p -158.56 165.03 35.48 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.754 1.622 . . . . 0.0 112.321 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -59.47 -27.52 66.18 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.581 -0.7 . . . . 0.0 110.156 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -67.53 -44.17 78.99 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.834 1.254 . . . . 0.0 111.831 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.3 tp -72.44 -39.75 67.57 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.531 0.732 . . . . 0.0 111.095 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.565 ' HB2' HG11 ' A' ' 46' ' ' VAL . 71.6 mt -63.52 -40.85 98.13 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.486 1.039 . . . . 0.0 110.653 174.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -59.16 -46.41 88.47 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.27 -33.13 67.24 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.504 1.047 . . . . 0.0 112.53 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.2 tt -69.03 -41.51 77.6 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.317 0.647 . . . . 0.0 112.206 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -89.57 8.57 30.56 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.806 1.242 . . . . 0.0 113.941 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -56.91 -48.79 77.4 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.263 -1.523 . . . . 0.0 113.131 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -74.19 -9.46 58.64 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.88 36.52 1.4 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -166.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.58 -165.83 40.97 Favored Glycine 0 CA--C 1.542 1.744 0 C-N-CA 123.764 0.697 . . . . 0.0 114.322 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -81.43 85.51 1.74 Allowed 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 121.446 1.431 . . . . 0.0 114.891 -168.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.82 129.92 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 126.648 1.979 . . . . 0.0 108.882 166.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mt -91.04 -54.49 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.17 1.788 . . . . 0.0 111.4 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.57 158.49 43.6 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.058 1.743 . . . . 0.0 111.624 -178.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.565 HG11 ' HB2' ' A' ' 33' ' ' LEU . 91.7 t -116.22 143.26 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.667 1.587 . . . . 0.0 111.529 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -121.59 132.25 54.57 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.38 1.872 . . . . 0.0 114.932 172.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.9 mm -118.47 119.14 33.21 Favored Pre-proline 0 N--CA 1.471 0.584 0 C-N-CA 128.039 2.536 . . . . 0.0 109.745 172.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.23 172.84 15.22 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.151 2.567 . . . . 0.0 113.691 169.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -153.17 108.92 3.29 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.513 2.325 . . . . 0.0 111.461 172.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -43.45 164.52 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 130.741 3.617 . . . . 0.0 115.643 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.25 -29.0 3.4 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 114.744 1.386 . . . . 0.0 114.744 165.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -93.73 -11.07 32.27 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 168.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.55 47.2 1.69 Allowed Glycine 0 N--CA 1.477 1.395 0 O-C-N 119.767 -1.833 . . . . 0.0 115.206 174.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -138.14 141.42 32.03 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 125.926 1.69 . . . . 0.0 113.31 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.81 14.27 0.2 Allowed 'Trans proline' 0 CA--C 1.545 1.028 1 C-N-CA 125.96 4.44 . . . . 0.0 115.145 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.68 21.78 6.18 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 174.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.476 HE22 ' HG2' ' A' ' 85' ' ' ARG . 9.5 mt-30 59.01 35.78 24.14 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 125.105 1.362 . . . . 0.0 113.93 -169.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -155.74 161.59 40.67 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.552 1.541 . . . . 0.0 113.849 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.55 167.06 15.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.982 1.313 . . . . 0.0 113.197 -174.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -120.76 156.12 32.53 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.858 0.863 . . . . 0.0 112.734 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.3 t -144.45 112.51 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 C-N-CA 123.509 0.724 . . . . 0.0 110.176 -178.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 . . . . . 0 N--CA 1.444 -0.774 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.206 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo . . . . . 0 CA--C 1.536 0.606 0 CA-C-O 120.846 0.269 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.497 ' CD2' HD12 ' A' ' 76' ' ' LEU . 32.7 t80 -56.06 -35.65 67.18 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.098 1.359 . . . . 0.0 112.208 -166.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.11 -21.16 64.78 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.35 -23.19 64.07 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.767 1.627 . . . . 0.0 114.167 175.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -112.61 -30.04 7.24 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.652 1.581 . . . . 0.0 111.459 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.497 HD12 ' CD2' ' A' ' 72' ' ' TYR . 0.8 OUTLIER -73.49 -45.65 52.67 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.972 0.909 . . . . 0.0 112.532 -178.369 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.472 HD22 ' HB3' ' A' ' 76' ' ' LEU . 1.3 mm? -111.14 -84.28 0.57 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.76 2.024 . . . . 0.0 107.802 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 17.27 70.01 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 128.668 2.787 . . . . 0.0 115.264 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.6 19.88 0.24 Allowed Glycine 0 N--CA 1.469 0.835 0 N-CA-C 116.706 1.442 . . . . 0.0 116.706 -175.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.99 147.5 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.233 1.013 . . . . 0.0 112.872 -163.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.48 166.77 16.15 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 123.06 1.41 . . . . 0.0 113.345 -164.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.8 mt -132.34 -19.16 2.48 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.006 -1.906 . . . . 0.0 114.67 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.409 ' HB2' ' CD ' ' A' ' 25' ' ' GLU . 55.0 m-85 -106.88 -50.82 3.03 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.357 1.863 . . . . 0.0 108.485 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 176.99 -39.44 0.1 OUTLIER Glycine 0 CA--C 1.544 1.862 0 N-CA-C 116.944 1.538 . . . . 0.0 116.944 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.492 ' HB2' ' HG3' ' A' ' 25' ' ' GLU . 1.7 mpt_? -97.47 109.23 49.35 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 126.519 1.928 . . . . 0.0 111.847 -170.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.48 121.13 8.61 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.676 2.917 . . . . 0.0 115.198 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.2 mm -51.85 132.43 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.536 1.534 . . . . 0.0 110.244 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -123.8 109.57 13.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.802 1.641 . . . . 0.0 111.739 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -92.74 136.18 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 O-C-N 121.655 -0.653 . . . . 0.0 110.049 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 117.769 2.507 . . . . 0.0 117.769 -178.507 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.557 1.241 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.4 tp -89.94 121.24 31.86 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 130.06 3.344 . . . . 0.0 112.28 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -75.83 138.33 41.07 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.451 1.023 . . . . 0.0 112.397 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.3 t -139.31 117.99 12.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 O-C-N 121.222 -0.924 . . . . 0.0 109.915 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.55 -173.65 15.92 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 122.303 0.946 . . . . 0.0 112.457 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.9 t30 65.83 35.66 6.57 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.679 1.191 . . . . 0.0 111.138 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.641 HD12 HG21 ' A' ' 28' ' ' VAL . 1.7 mm? -70.53 163.93 25.86 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.961 2.105 . . . . 0.0 111.35 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.41 161.9 17.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 123.624 1.678 . . . . 0.0 114.998 174.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.8 p -75.14 -24.16 57.93 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.999 1.32 . . . . 0.0 110.162 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -103.01 16.76 25.78 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.766 1.626 . . . . 0.0 113.357 171.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.641 HG21 HD12 ' A' ' 24' ' ' LEU . 5.8 p -66.23 153.02 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.427 ' N ' HG22 ' A' ' 28' ' ' VAL . 23.5 p -156.43 162.62 39.99 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.949 2.1 . . . . 0.0 112.342 177.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -64.7 -23.03 67.12 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.223 1.009 . . . . 0.0 112.016 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -66.85 -46.03 76.36 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 118.059 -0.972 . . . . 0.0 112.149 170.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.6 tp -64.74 -43.25 93.99 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.915 0.864 . . . . 0.0 109.562 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.505 ' HB2' HG11 ' A' ' 46' ' ' VAL . 69.1 mt -65.19 -33.81 76.89 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.04 -1.038 . . . . 0.0 113.161 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -70.1 -45.79 66.21 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.153 -0.967 . . . . 0.0 112.168 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.69 -23.33 66.12 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 121.512 -0.742 . . . . 0.0 112.684 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.443 ' CD1' HD11 ' A' ' 80' ' ' ILE . 3.8 tt -81.39 -44.59 17.34 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.184 176.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.473 ' HB3' HG11 ' A' ' 43' ' ' VAL . 45.1 m-85 -84.94 -20.97 29.83 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.168 1.349 . . . . 0.0 112.505 -170.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -52.42 -34.98 50.86 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 167.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -58.51 -32.71 69.08 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.503 2.321 . . . . 0.0 114.683 167.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.62 -12.86 55.48 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-O 121.357 0.599 . . . . 0.0 110.696 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.2 -163.56 26.33 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 126.909 2.195 . . . . 0.0 111.934 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -82.02 88.28 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 CA-C-N 120.559 2.18 . . . . 0.0 112.737 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.473 HG11 ' HB3' ' A' ' 37' ' ' PHE . 2.3 m -65.56 141.76 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 121.169 -0.957 . . . . 0.0 113.156 176.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.9 mm -71.05 -48.92 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 174.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HG2' ' HB3' ' A' ' 63' ' ' ASN . 11.2 ptpt -171.44 161.35 6.33 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.161 1.784 . . . . 0.0 111.891 -171.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' A' ' 33' ' ' LEU . 82.9 t -125.59 153.47 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 126.37 1.868 . . . . 0.0 110.871 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -128.15 141.27 51.53 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.11 2.564 . . . . 0.0 110.509 169.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mm -121.01 125.31 27.06 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 126.906 2.082 . . . . 0.0 108.727 163.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.86 172.14 15.15 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.779 2.986 . . . . 0.0 112.878 170.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -153.72 126.48 8.23 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 127.457 2.303 . . . . 0.0 110.774 164.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -55.57 163.3 1.34 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 112.128 -2.305 . . . . 0.0 111.487 162.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.96 -25.15 1.25 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 167.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -100.25 1.64 41.99 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.41 1.084 . . . . 0.0 113.304 176.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.78 39.88 4.82 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 120.92 -1.113 . . . . 0.0 115.449 170.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.448 ' CD ' ' HD2' ' A' ' 56' ' ' PRO . 3.0 tppt? -134.42 140.84 36.95 Favored Pre-proline 0 N--CA 1.476 0.836 0 CA-C-N 119.819 1.809 . . . . 0.0 114.68 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.448 ' HD2' ' CD ' ' A' ' 55' ' ' LYS . 53.6 Cg_endo -68.17 12.44 0.23 Allowed 'Trans proline' 0 CA--C 1.551 1.353 0 C-N-CA 124.124 3.216 . . . . 0.0 117.834 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.75 27.46 7.01 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 119.538 -1.976 . . . . 0.0 115.145 176.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.445 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 33.8 mt-30 55.05 37.35 28.76 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -150.91 160.58 43.81 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.189 1.396 . . . . 0.0 112.151 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.03 178.86 9.88 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.838 2.055 . . . . 0.0 109.057 175.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -137.72 153.16 49.8 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.7 t -141.26 138.6 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 126.198 1.799 . . . . 0.0 110.284 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.431 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 9.1 t-20 . . . . . 0 CA--C 1.541 0.604 0 C-N-CA 124.248 1.019 . . . . 0.0 110.938 172.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 CA--C 1.532 0.41 0 N-CA-C 112.758 0.253 . . . . 0.0 112.758 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -52.91 -44.41 66.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.782 1.233 . . . . 0.0 110.813 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.14 -31.64 63.53 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 ttp -66.42 -14.47 62.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.924 1.238 . . . . 0.0 113.244 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -105.92 -35.79 7.19 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 155.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.11 -55.51 21.5 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.477 0.711 . . . . 0.0 111.483 -171.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -91.96 -92.32 0.15 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 27.23 70.7 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 127.459 2.304 . . . . 0.0 113.908 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.7 14.5 0.68 Allowed Glycine 0 CA--C 1.535 1.34 0 N-CA-C 115.461 0.945 . . . . 0.0 115.461 -174.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.443 HD11 ' CD1' ' A' ' 36' ' ' LEU . 1.1 pp -130.55 145.25 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 -165.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.38 172.65 10.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.73 2.012 . . . . 0.0 110.126 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 57.9 mt -118.71 -48.71 2.47 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.999 0.92 . . . . 0.0 110.208 159.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -51.37 -59.24 4.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.748 1.219 . . . . 0.0 112.346 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.53 -64.16 0.07 OUTLIER Glycine 0 N--CA 1.47 0.931 0 N-CA-C 116.458 1.343 . . . . 0.0 116.458 -162.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -106.07 119.44 52.16 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 118.097 0.948 . . . . 0.0 111.031 -168.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -77.62 132.61 12.24 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.709 2.273 . . . . 0.0 113.926 -166.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.429 HG13 HD13 ' A' ' 36' ' ' LEU . 13.3 mm -59.38 119.81 4.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 123.811 0.844 . . . . 0.0 111.394 -177.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -108.19 103.15 12.28 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.902 2.081 . . . . 0.0 110.345 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.5 mp -74.83 141.61 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 . . . . . 0 CA--C 1.536 0.442 0 C-N-CA 126.779 2.032 . . . . 0.0 108.141 -179.067 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.474 0.767 0 CA-C-O 122.54 1.162 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.541 HD13 ' HG2' ' A' ' 71' ' ' PRO . 11.1 tp -116.44 124.04 49.0 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.903 2.481 . . . . 0.0 112.722 -161.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -74.65 132.89 42.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 122.198 0.999 . . . . 0.0 109.82 175.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.6 t -129.19 125.42 62.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 169.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.84 -169.23 13.78 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 122.456 1.031 . . . . 0.0 113.035 168.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.2 t30 65.92 29.67 10.2 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 128.545 2.738 . . . . 0.0 114.258 -173.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.646 HD12 HG21 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -69.14 156.67 38.3 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.764 1.225 . . . . 0.0 109.413 -175.521 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.519 ' HG2' ' H ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.4 165.12 24.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 123.914 1.816 . . . . 0.0 114.126 172.22 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.3 p -68.29 -14.78 63.24 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 128.49 2.716 . . . . 0.0 110.392 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -113.59 5.24 16.48 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 129.19 2.996 . . . . 0.0 114.435 -176.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.811 HG23 HD23 ' A' ' 32' ' ' LEU . 9.8 p -66.14 154.28 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 120.131 -1.606 . . . . 0.0 114.213 -170.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.5 p -148.46 171.4 16.13 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 127.218 2.207 . . . . 0.0 111.343 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -77.41 -15.89 59.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.49 1.516 . . . . 0.0 111.393 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -76.24 -45.99 30.3 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.63 1.572 . . . . 0.0 109.407 170.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.811 HD23 HG23 ' A' ' 28' ' ' VAL . 60.8 tp -63.95 -39.31 93.85 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.621 0.724 . . . . 0.0 110.778 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.421 HD21 ' CD1' ' A' ' 24' ' ' LEU . 92.6 mt -70.83 -48.44 54.04 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.569 0.747 . . . . 0.0 111.969 176.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -58.31 -43.03 87.98 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -65.25 -32.18 73.72 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.743 0.817 . . . . 0.0 110.986 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 tt -76.29 -43.27 42.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.817 2.047 . . . . 0.0 113.193 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.446 ' CE2' HG21 ' A' ' 62' ' ' VAL . 23.9 m-85 -87.48 -6.16 58.5 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.012 0.925 . . . . 0.0 112.018 -173.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -53.89 -43.01 69.29 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.314 0.646 . . . . 0.0 109.745 160.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -55.96 -25.95 46.02 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 173.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.38 -8.45 32.44 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.239 1.019 . . . . 0.0 112.681 -171.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.74 -153.55 17.55 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.643 1.116 . . . . 0.0 113.593 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.05 107.52 2.48 Favored 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 123.497 2.798 . . . . 0.0 111.936 -165.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.0 t -94.96 126.37 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 128.266 2.627 . . . . 0.0 109.666 169.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mt -78.37 -48.71 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.947 1.299 . . . . 0.0 109.672 173.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.57 163.78 19.34 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.317 1.047 . . . . 0.0 113.266 -175.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 82.9 t -122.94 145.27 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.74 1.616 . . . . 0.0 112.197 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -126.11 121.29 32.45 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.133 2.173 . . . . 0.0 112.603 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.0 mm -110.38 120.76 43.31 Favored Pre-proline 0 N--CA 1.467 0.405 0 C-N-CA 126.487 1.915 . . . . 0.0 107.241 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -74.11 172.25 16.35 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.018 2.479 . . . . 0.0 111.545 168.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -156.87 115.08 3.25 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.611 1.964 . . . . 0.0 108.413 169.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -56.38 168.61 0.52 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 129.115 2.966 . . . . 0.0 111.696 164.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.4 pptp? -47.0 -32.58 4.01 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.469 1.508 . . . . 0.0 114.272 170.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.8 -18.04 61.51 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.802 1.641 . . . . 0.0 114.327 173.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.32 56.98 2.72 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -175.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -143.15 133.18 12.03 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.286 1.034 . . . . 0.0 113.328 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.99 19.67 0.13 Allowed 'Trans proline' 0 CA--C 1.55 1.325 0 C-N-CA 124.978 3.785 . . . . 0.0 116.538 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 52.02 22.02 1.71 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 174.233 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 57.72 36.53 26.66 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 116.817 2.154 . . . . 0.0 116.817 -166.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 57' ' ' LYS . 13.5 p90 -153.93 167.54 29.38 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.926 1.29 . . . . 0.0 113.453 175.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -163.95 170.06 17.19 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.979 2.112 . . . . 0.0 110.295 176.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -127.38 146.49 50.45 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.862 1.265 . . . . 0.0 110.932 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.446 HG21 ' CE2' ' A' ' 37' ' ' PHE . 20.8 t -125.91 132.67 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 126.581 1.953 . . . . 0.0 110.247 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 CA--C 1.545 0.762 0 C-N-CA 124.596 1.158 . . . . 0.0 108.75 176.443 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.541 ' HG2' HD13 ' A' ' 19' ' ' LEU . 51.5 Cg_exo . . . . . 0 N--CA 1.447 -1.255 0 CA-C-O 123.932 1.555 . . . . 0.0 113.912 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -68.98 -40.94 78.53 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.665 2.386 . . . . 0.0 111.007 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.94 -28.92 66.71 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.06 -1.025 . . . . 0.0 113.239 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.0 ttp -64.19 -21.36 66.54 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.733 1.213 . . . . 0.0 113.609 -176.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -97.63 -29.04 13.65 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.504 1.522 . . . . 0.0 112.115 168.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.82 -40.96 13.6 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.186 -0.946 . . . . 0.0 113.238 -169.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -107.68 -97.68 0.37 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.055 1.342 . . . . 0.0 110.83 176.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 37.83 59.13 1.35 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.37 1.868 . . . . 0.0 115.584 175.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.17 16.47 0.11 Allowed Glycine 0 CA--C 1.519 0.311 0 O-C-N 120.869 -1.145 . . . . 0.0 114.236 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -128.71 149.46 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 117.829 0.814 . . . . 0.0 109.509 -163.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.21 172.68 9.68 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.737 1.215 . . . . 0.0 110.802 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.9 tp -133.59 -19.84 2.08 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.867 0.867 . . . . 0.0 109.806 163.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -72.82 -68.59 0.47 Allowed 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.164 -0.96 . . . . 0.0 112.399 167.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.17 -51.36 0.07 OUTLIER Glycine 0 C--N 1.339 0.735 0 N-CA-C 116.985 1.554 . . . . 0.0 116.985 -168.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.519 ' H ' ' HG2' ' A' ' 25' ' ' GLU . 5.8 mpt_? -100.96 121.87 50.8 Favored Pre-proline 0 N--CA 1.462 0.151 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -177.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.2 126.91 10.15 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.256 1.97 . . . . 0.0 113.963 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.1 mm -51.01 126.95 6.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.696 1.198 . . . . 0.0 109.758 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -121.86 116.81 25.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.206 1.802 . . . . 0.0 112.753 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.424 ' CG2' HD11 ' A' ' 19' ' ' LEU . 4.4 mp -91.34 134.07 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.178 -0.951 . . . . 0.0 111.206 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 . . . . . 0 CA--C 1.544 0.735 0 CA-C-O 123.831 1.777 . . . . 0.0 115.396 175.979 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.467 0.421 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.2 tp -92.55 140.75 29.24 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 128.363 2.665 . . . . 0.0 115.013 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -89.63 130.19 35.96 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 125.869 1.667 . . . . 0.0 110.033 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.2 t -132.4 128.61 58.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 120.756 -1.215 . . . . 0.0 107.78 173.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.59 -171.35 12.93 Favored Glycine 0 CA--C 1.543 1.794 0 CA-C-O 122.485 1.047 . . . . 0.0 111.854 171.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.6 t30 62.68 33.77 15.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.1 1.76 . . . . 0.0 112.897 -175.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -70.26 154.43 41.92 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.164 1.786 . . . . 0.0 111.145 177.192 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.409 ' HG3' ' HB2' ' A' ' 83' ' ' TYR . 0.3 OUTLIER -70.88 160.67 32.38 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 125.082 2.373 . . . . 0.0 114.059 173.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.6 p -67.85 -24.83 65.3 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 111.139 -2.755 . . . . 0.0 111.868 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -118.73 22.48 11.98 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 127.424 2.289 . . . . 0.0 115.938 174.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.741 HG23 HD23 ' A' ' 32' ' ' LEU . 8.5 p -60.71 170.77 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 116.733 2.123 . . . . 0.0 116.733 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.615 ' H ' HG22 ' A' ' 28' ' ' VAL . 10.6 p -165.88 156.59 13.21 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 128.113 2.565 . . . . 0.0 111.349 -177.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.71 -17.75 17.07 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.576 2.35 . . . . 0.0 110.546 174.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -78.48 -38.51 40.83 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.907 1.683 . . . . 0.0 112.097 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.741 HD23 HG23 ' A' ' 28' ' ' VAL . 40.9 tp -70.25 -47.81 59.69 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.004 1.322 . . . . 0.0 108.576 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.402 HD21 ' CD1' ' A' ' 24' ' ' LEU . 52.9 mt -59.04 -50.96 72.09 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.082 176.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -62.5 -41.5 98.87 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.318 1.417 . . . . 0.0 111.393 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.02 -23.69 64.11 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.357 1.244 . . . . 0.0 114.357 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.65 -39.85 35.79 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.793 1.637 . . . . 0.0 112.737 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -89.87 1.1 56.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.037 0.935 . . . . 0.0 111.792 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -64.8 -35.03 79.79 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.55 1.14 . . . . 0.0 113.9 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -79.21 -17.53 54.67 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.905 0.482 . . . . 0.0 110.694 167.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.69 21.59 0.65 Allowed 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.702 -1.249 . . . . 0.0 113.762 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.19 -125.62 7.47 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.23 0.919 . . . . 0.0 114.461 173.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -71.29 127.0 12.85 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 CA-C-N 118.38 1.09 . . . . 0.0 110.615 -173.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.1 t -138.35 124.82 25.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 168.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 mm -89.05 -54.68 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 125.443 1.497 . . . . 0.0 108.481 171.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.423 ' HG2' ' HB3' ' A' ' 63' ' ' ASN . 17.8 ptpt -151.7 153.37 34.24 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.918 0.887 . . . . 0.0 113.316 -173.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.8 t -117.79 152.1 19.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 126.876 2.07 . . . . 0.0 108.782 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -129.22 122.91 30.69 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.372 1.869 . . . . 0.0 114.465 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.5 mm -106.14 117.37 57.61 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 126.165 1.786 . . . . 0.0 110.573 168.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.5 165.07 33.04 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.704 3.603 . . . . 0.0 111.834 165.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -155.31 117.12 4.08 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 126.963 2.105 . . . . 0.0 109.297 172.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.431 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 28.8 t0 -55.22 169.53 0.26 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 128.453 2.701 . . . . 0.0 114.269 175.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.27 -40.69 25.64 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.155 -0.341 . . . . 0.0 111.826 164.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -81.97 3.64 25.71 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 126.045 1.738 . . . . 0.0 113.506 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.94 42.37 30.38 Favored Glycine 0 N--CA 1.474 1.226 0 C-N-CA 126.377 1.941 . . . . 0.0 113.607 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -129.79 138.31 32.83 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 119.241 1.521 . . . . 0.0 113.063 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.89 9.61 0.35 Allowed 'Trans proline' 0 CA--C 1.54 0.824 1 C-N-CA 126.699 4.933 . . . . 0.0 115.372 176.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HE2' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER 58.73 26.92 15.24 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 169.41 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.494 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 15.9 mt-30 59.47 24.93 13.64 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.991 1.316 . . . . 0.0 114.31 -172.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -150.9 165.91 32.2 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 119.93 -1.731 . . . . 0.0 113.408 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -169.0 177.34 4.96 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 128.214 2.606 . . . . 0.0 112.744 -172.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -131.43 158.4 40.9 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 126.154 1.781 . . . . 0.0 115.414 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.5 t -143.98 129.68 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 126.301 1.84 . . . . 0.0 111.487 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.423 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 4.4 t-20 . . . . . 0 N--CA 1.474 0.731 0 C-N-CA 125.878 1.671 . . . . 0.0 114.618 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 N--CA 1.457 -0.644 0 N-CA-C 113.958 0.714 . . . . 0.0 113.958 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -48.1 -41.92 27.63 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 125.205 1.402 . . . . 0.0 114.606 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.35 -20.56 63.85 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 123.855 0.862 . . . . 0.0 111.405 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.1 ttp -75.08 -22.39 58.33 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 119.12 0.873 . . . . 0.0 112.347 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -89.02 -30.58 18.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.049 0.94 . . . . 0.0 111.661 167.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tp -81.33 -51.73 8.05 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.71 -89.66 0.32 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.587 1.085 . . . . 0.0 113.348 -171.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 41.84 63.66 1.26 Allowed 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 125.251 1.421 . . . . 0.0 114.485 170.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.9 16.42 1.79 Allowed Glycine 0 CA--C 1.537 1.459 0 O-C-N 119.19 -2.194 . . . . 0.0 115.28 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.64 146.83 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.059 1.344 . . . . 0.0 112.163 -167.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.57 168.98 15.91 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -175.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.7 mt -130.17 -16.68 3.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 112.995 -1.911 . . . . 0.0 112.707 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.409 ' HB2' ' HG3' ' A' ' 25' ' ' GLU . 3.5 m-30 -103.03 -44.11 5.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.849 0.859 . . . . 0.0 112.111 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.28 -38.8 0.28 Allowed Glycine 0 CA--C 1.532 1.155 0 N-CA-C 115.752 1.061 . . . . 0.0 115.752 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -93.12 114.43 62.72 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 125.041 1.336 . . . . 0.0 108.99 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.8 128.9 16.65 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 124.578 3.519 . . . . 0.0 113.492 -175.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.8 mm -61.32 124.96 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.329 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -108.33 117.67 34.76 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 128.506 2.722 . . . . 0.0 110.392 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -93.08 140.91 15.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 . . . . . 0 CA--C 1.54 0.577 0 C-N-CA 124.084 0.954 . . . . 0.0 108.625 174.09 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.9 tp -83.78 128.08 34.27 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.811 2.045 . . . . 0.0 110.266 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -82.44 140.92 33.14 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 t -143.46 130.34 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.743 0.817 . . . . 0.0 109.089 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.96 -172.28 13.66 Favored Glycine 0 CA--C 1.546 1.99 0 C-N-CA 125.365 1.46 . . . . 0.0 112.925 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.4 t30 66.38 24.82 10.43 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 128.447 2.699 . . . . 0.0 113.693 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.619 ' HB3' HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -65.39 137.4 57.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.095 1.358 . . . . 0.0 111.009 -178.255 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.41 161.42 11.72 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 176.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.0 p -69.07 -12.01 61.3 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 126.565 1.946 . . . . 0.0 114.148 -168.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.23 5.28 7.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.829 2.852 . . . . 0.0 113.114 -175.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' ' 24' ' ' LEU . 8.2 p -54.06 158.26 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.97 1.308 . . . . 0.0 113.861 -175.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.4 p -155.56 169.17 24.92 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.749 2.02 . . . . 0.0 109.381 -177.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -64.83 -34.14 77.65 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.851 1.26 . . . . 0.0 108.367 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -66.02 -32.01 73.24 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.697 1.599 . . . . 0.0 114.607 175.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -72.2 -49.55 34.54 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.308 1.413 . . . . 0.0 108.552 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.483 HD21 ' CD1' ' A' ' 24' ' ' LEU . 79.8 mt -59.62 -48.73 80.51 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -60.77 -37.6 82.4 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.244 -0.91 . . . . 0.0 112.991 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -60.42 -50.63 72.83 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.763 0.825 . . . . 0.0 109.755 172.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 tt -72.83 -40.17 66.0 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.717 2.407 . . . . 0.0 113.529 -173.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -81.2 -1.78 46.09 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.077 1.351 . . . . 0.0 111.654 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -70.76 -25.78 63.06 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 121.33 1.877 . . . . 0.0 110.464 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -70.05 -29.07 66.0 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.179 1.392 . . . . 0.0 112.611 169.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.38 -20.04 24.46 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 138.22 -149.49 20.52 Favored Glycine 0 C--O 1.235 0.176 0 O-C-N 121.4 -0.813 . . . . 0.0 113.976 171.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.18 118.69 4.06 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 121.936 1.757 . . . . 0.0 110.414 -173.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.6 m -117.54 118.76 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.128 1.371 . . . . 0.0 109.514 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.1 mm -61.22 -53.49 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.717 1.607 . . . . 0.0 110.549 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.33 167.88 26.49 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 131.563 3.945 . . . . 0.0 109.25 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.5 t -116.81 163.54 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 128.368 2.667 . . . . 0.0 111.422 170.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -127.1 135.48 50.81 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.82 1.648 . . . . 0.0 113.569 164.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.1 mm -118.48 124.05 28.8 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 125.364 1.465 . . . . 0.0 108.145 167.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.67 167.33 27.45 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.926 2.417 . . . . 0.0 112.798 166.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -160.74 119.38 2.56 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 127.505 2.322 . . . . 0.0 108.58 172.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.81 173.28 0.21 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.626 1.17 . . . . 0.0 111.873 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -23.79 29.29 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 120.498 -1.376 . . . . 0.0 112.48 162.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -80.62 -2.77 47.85 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.492 1.117 . . . . 0.0 112.554 175.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.24 45.19 56.82 Favored Glycine 0 C--N 1.341 0.828 0 O-C-N 120.341 -1.475 . . . . 0.0 109.959 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.42 132.01 19.71 Favored Pre-proline 0 N--CA 1.465 0.293 0 C-N-CA 123.392 0.677 . . . . 0.0 111.828 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.45 ' HG3' HG12 ' A' ' 28' ' ' VAL . 71.8 Cg_endo -71.09 15.58 0.31 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 125.241 3.961 . . . . 0.0 116.105 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.77 24.62 2.53 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 176.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 55.85 30.94 16.75 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -171.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -144.88 161.75 38.54 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 120.222 -1.549 . . . . 0.0 112.41 -176.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.05 -177.78 5.99 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.079 2.151 . . . . 0.0 112.728 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -137.44 157.2 47.08 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.233 1.813 . . . . 0.0 113.19 171.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.2 t -128.41 140.58 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.796 1.638 . . . . 0.0 111.848 169.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 . . . . . 0 CA--C 1.539 0.538 0 C-N-CA 125.161 1.384 . . . . 0.0 111.111 178.008 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo . . . . . 0 CA--C 1.541 0.828 0 N-CA-C 111.7 -0.154 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -52.91 -42.36 65.3 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.885 1.274 . . . . 0.0 110.336 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.74 -27.67 65.15 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 175.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.8 tmm? -66.3 -26.82 67.49 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.302 1.441 . . . . 0.0 108.862 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -98.35 -30.66 12.45 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -79.69 -34.29 40.35 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.736 1.214 . . . . 0.0 114.211 -174.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.3 -82.11 0.6 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.94 1.296 . . . . 0.0 111.082 -175.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 19.99 70.52 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 127.97 2.508 . . . . 0.0 114.314 -176.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.79 9.78 0.28 Allowed Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 pp -135.86 158.24 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 119.306 1.553 . . . . 0.0 113.558 -164.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.44 172.8 8.02 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -172.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.4 tp -140.19 22.95 2.4 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.958 2.103 . . . . 0.0 112.812 -175.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -149.47 -49.66 0.14 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.621 1.968 . . . . 0.0 110.174 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.0 -48.89 0.16 Allowed Glycine 0 CA--C 1.541 1.658 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -95.52 124.25 53.7 Favored Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 120.743 2.271 . . . . 0.0 110.837 -175.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.28 126.6 11.84 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 124.146 3.231 . . . . 0.0 113.129 -170.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.6 mm -57.54 122.91 7.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.776 0.798 . . . . 0.0 109.442 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.404 ' HE3' ' NE2' ' A' ' 90' ' ' GLN . 54.0 tptt -109.02 115.75 30.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.15 1.78 . . . . 0.0 108.812 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 mp -92.58 144.58 9.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.668 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.404 ' NE2' ' HE3' ' A' ' 88' ' ' LYS . 7.3 mm-40 . . . . . 0 N--CA 1.468 0.453 0 C-N-CA 125.534 1.534 . . . . 0.0 111.966 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.0 m . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 123.595 1.664 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.5 tp -107.23 132.32 53.21 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 127.576 2.35 . . . . 0.0 109.956 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -86.62 137.02 32.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 123.442 1.592 . . . . 0.0 112.163 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.2 t -132.62 122.66 47.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.334 -175.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.91 -173.42 14.43 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.495 1.521 . . . . 0.0 112.293 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 t30 61.82 23.92 14.15 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.913 1.685 . . . . 0.0 113.637 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.656 HD12 HG21 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -66.58 140.94 57.98 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 125.5 1.52 . . . . 0.0 109.258 -177.212 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.24 165.61 1.93 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 123.088 1.423 . . . . 0.0 113.805 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.4 p -67.25 -26.39 66.55 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.158 -0.964 . . . . 0.0 112.844 -172.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -116.97 7.02 13.06 Favored 'General case' 0 N--CA 1.474 0.765 1 C-N-CA 132.547 4.339 . . . . 0.0 111.31 -168.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.656 HG21 HD12 ' A' ' 24' ' ' LEU . 7.5 p -53.6 156.39 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.908 1.683 . . . . 0.0 112.606 -177.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.2 p -151.13 158.68 44.32 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.508 1.523 . . . . 0.0 110.082 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -59.15 -30.22 67.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.18 0.992 . . . . 0.0 109.59 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -66.07 -42.12 89.85 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.225 0.92 . . . . 0.0 112.823 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.435 HD23 HG23 ' A' ' 28' ' ' VAL . 49.8 tp -66.18 -45.28 81.43 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.579 0.627 . . . . 0.0 109.315 178.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.64 HD21 ' CD1' ' A' ' 24' ' ' LEU . 91.8 mt -58.25 -49.53 76.77 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.43 1.492 . . . . 0.0 112.833 174.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -60.32 -42.57 95.88 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.85 -1.156 . . . . 0.0 111.654 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -65.87 -34.52 78.34 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.969 1.259 . . . . 0.0 111.614 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.448 ' CD2' HD13 ' A' ' 77' ' ' LEU . 8.0 tt -70.86 -50.03 39.69 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.701 1.6 . . . . 0.0 111.966 177.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -83.09 -15.46 50.75 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -170.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -51.4 -33.07 28.56 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 168.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -74.74 -18.25 60.52 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.185 0.994 . . . . 0.0 110.896 175.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.56 11.88 27.17 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.644 1.578 . . . . 0.0 113.328 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.57 -164.11 13.47 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 127.541 2.496 . . . . 0.0 115.51 167.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.74 101.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 123.484 2.789 . . . . 0.0 113.112 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.4 t -98.29 115.79 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.6 mm -69.21 -54.3 20.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 123.005 0.522 . . . . 0.0 111.077 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -163.08 157.79 21.17 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.952 2.101 . . . . 0.0 110.789 -172.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.2 t -117.35 152.63 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 128.699 2.8 . . . . 0.0 111.267 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -127.16 126.72 43.36 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 126.948 2.099 . . . . 0.0 112.384 170.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.4 mm -106.64 117.08 57.78 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.997 2.119 . . . . 0.0 108.948 165.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.0 163.16 34.97 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.866 2.377 . . . . 0.0 110.434 165.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -155.27 112.34 3.29 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.26 2.224 . . . . 0.0 110.767 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.72 175.76 0.08 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.746 2.418 . . . . 0.0 113.192 175.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -52.95 -26.33 14.77 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.742 1.217 . . . . 0.0 114.148 173.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -93.9 -9.81 35.94 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.79 61.13 1.11 Allowed Glycine 0 N--CA 1.47 0.9 0 C-N-CA 125.896 1.712 . . . . 0.0 114.331 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -144.54 132.88 10.85 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 118.65 1.225 . . . . 0.0 113.555 -172.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.471 ' HG3' HG12 ' A' ' 28' ' ' VAL . 72.9 Cg_endo -69.38 8.48 0.68 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.397 3.398 . . . . 0.0 115.78 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.76 18.32 3.69 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 120.417 -1.427 . . . . 0.0 114.438 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 63.21 31.17 15.73 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -169.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.518 ' HA ' HD23 ' A' ' 24' ' ' LEU . 1.5 p90 -146.56 167.99 22.35 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.077 1.751 . . . . 0.0 111.484 176.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -163.68 172.15 14.64 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 128.807 2.843 . . . . 0.0 111.217 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -124.9 149.45 47.56 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.34 -1.475 . . . . 0.0 110.879 176.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.5 t -132.08 136.86 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.038 1.335 . . . . 0.0 109.601 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 . . . . . 0 CA--C 1.548 0.872 0 C-N-CA 126.088 1.755 . . . . 0.0 108.508 -175.938 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 CA--C 1.557 1.641 0 N-CA-C 114.901 1.077 . . . . 0.0 114.901 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -48.16 -46.16 34.32 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.841 1.657 . . . . 0.0 114.635 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.79 -24.37 61.7 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.461 -1.4 . . . . 0.0 113.509 -176.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.0 ttp -68.94 -28.18 66.41 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.079 1.352 . . . . 0.0 110.865 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -82.84 -41.0 19.57 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.995 0.918 . . . . 0.0 110.438 171.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.3 tp -83.62 -36.63 23.72 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -161.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.448 HD13 ' CD2' ' A' ' 36' ' ' LEU . 22.8 mt -113.79 -86.02 0.59 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.31 1.444 . . . . 0.0 109.08 -169.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.264 0.2 OUTLIER 26.82 59.48 0.08 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.907 2.883 . . . . 0.0 113.419 172.429 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.36 11.99 0.14 Allowed Glycine 0 CA--C 1.538 1.501 0 CA-C-O 118.556 -1.136 . . . . 0.0 115.42 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -134.55 154.35 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 119.745 1.772 . . . . 0.0 112.399 -168.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.23 178.35 2.45 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.496 1.918 . . . . 0.0 112.675 -172.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -140.15 -22.32 0.85 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.901 2.48 . . . . 0.0 112.461 170.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -83.26 -49.12 9.73 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.211 1.404 . . . . 0.0 110.262 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 170.81 -50.57 0.19 Allowed Glycine 0 CA--C 1.535 1.324 0 N-CA-C 115.987 1.155 . . . . 0.0 115.987 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -102.63 117.56 60.57 Favored Pre-proline 0 N--CA 1.479 1.022 0 CA-C-N 119.424 1.612 . . . . 0.0 109.587 -172.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.03 128.93 20.66 Favored 'Trans proline' 0 C--N 1.347 0.474 1 C-N-CA 125.366 4.044 . . . . 0.0 113.375 -175.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.0 mm -61.65 125.27 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.556 1.142 . . . . 0.0 108.976 -176.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -110.64 105.02 13.78 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 124.724 1.21 . . . . 0.0 107.947 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -80.41 145.06 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 . . . . . 0 N--CA 1.468 0.445 0 C-N-CA 128.356 2.662 . . . . 0.0 108.966 178.297 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.362 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.9 m -108.59 -48.6 3.29 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.446 2.298 . . . . 0.0 113.211 -174.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -141.8 144.71 34.08 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.509 1.924 . . . . 0.0 110.475 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -107.53 -30.0 8.88 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.424 1.89 . . . . 0.0 113.72 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -117.27 27.33 9.16 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.538 1.535 . . . . 0.0 114.808 -164.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 6' ' ' LEU . 2.3 mm? -117.46 147.94 42.27 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 118.085 2.624 . . . . 0.0 118.085 -171.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.87 128.8 39.01 Favored 'General case' 0 C--N 1.345 0.407 0 C-N-CA 124.955 1.302 . . . . 0.0 114.171 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -88.8 53.73 2.79 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.327 1.851 . . . . 0.0 114.321 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -127.62 149.71 50.06 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.843 1.657 . . . . 0.0 107.435 169.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -55.34 -47.9 75.02 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -163.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.53 174.21 14.72 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 118.039 2.607 . . . . 0.0 118.039 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 34.0 mt -98.06 136.49 38.24 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.505 2.722 . . . . 0.0 113.082 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -161.11 -61.15 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.767 1.227 . . . . 0.0 113.69 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 51.33 7.82 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.31 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 -164.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.4 159.81 42.48 Favored 'General case' 0 C--N 1.343 0.286 0 O-C-N 120.027 -1.671 . . . . 0.0 114.138 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -116.52 -26.72 6.97 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 128.982 2.913 . . . . 0.0 111.055 -173.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.4 mtt-85 -114.82 -7.04 12.66 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 126.601 1.96 . . . . 0.0 112.128 176.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m -123.09 135.29 54.33 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.519 0.728 . . . . 0.0 111.214 -171.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.7 tp -92.33 129.0 38.38 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.478 1.511 . . . . 0.0 110.513 -176.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -83.23 130.58 35.09 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.235 0.54 . . . . 0.0 110.001 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.1 t -122.9 129.37 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 120.783 -1.198 . . . . 0.0 108.539 172.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.3 -175.8 14.19 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.314 1.911 . . . . 0.0 111.086 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.8 t30 66.67 19.49 10.78 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.207 2.203 . . . . 0.0 113.458 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.507 ' HB3' HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -67.1 145.76 54.98 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 125.411 1.484 . . . . 0.0 111.083 -168.269 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.479 ' CD ' ' HB2' ' A' ' 83' ' ' TYR . 10.6 mt-10 -60.87 161.65 7.88 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 177.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -73.42 -32.15 64.25 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.563 1.145 . . . . 0.0 113.168 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? -100.14 15.9 25.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.975 2.11 . . . . 0.0 113.417 172.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.507 HG11 ' HB3' ' A' ' 24' ' ' LEU . 2.0 p -62.54 156.18 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.0 p -156.03 161.57 40.43 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.508 2.323 . . . . 0.0 110.953 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -55.79 -31.76 62.91 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.535 1.534 . . . . 0.0 111.797 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.45 -35.78 79.88 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.177 1.391 . . . . 0.0 113.157 175.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.3 tp -72.31 -39.23 68.38 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 122.616 1.198 . . . . 0.0 108.598 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.505 HD21 ' CD1' ' A' ' 24' ' ' LEU . 89.4 mt -65.15 -54.66 26.36 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.412 1.085 . . . . 0.0 112.644 173.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -56.33 -37.18 69.61 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.193 1.36 . . . . 0.0 110.189 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -73.9 -37.11 64.78 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tt -67.5 -43.7 80.25 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.337 1.426 . . . . 0.0 111.156 172.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -82.96 -9.81 59.1 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -46.83 -37.42 8.69 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.35 1.86 . . . . 0.0 112.701 164.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -73.0 -30.6 63.91 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.173 1.389 . . . . 0.0 110.908 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.409 ' HA ' HD12 ' A' ' 76' ' ' LEU . . . -85.08 -2.99 58.63 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -166.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.59 -167.05 12.21 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 126.754 2.121 . . . . 0.0 111.375 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -48.77 121.02 5.95 Favored 'Trans proline' 0 C--N 1.346 0.426 1 C-N-CA 126.484 4.789 . . . . 0.0 112.242 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.23 136.02 54.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 173.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.7 -46.92 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 123.558 0.743 . . . . 0.0 109.26 -172.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.84 158.91 36.06 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.059 2.544 . . . . 0.0 110.46 171.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.5 t -105.91 162.4 5.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 126.208 1.803 . . . . 0.0 110.742 171.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -136.72 121.32 18.39 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.337 1.855 . . . . 0.0 114.37 169.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.2 mm -107.29 120.41 47.81 Favored Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 126.267 1.827 . . . . 0.0 110.556 166.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -75.44 167.98 25.47 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 125.032 3.821 . . . . 0.0 113.036 165.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -160.91 105.12 1.35 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.307 1.843 . . . . 0.0 113.205 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -53.1 173.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 130.435 3.494 . . . . 0.0 114.31 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.58 -24.47 8.32 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 168.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -91.43 -0.43 57.63 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.458 1.503 . . . . 0.0 114.852 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.0 41.5 54.55 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.361 1.458 . . . . 0.0 113.459 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -116.25 136.99 23.15 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 124.753 1.221 . . . . 0.0 112.92 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -70.82 17.05 0.26 Allowed 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.115 2.543 . . . . 0.0 115.644 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.19 20.61 3.49 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 120.627 -1.296 . . . . 0.0 113.899 175.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 62.28 33.83 16.31 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.356 1.862 . . . . 0.0 114.496 -172.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -153.79 165.13 36.98 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.318 -1.489 . . . . 0.0 110.447 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -159.14 178.38 10.09 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.007 2.123 . . . . 0.0 110.589 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -135.52 156.15 49.35 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.574 -1.329 . . . . 0.0 111.312 168.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.71 132.13 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.7 1.2 . . . . 0.0 109.57 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -88.18 139.42 30.52 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.254 -1.529 . . . . 0.0 110.006 176.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -151.79 167.63 27.65 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.219 1.008 . . . . 0.0 110.843 -160.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . 0.281 77.2 tttt -94.68 58.34 2.3 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.935 -1.103 . . . . 0.0 112.234 -157.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 53.76 42.62 31.74 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 122.3 1.048 . . . . 0.0 111.428 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -85.23 59.68 5.78 Favored 'General case' 0 CA--C 1.556 1.177 0 O-C-N 121.363 -0.836 . . . . 0.0 111.199 -171.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.2 m -81.67 -25.23 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 119.848 3.277 . . . . 0.0 119.848 -165.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -81.45 70.36 8.3 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.413 1.46 . . . . 0.0 109.043 171.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.8 t 73.52 119.14 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 128.513 2.725 . . . . 0.0 113.205 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -72.68 129.23 14.28 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 123.094 2.53 . . . . 0.0 108.441 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -60.63 -34.26 73.99 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -168.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.39 -34.57 64.47 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 117.148 -1.406 . . . . 0.0 114.166 173.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -59.68 -21.79 61.05 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 120.613 1.551 . . . . 0.0 112.563 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -104.38 -40.42 6.09 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 127.359 2.264 . . . . 0.0 113.093 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -66.93 -61.65 1.84 Allowed 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 123.527 0.731 . . . . 0.0 112.669 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.14 -85.13 0.2 Allowed 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.5 1.12 . . . . 0.0 108.565 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 26.81 76.85 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 125.66 1.584 . . . . 0.0 114.322 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 125.45 18.02 2.55 Favored Glycine 0 CA--C 1.549 2.166 0 N-CA-C 117.555 1.782 . . . . 0.0 117.555 177.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -129.13 156.44 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 127.848 2.459 . . . . 0.0 111.583 -171.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.409 ' HB2' ' OE2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -176.73 -176.8 0.74 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.095 0.958 . . . . 0.0 112.442 -170.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.3 mt -141.16 -11.69 0.95 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.425 1.89 . . . . 0.0 115.885 -177.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.479 ' HB2' ' CD ' ' A' ' 25' ' ' GLU . 19.8 m-85 -109.77 -48.38 3.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.65 2.38 . . . . 0.0 111.802 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 179.06 -39.23 0.08 OUTLIER Glycine 0 CA--C 1.542 1.74 0 C-N-CA 125.955 1.74 . . . . 0.0 114.411 171.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.421 ' HB2' ' HG3' ' A' ' 25' ' ' GLU . 2.2 mpt_? -98.91 113.6 64.69 Favored Pre-proline 0 N--CA 1.483 1.219 0 CA-C-N 121.379 2.59 . . . . 0.0 112.247 -168.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.25 134.17 47.42 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.801 2.334 . . . . 0.0 111.753 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.0 mm -63.04 127.27 22.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 O-C-N 121.457 -0.777 . . . . 0.0 109.523 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -109.83 110.52 21.53 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 124.989 1.315 . . . . 0.0 110.02 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -86.33 136.74 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 120.324 -1.485 . . . . 0.0 109.668 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -134.44 146.7 50.06 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.355 1.462 . . . . 0.0 111.632 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -162.13 168.26 22.85 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 113.771 -1.559 . . . . 0.0 113.708 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.54 -47.85 1.17 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 127.597 2.359 . . . . 0.0 115.976 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.7 m 58.76 69.19 0.75 Allowed 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 -177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 170.17 115.51 0.34 Allowed Glycine 0 CA--C 1.538 1.495 0 C-N-CA 126.07 1.795 . . . . 0.0 115.891 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.5 m -137.67 49.09 1.99 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.543 1.537 . . . . 0.0 107.938 163.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 51.7 p -150.41 139.86 21.46 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.515 1.126 . . . . 0.0 110.734 -175.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -63.64 -34.84 78.73 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.32 1.048 . . . . 0.0 111.583 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -158.76 153.72 21.43 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.838 1.255 . . . . 0.0 111.34 171.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -54.53 165.26 2.48 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.646 2.231 . . . . 0.0 114.531 170.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -81.61 -60.11 2.37 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 113.894 -1.503 . . . . 0.0 112.013 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.1 t70 . . . . . 0 C--O 1.256 1.437 0 C-N-CA 126.007 1.723 . . . . 0.0 112.357 -164.269 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.407 ' HA3' ' OE2' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.539 1.574 0 CA-C-O 121.448 0.471 . . . . 0.0 112.419 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -139.41 34.34 2.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 119.493 -2.181 . . . . 0.0 111.668 165.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.407 ' OE2' ' HA3' ' A' ' 1' ' ' GLY . 9.8 mp0 -86.96 104.36 16.21 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -162.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -130.11 -40.61 1.31 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.197 1.799 . . . . 0.0 113.12 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -85.53 10.27 13.55 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.962 1.705 . . . . 0.0 114.359 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.46 133.3 35.38 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.075 -1.016 . . . . 0.0 112.736 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.81 139.56 45.21 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.956 2.503 . . . . 0.0 110.774 170.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -139.6 -173.78 3.71 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 129.449 3.1 . . . . 0.0 108.072 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -111.15 167.35 10.34 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.084 -1.01 . . . . 0.0 111.64 160.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -74.51 -12.65 60.54 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.68 178.85 2.98 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.146 1.379 . . . . 0.0 110.636 -167.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 pp -126.43 145.94 50.28 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.817 1.647 . . . . 0.0 113.189 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.42 170.97 7.64 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 125.455 1.502 . . . . 0.0 114.127 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -146.45 159.67 43.1 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.3 156.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.89 142.15 54.12 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.215 2.206 . . . . 0.0 113.364 -172.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -160.64 143.37 13.02 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.626 1.971 . . . . 0.0 108.341 170.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -94.45 -13.18 26.46 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 127.71 2.404 . . . . 0.0 116.463 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 m -112.76 168.67 9.49 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.953 1.301 . . . . 0.0 109.907 -176.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.3 tp -131.28 131.01 43.54 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.797 2.439 . . . . 0.0 109.71 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -80.25 138.77 36.85 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.842 1.656 . . . . 0.0 112.226 167.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.48 128.58 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.834 1.253 . . . . 0.0 108.558 173.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.83 -170.84 13.62 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.556 1.55 . . . . 0.0 111.92 168.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.0 t30 66.44 19.37 10.93 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.92 2.088 . . . . 0.0 113.649 -175.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.512 ' CD1' HD21 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -63.35 135.69 57.16 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 125.358 1.463 . . . . 0.0 112.02 -174.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 2.0 mt-10 -55.88 152.98 9.15 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 174.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.0 p -68.24 -14.46 63.0 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.532 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -112.0 11.01 20.53 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.998 2.119 . . . . 0.0 111.566 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 24' ' ' LEU . 4.9 p -66.76 159.72 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 119.919 -1.738 . . . . 0.0 114.764 -172.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.4 p -155.38 170.59 21.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.255 1.422 . . . . 0.0 111.32 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -63.87 -28.29 69.74 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.501 -0.749 . . . . 0.0 110.611 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -64.81 -48.32 74.84 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.906 0.883 . . . . 0.0 109.699 174.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.8 tp -65.19 -38.03 89.18 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.209 0.459 . . . . 0.0 111.593 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.512 HD21 ' CD1' ' A' ' 24' ' ' LEU . 94.0 mt -67.72 -48.57 66.14 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.428 -1.42 . . . . 0.0 111.864 175.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -62.07 -44.9 95.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.722 -1.237 . . . . 0.0 113.0 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -68.73 -25.05 64.56 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.783 0.433 . . . . 0.0 111.162 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.0 tt -78.72 -46.57 18.68 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.838 1.255 . . . . 0.0 108.272 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -74.89 -5.81 45.69 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.784 -1.197 . . . . 0.0 113.274 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -58.8 -32.0 68.94 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.935 1.698 . . . . 0.0 111.277 171.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -72.35 -31.0 65.25 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.292 1.437 . . . . 0.0 111.426 176.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.03 3.29 39.33 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -171.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.77 -156.16 15.74 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.936 1.731 . . . . 0.0 114.885 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -85.05 90.75 0.76 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.148 1.899 . . . . 0.0 112.135 -167.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.68 134.65 29.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 112.709 -2.041 . . . . 0.0 106.993 168.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.426 HD12 ' OD1' ' A' ' 63' ' ' ASN . 44.1 mt -83.71 -63.12 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 165.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.495 ' HG2' ' HB3' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -155.18 147.13 23.49 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.878 1.271 . . . . 0.0 113.011 -164.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.5 t -108.77 145.14 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.312 2.245 . . . . 0.0 112.969 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -122.0 124.19 43.42 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 126.24 1.816 . . . . 0.0 113.01 170.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.434 HG23 ' HB3' ' A' ' 56' ' ' PRO . 2.5 mm -107.42 121.5 44.21 Favored Pre-proline 0 C--O 1.243 0.719 0 C-N-CA 125.952 1.701 . . . . 0.0 108.509 163.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 71.7 Cg_endo -72.2 162.25 42.22 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.269 2.646 . . . . 0.0 109.718 165.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -147.36 116.09 6.76 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.143 1.777 . . . . 0.0 107.632 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -54.48 171.99 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.568 2.347 . . . . 0.0 109.665 165.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.16 -34.17 55.71 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.952 0.901 . . . . 0.0 112.938 172.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -75.4 -9.31 58.45 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 128.123 2.569 . . . . 0.0 113.889 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.32 38.72 12.19 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.555 1.55 . . . . 0.0 111.4 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -125.47 135.27 26.7 Favored Pre-proline 0 N--CA 1.473 0.707 0 O-C-N 121.613 -0.933 . . . . 0.0 112.052 -172.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.434 ' HB3' HG23 ' A' ' 48' ' ' ILE . 58.6 Cg_endo -71.76 12.65 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.928 3.085 . . . . 0.0 116.782 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.486 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 61.0 25.11 15.17 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 173.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 24' ' ' LEU 0.25 6.0 mt-30 56.43 30.47 17.07 Favored 'General case' 0 CA--C 1.573 1.854 0 O-C-N 120.922 -1.111 . . . . 0.0 113.306 -171.411 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.486 ' CD2' ' HB2' ' A' ' 57' ' ' LYS . 3.6 p90 -150.08 155.42 39.83 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 128.24 2.616 . . . . 0.0 115.264 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -155.88 175.08 14.41 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 127.64 2.376 . . . . 0.0 112.552 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -140.08 141.8 36.15 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 120.568 -1.333 . . . . 0.0 114.503 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.9 t -131.33 130.02 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 120.555 -1.341 . . . . 0.0 111.116 -172.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.495 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 4.6 t-20 -89.09 140.75 29.13 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.944 1.698 . . . . 0.0 112.776 177.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -125.38 155.56 40.15 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.725 1.61 . . . . 0.0 110.552 -175.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -62.48 -42.76 99.71 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.83 0.852 . . . . 0.0 111.12 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -92.54 135.77 33.78 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 122.301 1.048 . . . . 0.0 111.862 -172.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -97.16 4.06 51.32 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.92 1.288 . . . . 0.0 112.543 -165.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.8 m -85.34 32.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 127.011 2.124 . . . . 0.0 115.251 -176.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.0 p 40.84 44.32 1.9 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.959 1.304 . . . . 0.0 113.282 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -85.85 119.4 71.88 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 127.322 2.249 . . . . 0.0 109.228 -174.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -106.75 57.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.648 3.565 . . . . 0.0 112.795 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -56.55 -42.41 78.47 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.118 -0.989 . . . . 0.0 111.474 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.84 -35.38 66.36 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.9 ttp -59.07 -8.63 1.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 126.89 2.076 . . . . 0.0 115.998 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -114.86 -32.54 5.75 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.491 1.517 . . . . 0.0 110.617 165.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.26 -56.85 5.2 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -98.29 -92.39 0.25 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.853 1.661 . . . . 0.0 110.115 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 32.89 69.92 0.11 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.27 1.428 . . . . 0.0 112.002 175.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.5 19.42 1.07 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 121.297 -0.877 . . . . 0.0 114.12 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -131.74 157.85 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.64 0.776 . . . . 0.0 109.36 -176.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.81 -179.25 7.42 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.5 tp -107.83 -47.44 3.59 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.849 1.26 . . . . 0.0 110.586 167.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.495 ' HB2' ' CD ' ' A' ' 25' ' ' GLU . 78.4 m-85 -95.09 -42.27 8.69 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.187 1.795 . . . . 0.0 113.9 -162.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.99 -23.46 0.32 Allowed Glycine 0 CA--C 1.55 2.276 0 C-N-CA 126.436 1.97 . . . . 0.0 116.766 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.498 ' HB2' ' HG3' ' A' ' 25' ' ' GLU . 2.5 mpt_? -103.7 109.35 61.93 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-N 121.991 2.895 . . . . 0.0 112.524 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.27 125.77 12.82 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.323 2.016 . . . . 0.0 114.615 -173.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.9 mm -54.07 124.61 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 124.795 1.238 . . . . 0.0 109.988 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -114.68 110.23 19.44 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.596 1.189 . . . . 0.0 111.178 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -83.73 148.03 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.792 174.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -128.09 160.81 30.85 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.075 1.35 . . . . 0.0 113.31 168.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -111.7 161.02 16.72 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.94 1.296 . . . . 0.0 112.172 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -104.95 138.89 40.47 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.371 1.868 . . . . 0.0 110.123 165.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.3 p -94.42 30.28 2.01 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 119.825 -1.797 . . . . 0.0 112.954 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.3 -177.92 53.96 Favored Glycine 0 CA--C 1.536 1.392 0 O-C-N 120.891 -1.131 . . . . 0.0 112.008 -163.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.6 t -117.4 157.95 25.3 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.3 m -140.15 102.34 4.35 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 128.298 2.639 . . . . 0.0 110.766 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -126.47 174.09 8.9 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.416 1.486 . . . . 0.0 111.546 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.84 164.54 56.78 Favored Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 124.491 1.116 . . . . 0.0 111.12 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -67.96 177.32 4.4 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.5 1.467 . . . . 0.0 112.148 157.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -135.29 -7.36 2.27 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.9 t70 . . . . . 0 C--O 1.256 1.425 0 C-N-CA 127.488 2.315 . . . . 0.0 110.112 169.648 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.659 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.7 m -137.77 34.64 2.42 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -164.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 68.16 135.2 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.722 2.409 . . . . 0.0 113.604 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -84.53 -33.72 23.44 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 119.821 -1.8 . . . . 0.0 109.706 164.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -107.33 46.39 0.94 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.663 1.585 . . . . 0.0 112.16 -173.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.77 138.2 58.38 Favored 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.756 -1.215 . . . . 0.0 111.504 -174.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -48.29 136.16 12.62 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.032 -1.668 . . . . 0.0 111.645 163.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -73.23 178.25 4.59 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.69 2.396 . . . . 0.0 112.068 -171.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -136.15 -21.11 1.42 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 165.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -70.84 11.4 0.39 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -172.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -157.91 -171.44 3.53 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 127.166 2.187 . . . . 0.0 112.018 -175.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.2 mt -45.98 145.04 1.62 Allowed 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 164.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.34 -31.83 71.52 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . 0.263 2.8 tp10 40.91 49.52 2.95 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 128.156 2.583 . . . . 0.0 116.853 -165.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.79 154.14 40.78 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 117.319 2.341 . . . . 0.0 117.319 -173.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -123.87 133.75 53.7 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.342 1.857 . . . . 0.0 108.986 170.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.8 mtm180 -65.84 -15.85 63.28 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -167.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m -67.39 130.41 42.99 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.068 1.347 . . . . 0.0 112.822 -176.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.9 tp -83.08 128.19 34.26 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.414 2.285 . . . . 0.0 108.705 -169.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -77.45 138.77 39.44 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.123 0.963 . . . . 0.0 110.936 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.0 t -134.15 124.05 45.18 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.71 -171.33 13.33 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 173.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.5 t30 60.92 41.47 14.24 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 123.089 1.423 . . . . 0.0 111.588 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.546 HD12 HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -86.94 148.65 25.24 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.698 1.599 . . . . 0.0 110.779 178.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.64 162.85 26.84 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 125.656 2.646 . . . . 0.0 116.89 170.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.6 p -69.45 -29.01 66.61 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 127.879 2.471 . . . . 0.0 109.445 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.612 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 8.5 mmpt? -103.42 15.93 27.8 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 128.129 2.571 . . . . 0.0 114.163 176.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.546 HG11 HD12 ' A' ' 24' ' ' LEU . 3.9 p -71.0 157.27 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 120.841 -1.162 . . . . 0.0 112.04 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.2 p -156.56 166.76 32.46 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.51 1.124 . . . . 0.0 110.546 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -60.75 -27.9 68.29 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.321 -0.862 . . . . 0.0 109.957 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -61.01 -35.1 75.95 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.065 2.546 . . . . 0.0 112.536 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.421 HD23 HG23 ' A' ' 28' ' ' VAL . 16.0 tp -79.52 -39.94 30.77 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.703 0.763 . . . . 0.0 110.732 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.3 mt -65.39 -45.9 82.19 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.187 -0.945 . . . . 0.0 112.917 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -58.65 -34.13 70.86 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.294 1.038 . . . . 0.0 112.036 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -88.6 -28.23 20.82 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.25 0.62 . . . . 0.0 112.5 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.423 HD13 HG13 ' A' ' 87' ' ' ILE . 2.5 tt -70.19 -41.17 74.07 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.356 -0.84 . . . . 0.0 111.176 176.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -81.54 21.42 0.8 Allowed 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 120.376 1.444 . . . . 0.0 112.773 -173.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.06 -9.07 59.44 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 117.576 2.436 . . . . 0.0 117.576 -156.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -116.55 7.2 13.62 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 125.581 1.552 . . . . 0.0 113.163 163.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.6 31.4 0.76 Allowed 'General case' 0 CA--C 1.55 0.956 0 O-C-N 119.871 -1.768 . . . . 0.0 115.041 -167.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.97 136.19 3.53 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 107.545 -2.222 . . . . 0.0 107.545 -163.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.68 101.55 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.715 1 C-N-CA 125.307 4.005 . . . . 0.0 114.187 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.53 133.17 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.535 1.134 . . . . 0.0 110.118 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.1 mt -87.33 -47.86 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.174 1.39 . . . . 0.0 108.948 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.33 161.77 16.79 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 126.929 2.092 . . . . 0.0 111.104 -173.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.3 t -116.53 149.24 18.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 127.663 2.385 . . . . 0.0 111.808 173.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -120.66 122.77 41.2 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.693 1.197 . . . . 0.0 113.741 166.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.431 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 3.6 mm -101.24 121.47 51.73 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 124.073 0.949 . . . . 0.0 110.208 165.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 52.1 Cg_endo -66.77 165.98 23.92 Favored 'Trans proline' 0 CA--C 1.55 1.291 1 C-N-CA 125.341 4.028 . . . . 0.0 110.12 164.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -156.35 112.25 3.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.198 1.799 . . . . 0.0 109.893 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -57.25 172.64 0.29 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.267 2.227 . . . . 0.0 113.149 174.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.51 -37.76 5.66 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.594 -0.691 . . . . 0.0 112.752 171.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -76.72 -13.41 60.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.444 2.698 . . . . 0.0 116.28 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.32 30.79 11.54 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.981 2.229 . . . . 0.0 114.818 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.32 141.22 31.46 Favored Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 119.801 1.801 . . . . 0.0 114.28 -174.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.04 8.07 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.599 2.866 . . . . 0.0 116.401 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.13 32.79 20.78 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 120.418 -1.426 . . . . 0.0 112.716 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.549 ' NE2' HH11 ' A' ' 85' ' ' ARG . 20.5 mt-30 56.93 30.32 17.83 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -176.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.409 ' HA ' HD23 ' A' ' 24' ' ' LEU . 2.0 p90 -151.29 165.01 35.31 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.009 -1.682 . . . . 0.0 111.097 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -155.46 -175.3 5.36 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 127.333 2.253 . . . . 0.0 111.254 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -138.08 160.7 38.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.738 1.615 . . . . 0.0 112.444 170.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.6 t -147.16 127.77 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 122.344 1.068 . . . . 0.0 113.726 -175.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -95.14 130.18 41.96 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.46 1.104 . . . . 0.0 109.582 171.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -149.21 171.26 16.76 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.458 1.903 . . . . 0.0 113.907 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -127.22 154.07 45.29 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.069 1.348 . . . . 0.0 111.749 166.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.445 ' CG ' ' H ' ' A' ' 67' ' ' GLU . 54.6 t-80 -158.07 174.64 14.92 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.014 1.726 . . . . 0.0 110.541 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.445 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 10.3 mt-10 -71.23 -16.6 62.51 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.459 1.504 . . . . 0.0 112.788 -172.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.406 HG12 HG13 ' A' ' 70' ' ' VAL . 60.9 t -142.71 152.99 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 130.51 3.524 . . . . 0.0 106.274 178.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.1 m -78.16 54.03 1.3 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.101 1.361 . . . . 0.0 111.86 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.406 HG13 HG12 ' A' ' 68' ' ' VAL . 1.3 m -105.79 146.32 32.62 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 124.561 1.144 . . . . 0.0 111.983 -172.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -78.05 76.78 4.21 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.387 2.058 . . . . 0.0 109.835 174.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -58.15 -42.59 86.24 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.133 -0.98 . . . . 0.0 112.921 -170.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.15 -29.79 70.59 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.939 -1.029 . . . . 0.0 113.767 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.5 ttp -58.36 -20.47 43.92 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.701 1.137 . . . . 0.0 112.289 176.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -103.34 -35.63 8.33 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 170.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.29 -34.18 72.45 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 120.003 1.274 . . . . 0.0 114.221 -175.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.0 mt -120.64 -92.75 0.53 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 128.727 2.811 . . . . 0.0 110.406 -170.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.436 ' OD1' ' HD2' ' A' ' 88' ' ' LYS . 1.5 t30 26.24 74.75 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 128.496 2.719 . . . . 0.0 115.449 175.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 135.48 16.97 0.88 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-N 113.775 -1.557 . . . . 0.0 112.87 -176.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -132.84 152.24 35.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 118.557 1.178 . . . . 0.0 111.827 -169.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.31 -173.23 1.21 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.976 2.51 . . . . 0.0 110.507 -167.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.5 tp -143.33 -39.05 0.32 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.392 1.477 . . . . 0.0 108.767 160.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -55.13 -57.13 13.0 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.224 1.01 . . . . 0.0 112.034 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.64 -46.54 0.23 Allowed Glycine 0 N--CA 1.48 1.62 0 N-CA-C 117.58 1.792 . . . . 0.0 117.58 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.549 HH11 ' NE2' ' A' ' 58' ' ' GLN . 3.3 mpt_? -95.13 117.61 66.72 Favored Pre-proline 0 C--O 1.238 0.467 0 CA-C-N 118.272 1.036 . . . . 0.0 108.244 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -71.06 128.75 15.24 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.849 1.699 . . . . 0.0 112.47 -174.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.423 HG13 HD13 ' A' ' 36' ' ' LEU . 12.1 mm -53.13 126.93 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 C-N-CA 123.481 0.712 . . . . 0.0 109.667 174.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.436 ' HD2' ' OD1' ' A' ' 78' ' ' ASN . 10.1 tptm -117.8 115.82 25.76 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.491 1.516 . . . . 0.0 110.058 177.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -87.49 141.05 14.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -125.67 167.11 15.57 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.163 0.985 . . . . 0.0 109.946 172.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -156.63 157.14 34.72 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -166.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -140.54 126.09 19.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.743 1.217 . . . . 0.0 112.188 169.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 86.9 p -95.97 155.78 16.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.475 1.11 . . . . 0.0 111.516 -170.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.09 174.98 34.67 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.704 1.145 . . . . 0.0 111.8 170.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.2 m -93.32 52.54 1.78 Allowed 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.625 -0.926 . . . . 0.0 111.418 -172.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 35.3 m -97.78 145.47 26.35 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -156.41 170.94 21.16 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.224 1.81 . . . . 0.0 111.013 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -149.81 159.53 35.7 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.46 1.504 . . . . 0.0 110.341 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -84.42 172.36 9.37 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 124.429 3.419 . . . . 0.0 113.803 171.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -68.16 -46.55 70.42 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.227 1.411 . . . . 0.0 109.797 167.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 C--O 1.257 1.499 0 C-N-CA 128.388 2.675 . . . . 0.0 109.08 176.889 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.3 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -91.29 151.22 20.98 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.48 151.75 24.41 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.146 -0.971 . . . . 0.0 111.524 -164.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -142.1 -37.44 0.4 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.716 1.206 . . . . 0.0 112.233 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -93.6 2.27 56.42 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 126.599 1.959 . . . . 0.0 115.965 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.33 161.2 30.85 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.523 1.529 . . . . 0.0 112.938 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.35 149.89 28.69 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.649 1.18 . . . . 0.0 113.117 156.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.6 ttt85 -140.23 51.63 1.68 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 128.097 2.559 . . . . 0.0 110.889 175.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -75.36 173.04 11.44 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.072 1.349 . . . . 0.0 114.185 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -111.87 -27.51 8.43 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 117.029 2.233 . . . . 0.0 117.029 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.86 -176.86 4.79 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 126.349 1.86 . . . . 0.0 112.733 -166.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.4 mt -50.89 147.86 4.64 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.266 -0.896 . . . . 0.0 110.45 163.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.4 112.05 23.83 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 176.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -141.8 154.18 45.04 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.025 1.73 . . . . 0.0 108.84 -170.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -113.67 156.04 24.45 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 120.496 1.498 . . . . 0.0 114.739 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -161.5 -170.1 2.5 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 129.162 2.985 . . . . 0.0 107.145 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.8 ptt-85 -55.36 -17.44 4.88 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.957 2.103 . . . . 0.0 116.411 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.1 m -92.48 151.24 20.31 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.693 1.597 . . . . 0.0 109.044 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.7 mp -108.47 129.62 55.27 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.258 2.223 . . . . 0.0 108.276 -174.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -79.46 139.93 37.49 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.625 0.77 . . . . 0.0 109.341 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.3 t -130.6 133.07 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 172.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.85 -177.55 14.92 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.742 1.163 . . . . 0.0 110.625 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.5 t30 75.17 19.34 2.29 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.646 1.579 . . . . 0.0 112.815 -176.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.648 HD12 HG21 ' A' ' 28' ' ' VAL . 0.6 OUTLIER -65.17 147.66 53.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.436 -168.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 0.5 OUTLIER -66.61 157.36 32.63 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 125.953 2.787 . . . . 0.0 113.277 173.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 p -66.39 -18.51 65.4 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 129.424 3.09 . . . . 0.0 112.548 -174.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -128.23 19.67 6.38 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 131.454 3.902 . . . . 0.0 112.208 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.648 HG21 HD12 ' A' ' 24' ' ' LEU . 5.8 p -60.53 151.59 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 O-C-N 120.931 -1.106 . . . . 0.0 112.216 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.4 p -152.24 168.99 23.57 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.542 1.537 . . . . 0.0 110.635 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -66.94 -29.03 68.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.115 0.966 . . . . 0.0 109.637 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -56.93 -47.54 80.37 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.6 tp -70.72 -43.59 68.61 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.864 1.265 . . . . 0.0 113.142 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.92 -41.96 95.12 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.238 -0.914 . . . . 0.0 112.022 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -61.16 -47.34 86.65 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 118.744 0.702 . . . . 0.0 111.292 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -64.96 -33.9 77.15 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 119.683 1.129 . . . . 0.0 112.301 176.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.1 tt -72.68 -39.93 66.69 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.814 1.245 . . . . 0.0 113.223 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.447 ' CD2' HG21 ' A' ' 62' ' ' VAL . 50.0 m-85 -94.71 -19.77 20.11 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 -175.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -49.18 -36.69 20.34 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.05 1.74 . . . . 0.0 112.922 167.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -73.5 -15.79 61.31 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 174.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.63 -4.81 47.05 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.758 0.823 . . . . 0.0 112.668 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 138.3 -157.34 24.42 Favored Glycine 0 CA--C 1.545 1.94 0 C-N-CA 126.501 2.0 . . . . 0.0 113.966 168.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.01 93.32 0.96 Allowed 'Trans proline' 0 CA--C 1.551 1.334 0 C-N-CA 123.358 2.706 . . . . 0.0 113.452 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.1 m -81.65 137.61 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 122.712 1.244 . . . . 0.0 110.857 171.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.9 mm -99.16 -51.02 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 125.645 1.578 . . . . 0.0 111.749 -171.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.01 158.11 41.54 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.446 1.099 . . . . 0.0 108.494 176.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.5 t -124.06 147.85 28.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 125.668 1.587 . . . . 0.0 110.07 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -132.02 119.82 21.56 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 125.004 1.321 . . . . 0.0 112.851 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 mm -103.57 124.01 39.44 Favored Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 126.452 1.901 . . . . 0.0 107.719 165.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.99 170.38 19.06 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.788 2.326 . . . . 0.0 111.842 162.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -158.17 114.73 2.82 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 127.065 2.146 . . . . 0.0 111.347 172.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -58.68 169.66 0.92 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.014 -1.903 . . . . 0.0 109.868 170.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -32.47 69.62 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 120.961 -1.087 . . . . 0.0 113.573 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -64.81 -25.69 68.02 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.34 2.256 . . . . 0.0 113.017 171.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.78 39.37 2.54 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.093 1.33 . . . . 0.0 112.845 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 tppt? -133.58 130.64 20.96 Favored Pre-proline 0 C--N 1.35 0.619 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 -170.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.53 15.81 0.11 Allowed 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 125.136 3.89 . . . . 0.0 115.449 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.87 28.27 10.21 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 119.633 -1.917 . . . . 0.0 114.07 169.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 56.29 33.81 22.92 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.745 1.618 . . . . 0.0 115.137 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -153.42 161.83 41.89 Favored 'General case' 0 CA--C 1.555 1.146 0 O-C-N 120.75 -1.219 . . . . 0.0 112.927 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -158.88 173.45 16.49 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 126.665 1.986 . . . . 0.0 113.19 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -127.08 155.68 42.91 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.287 2.235 . . . . 0.0 112.056 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 37' ' ' PHE . 43.7 t -148.71 122.37 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.333 1.453 . . . . 0.0 109.144 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -86.98 120.79 28.62 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.718 1.207 . . . . 0.0 110.997 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -108.7 156.37 19.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.733 1.613 . . . . 0.0 111.422 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -54.88 137.07 46.21 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.928 1.691 . . . . 0.0 112.829 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -61.01 157.85 14.69 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -160.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 55.74 43.21 28.28 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.698 1.999 . . . . 0.0 113.844 -174.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 m -54.87 129.08 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.079 1.351 . . . . 0.0 111.522 163.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 m -88.9 -33.43 17.3 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.9 m -143.29 146.56 36.79 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 126.856 2.062 . . . . 0.0 112.371 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -73.08 97.06 0.89 Allowed 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 121.756 1.637 . . . . 0.0 111.289 169.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -51.63 -46.76 63.78 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 128.493 2.717 . . . . 0.0 114.019 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . . . -59.44 -21.78 60.53 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.4 ttt -67.79 -26.46 66.1 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.95 0.795 . . . . 0.0 111.297 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -81.7 -35.27 30.01 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.521 -0.737 . . . . 0.0 111.908 167.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.453 ' HG ' HD13 ' A' ' 77' ' ' LEU . 43.2 tp -81.28 -53.43 6.35 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -163.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.453 HD13 ' HG ' ' A' ' 76' ' ' LEU . 1.2 mm? -97.13 -83.6 0.39 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 125.611 1.564 . . . . 0.0 110.479 -174.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 24.19 66.41 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 128.422 2.689 . . . . 0.0 116.243 173.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.04 20.26 0.94 Allowed Glycine 0 CA--C 1.538 1.492 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.908 -173.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.59 152.02 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-N 118.721 1.26 . . . . 0.0 112.576 -171.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.6 172.89 4.85 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.337 2.255 . . . . 0.0 110.185 -176.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.27 -45.0 2.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.314 1.446 . . . . 0.0 110.236 166.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -61.39 -51.57 68.22 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.569 1.148 . . . . 0.0 113.679 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.6 -63.29 0.18 Allowed Glycine 0 N--CA 1.477 1.423 0 N-CA-C 117.222 1.649 . . . . 0.0 117.222 -168.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.422 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 7.3 mpt_? -88.2 123.96 67.53 Favored Pre-proline 0 N--CA 1.478 0.929 0 CA-C-N 119.75 1.775 . . . . 0.0 110.642 -175.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -76.23 134.22 15.61 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.054 2.503 . . . . 0.0 115.734 -174.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 87' ' ' ILE . 4.1 mm -64.06 123.06 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.647 0.737 . . . . 0.0 109.912 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -110.06 117.2 33.12 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 113.779 -1.555 . . . . 0.0 108.923 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 mp -78.78 149.32 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 172.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -140.28 147.33 39.79 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.605 1.962 . . . . 0.0 110.146 176.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -165.19 139.78 5.01 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.376 -0.828 . . . . 0.0 112.059 -173.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -89.54 133.62 34.5 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.499 1.52 . . . . 0.0 109.44 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.3 p -68.8 165.09 20.41 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 175.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.87 -169.44 38.15 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 115.123 0.809 . . . . 0.0 115.123 170.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.5 t -154.41 161.46 41.7 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.175 1.39 . . . . 0.0 111.694 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 39.4 m -106.57 179.97 4.11 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.798 1.239 . . . . 0.0 110.153 168.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -104.94 166.23 10.52 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -165.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -147.33 146.16 24.24 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 120.535 -1.353 . . . . 0.0 113.503 -169.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.21 150.44 76.76 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.127 1.885 . . . . 0.0 114.221 -169.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.3 mm-40 -81.93 -49.82 9.87 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.821 0.82 . . . . 0.0 110.432 174.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.5 p30 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 129.751 3.22 . . . . 0.0 112.561 177.882 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.453 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.7 p -152.55 164.79 36.93 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.374 1.07 . . . . 0.0 110.281 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -77.47 154.01 32.96 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -97.06 -44.7 6.87 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 113.71 -1.587 . . . . 0.0 111.369 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -120.28 119.1 32.19 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 171.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mt -141.43 151.11 43.14 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.405 1.082 . . . . 0.0 113.759 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -87.61 130.81 34.64 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.181 1.392 . . . . 0.0 113.497 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -99.98 2.85 43.91 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 128.675 2.79 . . . . 0.0 114.755 167.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -78.23 -78.05 0.15 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.798 1.636 . . . . 0.0 110.112 169.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 52.03 -30.76 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.958 1 C-N-CA 132.883 4.473 . . . . 0.0 120.091 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.35 -171.88 3.49 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.23 2.612 . . . . 0.0 110.609 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.7 mt -71.55 174.46 6.65 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.998 1.719 . . . . 0.0 115.035 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.9 159.16 43.87 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.431 1.892 . . . . 0.0 111.396 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -139.76 144.94 37.68 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 120.687 -1.258 . . . . 0.0 110.193 167.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -121.2 160.43 23.83 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -170.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 55.07 58.07 5.05 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.858 1.663 . . . . 0.0 113.02 171.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 -82.96 23.41 0.84 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -173.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.1 m -139.56 142.92 37.16 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.594 1.158 . . . . 0.0 108.871 -169.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.8 tp -113.53 130.0 56.44 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.325 1.45 . . . . 0.0 110.436 -160.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -78.09 138.58 38.83 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.1 t -138.21 123.79 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 121.026 -1.047 . . . . 0.0 110.038 174.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.84 -170.34 15.05 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.616 2.055 . . . . 0.0 111.35 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.1 t30 58.23 35.8 25.25 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.446 1.499 . . . . 0.0 112.293 -176.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.587 HD12 HG21 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -68.13 163.19 23.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.364 1.078 . . . . 0.0 110.236 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 26' ' ' THR . 0.5 OUTLIER -86.34 170.27 12.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.087 171.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.415 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 43.5 p -83.48 -14.17 53.02 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.971 2.108 . . . . 0.0 113.646 -175.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 8.8 mmpt? -111.96 17.03 20.05 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 128.261 2.624 . . . . 0.0 112.33 177.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.587 HG21 HD12 ' A' ' 24' ' ' LEU . 3.7 p -72.18 153.03 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -173.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.3 p -155.71 160.83 40.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.45 1.9 . . . . 0.0 111.753 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -58.45 -20.05 41.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.956 0.902 . . . . 0.0 113.157 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -76.19 -34.54 59.3 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.597 1.159 . . . . 0.0 113.455 174.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.26 -48.44 70.48 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.854 0.862 . . . . 0.0 109.789 168.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.499 ' HB2' HG11 ' A' ' 46' ' ' VAL . 87.6 mt -59.89 -43.83 94.57 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.98 0.912 . . . . 0.0 111.113 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -65.45 -43.94 88.81 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 119.503 1.047 . . . . 0.0 110.723 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -61.11 -33.3 73.15 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.006 1.323 . . . . 0.0 113.344 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.493 HD13 HG13 ' A' ' 87' ' ' ILE . 3.7 tt -82.55 -42.46 18.33 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.844 2.057 . . . . 0.0 113.564 174.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.4 ' CD2' HG21 ' A' ' 62' ' ' VAL . 69.7 m-85 -84.87 -12.45 53.48 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.365 -1.459 . . . . 0.0 113.776 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -54.36 -36.65 64.07 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 121.309 1.868 . . . . 0.0 112.393 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -83.94 -0.31 50.91 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 173.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.42 14.68 14.02 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.915 1.286 . . . . 0.0 112.375 169.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.35 -157.45 23.19 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.459 1.504 . . . . 0.0 112.593 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.4 77.31 4.14 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.314 2.676 . . . . 0.0 112.643 -163.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.43 142.82 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 122.263 1.03 . . . . 0.0 108.527 167.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.0 mm -86.67 -51.83 12.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 124.951 1.3 . . . . 0.0 109.2 175.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -165.21 165.68 19.49 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.288 1.835 . . . . 0.0 111.696 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.499 HG11 ' HB2' ' A' ' 33' ' ' LEU . 74.4 t -119.65 150.9 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 125.66 1.584 . . . . 0.0 112.11 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.481 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 49.0 tptt -115.93 125.31 52.39 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 127.19 2.196 . . . . 0.0 114.131 165.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.6 mm -101.4 126.46 34.42 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 127.532 2.333 . . . . 0.0 111.64 158.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 60' ' ' ALA . 61.2 Cg_endo -77.74 172.2 16.13 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 125.294 3.996 . . . . 0.0 112.358 163.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.428 ' C ' ' HE3' ' A' ' 57' ' ' LYS . 25.9 mttt -161.06 122.61 2.96 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.755 2.022 . . . . 0.0 111.427 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.44 166.9 2.82 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.254 2.222 . . . . 0.0 112.882 170.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.86 -44.46 29.28 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.769 0.828 . . . . 0.0 111.257 166.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.43 -29.91 70.65 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.05 -1.031 . . . . 0.0 111.143 174.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.53 45.78 1.19 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.679 1.133 . . . . 0.0 114.782 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -129.64 141.11 40.7 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-N 119.924 1.862 . . . . 0.0 111.888 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.52 10.04 0.29 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.227 3.285 . . . . 0.0 117.285 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.428 ' HE3' ' C ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER 59.39 25.15 13.82 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 173.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.486 ' HA ' ' HB2' ' A' ' 24' ' ' LEU 0.283 35.6 mt-30 63.77 30.49 14.6 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.055 2.542 . . . . 0.0 114.688 -172.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -153.14 168.91 24.37 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 126.045 1.738 . . . . 0.0 111.747 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 47' ' ' LYS . . . -166.79 -174.06 2.62 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 130.51 3.524 . . . . 0.0 108.909 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -137.93 164.02 30.06 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 124.665 1.186 . . . . 0.0 112.287 169.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.4 HG21 ' CD2' ' A' ' 37' ' ' PHE . 34.7 t -139.98 139.19 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 125.577 1.551 . . . . 0.0 114.001 174.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -95.91 144.85 25.88 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.074 1.75 . . . . 0.0 114.989 -173.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -135.58 163.78 29.34 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.215 2.206 . . . . 0.0 109.548 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -88.02 62.01 6.62 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 129.922 3.289 . . . . 0.0 109.591 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 11.5 m80 56.38 29.84 15.88 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.523 1.529 . . . . 0.0 113.585 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . 0.286 13.2 pt-20 -123.94 36.07 4.7 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.181 1.392 . . . . 0.0 114.047 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 m -59.27 -16.93 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 168.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.7 t -65.98 139.67 58.24 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.714 1.606 . . . . 0.0 112.619 173.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.6 t 36.65 66.67 1.91 Allowed Pre-proline 0 N--CA 1.488 1.431 0 C-N-CA 126.063 1.745 . . . . 0.0 109.714 -165.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.95 121.31 9.84 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.02 2.48 . . . . 0.0 110.996 -173.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -58.9 -44.05 91.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.03 0.919 . . . . 0.0 111.245 -165.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.69 -27.53 68.76 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.152 1.381 . . . . 0.0 113.682 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -62.72 -22.52 66.58 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.79 1.236 . . . . 0.0 111.782 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -95.91 -38.91 10.06 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 163.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.87 -49.63 19.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 120.654 1.57 . . . . 0.0 114.658 -165.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -98.31 -94.58 0.23 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.733 1.213 . . . . 0.0 109.133 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 21.84 79.35 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 128.115 2.566 . . . . 0.0 115.097 -169.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.82 26.33 1.58 Allowed Glycine 0 N--CA 1.476 1.33 0 C-N-CA 125.223 1.392 . . . . 0.0 113.984 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -128.07 144.66 37.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-N 117.874 0.837 . . . . 0.0 109.405 -171.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.98 177.45 10.34 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 177.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.5 tp -136.31 -44.35 0.62 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 130.834 3.654 . . . . 0.0 108.508 171.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -65.97 -52.72 47.11 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.351 1.86 . . . . 0.0 111.942 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 160.86 -38.71 0.43 Allowed Glycine 0 N--CA 1.477 1.375 0 N-CA-C 115.64 1.016 . . . . 0.0 115.64 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -100.3 115.93 64.95 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 125.728 1.611 . . . . 0.0 108.97 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.62 137.11 29.58 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.472 2.781 . . . . 0.0 113.204 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.493 HG13 HD13 ' A' ' 36' ' ' LEU . 4.7 mm -67.56 125.32 24.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 123.502 0.721 . . . . 0.0 111.106 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -113.79 107.21 15.42 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.432 1.893 . . . . 0.0 112.041 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.79 140.23 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.387 1.075 . . . . 0.0 111.316 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -141.68 179.98 6.51 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.53 2.332 . . . . 0.0 111.139 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -147.14 158.57 43.99 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.688 165.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -139.91 145.8 38.43 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.975 1.71 . . . . 0.0 109.046 161.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.8 m -102.24 157.66 16.74 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.118 1.367 . . . . 0.0 111.331 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.7 -175.27 49.43 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 122.646 1.137 . . . . 0.0 114.996 168.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.4 m -69.01 153.3 44.03 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.802 2.041 . . . . 0.0 112.62 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.1 t -144.58 143.22 30.69 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.957 2.503 . . . . 0.0 108.202 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.5 m170 54.63 46.28 25.08 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.568 1.947 . . . . 0.0 112.81 -165.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.72 164.27 40.5 Favored Pre-proline 0 CA--C 1.553 1.083 0 O-C-N 119.885 -1.759 . . . . 0.0 111.869 171.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -84.49 135.96 6.26 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 125.229 3.953 . . . . 0.0 115.729 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -71.68 -30.4 65.65 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 C--O 1.26 1.607 0 C-N-CA 130.354 3.462 . . . . 0.0 110.267 175.598 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.532 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -92.31 -19.69 21.88 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 118.839 2.903 . . . . 0.0 118.839 169.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -104.14 150.47 24.31 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 122.023 2.192 . . . . 0.0 110.657 175.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -138.16 -47.36 0.53 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.051 1.74 . . . . 0.0 112.129 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -103.76 -5.25 22.66 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 119.835 -1.79 . . . . 0.0 114.769 -167.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.09 130.68 39.68 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.289 1.835 . . . . 0.0 107.438 175.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.22 144.98 56.82 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.745 1.218 . . . . 0.0 108.533 170.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -62.98 -28.65 70.24 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.951 1.301 . . . . 0.0 113.995 -172.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -141.81 157.74 44.64 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.395 1.478 . . . . 0.0 112.437 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -56.48 -57.59 11.67 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -158.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.79 169.58 21.88 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 126.349 1.86 . . . . 0.0 108.457 170.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.3 mt -59.08 134.73 57.25 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 126.481 1.912 . . . . 0.0 112.766 -175.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.33 10.81 5.34 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.83 4.63 0.99 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.655 1.982 . . . . 0.0 115.84 -178.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.27 -22.4 21.62 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.564 1.146 . . . . 0.0 113.493 -168.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -115.19 151.21 34.84 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.75 1.62 . . . . 0.0 113.006 -177.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -135.99 -1.33 2.44 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.891 1.677 . . . . 0.0 111.817 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m -134.26 141.36 46.95 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.882 1.673 . . . . 0.0 111.594 -174.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.5 tp -109.18 133.92 52.39 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.103 1.761 . . . . 0.0 114.47 -171.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -80.46 133.66 35.88 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.568 0.699 . . . . 0.0 110.602 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -128.62 127.85 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 169.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.27 -174.1 14.79 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.83 1.205 . . . . 0.0 112.236 170.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.7 t30 64.04 26.12 13.96 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.373 1.469 . . . . 0.0 114.739 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.421 ' HB3' HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -61.87 164.96 5.77 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.519 1.528 . . . . 0.0 109.64 177.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.81 172.97 12.72 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.059 1.504 . . . . 0.0 115.059 176.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.2 p -71.76 -21.23 61.77 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.015 2.126 . . . . 0.0 110.381 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.04 30.6 5.62 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 127.431 2.292 . . . . 0.0 116.369 173.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.45 HG22 ' N ' ' A' ' 29' ' ' THR . 8.6 p -69.68 165.47 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 118.885 -2.385 . . . . 0.0 115.472 176.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.45 ' N ' HG22 ' A' ' 28' ' ' VAL . 11.4 p -154.63 173.53 16.24 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.682 1.193 . . . . 0.0 112.743 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -73.29 -26.92 61.28 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.135 0.974 . . . . 0.0 110.195 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.72 -45.82 92.31 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 171.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.44 HD12 HG23 ' A' ' 28' ' ' VAL . 2.8 tm? -65.78 -47.22 75.87 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.825 0.85 . . . . 0.0 110.579 -174.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.406 HD21 ' CD1' ' A' ' 24' ' ' LEU . 96.5 mt -56.89 -48.69 77.58 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.854 1.262 . . . . 0.0 111.112 173.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -59.35 -37.95 79.16 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.363 0.983 . . . . 0.0 112.26 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -75.45 -33.41 60.87 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.995 0.816 . . . . 0.0 110.345 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.443 HD11 HD11 ' A' ' 80' ' ' ILE . 4.2 tt -68.18 -39.82 82.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.113 1.765 . . . . 0.0 113.35 176.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.479 ' CE2' HG21 ' A' ' 62' ' ' VAL . 60.3 m-85 -85.5 -1.2 56.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 117.9 -1.047 . . . . 0.0 113.694 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -60.32 -41.48 93.59 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.802 1.637 . . . . 0.0 110.904 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -75.25 -14.71 60.54 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 172.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.03 -24.41 47.83 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 120.709 1.595 . . . . 0.0 110.14 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 154.12 -172.58 32.75 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 128.639 3.018 . . . . 0.0 114.412 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.73 79.66 2.69 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 124.853 3.702 . . . . 0.0 110.403 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.6 m -52.7 141.2 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.842 1.257 . . . . 0.0 113.365 172.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 80.3 mt -79.69 -59.68 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 126.8 2.04 . . . . 0.0 107.818 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.36 168.47 25.94 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.337 1.455 . . . . 0.0 113.282 174.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.5 t -116.65 157.19 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 126.662 1.985 . . . . 0.0 112.631 171.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -134.93 123.56 23.59 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.616 1.966 . . . . 0.0 113.75 169.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.413 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 3.4 mm -100.16 124.74 42.21 Favored Pre-proline 0 C--N 1.324 -0.512 0 C-N-CA 126.681 1.993 . . . . 0.0 108.612 167.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 50.3 Cg_endo -72.76 167.08 28.17 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.461 2.774 . . . . 0.0 111.583 161.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -158.77 114.83 2.66 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.857 2.463 . . . . 0.0 109.054 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.541 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 30.6 t70 -54.04 174.59 0.05 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.413 2.285 . . . . 0.0 112.545 170.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.68 -35.08 60.68 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.289 -1.507 . . . . 0.0 112.881 167.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -68.65 -13.76 62.57 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.944 2.498 . . . . 0.0 113.486 175.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.84 54.21 6.67 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -173.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -135.85 132.91 19.63 Favored Pre-proline 0 CA--C 1.517 -0.309 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.61 22.25 0.4 Allowed 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 124.276 3.318 . . . . 0.0 114.594 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.541 ' HE2' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER 51.47 26.95 3.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 119.727 -1.858 . . . . 0.0 115.612 168.175 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 52.02 35.11 15.3 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 127.185 2.194 . . . . 0.0 114.418 -170.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -150.8 157.91 43.51 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 120.001 -1.687 . . . . 0.0 112.224 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -153.91 174.86 14.06 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.247 1.819 . . . . 0.0 111.541 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -126.9 153.29 45.95 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 119.848 -1.783 . . . . 0.0 111.956 175.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.479 HG21 ' CE2' ' A' ' 37' ' ' PHE . 84.3 t -139.44 124.51 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.122 0.969 . . . . 0.0 112.692 -177.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -91.59 133.68 35.33 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.347 1.859 . . . . 0.0 109.931 -177.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.08 159.96 39.54 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.734 1.614 . . . . 0.0 111.922 -168.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -132.33 135.87 46.48 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.251 1.82 . . . . 0.0 111.107 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -159.7 176.24 12.21 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.394 2.678 . . . . 0.0 107.531 173.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -128.84 126.71 40.41 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.156 -0.965 . . . . 0.0 109.653 166.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.35 13.7 m 48.11 32.23 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 129.353 3.061 . . . . 0.0 115.415 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.9 p -121.24 166.03 14.6 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 -172.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 m -66.39 154.72 90.08 Favored Pre-proline 0 N--CA 1.48 1.037 0 O-C-N 121.412 -0.805 . . . . 0.0 112.31 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -76.04 101.82 1.54 Allowed 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.778 2.319 . . . . 0.0 108.383 165.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -57.22 -34.91 69.04 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.608 1.563 . . . . 0.0 113.689 -169.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.35 -27.78 62.57 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.116 -0.99 . . . . 0.0 112.789 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.1 ttp -77.42 -13.24 59.97 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.831 0.852 . . . . 0.0 112.184 -170.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -106.34 -25.29 11.99 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.271 1.429 . . . . 0.0 113.627 163.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.3 tp -78.04 -49.34 14.21 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.773 1.229 . . . . 0.0 112.474 -172.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -100.8 -106.99 0.23 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 42.24 70.69 0.26 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.996 2.118 . . . . 0.0 114.805 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.98 16.9 1.07 Allowed Glycine 0 CA--C 1.53 0.998 0 CA-C-N 115.594 -0.73 . . . . 0.0 114.281 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.443 HD11 HD11 ' A' ' 36' ' ' LEU . 1.9 pp -132.86 151.64 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 118.37 1.085 . . . . 0.0 111.773 -167.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.95 175.12 9.79 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.437 1.495 . . . . 0.0 110.965 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 70.0 tp -119.28 -38.74 2.98 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.173 1.389 . . . . 0.0 112.072 161.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -79.04 -41.41 28.89 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.106 0.962 . . . . 0.0 113.509 -170.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.33 -44.18 0.29 Allowed Glycine 0 N--CA 1.473 1.108 0 N-CA-C 115.692 1.037 . . . . 0.0 115.692 173.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.54 124.98 55.58 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 124.339 1.056 . . . . 0.0 108.664 177.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -77.02 134.9 14.97 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 124.443 3.429 . . . . 0.0 115.012 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.422 HG13 HD13 ' A' ' 36' ' ' LEU . 10.1 mm -64.16 131.62 29.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 123.786 0.834 . . . . 0.0 110.736 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.4 tptm -121.01 112.01 18.19 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.252 1.821 . . . . 0.0 110.016 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.4 mp -88.28 140.73 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -139.8 154.99 47.51 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 123.087 1.422 . . . . 0.0 109.041 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -82.88 147.5 28.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.21 -1.814 . . . . 0.0 110.929 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -91.54 58.76 3.64 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 128.108 2.563 . . . . 0.0 110.005 -170.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.74 -178.1 6.97 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.827 0.822 . . . . 0.0 112.465 174.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.5 -172.04 32.43 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-O 122.089 0.827 . . . . 0.0 114.216 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.8 p -60.18 139.33 57.61 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.521 -0.84 . . . . 0.0 109.425 172.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 m -57.22 136.35 56.47 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -172.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -78.16 168.02 20.5 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.488 1.915 . . . . 0.0 112.161 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.11 157.54 50.54 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 124.875 1.27 . . . . 0.0 111.296 -173.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -64.96 152.38 82.55 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 CA-C-N 120.783 1.315 . . . . 0.0 111.92 170.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -71.96 -28.39 63.41 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.908 1.283 . . . . 0.0 113.19 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 t70 . . . . . 0 C--O 1.257 1.462 0 C-N-CA 127.626 2.37 . . . . 0.0 113.022 -179.184 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.277 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -125.1 11.37 8.22 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.975 1.31 . . . . 0.0 112.882 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -56.55 131.14 47.87 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.302 1.041 . . . . 0.0 112.072 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -57.64 -40.76 80.01 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.239 -1.538 . . . . 0.0 113.46 -170.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -71.96 2.43 5.64 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 127.326 2.25 . . . . 0.0 114.826 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.8 mt -81.35 138.17 35.67 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 120.464 -1.398 . . . . 0.0 109.882 173.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -81.52 97.75 7.96 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.983 0.913 . . . . 0.0 110.017 176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -125.53 78.59 1.74 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 128.348 2.659 . . . . 0.0 105.674 -176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -136.06 156.81 48.17 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -162.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -56.96 -28.78 62.59 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.12 160.66 42.16 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.497 1.044 . . . . 0.0 113.351 -175.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.8 mt 46.01 -4.49 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 130.009 3.323 . . . . 0.0 117.4 -170.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.09 -0.55 55.88 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -101.33 157.68 16.61 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.141 2.576 . . . . 0.0 111.119 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -112.99 166.95 10.92 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 -165.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -155.82 176.17 12.98 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.261 2.225 . . . . 0.0 109.793 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.4 mtt-85 -55.94 -37.33 68.83 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.255 1.822 . . . . 0.0 111.539 160.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.3 m -63.3 146.12 54.13 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.552 1.141 . . . . 0.0 108.836 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.22 132.75 39.85 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 125.216 1.407 . . . . 0.0 109.707 -175.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -81.04 129.92 34.77 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.929 0.871 . . . . 0.0 110.912 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.4 t -127.14 130.62 71.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.18 -173.56 13.31 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 122.61 1.117 . . . . 0.0 113.712 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.1 t30 62.8 36.14 13.29 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.877 1.671 . . . . 0.0 113.994 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.523 ' CD1' HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -73.15 154.96 40.11 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.478 1.111 . . . . 0.0 109.763 -174.301 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.34 162.58 12.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 123.752 1.739 . . . . 0.0 113.626 170.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.6 p -73.94 -7.54 52.74 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.152 2.181 . . . . 0.0 110.908 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -133.68 18.5 3.89 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.295 2.238 . . . . 0.0 114.279 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' A' ' 24' ' ' LEU . 9.1 p -57.42 161.03 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 O-C-N 120.837 -1.164 . . . . 0.0 113.594 176.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 p -158.18 161.43 37.85 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.262 1.825 . . . . 0.0 108.835 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -66.03 -25.52 67.09 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.806 1.643 . . . . 0.0 111.444 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -66.23 -35.86 81.52 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.592 1.157 . . . . 0.0 113.955 170.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.456 HD23 HG23 ' A' ' 28' ' ' VAL . 41.6 tp -77.3 -40.63 43.67 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.232 0.924 . . . . 0.0 110.388 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' A' ' 24' ' ' LEU . 82.8 mt -62.77 -46.65 87.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.397 175.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -60.15 -46.88 88.18 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.765 1.166 . . . . 0.0 111.844 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.04 -31.48 72.73 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.16 0.891 . . . . 0.0 111.919 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 tt -75.07 -42.48 56.78 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.459 1.104 . . . . 0.0 112.976 173.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -83.9 -20.4 33.08 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -70.01 -24.9 63.36 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.21 1.368 . . . . 0.0 110.66 172.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -60.7 -28.87 68.97 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.778 -1.201 . . . . 0.0 112.442 165.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.51 17.25 10.33 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.918 1.287 . . . . 0.0 114.05 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.54 -168.01 12.86 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.441 1.02 . . . . 0.0 114.706 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.3 79.41 3.09 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 124.657 3.571 . . . . 0.0 111.107 -176.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.0 t -55.91 148.92 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.652 0.781 . . . . 0.0 110.284 171.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.5 mm -92.54 -52.04 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 126.396 1.878 . . . . 0.0 112.283 172.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -158.85 160.79 36.58 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.895 2.478 . . . . 0.0 108.352 -171.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 33' ' ' LEU . 57.7 t -127.3 155.63 38.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 126.789 2.036 . . . . 0.0 107.217 173.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -133.01 137.29 46.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.542 1.937 . . . . 0.0 110.176 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.414 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 3.4 mm -114.13 125.35 29.45 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 126.655 1.982 . . . . 0.0 111.866 163.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 55.5 Cg_endo -75.2 167.53 26.65 Favored 'Trans proline' 0 C--N 1.347 0.485 1 C-N-CA 125.519 4.146 . . . . 0.0 112.713 167.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -152.65 116.58 4.84 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 125.848 1.659 . . . . 0.0 110.532 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -49.2 164.2 0.08 Allowed 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 126.407 1.883 . . . . 0.0 112.08 161.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.35 -38.02 62.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.456 1.102 . . . . 0.0 112.062 170.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -74.3 -14.34 60.89 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.202 1.001 . . . . 0.0 112.373 174.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.7 41.93 3.74 Favored Glycine 0 C--N 1.343 0.967 0 O-C-N 120.303 -1.498 . . . . 0.0 115.676 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -133.28 139.08 33.01 Favored Pre-proline 0 N--CA 1.469 0.491 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -67.26 14.83 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.377 1 C-N-CA 125.762 4.308 . . . . 0.0 117.14 -178.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.27 18.06 2.33 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.371 -1.456 . . . . 0.0 114.117 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 68.04 31.62 5.39 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.262 1.825 . . . . 0.0 111.955 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.4 158.91 44.68 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.755 1.222 . . . . 0.0 113.254 -174.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.42 169.66 24.21 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.06 1.744 . . . . 0.0 111.891 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -121.4 150.32 41.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.168 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.4 t -139.58 146.97 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.734 1.214 . . . . 0.0 109.899 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -121.57 139.57 53.35 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -173.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -134.45 150.7 50.86 Favored 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 128.695 2.798 . . . . 0.0 111.816 172.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -93.03 144.23 25.46 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 129.925 3.29 . . . . 0.0 112.439 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.3 t60 43.55 62.69 1.8 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.923 2.089 . . . . 0.0 111.833 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -65.24 151.41 46.23 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 m -128.24 153.74 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 126.689 1.996 . . . . 0.0 111.126 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.8 p -54.77 149.16 11.61 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.427 0.691 . . . . 0.0 111.5 170.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.4 t 61.98 76.7 0.38 Allowed Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 126.797 2.039 . . . . 0.0 114.134 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -38.09 125.79 0.82 Allowed 'Trans proline' 0 CA--C 1.542 0.881 1 C-N-CA 125.818 4.346 . . . . 0.0 117.067 170.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -58.54 -42.36 87.64 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.492 1.117 . . . . 0.0 112.779 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.14 -32.22 67.95 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 121.343 1.883 . . . . 0.0 111.751 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.3 tpt -65.64 -26.83 67.99 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 118.372 0.533 . . . . 0.0 112.189 -175.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -86.56 -21.35 26.94 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 121.217 -0.927 . . . . 0.0 113.033 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -105.35 -38.85 6.35 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.789 1.635 . . . . 0.0 111.798 -155.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.8 -96.77 0.42 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.114 1.766 . . . . 0.0 111.443 174.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 29.97 66.37 0.12 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.791 2.036 . . . . 0.0 111.938 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.88 17.91 0.16 Allowed Glycine 0 N--CA 1.468 0.776 0 N-CA-C 117.347 1.699 . . . . 0.0 117.347 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -139.48 148.98 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 117.769 0.784 . . . . 0.0 112.578 -160.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.62 175.3 13.37 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.1 tp -138.53 -18.87 1.08 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.302 2.641 . . . . 0.0 112.819 171.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -101.92 -40.76 6.75 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.453 1.501 . . . . 0.0 112.986 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.74 -45.48 0.22 Allowed Glycine 0 N--CA 1.479 1.532 0 N-CA-C 118.477 2.151 . . . . 0.0 118.477 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -113.98 122.47 34.63 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 126.231 1.812 . . . . 0.0 111.459 -173.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.25 123.33 7.66 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.371 2.047 . . . . 0.0 115.106 -171.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.1 mm -52.6 118.61 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 124.495 1.118 . . . . 0.0 113.005 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -103.57 114.72 29.2 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.242 1.817 . . . . 0.0 111.658 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mp -84.0 146.77 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 O-C-N 121.649 -0.657 . . . . 0.0 110.574 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -146.18 161.25 40.64 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.122 1.769 . . . . 0.0 113.986 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -155.13 149.87 26.52 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.42 1.088 . . . . 0.0 113.106 171.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -67.99 123.46 20.69 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 128.495 2.718 . . . . 0.0 111.332 -173.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.1 148.48 49.77 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.62 0.19 0.51 Allowed Glycine 0 CA--C 1.534 1.27 0 CA-C-O 117.387 -1.785 . . . . 0.0 116.468 176.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 51.5 m 35.1 53.48 0.69 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.923 2.089 . . . . 0.0 114.612 169.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 79.3 p -172.27 160.43 5.05 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.228 1.411 . . . . 0.0 113.482 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -106.7 169.35 8.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.074 1.75 . . . . 0.0 109.778 170.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -106.35 153.19 40.6 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 118.56 0.618 . . . . 0.0 111.224 169.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -76.39 166.1 28.09 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.553 2.835 . . . . 0.0 109.311 169.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -128.66 -8.84 5.06 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 128.438 2.695 . . . . 0.0 111.619 174.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 . . . . . 0 C--O 1.257 1.49 0 C-N-CA 127.24 2.216 . . . . 0.0 115.392 176.197 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.174 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 t -139.75 -163.52 1.52 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.282 1.833 . . . . 0.0 109.957 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -136.57 147.01 46.78 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.875 2.07 . . . . 0.0 108.368 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -49.04 -43.42 40.69 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 126.367 1.867 . . . . 0.0 113.334 -175.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -132.96 133.66 43.47 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 125.065 1.346 . . . . 0.0 108.262 172.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 mt -144.34 172.39 13.0 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.335 1.454 . . . . 0.0 111.2 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.71 131.5 34.12 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.885 1.674 . . . . 0.0 114.746 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -168.43 -17.55 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.872 2.069 . . . . 0.0 116.185 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -118.89 -23.05 7.07 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -164.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -78.31 22.72 0.31 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.587 1.555 . . . . 0.0 111.123 -174.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.61 159.35 35.33 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.502 2.321 . . . . 0.0 113.828 -169.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 12' ' ' LEU . 1.9 pp -103.01 158.47 16.27 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 128.355 2.662 . . . . 0.0 111.177 169.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -162.34 149.69 13.85 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 128.492 2.717 . . . . 0.0 111.568 -174.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -158.66 133.82 8.48 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 128.237 2.615 . . . . 0.0 109.647 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.73 140.72 49.67 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -118.23 59.28 0.81 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.278 1.431 . . . . 0.0 111.413 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 57.32 7.12 0.44 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 m -138.53 146.34 41.8 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.396 0.998 . . . . 0.0 111.457 -164.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.428 HD13 ' HG3' ' A' ' 71' ' ' PRO . 42.7 tp -117.47 133.63 55.75 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.981 2.112 . . . . 0.0 112.927 -166.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -85.03 124.57 31.88 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 123.322 1.534 . . . . 0.0 111.84 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 t -122.06 134.06 66.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.436 ' HA2' HD23 ' A' ' 24' ' ' LEU . . . -141.41 -171.13 12.59 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 121.201 -0.937 . . . . 0.0 112.18 174.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 35.4 t30 62.43 38.62 12.7 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.645 1.178 . . . . 0.0 111.165 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.69 HD12 HG21 ' A' ' 28' ' ' VAL . 0.9 OUTLIER -71.2 158.06 37.07 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.458 1.103 . . . . 0.0 109.065 -176.067 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.79 158.47 35.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.808 1.29 . . . . 0.0 110.0 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.2 p -73.26 -13.49 61.14 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.992 1.317 . . . . 0.0 113.3 -169.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HB3' ' HE3' ' A' ' 27' ' ' LYS . 25.4 mmmt -129.72 21.21 5.5 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 129.733 3.213 . . . . 0.0 112.364 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.69 HG21 HD12 ' A' ' 24' ' ' LEU . 9.2 p -53.64 160.69 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.524 1.13 . . . . 0.0 112.751 173.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.419 ' N ' HG22 ' A' ' 28' ' ' VAL . 36.3 p -148.41 162.15 40.16 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.931 1.692 . . . . 0.0 110.707 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -56.12 -37.34 69.29 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.707 1.203 . . . . 0.0 108.972 171.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -66.26 -32.32 73.67 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.577 HD23 HG23 ' A' ' 28' ' ' VAL . 13.4 tp -75.17 -35.49 61.59 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.009 -1.057 . . . . 0.0 111.906 175.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB2' HG11 ' A' ' 46' ' ' VAL . 26.0 mt -71.4 -43.67 66.37 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.049 171.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -53.5 -46.89 70.21 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.85 1.205 . . . . 0.0 110.658 175.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -73.14 -28.2 62.11 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.5 tt -77.58 -49.01 15.51 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.467 1.107 . . . . 0.0 112.666 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -81.25 -17.94 47.72 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 120.344 1.429 . . . . 0.0 113.263 -175.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -53.23 -32.4 48.12 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 120.312 1.415 . . . . 0.0 110.94 169.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -56.55 -38.4 71.85 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.464 1.505 . . . . 0.0 114.847 168.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.07 -20.37 30.49 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.227 1.811 . . . . 0.0 111.814 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.43 -168.78 29.08 Favored Glycine 0 CA--C 1.55 2.257 0 N-CA-C 117.774 1.869 . . . . 0.0 117.774 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.66 74.83 5.01 Favored 'Trans proline' 0 CA--C 1.548 1.185 1 C-N-CA 126.468 4.779 . . . . 0.0 110.806 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 m -57.72 127.11 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.827 1.651 . . . . 0.0 110.024 173.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.557 HG22 ' HE3' ' A' ' 45' ' ' LYS . 34.5 mm -69.08 -40.23 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.665 0.786 . . . . 0.0 111.018 -175.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.557 ' HE3' HG22 ' A' ' 44' ' ' ILE . 13.3 ptpt -171.49 160.14 5.84 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.59 2.356 . . . . 0.0 111.042 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.472 HG11 ' HB2' ' A' ' 33' ' ' LEU . 85.2 t -122.24 137.19 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 127.148 2.179 . . . . 0.0 112.156 -175.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -113.96 123.77 50.54 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.7 mm -110.91 111.9 56.14 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 125.754 1.622 . . . . 0.0 111.436 165.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.8 165.73 24.84 Favored 'Trans proline' 0 CA--C 1.552 1.399 1 C-N-CA 125.717 4.278 . . . . 0.0 111.258 172.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -157.24 114.82 3.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.966 2.107 . . . . 0.0 111.667 171.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.452 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 31.4 t0 -63.02 176.51 0.71 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 126.759 2.024 . . . . 0.0 113.093 170.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.79 -36.92 27.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.491 1.916 . . . . 0.0 113.072 172.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -77.04 -9.15 58.52 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.937 1.695 . . . . 0.0 114.538 174.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.08 41.54 6.61 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 125.669 1.604 . . . . 0.0 112.629 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -130.29 133.84 25.38 Favored Pre-proline 0 N--CA 1.467 0.412 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -169.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.24 13.63 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 1 C-N-CA 126.411 4.741 . . . . 0.0 115.037 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER 54.84 21.13 3.43 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 174.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 60.26 34.79 20.91 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.587 1.955 . . . . 0.0 112.96 -172.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.482 ' HA ' HD23 ' A' ' 24' ' ' LEU . 2.0 p90 -151.04 155.91 40.0 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.142 1.377 . . . . 0.0 113.343 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -151.3 169.62 21.5 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.496 1.919 . . . . 0.0 112.914 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -126.24 159.56 32.7 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 122.265 1.031 . . . . 0.0 113.283 172.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.7 t -144.49 133.22 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.995 0.918 . . . . 0.0 110.874 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -99.36 147.32 25.35 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.578 1.551 . . . . 0.0 113.069 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -137.22 157.9 45.63 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.102 2.161 . . . . 0.0 110.33 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -59.04 149.97 26.11 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 120.235 -1.54 . . . . 0.0 108.454 165.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -64.87 123.3 19.04 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 126.612 1.965 . . . . 0.0 112.784 -171.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -151.7 155.09 37.62 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.7 t -88.99 85.48 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 C-N-CA 126.633 1.973 . . . . 0.0 107.029 169.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.7 p -160.54 157.84 28.12 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.467 HG12 ' CD2' ' A' ' 91' ' ' PHE . 0.4 OUTLIER -75.13 142.39 75.64 Favored Pre-proline 0 N--CA 1.473 0.714 0 O-C-N 120.918 -1.114 . . . . 0.0 109.108 157.349 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.428 ' HG3' HD13 ' A' ' 19' ' ' LEU . 12.8 Cg_endo -53.39 128.64 30.06 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.628 2.219 . . . . 0.0 112.695 176.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -52.91 -39.88 63.11 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.93 -26.69 67.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.6 ttt -70.48 -24.63 62.9 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 121.024 1.738 . . . . 0.0 112.765 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -87.04 -27.53 23.13 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.234 1.013 . . . . 0.0 112.109 169.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.33 -57.78 2.59 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -167.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -88.69 -94.92 0.1 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.547 1.139 . . . . 0.0 108.813 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 30.32 78.04 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.397 1.879 . . . . 0.0 113.38 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.9 28.01 1.78 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.022 0.82 . . . . 0.0 112.648 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -130.66 148.01 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.99 -175.17 3.91 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.239 2.216 . . . . 0.0 112.258 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.6 mt -131.37 -31.85 1.59 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.601 1.56 . . . . 0.0 112.841 154.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.446 ' CE2' HD22 ' A' ' 32' ' ' LEU . 21.0 m-30 -65.61 -51.95 55.75 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.05 -50.03 0.16 Allowed Glycine 0 CA--C 1.534 1.264 0 O-C-N 121.134 -0.979 . . . . 0.0 115.191 170.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -93.45 111.91 54.29 Favored Pre-proline 0 N--CA 1.479 1.014 0 C-N-CA 124.472 1.109 . . . . 0.0 109.247 -172.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.56 127.22 12.24 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.776 2.317 . . . . 0.0 112.536 -170.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.528 HD11 HD13 ' A' ' 24' ' ' LEU . 4.8 mm -56.74 122.54 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 122.223 1.011 . . . . 0.0 109.121 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -103.39 121.27 42.43 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.671 1.988 . . . . 0.0 109.732 171.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mp -94.46 141.23 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 169.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -124.12 140.93 52.49 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.705 1.24 . . . . 0.0 111.552 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.467 ' CD2' HG12 ' A' ' 70' ' ' VAL . 84.1 t80 -147.03 147.28 30.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.057 -1.429 . . . . 0.0 112.288 173.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -140.01 134.55 31.62 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.278 1.831 . . . . 0.0 108.231 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 m -79.01 138.02 37.84 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.14 0.976 . . . . 0.0 111.729 -170.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.49 135.87 39.12 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 122.254 0.919 . . . . 0.0 111.726 168.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.3 p -71.47 -24.74 62.05 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.514 1.526 . . . . 0.0 113.781 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.5 m 48.98 33.17 4.34 Favored 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -167.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -73.94 -28.64 61.61 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 119.804 -1.81 . . . . 0.0 113.183 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.95 152.86 77.45 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.123 0.969 . . . . 0.0 111.829 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.55 140.34 21.25 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.257 2.638 . . . . 0.0 112.941 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -69.58 -34.53 74.28 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 122.104 -0.373 . . . . 0.0 111.408 167.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.071 1.348 . . . . 0.0 114.044 179.74 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.215 0 CA-C-O 121.449 0.472 . . . . 0.0 112.592 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 t -53.16 137.29 34.34 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.554 2.342 . . . . 0.0 114.726 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.262 29.7 mt-10 47.93 31.49 2.38 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 131.675 3.99 . . . . 0.0 117.186 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -68.46 -21.26 64.64 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -173.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -83.06 3.82 28.79 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 168.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.27 170.26 8.17 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 129.129 2.971 . . . . 0.0 108.721 169.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -82.4 139.09 34.23 Favored 'General case' 0 C--N 1.339 0.112 0 O-C-N 120.394 -1.441 . . . . 0.0 107.956 165.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -119.32 84.4 2.19 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.508 1.523 . . . . 0.0 113.626 -170.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.3 mp0 -140.35 173.83 11.11 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 129.293 3.037 . . . . 0.0 113.149 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -68.44 -14.18 62.82 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -173.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.13 179.73 5.0 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.4 1.48 . . . . 0.0 112.139 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.9 mt -66.93 148.8 51.48 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.088 1.355 . . . . 0.0 111.076 167.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.79 -14.68 0.73 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 166.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -83.79 -3.18 57.63 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 126.193 1.797 . . . . 0.0 111.581 167.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.57 166.38 28.43 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 129.982 3.313 . . . . 0.0 108.223 159.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -148.21 -45.47 0.16 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.014 1.326 . . . . 0.0 113.397 171.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.8 mmt-85 -91.9 17.76 8.75 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.954 1.701 . . . . 0.0 113.722 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 83.7 m -151.54 144.33 24.4 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.624 1.169 . . . . 0.0 112.595 -165.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.9 tp -89.41 127.43 35.82 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.29 1.436 . . . . 0.0 113.367 -160.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -72.26 135.56 46.05 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.965 0.888 . . . . 0.0 111.769 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.04 134.97 62.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 168.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.82 -175.53 13.96 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 126.187 1.851 . . . . 0.0 111.23 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 42.9 t30 65.82 24.71 11.34 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.095 1.358 . . . . 0.0 112.315 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.613 HD12 HG21 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -64.8 160.09 21.01 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 123.282 1.515 . . . . 0.0 110.654 -175.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.27 163.36 27.11 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.995 -1.912 . . . . 0.0 110.511 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.2 p -64.29 -27.4 69.01 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.17 1.788 . . . . 0.0 109.869 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -123.59 26.13 7.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.613 HG21 HD12 ' A' ' 24' ' ' LEU . 8.0 p -51.8 161.46 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.839 1.2 . . . . 0.0 111.777 169.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.41 ' N ' HG22 ' A' ' 28' ' ' VAL . 1.6 p -158.93 159.46 34.95 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.458 1.903 . . . . 0.0 110.542 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -55.02 -38.82 68.42 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 126.478 1.911 . . . . 0.0 109.171 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -67.26 -30.87 70.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.594 1.958 . . . . 0.0 112.376 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.3 tp -75.4 -43.74 48.46 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.8 0.727 . . . . 0.0 111.422 168.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.447 ' HB2' HG11 ' A' ' 46' ' ' VAL . 95.1 mt -60.82 -54.42 45.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.106 0.963 . . . . 0.0 110.521 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -53.9 -45.41 71.1 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.059 0.845 . . . . 0.0 112.425 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -69.33 -31.76 70.42 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.127 1.33 . . . . 0.0 112.714 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.2 tt -74.18 -36.17 64.02 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.458 1.103 . . . . 0.0 111.014 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -95.54 -12.78 25.19 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -56.2 -35.74 67.63 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.969 1.708 . . . . 0.0 109.804 163.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.6 mm100 -62.36 -36.19 81.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.773 1.229 . . . . 0.0 113.284 168.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.86 2.76 44.59 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.574 1.15 . . . . 0.0 113.401 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 134.38 -169.63 22.98 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.737 1.637 . . . . 0.0 115.369 167.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.32 99.82 0.17 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.695 2.93 . . . . 0.0 111.159 167.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.5 t -88.2 131.69 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.019 1.727 . . . . 0.0 110.19 172.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.42 -46.29 20.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.949 1.3 . . . . 0.0 111.18 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -171.07 150.46 3.05 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.689 1.596 . . . . 0.0 112.033 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' ' 33' ' ' LEU . 96.2 t -115.87 151.17 17.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 129.297 3.039 . . . . 0.0 110.383 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -129.68 121.09 26.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.93 2.092 . . . . 0.0 111.209 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.5 mm -101.0 122.33 49.11 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.583 1.553 . . . . 0.0 110.124 160.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.36 163.75 35.24 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 125.188 3.925 . . . . 0.0 111.114 164.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -154.92 113.64 3.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.525 1.53 . . . . 0.0 113.149 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -53.04 168.9 0.11 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 130.444 3.497 . . . . 0.0 113.83 173.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -28.4 59.96 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.852 0.461 . . . . 0.0 110.471 168.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -83.37 -6.17 59.38 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.67 40.91 8.57 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 126.556 2.027 . . . . 0.0 111.943 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -128.82 137.11 30.28 Favored Pre-proline 0 N--CA 1.465 0.325 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.58 14.23 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 124.275 3.316 . . . . 0.0 116.682 176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.42 27.81 6.82 Favored 'General case' 0 CA--C 1.554 1.125 0 O-C-N 120.538 -1.351 . . . . 0.0 114.307 175.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 57.42 32.47 21.83 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 127.464 2.305 . . . . 0.0 116.156 -173.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -147.0 162.57 38.51 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 127.205 2.202 . . . . 0.0 112.53 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -158.67 177.43 11.21 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.622 1.969 . . . . 0.0 110.362 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -129.06 154.35 46.74 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.106 1.362 . . . . 0.0 114.22 171.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.16 133.52 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.523 1.529 . . . . 0.0 110.609 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -99.06 141.25 32.06 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.914 1.686 . . . . 0.0 112.207 173.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -147.17 1.3 0.74 Allowed 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 176.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -172.01 161.11 5.56 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 127.676 2.39 . . . . 0.0 111.473 -170.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -71.34 -47.32 57.24 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 120.696 1.589 . . . . 0.0 114.71 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -112.85 146.41 38.94 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 167.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.1 t -82.23 102.0 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -176.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.2 p -76.53 -81.53 0.08 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 113.468 -1.696 . . . . 0.0 108.984 168.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.2 p -165.45 127.79 1.5 Allowed Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 125.159 1.384 . . . . 0.0 113.223 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.412 ' HG2' ' HG2' ' A' ' 74' ' ' MET . 33.0 Cg_endo -88.49 149.1 6.33 Favored 'Trans proline' 0 CA--C 1.551 1.338 0 C-N-CA 123.692 2.928 . . . . 0.0 114.48 -169.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -74.55 -42.09 59.42 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 120.521 -1.362 . . . . 0.0 112.044 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . . . -56.91 -42.28 79.65 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.089 1.755 . . . . 0.0 114.482 -166.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.412 ' HG2' ' HG2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -51.18 -22.95 2.91 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 173.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -109.06 -34.3 6.64 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 125.257 1.423 . . . . 0.0 110.343 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.44 ' HB3' HD22 ' A' ' 77' ' ' LEU . 28.2 tp -64.1 -60.85 2.73 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 118.831 0.741 . . . . 0.0 111.298 -176.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.44 HD22 ' HB3' ' A' ' 76' ' ' LEU . 2.1 mm? -87.88 -86.42 0.16 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.458 1.903 . . . . 0.0 106.662 -174.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 37.57 64.56 0.63 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 126.289 1.836 . . . . 0.0 114.621 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.97 35.1 0.56 Allowed Glycine 0 N--CA 1.481 1.658 0 O-C-N 120.814 -1.179 . . . . 0.0 115.234 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.01 143.95 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.525 1.53 . . . . 0.0 112.476 -174.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.23 170.7 12.97 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.82 2.048 . . . . 0.0 112.653 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 15.5 tp -123.21 -30.73 3.68 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.867 2.467 . . . . 0.0 112.272 163.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -83.7 -21.52 32.34 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.082 2.153 . . . . 0.0 114.001 -172.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 150.79 -59.8 0.42 Allowed Glycine 0 N--CA 1.483 1.791 0 N-CA-C 116.166 1.226 . . . . 0.0 116.166 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -102.47 129.04 26.84 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 126.267 1.827 . . . . 0.0 109.033 -173.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -76.38 134.68 15.83 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.76 2.974 . . . . 0.0 113.747 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 mm -57.57 129.33 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 O-C-N 121.834 -0.541 . . . . 0.0 110.4 176.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -119.37 110.52 17.05 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.528 1.931 . . . . 0.0 109.582 170.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -85.32 134.29 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 126.125 1.77 . . . . 0.0 109.256 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -130.09 147.92 51.88 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.679 1.992 . . . . 0.0 111.399 -166.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.4 t80 64.32 130.19 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.302 1.841 . . . . 0.0 111.644 -154.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -107.07 -63.24 1.31 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.506 1.522 . . . . 0.0 109.907 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.9 t -162.14 162.66 28.59 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -78.94 108.96 2.76 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 125.058 1.314 . . . . 0.0 112.739 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.8 m -122.47 157.97 30.81 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.766 1.626 . . . . 0.0 110.008 171.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.3 m -65.53 151.88 45.35 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.305 1.842 . . . . 0.0 114.121 -172.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -172.34 134.71 0.7 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.054 2.542 . . . . 0.0 110.908 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 78.67 166.66 0.12 Allowed Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 127.325 2.25 . . . . 0.0 115.016 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -62.8 161.57 28.45 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.921 2.414 . . . . 0.0 115.888 167.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -135.71 -47.28 0.67 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.001 -1.062 . . . . 0.0 109.091 167.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.4 t70 . . . . . 0 C--O 1.259 1.567 0 C-N-CA 125.586 1.555 . . . . 0.0 113.545 179.924 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.733 0 N-CA-C 107.627 -2.189 . . . . 0.0 107.627 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 m -85.92 -46.31 10.69 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.562 2.345 . . . . 0.0 115.764 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.326 3.0 mp0 67.07 175.76 0.25 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 130.385 3.474 . . . . 0.0 116.594 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -117.31 -44.1 2.79 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.49 1.116 . . . . 0.0 112.664 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -93.18 37.48 1.04 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.672 1.989 . . . . 0.0 113.293 -171.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.9 mt -95.89 155.63 16.67 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.511 1.925 . . . . 0.0 113.857 173.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.63 159.76 0.73 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.018 1.727 . . . . 0.0 115.363 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -66.33 147.78 52.81 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.338 1.855 . . . . 0.0 111.23 172.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -108.88 -24.46 11.25 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.318 1.847 . . . . 0.0 111.758 -174.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -68.59 12.19 0.14 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.046 2.139 . . . . 0.0 112.883 163.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.05 167.56 15.17 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -162.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.2 mt -65.87 156.6 32.88 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.746 1.618 . . . . 0.0 113.928 -165.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.81 -43.1 65.7 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.568 1.147 . . . . 0.0 113.372 -172.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 41.27 38.49 0.79 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 127.997 2.519 . . . . 0.0 115.303 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.43 145.77 28.8 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 120.452 -1.405 . . . . 0.0 110.942 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.97 -175.59 4.47 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.09 0.956 . . . . 0.0 112.797 -175.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.28 7.32 6.59 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.3 m -105.37 152.95 22.31 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 122.532 1.158 . . . . 0.0 108.102 -175.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.5 tp -119.28 125.12 48.35 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 130.917 3.687 . . . . 0.0 111.01 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -80.65 135.95 36.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.602 1.161 . . . . 0.0 108.47 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.3 t -135.37 139.39 46.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 125.098 1.359 . . . . 0.0 108.753 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.02 -174.7 14.24 Favored Glycine 0 N--CA 1.449 -0.454 0 O-C-N 121.098 -1.001 . . . . 0.0 112.448 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.5 t30 71.19 24.44 3.84 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.943 1.697 . . . . 0.0 112.383 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.752 HD12 HG21 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -72.24 145.75 47.73 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 125.191 1.397 . . . . 0.0 109.766 -169.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.24 162.05 18.1 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 176.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.4 p -63.1 -22.41 66.84 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.822 1.649 . . . . 0.0 111.639 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -113.38 23.2 13.46 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.466 1.506 . . . . 0.0 113.618 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.752 HG21 HD12 ' A' ' 24' ' ' LEU . 6.7 p -60.25 155.47 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 O-C-N 119.784 -1.823 . . . . 0.0 112.131 171.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.6 p -153.52 159.8 42.33 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 129.132 2.973 . . . . 0.0 108.58 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -59.9 -28.06 67.25 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.08 2.152 . . . . 0.0 111.9 177.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -73.08 -32.58 65.09 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.067 1.347 . . . . 0.0 112.252 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.436 HD22 ' CZ ' ' A' ' 83' ' ' TYR . 21.7 tp -76.08 -36.49 58.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.676 0.79 . . . . 0.0 112.999 172.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.491 HD21 ' CD1' ' A' ' 24' ' ' LEU . 95.0 mt -69.71 -42.31 74.21 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 176.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -63.03 -40.74 98.63 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.786 1.63 . . . . 0.0 112.938 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -69.86 -29.72 67.02 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.141 -0.975 . . . . 0.0 111.37 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.471 HD13 HG13 ' A' ' 87' ' ' ILE . 6.1 tt -73.38 -39.06 65.41 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.58 0.752 . . . . 0.0 110.388 175.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -93.41 17.36 11.54 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.779 1.231 . . . . 0.0 114.274 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -67.39 -30.28 70.01 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 120.286 1.403 . . . . 0.0 114.671 -173.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -101.24 0.24 37.06 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.126 1.77 . . . . 0.0 113.123 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.77 30.95 0.54 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.14 179.28 39.97 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.104 0.859 . . . . 0.0 111.748 -173.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -62.13 109.24 0.79 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.43 2.086 . . . . 0.0 109.716 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.9 t -94.04 105.05 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.798 1.239 . . . . 0.0 109.11 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.1 mt -62.51 -49.37 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.437 1.895 . . . . 0.0 111.825 171.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.17 170.1 19.66 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.681 0.792 . . . . 0.0 110.13 175.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' A' ' 33' ' ' LEU . 87.3 t -119.58 160.77 19.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 125.355 1.462 . . . . 0.0 109.132 169.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -138.54 124.05 19.54 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.884 1.273 . . . . 0.0 111.939 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.432 HD12 HG13 ' A' ' 28' ' ' VAL . 4.5 mm -108.37 121.69 42.73 Favored Pre-proline 0 C--N 1.32 -0.692 0 C-N-CA 125.721 1.608 . . . . 0.0 109.896 169.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.16 164.83 33.37 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 125.198 3.932 . . . . 0.0 112.304 165.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -159.51 118.32 2.85 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 126.923 2.089 . . . . 0.0 108.769 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -55.53 168.92 0.35 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 127.106 2.162 . . . . 0.0 113.06 171.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.35 -35.44 62.74 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.001 1.32 . . . . 0.0 110.116 172.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -89.16 6.79 38.44 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 128.321 2.648 . . . . 0.0 114.79 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.47 46.55 7.34 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 126.759 2.123 . . . . 0.0 115.416 168.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 9.0 tppt? -136.26 137.27 24.1 Favored Pre-proline 0 N--CA 1.476 0.842 0 CA-C-N 118.761 1.281 . . . . 0.0 113.467 -173.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.474 ' HD2' ' HG3' ' A' ' 55' ' ' LYS . 72.9 Cg_endo -77.79 17.88 0.92 Allowed 'Trans proline' 0 C--O 1.223 -0.261 1 C-N-CA 126.412 4.741 . . . . 0.0 115.596 -176.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.45 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 50.5 27.86 3.07 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.815 1.646 . . . . 0.0 113.341 175.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . 0.25 11.3 mt-30 53.83 32.59 15.29 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -171.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.45 ' CD2' ' HB2' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -149.21 150.98 33.5 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 126.337 1.855 . . . . 0.0 112.873 -176.04 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -155.1 176.06 13.03 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.911 1.685 . . . . 0.0 112.505 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -135.39 163.16 30.66 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.1 t -145.48 143.6 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.608 1.563 . . . . 0.0 109.813 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -112.26 130.76 55.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.885 0.85 . . . . 0.0 110.499 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -145.96 141.89 28.16 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.074 1.349 . . . . 0.0 111.953 -161.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -149.04 127.88 12.58 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.089 0.955 . . . . 0.0 109.846 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.487 ' CD2' ' H ' ' A' ' 68' ' ' VAL . 76.0 t60 -150.15 167.01 28.1 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 126.309 1.844 . . . . 0.0 109.79 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -55.98 -30.86 62.42 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 177.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.487 ' H ' ' CD2' ' A' ' 66' ' ' HIS . 13.7 m -118.39 147.26 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 120.231 -1.543 . . . . 0.0 111.222 160.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.5 m -89.16 76.83 7.65 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 119.962 -1.712 . . . . 0.0 113.582 174.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 m -121.98 156.23 59.87 Favored Pre-proline 0 N--CA 1.483 1.185 0 C-N-CA 124.857 1.263 . . . . 0.0 110.794 174.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -94.74 84.54 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.467 2.111 . . . . 0.0 109.266 -164.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -61.48 -40.9 96.24 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 120.084 -1.635 . . . . 0.0 112.888 -169.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.455 ' HB1' HD12 ' A' ' 77' ' ' LEU . . . -57.99 -27.96 63.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.145 1.378 . . . . 0.0 112.348 174.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.5 ttt -69.69 -17.7 63.5 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.323 1.049 . . . . 0.0 111.893 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -98.92 -38.87 8.84 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.216 0.917 . . . . 0.0 111.787 166.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.51 -40.09 94.99 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 118.8 0.727 . . . . 0.0 111.392 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.46 HD22 HD11 ' A' ' 80' ' ' ILE . 2.8 mt -124.81 -86.45 0.63 Allowed 'General case' 0 C--N 1.348 0.527 0 CA-C-O 116.36 -1.781 . . . . 0.0 111.191 -158.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 23.03 71.67 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.769 2.028 . . . . 0.0 112.439 169.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.75 25.19 0.7 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.752 1.644 . . . . 0.0 114.289 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.46 HD11 HD22 ' A' ' 77' ' ' LEU . 1.1 pp -134.81 151.68 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.645 1.178 . . . . 0.0 113.096 -172.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.94 168.95 20.43 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.416 1.486 . . . . 0.0 112.526 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.0 tp -111.89 -33.59 6.25 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 128.553 2.741 . . . . 0.0 111.146 173.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.436 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 6.4 m-30 -93.57 -67.0 0.88 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.632 1.573 . . . . 0.0 110.687 -173.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.37 -38.55 0.07 OUTLIER Glycine 0 CA--C 1.53 1.003 0 CA-C-O 117.92 -1.489 . . . . 0.0 116.108 -175.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.417 ' HA ' ' HD2' ' A' ' 86' ' ' PRO . 3.4 mpt_? -101.94 108.07 54.89 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 120.205 2.003 . . . . 0.0 110.86 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 21.1 Cg_endo -65.73 128.9 20.92 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.236 3.291 . . . . 0.0 113.585 -166.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.471 HG13 HD13 ' A' ' 36' ' ' LEU . 7.0 mm -58.85 124.78 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -117.13 109.8 17.38 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 128.258 2.623 . . . . 0.0 110.749 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.2 mp -88.93 142.74 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.255 0.622 . . . . 0.0 109.677 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -132.84 154.48 50.29 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 123.467 1.603 . . . . 0.0 113.93 -176.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -164.96 152.26 11.09 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.09 -163.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -158.47 138.98 12.63 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.143 0.977 . . . . 0.0 112.722 175.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.5 p -150.29 164.36 35.95 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 120.978 -1.076 . . . . 0.0 113.641 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 155.22 -28.92 0.63 Allowed Glycine 0 CA--C 1.541 1.704 0 C-N-CA 125.474 1.511 . . . . 0.0 114.714 175.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.0 m -108.75 -1.59 19.23 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.3 m -104.11 17.0 25.0 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.862 1.665 . . . . 0.0 113.992 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -64.62 142.45 58.42 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.083 2.153 . . . . 0.0 112.523 174.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -143.98 165.66 23.13 Favored Pre-proline 0 C--O 1.236 0.361 0 C-N-CA 126.999 2.12 . . . . 0.0 111.16 -168.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.96 157.67 57.43 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 CA-C-O 123.373 1.322 . . . . 0.0 115.217 170.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -80.5 -73.93 0.34 Allowed 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.921 1.688 . . . . 0.0 107.777 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.5 t70 . . . . . 0 C--O 1.26 1.654 0 C-N-CA 125.012 1.325 . . . . 0.0 113.254 174.784 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 CA-C-O 119.291 -0.727 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 p -143.92 155.92 44.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.204 2.602 . . . . 0.0 111.951 -170.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -151.11 139.9 20.82 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 123.093 1.425 . . . . 0.0 114.024 174.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -121.45 -42.67 2.43 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 128.028 2.531 . . . . 0.0 111.581 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -88.55 56.65 3.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.273 1.429 . . . . 0.0 109.267 171.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.0 tp -91.25 163.7 14.15 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 122.61 1.195 . . . . 0.0 111.0 -175.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.94 124.77 21.94 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.071 -1.422 . . . . 0.0 108.42 175.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -157.03 148.47 22.23 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -133.61 175.09 9.74 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 128.41 2.684 . . . . 0.0 112.495 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -90.09 -30.25 17.81 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 119.545 -1.972 . . . . 0.0 113.429 -166.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -170.82 -176.53 2.05 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 129.36 3.064 . . . . 0.0 109.612 -175.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.7 mt -55.16 125.9 22.53 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.378 1.871 . . . . 0.0 112.232 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.11 136.32 36.61 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.816 0.846 . . . . 0.0 112.763 -163.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -125.56 143.54 50.97 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.648 1.579 . . . . 0.0 110.18 176.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.93 141.48 54.98 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 153.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -156.57 104.26 2.17 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.882 1.273 . . . . 0.0 109.292 177.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 61.03 -14.66 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.72 2.408 . . . . 0.0 117.033 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.54 167.24 21.46 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.703 1.601 . . . . 0.0 109.252 -163.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.3 tp -122.85 123.6 41.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.873 1.669 . . . . 0.0 114.347 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -71.77 132.53 44.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.298 1.047 . . . . 0.0 112.497 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.43 119.88 51.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 174.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.43 -171.48 16.6 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 122.988 1.327 . . . . 0.0 112.067 166.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.3 t30 71.39 31.22 2.37 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.438 2.295 . . . . 0.0 114.595 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.725 HD12 HG21 ' A' ' 28' ' ' VAL . 0.9 OUTLIER -74.16 155.78 38.02 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.879 1.272 . . . . 0.0 113.91 -172.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -65.79 160.32 23.31 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.1 p -62.64 -26.75 68.79 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 128.712 2.805 . . . . 0.0 111.867 168.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -113.38 10.4 18.34 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.43 1.892 . . . . 0.0 113.448 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.725 HG21 HD12 ' A' ' 24' ' ' LEU . 9.2 p -61.92 158.97 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -174.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.6 p -154.1 168.92 24.86 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 128.356 2.662 . . . . 0.0 110.625 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -62.44 -25.2 67.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.409 1.484 . . . . 0.0 110.22 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -80.66 -26.48 37.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 117.361 -1.304 . . . . 0.0 113.672 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.526 HD23 HG23 ' A' ' 28' ' ' VAL . 20.8 tp -73.65 -29.89 62.6 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.283 0.947 . . . . 0.0 111.681 169.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.461 ' HB2' HG11 ' A' ' 46' ' ' VAL . 77.4 mt -78.83 -44.69 22.47 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.298 1.039 . . . . 0.0 113.663 171.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -63.9 -43.67 95.3 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 120.137 -1.602 . . . . 0.0 110.971 -174.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -63.42 -18.38 63.66 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.292 1.037 . . . . 0.0 113.573 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 tt -99.19 -43.95 6.44 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 129.093 2.957 . . . . 0.0 110.224 -169.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -78.69 -14.13 59.46 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.152 1.381 . . . . 0.0 111.841 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -66.62 -27.4 67.66 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 120.37 -1.456 . . . . 0.0 111.877 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -68.14 -23.99 64.95 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 127.754 2.422 . . . . 0.0 114.117 165.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.71 -22.15 23.51 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.707 1.603 . . . . 0.0 110.325 -176.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 132.81 -147.15 18.82 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.447 1.022 . . . . 0.0 114.299 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -81.25 114.73 2.84 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 123.917 3.078 . . . . 0.0 110.306 -172.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.1 t -110.6 120.39 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.422 1.489 . . . . 0.0 110.57 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.578 HG22 ' HD2' ' A' ' 45' ' ' LYS . 4.2 mt -61.41 -57.14 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.578 ' HD2' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -157.1 163.87 38.5 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 127.281 2.232 . . . . 0.0 113.582 -178.148 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 33' ' ' LEU . 73.2 t -118.22 146.66 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 128.651 2.78 . . . . 0.0 110.136 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -122.58 128.52 50.82 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.803 1.638 . . . . 0.0 113.607 171.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 4.3 mm -107.35 120.96 46.01 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 125.459 1.503 . . . . 0.0 110.647 163.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 72.9 Cg_endo -73.42 168.45 24.72 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 125.029 3.819 . . . . 0.0 113.318 165.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -158.6 122.55 3.99 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.639 2.775 . . . . 0.0 111.965 166.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.62 164.95 0.3 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.218 2.607 . . . . 0.0 113.248 165.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -49.88 -29.71 8.67 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 164.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.12 -7.84 59.11 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.002 1.321 . . . . 0.0 114.555 170.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.15 38.93 7.6 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 119.88 -1.763 . . . . 0.0 111.952 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.28 132.91 24.6 Favored Pre-proline 0 C--N 1.347 0.493 0 CA-C-N 118.619 1.209 . . . . 0.0 114.26 -176.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.21 12.16 0.3 Allowed 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.308 3.339 . . . . 0.0 113.861 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.439 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 58.82 22.32 10.02 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 120.485 -1.384 . . . . 0.0 113.147 172.244 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.444 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 19.8 mt-30 57.86 34.39 24.31 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.13 1.372 . . . . 0.0 114.106 -171.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.556 ' HA ' HD23 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -150.8 158.74 44.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.75 1.22 . . . . 0.0 113.247 -176.488 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.64 -176.86 6.18 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.251 1.42 . . . . 0.0 112.501 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -140.43 154.57 46.7 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.159 -0.963 . . . . 0.0 113.189 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.46 139.34 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.766 0.826 . . . . 0.0 113.174 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -95.3 123.91 39.06 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.113 1.365 . . . . 0.0 112.881 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -100.14 152.26 20.45 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 122.612 1.196 . . . . 0.0 114.119 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -91.13 -27.07 18.79 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 128.223 2.609 . . . . 0.0 112.809 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -150.97 -7.57 0.26 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 116.778 2.14 . . . . 0.0 116.778 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -79.98 38.12 0.39 Allowed 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -159.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.5 t -67.56 123.63 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 120.364 -1.46 . . . . 0.0 108.986 -175.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.268 3.0 m 69.74 -8.42 0.78 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.68 82.93 15.17 Favored Pre-proline 0 N--CA 1.493 1.687 0 CA-C-N 121.816 2.098 . . . . 0.0 112.909 169.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.83 115.01 3.74 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 125.284 3.989 . . . . 0.0 109.993 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -64.59 -29.29 70.3 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.844 -1.16 . . . . 0.0 113.593 -161.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.06 -18.68 64.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.7 ttp -61.12 -17.84 54.88 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 120.137 1.335 . . . . 0.0 112.206 173.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -109.22 -44.2 3.99 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.54 1.136 . . . . 0.0 111.888 171.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.29 -43.15 95.68 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.566 0.347 . . . . 0.0 111.55 -170.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -107.96 -88.34 0.48 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.616 1.166 . . . . 0.0 111.258 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 27.01 71.11 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 129.73 3.212 . . . . 0.0 115.712 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.43 14.98 1.49 Allowed Glycine 0 CA--C 1.532 1.155 0 CA-C-O 117.598 -1.668 . . . . 0.0 116.085 -174.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -125.08 150.98 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 119.793 1.797 . . . . 0.0 111.2 -168.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.88 171.21 16.98 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.745 1.218 . . . . 0.0 113.742 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.8 tp -120.28 -46.58 2.39 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.637 1.175 . . . . 0.0 109.75 166.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -69.32 -54.8 12.72 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.29 -46.2 0.06 OUTLIER Glycine 0 CA--C 1.537 1.414 0 N-CA-C 116.265 1.266 . . . . 0.0 116.265 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -105.15 114.71 63.28 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 127.619 2.368 . . . . 0.0 114.101 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.92 119.5 6.53 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.715 2.943 . . . . 0.0 113.033 -171.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.416 HD11 ' CD2' ' A' ' 33' ' ' LEU . 1.7 mm -50.24 124.08 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.903 1.281 . . . . 0.0 110.1 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -118.86 109.88 16.54 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 124.487 1.115 . . . . 0.0 112.037 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mp -81.88 131.23 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -118.35 145.01 45.45 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -158.63 145.19 17.22 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 118.366 2.728 . . . . 0.0 118.366 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -105.27 131.88 52.17 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 129.465 3.106 . . . . 0.0 111.333 174.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 86.0 p -69.64 162.44 27.65 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.455 1.102 . . . . 0.0 112.148 170.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.11 -9.2 0.03 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.472 1.51 . . . . 0.0 114.123 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 56.8 m -95.01 151.17 19.4 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.88 2.072 . . . . 0.0 110.234 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 40.2 m -116.16 161.28 19.18 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 127.182 2.193 . . . . 0.0 111.935 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -74.56 -24.8 58.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.433 1.493 . . . . 0.0 111.881 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . 0.257 . . 68.89 153.73 0.14 Allowed Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 127.856 2.462 . . . . 0.0 114.195 177.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -94.49 -173.13 0.3 Allowed 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 124.985 3.79 . . . . 0.0 113.23 174.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -151.49 -29.68 0.18 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 176.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 C--O 1.256 1.412 0 C-N-CA 128.086 2.554 . . . . 0.0 115.946 174.88 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.748 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.9 m -94.43 64.79 3.16 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.248 1.419 . . . . 0.0 110.765 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -66.76 145.53 55.42 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -172.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -64.09 -37.94 89.26 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.241 -1.537 . . . . 0.0 112.269 -178.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -80.76 31.37 0.3 Allowed 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -175.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.1 mt -120.55 148.34 43.98 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 127.214 2.206 . . . . 0.0 112.616 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -68.45 95.88 0.65 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 122.889 1.328 . . . . 0.0 110.404 164.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.3 mtm105 -134.46 9.68 3.71 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 129.17 2.988 . . . . 0.0 115.269 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -78.73 158.43 28.29 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 127.157 2.183 . . . . 0.0 111.756 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -34.89 -28.06 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 131.259 3.824 . . . . 0.0 120.845 -175.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.71 162.89 40.67 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.556 1.071 . . . . 0.0 111.41 -173.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 29.2 mt 59.3 4.19 0.45 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 127.593 2.357 . . . . 0.0 117.206 171.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.39 -5.02 55.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.956 2.102 . . . . 0.0 115.372 -167.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -118.76 167.89 11.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -153.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.97 151.61 46.4 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.676 2.39 . . . . 0.0 111.791 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -162.42 165.39 26.41 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.343 1.457 . . . . 0.0 113.122 -174.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -70.95 -15.32 62.58 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.867 -1.145 . . . . 0.0 113.687 161.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.5 m -104.41 138.28 41.05 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.723 2.009 . . . . 0.0 111.218 -175.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.8 tp -75.28 132.53 41.1 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.732 2.413 . . . . 0.0 110.549 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -84.79 137.73 33.01 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 120.288 1.404 . . . . 0.0 110.622 175.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.57 115.79 32.77 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 172.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.87 -177.28 18.37 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.357 1.456 . . . . 0.0 110.396 172.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.2 t30 65.52 37.72 5.9 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.119 1.368 . . . . 0.0 111.698 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.576 ' CD1' HG21 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -74.81 152.04 39.02 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.028 1.731 . . . . 0.0 109.468 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 26' ' ' THR . 0.7 OUTLIER -67.9 170.96 7.27 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 123.966 1.841 . . . . 0.0 112.587 169.451 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.487 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 24.9 p -82.54 -13.77 56.06 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 126.293 1.837 . . . . 0.0 113.331 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -119.11 20.33 12.69 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.25 2.62 . . . . 0.0 113.08 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.576 HG21 ' CD1' ' A' ' 24' ' ' LEU . 8.0 p -71.67 158.23 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -177.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.1 p -153.5 167.0 30.93 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.441 1.096 . . . . 0.0 111.697 -173.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.442 ' HA ' HG11 ' A' ' 46' ' ' VAL . 43.0 mt-10 -63.78 -32.12 73.52 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.011 0.924 . . . . 0.0 108.713 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.12 -47.85 81.03 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.559 1.944 . . . . 0.0 113.109 172.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.3 tp -67.11 -36.94 83.01 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.095 0.558 . . . . 0.0 110.922 -175.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.533 HD21 ' CD1' ' A' ' 24' ' ' LEU . 99.2 mt -65.89 -51.17 61.02 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.17 1.388 . . . . 0.0 111.042 172.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -52.59 -43.52 65.36 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.838 2.055 . . . . 0.0 113.523 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -75.23 -27.63 59.6 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -76.14 -38.73 56.4 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.608 -0.683 . . . . 0.0 112.067 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.466 ' CE2' HG21 ' A' ' 62' ' ' VAL . 56.8 m-85 -82.03 11.53 5.06 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.595 -1.315 . . . . 0.0 114.06 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -62.95 -44.78 95.12 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.124 1.37 . . . . 0.0 113.786 -174.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.72 6.7 44.93 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.639 1.576 . . . . 0.0 111.351 168.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.66 3.66 43.72 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 120.744 1.611 . . . . 0.0 112.673 171.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.85 -167.94 12.59 Favored Glycine 0 CA--C 1.538 1.515 0 C-N-CA 127.918 2.675 . . . . 0.0 111.831 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.04 97.74 0.93 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.697 2.264 . . . . 0.0 111.328 -173.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.8 t -68.33 119.23 13.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 122.58 1.181 . . . . 0.0 110.335 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.9 mm -80.54 -46.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -175.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.99 155.19 30.87 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.885 1.674 . . . . 0.0 110.111 174.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.442 HG11 ' HA ' ' A' ' 30' ' ' GLU . 42.5 t -112.64 153.87 14.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 125.681 1.593 . . . . 0.0 107.45 170.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -126.91 126.4 43.19 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.905 1.282 . . . . 0.0 112.39 169.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.429 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 1.6 mm -105.54 122.78 41.59 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 123.892 0.877 . . . . 0.0 109.594 164.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 65.4 Cg_endo -71.71 166.21 30.17 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.847 3.031 . . . . 0.0 110.153 164.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -160.72 120.06 2.67 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 128.087 2.555 . . . . 0.0 106.072 174.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.25 172.81 2.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.359 -1.746 . . . . 0.0 110.75 167.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -32.61 62.97 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 122.405 1.098 . . . . 0.0 111.045 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -77.45 -3.61 41.23 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.648 1.979 . . . . 0.0 113.116 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.95 41.51 8.1 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.541 2.019 . . . . 0.0 113.618 170.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -136.46 135.48 20.77 Favored Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.32 15.39 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.585 1 C-N-CA 126.106 4.537 . . . . 0.0 116.005 -174.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.76 29.22 9.24 Favored 'General case' 0 CA--C 1.557 1.22 0 O-C-N 121.548 -0.72 . . . . 0.0 111.91 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 53.99 38.41 28.83 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -174.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.408 ' HA ' HD23 ' A' ' 24' ' ' LEU . 1.1 p90 -152.72 173.36 15.37 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 127.787 2.435 . . . . 0.0 113.257 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -169.71 174.51 5.72 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 128.882 2.873 . . . . 0.0 112.737 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -127.01 153.92 45.3 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.706 2.003 . . . . 0.0 112.274 170.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.466 HG21 ' CE2' ' A' ' 37' ' ' PHE . 4.7 t -141.2 140.17 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.66 1.984 . . . . 0.0 108.008 -178.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -105.86 131.07 53.64 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -127.57 152.92 47.01 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.878 1.671 . . . . 0.0 109.293 162.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -98.61 158.02 15.87 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.499 -1.376 . . . . 0.0 111.99 -176.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 37.9 56.45 1.58 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.619 2.368 . . . . 0.0 113.29 176.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -88.75 146.83 24.79 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.49 1.916 . . . . 0.0 110.322 -173.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.3 m -118.8 -171.36 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 127.295 2.238 . . . . 0.0 108.984 175.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.4 143.81 56.91 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.475 1.11 . . . . 0.0 111.076 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 t 70.04 107.35 0.03 OUTLIER Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 127.869 2.468 . . . . 0.0 116.745 -175.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.23 137.34 36.75 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 124.629 3.553 . . . . 0.0 113.731 173.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -59.7 -42.6 93.36 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.847 1.259 . . . . 0.0 109.547 -175.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.86 -25.4 28.54 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 173.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 tpt -71.93 -16.05 62.1 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 121.456 1.935 . . . . 0.0 113.788 -173.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -103.16 -35.96 8.29 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.315 1.846 . . . . 0.0 111.271 169.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.67 -48.98 23.1 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.964 1.706 . . . . 0.0 112.633 -169.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.15 -97.14 0.33 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.73 1.612 . . . . 0.0 108.63 177.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 39.55 57.57 2.13 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.447 1.899 . . . . 0.0 112.69 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.52 22.54 0.13 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.89 151.6 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 118.711 1.255 . . . . 0.0 113.806 -168.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.51 176.91 6.24 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.91 1.684 . . . . 0.0 110.93 -170.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.9 tp -125.87 -35.83 2.45 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.088 1.755 . . . . 0.0 112.428 170.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 14.7 m-30 -81.79 -61.23 1.98 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.986 1.715 . . . . 0.0 111.059 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.87 -49.1 0.06 OUTLIER Glycine 0 N--CA 1.468 0.809 0 N-CA-C 117.297 1.679 . . . . 0.0 117.297 -176.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -90.87 116.67 66.91 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -171.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.08 128.82 13.43 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.177 2.585 . . . . 0.0 110.393 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.3 mm -63.87 118.65 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.155 -174.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -103.5 91.73 4.17 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.87 1.668 . . . . 0.0 110.799 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.45 ' H ' HD12 ' A' ' 89' ' ' ILE . 4.2 mp -60.14 139.13 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.203 165.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -138.71 157.31 46.35 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.282 1.433 . . . . 0.0 112.342 167.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -150.95 155.27 38.75 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 174.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.7 mmm-85 -89.44 149.13 23.08 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.9 m -124.06 173.02 8.54 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 128.64 2.776 . . . . 0.0 112.938 165.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 158.5 23.9 0.03 OUTLIER Glycine 0 CA--C 1.551 2.327 0 N-CA-C 118.338 2.095 . . . . 0.0 118.338 -172.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.8 m 45.86 44.69 11.24 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.785 2.292 . . . . 0.0 116.862 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.1 p -163.07 163.13 26.0 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.682 -1.261 . . . . 0.0 113.628 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -133.6 141.93 47.89 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 127.508 2.323 . . . . 0.0 112.191 -168.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -51.45 142.0 22.31 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.018 0.927 . . . . 0.0 110.506 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -81.98 129.39 6.15 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 124.183 3.255 . . . . 0.0 111.774 172.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -103.14 -22.64 13.72 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 127.552 2.341 . . . . 0.0 114.984 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 N--CA 1.489 1.511 0 C-N-CA 128.405 2.682 . . . . 0.0 113.57 -171.509 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.515 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.8 m -61.5 145.4 51.98 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.545 1.138 . . . . 0.0 113.185 -167.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -62.83 146.69 52.08 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.028 0.531 . . . . 0.0 110.874 -173.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -148.85 -25.74 0.31 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.658 1.983 . . . . 0.0 115.238 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -110.3 2.77 19.36 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.599 1.56 . . . . 0.0 113.162 -177.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.43 156.9 30.89 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 120.784 1.629 . . . . 0.0 108.936 163.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -64.75 138.94 58.68 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 169.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.4 -23.41 37.63 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.463 1.105 . . . . 0.0 112.848 171.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -86.58 160.18 19.01 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.745 1.218 . . . . 0.0 110.235 164.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -61.55 -31.63 71.67 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 -168.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.1 167.4 24.19 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 120.803 1.638 . . . . 0.0 113.265 -172.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 pp -54.92 153.1 6.59 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.361 1.865 . . . . 0.0 108.331 160.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -132.27 1.46 3.82 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 120.45 -1.406 . . . . 0.0 114.589 -150.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -145.93 136.06 23.73 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 118.814 0.733 . . . . 0.0 112.854 -172.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.44 166.53 32.97 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 126.585 1.954 . . . . 0.0 112.383 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -146.38 153.87 40.99 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 127.006 2.122 . . . . 0.0 111.529 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.24 13.04 4.52 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 -174.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.52 149.81 39.61 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -155.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 51.1 tp -106.83 133.37 51.59 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.195 2.598 . . . . 0.0 111.792 -172.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -88.0 133.0 34.05 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.56 0.618 . . . . 0.0 110.492 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.3 t -130.57 122.87 53.86 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 O-C-N 120.966 -1.084 . . . . 0.0 108.76 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 59' ' ' PHE . . . -125.32 -175.78 14.33 Favored Glycine 0 N--CA 1.464 0.548 0 C-N-CA 126.264 1.888 . . . . 0.0 112.057 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.1 t30 64.45 31.95 12.21 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.854 2.062 . . . . 0.0 111.907 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.465 ' HB3' HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -66.74 166.4 13.18 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.391 1.876 . . . . 0.0 111.531 -178.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 26' ' ' THR . 1.0 OUTLIER -82.74 165.82 19.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 123.126 1.441 . . . . 0.0 113.65 166.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.486 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 67.4 p -65.91 -34.2 77.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.505 1.522 . . . . 0.0 111.88 175.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.09 19.52 20.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.736 2.014 . . . . 0.0 115.395 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.465 HG11 ' HB3' ' A' ' 24' ' ' LEU . 3.8 p -64.88 155.85 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 125.012 1.325 . . . . 0.0 111.264 174.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.7 p -159.75 162.06 34.83 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.667 1.987 . . . . 0.0 110.319 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -60.09 -30.49 69.28 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.204 0.602 . . . . 0.0 110.316 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -59.94 -41.87 92.78 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.153 1.781 . . . . 0.0 112.321 174.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.585 HD21 HD13 ' A' ' 82' ' ' LEU . 1.6 tm? -72.04 -51.99 19.05 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.7 mt -56.41 -39.87 73.75 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -66.44 -46.36 76.72 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.01 0.823 . . . . 0.0 110.757 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -57.04 -39.71 75.36 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.807 1.643 . . . . 0.0 111.721 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -81.61 -42.85 19.45 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.933 1.693 . . . . 0.0 112.884 -175.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . 0.329 48.0 m-85 -76.54 -4.93 45.37 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 172.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -54.7 -42.62 71.69 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 121.902 2.137 . . . . 0.0 111.503 164.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -72.66 -15.86 61.71 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.16 -1.23 57.89 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.495 1.043 . . . . 0.0 113.773 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.64 -148.51 18.41 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.071 0.843 . . . . 0.0 111.221 -174.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -75.62 157.5 40.17 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.798 2.332 . . . . 0.0 112.78 171.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.1 147.32 21.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 127.116 2.167 . . . . 0.0 107.502 170.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.7 mm -88.49 -51.6 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 121.006 -1.059 . . . . 0.0 109.608 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.74 168.84 25.9 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.549 2.339 . . . . 0.0 112.561 175.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.8 t -122.9 144.63 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 129.874 3.269 . . . . 0.0 110.609 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -127.41 122.58 33.96 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 130.307 3.443 . . . . 0.0 115.275 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.0 mm -107.09 125.89 31.44 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.145 1.778 . . . . 0.0 110.067 167.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.14 167.62 23.06 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.776 3.65 . . . . 0.0 111.289 163.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -160.58 118.56 2.51 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 128.111 2.564 . . . . 0.0 110.35 171.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -52.37 163.43 0.41 Allowed 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 126.852 2.061 . . . . 0.0 113.698 169.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -30.6 43.46 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.031 1.332 . . . . 0.0 113.093 172.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -87.04 -9.67 54.91 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 171.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.25 51.71 1.21 Allowed Glycine 0 C--N 1.338 0.653 0 C-N-CA 125.937 1.732 . . . . 0.0 113.453 165.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -141.13 134.93 14.82 Favored Pre-proline 0 N--CA 1.467 0.392 0 CA-C-O 117.547 -1.216 . . . . 0.0 112.988 -176.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.53 12.51 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.531 1 C-N-CA 126.673 4.916 . . . . 0.0 115.422 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.11 20.81 10.05 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.703 -1.248 . . . . 0.0 111.722 173.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.441 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 44.0 mt-30 59.08 38.47 23.91 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.701 2.0 . . . . 0.0 113.515 -173.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.412 ' HA ' ' HA2' ' A' ' 22' ' ' GLY . 0.2 OUTLIER -156.32 165.01 37.6 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.837 2.055 . . . . 0.0 111.529 -179.114 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.03 -179.21 6.07 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 128.671 2.788 . . . . 0.0 111.149 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -142.42 154.17 44.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.464 1.506 . . . . 0.0 114.411 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.8 t -143.32 120.92 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.958 1.303 . . . . 0.0 111.73 -176.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -73.21 129.9 39.06 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.848 -1.157 . . . . 0.0 111.58 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -148.64 140.92 24.11 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.706 1.202 . . . . 0.0 113.784 -164.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.0 3.67 44.98 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 128.19 2.596 . . . . 0.0 116.33 -167.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -80.11 139.93 36.65 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.921 0.782 . . . . 0.0 112.337 175.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -105.8 2.45 27.82 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.412 1.485 . . . . 0.0 112.322 -173.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.02 165.34 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.457 1.903 . . . . 0.0 111.114 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.6 m -83.06 31.37 0.44 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.49 1.916 . . . . 0.0 115.391 -160.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.256 18.0 m -118.65 55.18 2.39 Favored Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -174.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -65.99 119.03 6.0 Favored 'Trans proline' 0 C--N 1.355 0.878 1 C-N-CA 125.412 4.075 . . . . 0.0 112.128 -166.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -50.5 -36.56 34.44 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -164.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.446 ' HB1' HD23 ' A' ' 77' ' ' LEU . . . -72.96 -22.92 60.63 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.439 1.496 . . . . 0.0 114.528 -176.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.7 ttt -64.45 -21.01 66.53 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.652 1.181 . . . . 0.0 110.192 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -101.36 -34.63 9.53 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.253 1.821 . . . . 0.0 112.987 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.61 -39.92 23.75 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -172.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.446 HD23 ' HB1' ' A' ' 73' ' ' ALA . 1.6 mm? -113.3 -84.25 0.59 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.293 1.037 . . . . 0.0 109.852 -176.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.263 0.4 OUTLIER 23.7 59.85 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 129.306 3.043 . . . . 0.0 114.277 176.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 143.14 18.51 0.24 Allowed Glycine 0 CA--C 1.549 2.201 0 N-CA-C 118.162 2.025 . . . . 0.0 118.162 -169.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -138.41 149.71 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 121.124 2.462 . . . . 0.0 110.784 -165.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.33 156.76 24.36 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.585 HD13 HD21 ' A' ' 32' ' ' LEU . 1.3 mp -110.12 3.15 19.94 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.097 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -129.27 -85.56 0.55 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 129.033 2.933 . . . . 0.0 108.141 -173.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.43 -43.39 0.02 OUTLIER Glycine 0 N--CA 1.481 1.679 0 N-CA-C 115.91 1.124 . . . . 0.0 115.91 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' A' ' 86' ' ' PRO . 3.6 mpt_? -95.59 118.94 65.9 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 118.154 -0.927 . . . . 0.0 109.792 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 36.9 Cg_endo -74.9 125.95 9.72 Favored 'Trans proline' 0 C--N 1.351 0.705 1 C-N-CA 125.801 4.334 . . . . 0.0 114.373 -172.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.2 mm -55.31 124.99 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 122.808 0.443 . . . . 0.0 110.292 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -109.38 118.14 35.87 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 126.764 2.026 . . . . 0.0 110.055 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.5 mp -93.0 141.18 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.423 -0.798 . . . . 0.0 110.074 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -135.18 167.25 21.33 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.445 1.498 . . . . 0.0 110.338 171.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -129.01 156.94 43.02 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.671 1.988 . . . . 0.0 113.572 175.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -123.68 20.66 9.37 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.622 2.369 . . . . 0.0 114.024 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.52 130.85 40.95 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.348 -1.47 . . . . 0.0 108.951 176.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.02 -137.4 26.61 Favored Glycine 0 CA--C 1.538 1.483 0 O-C-N 121.116 -0.99 . . . . 0.0 113.604 -170.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 57.4 m -130.09 133.04 46.41 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.639 1.576 . . . . 0.0 110.859 -168.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.3 m -69.59 -31.0 68.89 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.39 0.995 . . . . 0.0 113.622 170.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -123.62 156.28 36.11 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.177 2.191 . . . . 0.0 110.585 -173.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.34 153.83 41.75 Favored Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 120.566 -1.334 . . . . 0.0 111.093 -173.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -63.82 158.46 46.69 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 122.08 1.853 . . . . 0.0 111.505 168.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -93.88 -29.41 15.32 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 127.532 2.333 . . . . 0.0 112.737 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.7 t0 . . . . . 0 C--O 1.258 1.539 0 C-N-CA 130.364 3.466 . . . . 0.0 106.744 167.323 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.678 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -131.08 -9.62 3.81 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.79 1.636 . . . . 0.0 113.533 169.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.1 mp0 -85.93 120.45 27.35 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.095 1.358 . . . . 0.0 112.134 -161.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -110.37 -30.55 7.63 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.294 1.038 . . . . 0.0 113.333 -169.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -104.9 -6.54 20.08 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.243 1.817 . . . . 0.0 114.709 -162.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.0 mt -69.92 157.48 37.37 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.932 -0.48 . . . . 0.0 110.761 173.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.06 149.23 39.25 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 127.387 2.275 . . . . 0.0 110.951 -171.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -155.75 161.56 40.67 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.389 2.275 . . . . 0.0 111.571 170.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -59.44 164.22 3.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.443 0.697 . . . . 0.0 112.723 173.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -53.76 -36.85 62.8 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.296 1.438 . . . . 0.0 112.02 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.69 166.66 15.81 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 125.746 1.618 . . . . 0.0 109.625 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.92 160.15 18.28 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 121.948 0.88 . . . . 0.0 111.76 173.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -152.2 167.15 29.51 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.388 1.475 . . . . 0.0 113.001 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -139.71 -171.83 3.24 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.251 1.021 . . . . 0.0 110.61 -158.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.48 149.22 28.83 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -152.92 122.57 6.83 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.346 2.658 . . . . 0.0 111.185 166.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -85.95 -12.28 50.89 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.776 1.23 . . . . 0.0 113.971 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.7 m -127.58 128.38 45.47 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 122.41 1.1 . . . . 0.0 110.563 -163.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.7 tp -99.93 138.08 37.5 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.949 2.1 . . . . 0.0 111.803 -170.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -88.17 137.94 31.89 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 122.06 0.933 . . . . 0.0 111.746 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -133.74 131.07 56.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.356 -0.84 . . . . 0.0 109.166 178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.64 -176.73 14.54 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 126.225 1.869 . . . . 0.0 110.262 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.9 t30 69.09 13.2 8.7 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.807 1.643 . . . . 0.0 114.646 -178.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.797 HD12 HG21 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -61.99 144.26 55.35 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 126.253 1.821 . . . . 0.0 112.878 179.35 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 83' ' ' TYR . 13.3 mp0 -50.77 162.22 0.28 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 173.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.5 p -72.51 -22.37 61.05 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.948 175.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.96 21.28 9.88 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 129.895 3.278 . . . . 0.0 113.014 -177.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.797 HG21 HD12 ' A' ' 24' ' ' LEU . 4.9 p -64.15 162.04 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 120.855 -1.153 . . . . 0.0 112.066 173.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.3 p -159.64 168.91 24.91 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.31 1.844 . . . . 0.0 112.86 174.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HA ' HG11 ' A' ' 46' ' ' VAL . 45.2 mt-10 -62.66 -27.17 69.04 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.174 1.39 . . . . 0.0 112.31 177.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -62.8 -49.94 72.98 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.76 1.164 . . . . 0.0 111.921 170.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.8 tp -64.66 -47.57 77.98 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.408 HD22 ' HE2' ' A' ' 37' ' ' PHE . 31.1 mt -62.57 -37.49 86.37 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -63.14 -47.09 84.19 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.06 0.845 . . . . 0.0 112.11 173.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -72.05 -19.57 61.82 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.451 1.5 . . . . 0.0 113.324 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.5 tt -92.61 -49.25 6.2 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.146 1.779 . . . . 0.0 112.162 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.408 ' HE2' HD22 ' A' ' 33' ' ' LEU . 61.6 m-85 -72.77 -18.07 61.53 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.209 -0.932 . . . . 0.0 112.442 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -60.86 -26.5 67.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.775 1.625 . . . . 0.0 113.356 171.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -64.25 -31.39 72.57 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.247 -1.533 . . . . 0.0 112.78 168.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.86 1.45 34.94 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.39 1.076 . . . . 0.0 112.465 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.52 -146.53 16.91 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.295 1.426 . . . . 0.0 113.631 169.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -74.13 90.8 0.96 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 CA-C-N 119.567 1.684 . . . . 0.0 114.637 -167.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.7 t -74.91 133.42 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 125.535 1.534 . . . . 0.0 109.791 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.8 mt -85.24 -55.69 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 127.272 2.229 . . . . 0.0 111.047 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.06 152.65 28.3 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 128.019 2.528 . . . . 0.0 107.54 -175.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' A' ' 30' ' ' GLU . 38.3 t -106.48 151.13 8.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 127.946 2.498 . . . . 0.0 105.423 172.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -127.75 124.33 37.49 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 124.113 0.965 . . . . 0.0 113.358 166.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.428 ' HA ' ' HD2' ' A' ' 49' ' ' PRO . 6.9 mm -101.57 120.31 54.85 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.053 163.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 48' ' ' ILE . 43.0 Cg_endo -68.95 167.95 21.89 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 124.689 3.592 . . . . 0.0 110.222 165.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -157.45 115.87 3.19 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.134 1.374 . . . . 0.0 107.829 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -50.54 164.32 0.14 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.237 2.215 . . . . 0.0 111.264 161.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.5 pptp? -53.24 -29.53 33.08 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 120.808 -1.183 . . . . 0.0 113.567 167.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.29 -4.37 55.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.077 0.951 . . . . 0.0 112.604 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.55 35.62 8.46 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 125.962 1.744 . . . . 0.0 111.532 170.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -124.11 136.66 27.83 Favored Pre-proline 0 C--N 1.345 0.388 0 CA-C-N 118.958 1.379 . . . . 0.0 113.641 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.25 12.11 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 124.01 3.14 . . . . 0.0 118.316 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.62 27.78 11.0 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 121.286 1.857 . . . . 0.0 113.383 176.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 54.36 35.26 22.55 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.199 1.8 . . . . 0.0 113.413 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.549 ' HA ' HD23 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -147.93 162.66 38.85 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.783 -1.198 . . . . 0.0 110.494 -177.125 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -154.68 -179.23 7.81 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.213 1.405 . . . . 0.0 110.763 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -134.96 163.83 28.96 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.058 1.743 . . . . 0.0 109.808 165.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.4 t -145.96 134.7 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 127.145 2.178 . . . . 0.0 108.449 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -104.2 144.31 31.76 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.938 1.695 . . . . 0.0 111.059 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -133.07 157.35 45.48 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 121.949 2.158 . . . . 0.0 114.033 -167.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.1 mmtp -68.88 -22.03 64.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.156 -1.59 . . . . 0.0 113.538 166.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -69.93 146.52 51.12 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.768 0.827 . . . . 0.0 110.418 172.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -123.97 -23.64 4.58 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 m -68.3 27.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 128.775 2.83 . . . . 0.0 115.953 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 99.8 p 50.13 46.79 24.36 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.938 2.095 . . . . 0.0 111.032 177.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 p -97.44 103.17 14.97 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 126.139 1.775 . . . . 0.0 111.381 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -80.75 70.71 7.41 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.93 2.42 . . . . 0.0 113.111 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -51.06 -36.09 38.11 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.98 0.912 . . . . 0.0 111.748 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.96 -27.21 64.55 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 ttt -59.55 -28.22 66.92 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 119.754 1.161 . . . . 0.0 111.069 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -86.98 -19.32 28.89 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.753 2.021 . . . . 0.0 110.787 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.62 -45.05 4.12 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.348 1.459 . . . . 0.0 112.533 -161.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.54 -92.85 0.43 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.955 1.702 . . . . 0.0 109.322 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.261 0.9 OUTLIER 37.75 52.23 1.4 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.742 2.017 . . . . 0.0 115.191 165.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.38 17.79 0.21 Allowed Glycine 0 CA--C 1.534 1.246 0 CA-C-N 114.795 -1.093 . . . . 0.0 115.749 -167.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -141.82 150.59 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 118.285 1.043 . . . . 0.0 113.734 -170.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.09 167.32 26.54 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -173.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.0 tp -98.0 -34.93 10.61 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 113.349 -1.75 . . . . 0.0 111.593 169.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.409 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 43.9 m-85 -104.26 -50.22 3.4 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -167.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 172.39 -30.9 0.11 Allowed Glycine 0 CA--C 1.543 1.785 0 CA-C-O 117.991 -1.45 . . . . 0.0 115.192 -175.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -99.69 97.47 5.8 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 127.148 2.179 . . . . 0.0 115.242 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.05 114.99 2.86 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.943 3.095 . . . . 0.0 113.249 -173.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.6 mm -47.83 124.7 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 C-N-CA 125.926 1.69 . . . . 0.0 111.906 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -108.63 113.0 25.62 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 124.479 1.112 . . . . 0.0 111.584 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mp -88.64 137.93 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -130.49 172.6 11.71 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 172.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -151.81 146.5 25.75 Favored 'General case' 0 C--N 1.317 -0.824 0 O-C-N 120.013 -1.679 . . . . 0.0 113.132 -160.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -113.61 148.14 36.79 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.016 1.326 . . . . 0.0 108.382 165.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.8 p -102.24 3.92 38.74 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 125.25 1.42 . . . . 0.0 112.882 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.61 172.8 18.82 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.39 1.472 . . . . 0.0 113.308 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.6 m -102.92 114.19 28.27 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.493 1.117 . . . . 0.0 112.305 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 68.5 m -53.99 142.06 26.05 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 161.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.43 148.87 35.15 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.766 1.226 . . . . 0.0 110.372 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.87 160.06 27.46 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.022 0.929 . . . . 0.0 113.361 -171.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.68 166.06 29.09 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 122.829 2.353 . . . . 0.0 112.195 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -114.77 -19.73 10.92 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 128.668 2.787 . . . . 0.0 113.696 172.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 N--CA 1.493 1.7 0 C-N-CA 126.676 1.991 . . . . 0.0 111.667 -179.085 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.164 0 N-CA-C 114.959 0.743 . . . . 0.0 114.959 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 m -64.76 -21.6 66.8 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 117.271 2.323 . . . . 0.0 117.271 -162.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -113.3 133.76 54.95 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.343 0.974 . . . . 0.0 111.62 -170.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -159.79 -15.06 0.06 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 127.754 2.422 . . . . 0.0 112.806 168.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -92.64 0.92 57.49 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 119.65 -1.906 . . . . 0.0 113.246 176.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -96.36 167.31 11.25 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.361 1.464 . . . . 0.0 111.041 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.601 ' H ' ' HD3' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -47.12 135.9 9.36 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 129.195 2.998 . . . . 0.0 111.592 169.366 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -129.93 18.07 5.61 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 118.628 2.825 . . . . 0.0 118.628 -165.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -73.38 164.22 26.98 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 119.875 -1.766 . . . . 0.0 110.367 169.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . 0.309 8.3 pt20 -73.91 -77.11 0.12 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -174.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -164.17 173.5 12.33 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.257 1.023 . . . . 0.0 113.114 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.9 mt -109.87 153.66 24.14 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 130.029 3.331 . . . . 0.0 113.648 -175.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.88 -50.53 0.16 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 170.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 57.13 -14.34 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 119.149 3.018 . . . . 0.0 119.149 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -157.36 169.65 24.24 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 129.075 2.95 . . . . 0.0 111.013 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -128.77 -25.96 2.76 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 173.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -88.63 -13.03 40.86 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 127.402 2.281 . . . . 0.0 110.891 168.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.7 m -126.74 132.23 51.15 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.07 1.348 . . . . 0.0 108.832 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.3 tp -100.33 133.23 45.06 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 125.083 1.353 . . . . 0.0 112.163 -167.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -82.26 130.45 35.1 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.143 1.377 . . . . 0.0 114.042 177.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 t -145.39 128.45 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 124.941 1.296 . . . . 0.0 107.581 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.5 -176.51 14.45 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 126.308 1.908 . . . . 0.0 110.581 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.5 t30 71.67 16.78 5.68 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.846 2.059 . . . . 0.0 114.085 -172.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.419 ' HB2' ' C ' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -61.85 139.57 58.35 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 127.295 2.238 . . . . 0.0 110.392 -172.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.492 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 4.6 mt-10 -60.41 162.13 6.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 124.414 2.054 . . . . 0.0 116.109 175.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.1 p -68.94 -28.14 66.38 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.888 1.675 . . . . 0.0 111.615 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.1 tppt? -107.11 9.18 30.45 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 131.056 3.743 . . . . 0.0 115.649 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 p -59.7 161.73 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.127 1.371 . . . . 0.0 112.885 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 p -158.56 165.03 35.48 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.754 1.622 . . . . 0.0 112.321 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -59.47 -27.52 66.18 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.581 -0.7 . . . . 0.0 110.156 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -67.53 -44.17 78.99 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.834 1.254 . . . . 0.0 111.831 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.3 tp -72.44 -39.75 67.57 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.531 0.732 . . . . 0.0 111.095 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.565 ' HB2' HG11 ' A' ' 46' ' ' VAL . 71.6 mt -63.52 -40.85 98.13 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.486 1.039 . . . . 0.0 110.653 174.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -59.16 -46.41 88.47 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.27 -33.13 67.24 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.504 1.047 . . . . 0.0 112.53 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.2 tt -69.03 -41.51 77.6 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.317 0.647 . . . . 0.0 112.206 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -89.57 8.57 30.56 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.806 1.242 . . . . 0.0 113.941 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -56.91 -48.79 77.4 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 120.263 -1.523 . . . . 0.0 113.131 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -74.19 -9.46 58.64 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.88 36.52 1.4 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -166.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.58 -165.83 40.97 Favored Glycine 0 CA--C 1.542 1.744 0 C-N-CA 123.764 0.697 . . . . 0.0 114.322 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -81.43 85.51 1.74 Allowed 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 121.446 1.431 . . . . 0.0 114.891 -168.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.82 129.92 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 126.648 1.979 . . . . 0.0 108.882 166.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mt -91.04 -54.49 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.17 1.788 . . . . 0.0 111.4 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.57 158.49 43.6 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.058 1.743 . . . . 0.0 111.624 -178.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.565 HG11 ' HB2' ' A' ' 33' ' ' LEU . 91.7 t -116.22 143.26 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.667 1.587 . . . . 0.0 111.529 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -121.59 132.25 54.57 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.38 1.872 . . . . 0.0 114.932 172.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.9 mm -118.47 119.14 33.21 Favored Pre-proline 0 N--CA 1.471 0.584 0 C-N-CA 128.039 2.536 . . . . 0.0 109.745 172.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.23 172.84 15.22 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.151 2.567 . . . . 0.0 113.691 169.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -153.17 108.92 3.29 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.513 2.325 . . . . 0.0 111.461 172.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -43.45 164.52 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 130.741 3.617 . . . . 0.0 115.643 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.25 -29.0 3.4 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 114.744 1.386 . . . . 0.0 114.744 165.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -93.73 -11.07 32.27 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 168.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.55 47.2 1.69 Allowed Glycine 0 N--CA 1.477 1.395 0 O-C-N 119.767 -1.833 . . . . 0.0 115.206 174.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -138.14 141.42 32.03 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 125.926 1.69 . . . . 0.0 113.31 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.81 14.27 0.2 Allowed 'Trans proline' 0 CA--C 1.545 1.028 1 C-N-CA 125.96 4.44 . . . . 0.0 115.145 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.68 21.78 6.18 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 174.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.476 HE22 ' HG2' ' A' ' 85' ' ' ARG . 9.5 mt-30 59.01 35.78 24.14 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 125.105 1.362 . . . . 0.0 113.93 -169.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -155.74 161.59 40.67 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.552 1.541 . . . . 0.0 113.849 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.55 167.06 15.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.982 1.313 . . . . 0.0 113.197 -174.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -120.76 156.12 32.53 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.858 0.863 . . . . 0.0 112.734 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.3 t -144.45 112.51 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 C-N-CA 123.509 0.724 . . . . 0.0 110.176 -178.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -76.4 125.04 28.48 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -132.8 146.53 51.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 122.774 1.273 . . . . 0.0 110.683 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -75.87 105.85 7.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.793 -171.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 56.84 18.07 3.62 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 166.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -80.83 69.81 7.47 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 171.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.42 6.54 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 119.923 -1.736 . . . . 0.0 114.981 -169.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.5 t -170.68 164.04 8.11 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.585 1.554 . . . . 0.0 112.335 -160.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t 31.68 59.68 1.21 Allowed Pre-proline 0 N--CA 1.485 1.283 0 C-N-CA 127.592 2.357 . . . . 0.0 111.735 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.41 120.88 8.77 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.449 3.433 . . . . 0.0 112.499 -171.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.497 ' CD2' HD12 ' A' ' 76' ' ' LEU . 32.7 t80 -56.06 -35.65 67.18 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.098 1.359 . . . . 0.0 112.208 -166.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.11 -21.16 64.78 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -178.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.35 -23.19 64.07 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.767 1.627 . . . . 0.0 114.167 175.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -112.61 -30.04 7.24 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.652 1.581 . . . . 0.0 111.459 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.497 HD12 ' CD2' ' A' ' 72' ' ' TYR . 0.8 OUTLIER -73.49 -45.65 52.67 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.972 0.909 . . . . 0.0 112.532 -178.369 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.472 HD22 ' HB3' ' A' ' 76' ' ' LEU . 1.3 mm? -111.14 -84.28 0.57 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.76 2.024 . . . . 0.0 107.802 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 17.27 70.01 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 128.668 2.787 . . . . 0.0 115.264 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.6 19.88 0.24 Allowed Glycine 0 N--CA 1.469 0.835 0 N-CA-C 116.706 1.442 . . . . 0.0 116.706 -175.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.99 147.5 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.233 1.013 . . . . 0.0 112.872 -163.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.48 166.77 16.15 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 123.06 1.41 . . . . 0.0 113.345 -164.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.8 mt -132.34 -19.16 2.48 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.006 -1.906 . . . . 0.0 114.67 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.409 ' HB2' ' CD ' ' A' ' 25' ' ' GLU . 55.0 m-85 -106.88 -50.82 3.03 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.357 1.863 . . . . 0.0 108.485 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 176.99 -39.44 0.1 OUTLIER Glycine 0 CA--C 1.544 1.862 0 N-CA-C 116.944 1.538 . . . . 0.0 116.944 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.492 ' HB2' ' HG3' ' A' ' 25' ' ' GLU . 1.7 mpt_? -97.47 109.23 49.35 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 126.519 1.928 . . . . 0.0 111.847 -170.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.48 121.13 8.61 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.676 2.917 . . . . 0.0 115.198 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.2 mm -51.85 132.43 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.536 1.534 . . . . 0.0 110.244 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -123.8 109.57 13.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.802 1.641 . . . . 0.0 111.739 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -92.74 136.18 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 O-C-N 121.655 -0.653 . . . . 0.0 110.049 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -121.44 142.6 49.87 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 117.769 2.507 . . . . 0.0 117.769 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -124.84 136.37 53.75 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 111.757 -2.474 . . . . 0.0 109.148 167.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.74 -28.68 11.05 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.925 1.69 . . . . 0.0 111.3 165.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.8 m 51.39 38.15 21.0 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.674 2.39 . . . . 0.0 113.695 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.18 73.25 0.23 Allowed Glycine 0 CA--C 1.526 0.753 0 O-C-N 121.515 -0.741 . . . . 0.0 114.341 -169.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -145.04 -22.27 0.49 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.355 1.462 . . . . 0.0 114.566 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 55.3 p -100.61 -179.9 4.23 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.338 1.855 . . . . 0.0 113.453 174.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -132.38 -24.11 2.07 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -165.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -139.7 155.06 71.59 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.805 0.842 . . . . 0.0 111.222 -169.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.64 140.07 35.23 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.757 2.305 . . . . 0.0 111.022 170.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -88.89 -17.04 30.43 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.504 2.722 . . . . 0.0 116.237 -159.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.1 t0 . . . . . 0 C--O 1.259 1.593 0 CA-C-N 120.424 1.465 . . . . 0.0 112.857 -171.168 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.214 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -142.47 120.31 11.96 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.877 0.838 . . . . 0.0 112.045 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -59.64 145.36 44.95 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.118 0.967 . . . . 0.0 111.086 177.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -71.44 -44.72 64.32 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -164.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -133.38 55.47 1.9 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.83 2.052 . . . . 0.0 111.66 -173.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.5 mt -81.65 147.28 29.62 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.327 -0.858 . . . . 0.0 109.086 168.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.32 141.19 58.86 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.934 0.894 . . . . 0.0 108.996 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -158.15 -28.47 0.08 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -152.79 -36.51 0.11 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -171.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -63.7 -2.4 1.72 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.849 1.659 . . . . 0.0 115.213 -176.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.96 151.63 28.73 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.116 1.366 . . . . 0.0 110.737 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 pp -75.52 133.96 40.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.291 1.044 . . . . 0.0 112.002 -169.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -157.96 155.03 28.74 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.834 1.654 . . . . 0.0 110.47 165.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -129.37 169.86 14.37 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.612 1.165 . . . . 0.0 111.955 161.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.46 166.24 19.19 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 171.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -128.32 60.69 1.48 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 123.273 1.511 . . . . 0.0 111.189 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.6 mtp85 52.62 11.98 0.22 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 128.53 2.732 . . . . 0.0 113.972 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 m -136.04 152.07 50.52 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 129.513 3.125 . . . . 0.0 110.797 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.4 tp -89.94 121.24 31.86 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 130.06 3.344 . . . . 0.0 112.28 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -75.83 138.33 41.07 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.451 1.023 . . . . 0.0 112.397 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.3 t -139.31 117.99 12.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 O-C-N 121.222 -0.924 . . . . 0.0 109.915 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.55 -173.65 15.92 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 122.303 0.946 . . . . 0.0 112.457 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.9 t30 65.83 35.66 6.57 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.679 1.191 . . . . 0.0 111.138 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.641 HD12 HG21 ' A' ' 28' ' ' VAL . 1.7 mm? -70.53 163.93 25.86 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.961 2.105 . . . . 0.0 111.35 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.41 161.9 17.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 123.624 1.678 . . . . 0.0 114.998 174.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.8 p -75.14 -24.16 57.93 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.999 1.32 . . . . 0.0 110.162 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -103.01 16.76 25.78 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.766 1.626 . . . . 0.0 113.357 171.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.641 HG21 HD12 ' A' ' 24' ' ' LEU . 5.8 p -66.23 153.02 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.427 ' N ' HG22 ' A' ' 28' ' ' VAL . 23.5 p -156.43 162.62 39.99 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.949 2.1 . . . . 0.0 112.342 177.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -64.7 -23.03 67.12 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.223 1.009 . . . . 0.0 112.016 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -66.85 -46.03 76.36 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 118.059 -0.972 . . . . 0.0 112.149 170.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.6 tp -64.74 -43.25 93.99 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.915 0.864 . . . . 0.0 109.562 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.505 ' HB2' HG11 ' A' ' 46' ' ' VAL . 69.1 mt -65.19 -33.81 76.89 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.04 -1.038 . . . . 0.0 113.161 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -70.1 -45.79 66.21 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.153 -0.967 . . . . 0.0 112.168 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.69 -23.33 66.12 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 121.512 -0.742 . . . . 0.0 112.684 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.443 ' CD1' HD11 ' A' ' 80' ' ' ILE . 3.8 tt -81.39 -44.59 17.34 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 118.567 -0.73 . . . . 0.0 111.184 176.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.473 ' HB3' HG11 ' A' ' 43' ' ' VAL . 45.1 m-85 -84.94 -20.97 29.83 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.168 1.349 . . . . 0.0 112.505 -170.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -52.42 -34.98 50.86 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 167.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -58.51 -32.71 69.08 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.503 2.321 . . . . 0.0 114.683 167.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.62 -12.86 55.48 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-O 121.357 0.599 . . . . 0.0 110.696 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.2 -163.56 26.33 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 126.909 2.195 . . . . 0.0 111.934 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -82.02 88.28 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 CA-C-N 120.559 2.18 . . . . 0.0 112.737 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.488 HG12 ' CZ ' ' A' ' 64' ' ' PHE . 2.3 m -65.56 141.76 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 121.169 -0.957 . . . . 0.0 113.156 176.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.9 mm -71.05 -48.92 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 174.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HG2' ' HB3' ' A' ' 63' ' ' ASN . 11.2 ptpt -171.44 161.35 6.33 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.161 1.784 . . . . 0.0 111.891 -171.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' A' ' 33' ' ' LEU . 82.9 t -125.59 153.47 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 126.37 1.868 . . . . 0.0 110.871 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -128.15 141.27 51.53 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 128.11 2.564 . . . . 0.0 110.509 169.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mm -121.01 125.31 27.06 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 126.906 2.082 . . . . 0.0 108.727 163.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.86 172.14 15.15 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.779 2.986 . . . . 0.0 112.878 170.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -153.72 126.48 8.23 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 127.457 2.303 . . . . 0.0 110.774 164.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -55.57 163.3 1.34 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 112.128 -2.305 . . . . 0.0 111.487 162.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.96 -25.15 1.25 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 167.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -100.25 1.64 41.99 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.41 1.084 . . . . 0.0 113.304 176.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.78 39.88 4.82 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 120.92 -1.113 . . . . 0.0 115.449 170.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.448 ' CD ' ' HD2' ' A' ' 56' ' ' PRO . 3.0 tppt? -134.42 140.84 36.95 Favored Pre-proline 0 N--CA 1.476 0.836 0 CA-C-N 119.819 1.809 . . . . 0.0 114.68 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.448 ' HD2' ' CD ' ' A' ' 55' ' ' LYS . 53.6 Cg_endo -68.17 12.44 0.23 Allowed 'Trans proline' 0 CA--C 1.551 1.353 0 C-N-CA 124.124 3.216 . . . . 0.0 117.834 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.75 27.46 7.01 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 119.538 -1.976 . . . . 0.0 115.145 176.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.445 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 33.8 mt-30 55.05 37.35 28.76 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -150.91 160.58 43.81 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.189 1.396 . . . . 0.0 112.151 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.03 178.86 9.88 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.838 2.055 . . . . 0.0 109.057 175.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -137.72 153.16 49.8 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.7 t -141.26 138.6 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 126.198 1.799 . . . . 0.0 110.284 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.431 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 9.1 t-20 -99.19 140.75 32.88 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.248 1.019 . . . . 0.0 110.938 172.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.488 ' CZ ' HG12 ' A' ' 43' ' ' VAL . 43.8 m-85 -139.69 150.15 44.54 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 128.468 2.707 . . . . 0.0 108.358 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -58.63 119.56 7.3 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 173.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -55.39 154.27 6.39 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.356 1.062 . . . . 0.0 113.406 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 69' ' ' SER . 5.0 tp10 -162.21 165.71 26.49 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.648 -1.283 . . . . 0.0 112.76 -170.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.3 t -88.45 5.47 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 O-C-N 120.481 -1.387 . . . . 0.0 112.102 173.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.405 ' H ' ' HG3' ' A' ' 67' ' ' GLU . 16.2 p -95.11 168.15 10.93 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 118.869 -2.394 . . . . 0.0 111.914 174.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.2 m -79.25 153.71 76.9 Favored Pre-proline 0 N--CA 1.483 1.206 0 O-C-N 120.99 -1.069 . . . . 0.0 111.227 162.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.47 124.11 15.35 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.753 2.969 . . . . 0.0 112.758 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -52.91 -44.41 66.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.782 1.233 . . . . 0.0 110.813 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.14 -31.64 63.53 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 ttp -66.42 -14.47 62.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.924 1.238 . . . . 0.0 113.244 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -105.92 -35.79 7.19 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 155.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.11 -55.51 21.5 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.477 0.711 . . . . 0.0 111.483 -171.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -91.96 -92.32 0.15 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 27.23 70.7 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 127.459 2.304 . . . . 0.0 113.908 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.7 14.5 0.68 Allowed Glycine 0 CA--C 1.535 1.34 0 N-CA-C 115.461 0.945 . . . . 0.0 115.461 -174.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.443 HD11 ' CD1' ' A' ' 36' ' ' LEU . 1.1 pp -130.55 145.25 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 -165.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.38 172.65 10.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.73 2.012 . . . . 0.0 110.126 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 57.9 mt -118.71 -48.71 2.47 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.999 0.92 . . . . 0.0 110.208 159.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -51.37 -59.24 4.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.748 1.219 . . . . 0.0 112.346 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.53 -64.16 0.07 OUTLIER Glycine 0 N--CA 1.47 0.931 0 N-CA-C 116.458 1.343 . . . . 0.0 116.458 -162.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -106.07 119.44 52.16 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 118.097 0.948 . . . . 0.0 111.031 -168.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -77.62 132.61 12.24 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.709 2.273 . . . . 0.0 113.926 -166.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.429 HG13 HD13 ' A' ' 36' ' ' LEU . 13.3 mm -59.38 119.81 4.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 123.811 0.844 . . . . 0.0 111.394 -177.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -108.19 103.15 12.28 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.902 2.081 . . . . 0.0 110.345 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.5 mp -74.83 141.61 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -132.28 136.3 46.84 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.779 2.032 . . . . 0.0 108.141 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -140.72 144.28 35.49 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.0 1.32 . . . . 0.0 110.897 -174.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -127.85 129.88 47.66 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 125.017 1.327 . . . . 0.0 108.883 162.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.7 p -70.44 154.81 41.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 122.585 1.183 . . . . 0.0 112.473 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.88 139.21 25.86 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.421 1.01 . . . . 0.0 114.503 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.6 p -76.96 -31.06 56.31 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.245 1.818 . . . . 0.0 113.203 172.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.7 m 53.93 13.43 0.55 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 129.846 3.258 . . . . 0.0 117.513 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -66.56 -25.59 66.72 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 128.213 2.605 . . . . 0.0 115.123 -167.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.09 157.07 85.65 Favored Pre-proline 0 CA--C 1.561 1.372 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.38 138.69 30.08 Favored 'Trans proline' 0 CA--C 1.551 1.351 0 C-N-CA 124.963 3.775 . . . . 0.0 111.149 172.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -67.77 -40.92 83.99 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 120.306 -1.496 . . . . 0.0 113.598 -162.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.4 t70 . . . . . 0 C--O 1.26 1.647 0 C-N-CA 128.238 2.615 . . . . 0.0 110.181 178.481 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.895 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.7 m -109.41 154.57 22.4 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 128.086 2.554 . . . . 0.0 111.368 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -105.98 120.29 41.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 126.964 2.106 . . . . 0.0 113.802 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -130.02 -42.98 1.22 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.257 1.423 . . . . 0.0 113.476 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -77.57 17.91 0.49 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 -173.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 mp -109.72 147.93 32.31 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 120.729 -1.232 . . . . 0.0 111.117 -170.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.04 145.74 55.5 Favored 'General case' 0 CA--C 1.556 1.207 0 O-C-N 121.228 -0.92 . . . . 0.0 112.848 176.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 28.7 ptt-85 -146.66 169.69 18.49 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 129.783 3.233 . . . . 0.0 108.433 175.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -120.43 175.01 6.19 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.657 1.983 . . . . 0.0 108.056 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -80.68 -42.94 21.16 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 121.171 -0.956 . . . . 0.0 111.381 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.33 -154.08 0.33 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 128.52 2.728 . . . . 0.0 109.027 168.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.9 mt -85.34 157.82 20.44 Favored 'General case' 0 CA--C 1.552 1.043 0 O-C-N 120.04 -1.663 . . . . 0.0 111.052 -173.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.63 166.73 30.34 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.684 1.594 . . . . 0.0 111.67 -175.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -149.04 163.19 38.25 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.803 1.641 . . . . 0.0 112.447 170.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.67 149.74 35.02 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -171.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -139.15 107.61 5.84 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 129.905 3.282 . . . . 0.0 105.785 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 48.51 20.92 0.34 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 130.123 3.369 . . . . 0.0 116.945 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.28 138.01 39.61 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.675 -1.266 . . . . 0.0 111.575 -171.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.541 HD13 ' HG2' ' A' ' 71' ' ' PRO . 11.1 tp -116.44 124.04 49.0 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.903 2.481 . . . . 0.0 112.722 -161.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -74.65 132.89 42.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 122.198 0.999 . . . . 0.0 109.82 175.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.6 t -129.19 125.42 62.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 169.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.84 -169.23 13.78 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 122.456 1.031 . . . . 0.0 113.035 168.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.2 t30 65.92 29.67 10.2 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 128.545 2.738 . . . . 0.0 114.258 -173.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.646 HD12 HG21 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -69.14 156.67 38.3 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.764 1.225 . . . . 0.0 109.413 -175.521 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.519 ' HG2' ' H ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.4 165.12 24.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 123.914 1.816 . . . . 0.0 114.126 172.22 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.3 p -68.29 -14.78 63.24 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 128.49 2.716 . . . . 0.0 110.392 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -113.59 5.24 16.48 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 129.19 2.996 . . . . 0.0 114.435 -176.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.811 HG23 HD23 ' A' ' 32' ' ' LEU . 9.8 p -66.14 154.28 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 120.131 -1.606 . . . . 0.0 114.213 -170.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.5 p -148.46 171.4 16.13 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 127.218 2.207 . . . . 0.0 111.343 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -77.41 -15.89 59.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.49 1.516 . . . . 0.0 111.393 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -76.24 -45.99 30.3 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.63 1.572 . . . . 0.0 109.407 170.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.811 HD23 HG23 ' A' ' 28' ' ' VAL . 60.8 tp -63.95 -39.31 93.85 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.621 0.724 . . . . 0.0 110.778 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.421 HD21 ' CD1' ' A' ' 24' ' ' LEU . 92.6 mt -70.83 -48.44 54.04 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.569 0.747 . . . . 0.0 111.969 176.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -58.31 -43.03 87.98 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -65.25 -32.18 73.72 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.743 0.817 . . . . 0.0 110.986 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 tt -76.29 -43.27 42.32 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.817 2.047 . . . . 0.0 113.193 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.446 ' CE2' HG21 ' A' ' 62' ' ' VAL . 23.9 m-85 -87.48 -6.16 58.5 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.012 0.925 . . . . 0.0 112.018 -173.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -53.89 -43.01 69.29 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.314 0.646 . . . . 0.0 109.745 160.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -55.96 -25.95 46.02 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 173.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.38 -8.45 32.44 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.239 1.019 . . . . 0.0 112.681 -171.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.74 -153.55 17.55 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.643 1.116 . . . . 0.0 113.593 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.05 107.52 2.48 Favored 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 123.497 2.798 . . . . 0.0 111.936 -165.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.0 t -94.96 126.37 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 128.266 2.627 . . . . 0.0 109.666 169.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mt -78.37 -48.71 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.947 1.299 . . . . 0.0 109.672 173.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.57 163.78 19.34 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.317 1.047 . . . . 0.0 113.266 -175.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 82.9 t -122.94 145.27 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.74 1.616 . . . . 0.0 112.197 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -126.11 121.29 32.45 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.133 2.173 . . . . 0.0 112.603 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.0 mm -110.38 120.76 43.31 Favored Pre-proline 0 N--CA 1.467 0.405 0 C-N-CA 126.487 1.915 . . . . 0.0 107.241 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -74.11 172.25 16.35 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.018 2.479 . . . . 0.0 111.545 168.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -156.87 115.08 3.25 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.611 1.964 . . . . 0.0 108.413 169.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -56.38 168.61 0.52 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 129.115 2.966 . . . . 0.0 111.696 164.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.4 pptp? -47.0 -32.58 4.01 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.469 1.508 . . . . 0.0 114.272 170.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.8 -18.04 61.51 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.802 1.641 . . . . 0.0 114.327 173.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.32 56.98 2.72 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -175.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -143.15 133.18 12.03 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.286 1.034 . . . . 0.0 113.328 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.99 19.67 0.13 Allowed 'Trans proline' 0 CA--C 1.55 1.325 0 C-N-CA 124.978 3.785 . . . . 0.0 116.538 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER 52.02 22.02 1.71 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 174.233 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 57.72 36.53 26.66 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 116.817 2.154 . . . . 0.0 116.817 -166.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 57' ' ' LYS . 13.5 p90 -153.93 167.54 29.38 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.926 1.29 . . . . 0.0 113.453 175.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -163.95 170.06 17.19 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.979 2.112 . . . . 0.0 110.295 176.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -127.38 146.49 50.45 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.862 1.265 . . . . 0.0 110.932 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.446 HG21 ' CE2' ' A' ' 37' ' ' PHE . 20.8 t -125.91 132.67 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 126.581 1.953 . . . . 0.0 110.247 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -93.4 132.74 37.36 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.596 1.158 . . . . 0.0 108.75 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -124.44 162.52 23.73 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 126.6 1.96 . . . . 0.0 113.172 -166.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -101.7 -49.61 3.94 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.684 1.594 . . . . 0.0 113.846 -171.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -144.37 -6.93 0.71 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 -171.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -79.12 40.21 0.4 Allowed 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 121.282 1.856 . . . . 0.0 111.822 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.6 t -53.58 141.22 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 C-N-CA 127.09 2.156 . . . . 0.0 109.225 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.2 m 68.77 -28.45 0.16 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 129.245 3.018 . . . . 0.0 118.472 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 p -149.39 93.2 4.12 Favored Pre-proline 0 N--CA 1.471 0.593 0 CA-C-N 119.721 1.146 . . . . 0.0 110.919 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.541 ' HG2' HD13 ' A' ' 19' ' ' LEU . 51.5 Cg_exo -56.84 136.47 76.65 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 123.526 2.817 . . . . 0.0 113.912 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -68.98 -40.94 78.53 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.665 2.386 . . . . 0.0 111.007 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.94 -28.92 66.71 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.06 -1.025 . . . . 0.0 113.239 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.0 ttp -64.19 -21.36 66.54 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.733 1.213 . . . . 0.0 113.609 -176.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -97.63 -29.04 13.65 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.504 1.522 . . . . 0.0 112.115 168.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.82 -40.96 13.6 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.186 -0.946 . . . . 0.0 113.238 -169.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -107.68 -97.68 0.37 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.055 1.342 . . . . 0.0 110.83 176.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 37.83 59.13 1.35 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.37 1.868 . . . . 0.0 115.584 175.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.17 16.47 0.11 Allowed Glycine 0 CA--C 1.519 0.311 0 O-C-N 120.869 -1.145 . . . . 0.0 114.236 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.1 pp -128.71 149.46 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 117.829 0.814 . . . . 0.0 109.509 -163.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.21 172.68 9.68 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.737 1.215 . . . . 0.0 110.802 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.9 tp -133.59 -19.84 2.08 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.867 0.867 . . . . 0.0 109.806 163.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -72.82 -68.59 0.47 Allowed 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.164 -0.96 . . . . 0.0 112.399 167.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.17 -51.36 0.07 OUTLIER Glycine 0 C--N 1.339 0.735 0 N-CA-C 116.985 1.554 . . . . 0.0 116.985 -168.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.519 ' H ' ' HG2' ' A' ' 25' ' ' GLU . 5.8 mpt_? -100.96 121.87 50.8 Favored Pre-proline 0 N--CA 1.462 0.151 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -177.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.2 126.91 10.15 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.256 1.97 . . . . 0.0 113.963 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.1 mm -51.01 126.95 6.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.696 1.198 . . . . 0.0 109.758 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -121.86 116.81 25.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.206 1.802 . . . . 0.0 112.753 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.424 ' CG2' HD11 ' A' ' 19' ' ' LEU . 4.4 mp -91.34 134.07 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 121.178 -0.951 . . . . 0.0 111.206 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -134.42 148.76 50.69 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 123.831 1.777 . . . . 0.0 115.396 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -166.44 133.37 2.56 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.667 2.387 . . . . 0.0 111.691 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -79.67 135.29 36.51 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 126.394 1.878 . . . . 0.0 110.999 169.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.7 p -57.48 99.59 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.313 1.845 . . . . 0.0 115.494 -167.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -68.86 -14.88 68.44 Favored Glycine 0 N--CA 1.477 1.373 0 C-N-CA 126.991 2.234 . . . . 0.0 117.269 -166.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.3 m -151.08 138.99 19.91 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 175.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.1 m -109.77 144.45 38.16 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.62 1.568 . . . . 0.0 112.288 172.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -100.5 -14.89 18.07 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 129.553 3.141 . . . . 0.0 112.159 -166.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 70.3 152.62 0.14 Allowed Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 127.522 2.329 . . . . 0.0 115.904 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -66.41 165.62 24.28 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.414 2.076 . . . . 0.0 111.442 170.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -97.94 -24.42 15.39 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -168.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 C--O 1.261 1.683 0 C-N-CA 126.55 1.94 . . . . 0.0 112.985 -171.296 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.942 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.5 m -68.97 125.83 27.88 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 117.42 0.61 . . . . 0.0 110.925 -173.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 58.37 16.91 4.38 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 119.12 3.007 . . . . 0.0 119.12 171.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -51.56 -43.43 62.39 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.461 1.105 . . . . 0.0 113.881 172.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -89.25 -4.01 58.33 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.59 172.28 12.84 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.115 0.966 . . . . 0.0 112.234 173.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -68.65 118.03 11.13 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -94.54 -9.52 35.02 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.846 1.658 . . . . 0.0 113.446 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -59.51 157.12 11.95 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.06 2.144 . . . . 0.0 111.77 -169.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -63.06 -26.67 68.95 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.75 174.41 10.65 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.818 1.647 . . . . 0.0 110.707 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.0 mt -82.67 166.98 18.68 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.391 1.076 . . . . 0.0 111.666 -175.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.01 -4.96 0.47 Allowed 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 125.885 1.674 . . . . 0.0 114.817 172.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -130.82 -5.74 4.03 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 127.422 2.289 . . . . 0.0 114.7 -169.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.57 146.72 22.57 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 119.709 -1.869 . . . . 0.0 113.276 -173.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -157.39 -23.34 0.09 Allowed 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 125.082 1.353 . . . . 0.0 114.517 174.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.87 -9.39 3.92 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 128.221 2.608 . . . . 0.0 117.121 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.7 m -107.41 150.1 27.14 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.373 2.269 . . . . 0.0 105.649 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.2 tp -92.55 140.75 29.24 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 128.363 2.665 . . . . 0.0 115.013 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -89.63 130.19 35.96 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 125.869 1.667 . . . . 0.0 110.033 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.2 t -132.4 128.61 58.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 120.756 -1.215 . . . . 0.0 107.78 173.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.59 -171.35 12.93 Favored Glycine 0 CA--C 1.543 1.794 0 CA-C-O 122.485 1.047 . . . . 0.0 111.854 171.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.6 t30 62.68 33.77 15.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.1 1.76 . . . . 0.0 112.897 -175.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -70.26 154.43 41.92 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.164 1.786 . . . . 0.0 111.145 177.192 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.409 ' HG3' ' HB2' ' A' ' 83' ' ' TYR . 0.3 OUTLIER -70.88 160.67 32.38 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 125.082 2.373 . . . . 0.0 114.059 173.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.6 p -67.85 -24.83 65.3 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 111.139 -2.755 . . . . 0.0 111.868 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -118.73 22.48 11.98 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 127.424 2.289 . . . . 0.0 115.938 174.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.741 HG23 HD23 ' A' ' 32' ' ' LEU . 8.5 p -60.71 170.77 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 116.733 2.123 . . . . 0.0 116.733 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.615 ' H ' HG22 ' A' ' 28' ' ' VAL . 10.6 p -165.88 156.59 13.21 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 128.113 2.565 . . . . 0.0 111.349 -177.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.71 -17.75 17.07 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.576 2.35 . . . . 0.0 110.546 174.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -78.48 -38.51 40.83 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.907 1.683 . . . . 0.0 112.097 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.741 HD23 HG23 ' A' ' 28' ' ' VAL . 40.9 tp -70.25 -47.81 59.69 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.004 1.322 . . . . 0.0 108.576 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.402 HD21 ' CD1' ' A' ' 24' ' ' LEU . 52.9 mt -59.04 -50.96 72.09 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.082 176.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -62.5 -41.5 98.87 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.318 1.417 . . . . 0.0 111.393 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.02 -23.69 64.11 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.357 1.244 . . . . 0.0 114.357 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.65 -39.85 35.79 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.793 1.637 . . . . 0.0 112.737 173.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -89.87 1.1 56.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.037 0.935 . . . . 0.0 111.792 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -64.8 -35.03 79.79 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.55 1.14 . . . . 0.0 113.9 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -79.21 -17.53 54.67 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.905 0.482 . . . . 0.0 110.694 167.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.69 21.59 0.65 Allowed 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.702 -1.249 . . . . 0.0 113.762 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.19 -125.62 7.47 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.23 0.919 . . . . 0.0 114.461 173.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -71.29 127.0 12.85 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 CA-C-N 118.38 1.09 . . . . 0.0 110.615 -173.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.1 t -138.35 124.82 25.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 168.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 mm -89.05 -54.68 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 125.443 1.497 . . . . 0.0 108.481 171.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.423 ' HG2' ' HB3' ' A' ' 63' ' ' ASN . 17.8 ptpt -151.7 153.37 34.24 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.918 0.887 . . . . 0.0 113.316 -173.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.8 t -117.79 152.1 19.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 126.876 2.07 . . . . 0.0 108.782 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -129.22 122.91 30.69 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 126.372 1.869 . . . . 0.0 114.465 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.5 mm -106.14 117.37 57.61 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 126.165 1.786 . . . . 0.0 110.573 168.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.5 165.07 33.04 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.704 3.603 . . . . 0.0 111.834 165.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -155.31 117.12 4.08 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 126.963 2.105 . . . . 0.0 109.297 172.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.431 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 28.8 t0 -55.22 169.53 0.26 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 128.453 2.701 . . . . 0.0 114.269 175.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.27 -40.69 25.64 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.155 -0.341 . . . . 0.0 111.826 164.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -81.97 3.64 25.71 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 126.045 1.738 . . . . 0.0 113.506 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.94 42.37 30.38 Favored Glycine 0 N--CA 1.474 1.226 0 C-N-CA 126.377 1.941 . . . . 0.0 113.607 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -129.79 138.31 32.83 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 119.241 1.521 . . . . 0.0 113.063 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.89 9.61 0.35 Allowed 'Trans proline' 0 CA--C 1.54 0.824 1 C-N-CA 126.699 4.933 . . . . 0.0 115.372 176.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HE2' ' HB2' ' A' ' 51' ' ' ASP . 0.0 OUTLIER 58.73 26.92 15.24 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 169.41 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.494 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 15.9 mt-30 59.47 24.93 13.64 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.991 1.316 . . . . 0.0 114.31 -172.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -150.9 165.91 32.2 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 119.93 -1.731 . . . . 0.0 113.408 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -169.0 177.34 4.96 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 128.214 2.606 . . . . 0.0 112.744 -172.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -131.43 158.4 40.9 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 126.154 1.781 . . . . 0.0 115.414 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.5 t -143.98 129.68 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 126.301 1.84 . . . . 0.0 111.487 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.423 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 4.4 t-20 -107.33 139.26 42.09 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.878 1.671 . . . . 0.0 114.618 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -154.98 -18.32 0.12 Allowed 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 117.74 2.496 . . . . 0.0 117.74 -172.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.2 tttp -156.0 144.84 20.38 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 121.616 2.007 . . . . 0.0 115.859 -166.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -68.17 -34.46 76.35 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 118.068 -0.968 . . . . 0.0 113.576 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -139.21 138.65 37.05 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 121.573 1.988 . . . . 0.0 107.547 164.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 36.0 t -107.25 142.11 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 125.14 1.376 . . . . 0.0 112.27 -170.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.7 p -133.65 -28.36 1.43 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 127.405 2.282 . . . . 0.0 114.989 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.442 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 1.8 p -159.03 145.58 12.6 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 123.957 0.903 . . . . 0.0 110.388 -176.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 70' ' ' VAL . 36.5 Cg_endo -105.08 114.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 124.047 3.165 . . . . 0.0 113.958 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -48.1 -41.92 27.63 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 125.205 1.402 . . . . 0.0 114.606 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.35 -20.56 63.85 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 123.855 0.862 . . . . 0.0 111.405 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.1 ttp -75.08 -22.39 58.33 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 119.12 0.873 . . . . 0.0 112.347 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -89.02 -30.58 18.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.049 0.94 . . . . 0.0 111.661 167.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tp -81.33 -51.73 8.05 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.71 -89.66 0.32 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.587 1.085 . . . . 0.0 113.348 -171.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 41.84 63.66 1.26 Allowed 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 125.251 1.421 . . . . 0.0 114.485 170.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.9 16.42 1.79 Allowed Glycine 0 CA--C 1.537 1.459 0 O-C-N 119.19 -2.194 . . . . 0.0 115.28 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.64 146.83 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.059 1.344 . . . . 0.0 112.163 -167.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.57 168.98 15.91 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -175.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.7 mt -130.17 -16.68 3.55 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 112.995 -1.911 . . . . 0.0 112.707 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.409 ' HB2' ' HG3' ' A' ' 25' ' ' GLU . 3.5 m-30 -103.03 -44.11 5.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.849 0.859 . . . . 0.0 112.111 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.28 -38.8 0.28 Allowed Glycine 0 CA--C 1.532 1.155 0 N-CA-C 115.752 1.061 . . . . 0.0 115.752 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -93.12 114.43 62.72 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 125.041 1.336 . . . . 0.0 108.99 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.8 128.9 16.65 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 124.578 3.519 . . . . 0.0 113.492 -175.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.8 mm -61.32 124.96 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.329 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -108.33 117.67 34.76 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 128.506 2.722 . . . . 0.0 110.392 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mp -93.08 140.91 15.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -129.71 174.2 9.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.084 0.954 . . . . 0.0 108.625 174.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . 0.277 51.0 t80 77.53 157.01 0.17 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 129.099 2.959 . . . . 0.0 112.347 -170.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -147.58 -68.2 0.25 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.171 2.189 . . . . 0.0 110.423 173.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.8 t -157.62 158.71 36.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.569 1.548 . . . . 0.0 110.841 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -72.8 162.67 54.78 Favored Glycine 0 CA--C 1.545 1.946 0 CA-C-N 119.736 1.153 . . . . 0.0 111.094 168.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.3 m -141.61 167.88 21.1 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 -173.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 96.7 p -64.65 163.68 13.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 128.075 2.55 . . . . 0.0 114.33 162.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -148.35 135.23 20.03 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.608 1.163 . . . . 0.0 110.099 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . 58.72 154.1 0.09 OUTLIER Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 129.599 3.16 . . . . 0.0 116.302 170.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.31 172.18 15.0 Favored 'Trans proline' 0 N--CA 1.452 -0.971 0 C-N-CA 122.428 2.085 . . . . 0.0 112.172 -171.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -66.08 -36.93 84.5 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.674 1.19 . . . . 0.0 114.085 -172.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 41.9 t0 . . . . . 0 C--O 1.257 1.487 0 C-N-CA 126.238 1.815 . . . . 0.0 111.464 -175.762 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.906 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 95.1 p -85.01 177.44 7.93 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -69.29 120.24 14.8 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 129.514 3.126 . . . . 0.0 112.16 173.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -96.08 -27.35 15.13 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 127.069 2.148 . . . . 0.0 114.065 -175.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -109.67 -8.67 14.92 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -160.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.6 mt -62.48 138.07 58.39 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 121.521 0.677 . . . . 0.0 112.612 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.01 158.41 3.9 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.156 1.783 . . . . 0.0 112.297 173.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -79.68 -41.11 27.53 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.849 2.06 . . . . 0.0 110.0 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -62.71 140.4 58.72 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.59 -1.319 . . . . 0.0 107.685 159.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -77.97 -13.91 59.71 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -176.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.71 166.13 24.77 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.594 1.157 . . . . 0.0 111.903 -168.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 pp -96.08 134.4 39.18 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.18 1.392 . . . . 0.0 109.524 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.11 9.42 36.33 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -60.34 125.56 24.14 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.2 1.4 . . . . 0.0 110.96 -177.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -122.37 156.07 34.73 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.174 1.39 . . . . 0.0 109.063 -176.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -152.1 162.89 40.42 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.2 1.0 . . . . 0.0 110.945 162.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -119.62 0.71 11.03 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.475 1.91 . . . . 0.0 112.796 171.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.42 137.72 51.06 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -154.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.9 tp -83.78 128.08 34.27 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.811 2.045 . . . . 0.0 110.266 170.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -82.44 140.92 33.14 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 176.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 t -143.46 130.34 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.743 0.817 . . . . 0.0 109.089 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.96 -172.28 13.66 Favored Glycine 0 CA--C 1.546 1.99 0 C-N-CA 125.365 1.46 . . . . 0.0 112.925 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.4 t30 66.38 24.82 10.43 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 128.447 2.699 . . . . 0.0 113.693 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.619 ' HB3' HG11 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -65.39 137.4 57.46 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.095 1.358 . . . . 0.0 111.009 -178.255 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.41 161.42 11.72 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 176.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.0 p -69.07 -12.01 61.3 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 126.565 1.946 . . . . 0.0 114.148 -168.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.23 5.28 7.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.829 2.852 . . . . 0.0 113.114 -175.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' ' 24' ' ' LEU . 8.2 p -54.06 158.26 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.97 1.308 . . . . 0.0 113.861 -175.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.4 p -155.56 169.17 24.92 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.749 2.02 . . . . 0.0 109.381 -177.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -64.83 -34.14 77.65 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.851 1.26 . . . . 0.0 108.367 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -66.02 -32.01 73.24 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.697 1.599 . . . . 0.0 114.607 175.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -72.2 -49.55 34.54 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.308 1.413 . . . . 0.0 108.552 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.483 HD21 ' CD1' ' A' ' 24' ' ' LEU . 79.8 mt -59.62 -48.73 80.51 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -60.77 -37.6 82.4 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.244 -0.91 . . . . 0.0 112.991 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -60.42 -50.63 72.83 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.763 0.825 . . . . 0.0 109.755 172.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 tt -72.83 -40.17 66.0 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.717 2.407 . . . . 0.0 113.529 -173.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -81.2 -1.78 46.09 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.077 1.351 . . . . 0.0 111.654 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -70.76 -25.78 63.06 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 121.33 1.877 . . . . 0.0 110.464 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -70.05 -29.07 66.0 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.179 1.392 . . . . 0.0 112.611 169.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.38 -20.04 24.46 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 138.22 -149.49 20.52 Favored Glycine 0 C--O 1.235 0.176 0 O-C-N 121.4 -0.813 . . . . 0.0 113.976 171.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.18 118.69 4.06 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 121.936 1.757 . . . . 0.0 110.414 -173.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.6 m -117.54 118.76 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.128 1.371 . . . . 0.0 109.514 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.1 mm -61.22 -53.49 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.717 1.607 . . . . 0.0 110.549 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.33 167.88 26.49 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 131.563 3.945 . . . . 0.0 109.25 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.5 t -116.81 163.54 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 128.368 2.667 . . . . 0.0 111.422 170.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -127.1 135.48 50.81 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.82 1.648 . . . . 0.0 113.569 164.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.1 mm -118.48 124.05 28.8 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 125.364 1.465 . . . . 0.0 108.145 167.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.67 167.33 27.45 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.926 2.417 . . . . 0.0 112.798 166.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -160.74 119.38 2.56 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 127.505 2.322 . . . . 0.0 108.58 172.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.81 173.28 0.21 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.626 1.17 . . . . 0.0 111.873 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -23.79 29.29 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 120.498 -1.376 . . . . 0.0 112.48 162.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -80.62 -2.77 47.85 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.492 1.117 . . . . 0.0 112.554 175.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.24 45.19 56.82 Favored Glycine 0 C--N 1.341 0.828 0 O-C-N 120.341 -1.475 . . . . 0.0 109.959 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.42 132.01 19.71 Favored Pre-proline 0 N--CA 1.465 0.293 0 C-N-CA 123.392 0.677 . . . . 0.0 111.828 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.45 ' HG3' HG12 ' A' ' 28' ' ' VAL . 71.8 Cg_endo -71.09 15.58 0.31 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 125.241 3.961 . . . . 0.0 116.105 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.77 24.62 2.53 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 176.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 55.85 30.94 16.75 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -171.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -144.88 161.75 38.54 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 120.222 -1.549 . . . . 0.0 112.41 -176.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.05 -177.78 5.99 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.079 2.151 . . . . 0.0 112.728 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -137.44 157.2 47.08 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.233 1.813 . . . . 0.0 113.19 171.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.2 t -128.41 140.58 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.796 1.638 . . . . 0.0 111.848 169.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -95.46 127.66 41.68 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.161 1.384 . . . . 0.0 111.111 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.527 ' CZ ' ' HA ' ' A' ' 69' ' ' SER . 5.1 p90 -105.85 165.43 11.19 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.04 2.136 . . . . 0.0 109.62 173.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -88.0 -29.44 20.74 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -173.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -75.14 171.78 13.55 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.311 1.044 . . . . 0.0 111.134 -175.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -89.76 -20.04 24.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.0 p -119.47 144.72 27.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 123.972 0.909 . . . . 0.0 109.089 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.527 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 9.7 t -52.67 137.02 31.98 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.825 1.65 . . . . 0.0 114.128 -173.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.78 76.15 37.66 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.432 1.893 . . . . 0.0 108.735 177.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -82.87 48.63 2.81 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.762 2.975 . . . . 0.0 111.7 -167.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -52.91 -42.36 65.3 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.885 1.274 . . . . 0.0 110.336 -178.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.74 -27.67 65.15 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 175.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.8 tmm? -66.3 -26.82 67.49 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.302 1.441 . . . . 0.0 108.862 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -98.35 -30.66 12.45 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -79.69 -34.29 40.35 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.736 1.214 . . . . 0.0 114.211 -174.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.3 -82.11 0.6 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.94 1.296 . . . . 0.0 111.082 -175.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 19.99 70.52 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 127.97 2.508 . . . . 0.0 114.314 -176.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.79 9.78 0.28 Allowed Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 pp -135.86 158.24 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 119.306 1.553 . . . . 0.0 113.558 -164.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.44 172.8 8.02 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -172.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.4 tp -140.19 22.95 2.4 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.958 2.103 . . . . 0.0 112.812 -175.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -149.47 -49.66 0.14 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.621 1.968 . . . . 0.0 110.174 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.0 -48.89 0.16 Allowed Glycine 0 CA--C 1.541 1.658 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -95.52 124.25 53.7 Favored Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 120.743 2.271 . . . . 0.0 110.837 -175.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.28 126.6 11.84 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 124.146 3.231 . . . . 0.0 113.129 -170.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.6 mm -57.54 122.91 7.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.776 0.798 . . . . 0.0 109.442 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.404 ' HE3' ' NE2' ' A' ' 90' ' ' GLN . 54.0 tptt -109.02 115.75 30.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.15 1.78 . . . . 0.0 108.812 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 mp -92.58 144.58 9.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.668 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.404 ' NE2' ' HE3' ' A' ' 88' ' ' LYS . 7.3 mm-40 -138.17 151.9 48.17 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.534 1.534 . . . . 0.0 111.966 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -104.17 153.29 21.13 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 126.75 2.02 . . . . 0.0 114.61 -171.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -99.35 -2.75 35.55 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.559 2.344 . . . . 0.0 115.085 -166.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.3 p -91.22 139.27 30.9 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -168.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 90.97 168.15 41.79 Favored Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.997 1.159 . . . . 0.0 115.997 176.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 87.5 p -86.32 154.31 21.32 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.22 1.808 . . . . 0.0 115.834 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.6 m -127.32 -41.61 1.73 Allowed 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 173.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -133.22 148.56 52.02 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 121.772 2.078 . . . . 0.0 108.999 -171.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -150.22 153.04 34.58 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.61 145.51 14.66 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.13 3.22 . . . . 0.0 110.715 167.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -61.85 -36.1 80.22 Favored 'General case' 0 CA--C 1.554 1.117 0 O-C-N 121.047 -1.033 . . . . 0.0 111.678 173.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.9 t70 . . . . . 0 N--CA 1.49 1.556 0 C-N-CA 128.545 2.738 . . . . 0.0 112.86 173.036 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.684 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.7 p -167.37 48.77 0.06 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.252 1.421 . . . . 0.0 111.151 170.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -104.91 136.77 43.79 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.318 -1.489 . . . . 0.0 113.236 -175.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -142.26 -39.53 0.36 Allowed 'General case' 0 CA--C 1.562 1.44 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -168.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -112.44 60.86 0.63 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 129.155 2.982 . . . . 0.0 111.321 -174.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.2 -8.66 12.94 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.745 2.418 . . . . 0.0 114.793 -175.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? 46.09 37.49 3.91 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 128.515 2.726 . . . . 0.0 116.77 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -56.34 -46.69 79.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.743 1.617 . . . . 0.0 112.245 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -150.0 169.62 20.78 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.387 1.875 . . . . 0.0 109.436 168.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -66.19 -42.95 88.15 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.873 -1.142 . . . . 0.0 113.348 174.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.56 -162.72 1.57 Allowed 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 127.671 2.388 . . . . 0.0 110.822 -170.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 73.2 mt -102.15 4.5 39.58 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 119.661 -1.899 . . . . 0.0 114.899 -174.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 46.16 2.32 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 121.088 3.736 . . . . 0.0 121.088 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -148.34 172.05 15.02 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 130.179 3.392 . . . . 0.0 108.822 -172.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.42 136.32 3.22 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.106 0.962 . . . . 0.0 111.214 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -150.28 139.83 21.55 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 172.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.3 mtm105 -68.59 -12.67 61.62 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 120.453 1.479 . . . . 0.0 114.728 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.0 m -98.47 130.33 45.07 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 123.595 1.664 . . . . 0.0 111.56 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.5 tp -107.23 132.32 53.21 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 127.576 2.35 . . . . 0.0 109.956 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -86.62 137.02 32.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 123.442 1.592 . . . . 0.0 112.163 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.2 t -132.62 122.66 47.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.334 -175.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.91 -173.42 14.43 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.495 1.521 . . . . 0.0 112.293 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 t30 61.82 23.92 14.15 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.913 1.685 . . . . 0.0 113.637 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.656 HD12 HG21 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -66.58 140.94 57.98 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 125.5 1.52 . . . . 0.0 109.258 -177.212 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.24 165.61 1.93 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 123.088 1.423 . . . . 0.0 113.805 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.4 p -67.25 -26.39 66.55 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.158 -0.964 . . . . 0.0 112.844 -172.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -116.97 7.02 13.06 Favored 'General case' 0 N--CA 1.474 0.765 1 C-N-CA 132.547 4.339 . . . . 0.0 111.31 -168.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.656 HG21 HD12 ' A' ' 24' ' ' LEU . 7.5 p -53.6 156.39 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.908 1.683 . . . . 0.0 112.606 -177.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.2 p -151.13 158.68 44.32 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.508 1.523 . . . . 0.0 110.082 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -59.15 -30.22 67.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.18 0.992 . . . . 0.0 109.59 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -66.07 -42.12 89.85 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.225 0.92 . . . . 0.0 112.823 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.435 HD23 HG23 ' A' ' 28' ' ' VAL . 49.8 tp -66.18 -45.28 81.43 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.579 0.627 . . . . 0.0 109.315 178.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.64 HD21 ' CD1' ' A' ' 24' ' ' LEU . 91.8 mt -58.25 -49.53 76.77 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.43 1.492 . . . . 0.0 112.833 174.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -60.32 -42.57 95.88 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.85 -1.156 . . . . 0.0 111.654 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -65.87 -34.52 78.34 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.969 1.259 . . . . 0.0 111.614 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.448 ' CD2' HD13 ' A' ' 77' ' ' LEU . 8.0 tt -70.86 -50.03 39.69 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.701 1.6 . . . . 0.0 111.966 177.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -83.09 -15.46 50.75 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -170.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -51.4 -33.07 28.56 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 168.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -74.74 -18.25 60.52 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.185 0.994 . . . . 0.0 110.896 175.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.56 11.88 27.17 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.644 1.578 . . . . 0.0 113.328 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.57 -164.11 13.47 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 127.541 2.496 . . . . 0.0 115.51 167.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.74 101.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 123.484 2.789 . . . . 0.0 113.112 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.4 t -98.29 115.79 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.6 mm -69.21 -54.3 20.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 123.005 0.522 . . . . 0.0 111.077 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -163.08 157.79 21.17 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.952 2.101 . . . . 0.0 110.789 -172.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.2 t -117.35 152.63 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 128.699 2.8 . . . . 0.0 111.267 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -127.16 126.72 43.36 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 126.948 2.099 . . . . 0.0 112.384 170.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.4 mm -106.64 117.08 57.78 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.997 2.119 . . . . 0.0 108.948 165.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.0 163.16 34.97 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.866 2.377 . . . . 0.0 110.434 165.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -155.27 112.34 3.29 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.26 2.224 . . . . 0.0 110.767 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.72 175.76 0.08 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.746 2.418 . . . . 0.0 113.192 175.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -52.95 -26.33 14.77 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.742 1.217 . . . . 0.0 114.148 173.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -93.9 -9.81 35.94 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.79 61.13 1.11 Allowed Glycine 0 N--CA 1.47 0.9 0 C-N-CA 125.896 1.712 . . . . 0.0 114.331 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -144.54 132.88 10.85 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 118.65 1.225 . . . . 0.0 113.555 -172.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.471 ' HG3' HG12 ' A' ' 28' ' ' VAL . 72.9 Cg_endo -69.38 8.48 0.68 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.397 3.398 . . . . 0.0 115.78 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.76 18.32 3.69 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 120.417 -1.427 . . . . 0.0 114.438 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 63.21 31.17 15.73 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -169.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.518 ' HA ' HD23 ' A' ' 24' ' ' LEU . 1.5 p90 -146.56 167.99 22.35 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.077 1.751 . . . . 0.0 111.484 176.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -163.68 172.15 14.64 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 128.807 2.843 . . . . 0.0 111.217 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -124.9 149.45 47.56 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.34 -1.475 . . . . 0.0 110.879 176.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.5 t -132.08 136.86 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.038 1.335 . . . . 0.0 109.601 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -108.78 138.36 45.23 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.088 1.755 . . . . 0.0 108.508 -175.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -122.47 140.55 52.6 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.901 1.68 . . . . 0.0 112.707 -177.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -55.33 144.25 25.72 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.848 -1.158 . . . . 0.0 111.892 171.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -56.94 -31.29 64.82 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.902 2.081 . . . . 0.0 113.437 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -75.09 -19.23 60.05 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.294 -1.504 . . . . 0.0 113.948 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.4 m -116.78 27.45 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 127.905 2.482 . . . . 0.0 113.03 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 t -75.68 78.66 2.65 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.45 149.15 53.39 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 112.514 -2.13 . . . . 0.0 110.223 165.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -73.91 52.49 2.61 Favored 'Trans proline' 0 CA--C 1.557 1.641 0 C-N-CA 123.134 2.556 . . . . 0.0 114.901 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -48.16 -46.16 34.32 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.841 1.657 . . . . 0.0 114.635 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.79 -24.37 61.7 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.461 -1.4 . . . . 0.0 113.509 -176.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.0 ttp -68.94 -28.18 66.41 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.079 1.352 . . . . 0.0 110.865 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -82.84 -41.0 19.57 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.995 0.918 . . . . 0.0 110.438 171.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.3 tp -83.62 -36.63 23.72 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -161.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.448 HD13 ' CD2' ' A' ' 36' ' ' LEU . 22.8 mt -113.79 -86.02 0.59 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.31 1.444 . . . . 0.0 109.08 -169.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . 0.264 0.2 OUTLIER 26.82 59.48 0.08 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.907 2.883 . . . . 0.0 113.419 172.429 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.36 11.99 0.14 Allowed Glycine 0 CA--C 1.538 1.501 0 CA-C-O 118.556 -1.136 . . . . 0.0 115.42 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -134.55 154.35 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 119.745 1.772 . . . . 0.0 112.399 -168.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.23 178.35 2.45 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.496 1.918 . . . . 0.0 112.675 -172.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -140.15 -22.32 0.85 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.901 2.48 . . . . 0.0 112.461 170.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -83.26 -49.12 9.73 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.211 1.404 . . . . 0.0 110.262 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 170.81 -50.57 0.19 Allowed Glycine 0 CA--C 1.535 1.324 0 N-CA-C 115.987 1.155 . . . . 0.0 115.987 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -102.63 117.56 60.57 Favored Pre-proline 0 N--CA 1.479 1.022 0 CA-C-N 119.424 1.612 . . . . 0.0 109.587 -172.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.03 128.93 20.66 Favored 'Trans proline' 0 C--N 1.347 0.474 1 C-N-CA 125.366 4.044 . . . . 0.0 113.375 -175.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.0 mm -61.65 125.27 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.556 1.142 . . . . 0.0 108.976 -176.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -110.64 105.02 13.78 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 124.724 1.21 . . . . 0.0 107.947 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.3 mp -80.41 145.06 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -137.46 163.06 32.01 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 128.356 2.662 . . . . 0.0 108.966 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -120.85 129.99 53.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.884 0.85 . . . . 0.0 109.642 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -146.08 161.06 40.99 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.691 1.596 . . . . 0.0 108.667 175.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.5 t -125.52 163.25 23.11 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.566 1.946 . . . . 0.0 114.784 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 162.87 126.07 0.8 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.998 1.285 . . . . 0.0 111.375 168.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.1 m -150.17 143.0 24.74 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.796 2.038 . . . . 0.0 108.505 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.0 m -168.08 140.2 2.98 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.389 1.475 . . . . 0.0 113.164 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -158.86 117.69 2.99 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 128.081 2.552 . . . . 0.0 110.887 167.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -97.56 154.92 37.77 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.952 2.101 . . . . 0.0 108.407 168.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -68.62 152.6 74.52 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 CA-C-N 120.569 1.239 . . . . 0.0 109.309 167.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -101.88 -38.11 7.96 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--O 1.259 1.592 0 C-N-CA 125.799 1.64 . . . . 0.0 114.215 177.324 . . . . . . . . 0 0 . 1 stop_ save_